data_2rq4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rq4 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.587 0 CA-C-O 121.29 0.567 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.35 -6.53 81.71 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.66 1.6 . . . . 0.0 113.168 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 4.2 t -82.63 157.29 23.47 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.455 1.128 . . . . 0.0 113.421 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -128.54 13.87 6.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.994 1.318 . . . . 0.0 112.26 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -70.62 176.08 4.41 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.377 -0.827 . . . . 0.0 110.195 167.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.48 157.46 39.87 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.263 -0.898 . . . . 0.0 112.355 168.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.82 -157.39 22.72 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.339 1.447 . . . . 0.0 113.235 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.92 160.61 43.31 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.197 2.598 . . . . 0.0 111.488 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.04 124.33 20.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.103 0.561 . . . . 0.0 110.983 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.58 -8.74 60.27 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.024 1.297 . . . . 0.0 113.68 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.85 22.1 7.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.168 1.387 . . . . 0.0 112.646 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.7 118.6 25.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.413 1.485 . . . . 0.0 110.084 -167.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 27.9 mt -125.33 141.95 51.78 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.106 1.763 . . . . 0.0 112.659 -168.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -114.54 134.06 55.32 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.382 1.473 . . . . 0.0 109.283 168.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.56 134.71 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.318 1.847 . . . . 0.0 107.884 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -133.08 158.62 42.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.743 1.217 . . . . 0.0 112.87 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 73.2 26.86 2.05 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.984 2.513 . . . . 0.0 113.528 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.45 149.6 97.9 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.599 1.16 . . . . 0.0 111.373 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -58.32 149.87 70.78 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.247 2.631 . . . . 0.0 112.454 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -69.23 -9.72 54.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.63 -11.32 23.73 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.969 1.708 . . . . 0.0 114.168 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.07 126.34 30.31 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.261 1.024 . . . . 0.0 111.549 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -108.3 -171.65 21.47 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.545 1.545 . . . . 0.0 112.096 169.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.73 -32.56 74.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.047 0.939 . . . . 0.0 113.145 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -78.5 -30.38 47.18 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.993 0.917 . . . . 0.0 112.079 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -70.55 -40.78 73.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.71 0.686 . . . . 0.0 110.632 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 28.6 tp -65.63 -37.66 87.22 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.382 0.673 . . . . 0.0 111.838 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 65.1 tp -62.52 -51.71 66.33 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.702 0.683 . . . . 0.0 111.253 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -63.92 -30.78 71.84 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.1 0.56 . . . . 0.0 112.423 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.0 ttm -68.57 -29.45 67.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.345 1.058 . . . . 0.0 113.11 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -106.36 -13.23 15.43 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 29.7 mtt -49.66 -37.36 23.26 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -61.78 -17.73 56.65 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.127 2.552 . . . . 0.0 116.015 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -99.67 -7.82 25.18 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.49 -163.73 28.46 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.326 1.441 . . . . 0.0 114.44 171.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -72.52 97.78 2.17 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.054 0.942 . . . . 0.0 111.853 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.6 t -74.55 126.93 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.56 1.144 . . . . 0.0 109.815 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 39.9 t -91.06 -36.47 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.437 1.895 . . . . 0.0 111.032 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 53.6 m -149.81 147.77 28.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.737 1.215 . . . . 0.0 110.92 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.14 136.48 20.11 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.237 1.815 . . . . 0.0 109.013 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -153.74 138.32 16.88 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.556 -0.715 . . . . 0.0 111.656 -168.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.58 128.36 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.214 1.406 . . . . 0.0 107.976 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 123.607 0.763 . . . . 0.0 110.85 -177.059 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 35.3 m 64.97 20.1 12.02 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.996 2.118 . . . . 0.0 112.973 -171.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -147.35 156.07 42.57 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.143 0.977 . . . . 0.0 112.033 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.52 -177.55 27.99 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 126.008 1.766 . . . . 0.0 113.605 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -135.18 146.68 48.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.521 1.928 . . . . 0.0 110.133 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.9 t -143.22 144.86 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.309 1.443 . . . . 0.0 108.719 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 8.1 t -143.65 146.85 33.55 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.455 -0.778 . . . . 0.0 112.37 173.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -115.87 165.42 13.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.138 1.775 . . . . 0.0 113.128 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.0 -18.43 64.72 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.371 1.069 . . . . 0.0 113.281 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -145.27 149.59 41.91 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.122 1.369 . . . . 0.0 112.16 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.29 -28.08 55.47 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.757 2.971 . . . . 0.0 113.774 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.36 -38.67 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.879 0.872 . . . . 0.0 110.896 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 9.9 m -62.68 -34.63 77.52 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.966 0.906 . . . . 0.0 111.707 171.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.71 -48.14 41.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.54 1.136 . . . . 0.0 111.964 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -60.67 -34.32 74.15 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 112.16 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.0 -30.01 70.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.431 0.693 . . . . 0.0 112.696 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.73 -41.49 53.22 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.349 0.66 . . . . 0.0 111.491 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.9 -48.07 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.896 0.771 . . . . 0.0 110.12 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.58 -14.23 62.41 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -102.76 -29.07 11.71 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 92.2 mmm -114.54 -19.14 11.27 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -169.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -70.81 111.28 6.12 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.277 0.944 . . . . 0.0 109.951 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 97.46 1.36 59.14 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.682 1.61 . . . . 0.0 114.841 -172.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -64.62 120.36 12.24 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.676 1.738 . . . . 0.0 111.173 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -76.78 131.93 38.97 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.976 0.417 . . . . 0.0 110.452 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.1 tt . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 124.492 1.117 . . . . 0.0 109.018 179.127 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.81 150.54 47.7 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.169 1.388 . . . . 0.0 111.591 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -121.22 141.99 50.33 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.64 1.176 . . . . 0.0 108.777 168.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.26 133.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.364 1.066 . . . . 0.0 108.82 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -142.53 157.69 44.47 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.563 1.145 . . . . 0.0 111.075 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.47 156.98 30.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.821 0.819 . . . . 0.0 112.132 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 CA--C 1.545 0.754 0 C-N-CA 124.54 1.136 . . . . 0.0 112.189 171.855 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.477 0 CA-C-O 120.828 0.347 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.29 84.64 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.373 0.987 . . . . 0.0 113.347 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.3 t -85.47 173.82 9.96 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.002 0.901 . . . . 0.0 111.411 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -139.7 28.53 2.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.392 1.477 . . . . 0.0 110.846 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -66.98 164.16 18.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.982 0.913 . . . . 0.0 112.684 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.7 154.66 37.82 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.73 -160.38 26.77 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.101 1.81 . . . . 0.0 113.473 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.08 171.74 15.29 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.907 3.071 . . . . 0.0 112.576 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.45 122.34 13.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.069 0.948 . . . . 0.0 111.337 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.63 -4.33 75.91 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.844 1.212 . . . . 0.0 114.587 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.66 1.56 53.63 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.069 1.434 . . . . 0.0 114.39 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -116.98 125.17 50.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.899 1.28 . . . . 0.0 111.162 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.3 mt -124.22 140.29 53.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.528 1.931 . . . . 0.0 112.403 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -110.8 133.38 53.4 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.506 1.522 . . . . 0.0 108.52 167.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.5 mm -117.05 139.23 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.98 1.712 . . . . 0.0 108.71 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -140.65 160.89 39.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.335 1.054 . . . . 0.0 113.131 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 66.52 26.81 9.86 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.832 2.453 . . . . 0.0 114.037 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 68.4 mt -66.14 155.9 86.15 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.595 1.158 . . . . 0.0 112.219 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -59.95 148.76 87.54 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.291 2.661 . . . . 0.0 111.953 171.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.71 -19.17 65.7 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -91.93 -10.04 40.93 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.033 1.333 . . . . 0.0 114.556 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.1 134.36 51.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.272 1.029 . . . . 0.0 112.495 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.62 -176.78 19.76 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.402 1.477 . . . . 0.0 112.213 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -62.25 -32.49 73.2 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -78.13 -29.57 48.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.967 0.907 . . . . 0.0 112.268 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -70.45 -40.33 73.79 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.741 0.7 . . . . 0.0 110.692 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.37 -36.71 79.6 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.953 0.501 . . . . 0.0 111.745 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -62.27 -49.7 74.65 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.917 0.78 . . . . 0.0 110.947 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -67.96 -22.97 65.01 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.7 ttm -73.96 -27.82 61.18 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.024 0.93 . . . . 0.0 113.108 171.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -112.58 -16.37 12.85 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -171.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.7 mtm -53.92 -33.92 18.0 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -59.15 -16.17 32.13 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.492 2.794 . . . . 0.0 116.325 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -99.85 -10.22 22.0 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.42 -159.66 28.08 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 124.657 1.122 . . . . 0.0 114.909 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.34 92.83 1.85 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.201 1.0 . . . . 0.0 112.201 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.5 t -72.1 128.12 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.951 1.3 . . . . 0.0 110.018 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.93 -31.9 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.126 2.17 . . . . 0.0 111.494 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.9 t -157.64 151.12 23.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.458 1.103 . . . . 0.0 110.916 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.06 132.15 14.36 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.246 1.418 . . . . 0.0 110.19 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -153.68 132.44 12.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.43 0.692 . . . . 0.0 112.005 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 64.0 t -103.25 135.03 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.653 1.581 . . . . 0.0 107.27 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.352 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 58.3 m 74.27 18.99 2.95 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.575 2.75 . . . . 0.0 113.206 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.15 156.77 43.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.991 0.814 . . . . 0.0 112.382 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.93 -175.16 28.54 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.85 1.69 . . . . 0.0 113.708 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -141.57 144.25 34.15 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.542 1.937 . . . . 0.0 110.111 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.1 t -144.33 140.67 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.203 1.401 . . . . 0.0 108.765 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 88.3 p -135.8 153.1 51.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.648 0.779 . . . . 0.0 112.36 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -126.6 164.89 20.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.213 1.405 . . . . 0.0 113.078 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.98 -10.88 59.78 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.488 1.115 . . . . 0.0 113.007 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.74 145.51 28.3 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.062 1.345 . . . . 0.0 111.744 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.69 -29.78 69.38 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.464 2.776 . . . . 0.0 113.718 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.14 -41.57 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.815 0.846 . . . . 0.0 111.382 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.4 p -66.83 -31.13 71.54 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.605 0.762 . . . . 0.0 112.377 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -68.9 -49.8 55.02 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.769 0.828 . . . . 0.0 111.849 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -58.93 -39.37 81.38 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.582 -0.699 . . . . 0.0 111.941 175.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.44 -28.82 65.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 174.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.65 -43.66 30.67 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.652 0.66 . . . . 0.0 112.036 171.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.1 mt -58.12 -49.96 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 119.479 1.036 . . . . 0.0 110.408 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -73.79 -11.71 60.47 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.5 m -100.1 -30.65 11.83 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.5 mmm -111.66 -19.77 12.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -169.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.71 111.54 5.56 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.286 0.948 . . . . 0.0 109.903 173.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.01 3.31 65.76 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.404 1.478 . . . . 0.0 115.104 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -63.86 124.28 21.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.438 1.619 . . . . 0.0 111.258 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -81.04 131.3 35.3 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.263 0.554 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.2 tt . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 125.247 1.419 . . . . 0.0 108.447 -178.179 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 120.691 0.281 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.2 mt -68.12 160.5 28.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.276 1.43 . . . . 0.0 111.787 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -133.14 143.4 49.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.246 1.418 . . . . 0.0 109.67 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 30.1 t -138.44 136.02 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.648 1.179 . . . . 0.0 109.172 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -140.71 154.9 46.53 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.451 1.101 . . . . 0.0 111.173 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.15 155.64 38.24 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 122.317 1.056 . . . . 0.0 111.802 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 CA--C 1.546 0.822 0 C-N-CA 123.709 0.804 . . . . 0.0 111.162 169.868 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.27 0.557 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.81 -6.79 82.73 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.517 1.532 . . . . 0.0 113.272 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 6.8 t -84.03 158.0 21.62 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.676 1.238 . . . . 0.0 112.64 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -128.78 14.39 6.41 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.041 1.336 . . . . 0.0 112.34 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -68.13 177.16 2.35 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.394 -0.816 . . . . 0.0 110.349 167.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -154.74 157.66 38.36 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.235 -0.916 . . . . 0.0 112.079 168.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.59 -158.42 24.17 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.176 1.37 . . . . 0.0 113.314 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.31 160.73 43.85 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.216 2.611 . . . . 0.0 111.439 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.87 123.4 18.39 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.828 -0.545 . . . . 0.0 110.928 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.96 -9.07 58.0 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.013 1.292 . . . . 0.0 113.752 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.17 20.19 10.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.169 1.387 . . . . 0.0 112.728 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 120.38 30.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.434 1.493 . . . . 0.0 110.052 -167.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.92 139.77 53.52 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.239 1.815 . . . . 0.0 112.372 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -112.14 133.37 54.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.213 1.405 . . . . 0.0 108.993 167.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -118.46 136.08 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.19 1.796 . . . . 0.0 107.748 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -133.55 160.77 36.48 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.185 1.394 . . . . 0.0 112.404 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 67.49 30.34 6.82 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.266 2.226 . . . . 0.0 113.478 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.38 155.65 90.34 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.889 0.876 . . . . 0.0 111.257 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.68 151.91 52.27 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.291 2.661 . . . . 0.0 111.981 169.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -70.48 -15.28 62.79 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.329 1.052 . . . . 0.0 113.517 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -102.89 -4.75 24.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.482 1.913 . . . . 0.0 114.29 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.29 134.51 52.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.925 1.29 . . . . 0.0 112.105 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -111.27 -179.14 20.25 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.105 1.336 . . . . 0.0 113.147 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -66.99 -31.84 72.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.455 0.702 . . . . 0.0 112.838 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -73.18 -35.89 66.47 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.353 1.061 . . . . 0.0 112.003 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -64.95 -41.69 95.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.909 0.484 . . . . 0.0 110.857 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -69.44 -42.2 75.27 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.973 -0.537 . . . . 0.0 112.035 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.1 tp -58.64 -54.81 42.91 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.742 0.701 . . . . 0.0 111.501 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -75.58 -15.53 60.35 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -170.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.4 ttp -80.71 -20.76 42.14 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.125 0.97 . . . . 0.0 112.738 169.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -105.71 -15.33 14.99 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.553 1.541 . . . . 0.0 114.013 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 37.1 mtt -47.89 -37.37 13.46 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 168.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -62.07 -16.9 53.21 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.976 2.451 . . . . 0.0 115.696 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -99.37 -8.34 24.95 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.94 0.896 . . . . 0.0 113.327 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 148.48 -167.28 29.14 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.324 1.44 . . . . 0.0 114.447 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -75.06 97.42 3.41 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.615 1.166 . . . . 0.0 112.792 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.25 132.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.558 1.543 . . . . 0.0 110.263 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.66 -35.41 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 127.07 2.148 . . . . 0.0 111.39 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 24.0 m -150.77 147.41 27.27 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.19 1.396 . . . . 0.0 110.896 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.26 134.19 14.88 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.846 1.658 . . . . 0.0 109.187 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -154.27 136.61 14.92 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.727 -0.608 . . . . 0.0 111.805 -168.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 84.1 t -112.62 132.08 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.238 1.415 . . . . 0.0 107.926 169.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 64.0 mttm . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 23.3 m 75.06 19.3 2.35 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.166 2.586 . . . . 0.0 113.074 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -149.21 158.48 44.22 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.618 0.767 . . . . 0.0 112.051 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.55 -177.67 31.85 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.696 1.617 . . . . 0.0 113.599 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -137.42 145.77 43.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.392 1.877 . . . . 0.0 110.021 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 94.9 t -143.41 143.91 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.204 1.402 . . . . 0.0 108.532 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 8.1 t -143.77 145.61 32.51 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.394 -0.816 . . . . 0.0 112.146 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -114.74 167.5 10.71 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.41 1.884 . . . . 0.0 112.225 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.63 -16.89 63.46 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -144.86 149.51 43.06 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.967 1.307 . . . . 0.0 112.168 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.91 -27.88 58.58 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.721 2.947 . . . . 0.0 113.66 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.46 -40.27 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.884 0.873 . . . . 0.0 110.927 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 15.3 m -62.73 -33.49 75.25 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.687 0.795 . . . . 0.0 111.833 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.14 -47.34 36.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.731 1.212 . . . . 0.0 112.083 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -61.17 -34.83 75.68 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.125 0.97 . . . . 0.0 112.041 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.39 70.4 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.476 0.711 . . . . 0.0 112.803 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.06 47.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.26 0.624 . . . . 0.0 111.163 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.05 -46.85 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 119.335 0.97 . . . . 0.0 110.304 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -69.85 -14.6 62.83 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.0 m -104.21 -26.48 12.5 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.7 mmm -115.08 -19.28 10.94 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -71.02 110.5 5.75 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.321 0.964 . . . . 0.0 110.186 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.73 2.34 65.11 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.766 1.65 . . . . 0.0 114.857 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -61.16 123.97 19.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.453 1.626 . . . . 0.0 111.669 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -78.37 131.3 36.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.128 0.489 . . . . 0.0 110.412 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.1 tt . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 125.043 1.337 . . . . 0.0 108.852 -178.354 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 111.587 0.218 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.74 161.59 29.49 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.118 1.367 . . . . 0.0 112.588 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -130.97 141.55 50.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.596 1.558 . . . . 0.0 108.781 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.02 138.46 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.392 1.077 . . . . 0.0 109.43 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -147.5 151.13 35.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.548 1.139 . . . . 0.0 110.791 -174.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.33 157.54 25.88 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.914 0.864 . . . . 0.0 111.787 168.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 CA--C 1.548 0.873 0 C-N-CA 124.523 1.129 . . . . 0.0 113.26 170.32 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 120.841 0.353 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 87.44 -5.2 85.44 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.922 1.249 . . . . 0.0 113.375 -176.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 40.4 m -78.21 158.52 28.96 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.902 1.281 . . . . 0.0 111.371 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -131.7 27.79 4.62 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.441 1.096 . . . . 0.0 112.086 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -71.95 171.03 12.55 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.386 -0.822 . . . . 0.0 110.47 167.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.09 156.23 35.48 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 169.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -87.43 -158.44 32.72 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.898 1.713 . . . . 0.0 114.172 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.7 165.84 26.25 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.544 2.829 . . . . 0.0 111.625 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.95 125.72 24.76 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.597 -0.689 . . . . 0.0 111.274 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.5 -6.64 68.15 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.75 1.167 . . . . 0.0 113.689 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.81 18.41 14.55 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.211 1.404 . . . . 0.0 112.824 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.25 119.95 27.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.519 1.527 . . . . 0.0 109.779 -168.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 33.5 mt -124.86 133.9 52.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.122 1.769 . . . . 0.0 112.087 -168.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -105.11 134.25 48.52 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.964 1.306 . . . . 0.0 108.673 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 9.4 mm -118.24 137.72 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.897 1.679 . . . . 0.0 108.526 -169.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -137.06 161.68 35.42 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.487 1.115 . . . . 0.0 112.492 -175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 62.57 34.39 15.15 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.259 1.824 . . . . 0.0 113.14 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.23 158.46 86.61 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.218 1.407 . . . . 0.0 111.818 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.85 142.6 99.15 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.82 2.347 . . . . 0.0 111.26 169.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -68.44 -9.18 46.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.519 1.127 . . . . 0.0 113.644 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -98.53 -10.79 22.98 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.826 1.65 . . . . 0.0 113.922 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.54 132.31 40.64 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.937 1.295 . . . . 0.0 112.132 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.69 -172.62 18.72 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.282 1.42 . . . . 0.0 113.274 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -67.64 -34.43 76.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.953 0.901 . . . . 0.0 113.219 -172.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -77.81 -30.89 51.41 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.542 0.737 . . . . 0.0 111.756 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -67.01 -43.5 82.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.16 0.584 . . . . 0.0 110.396 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 26.5 tp -65.48 -43.27 90.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.291 0.637 . . . . 0.0 111.636 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.53 -54.1 50.72 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.599 0.76 . . . . 0.0 111.259 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -73.95 -20.72 60.27 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.8 ttp -76.59 -22.61 54.0 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.031 0.832 . . . . 0.0 113.016 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -102.77 -16.3 16.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.077 1.351 . . . . 0.0 113.754 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 36.6 mtt -47.63 -38.03 15.23 Favored Pre-proline 0 CA--C 1.552 1.035 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -62.26 -17.73 58.63 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.158 2.572 . . . . 0.0 115.54 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -97.7 -9.94 25.85 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.0 0.92 . . . . 0.0 113.325 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.38 -164.17 28.39 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.371 1.462 . . . . 0.0 114.518 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.69 100.63 2.87 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.972 0.909 . . . . 0.0 111.874 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.3 t -76.73 127.09 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.876 1.27 . . . . 0.0 109.874 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 43.0 t -86.86 -35.51 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.502 1.921 . . . . 0.0 111.246 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.8 m -161.79 151.21 16.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.736 1.614 . . . . 0.0 110.636 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.91 132.97 12.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.07 1.748 . . . . 0.0 109.977 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -154.22 148.32 25.78 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.49 130.14 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 126.699 2.0 . . . . 0.0 107.685 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 111.511 -175.38 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 83.0 m 62.87 22.03 13.18 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.652 1.981 . . . . 0.0 113.364 -172.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -141.76 155.48 45.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.116 0.966 . . . . 0.0 111.67 172.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.27 -172.33 24.35 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.831 1.681 . . . . 0.0 113.912 -169.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -143.75 147.36 34.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.945 1.698 . . . . 0.0 110.257 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 59.7 t -144.0 145.65 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.765 1.626 . . . . 0.0 108.976 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.2 t -143.14 151.81 41.1 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.216 -0.927 . . . . 0.0 112.55 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -120.94 164.64 16.39 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.015 1.726 . . . . 0.0 113.247 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.11 -18.67 64.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.347 1.059 . . . . 0.0 113.143 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -145.28 150.21 44.02 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.118 1.367 . . . . 0.0 112.222 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.71 -29.22 60.0 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.797 2.998 . . . . 0.0 113.845 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.58 -38.4 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.779 0.832 . . . . 0.0 110.852 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.3 m -62.54 -35.19 78.65 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.003 0.921 . . . . 0.0 111.695 171.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.42 -47.83 46.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.571 1.148 . . . . 0.0 112.007 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -60.28 -35.46 75.6 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.03 0.932 . . . . 0.0 112.113 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.03 71.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.566 0.746 . . . . 0.0 112.685 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.92 56.01 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.298 0.639 . . . . 0.0 111.196 174.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.48 -46.62 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 119.434 1.015 . . . . 0.0 110.362 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -69.6 -15.82 63.28 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.1 m -104.54 -23.12 13.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.5 mmt -113.37 -22.89 10.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.898 1.279 . . . . 0.0 113.626 -171.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -71.41 113.44 8.45 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.974 1.261 . . . . 0.0 110.698 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.68 4.13 83.03 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.554 1.55 . . . . 0.0 114.626 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -63.34 126.47 27.56 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.904 1.352 . . . . 0.0 111.171 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -85.04 130.93 34.53 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.115 0.566 . . . . 0.0 110.866 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.6 tt . . . . . 0 CA--C 1.536 0.413 0 C-N-CA 125.425 1.49 . . . . 0.0 109.799 -170.292 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.4 mt -68.72 163.35 24.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.405 1.482 . . . . 0.0 112.618 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -139.57 142.33 37.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.417 1.487 . . . . 0.0 108.83 168.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.46 139.79 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.314 1.046 . . . . 0.0 109.452 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -144.86 148.13 33.61 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.316 1.046 . . . . 0.0 110.931 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.24 155.33 28.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.962 0.887 . . . . 0.0 112.256 168.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.6 tttt . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 124.358 1.063 . . . . 0.0 111.058 168.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 121.156 0.503 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.25 -3.37 85.51 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.195 1.855 . . . . 0.0 113.889 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 38.8 t -74.69 156.03 37.1 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.667 1.187 . . . . 0.0 112.498 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -118.43 10.34 12.66 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.016 1.326 . . . . 0.0 112.519 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -64.95 165.43 10.89 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.268 -0.895 . . . . 0.0 112.273 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.66 163.83 36.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.205 1.002 . . . . 0.0 112.433 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -102.42 -161.51 26.17 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 126.102 1.81 . . . . 0.0 113.685 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.73 178.98 6.45 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.055 3.17 . . . . 0.0 112.791 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -54.68 123.88 14.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.796 1.238 . . . . 0.0 111.696 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.33 -5.06 85.72 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.692 1.139 . . . . 0.0 114.694 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.22 -3.38 53.87 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.808 1.304 . . . . 0.0 114.439 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -114.49 124.68 52.51 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.51 1.124 . . . . 0.0 111.263 -168.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.8 mt -124.68 141.85 51.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.625 1.97 . . . . 0.0 112.69 -168.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -112.18 134.58 53.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.588 1.555 . . . . 0.0 109.035 168.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.31 136.24 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.932 1.693 . . . . 0.0 108.249 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -134.23 159.9 39.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.879 1.272 . . . . 0.0 112.865 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 70.45 27.72 3.86 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.945 2.498 . . . . 0.0 113.898 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.89 155.45 86.64 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.828 1.251 . . . . 0.0 112.054 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.48 150.3 69.29 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.019 2.48 . . . . 0.0 111.557 168.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -69.83 -11.82 61.16 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.447 1.099 . . . . 0.0 113.709 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.08 -7.61 16.82 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.895 2.078 . . . . 0.0 113.799 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.47 116.68 14.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.09 1.356 . . . . 0.0 110.429 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -99.28 -175.7 31.55 Favored Glycine 0 N--CA 1.467 0.757 0 C-N-CA 124.19 0.9 . . . . 0.0 113.743 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.14 -35.45 78.8 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.477 1.111 . . . . 0.0 112.631 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -77.52 -31.05 53.21 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.081 0.953 . . . . 0.0 111.981 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -70.82 -41.6 71.36 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.791 0.723 . . . . 0.0 110.715 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.5 tp -64.61 -42.28 95.65 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.217 0.607 . . . . 0.0 111.144 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.88 -51.01 71.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.325 0.65 . . . . 0.0 111.229 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -71.24 -20.07 62.28 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.5 ttp -82.92 -21.63 34.11 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.043 0.838 . . . . 0.0 113.044 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -106.17 -23.23 12.64 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.1 mtm -54.3 -33.02 13.24 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 170.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -58.09 -18.22 35.33 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.627 2.885 . . . . 0.0 115.787 174.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -94.82 -12.16 27.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.231 0.923 . . . . 0.0 113.41 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.8 -157.78 27.47 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.926 1.251 . . . . 0.0 115.027 170.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -74.06 84.23 1.79 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.261 1.024 . . . . 0.0 112.757 -169.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 84.8 t -66.79 127.87 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.872 1.269 . . . . 0.0 109.707 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 55.6 t -91.46 -35.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.011 1.724 . . . . 0.0 110.978 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 27.5 m -158.73 147.36 18.54 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.528 1.531 . . . . 0.0 110.854 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.46 140.28 20.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.828 1.651 . . . . 0.0 110.439 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -154.41 149.22 26.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.635 0.774 . . . . 0.0 112.887 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.89 137.19 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.428 1.891 . . . . 0.0 108.535 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 123.845 0.858 . . . . 0.0 110.692 -178.855 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 50.6 m 71.33 18.28 5.65 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.602 2.361 . . . . 0.0 113.935 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -145.15 154.79 42.82 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.504 1.047 . . . . 0.0 112.357 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.01 -172.34 25.98 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.948 1.737 . . . . 0.0 113.608 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -148.77 141.59 24.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.986 1.714 . . . . 0.0 109.95 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 61.3 t -146.22 136.32 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.908 1.283 . . . . 0.0 109.31 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 68.3 m -134.23 140.43 46.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.618 0.767 . . . . 0.0 112.293 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -110.08 168.85 9.13 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.804 1.642 . . . . 0.0 113.145 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.51 -21.15 66.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.401 1.481 . . . . 0.0 113.295 169.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -160.94 157.42 22.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.24 1.416 . . . . 0.0 112.378 -171.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.9 -16.09 40.88 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.7 2.267 . . . . 0.0 113.936 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.82 -44.19 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 120.459 1.481 . . . . 0.0 110.459 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.8 m -69.21 -30.91 69.18 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.967 0.907 . . . . 0.0 112.114 174.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -75.03 -47.13 30.57 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.851 0.86 . . . . 0.0 112.327 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -62.69 -32.57 73.68 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.469 -0.769 . . . . 0.0 111.806 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.59 70.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.14 -43.35 34.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.27 0.628 . . . . 0.0 111.174 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.03 -45.71 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.07 0.85 . . . . 0.0 110.351 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -70.76 -14.87 62.59 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.4 m -104.33 -22.94 13.27 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 2.1 mmt -114.15 -24.18 9.11 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 113.768 -170.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -71.69 112.48 7.83 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.687 1.13 . . . . 0.0 110.348 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.73 3.01 74.74 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.473 1.511 . . . . 0.0 114.683 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -64.41 127.68 32.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.11 1.455 . . . . 0.0 111.291 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -85.96 129.6 34.79 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.048 0.539 . . . . 0.0 110.951 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.6 tt . . . . . 0 CA--C 1.537 0.449 0 C-N-CA 125.545 1.538 . . . . 0.0 110.108 -173.356 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 120.701 0.286 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.39 162.04 30.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.287 1.435 . . . . 0.0 112.521 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -130.91 139.17 50.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.232 1.413 . . . . 0.0 109.079 168.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 32.0 t -139.3 134.42 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.393 1.077 . . . . 0.0 109.259 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -146.71 159.35 43.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.023 0.929 . . . . 0.0 112.24 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 62.0 mt -66.38 152.71 44.49 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.095 0.958 . . . . 0.0 112.866 173.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 124.033 0.933 . . . . 0.0 110.614 168.47 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 120.878 0.371 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 87.14 0.02 85.54 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.269 1.414 . . . . 0.0 113.563 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.4 t -98.43 170.51 8.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.303 1.052 . . . . 0.0 111.898 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -132.42 32.35 3.94 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.179 1.392 . . . . 0.0 111.28 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -67.74 164.75 18.74 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.498 -0.751 . . . . 0.0 110.329 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -155.99 161.61 40.45 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.53 -159.32 24.89 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.055 1.788 . . . . 0.0 113.61 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.94 171.99 15.51 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.956 3.104 . . . . 0.0 112.85 -172.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.68 123.46 16.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.019 0.928 . . . . 0.0 111.381 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.62 -3.78 78.79 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.798 1.189 . . . . 0.0 114.584 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.72 1.41 53.4 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.908 1.354 . . . . 0.0 114.355 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -118.27 124.31 47.53 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.494 1.118 . . . . 0.0 110.884 -169.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 18.9 mt -123.62 146.78 47.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.796 2.038 . . . . 0.0 113.052 -168.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -117.43 135.09 54.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.718 1.607 . . . . 0.0 109.099 168.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -119.84 137.36 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.181 1.792 . . . . 0.0 107.831 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -134.99 161.3 35.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.128 1.371 . . . . 0.0 112.584 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 67.46 27.41 8.01 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.433 2.293 . . . . 0.0 113.92 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 67.7 mt -64.92 157.77 73.88 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.014 1.325 . . . . 0.0 112.06 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.53 147.48 91.42 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.992 2.461 . . . . 0.0 111.434 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -69.73 -8.29 46.69 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.43 -8.09 15.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.511 1.924 . . . . 0.0 114.166 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.47 124.27 23.09 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.8 1.24 . . . . 0.0 110.805 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.25 -176.27 26.39 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.481 1.039 . . . . 0.0 114.065 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.35 -36.36 82.69 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.83 0.852 . . . . 0.0 112.782 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.59 -28.36 56.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.83 0.852 . . . . 0.0 111.769 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.1 -42.11 73.13 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.655 0.661 . . . . 0.0 110.646 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.8 tp -67.03 -36.41 82.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.184 0.594 . . . . 0.0 111.797 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.11 -51.68 66.91 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.686 0.675 . . . . 0.0 110.931 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -63.51 -28.43 69.94 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.0 ttm -72.62 -29.18 63.26 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.453 1.101 . . . . 0.0 113.159 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -109.51 -18.34 13.54 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 47.3 mtm -55.4 -32.24 12.02 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -58.09 -16.33 26.7 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.661 2.908 . . . . 0.0 116.291 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -100.34 -8.35 23.46 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.48 -163.44 28.48 Favored Glycine 0 N--CA 1.47 0.906 0 C-N-CA 125.173 1.368 . . . . 0.0 114.513 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -72.4 90.58 1.3 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.749 0.82 . . . . 0.0 112.026 -173.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 79.9 t -65.42 128.92 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.714 1.206 . . . . 0.0 109.843 172.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 37.5 t -91.62 -36.61 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.94 2.096 . . . . 0.0 110.913 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.85 152.8 25.4 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.618 1.167 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -155.35 133.39 11.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.505 1.122 . . . . 0.0 110.705 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -154.45 147.99 25.19 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.398 -0.814 . . . . 0.0 112.925 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.8 t -124.68 131.4 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 126.214 1.806 . . . . 0.0 107.899 172.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 CA--C 1.538 0.508 0 C-N-CA 123.504 0.722 . . . . 0.0 110.962 -175.824 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.549 0.92 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 58.4 m 68.17 17.62 9.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.514 2.326 . . . . 0.0 113.582 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -144.46 154.77 43.28 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.585 1.084 . . . . 0.0 112.758 175.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.74 -177.64 31.03 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.982 1.754 . . . . 0.0 114.087 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -134.61 145.96 49.12 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.704 2.002 . . . . 0.0 110.193 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 92.5 t -144.78 138.75 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.826 1.25 . . . . 0.0 109.236 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 64.7 p -130.47 152.24 50.08 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.211 1.004 . . . . 0.0 112.074 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -125.77 163.82 22.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.344 1.457 . . . . 0.0 113.106 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -71.33 -18.46 62.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.031 0.932 . . . . 0.0 113.048 173.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -144.6 150.77 48.37 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.078 1.351 . . . . 0.0 112.197 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.76 -29.69 59.36 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.856 3.037 . . . . 0.0 113.722 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.08 -40.25 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.811 0.844 . . . . 0.0 110.963 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 8.8 m -61.95 -34.24 75.76 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.971 0.908 . . . . 0.0 111.817 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.79 -49.27 26.16 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.88 1.272 . . . . 0.0 112.029 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -60.93 -33.91 73.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.961 0.904 . . . . 0.0 112.15 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 -30.56 71.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.412 0.685 . . . . 0.0 112.611 172.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.3 -41.54 48.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.294 0.638 . . . . 0.0 111.451 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 45.5 mt -57.88 -47.47 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.014 0.824 . . . . 0.0 110.129 174.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.08 -14.69 62.4 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.8 m -101.94 -28.47 12.37 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 91.7 mmm -114.44 -19.13 11.32 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -169.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -70.33 110.28 5.19 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.289 0.949 . . . . 0.0 109.933 173.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.37 2.91 60.18 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.369 1.462 . . . . 0.0 114.933 -172.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.17 123.47 18.71 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.427 1.613 . . . . 0.0 111.587 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -79.0 130.53 35.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.222 0.609 . . . . 0.0 110.988 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 125.11 1.364 . . . . 0.0 110.43 -178.339 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 66.9 mt -70.71 160.72 32.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.032 1.333 . . . . 0.0 111.75 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -132.3 141.9 49.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.226 1.41 . . . . 0.0 109.194 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.5 t -139.42 136.14 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.505 1.122 . . . . 0.0 109.062 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -145.73 165.22 29.42 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.018 1.327 . . . . 0.0 111.044 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.48 159.88 26.23 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.861 0.864 . . . . 0.0 111.859 169.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.0 tttt . . . . . 0 CA--C 1.547 0.856 0 C-N-CA 125.411 1.484 . . . . 0.0 112.324 171.491 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 120.984 0.421 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.26 -2.4 71.22 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.456 1.027 . . . . 0.0 113.375 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.0 t -77.35 165.75 24.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.156 0.978 . . . . 0.0 112.093 174.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -134.09 23.19 3.84 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.017 1.327 . . . . 0.0 110.791 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -65.75 174.73 2.2 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.903 1.281 . . . . 0.0 111.751 168.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -156.26 161.53 40.23 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.791 0.836 . . . . 0.0 112.432 168.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.35 -163.19 29.47 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.965 1.745 . . . . 0.0 113.376 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.99 172.79 13.95 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.754 2.97 . . . . 0.0 112.43 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.51 128.39 36.95 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.495 0.664 . . . . 0.0 111.342 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.6 -10.2 75.24 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.796 1.189 . . . . 0.0 113.962 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.9 -5.73 47.24 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.639 1.22 . . . . 0.0 114.218 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -112.08 123.95 51.36 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.317 1.047 . . . . 0.0 110.55 -169.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.9 mt -124.07 143.26 50.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.675 1.99 . . . . 0.0 112.549 -168.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -112.92 134.26 54.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.417 1.487 . . . . 0.0 109.073 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.01 134.17 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.346 1.858 . . . . 0.0 107.737 -171.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -132.65 158.5 42.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.878 1.271 . . . . 0.0 112.694 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 71.69 27.33 2.93 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.604 2.362 . . . . 0.0 113.747 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 76.8 mt -65.13 161.11 51.56 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.986 1.315 . . . . 0.0 111.803 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.62 149.19 91.94 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.921 2.414 . . . . 0.0 110.845 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -67.7 -20.47 65.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -88.94 -11.18 45.16 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.53 129.1 38.83 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.504 1.122 . . . . 0.0 111.886 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.12 -173.95 23.48 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.296 1.427 . . . . 0.0 112.273 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.02 -33.48 73.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.757 0.823 . . . . 0.0 112.493 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -67.84 -44.98 75.92 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.099 1.76 . . . . 0.0 111.472 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.89 -40.92 95.84 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.974 0.91 . . . . 0.0 111.528 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 30.4 tp -67.13 -38.94 86.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.267 0.627 . . . . 0.0 111.891 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 66.1 tp -63.11 -48.7 77.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.87 0.759 . . . . 0.0 111.077 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -67.88 -23.2 65.09 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.8 ttm -74.91 -25.91 59.25 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.112 0.965 . . . . 0.0 113.148 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -113.63 -16.67 12.31 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.4 mtm -54.16 -33.82 17.99 Favored Pre-proline 0 CA--C 1.549 0.914 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -58.99 -16.3 31.83 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.476 2.784 . . . . 0.0 116.296 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.12 -11.38 20.54 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 149.01 -163.06 29.07 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.931 1.253 . . . . 0.0 114.823 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -71.55 102.1 2.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.118 0.967 . . . . 0.0 112.385 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 69.7 t -80.44 128.69 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.071 1.348 . . . . 0.0 110.083 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.12 -22.44 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.956 2.502 . . . . 0.0 112.087 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 8.8 t -159.7 146.05 16.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.266 1.427 . . . . 0.0 110.341 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.58 129.39 10.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.196 1.399 . . . . 0.0 110.687 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -156.0 132.03 9.93 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.584 0.754 . . . . 0.0 112.557 -174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.9 135.14 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.486 1.514 . . . . 0.0 107.299 167.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 123.275 0.63 . . . . 0.0 111.295 -178.095 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 57.9 mttm . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.1 m 66.87 21.62 10.37 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.067 2.147 . . . . 0.0 113.207 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -146.52 156.17 43.06 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.129 0.972 . . . . 0.0 111.687 172.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.58 -177.71 29.09 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.868 1.699 . . . . 0.0 113.767 -170.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -138.58 141.16 39.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.015 2.126 . . . . 0.0 109.901 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 94.9 t -144.03 137.31 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.076 1.35 . . . . 0.0 108.867 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.0 m -131.03 148.43 52.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.474 0.71 . . . . 0.0 112.068 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -117.57 170.24 8.91 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.405 1.482 . . . . 0.0 113.287 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.52 -25.02 67.01 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.381 1.472 . . . . 0.0 113.648 170.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -160.12 162.2 24.57 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.096 1.358 . . . . 0.0 112.109 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.98 -13.52 31.65 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.332 2.021 . . . . 0.0 114.03 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 22.8 t -75.4 -45.92 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 121.032 1.742 . . . . 0.0 110.892 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.5 p -69.73 -32.52 71.11 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.811 0.844 . . . . 0.0 112.631 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -67.14 -49.0 66.37 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.365 0.666 . . . . 0.0 112.435 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -63.2 -31.71 72.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.376 -0.828 . . . . 0.0 112.056 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.79 70.47 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.7 0.682 . . . . 0.0 112.595 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.79 -42.0 51.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.717 0.689 . . . . 0.0 111.411 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.27 -47.22 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 118.914 0.779 . . . . 0.0 110.199 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -70.36 -15.45 62.86 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.0 m -99.78 -29.38 12.66 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 88.4 mmm -113.97 -19.93 11.24 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -71.68 110.6 6.34 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.441 1.019 . . . . 0.0 109.987 174.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 90.92 8.64 64.85 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.393 1.473 . . . . 0.0 114.433 -171.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.76 122.64 17.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.764 1.782 . . . . 0.0 110.568 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -74.36 131.88 41.51 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 122.063 -0.398 . . . . 0.0 110.292 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 124.556 1.143 . . . . 0.0 108.579 173.906 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.691 0.282 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.18 155.96 40.13 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.854 1.262 . . . . 0.0 111.502 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.38 140.7 52.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.857 1.263 . . . . 0.0 109.46 169.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 23.4 t -139.61 136.27 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.541 1.136 . . . . 0.0 109.245 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -150.77 162.04 41.49 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.08 0.952 . . . . 0.0 112.097 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 75.4 mt -64.5 157.16 27.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.599 1.16 . . . . 0.0 113.071 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 CA--C 1.548 0.866 0 C-N-CA 124.537 1.135 . . . . 0.0 113.152 169.708 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.6 -6.36 83.7 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.584 1.087 . . . . 0.0 113.281 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 7.6 t -86.92 160.21 18.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.461 1.131 . . . . 0.0 111.117 172.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -135.83 22.93 3.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.399 1.08 . . . . 0.0 112.477 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -68.81 173.96 4.8 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.314 -0.866 . . . . 0.0 111.676 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -148.88 158.44 44.17 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.756 0.822 . . . . 0.0 112.196 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.55 -160.95 27.99 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.994 1.759 . . . . 0.0 113.451 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.08 176.03 9.67 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.94 3.094 . . . . 0.0 112.576 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -56.32 124.67 18.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.266 1.026 . . . . 0.0 111.501 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.04 -7.64 81.27 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.811 1.196 . . . . 0.0 114.556 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.72 -5.21 54.04 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.919 1.359 . . . . 0.0 114.364 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -112.68 122.53 47.95 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.576 1.15 . . . . 0.0 110.676 -168.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.1 mt -123.32 141.65 51.77 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.562 1.945 . . . . 0.0 112.535 -168.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -111.09 134.83 52.39 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.574 1.549 . . . . 0.0 108.729 167.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.5 133.51 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.93 1.692 . . . . 0.0 107.791 -171.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -129.58 160.64 32.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.858 1.263 . . . . 0.0 112.22 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 65.8 38.37 5.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.07 1.748 . . . . 0.0 113.193 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 54.1 mt -71.59 161.45 78.45 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.104 1.362 . . . . 0.0 111.696 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.6 154.59 47.45 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.233 2.622 . . . . 0.0 111.469 168.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -68.12 -28.19 67.12 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.58 -11.19 57.66 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.83 128.25 35.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.405 1.082 . . . . 0.0 112.494 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.78 -171.55 18.29 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.796 1.665 . . . . 0.0 112.362 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -62.15 -35.51 79.02 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.838 0.855 . . . . 0.0 113.195 -174.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -74.16 -29.29 61.71 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.161 0.985 . . . . 0.0 112.089 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -76.12 -42.13 47.99 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.815 0.846 . . . . 0.0 110.695 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 32.8 tp -63.69 -38.01 89.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.359 0.664 . . . . 0.0 111.572 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.8 tp -63.69 -49.6 72.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.613 0.642 . . . . 0.0 111.116 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -68.81 -20.1 64.31 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.0 ttm -74.56 -26.85 60.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.945 0.898 . . . . 0.0 112.852 169.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -111.61 -19.44 12.51 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -172.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.3 mtm -53.72 -34.39 20.08 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -59.18 -17.31 38.25 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.505 2.803 . . . . 0.0 116.097 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.68 -10.79 21.52 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.32 -160.12 28.11 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.713 1.149 . . . . 0.0 115.033 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -74.06 96.07 2.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.15 0.98 . . . . 0.0 112.18 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.7 t -77.19 127.29 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.104 1.362 . . . . 0.0 109.677 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.53 -34.23 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.682 1.993 . . . . 0.0 111.319 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.8 m -160.07 147.37 16.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.533 1.533 . . . . 0.0 110.786 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.04 134.23 16.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.596 1.559 . . . . 0.0 110.129 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -153.64 132.65 12.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.48 0.712 . . . . 0.0 111.887 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 91.8 t -101.42 131.13 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.634 1.574 . . . . 0.0 107.169 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.19 0.519 . . . . 0.0 111.178 -177.318 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 78.5 m 65.66 22.99 11.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.271 2.229 . . . . 0.0 113.735 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -143.69 156.02 44.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.236 1.014 . . . . 0.0 111.455 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.64 -174.15 26.02 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.889 1.709 . . . . 0.0 114.006 -169.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -144.96 140.99 28.61 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.757 2.023 . . . . 0.0 109.837 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 89.0 t -145.5 135.97 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.222 1.409 . . . . 0.0 109.072 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 65.8 m -132.44 141.79 48.98 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.37 0.668 . . . . 0.0 112.378 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -111.0 169.49 8.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.598 1.559 . . . . 0.0 113.56 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.06 -23.5 65.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.941 1.696 . . . . 0.0 113.59 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -161.27 160.89 24.01 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.323 1.449 . . . . 0.0 112.05 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.85 -12.38 26.26 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.652 2.234 . . . . 0.0 114.272 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 40.6 t -77.37 -46.33 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.665 1.575 . . . . 0.0 110.494 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 21.6 m -64.78 -29.75 70.74 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.671 1.189 . . . . 0.0 111.896 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.12 -50.34 19.88 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.032 0.933 . . . . 0.0 111.934 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -59.68 -37.8 79.8 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.476 -0.765 . . . . 0.0 111.735 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.34 -28.09 64.75 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -80.44 -43.97 20.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.65 0.78 . . . . 0.0 111.898 172.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.31 -50.18 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.138 0.881 . . . . 0.0 110.523 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -74.78 -11.58 60.19 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 66.1 m -99.2 -31.4 11.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 89.7 mmm -112.35 -18.04 12.58 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -168.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -68.47 110.83 4.35 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.559 1.072 . . . . 0.0 110.489 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.71 3.8 66.03 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.959 1.743 . . . . 0.0 115.038 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.41 128.36 35.46 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.409 1.605 . . . . 0.0 111.721 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -84.77 130.37 34.69 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.227 0.611 . . . . 0.0 111.3 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.3 tt . . . . . 0 N--CA 1.468 0.446 0 C-N-CA 125.212 1.405 . . . . 0.0 110.145 -173.745 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 62.0 mt -66.45 160.44 24.94 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.34 1.456 . . . . 0.0 112.196 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -136.78 139.64 41.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.162 1.385 . . . . 0.0 108.925 167.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.2 t -139.33 135.69 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.497 1.119 . . . . 0.0 109.066 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -153.72 153.68 32.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.701 0.8 . . . . 0.0 111.394 -176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 82.3 mt -61.78 154.89 24.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.562 1.145 . . . . 0.0 113.206 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.8 tttt . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 124.251 1.021 . . . . 0.0 111.122 169.753 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.8 -9.3 76.91 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.588 1.089 . . . . 0.0 113.093 -175.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 74.2 m -81.49 149.56 28.67 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.435 1.094 . . . . 0.0 110.62 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -132.85 29.53 4.12 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.211 1.004 . . . . 0.0 111.83 -170.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -71.68 176.29 4.96 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.471 -0.768 . . . . 0.0 110.907 168.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.81 157.53 42.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 168.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.92 -163.26 27.82 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 127.79 2.614 . . . . 0.0 113.775 -170.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.15 173.13 13.45 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.024 3.15 . . . . 0.0 112.759 -173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.54 124.28 18.48 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.059 0.943 . . . . 0.0 111.108 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.45 -10.48 69.13 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.783 1.182 . . . . 0.0 114.497 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.77 -0.76 47.59 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -111.57 118.14 34.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.837 1.255 . . . . 0.0 110.938 -169.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.3 mt -121.48 135.37 55.04 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.855 1.662 . . . . 0.0 112.016 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -106.16 133.29 51.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.936 1.294 . . . . 0.0 108.725 167.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.6 mm -118.08 138.39 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.092 1.757 . . . . 0.0 108.788 -169.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -140.34 161.94 36.48 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.626 1.171 . . . . 0.0 113.029 -172.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 63.83 25.96 14.2 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.474 2.31 . . . . 0.0 113.926 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.33 156.06 82.88 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.477 1.111 . . . . 0.0 111.115 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.27 145.8 91.72 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.791 2.327 . . . . 0.0 111.76 171.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -67.43 -17.43 64.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.908 0.883 . . . . 0.0 113.161 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -99.71 -8.83 23.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.829 1.252 . . . . 0.0 114.033 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.58 125.4 26.41 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.448 1.499 . . . . 0.0 111.205 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -102.68 -177.67 27.04 Favored Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.344 0.973 . . . . 0.0 113.745 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -61.76 -36.12 80.09 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.122 0.969 . . . . 0.0 112.673 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -76.44 -30.69 57.48 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.82 0.848 . . . . 0.0 111.786 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -70.73 -41.19 72.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.614 0.643 . . . . 0.0 110.685 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 28.1 tp -64.86 -38.73 91.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.559 0.744 . . . . 0.0 111.674 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.26 -50.16 71.25 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.573 0.624 . . . . 0.0 111.095 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -63.39 -27.11 69.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.3 ttm -73.31 -29.41 62.68 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.433 1.093 . . . . 0.0 113.229 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -110.22 -18.15 13.36 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 44.7 mtm -55.54 -33.05 14.71 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 171.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.75 -16.06 23.64 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.57 2.846 . . . . 0.0 116.157 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -100.73 -9.78 21.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.32 -162.11 28.39 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.988 1.28 . . . . 0.0 115.127 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -71.88 92.58 1.26 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.753 1.221 . . . . 0.0 112.38 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.23 128.38 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.816 1.246 . . . . 0.0 109.722 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 44.8 t -92.6 -34.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.909 2.084 . . . . 0.0 111.478 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.3 m -159.53 145.54 16.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 110.377 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.9 134.59 17.62 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.949 1.699 . . . . 0.0 110.208 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -154.92 136.83 14.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.63 0.772 . . . . 0.0 111.588 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.06 135.29 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.969 1.708 . . . . 0.0 107.873 169.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 123.085 0.554 . . . . 0.0 110.994 -179.078 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 30.8 m 69.79 18.52 7.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.515 2.326 . . . . 0.0 113.406 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -145.91 156.09 43.3 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.094 0.958 . . . . 0.0 112.091 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.52 -175.29 28.28 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 126.099 1.809 . . . . 0.0 113.546 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -139.71 144.84 37.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.244 1.818 . . . . 0.0 110.262 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 81.2 t -142.84 139.82 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.514 1.526 . . . . 0.0 108.708 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 34.3 t -136.74 144.99 44.12 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.631 0.772 . . . . 0.0 112.277 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -116.44 166.02 12.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.869 1.667 . . . . 0.0 113.431 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.51 -19.3 63.73 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.663 1.185 . . . . 0.0 113.204 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -147.74 159.69 40.23 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 126.23 1.812 . . . . 0.0 110.843 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 -18.67 8.19 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.297 1.998 . . . . 0.0 113.816 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 70.7 t -72.67 -43.57 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 119.812 1.187 . . . . 0.0 111.0 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.6 p -65.8 -31.74 72.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.775 0.83 . . . . 0.0 112.427 172.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -69.51 -50.47 44.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.85 0.86 . . . . 0.0 112.327 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.89 -29.97 70.0 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.266 -0.896 . . . . 0.0 112.097 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.05 -31.25 71.64 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.606 0.639 . . . . 0.0 112.485 169.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.08 63.94 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.838 0.745 . . . . 0.0 111.834 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 30.0 mt -57.55 -49.06 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.116 0.871 . . . . 0.0 110.047 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -70.97 -15.05 62.56 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 53.1 m -99.35 -30.42 12.23 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.5 mmm -112.79 -20.69 11.53 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -69.99 112.71 6.58 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.413 1.006 . . . . 0.0 109.786 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.25 2.54 68.28 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.392 1.472 . . . . 0.0 115.268 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -65.24 123.3 19.19 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.628 1.714 . . . . 0.0 111.169 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -81.18 131.12 35.28 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.878 -0.514 . . . . 0.0 111.233 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.8 tt . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 122.772 1.272 . . . . 0.0 109.468 -178.815 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.755 0.312 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 72.2 mt -63.84 159.48 19.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.331 1.453 . . . . 0.0 111.473 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -135.42 139.35 44.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.352 1.461 . . . . 0.0 109.715 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 29.2 t -139.24 136.9 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.324 1.049 . . . . 0.0 109.688 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -143.07 155.74 44.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.389 1.075 . . . . 0.0 111.488 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.29 156.8 33.32 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.851 0.86 . . . . 0.0 112.216 169.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.091 0.956 . . . . 0.0 113.119 172.506 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 120.931 0.396 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 95.22 -3.21 66.33 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.434 1.016 . . . . 0.0 113.33 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 3.2 m -70.13 154.15 42.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.598 1.199 . . . . 0.0 110.927 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -127.81 26.37 5.87 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.643 1.177 . . . . 0.0 110.078 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -73.26 179.93 3.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.383 1.473 . . . . 0.0 110.662 168.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.83 167.08 31.55 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.587 -0.695 . . . . 0.0 112.873 168.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.24 -163.82 28.57 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 126.133 1.825 . . . . 0.0 113.892 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.35 174.61 11.83 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.019 3.146 . . . . 0.0 112.693 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -57.46 125.75 24.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.179 0.992 . . . . 0.0 111.286 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.03 71.49 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.864 1.221 . . . . 0.0 114.301 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.64 -0.54 42.8 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -113.67 123.65 50.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.422 1.089 . . . . 0.0 110.645 -169.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.9 mt -122.52 142.93 50.07 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.815 2.046 . . . . 0.0 112.861 -168.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -111.61 135.21 52.5 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.78 1.632 . . . . 0.0 108.595 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.6 mm -119.56 138.22 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.993 1.717 . . . . 0.0 108.369 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -138.8 162.27 35.18 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.597 0.759 . . . . 0.0 112.867 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 64.57 26.34 13.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.34 2.256 . . . . 0.0 113.87 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 72.1 mt -65.56 159.46 67.61 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.023 1.329 . . . . 0.0 111.823 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.71 149.38 77.39 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.065 2.51 . . . . 0.0 111.929 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -71.64 -8.4 53.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.77 1.228 . . . . 0.0 113.922 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -113.56 -6.01 13.41 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.271 2.228 . . . . 0.0 113.865 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 125.72 27.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.153 1.381 . . . . 0.0 110.869 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.67 -177.75 25.9 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.443 1.02 . . . . 0.0 113.745 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -62.4 -36.07 81.18 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.892 0.877 . . . . 0.0 112.66 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.22 -31.23 58.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.992 0.917 . . . . 0.0 111.95 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.495 0.589 . . . . 0.0 110.762 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.19 -37.06 83.02 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.286 0.635 . . . . 0.0 111.694 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -62.75 -50.17 72.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.838 0.745 . . . . 0.0 111.062 172.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -63.19 -28.08 69.8 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.427 0.691 . . . . 0.0 112.767 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.9 ttm -73.31 -28.76 62.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.478 1.111 . . . . 0.0 113.241 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -110.54 -17.47 13.42 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.0 mtm -55.29 -32.49 12.69 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -57.99 -15.48 22.61 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.66 2.907 . . . . 0.0 116.372 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -101.59 -7.94 22.3 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.07 -160.74 28.09 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.895 1.236 . . . . 0.0 114.718 171.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -72.52 95.79 1.85 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.257 1.023 . . . . 0.0 112.144 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.5 t -77.38 127.73 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.061 1.344 . . . . 0.0 109.814 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.14 -26.02 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.378 2.271 . . . . 0.0 111.788 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.6 t -154.27 144.37 21.96 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.678 1.191 . . . . 0.0 110.339 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.26 126.39 5.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.935 1.694 . . . . 0.0 110.246 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 28.9 tptt -154.83 138.01 15.66 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.427 -0.796 . . . . 0.0 111.813 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.36 135.09 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.779 1.632 . . . . 0.0 108.167 169.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 123.453 0.701 . . . . 0.0 111.086 -178.419 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.8 m 67.53 18.78 10.0 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.209 2.204 . . . . 0.0 113.439 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -144.35 155.34 43.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.205 0.911 . . . . 0.0 112.124 173.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.35 -176.04 28.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.945 1.736 . . . . 0.0 113.653 -170.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -141.47 142.43 33.63 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.437 1.895 . . . . 0.0 110.077 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.8 t -143.89 141.55 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.205 1.402 . . . . 0.0 108.88 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 75.5 m -137.48 144.25 42.16 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.431 -0.793 . . . . 0.0 112.296 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -112.93 166.1 11.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.313 1.445 . . . . 0.0 113.131 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.0 -19.5 62.51 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.423 1.089 . . . . 0.0 113.078 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -148.34 153.39 40.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.589 1.556 . . . . 0.0 111.476 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.5 -17.66 11.23 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.071 2.514 . . . . 0.0 114.027 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.1 t -72.37 -40.57 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.175 0.898 . . . . 0.0 110.395 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.3 m -62.97 -32.82 74.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.866 0.866 . . . . 0.0 111.719 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.79 -49.44 25.31 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.593 1.157 . . . . 0.0 112.017 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -59.14 -38.75 80.42 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.528 -0.733 . . . . 0.0 111.964 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.01 -28.41 64.4 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -80.14 -44.47 19.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 111.899 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 43.4 mt -57.94 -49.3 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.537 1.062 . . . . 0.0 110.372 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 -74.42 -11.52 60.26 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.4 m -101.1 -29.86 11.91 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.46 -18.64 12.81 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -169.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.01 109.24 3.87 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.925 0.784 . . . . 0.0 109.737 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.72 9.98 60.68 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.392 1.472 . . . . 0.0 114.966 -171.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -64.86 124.48 22.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.051 1.926 . . . . 0.0 111.145 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -79.25 131.05 36.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.095 0.558 . . . . 0.0 110.887 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.4 tt . . . . . 0 N--CA 1.472 0.64 0 C-N-CA 124.809 1.244 . . . . 0.0 110.556 -179.086 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 . . . . . 0 N--CA 1.474 0.725 0 CA-C-O 120.577 0.227 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 56.6 mt -70.99 162.88 28.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.176 1.39 . . . . 0.0 111.933 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -133.9 147.33 51.1 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.309 1.444 . . . . 0.0 109.327 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 29.6 t -139.21 137.81 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.647 1.179 . . . . 0.0 109.386 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -141.75 160.54 39.96 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.458 1.103 . . . . 0.0 111.191 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 69.9 mt -69.31 157.95 35.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.653 0.74 . . . . 0.0 111.18 168.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 124.539 1.136 . . . . 0.0 112.334 172.516 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.319 0.58 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.61 -7.47 77.42 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.75 1.643 . . . . 0.0 113.254 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.4 t -85.08 172.37 11.31 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.376 1.088 . . . . 0.0 112.186 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.07 31.98 2.93 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.101 1.361 . . . . 0.0 111.065 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -68.74 165.75 18.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.065 0.946 . . . . 0.0 112.528 169.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.63 156.77 45.11 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.25 -169.23 29.27 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 126.156 1.836 . . . . 0.0 113.246 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.14 175.28 7.79 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.086 3.19 . . . . 0.0 112.676 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.85 121.96 11.75 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.094 0.957 . . . . 0.0 111.44 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.88 -1.73 78.56 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.862 1.22 . . . . 0.0 114.659 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.41 6.76 46.98 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.957 1.378 . . . . 0.0 114.372 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -118.36 122.12 42.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.293 1.437 . . . . 0.0 111.08 -171.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.7 140.76 52.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.439 1.896 . . . . 0.0 112.343 -169.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -110.99 133.09 53.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.889 1.676 . . . . 0.0 108.801 168.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.29 135.1 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.946 1.698 . . . . 0.0 107.884 -171.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -132.98 156.78 46.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.933 1.293 . . . . 0.0 112.585 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 74.55 27.9 1.31 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.732 2.413 . . . . 0.0 113.849 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.2 mt -64.96 157.29 76.76 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.103 1.361 . . . . 0.0 112.057 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.81 152.56 34.86 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.388 2.725 . . . . 0.0 112.126 169.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -67.21 -29.33 68.96 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.9 -9.79 56.35 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.01 129.2 39.2 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.9 1.28 . . . . 0.0 111.793 -175.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -113.74 -174.28 18.73 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.312 1.434 . . . . 0.0 113.314 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.25 -34.7 78.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.077 0.951 . . . . 0.0 112.991 -174.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -76.77 -31.56 57.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.893 0.877 . . . . 0.0 111.782 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -67.66 -41.59 83.53 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.705 0.684 . . . . 0.0 110.649 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 23.3 tp -65.59 -41.09 93.23 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.334 0.654 . . . . 0.0 111.562 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.26 -51.69 67.86 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.661 0.664 . . . . 0.0 111.37 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -63.72 -28.04 69.61 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.8 ttp -81.4 -20.39 40.56 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -109.61 -19.78 13.08 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 51.5 mtm -54.8 -31.85 10.46 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -57.34 -16.78 23.98 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.616 2.877 . . . . 0.0 116.273 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -97.71 -8.79 27.92 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.406 1.003 . . . . 0.0 113.636 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.18 -162.92 28.16 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.089 1.328 . . . . 0.0 114.67 170.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -71.03 95.01 1.15 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.437 1.095 . . . . 0.0 111.842 -173.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.1 t -73.43 129.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.027 1.331 . . . . 0.0 109.733 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 35.7 t -94.56 -33.78 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.16 2.184 . . . . 0.0 111.505 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.3 t -155.22 150.45 27.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.462 1.105 . . . . 0.0 110.836 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.29 14.86 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.178 1.391 . . . . 0.0 109.915 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -151.58 138.74 19.23 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.466 -0.771 . . . . 0.0 111.705 -168.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 85.8 t -119.32 126.99 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.534 1.534 . . . . 0.0 107.468 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 123.361 0.664 . . . . 0.0 111.308 -174.627 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.549 0.939 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 76.3 m 65.63 22.8 11.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.912 2.085 . . . . 0.0 113.396 -172.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -146.14 155.57 42.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.004 0.922 . . . . 0.0 111.68 171.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.05 -173.43 24.63 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.749 1.643 . . . . 0.0 113.918 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -139.79 146.24 39.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.304 1.842 . . . . 0.0 110.243 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 58.1 t -143.61 138.58 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.115 1.366 . . . . 0.0 109.006 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 85.6 p -130.71 152.69 49.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.911 0.885 . . . . 0.0 112.358 175.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.73 161.86 26.36 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.933 1.293 . . . . 0.0 113.504 -174.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.65 -18.37 64.27 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.72 1.208 . . . . 0.0 112.885 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -146.16 151.24 44.08 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 125.596 1.559 . . . . 0.0 112.05 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.26 -28.16 55.66 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.035 3.157 . . . . 0.0 114.035 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.7 t -74.43 -38.46 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.958 0.903 . . . . 0.0 110.828 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 8.2 m -63.9 -31.79 73.1 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.916 0.886 . . . . 0.0 111.82 171.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.91 -48.58 29.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.403 1.081 . . . . 0.0 111.926 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -59.05 -38.97 80.62 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.383 -0.823 . . . . 0.0 111.879 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.75 -27.33 64.84 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -79.9 -44.65 20.01 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.458 171.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.56 -49.4 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.871 1.214 . . . . 0.0 110.618 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -73.87 -11.21 60.3 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.6 m -102.1 -27.71 12.76 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.5 mmm -112.47 -20.63 11.7 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -168.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.29 110.1 5.06 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.197 0.908 . . . . 0.0 109.84 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.31 1.85 62.34 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.533 1.539 . . . . 0.0 115.028 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -62.63 125.79 25.15 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.54 1.67 . . . . 0.0 111.866 -178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -79.72 125.96 30.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.592 0.757 . . . . 0.0 110.075 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt . . . . . 0 N--CA 1.469 0.504 0 C-N-CA 125.058 1.343 . . . . 0.0 109.811 -177.708 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 120.569 0.223 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 75.8 mt -76.79 162.9 27.28 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.149 1.38 . . . . 0.0 112.652 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -131.51 141.91 49.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.758 1.623 . . . . 0.0 109.678 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.75 138.1 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.735 1.214 . . . . 0.0 109.392 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -147.76 142.53 26.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.815 1.246 . . . . 0.0 110.597 -169.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 41.1 mt -65.8 151.41 46.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.011 0.925 . . . . 0.0 112.308 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.5 tttt . . . . . 0 CA--C 1.547 0.85 0 C-N-CA 124.303 1.041 . . . . 0.0 111.329 170.934 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.869 0.366 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.34 79.29 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.283 0.944 . . . . 0.0 113.086 -175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 10.1 t -75.61 162.68 28.06 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.25 1.025 . . . . 0.0 111.88 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -134.79 20.21 3.53 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.169 1.388 . . . . 0.0 111.224 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -66.83 173.67 3.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.133 0.973 . . . . 0.0 111.484 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.47 167.1 29.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 167.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -94.81 -167.14 36.2 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.113 1.34 . . . . 0.0 113.638 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.6 171.06 13.78 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.358 2.705 . . . . 0.0 111.521 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.94 123.27 15.24 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.641 0.777 . . . . 0.0 111.259 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.79 -9.66 70.76 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.725 1.155 . . . . 0.0 114.276 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.07 -6.25 54.06 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.895 1.347 . . . . 0.0 113.686 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.3 118.54 36.2 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.282 2.233 . . . . 0.0 111.404 -174.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 22.0 mt -119.68 136.63 54.33 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.386 1.875 . . . . 0.0 111.989 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -109.69 131.99 54.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.451 1.5 . . . . 0.0 108.796 168.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.56 135.33 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.938 1.695 . . . . 0.0 107.951 -171.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -131.42 160.4 35.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.247 1.419 . . . . 0.0 112.687 -175.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 68.27 28.26 6.39 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.496 2.318 . . . . 0.0 113.601 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 52.9 mt -65.69 155.24 86.65 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.491 1.116 . . . . 0.0 111.727 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.21 143.19 94.13 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.047 2.498 . . . . 0.0 112.575 172.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -62.69 -6.9 3.98 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.791 2.036 . . . . 0.0 114.845 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -113.14 -9.04 13.55 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.58 1.952 . . . . 0.0 114.241 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.44 134.03 47.41 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.635 1.174 . . . . 0.0 112.287 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.42 -172.7 18.9 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.663 1.601 . . . . 0.0 112.447 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -63.53 -34.66 78.27 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -172.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -77.09 -28.31 54.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.145 0.578 . . . . 0.0 112.448 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -69.95 -41.79 74.08 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.586 0.63 . . . . 0.0 110.796 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 31.8 tp -65.56 -37.6 87.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.491 0.716 . . . . 0.0 111.811 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.72 -50.4 67.07 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.709 0.686 . . . . 0.0 111.462 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -63.42 -26.33 68.69 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.409 0.684 . . . . 0.0 112.551 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 48.1 ttm -73.95 -28.79 61.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.169 0.988 . . . . 0.0 113.373 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -109.84 -18.52 13.39 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.6 mtm -56.16 -32.61 13.51 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -57.63 -16.23 23.63 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.578 2.852 . . . . 0.0 116.165 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -100.28 -9.7 22.08 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.7 -163.35 28.55 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.087 1.327 . . . . 0.0 114.957 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -70.37 99.82 1.64 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.335 1.054 . . . . 0.0 112.542 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 85.5 t -79.35 128.54 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.163 1.385 . . . . 0.0 110.038 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 56.0 t -98.97 -24.33 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.568 2.347 . . . . 0.0 111.787 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 9.4 t -156.98 144.27 18.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.762 1.225 . . . . 0.0 110.711 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.36 130.3 12.52 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.158 1.383 . . . . 0.0 110.89 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -156.11 132.85 10.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.578 0.751 . . . . 0.0 112.657 -174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 64.8 t -102.12 134.71 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.683 1.593 . . . . 0.0 106.943 167.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 123.293 0.637 . . . . 0.0 110.423 178.137 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.9 m 63.82 21.32 12.61 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.017 2.127 . . . . 0.0 113.119 -170.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.84 155.14 43.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.109 0.868 . . . . 0.0 112.4 173.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.56 179.83 31.22 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.926 1.727 . . . . 0.0 113.513 -170.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -137.04 142.22 42.46 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.549 1.94 . . . . 0.0 110.228 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 84.8 t -141.7 142.98 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.137 1.375 . . . . 0.0 108.608 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 18.3 m -136.86 148.81 47.31 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -115.35 171.59 7.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.546 1.539 . . . . 0.0 113.165 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.49 -23.71 66.09 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.42 1.488 . . . . 0.0 113.427 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -161.33 161.13 23.65 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.199 1.4 . . . . 0.0 112.104 -172.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.08 -13.77 34.27 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.504 2.136 . . . . 0.0 114.082 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.34 -46.01 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 121.043 1.747 . . . . 0.0 110.608 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 45.6 m -65.93 -30.66 71.28 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.312 1.045 . . . . 0.0 111.924 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.37 -48.4 28.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.04 0.936 . . . . 0.0 111.981 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -61.68 -32.29 72.46 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.523 -0.736 . . . . 0.0 112.094 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.71 71.76 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.46 -42.95 41.96 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.564 0.746 . . . . 0.0 111.732 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.7 mt -58.42 -46.67 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 118.798 0.727 . . . . 0.0 110.274 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.48 -12.52 61.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 66.6 m -103.54 -29.85 10.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 87.6 mmm -114.29 -18.71 11.52 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -168.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -70.87 111.48 6.32 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.42 1.009 . . . . 0.0 110.191 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.24 0.53 63.23 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.719 1.628 . . . . 0.0 114.953 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.12 122.74 16.85 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.403 1.601 . . . . 0.0 111.251 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -75.64 131.95 40.27 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 110.631 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.0 tt . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 125.011 1.324 . . . . 0.0 108.757 176.975 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 . . . . . 0 N--CA 1.473 0.706 0 CA-C-O 120.477 0.179 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.47 155.58 37.17 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.051 1.341 . . . . 0.0 111.547 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -130.3 141.9 50.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.935 1.294 . . . . 0.0 109.143 168.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.4 t -139.0 132.95 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.454 1.102 . . . . 0.0 109.169 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -143.85 154.95 43.91 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.514 1.126 . . . . 0.0 111.232 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 60.4 mt -66.95 160.12 27.02 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.527 0.731 . . . . 0.0 112.722 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 78.1 tttt . . . . . 0 CA--C 1.555 1.154 0 C-N-CA 125.102 1.361 . . . . 0.0 110.388 167.466 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 120.979 0.418 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 94.88 -5.45 69.14 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.992 1.282 . . . . 0.0 113.442 -175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 36.2 t -79.7 143.55 34.48 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.574 1.187 . . . . 0.0 111.341 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -118.93 15.25 13.38 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.852 1.261 . . . . 0.0 111.755 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -66.33 173.64 3.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.807 0.843 . . . . 0.0 111.655 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -153.43 160.34 42.57 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.6 -161.62 29.03 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 128.243 2.83 . . . . 0.0 113.365 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 169.01 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.68 2.92 . . . . 0.0 112.49 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -59.36 127.09 30.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.41 0.684 . . . . 0.0 111.145 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.36 -11.18 70.68 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.92 1.248 . . . . 0.0 114.01 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.86 -4.49 46.9 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.722 1.261 . . . . 0.0 114.118 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -108.29 118.21 36.18 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.118 1.367 . . . . 0.0 110.93 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.7 mt -120.19 132.0 55.21 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.175 1.79 . . . . 0.0 111.861 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -103.04 133.2 48.56 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.785 1.234 . . . . 0.0 108.557 167.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.3 mm -118.16 135.65 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.771 1.629 . . . . 0.0 108.26 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -133.93 160.45 37.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.574 1.15 . . . . 0.0 112.308 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 62.62 33.94 15.36 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.477 1.911 . . . . 0.0 113.282 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 45.2 mt -70.03 164.68 50.07 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.659 1.584 . . . . 0.0 111.455 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.03 141.47 94.36 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.702 2.268 . . . . 0.0 110.888 168.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -67.86 -8.29 35.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.959 1.304 . . . . 0.0 113.962 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.52 -9.2 16.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.424 1.889 . . . . 0.0 114.144 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.3 130.85 43.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.138 1.375 . . . . 0.0 111.643 -175.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -101.96 -179.63 27.69 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.367 0.984 . . . . 0.0 113.582 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.15 -33.69 74.98 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.149 0.98 . . . . 0.0 112.326 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -73.56 -40.81 63.65 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.989 1.716 . . . . 0.0 110.917 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -64.77 -41.38 95.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.708 0.803 . . . . 0.0 111.351 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.0 tp -67.0 -37.7 84.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.277 0.631 . . . . 0.0 111.858 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.63 -49.88 73.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.758 0.708 . . . . 0.0 110.943 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -63.39 -27.56 69.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.608 0.763 . . . . 0.0 112.851 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.5 ttm -72.45 -32.06 65.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.231 1.012 . . . . 0.0 113.051 173.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -107.38 -18.49 13.85 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -171.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 44.4 mtm -55.61 -33.49 18.09 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -57.77 -16.72 26.44 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.556 2.837 . . . . 0.0 115.992 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -99.23 -10.85 21.89 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.47 -154.36 25.88 Favored Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.411 1.005 . . . . 0.0 115.494 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -74.49 82.46 1.97 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.528 1.131 . . . . 0.0 112.962 -169.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.46 128.39 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.551 1.14 . . . . 0.0 109.951 172.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 73.5 t -94.13 -37.77 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.801 2.04 . . . . 0.0 110.85 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 63.3 m -151.29 146.01 25.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.859 1.263 . . . . 0.0 110.807 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.53 134.66 14.96 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.247 1.419 . . . . 0.0 110.402 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -155.6 136.26 13.42 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.692 0.797 . . . . 0.0 111.839 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.17 134.78 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.922 1.689 . . . . 0.0 107.734 169.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 123.033 0.533 . . . . 0.0 110.925 -179.358 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 CA--C 1.547 0.864 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.1 m 67.33 20.49 10.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.387 2.275 . . . . 0.0 113.061 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -145.02 156.18 43.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.854 0.862 . . . . 0.0 111.711 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.0 -174.86 28.26 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.906 1.717 . . . . 0.0 113.736 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -142.06 144.25 33.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.181 1.792 . . . . 0.0 110.196 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 98.8 t -141.97 142.72 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.499 1.519 . . . . 0.0 108.482 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 37.9 t -139.98 142.44 36.31 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.567 -0.708 . . . . 0.0 112.106 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.69 168.2 9.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.808 1.643 . . . . 0.0 113.422 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.17 -22.89 66.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.616 1.567 . . . . 0.0 113.282 170.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -160.07 157.69 25.47 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.232 1.413 . . . . 0.0 112.19 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.25 -15.65 39.16 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.629 2.219 . . . . 0.0 113.794 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.52 -43.72 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.53 1.514 . . . . 0.0 110.535 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.4 m -68.7 -31.26 70.22 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 112.072 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -75.84 -47.43 25.62 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.808 0.843 . . . . 0.0 112.474 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -62.47 -31.32 72.04 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.5 -0.75 . . . . 0.0 111.981 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.44 -30.92 71.95 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.312 0.645 . . . . 0.0 112.632 172.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.46 -42.59 43.24 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.447 0.699 . . . . 0.0 111.879 175.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.52 -46.08 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 118.738 0.699 . . . . 0.0 110.065 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -72.16 -12.46 61.19 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.6 m -104.02 -30.95 9.95 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.7 mmm -111.86 -18.04 12.78 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -70.06 112.1 6.2 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.429 1.013 . . . . 0.0 110.755 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.87 71.5 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.038 1.78 . . . . 0.0 114.94 -173.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -61.47 124.07 19.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.189 1.495 . . . . 0.0 111.331 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -78.39 131.0 36.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.215 0.531 . . . . 0.0 110.42 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 125.027 1.331 . . . . 0.0 108.493 177.261 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 119.951 -0.071 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.96 158.86 24.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.211 1.404 . . . . 0.0 112.224 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -136.85 141.99 42.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.069 1.348 . . . . 0.0 109.063 167.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.7 t -138.29 136.73 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.421 1.089 . . . . 0.0 108.95 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -149.13 151.28 34.11 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.774 0.83 . . . . 0.0 110.829 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.7 mt -60.24 156.65 15.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.931 0.872 . . . . 0.0 112.805 170.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 CA--C 1.548 0.877 0 C-N-CA 124.359 1.064 . . . . 0.0 113.175 169.707 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.561 0 CA-C-O 121.59 0.709 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.86 -3.71 84.82 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.613 1.577 . . . . 0.0 112.911 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.8 m -78.01 163.68 25.73 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.0 1.32 . . . . 0.0 111.991 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -125.26 33.12 5.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.746 1.218 . . . . 0.0 110.657 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -69.4 171.59 8.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.83 1.252 . . . . 0.0 110.74 168.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -158.83 165.41 34.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.474 0.709 . . . . 0.0 112.903 168.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -102.57 -165.23 26.29 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 126.074 1.797 . . . . 0.0 113.876 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.73 179.74 5.69 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.259 3.306 . . . . 0.0 112.702 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -54.63 124.3 15.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.538 1.135 . . . . 0.0 111.738 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.84 -6.32 83.64 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.775 1.179 . . . . 0.0 114.547 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.62 -3.15 55.44 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.765 1.283 . . . . 0.0 114.362 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -115.39 128.36 56.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.343 1.057 . . . . 0.0 111.005 -169.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 23.0 mt -126.01 143.1 51.23 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.041 2.136 . . . . 0.0 112.483 -168.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -110.65 135.59 51.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.693 1.597 . . . . 0.0 108.499 167.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.66 135.56 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.707 1.603 . . . . 0.0 107.905 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -131.84 160.59 35.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.872 1.269 . . . . 0.0 112.771 -176.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 69.76 27.74 4.55 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.732 2.413 . . . . 0.0 113.858 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.7 mt -66.59 158.52 78.69 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 124.916 1.286 . . . . 0.0 112.133 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.24 147.26 96.08 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.972 2.448 . . . . 0.0 111.299 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -70.97 -9.06 57.24 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.25 -8.29 17.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.505 1.922 . . . . 0.0 114.035 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.8 124.79 24.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.869 1.268 . . . . 0.0 110.741 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.23 -173.97 24.25 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.54 1.067 . . . . 0.0 113.914 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -70.07 -35.22 74.06 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -172.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -74.95 -28.64 60.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.477 0.711 . . . . 0.0 111.641 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -70.39 -43.14 70.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.236 0.614 . . . . 0.0 110.698 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.18 -35.81 80.46 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.069 0.548 . . . . 0.0 111.764 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.7 tp -62.07 -51.01 69.7 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.84 0.746 . . . . 0.0 110.913 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -68.07 -22.81 64.91 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.4 ttm -73.93 -28.76 61.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.316 1.046 . . . . 0.0 112.888 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -109.86 -17.85 13.54 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.6 mtm -54.28 -33.62 17.07 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 170.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -58.95 -15.94 29.81 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.569 2.846 . . . . 0.0 116.229 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -101.48 -9.3 21.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.59 -158.93 27.88 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.831 1.205 . . . . 0.0 114.884 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -75.0 94.42 2.85 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.084 0.954 . . . . 0.0 112.172 -170.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 96.2 t -74.27 131.48 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.972 1.309 . . . . 0.0 110.445 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 34.1 t -106.75 -20.9 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 128.082 2.553 . . . . 0.0 112.06 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.8 t -160.26 148.3 16.62 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.659 1.184 . . . . 0.0 110.657 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -159.91 124.46 3.86 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.143 1.377 . . . . 0.0 110.573 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -155.16 146.78 23.16 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.129 -0.982 . . . . 0.0 112.695 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 23.9 t -119.42 131.03 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.036 1.734 . . . . 0.0 107.763 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 123.111 0.564 . . . . 0.0 110.54 -177.497 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 57.0 m 68.47 19.11 8.88 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.441 2.296 . . . . 0.0 113.69 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -145.56 154.34 42.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.453 1.024 . . . . 0.0 112.534 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.2 -176.1 27.01 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.282 1.896 . . . . 0.0 113.509 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -143.49 143.65 31.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.354 1.862 . . . . 0.0 110.068 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 80.7 t -142.53 147.48 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.442 1.497 . . . . 0.0 108.815 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.1 m -139.92 152.18 46.18 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.668 0.787 . . . . 0.0 112.003 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -121.24 169.02 10.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.535 1.534 . . . . 0.0 113.126 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.71 -22.53 65.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.081 1.353 . . . . 0.0 113.356 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -160.7 158.07 24.29 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.304 1.441 . . . . 0.0 112.306 -171.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.24 -16.04 43.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.656 2.238 . . . . 0.0 113.969 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.27 -44.31 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.595 1.543 . . . . 0.0 110.569 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.7 m -68.58 -31.47 70.68 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.01 0.924 . . . . 0.0 111.91 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.22 -48.47 34.75 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.931 0.892 . . . . 0.0 112.071 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -62.59 -32.89 73.96 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.436 -0.79 . . . . 0.0 111.882 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.65 -29.42 70.42 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.88 -42.3 33.84 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.525 0.73 . . . . 0.0 111.439 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.7 mt -58.5 -46.32 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 118.859 0.754 . . . . 0.0 110.201 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -71.18 -13.02 61.79 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.4 m -104.17 -27.78 11.85 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.5 mmm -115.34 -19.23 10.81 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -169.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -70.93 109.96 5.37 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.177 0.899 . . . . 0.0 109.903 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 97.18 2.36 59.2 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.619 1.58 . . . . 0.0 114.978 -171.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -62.04 125.06 22.55 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.574 1.687 . . . . 0.0 111.699 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -80.73 129.98 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.387 0.675 . . . . 0.0 110.965 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt . . . . . 0 N--CA 1.471 0.589 0 C-N-CA 124.866 1.266 . . . . 0.0 110.492 -178.12 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 120.556 0.217 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 69.1 mt -72.29 159.43 34.06 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.177 1.391 . . . . 0.0 111.992 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -129.17 141.92 51.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.178 1.391 . . . . 0.0 109.24 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 25.2 t -139.46 135.56 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.587 1.155 . . . . 0.0 109.144 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -155.97 151.06 26.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.195 0.598 . . . . 0.0 111.938 -172.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.04 152.41 40.34 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 79.4 tttt . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 124.799 1.239 . . . . 0.0 113.104 169.195 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 120.896 0.379 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.65 6.48 70.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.747 1.641 . . . . 0.0 113.256 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.3 t -80.02 163.47 24.19 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.391 1.076 . . . . 0.0 113.224 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -126.99 8.73 6.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.917 1.287 . . . . 0.0 112.243 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -68.3 166.8 15.74 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.342 -0.849 . . . . 0.0 111.966 168.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.01 165.85 34.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.319 1.048 . . . . 0.0 112.267 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.63 -161.41 25.01 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 126.007 1.765 . . . . 0.0 113.976 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.26 177.64 8.01 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.098 3.199 . . . . 0.0 112.749 -174.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.9 126.83 28.8 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.107 0.963 . . . . 0.0 111.408 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.02 -7.27 82.59 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.042 1.306 . . . . 0.0 114.463 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.59 -2.11 45.55 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -114.8 122.22 45.68 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.27 1.028 . . . . 0.0 110.775 -168.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.7 mt -121.92 138.22 54.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.39 1.876 . . . . 0.0 111.971 -168.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -108.85 135.01 50.76 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.099 1.359 . . . . 0.0 108.834 167.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.95 135.31 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.978 1.711 . . . . 0.0 107.833 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -133.56 159.34 40.74 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.783 1.233 . . . . 0.0 112.434 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 68.5 30.58 5.19 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.218 2.207 . . . . 0.0 113.234 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.29 156.12 86.04 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.355 1.062 . . . . 0.0 111.556 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.71 148.41 74.49 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.183 2.589 . . . . 0.0 111.639 169.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -66.62 -19.36 65.75 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.45 -10.14 39.02 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -176.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.29 136.85 57.08 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.568 1.147 . . . . 0.0 113.203 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -113.11 -178.77 19.5 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.548 1.547 . . . . 0.0 112.799 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -64.48 -32.06 73.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.016 0.926 . . . . 0.0 113.131 -174.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -72.57 -35.21 67.92 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.08 0.952 . . . . 0.0 111.65 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -67.45 -41.69 84.31 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.737 0.699 . . . . 0.0 110.934 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.96 -36.53 78.0 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.101 0.56 . . . . 0.0 112.126 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 64.8 tp -64.08 -51.25 64.94 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.711 0.687 . . . . 0.0 111.097 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -65.47 -29.02 69.63 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.328 0.651 . . . . 0.0 112.274 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 47.0 ttm -67.85 -29.95 69.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.35 1.06 . . . . 0.0 113.006 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -106.24 -14.06 15.23 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.9 mtt -50.3 -37.64 30.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -61.06 -18.77 59.89 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.212 2.608 . . . . 0.0 115.75 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -97.4 -10.34 25.68 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.39 -159.37 27.73 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 125.217 1.389 . . . . 0.0 114.64 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -74.15 85.8 1.87 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.461 1.105 . . . . 0.0 112.436 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.18 125.89 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.134 0.974 . . . . 0.0 109.281 169.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.83 -33.68 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.146 1.779 . . . . 0.0 110.864 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 19.4 m -159.44 145.48 16.22 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.498 1.519 . . . . 0.0 110.875 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.78 143.74 24.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.582 1.553 . . . . 0.0 110.826 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -159.06 142.66 14.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.089 0.955 . . . . 0.0 112.947 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.97 138.88 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.136 1.774 . . . . 0.0 107.166 169.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.083 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 28.3 m 75.78 20.56 1.78 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.388 2.675 . . . . 0.0 113.179 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.52 158.02 43.8 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.816 0.846 . . . . 0.0 112.168 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.63 -173.7 28.44 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.979 1.752 . . . . 0.0 113.757 -170.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -147.09 140.44 25.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.592 1.957 . . . . 0.0 110.041 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 71.7 t -146.29 137.49 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.346 1.458 . . . . 0.0 109.278 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.0 m -135.56 141.72 45.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.638 0.775 . . . . 0.0 112.681 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -110.37 170.78 7.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.315 1.846 . . . . 0.0 112.183 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.72 -2.21 45.93 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -157.6 157.3 29.83 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 126.023 1.729 . . . . 0.0 111.887 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.06 -12.61 15.99 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.281 1.987 . . . . 0.0 113.899 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.9 t -79.28 -44.29 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.891 1.678 . . . . 0.0 110.648 -174.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 40.6 m -63.55 -31.96 73.28 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.339 1.056 . . . . 0.0 111.875 171.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -71.43 -51.47 23.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.088 0.955 . . . . 0.0 111.741 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -66.85 -29.66 69.63 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.312 -0.868 . . . . 0.0 112.241 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.44 71.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.791 0.723 . . . . 0.0 112.733 170.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.91 -41.71 61.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.78 0.718 . . . . 0.0 111.466 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 38.1 mt -56.59 -49.29 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 118.964 0.802 . . . . 0.0 110.308 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -70.45 -12.27 61.46 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.5 m -104.06 -28.0 11.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.7 mmm -116.43 -18.09 10.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -70.6 112.2 6.67 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.416 1.007 . . . . 0.0 110.113 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.57 3.22 64.77 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.953 1.74 . . . . 0.0 114.815 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.71 125.43 23.93 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.332 1.566 . . . . 0.0 111.355 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -86.15 130.04 34.65 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.034 0.533 . . . . 0.0 111.066 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.8 tt . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 125.3 1.44 . . . . 0.0 110.081 -173.626 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 60.8 mt -69.58 154.5 41.9 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.051 1.34 . . . . 0.0 112.343 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -124.17 138.98 54.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.639 1.176 . . . . 0.0 108.156 166.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 33.1 t -135.23 135.23 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.362 1.065 . . . . 0.0 108.212 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -152.02 146.66 25.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.277 0.631 . . . . 0.0 111.593 -169.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.75 157.77 29.37 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.862 0.865 . . . . 0.0 112.821 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 75.5 tttt . . . . . 0 CA--C 1.555 1.15 0 C-N-CA 125.282 1.433 . . . . 0.0 110.581 168.132 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 121.082 0.468 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.67 3.28 86.28 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.608 1.575 . . . . 0.0 113.652 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 17.1 t -84.8 174.63 9.72 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.225 1.013 . . . . 0.0 112.514 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -132.77 21.36 4.21 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.067 1.747 . . . . 0.0 110.852 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -61.83 161.28 10.55 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.001 0.92 . . . . 0.0 112.6 168.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.56 155.62 45.02 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.04 -170.48 32.35 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.155 1.836 . . . . 0.0 113.301 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -70.03 177.43 5.77 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.151 3.234 . . . . 0.0 112.558 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.13 125.76 24.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.866 0.866 . . . . 0.0 111.198 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.23 -7.46 75.75 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.99 1.281 . . . . 0.0 114.609 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -103.55 8.7 37.69 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -117.96 123.95 47.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.03 1.332 . . . . 0.0 110.709 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 30.7 mt -124.64 140.4 52.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.351 1.86 . . . . 0.0 112.531 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -111.19 133.72 53.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.445 1.498 . . . . 0.0 109.147 168.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.29 137.33 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 126.108 1.763 . . . . 0.0 107.935 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -134.04 161.63 34.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.459 1.504 . . . . 0.0 112.051 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 63.01 33.28 14.92 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.233 1.813 . . . . 0.0 113.307 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 52.9 mt -65.75 159.07 71.63 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.296 1.038 . . . . 0.0 111.01 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -55.46 144.42 73.35 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.89 2.394 . . . . 0.0 111.967 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -55.69 -11.9 1.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.811 2.444 . . . . 0.0 115.587 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -131.05 0.74 4.22 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.294 1.838 . . . . 0.0 114.264 -169.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.04 133.64 51.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.604 1.562 . . . . 0.0 111.363 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.32 -179.86 23.91 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.899 1.238 . . . . 0.0 113.563 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -65.41 -32.45 74.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.046 0.938 . . . . 0.0 112.541 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -74.68 -39.96 61.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.828 1.651 . . . . 0.0 110.876 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -62.13 -44.36 96.81 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.93 0.892 . . . . 0.0 111.015 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 26.4 tp -66.16 -43.09 87.97 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.156 0.582 . . . . 0.0 111.803 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.4 tp -57.21 -54.17 49.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 111.211 175.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -73.96 -20.88 60.22 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.7 ttp -76.97 -22.29 53.43 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.037 0.835 . . . . 0.0 113.03 170.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -102.97 -15.59 16.08 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.964 1.305 . . . . 0.0 113.872 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 36.1 mtt -48.21 -37.86 17.68 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -62.41 -17.62 58.67 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.108 2.538 . . . . 0.0 115.488 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -97.04 -10.43 26.15 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.94 0.896 . . . . 0.0 113.327 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.41 -163.91 28.72 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.405 1.478 . . . . 0.0 114.449 171.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.12 100.61 2.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.932 0.893 . . . . 0.0 111.896 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.6 t -76.19 129.14 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.911 1.284 . . . . 0.0 110.191 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 42.1 t -94.63 -33.6 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.742 2.017 . . . . 0.0 111.541 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 8.6 t -155.75 152.96 29.15 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.96 1.304 . . . . 0.0 110.748 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.91 130.8 8.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.387 1.475 . . . . 0.0 110.351 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -153.95 144.93 22.71 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.465 -0.772 . . . . 0.0 112.544 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.31 131.46 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.203 1.801 . . . . 0.0 107.229 170.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 CA--C 1.537 0.451 0 CA-C-O 121.39 0.614 . . . . 0.0 111.11 -177.628 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 73.1 mttt . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 34.5 m 69.15 20.16 7.7 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.966 2.107 . . . . 0.0 113.626 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -144.43 156.33 44.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.184 0.994 . . . . 0.0 111.444 172.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.54 -175.36 28.38 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.715 1.626 . . . . 0.0 114.103 -169.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -139.3 146.67 40.63 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.571 1.948 . . . . 0.0 110.049 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 64.2 t -144.94 144.09 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.165 1.386 . . . . 0.0 109.188 174.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 95.7 p -137.16 155.12 49.96 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.389 -0.819 . . . . 0.0 112.884 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -126.82 162.24 26.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.321 1.448 . . . . 0.0 113.462 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.5 -19.78 64.55 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.277 1.031 . . . . 0.0 113.252 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -147.68 153.71 43.43 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.721 1.608 . . . . 0.0 111.066 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.61 -17.53 11.16 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.896 2.397 . . . . 0.0 113.785 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 90.8 t -71.45 -39.6 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.314 0.961 . . . . 0.0 110.333 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 7.8 m -62.44 -34.37 76.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.041 0.936 . . . . 0.0 111.77 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.01 -48.2 38.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.583 1.153 . . . . 0.0 111.97 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -59.3 -38.75 81.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.673 0.789 . . . . 0.0 111.895 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.95 -29.16 70.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.587 0.755 . . . . 0.0 112.957 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.91 -43.38 45.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.626 0.648 . . . . 0.0 111.098 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.4 mt -58.24 -47.39 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.272 0.942 . . . . 0.0 110.246 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -67.14 -17.93 65.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.327 1.051 . . . . 0.0 113.589 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.7 m -104.41 -23.66 13.15 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.5 mmt -112.49 -22.52 10.78 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.686 1.194 . . . . 0.0 113.542 -171.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -70.9 112.52 7.14 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 120.014 1.279 . . . . 0.0 110.831 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 88.15 1.88 81.23 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.587 1.565 . . . . 0.0 114.694 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.88 125.31 23.24 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.937 1.369 . . . . 0.0 111.3 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -77.35 131.71 38.21 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.34 0.59 . . . . 0.0 110.37 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 18.8 tt . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 125.394 1.477 . . . . 0.0 108.093 -178.746 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.53 163.91 26.83 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.183 1.393 . . . . 0.0 112.574 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -137.33 139.68 41.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.863 1.665 . . . . 0.0 108.693 167.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.42 140.34 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.39 1.076 . . . . 0.0 109.881 -175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -149.19 154.28 38.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.683 1.193 . . . . 0.0 110.643 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.06 159.23 14.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.957 0.884 . . . . 0.0 111.562 167.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 CA--C 1.546 0.812 0 C-N-CA 124.553 1.141 . . . . 0.0 110.18 168.511 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.754 0.311 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.25 -0.88 84.06 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.5 1.524 . . . . 0.0 113.537 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.1 t -79.53 166.0 22.4 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.177 0.989 . . . . 0.0 112.881 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -128.68 18.1 6.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.665 1.586 . . . . 0.0 111.156 174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -64.62 167.25 7.48 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.999 0.92 . . . . 0.0 111.672 167.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -153.43 154.98 35.48 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.664 0.786 . . . . 0.0 112.187 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.57 -154.72 23.72 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.393 1.473 . . . . 0.0 113.153 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -67.35 161.1 44.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.188 2.592 . . . . 0.0 111.494 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.49 124.58 21.31 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.982 0.513 . . . . 0.0 110.678 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.6 -16.51 44.19 Favored Glycine 0 N--CA 1.473 1.132 0 C-N-CA 124.985 1.278 . . . . 0.0 113.454 -171.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.71 21.93 8.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.35 1.46 . . . . 0.0 112.716 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.94 116.23 21.17 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.298 1.439 . . . . 0.0 110.449 -167.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.5 mt -123.67 138.97 54.43 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.855 1.662 . . . . 0.0 112.361 -169.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.96 134.21 52.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.311 1.444 . . . . 0.0 108.99 167.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -118.51 135.74 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.089 1.755 . . . . 0.0 107.758 -172.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -134.32 158.99 42.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.035 1.334 . . . . 0.0 112.526 -174.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 70.75 27.47 3.61 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.892 2.477 . . . . 0.0 113.749 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.81 157.03 81.58 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.652 1.181 . . . . 0.0 112.038 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -59.36 150.82 72.5 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.001 2.467 . . . . 0.0 111.741 169.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -71.07 -10.3 59.53 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.509 1.123 . . . . 0.0 113.901 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.84 -6.97 15.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.949 2.1 . . . . 0.0 113.817 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.33 123.31 21.39 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.079 1.351 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -102.48 -176.81 27.35 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.405 1.002 . . . . 0.0 113.809 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -65.71 -34.7 78.8 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.793 0.837 . . . . 0.0 112.791 -175.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -77.58 -29.7 52.21 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.868 0.867 . . . . 0.0 111.807 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -68.4 -42.91 78.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.87 0.759 . . . . 0.0 110.657 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.5 tp -65.49 -40.27 92.88 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.184 0.593 . . . . 0.0 111.525 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 62.4 tp -61.19 -52.14 66.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.569 0.622 . . . . 0.0 111.313 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -64.37 -27.1 68.78 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.9 ttp -81.21 -20.15 41.71 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -110.3 -20.55 12.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 48.5 mtm -55.05 -31.57 9.86 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 169.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -57.28 -16.5 22.6 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.63 2.887 . . . . 0.0 116.106 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -98.26 -9.66 25.2 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.246 0.93 . . . . 0.0 113.437 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.79 -159.29 27.9 Favored Glycine 0 N--CA 1.469 0.892 0 C-N-CA 125.075 1.322 . . . . 0.0 115.047 170.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.0 90.71 1.51 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.3 1.04 . . . . 0.0 112.278 -171.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 86.1 t -71.58 130.47 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.762 1.225 . . . . 0.0 110.112 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 53.4 t -100.78 -27.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.286 2.235 . . . . 0.0 111.389 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 20.9 t -156.33 146.32 21.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.48 1.112 . . . . 0.0 110.657 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.63 132.36 9.53 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.573 1.549 . . . . 0.0 110.434 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -156.51 147.95 22.48 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.299 -0.876 . . . . 0.0 113.016 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.72 135.66 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.433 1.893 . . . . 0.0 107.646 173.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 123.41 0.684 . . . . 0.0 110.392 -179.969 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 55.5 m 69.72 19.16 7.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.53 2.332 . . . . 0.0 113.894 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -146.9 156.93 43.47 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.442 1.019 . . . . 0.0 112.528 173.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.81 -174.63 30.89 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.789 1.662 . . . . 0.0 113.702 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -138.99 147.48 42.21 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.333 1.853 . . . . 0.0 110.421 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.4 t -143.58 145.02 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.486 1.514 . . . . 0.0 108.865 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.5 t -143.47 147.99 35.38 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.416 -0.802 . . . . 0.0 112.647 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -117.85 167.17 11.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.154 1.782 . . . . 0.0 113.066 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.37 -13.58 62.14 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.143 1.377 . . . . 0.0 113.63 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -158.86 158.27 28.99 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 126.206 1.803 . . . . 0.0 111.664 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.98 -10.86 19.76 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.347 2.031 . . . . 0.0 113.844 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 29.0 t -77.1 -43.11 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 120.882 1.673 . . . . 0.0 110.555 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 27.2 m -64.86 -31.29 72.46 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.672 1.189 . . . . 0.0 111.773 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.75 -49.32 31.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.035 0.934 . . . . 0.0 111.76 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -61.76 -33.88 74.86 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.388 -0.82 . . . . 0.0 111.987 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.03 -29.63 70.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.318 0.647 . . . . 0.0 112.72 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.68 -41.53 45.09 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.704 0.684 . . . . 0.0 111.086 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 51.4 mt -57.99 -46.8 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 119.388 0.995 . . . . 0.0 110.208 174.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -70.87 -14.25 62.32 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 51.6 m -103.95 -26.6 12.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.9 mmm -114.69 -20.22 10.76 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -168.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -70.93 109.94 5.36 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.295 0.952 . . . . 0.0 109.765 173.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.46 2.4 61.8 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.443 1.497 . . . . 0.0 114.907 -171.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -63.94 126.42 27.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.489 1.645 . . . . 0.0 111.703 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -80.44 125.73 30.31 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.595 0.758 . . . . 0.0 110.203 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.5 tt . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 125.075 1.35 . . . . 0.0 109.953 -178.852 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.1 mt -76.7 161.64 28.35 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.297 1.439 . . . . 0.0 112.751 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -128.89 141.03 51.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.554 1.542 . . . . 0.0 108.709 167.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.4 t -138.47 136.82 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.481 1.112 . . . . 0.0 109.16 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -152.1 151.17 30.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.979 0.912 . . . . 0.0 111.056 -172.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.7 155.41 22.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.03 0.919 . . . . 0.0 112.899 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 CA--C 1.546 0.797 0 C-N-CA 124.759 1.224 . . . . 0.0 111.901 169.783 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 121.11 0.481 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.68 -6.61 82.27 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.343 1.449 . . . . 0.0 113.293 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 66.2 m -98.42 131.4 44.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.242 1.417 . . . . 0.0 110.067 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -103.74 38.51 1.8 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.186 0.995 . . . . 0.0 112.254 -170.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -74.24 -177.44 3.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.667 0.787 . . . . 0.0 110.877 168.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.42 166.63 31.77 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 169.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.77 -165.48 29.28 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.158 1.837 . . . . 0.0 113.572 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.44 171.32 16.44 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.031 3.154 . . . . 0.0 112.47 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.98 126.62 28.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.663 0.785 . . . . 0.0 111.334 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.79 -11.71 71.49 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.8 1.19 . . . . 0.0 114.027 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.82 -1.44 57.35 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.659 1.229 . . . . 0.0 113.963 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -113.4 125.04 53.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.941 1.296 . . . . 0.0 111.458 -169.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.0 mt -124.71 140.23 53.12 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.756 2.022 . . . . 0.0 111.751 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -110.84 132.25 54.36 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.09 1.356 . . . . 0.0 108.594 167.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.67 134.96 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.982 1.713 . . . . 0.0 107.602 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.8 160.34 37.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.242 1.417 . . . . 0.0 112.292 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 69.66 28.88 4.36 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.555 2.342 . . . . 0.0 113.693 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 58.5 mt -68.58 161.2 72.37 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.653 1.181 . . . . 0.0 111.417 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.68 151.1 78.66 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.96 2.44 . . . . 0.0 111.259 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -72.06 -9.07 57.89 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.692 1.197 . . . . 0.0 113.959 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -112.76 -6.72 13.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.256 2.222 . . . . 0.0 113.838 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 130.15 42.29 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.167 1.387 . . . . 0.0 110.898 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.77 178.9 25.16 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.387 0.994 . . . . 0.0 113.842 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -64.6 -33.97 77.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.725 0.81 . . . . 0.0 112.58 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.4 -31.17 57.81 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.087 0.955 . . . . 0.0 111.812 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -66.99 -42.68 84.63 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.821 0.737 . . . . 0.0 110.652 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.55 -39.87 88.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.357 0.663 . . . . 0.0 111.745 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.17 -52.08 65.26 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.641 0.655 . . . . 0.0 111.31 174.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -63.72 -28.01 69.59 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.7 ttp -80.61 -19.93 44.35 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -111.19 -19.48 12.67 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.3 mtm -55.05 -31.73 10.33 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -57.52 -16.74 24.95 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.579 2.853 . . . . 0.0 116.25 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -97.51 -9.53 26.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.41 -162.32 28.21 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.17 1.367 . . . . 0.0 114.348 172.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -72.8 88.14 1.31 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.642 0.777 . . . . 0.0 112.182 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.5 t -65.27 127.41 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.363 1.065 . . . . 0.0 109.403 170.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 45.5 t -91.64 -38.86 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.671 1.988 . . . . 0.0 110.841 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.61 149.52 23.89 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.641 1.176 . . . . 0.0 111.181 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.39 140.29 20.07 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.345 1.458 . . . . 0.0 110.738 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -155.8 140.14 16.68 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.474 -0.766 . . . . 0.0 111.788 -169.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.47 130.8 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.548 1.539 . . . . 0.0 107.498 168.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 . . . . . 0 CA--C 1.537 0.447 0 C-N-CA 123.32 0.648 . . . . 0.0 111.172 -176.255 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 CA--C 1.549 0.91 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.9 m 67.11 19.76 10.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.863 2.065 . . . . 0.0 113.115 -172.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -146.81 155.25 42.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.864 0.865 . . . . 0.0 112.311 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.88 -175.6 27.99 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.152 1.834 . . . . 0.0 113.559 -170.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -136.25 145.5 45.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.716 2.006 . . . . 0.0 110.285 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 61.4 t -143.27 141.14 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.318 1.447 . . . . 0.0 108.529 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 37.3 p -137.53 146.7 44.45 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.027 0.931 . . . . 0.0 112.18 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -119.82 169.29 10.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.178 1.391 . . . . 0.0 113.223 -174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.03 -23.75 66.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.972 1.309 . . . . 0.0 113.26 169.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -160.0 157.93 25.96 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.24 1.416 . . . . 0.0 112.394 -171.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.13 -15.14 42.47 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.765 2.31 . . . . 0.0 114.026 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.18 -44.78 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 120.754 1.615 . . . . 0.0 110.679 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 57.4 m -68.06 -30.97 70.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.991 0.917 . . . . 0.0 111.886 174.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.64 42.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.659 0.784 . . . . 0.0 111.81 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -58.57 -39.24 79.77 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.487 -0.758 . . . . 0.0 111.947 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.84 -28.76 69.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -79.14 -44.27 22.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.705 0.684 . . . . 0.0 111.386 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 49.4 mt -57.07 -47.53 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.523 1.056 . . . . 0.0 110.151 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -74.66 -10.86 59.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.199 0.999 . . . . 0.0 113.227 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -104.28 -26.55 12.44 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.7 mmm -113.12 -19.86 11.69 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -168.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -70.9 111.19 6.12 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 119.385 0.993 . . . . 0.0 109.954 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.48 2.55 65.45 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.142 1.83 . . . . 0.0 115.172 -171.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.06 124.99 23.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.256 1.528 . . . . 0.0 111.543 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -73.5 131.12 41.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.852 0.296 . . . . 0.0 110.594 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.0 tt . . . . . 0 N--CA 1.467 0.408 0 C-N-CA 124.311 1.044 . . . . 0.0 108.325 175.118 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 79.7 mt -68.81 160.98 29.5 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.349 1.06 . . . . 0.0 112.079 -176.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -126.2 141.39 51.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.636 1.574 . . . . 0.0 108.638 168.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.07 136.45 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.121 0.968 . . . . 0.0 109.418 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -149.83 146.1 26.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.178 0.991 . . . . 0.0 111.279 -172.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.74 150.17 47.83 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.786 0.834 . . . . 0.0 113.236 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.5 tttt . . . . . 0 CA--C 1.546 0.822 0 C-N-CA 123.568 0.747 . . . . 0.0 111.322 168.395 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 120.806 0.336 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.76 -3.24 74.08 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.194 0.902 . . . . 0.0 113.211 -176.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.1 t -98.35 163.8 12.55 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.356 1.062 . . . . 0.0 111.62 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -134.4 18.06 3.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.947 1.299 . . . . 0.0 112.216 -170.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.52 169.59 3.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.461 1.104 . . . . 0.0 111.783 168.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.41 158.9 44.32 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.838 -1.164 . . . . 0.0 111.855 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.72 -162.08 26.92 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.903 1.716 . . . . 0.0 113.401 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.46 171.23 14.51 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.822 3.015 . . . . 0.0 112.628 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.31 121.09 9.94 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.084 0.954 . . . . 0.0 111.359 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.11 -4.0 73.84 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.949 1.261 . . . . 0.0 114.675 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.15 2.71 55.92 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.002 1.401 . . . . 0.0 114.173 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -118.35 125.66 50.5 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.721 1.208 . . . . 0.0 111.343 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.47 137.45 54.79 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.477 1.911 . . . . 0.0 112.026 -169.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.64 133.88 50.63 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.155 1.382 . . . . 0.0 108.352 167.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 9.3 mm -117.53 136.41 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.641 1.576 . . . . 0.0 108.517 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -135.37 161.5 35.26 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.114 0.965 . . . . 0.0 112.569 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 62.03 36.62 15.36 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.334 1.854 . . . . 0.0 113.299 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 46.0 mt -70.93 162.92 69.29 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.052 1.341 . . . . 0.0 111.392 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.87 149.06 90.32 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.04 2.493 . . . . 0.0 111.231 168.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -71.07 -10.45 59.78 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -104.1 -9.53 18.67 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.473 1.909 . . . . 0.0 114.27 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.28 126.94 31.14 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.608 1.163 . . . . 0.0 111.211 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.22 -174.79 24.31 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.961 1.267 . . . . 0.0 112.9 171.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -62.51 -34.6 77.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.743 0.817 . . . . 0.0 112.925 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -77.55 -30.52 52.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.856 0.862 . . . . 0.0 112.001 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -70.1 -40.43 74.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.606 0.639 . . . . 0.0 110.615 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 23.4 tp -66.42 -39.23 88.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.342 0.657 . . . . 0.0 111.601 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 64.1 tp -61.61 -49.67 75.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.81 0.732 . . . . 0.0 111.053 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -68.64 -23.02 64.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.7 ttm -73.56 -29.88 62.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.021 0.929 . . . . 0.0 113.002 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -109.23 -17.8 13.75 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -171.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.0 mtm -53.61 -33.09 12.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -59.53 -15.36 30.2 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.479 2.786 . . . . 0.0 116.475 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -102.48 -10.69 19.15 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -175.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 154.09 -169.45 32.58 Favored Glycine 0 N--CA 1.469 0.882 0 C-N-CA 125.089 1.328 . . . . 0.0 113.991 174.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -73.93 99.68 3.32 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.14 -0.624 . . . . 0.0 110.991 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.7 t -72.2 125.73 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.22 1.008 . . . . 0.0 109.336 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 37.3 t -86.64 -36.12 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.363 1.865 . . . . 0.0 111.017 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.7 m -161.22 151.59 17.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.213 1.805 . . . . 0.0 110.47 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.14 134.22 15.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.523 1.529 . . . . 0.0 110.225 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -153.36 135.5 14.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.392 0.677 . . . . 0.0 112.08 -174.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.7 t -106.73 135.02 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.205 1.802 . . . . 0.0 107.086 168.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 123.249 0.62 . . . . 0.0 111.171 -178.766 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 64.1 m 69.11 20.03 7.8 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.167 2.187 . . . . 0.0 113.614 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.27 156.86 44.83 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.898 0.879 . . . . 0.0 112.063 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.1 -172.01 26.74 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.664 1.602 . . . . 0.0 114.316 -169.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -144.32 144.89 31.68 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.491 1.916 . . . . 0.0 110.127 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 78.9 t -144.88 139.08 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.529 1.532 . . . . 0.0 109.049 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 77.8 p -134.43 153.39 51.94 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.913 0.885 . . . . 0.0 112.66 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -128.65 167.57 17.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.86 1.264 . . . . 0.0 114.179 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -67.57 -21.48 65.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.487 1.515 . . . . 0.0 114.607 172.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -152.4 156.48 33.56 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.526 1.531 . . . . 0.0 111.931 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -63.37 -29.77 72.38 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.652 2.901 . . . . 0.0 113.415 174.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.8 -39.57 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.001 0.921 . . . . 0.0 110.865 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 16.3 m -58.92 -35.61 73.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.089 0.955 . . . . 0.0 111.61 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -76.95 -48.41 18.18 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.237 1.415 . . . . 0.0 112.576 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -61.18 -32.21 71.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.321 1.048 . . . . 0.0 112.367 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.15 72.22 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.305 0.642 . . . . 0.0 112.64 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.81 33.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.532 0.733 . . . . 0.0 111.841 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 38.6 mt -58.01 -46.5 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.121 0.873 . . . . 0.0 110.235 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -72.39 -12.81 61.28 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.9 m -103.9 -30.4 10.36 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 83.9 mmm -112.84 -18.75 12.2 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -169.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -70.16 111.97 6.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.66 1.118 . . . . 0.0 110.496 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.24 1.76 69.11 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.744 1.64 . . . . 0.0 114.821 -173.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.13 124.72 21.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.255 1.528 . . . . 0.0 111.636 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -80.27 127.48 32.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.603 0.761 . . . . 0.0 110.19 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 N--CA 1.467 0.408 0 C-N-CA 124.953 1.301 . . . . 0.0 109.793 -176.389 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 119.862 -0.114 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 53.3 mt -68.14 161.65 26.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.19 1.396 . . . . 0.0 112.485 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -137.55 142.61 41.37 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.668 1.587 . . . . 0.0 109.161 167.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 34.6 t -139.31 133.11 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.591 1.156 . . . . 0.0 109.019 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -142.25 151.92 42.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.195 0.998 . . . . 0.0 111.482 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 58.9 mt -66.36 152.8 44.28 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.938 0.875 . . . . 0.0 113.151 172.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.0 tttt . . . . . 0 CA--C 1.547 0.861 0 C-N-CA 124.536 1.134 . . . . 0.0 111.534 169.07 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 120.898 0.38 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.0 -9.08 67.29 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.452 1.501 . . . . 0.0 113.173 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.6 m -76.52 158.67 31.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.168 0.987 . . . . 0.0 110.078 169.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -139.86 31.51 2.02 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.379 -0.826 . . . . 0.0 112.133 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -69.33 174.15 5.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.548 0.739 . . . . 0.0 111.007 167.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.78 160.59 43.43 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.92 -160.19 26.56 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.982 1.753 . . . . 0.0 113.453 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.23 172.41 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.899 3.066 . . . . 0.0 112.862 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -59.18 120.63 9.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.419 1.088 . . . . 0.0 110.917 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.01 -3.53 70.32 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.003 1.287 . . . . 0.0 114.708 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.18 0.86 51.74 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.975 1.388 . . . . 0.0 114.421 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -117.15 123.54 46.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.645 1.178 . . . . 0.0 111.271 -169.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.0 mt -123.6 141.51 51.94 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.532 1.933 . . . . 0.0 112.525 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -111.61 134.19 53.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.784 1.634 . . . . 0.0 108.463 167.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.87 135.64 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.733 1.613 . . . . 0.0 107.832 -172.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -131.55 162.42 30.34 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.128 1.371 . . . . 0.0 111.92 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 63.02 37.06 12.0 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.465 1.906 . . . . 0.0 113.273 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 54.6 mt -70.11 161.62 74.47 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.792 1.237 . . . . 0.0 112.083 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.99 154.14 58.88 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.418 2.746 . . . . 0.0 111.123 168.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -75.51 -19.91 59.06 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -96.76 -6.38 36.36 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.57 1.548 . . . . 0.0 114.207 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.01 128.12 35.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.862 1.265 . . . . 0.0 111.819 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -107.26 -177.56 22.67 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.963 1.268 . . . . 0.0 113.506 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.46 -34.2 77.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.11 0.964 . . . . 0.0 112.703 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -75.97 -27.24 57.41 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.402 1.081 . . . . 0.0 111.676 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -75.5 -42.29 53.17 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.881 0.872 . . . . 0.0 110.723 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 27.1 tp -64.76 -36.63 84.91 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.334 0.653 . . . . 0.0 111.686 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.4 -51.22 69.64 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.417 0.553 . . . . 0.0 110.702 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -69.01 -20.99 64.16 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.7 ttm -73.98 -26.95 60.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.108 0.963 . . . . 0.0 112.817 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -113.03 -18.29 12.23 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.9 mtm -53.24 -34.03 16.77 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 170.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -59.44 -16.88 37.75 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.559 2.839 . . . . 0.0 116.215 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -100.2 -9.01 22.92 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.408 1.004 . . . . 0.0 113.664 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.78 -163.37 28.57 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.981 1.277 . . . . 0.0 114.75 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -70.68 96.53 1.23 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.311 1.044 . . . . 0.0 112.285 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 80.3 t -74.85 128.43 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.089 1.355 . . . . 0.0 109.881 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 38.7 t -88.69 -36.78 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.57 1.948 . . . . 0.0 111.045 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.8 m -160.25 150.73 18.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.511 1.525 . . . . 0.0 110.814 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.4 130.39 11.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.232 1.813 . . . . 0.0 109.637 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -152.71 144.73 23.76 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.539 -0.726 . . . . 0.0 112.854 -171.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.0 t -119.18 135.93 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.554 1.942 . . . . 0.0 108.219 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 123.539 0.736 . . . . 0.0 109.853 177.439 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 66.5 m 73.52 20.36 3.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.265 2.626 . . . . 0.0 113.003 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -146.38 155.68 42.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.678 0.791 . . . . 0.0 112.394 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.38 -173.95 29.57 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.968 1.747 . . . . 0.0 113.675 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -140.94 145.67 36.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.406 1.883 . . . . 0.0 110.141 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.1 t -145.36 139.18 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.155 1.382 . . . . 0.0 109.279 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.1 p -133.38 149.06 51.86 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.327 1.051 . . . . 0.0 112.328 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -121.55 163.34 19.03 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.099 1.359 . . . . 0.0 113.323 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.27 -18.2 63.12 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.293 1.037 . . . . 0.0 113.073 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -145.52 151.78 47.8 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.273 1.429 . . . . 0.0 112.182 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.91 -29.34 58.09 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.829 3.019 . . . . 0.0 113.868 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.45 -40.97 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.705 0.802 . . . . 0.0 110.916 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.1 m -62.06 -33.27 74.09 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.856 0.862 . . . . 0.0 111.918 173.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.72 -49.26 21.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.993 1.317 . . . . 0.0 112.129 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -60.99 -33.65 73.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.062 0.945 . . . . 0.0 112.126 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.11 -31.05 72.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.358 0.663 . . . . 0.0 112.642 172.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.36 -41.53 47.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.344 0.658 . . . . 0.0 111.68 175.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 40.2 mt -58.14 -47.29 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.03 0.832 . . . . 0.0 110.153 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.24 -14.27 62.18 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.9 m -102.18 -29.78 11.52 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 86.1 mmm -113.32 -18.04 12.15 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -169.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -70.26 111.78 6.12 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.491 1.041 . . . . 0.0 110.551 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.93 1.75 67.27 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.885 1.707 . . . . 0.0 114.77 -173.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.9 124.43 20.46 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.215 1.507 . . . . 0.0 111.615 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -80.39 127.71 32.71 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.613 0.765 . . . . 0.0 110.175 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.5 tt . . . . . 0 N--CA 1.468 0.466 0 C-N-CA 124.888 1.275 . . . . 0.0 109.713 -176.188 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 119.923 -0.084 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 59.5 mt -68.96 161.01 29.77 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.978 1.311 . . . . 0.0 112.328 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.96 141.21 42.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.435 1.494 . . . . 0.0 108.967 168.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.35 138.2 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.532 1.133 . . . . 0.0 109.302 -175.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -151.02 152.76 33.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.241 1.016 . . . . 0.0 110.757 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.32 157.63 16.13 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.6 0.76 . . . . 0.0 112.778 170.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.1 tttt . . . . . 0 CA--C 1.55 0.949 0 C-N-CA 124.942 1.297 . . . . 0.0 112.673 172.178 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 17.4 m 71.66 -0.47 3.15 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.443 1.897 . . . . 0.0 115.514 171.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.3 t -166.6 157.48 12.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.34 1.856 . . . . 0.0 110.676 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -129.96 151.02 19.23 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.454 1.502 . . . . 0.0 112.76 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 57.3 p -83.88 -15.73 47.04 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 42.2 m -132.45 10.01 4.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.367 1.467 . . . . 0.0 113.302 -175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 165.49 -164.12 37.06 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.102 1.334 . . . . 0.0 113.701 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.58 170.08 23.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.98 1.712 . . . . 0.0 112.026 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 79.4 p -79.99 173.17 12.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.534 1.534 . . . . 0.0 112.093 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -78.53 12.24 2.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.616 1.166 . . . . 0.0 113.07 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -70.55 -9.39 56.64 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.905 -1.122 . . . . 0.0 113.468 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 32.7 m -64.27 6.49 0.19 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.015 1.726 . . . . 0.0 115.01 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 2.2 pp -76.73 -9.92 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.576 1.551 . . . . 0.0 113.135 169.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -83.5 -138.28 3.42 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.778 1.656 . . . . 0.0 111.485 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -99.33 -59.87 1.64 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.363 0.665 . . . . 0.0 112.357 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.46 128.01 34.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.078 0.951 . . . . 0.0 111.423 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.35 -6.53 81.71 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.66 1.6 . . . . 0.0 113.168 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 4.2 t -82.63 157.29 23.47 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.455 1.128 . . . . 0.0 113.421 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -128.54 13.87 6.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.994 1.318 . . . . 0.0 112.26 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -70.62 176.08 4.41 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.377 -0.827 . . . . 0.0 110.195 167.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.48 157.46 39.87 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.263 -0.898 . . . . 0.0 112.355 168.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.82 -157.39 22.72 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.339 1.447 . . . . 0.0 113.235 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.92 160.61 43.31 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.197 2.598 . . . . 0.0 111.488 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.04 124.33 20.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.103 0.561 . . . . 0.0 110.983 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.58 -8.74 60.27 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.024 1.297 . . . . 0.0 113.68 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.85 22.1 7.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.168 1.387 . . . . 0.0 112.646 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.7 118.6 25.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.413 1.485 . . . . 0.0 110.084 -167.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 27.9 mt -125.33 141.95 51.78 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.106 1.763 . . . . 0.0 112.659 -168.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -114.54 134.06 55.32 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.382 1.473 . . . . 0.0 109.283 168.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.56 134.71 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.318 1.847 . . . . 0.0 107.884 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -133.08 158.62 42.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.743 1.217 . . . . 0.0 112.87 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 73.2 26.86 2.05 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.984 2.513 . . . . 0.0 113.528 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.45 149.6 97.9 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.599 1.16 . . . . 0.0 111.373 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -58.32 149.87 70.78 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.247 2.631 . . . . 0.0 112.454 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -69.23 -9.72 54.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.63 -11.32 23.73 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.969 1.708 . . . . 0.0 114.168 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.07 126.34 30.31 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.261 1.024 . . . . 0.0 111.549 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -108.3 -171.65 21.47 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.545 1.545 . . . . 0.0 112.096 169.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.73 -32.56 74.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.047 0.939 . . . . 0.0 113.145 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -78.5 -30.38 47.18 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.993 0.917 . . . . 0.0 112.079 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -70.55 -40.78 73.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.71 0.686 . . . . 0.0 110.632 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 28.6 tp -65.63 -37.66 87.22 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.382 0.673 . . . . 0.0 111.838 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 65.1 tp -62.52 -51.71 66.33 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.702 0.683 . . . . 0.0 111.253 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -63.92 -30.78 71.84 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.1 0.56 . . . . 0.0 112.423 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.0 ttm -68.57 -29.45 67.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.345 1.058 . . . . 0.0 113.11 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -106.36 -13.23 15.43 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 29.7 mtt -49.66 -37.36 23.26 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -61.78 -17.73 56.65 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.127 2.552 . . . . 0.0 116.015 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -99.67 -7.82 25.18 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.49 -163.73 28.46 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.326 1.441 . . . . 0.0 114.44 171.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -72.52 97.78 2.17 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.054 0.942 . . . . 0.0 111.853 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.6 t -74.55 126.93 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.56 1.144 . . . . 0.0 109.815 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 39.9 t -91.06 -36.47 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.437 1.895 . . . . 0.0 111.032 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 53.6 m -149.81 147.77 28.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.737 1.215 . . . . 0.0 110.92 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.14 136.48 20.11 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.237 1.815 . . . . 0.0 109.013 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -153.74 138.32 16.88 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.556 -0.715 . . . . 0.0 111.656 -168.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.58 128.36 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.214 1.406 . . . . 0.0 107.976 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -82.24 142.84 31.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.607 0.763 . . . . 0.0 110.85 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 37.8 mm -120.45 133.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.994 1.318 . . . . 0.0 110.339 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -76.32 125.91 30.04 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.35 1.06 . . . . 0.0 110.951 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -76.08 -7.29 54.4 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -172.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -98.93 -17.1 18.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.388 1.075 . . . . 0.0 112.904 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 60.9 p -129.57 -16.85 3.77 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.745 1.218 . . . . 0.0 114.144 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 21.9 m120 64.33 14.46 8.77 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.648 1.979 . . . . 0.0 113.363 -173.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 80.7 mt -89.15 156.34 18.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.362 1.465 . . . . 0.0 110.779 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 67.5 p -69.49 144.62 53.15 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.065 0.936 . . . . 0.0 112.149 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -76.42 5.41 7.26 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 35.3 m 64.97 20.1 12.02 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.996 2.118 . . . . 0.0 112.973 -171.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -147.35 156.07 42.57 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.143 0.977 . . . . 0.0 112.033 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.52 -177.55 27.99 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 126.008 1.766 . . . . 0.0 113.605 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -135.18 146.68 48.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.521 1.928 . . . . 0.0 110.133 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.9 t -143.22 144.86 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.309 1.443 . . . . 0.0 108.719 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 8.1 t -143.65 146.85 33.55 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.455 -0.778 . . . . 0.0 112.37 173.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -115.87 165.42 13.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.138 1.775 . . . . 0.0 113.128 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.0 -18.43 64.72 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.371 1.069 . . . . 0.0 113.281 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -145.27 149.59 41.91 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.122 1.369 . . . . 0.0 112.16 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.29 -28.08 55.47 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.757 2.971 . . . . 0.0 113.774 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.36 -38.67 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.879 0.872 . . . . 0.0 110.896 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 9.9 m -62.68 -34.63 77.52 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.966 0.906 . . . . 0.0 111.707 171.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.71 -48.14 41.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.54 1.136 . . . . 0.0 111.964 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -60.67 -34.32 74.15 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 112.16 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.0 -30.01 70.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.431 0.693 . . . . 0.0 112.696 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.73 -41.49 53.22 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.349 0.66 . . . . 0.0 111.491 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.9 -48.07 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.896 0.771 . . . . 0.0 110.12 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.58 -14.23 62.41 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -102.76 -29.07 11.71 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 92.2 mmm -114.54 -19.14 11.27 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -169.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -70.81 111.28 6.12 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.277 0.944 . . . . 0.0 109.951 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 97.46 1.36 59.14 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.682 1.61 . . . . 0.0 114.841 -172.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -64.62 120.36 12.24 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.676 1.738 . . . . 0.0 111.173 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -76.78 131.93 38.97 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.976 0.417 . . . . 0.0 110.452 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.1 tt -139.56 93.18 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.492 1.117 . . . . 0.0 109.018 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 81.41 -124.3 6.39 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -169.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 62.4 mtt -99.22 7.73 45.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.915 1.286 . . . . 0.0 113.694 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.04 170.39 15.79 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.684 1.594 . . . . 0.0 112.74 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -119.46 138.4 53.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.999 1.32 . . . . 0.0 112.018 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.81 150.54 47.7 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.169 1.388 . . . . 0.0 111.591 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -121.22 141.99 50.33 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.64 1.176 . . . . 0.0 108.777 168.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.26 133.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.364 1.066 . . . . 0.0 108.82 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -142.53 157.69 44.47 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.563 1.145 . . . . 0.0 111.075 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.47 156.98 30.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.821 0.819 . . . . 0.0 112.132 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -58.79 121.95 12.36 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.54 1.136 . . . . 0.0 112.189 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -79.98 138.59 37.1 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.755 1.222 . . . . 0.0 110.272 171.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 7.0 t -163.52 176.72 9.46 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.138 1.375 . . . . 0.0 111.245 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -69.97 155.02 41.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.634 1.174 . . . . 0.0 112.517 176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -142.21 157.41 44.88 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.689 1.595 . . . . 0.0 111.496 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -151.95 -33.13 0.14 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.855 1.262 . . . . 0.0 113.218 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 33.0 p -76.84 -5.37 48.06 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.761 1.224 . . . . 0.0 113.743 171.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -157.37 146.89 20.24 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.713 2.005 . . . . 0.0 110.511 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 37.3 p -80.94 -10.14 59.75 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 170.55 -172.97 44.36 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.727 1.156 . . . . 0.0 114.052 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.59 -11.91 20.41 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.93 3.087 . . . . 0.0 114.036 -176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 19.8 m 68.43 3.92 4.0 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.296 1.838 . . . . 0.0 114.79 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 10.7 t -163.2 159.77 23.28 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.328 1.851 . . . . 0.0 110.998 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 C-N-CA 125.256 1.408 . . . . 0.0 112.843 -177.848 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.479 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.3 m -66.32 -18.32 65.28 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 52.8 p -90.99 -8.62 48.67 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.19 1.396 . . . . 0.0 113.879 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 75.95 -43.24 1.67 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.824 1.678 . . . . 0.0 113.692 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 22.5 t -166.22 154.4 10.57 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.531 1.932 . . . . 0.0 110.932 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 4.6 m -78.78 -3.37 44.05 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 108.3 -162.02 13.19 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.843 1.687 . . . . 0.0 112.791 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 43.2 tp -60.31 -29.99 69.21 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.082 0.953 . . . . 0.0 113.464 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 37.0 p -67.95 -10.91 57.19 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.672 1.589 . . . . 0.0 113.971 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 6.96 38.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.538 1.535 . . . . 0.0 111.655 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -141.39 -53.69 0.46 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.927 1.291 . . . . 0.0 111.642 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 50.4 m -107.02 109.24 21.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.316 1.047 . . . . 0.0 110.156 -171.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.57 152.74 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.534 1.534 . . . . 0.0 111.625 -171.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -90.89 130.76 10.44 Favored Glycine 0 N--CA 1.471 1.016 0 C-N-CA 124.379 0.99 . . . . 0.0 111.994 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -79.79 -36.99 36.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.857 0.863 . . . . 0.0 113.076 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -68.37 121.7 16.83 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.742 1.217 . . . . 0.0 110.623 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.29 84.64 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.373 0.987 . . . . 0.0 113.347 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.3 t -85.47 173.82 9.96 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.002 0.901 . . . . 0.0 111.411 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -139.7 28.53 2.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.392 1.477 . . . . 0.0 110.846 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -66.98 164.16 18.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.982 0.913 . . . . 0.0 112.684 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.7 154.66 37.82 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.73 -160.38 26.77 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.101 1.81 . . . . 0.0 113.473 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.08 171.74 15.29 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.907 3.071 . . . . 0.0 112.576 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.45 122.34 13.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.069 0.948 . . . . 0.0 111.337 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.63 -4.33 75.91 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.844 1.212 . . . . 0.0 114.587 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.66 1.56 53.63 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.069 1.434 . . . . 0.0 114.39 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -116.98 125.17 50.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.899 1.28 . . . . 0.0 111.162 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.3 mt -124.22 140.29 53.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.528 1.931 . . . . 0.0 112.403 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -110.8 133.38 53.4 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.506 1.522 . . . . 0.0 108.52 167.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.5 mm -117.05 139.23 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.98 1.712 . . . . 0.0 108.71 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -140.65 160.89 39.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.335 1.054 . . . . 0.0 113.131 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 66.52 26.81 9.86 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.832 2.453 . . . . 0.0 114.037 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 68.4 mt -66.14 155.9 86.15 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.595 1.158 . . . . 0.0 112.219 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -59.95 148.76 87.54 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.291 2.661 . . . . 0.0 111.953 171.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.71 -19.17 65.7 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -91.93 -10.04 40.93 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.033 1.333 . . . . 0.0 114.556 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.1 134.36 51.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.272 1.029 . . . . 0.0 112.495 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.62 -176.78 19.76 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.402 1.477 . . . . 0.0 112.213 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -62.25 -32.49 73.2 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -78.13 -29.57 48.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.967 0.907 . . . . 0.0 112.268 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -70.45 -40.33 73.79 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.741 0.7 . . . . 0.0 110.692 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.37 -36.71 79.6 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.953 0.501 . . . . 0.0 111.745 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -62.27 -49.7 74.65 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.917 0.78 . . . . 0.0 110.947 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -67.96 -22.97 65.01 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.7 ttm -73.96 -27.82 61.18 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.024 0.93 . . . . 0.0 113.108 171.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -112.58 -16.37 12.85 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -171.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.7 mtm -53.92 -33.92 18.0 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -59.15 -16.17 32.13 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.492 2.794 . . . . 0.0 116.325 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -99.85 -10.22 22.0 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.42 -159.66 28.08 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 124.657 1.122 . . . . 0.0 114.909 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.34 92.83 1.85 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.201 1.0 . . . . 0.0 112.201 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.5 t -72.1 128.12 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.951 1.3 . . . . 0.0 110.018 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.93 -31.9 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.126 2.17 . . . . 0.0 111.494 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.9 t -157.64 151.12 23.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.458 1.103 . . . . 0.0 110.916 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.06 132.15 14.36 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.246 1.418 . . . . 0.0 110.19 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -153.68 132.44 12.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.43 0.692 . . . . 0.0 112.005 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 64.0 t -103.25 135.03 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.653 1.581 . . . . 0.0 107.27 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -82.64 127.71 33.64 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 48.3 mt -127.64 140.67 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.287 1.435 . . . . 0.0 110.15 -168.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -84.71 126.82 33.73 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.73 0.812 . . . . 0.0 111.366 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -66.78 -11.78 56.3 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -84.8 -21.15 30.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.126 0.97 . . . . 0.0 112.632 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 73.7 p -133.53 -18.75 2.17 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -172.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 58.6 t30 62.4 19.26 10.99 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.135 1.774 . . . . 0.0 112.857 -171.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.3 mt -95.34 149.15 21.67 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.153 1.381 . . . . 0.0 111.402 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.7 t -56.77 136.75 55.29 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.324 1.049 . . . . 0.0 111.615 169.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -75.38 5.37 5.81 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.393 1.077 . . . . 0.0 113.085 170.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 58.3 m 74.27 18.99 2.95 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.575 2.75 . . . . 0.0 113.206 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.15 156.77 43.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.991 0.814 . . . . 0.0 112.382 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.93 -175.16 28.54 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.85 1.69 . . . . 0.0 113.708 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -141.57 144.25 34.15 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.542 1.937 . . . . 0.0 110.111 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.1 t -144.33 140.67 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.203 1.401 . . . . 0.0 108.765 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 88.3 p -135.8 153.1 51.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.648 0.779 . . . . 0.0 112.36 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -126.6 164.89 20.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.213 1.405 . . . . 0.0 113.078 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.98 -10.88 59.78 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.488 1.115 . . . . 0.0 113.007 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.74 145.51 28.3 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.062 1.345 . . . . 0.0 111.744 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.69 -29.78 69.38 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.464 2.776 . . . . 0.0 113.718 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.14 -41.57 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.815 0.846 . . . . 0.0 111.382 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.4 p -66.83 -31.13 71.54 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.605 0.762 . . . . 0.0 112.377 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -68.9 -49.8 55.02 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.769 0.828 . . . . 0.0 111.849 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -58.93 -39.37 81.38 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.582 -0.699 . . . . 0.0 111.941 175.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.44 -28.82 65.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 174.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.65 -43.66 30.67 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.652 0.66 . . . . 0.0 112.036 171.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.1 mt -58.12 -49.96 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 119.479 1.036 . . . . 0.0 110.408 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -73.79 -11.71 60.47 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.5 m -100.1 -30.65 11.83 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.5 mmm -111.66 -19.77 12.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -169.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.71 111.54 5.56 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.286 0.948 . . . . 0.0 109.903 173.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.01 3.31 65.76 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.404 1.478 . . . . 0.0 115.104 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -63.86 124.28 21.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.438 1.619 . . . . 0.0 111.258 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -81.04 131.3 35.3 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.263 0.554 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.2 tt -141.89 109.83 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.247 1.419 . . . . 0.0 108.447 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.88 -122.48 22.04 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -169.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.56 13.26 34.96 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.351 1.46 . . . . 0.0 113.501 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -142.05 173.15 11.78 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.742 1.217 . . . . 0.0 113.382 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -123.44 133.4 54.07 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.968 1.307 . . . . 0.0 111.417 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.2 mt -68.12 160.5 28.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.276 1.43 . . . . 0.0 111.787 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -133.14 143.4 49.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.246 1.418 . . . . 0.0 109.67 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 30.1 t -138.44 136.02 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.648 1.179 . . . . 0.0 109.172 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -140.71 154.9 46.53 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.451 1.101 . . . . 0.0 111.173 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.15 155.64 38.24 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 122.317 1.056 . . . . 0.0 111.802 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -58.47 128.18 35.85 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.709 0.804 . . . . 0.0 111.162 169.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 72.58 20.06 3.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.551 1.94 . . . . 0.0 114.338 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 38.6 m -65.51 152.87 42.98 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.513 -1.367 . . . . 0.0 112.614 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -137.34 157.85 45.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.643 1.577 . . . . 0.0 111.847 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -158.63 146.22 17.91 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.246 1.418 . . . . 0.0 111.556 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -156.92 149.15 23.05 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.82 1.648 . . . . 0.0 111.018 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 65.5 p -113.02 5.27 17.12 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -171.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -140.81 -21.23 0.8 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -170.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 71.8 m -76.45 149.6 36.8 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.679 1.127 . . . . 0.0 112.282 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -163.39 178.44 38.97 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 124.74 1.162 . . . . 0.0 114.009 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.96 162.77 36.65 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.225 3.283 . . . . 0.0 111.969 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 48.5 p -76.94 0.93 19.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.865 1.266 . . . . 0.0 113.94 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 15.6 m -72.3 -8.89 57.34 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.679 1.592 . . . . 0.0 114.708 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.242 1.401 . . . . 0.0 112.985 179.319 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 36.5 t -163.09 150.02 12.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.981 1.312 . . . . 0.0 111.393 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 53.1 p -85.31 -5.63 59.3 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.762 1.225 . . . . 0.0 113.336 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -76.08 0.43 62.87 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.274 1.416 . . . . 0.0 115.332 -174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 23.9 m -73.85 -4.46 34.97 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.093 1.357 . . . . 0.0 114.207 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.2 t -159.32 166.13 31.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.792 1.637 . . . . 0.0 111.303 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 76.82 -140.87 25.58 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.469 1.033 . . . . 0.0 112.945 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -158.94 168.53 26.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.345 1.858 . . . . 0.0 111.681 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.0 p -99.08 173.27 6.9 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.845 1.258 . . . . 0.0 111.497 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -100.82 15.14 29.41 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.992 1.317 . . . . 0.0 110.458 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.95 -17.34 5.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.681 1.192 . . . . 0.0 113.688 -170.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 56.9 p -78.53 2.49 18.94 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.89 -10.55 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.487 1.515 . . . . 0.0 113.914 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -74.21 154.43 47.82 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.77 1.176 . . . . 0.0 112.041 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -102.23 -49.79 3.8 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -172.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.22 120.25 12.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.103 0.961 . . . . 0.0 111.262 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.81 -6.79 82.73 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.517 1.532 . . . . 0.0 113.272 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 6.8 t -84.03 158.0 21.62 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.676 1.238 . . . . 0.0 112.64 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -128.78 14.39 6.41 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.041 1.336 . . . . 0.0 112.34 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -68.13 177.16 2.35 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.394 -0.816 . . . . 0.0 110.349 167.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -154.74 157.66 38.36 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.235 -0.916 . . . . 0.0 112.079 168.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.59 -158.42 24.17 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.176 1.37 . . . . 0.0 113.314 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.31 160.73 43.85 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.216 2.611 . . . . 0.0 111.439 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.87 123.4 18.39 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.828 -0.545 . . . . 0.0 110.928 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.96 -9.07 58.0 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.013 1.292 . . . . 0.0 113.752 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.17 20.19 10.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.169 1.387 . . . . 0.0 112.728 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 120.38 30.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.434 1.493 . . . . 0.0 110.052 -167.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.92 139.77 53.52 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.239 1.815 . . . . 0.0 112.372 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -112.14 133.37 54.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.213 1.405 . . . . 0.0 108.993 167.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -118.46 136.08 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.19 1.796 . . . . 0.0 107.748 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -133.55 160.77 36.48 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.185 1.394 . . . . 0.0 112.404 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 67.49 30.34 6.82 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.266 2.226 . . . . 0.0 113.478 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.38 155.65 90.34 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.889 0.876 . . . . 0.0 111.257 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.68 151.91 52.27 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.291 2.661 . . . . 0.0 111.981 169.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -70.48 -15.28 62.79 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.329 1.052 . . . . 0.0 113.517 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -102.89 -4.75 24.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.482 1.913 . . . . 0.0 114.29 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.29 134.51 52.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.925 1.29 . . . . 0.0 112.105 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -111.27 -179.14 20.25 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.105 1.336 . . . . 0.0 113.147 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -66.99 -31.84 72.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.455 0.702 . . . . 0.0 112.838 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -73.18 -35.89 66.47 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.353 1.061 . . . . 0.0 112.003 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -64.95 -41.69 95.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.909 0.484 . . . . 0.0 110.857 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -69.44 -42.2 75.27 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.973 -0.537 . . . . 0.0 112.035 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.1 tp -58.64 -54.81 42.91 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.742 0.701 . . . . 0.0 111.501 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -75.58 -15.53 60.35 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -170.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.4 ttp -80.71 -20.76 42.14 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.125 0.97 . . . . 0.0 112.738 169.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -105.71 -15.33 14.99 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.553 1.541 . . . . 0.0 114.013 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 37.1 mtt -47.89 -37.37 13.46 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 168.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -62.07 -16.9 53.21 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.976 2.451 . . . . 0.0 115.696 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -99.37 -8.34 24.95 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.94 0.896 . . . . 0.0 113.327 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 148.48 -167.28 29.14 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.324 1.44 . . . . 0.0 114.447 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -75.06 97.42 3.41 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.615 1.166 . . . . 0.0 112.792 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.25 132.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.558 1.543 . . . . 0.0 110.263 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.66 -35.41 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 127.07 2.148 . . . . 0.0 111.39 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 24.0 m -150.77 147.41 27.27 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.19 1.396 . . . . 0.0 110.896 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.26 134.19 14.88 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.846 1.658 . . . . 0.0 109.187 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -154.27 136.61 14.92 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.727 -0.608 . . . . 0.0 111.805 -168.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 84.1 t -112.62 132.08 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.238 1.415 . . . . 0.0 107.926 169.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -79.29 126.73 31.17 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 50.5 mt -131.36 141.25 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.386 1.475 . . . . 0.0 110.073 -169.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -86.48 130.59 34.44 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.654 0.782 . . . . 0.0 112.0 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.97 -12.66 61.18 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -85.4 -20.34 30.0 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.05 0.94 . . . . 0.0 112.694 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.6 p -133.9 -20.68 1.96 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.583 1.153 . . . . 0.0 114.039 -172.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 62.96 19.13 11.4 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.355 1.862 . . . . 0.0 113.045 -171.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.61 148.99 21.59 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.006 1.323 . . . . 0.0 111.464 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.0 t -59.22 136.38 57.94 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.298 1.039 . . . . 0.0 111.85 170.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -76.18 6.72 5.02 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.795 1.238 . . . . 0.0 113.307 170.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 23.3 m 75.06 19.3 2.35 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.166 2.586 . . . . 0.0 113.074 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -149.21 158.48 44.22 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.618 0.767 . . . . 0.0 112.051 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.55 -177.67 31.85 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.696 1.617 . . . . 0.0 113.599 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -137.42 145.77 43.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.392 1.877 . . . . 0.0 110.021 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 94.9 t -143.41 143.91 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.204 1.402 . . . . 0.0 108.532 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 8.1 t -143.77 145.61 32.51 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.394 -0.816 . . . . 0.0 112.146 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -114.74 167.5 10.71 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.41 1.884 . . . . 0.0 112.225 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.63 -16.89 63.46 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -144.86 149.51 43.06 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.967 1.307 . . . . 0.0 112.168 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.91 -27.88 58.58 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.721 2.947 . . . . 0.0 113.66 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.46 -40.27 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.884 0.873 . . . . 0.0 110.927 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 15.3 m -62.73 -33.49 75.25 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.687 0.795 . . . . 0.0 111.833 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.14 -47.34 36.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.731 1.212 . . . . 0.0 112.083 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -61.17 -34.83 75.68 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.125 0.97 . . . . 0.0 112.041 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.39 70.4 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.476 0.711 . . . . 0.0 112.803 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.06 47.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.26 0.624 . . . . 0.0 111.163 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.05 -46.85 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 119.335 0.97 . . . . 0.0 110.304 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -69.85 -14.6 62.83 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.0 m -104.21 -26.48 12.5 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.7 mmm -115.08 -19.28 10.94 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -71.02 110.5 5.75 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.321 0.964 . . . . 0.0 110.186 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.73 2.34 65.11 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.766 1.65 . . . . 0.0 114.857 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -61.16 123.97 19.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.453 1.626 . . . . 0.0 111.669 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -78.37 131.3 36.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.128 0.489 . . . . 0.0 110.412 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.1 tt -135.29 86.79 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.043 1.337 . . . . 0.0 108.852 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 74.8 -118.19 5.64 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -169.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -99.79 12.9 35.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.446 1.498 . . . . 0.0 113.454 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -139.8 166.81 23.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.784 1.634 . . . . 0.0 112.533 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -122.94 138.01 54.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.882 1.273 . . . . 0.0 111.587 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.74 161.59 29.49 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.118 1.367 . . . . 0.0 112.588 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -130.97 141.55 50.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.596 1.558 . . . . 0.0 108.781 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.02 138.46 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.392 1.077 . . . . 0.0 109.43 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -147.5 151.13 35.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.548 1.139 . . . . 0.0 110.791 -174.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.33 157.54 25.88 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.914 0.864 . . . . 0.0 111.787 168.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -65.61 -27.68 68.58 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.523 1.129 . . . . 0.0 113.26 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -162.81 153.36 16.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.96 1.704 . . . . 0.0 110.796 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 74.1 p -145.27 157.84 43.97 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.604 1.562 . . . . 0.0 110.9 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -109.92 -3.53 16.52 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -162.19 151.68 15.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.786 1.635 . . . . 0.0 112.064 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -123.72 7.16 8.79 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.17 1.788 . . . . 0.0 113.081 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 59.1 m -148.94 157.92 43.79 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.716 2.006 . . . . 0.0 111.36 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 45.0 tttp 76.36 133.29 0.05 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.677 2.791 . . . . 0.0 113.887 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 67.5 m -149.86 151.77 34.01 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.836 1.654 . . . . 0.0 110.742 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 80.18 -141.66 23.39 Favored Glycine 0 CA--C 1.542 1.755 0 CA-C-O 118.519 -1.156 . . . . 0.0 112.671 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -76.61 176.26 10.31 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.881 3.054 . . . . 0.0 111.881 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.6 m -59.94 -25.95 65.58 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.981 0.912 . . . . 0.0 113.276 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 21.9 m -86.23 -2.04 58.01 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.278 1.431 . . . . 0.0 113.786 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.634 1.587 . . . . 0.0 113.892 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.039 -0.424 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 29.4 t -163.58 158.05 20.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.337 1.455 . . . . 0.0 111.234 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 53.6 p -82.14 -11.63 58.63 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.344 1.058 . . . . 0.0 113.133 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -89.24 150.63 21.48 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.192 1.377 . . . . 0.0 112.123 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 77.7 p -167.96 -46.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.657 1.183 . . . . 0.0 112.87 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 80.7 p -165.89 168.28 15.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.411 1.484 . . . . 0.0 111.782 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -177.73 164.03 32.78 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.265 0.936 . . . . 0.0 113.715 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.27 149.02 45.3 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.708 1.603 . . . . 0.0 110.278 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 24.2 p -144.43 145.33 31.85 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.29 1.836 . . . . 0.0 110.355 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -140.89 89.72 2.28 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 109.3 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -163.56 145.32 9.46 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.388 1.475 . . . . 0.0 110.064 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 22.7 t -159.93 118.82 2.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.898 1.279 . . . . 0.0 109.923 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.74 -3.83 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 84.19 143.43 5.8 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.176 1.37 . . . . 0.0 113.011 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 67.87 -54.13 0.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.824 2.85 . . . . 0.0 113.629 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -68.39 113.17 5.73 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.965 1.306 . . . . 0.0 110.3 173.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 87.44 -5.2 85.44 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.922 1.249 . . . . 0.0 113.375 -176.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 40.4 m -78.21 158.52 28.96 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.902 1.281 . . . . 0.0 111.371 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -131.7 27.79 4.62 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.441 1.096 . . . . 0.0 112.086 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -71.95 171.03 12.55 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.386 -0.822 . . . . 0.0 110.47 167.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.09 156.23 35.48 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 169.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -87.43 -158.44 32.72 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.898 1.713 . . . . 0.0 114.172 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.7 165.84 26.25 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.544 2.829 . . . . 0.0 111.625 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.95 125.72 24.76 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.597 -0.689 . . . . 0.0 111.274 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.5 -6.64 68.15 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.75 1.167 . . . . 0.0 113.689 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.81 18.41 14.55 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.211 1.404 . . . . 0.0 112.824 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.25 119.95 27.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.519 1.527 . . . . 0.0 109.779 -168.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 33.5 mt -124.86 133.9 52.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.122 1.769 . . . . 0.0 112.087 -168.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -105.11 134.25 48.52 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.964 1.306 . . . . 0.0 108.673 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 9.4 mm -118.24 137.72 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.897 1.679 . . . . 0.0 108.526 -169.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -137.06 161.68 35.42 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.487 1.115 . . . . 0.0 112.492 -175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 62.57 34.39 15.15 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.259 1.824 . . . . 0.0 113.14 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.23 158.46 86.61 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.218 1.407 . . . . 0.0 111.818 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.85 142.6 99.15 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.82 2.347 . . . . 0.0 111.26 169.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -68.44 -9.18 46.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.519 1.127 . . . . 0.0 113.644 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -98.53 -10.79 22.98 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.826 1.65 . . . . 0.0 113.922 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.54 132.31 40.64 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.937 1.295 . . . . 0.0 112.132 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.69 -172.62 18.72 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.282 1.42 . . . . 0.0 113.274 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -67.64 -34.43 76.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.953 0.901 . . . . 0.0 113.219 -172.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -77.81 -30.89 51.41 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.542 0.737 . . . . 0.0 111.756 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -67.01 -43.5 82.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.16 0.584 . . . . 0.0 110.396 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 26.5 tp -65.48 -43.27 90.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.291 0.637 . . . . 0.0 111.636 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.53 -54.1 50.72 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.599 0.76 . . . . 0.0 111.259 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -73.95 -20.72 60.27 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.8 ttp -76.59 -22.61 54.0 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.031 0.832 . . . . 0.0 113.016 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -102.77 -16.3 16.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.077 1.351 . . . . 0.0 113.754 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 36.6 mtt -47.63 -38.03 15.23 Favored Pre-proline 0 CA--C 1.552 1.035 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -62.26 -17.73 58.63 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.158 2.572 . . . . 0.0 115.54 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -97.7 -9.94 25.85 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.0 0.92 . . . . 0.0 113.325 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.38 -164.17 28.39 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.371 1.462 . . . . 0.0 114.518 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.69 100.63 2.87 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.972 0.909 . . . . 0.0 111.874 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.3 t -76.73 127.09 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.876 1.27 . . . . 0.0 109.874 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 43.0 t -86.86 -35.51 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.502 1.921 . . . . 0.0 111.246 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.8 m -161.79 151.21 16.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.736 1.614 . . . . 0.0 110.636 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.91 132.97 12.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.07 1.748 . . . . 0.0 109.977 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -154.22 148.32 25.78 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.49 130.14 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 126.699 2.0 . . . . 0.0 107.685 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -83.39 143.77 30.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 111.511 -175.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 37.5 mm -121.2 135.87 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.513 1.525 . . . . 0.0 110.004 -169.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -82.38 124.86 30.4 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.834 0.854 . . . . 0.0 111.419 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -69.52 -7.6 39.66 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -90.98 -17.89 25.57 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.602 1.161 . . . . 0.0 112.777 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 79.7 p -137.43 -19.32 1.24 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 40.4 t30 66.17 14.86 9.85 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.388 1.875 . . . . 0.0 113.262 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.78 155.89 16.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.276 1.43 . . . . 0.0 110.664 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 89.8 p -72.97 146.8 45.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.277 1.036 . . . . 0.0 112.675 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -81.15 3.5 23.36 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.454 1.101 . . . . 0.0 113.886 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 83.0 m 62.87 22.03 13.18 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.652 1.981 . . . . 0.0 113.364 -172.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -141.76 155.48 45.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.116 0.966 . . . . 0.0 111.67 172.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.27 -172.33 24.35 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.831 1.681 . . . . 0.0 113.912 -169.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -143.75 147.36 34.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.945 1.698 . . . . 0.0 110.257 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 59.7 t -144.0 145.65 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.765 1.626 . . . . 0.0 108.976 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.2 t -143.14 151.81 41.1 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.216 -0.927 . . . . 0.0 112.55 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -120.94 164.64 16.39 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.015 1.726 . . . . 0.0 113.247 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.11 -18.67 64.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.347 1.059 . . . . 0.0 113.143 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -145.28 150.21 44.02 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.118 1.367 . . . . 0.0 112.222 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.71 -29.22 60.0 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.797 2.998 . . . . 0.0 113.845 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.58 -38.4 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.779 0.832 . . . . 0.0 110.852 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.3 m -62.54 -35.19 78.65 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.003 0.921 . . . . 0.0 111.695 171.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.42 -47.83 46.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.571 1.148 . . . . 0.0 112.007 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -60.28 -35.46 75.6 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.03 0.932 . . . . 0.0 112.113 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.03 71.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.566 0.746 . . . . 0.0 112.685 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.92 56.01 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.298 0.639 . . . . 0.0 111.196 174.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.48 -46.62 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 119.434 1.015 . . . . 0.0 110.362 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -69.6 -15.82 63.28 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.1 m -104.54 -23.12 13.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.5 mmt -113.37 -22.89 10.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.898 1.279 . . . . 0.0 113.626 -171.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -71.41 113.44 8.45 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.974 1.261 . . . . 0.0 110.698 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.68 4.13 83.03 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.554 1.55 . . . . 0.0 114.626 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -63.34 126.47 27.56 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.904 1.352 . . . . 0.0 111.171 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -85.04 130.93 34.53 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.115 0.566 . . . . 0.0 110.866 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.6 tt -149.46 126.89 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.425 1.49 . . . . 0.0 109.799 -170.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.0 -98.86 0.32 Allowed Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -173.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 89.0 mtp -136.31 19.66 3.16 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.404 1.881 . . . . 0.0 112.322 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -138.48 175.5 9.52 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.758 1.623 . . . . 0.0 112.282 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -125.69 132.93 52.31 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.334 1.053 . . . . 0.0 111.517 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.4 mt -68.72 163.35 24.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.405 1.482 . . . . 0.0 112.618 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -139.57 142.33 37.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.417 1.487 . . . . 0.0 108.83 168.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.46 139.79 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.314 1.046 . . . . 0.0 109.452 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -144.86 148.13 33.61 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.316 1.046 . . . . 0.0 110.931 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.24 155.33 28.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.962 0.887 . . . . 0.0 112.256 168.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -65.1 137.8 57.9 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.358 1.063 . . . . 0.0 111.058 168.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -63.02 -40.94 99.24 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.471 1.108 . . . . 0.0 113.864 -170.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 10.4 t -168.78 166.79 11.43 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.682 1.593 . . . . 0.0 110.709 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -135.22 119.83 18.18 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.261 1.425 . . . . 0.0 111.329 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -84.63 -17.71 37.78 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.19 0.996 . . . . 0.0 113.093 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -83.42 97.72 9.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.135 1.774 . . . . 0.0 110.492 173.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 18.0 t -166.58 151.5 7.79 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.197 1.399 . . . . 0.0 111.628 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -159.39 154.17 24.59 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.198 1.799 . . . . 0.0 110.718 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 32.6 p -72.31 -8.19 53.57 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 173.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 110.69 -107.88 2.32 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.518 1.533 . . . . 0.0 112.486 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.78 170.29 19.96 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.79 2.993 . . . . 0.0 112.553 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 74.5 m -141.72 144.95 34.31 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.575 1.55 . . . . 0.0 110.945 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 16.0 m -78.0 -5.09 50.18 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -171.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.209 0 C-N-CA 125.527 1.536 . . . . 0.0 112.945 -178.832 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 36.8 p -71.38 -16.0 62.4 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.306 -1.114 . . . . 0.0 113.794 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 42.2 p -85.44 -3.42 58.85 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.905 1.682 . . . . 0.0 113.971 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 127.5 179.05 15.61 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.786 1.66 . . . . 0.0 114.053 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 57.9 p -113.17 2.61 15.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.517 1.527 . . . . 0.0 114.144 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 91.9 p -161.37 167.35 25.89 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.445 1.498 . . . . 0.0 112.174 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -155.48 171.18 33.54 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.021 1.296 . . . . 0.0 113.673 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -151.66 14.75 0.66 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.243 1.417 . . . . 0.0 114.118 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 46.3 p -140.54 170.51 15.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.937 2.095 . . . . 0.0 110.794 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -150.15 139.46 21.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.965 1.306 . . . . 0.0 109.742 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -106.22 9.79 32.02 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.245 1.018 . . . . 0.0 113.201 -171.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 3.4 m -77.54 7.02 6.04 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.058 1.343 . . . . 0.0 114.426 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.21 -13.11 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.139 1.376 . . . . 0.0 113.982 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -138.85 146.62 18.39 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.37 1.938 . . . . 0.0 110.934 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.76 -34.44 71.83 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -71.37 120.83 17.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.437 1.095 . . . . 0.0 111.52 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.25 -3.37 85.51 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.195 1.855 . . . . 0.0 113.889 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 38.8 t -74.69 156.03 37.1 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.667 1.187 . . . . 0.0 112.498 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -118.43 10.34 12.66 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.016 1.326 . . . . 0.0 112.519 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -64.95 165.43 10.89 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.268 -0.895 . . . . 0.0 112.273 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.66 163.83 36.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.205 1.002 . . . . 0.0 112.433 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -102.42 -161.51 26.17 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 126.102 1.81 . . . . 0.0 113.685 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.73 178.98 6.45 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.055 3.17 . . . . 0.0 112.791 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -54.68 123.88 14.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.796 1.238 . . . . 0.0 111.696 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.33 -5.06 85.72 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.692 1.139 . . . . 0.0 114.694 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.22 -3.38 53.87 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.808 1.304 . . . . 0.0 114.439 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -114.49 124.68 52.51 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.51 1.124 . . . . 0.0 111.263 -168.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.8 mt -124.68 141.85 51.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.625 1.97 . . . . 0.0 112.69 -168.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -112.18 134.58 53.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.588 1.555 . . . . 0.0 109.035 168.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.31 136.24 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.932 1.693 . . . . 0.0 108.249 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -134.23 159.9 39.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.879 1.272 . . . . 0.0 112.865 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 70.45 27.72 3.86 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.945 2.498 . . . . 0.0 113.898 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.89 155.45 86.64 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.828 1.251 . . . . 0.0 112.054 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.48 150.3 69.29 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.019 2.48 . . . . 0.0 111.557 168.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -69.83 -11.82 61.16 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.447 1.099 . . . . 0.0 113.709 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.08 -7.61 16.82 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.895 2.078 . . . . 0.0 113.799 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.47 116.68 14.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.09 1.356 . . . . 0.0 110.429 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -99.28 -175.7 31.55 Favored Glycine 0 N--CA 1.467 0.757 0 C-N-CA 124.19 0.9 . . . . 0.0 113.743 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.14 -35.45 78.8 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.477 1.111 . . . . 0.0 112.631 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -77.52 -31.05 53.21 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.081 0.953 . . . . 0.0 111.981 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -70.82 -41.6 71.36 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.791 0.723 . . . . 0.0 110.715 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.5 tp -64.61 -42.28 95.65 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.217 0.607 . . . . 0.0 111.144 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.88 -51.01 71.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.325 0.65 . . . . 0.0 111.229 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -71.24 -20.07 62.28 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.5 ttp -82.92 -21.63 34.11 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.043 0.838 . . . . 0.0 113.044 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -106.17 -23.23 12.64 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.1 mtm -54.3 -33.02 13.24 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 170.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -58.09 -18.22 35.33 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.627 2.885 . . . . 0.0 115.787 174.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -94.82 -12.16 27.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.231 0.923 . . . . 0.0 113.41 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.8 -157.78 27.47 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.926 1.251 . . . . 0.0 115.027 170.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -74.06 84.23 1.79 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.261 1.024 . . . . 0.0 112.757 -169.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 84.8 t -66.79 127.87 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.872 1.269 . . . . 0.0 109.707 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 55.6 t -91.46 -35.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.011 1.724 . . . . 0.0 110.978 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 27.5 m -158.73 147.36 18.54 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.528 1.531 . . . . 0.0 110.854 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.46 140.28 20.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.828 1.651 . . . . 0.0 110.439 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -154.41 149.22 26.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.635 0.774 . . . . 0.0 112.887 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.89 137.19 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.428 1.891 . . . . 0.0 108.535 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -86.9 134.98 33.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.845 0.858 . . . . 0.0 110.692 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 30.7 mm -119.16 139.55 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.445 1.498 . . . . 0.0 110.42 -169.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.5 126.24 34.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.007 0.923 . . . . 0.0 111.571 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -65.05 -18.17 65.07 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -80.38 -23.21 40.63 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.171 -0.955 . . . . 0.0 112.828 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 76.4 p -133.81 -16.86 2.24 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 56.7 t30 63.37 16.83 9.82 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.294 1.838 . . . . 0.0 112.816 -169.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.1 mt -95.55 156.75 16.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.2 1.4 . . . . 0.0 111.213 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 58.8 m -77.09 137.99 39.26 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.468 1.107 . . . . 0.0 112.082 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -75.33 8.8 2.47 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.343 1.457 . . . . 0.0 114.402 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 50.6 m 71.33 18.28 5.65 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.602 2.361 . . . . 0.0 113.935 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -145.15 154.79 42.82 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.504 1.047 . . . . 0.0 112.357 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.01 -172.34 25.98 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.948 1.737 . . . . 0.0 113.608 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -148.77 141.59 24.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.986 1.714 . . . . 0.0 109.95 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 61.3 t -146.22 136.32 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.908 1.283 . . . . 0.0 109.31 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 68.3 m -134.23 140.43 46.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.618 0.767 . . . . 0.0 112.293 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -110.08 168.85 9.13 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.804 1.642 . . . . 0.0 113.145 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.51 -21.15 66.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.401 1.481 . . . . 0.0 113.295 169.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -160.94 157.42 22.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.24 1.416 . . . . 0.0 112.378 -171.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.9 -16.09 40.88 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.7 2.267 . . . . 0.0 113.936 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.82 -44.19 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 120.459 1.481 . . . . 0.0 110.459 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.8 m -69.21 -30.91 69.18 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.967 0.907 . . . . 0.0 112.114 174.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -75.03 -47.13 30.57 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.851 0.86 . . . . 0.0 112.327 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -62.69 -32.57 73.68 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.469 -0.769 . . . . 0.0 111.806 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.59 70.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.14 -43.35 34.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.27 0.628 . . . . 0.0 111.174 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.03 -45.71 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.07 0.85 . . . . 0.0 110.351 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -70.76 -14.87 62.59 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.4 m -104.33 -22.94 13.27 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 2.1 mmt -114.15 -24.18 9.11 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 113.768 -170.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -71.69 112.48 7.83 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.687 1.13 . . . . 0.0 110.348 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.73 3.01 74.74 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.473 1.511 . . . . 0.0 114.683 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -64.41 127.68 32.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.11 1.455 . . . . 0.0 111.291 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -85.96 129.6 34.79 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.048 0.539 . . . . 0.0 110.951 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.6 tt -149.27 131.68 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.545 1.538 . . . . 0.0 110.108 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 68.33 -93.93 0.31 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 121.622 -0.674 . . . . 0.0 111.521 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 28.5 ptm -141.05 16.16 2.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.244 1.818 . . . . 0.0 113.101 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -145.12 177.98 8.39 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.431 1.492 . . . . 0.0 112.623 -172.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -122.91 133.9 54.38 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.51 1.124 . . . . 0.0 111.723 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.39 162.04 30.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.287 1.435 . . . . 0.0 112.521 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -130.91 139.17 50.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.232 1.413 . . . . 0.0 109.079 168.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 32.0 t -139.3 134.42 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.393 1.077 . . . . 0.0 109.259 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -146.71 159.35 43.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.023 0.929 . . . . 0.0 112.24 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 62.0 mt -66.38 152.71 44.49 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.095 0.958 . . . . 0.0 112.866 173.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -59.38 138.33 57.68 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.033 0.933 . . . . 0.0 110.614 168.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -59.61 141.67 54.48 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.562 0.745 . . . . 0.0 112.181 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 21.0 t -163.81 176.19 9.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.374 1.87 . . . . 0.0 109.6 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.71 -20.21 60.6 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.61 -1.306 . . . . 0.0 113.72 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -85.32 -15.04 44.61 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.112 1.765 . . . . 0.0 113.774 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -132.8 -10.08 3.09 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -168.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 19.5 m -83.33 81.88 8.52 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.795 1.238 . . . . 0.0 109.707 171.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -132.03 159.81 37.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.948 1.299 . . . . 0.0 113.196 -168.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 36.5 p -79.35 173.17 12.85 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.573 1.549 . . . . 0.0 113.437 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -76.62 177.16 51.84 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 124.711 1.148 . . . . 0.0 114.334 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.46 -8.45 17.22 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.278 3.319 . . . . 0.0 114.428 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 81.4 p -161.32 162.43 30.89 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.121 1.368 . . . . 0.0 111.819 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 78.0 p -144.65 5.94 1.21 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.136 1.35 . . . . 0.0 112.823 -179.438 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.8 m -67.85 -12.13 60.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -171.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 85.6 p -79.21 -10.1 59.73 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.072 1.349 . . . . 0.0 113.802 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 64.94 17.05 62.65 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.122 0.868 . . . . 0.0 113.176 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 20.6 m 72.01 10.26 6.1 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.242 2.217 . . . . 0.0 113.343 -169.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.7 t 68.23 -167.73 0.19 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.622 1.969 . . . . 0.0 113.535 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 89.75 -176.36 42.72 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.623 1.582 . . . . 0.0 113.479 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 49.0 tp -82.25 130.4 35.09 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.528 1.131 . . . . 0.0 111.052 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 62.3 p -134.0 30.21 3.68 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.949 1.7 . . . . 0.0 112.424 -174.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -54.85 -17.56 3.75 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.655 1.982 . . . . 0.0 116.344 -169.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -145.69 11.22 1.25 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.885 1.274 . . . . 0.0 112.858 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 16.4 m -73.81 -4.25 33.57 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.92 -1.112 . . . . 0.0 113.785 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.79 -11.36 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.247 2.219 . . . . 0.0 113.541 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -87.24 177.83 47.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.112 1.339 . . . . 0.0 112.926 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -156.51 -59.64 0.09 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.363 1.065 . . . . 0.0 111.968 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -64.76 114.93 4.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.898 0.879 . . . . 0.0 110.781 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 87.14 0.02 85.54 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.269 1.414 . . . . 0.0 113.563 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.4 t -98.43 170.51 8.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.303 1.052 . . . . 0.0 111.898 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -132.42 32.35 3.94 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.179 1.392 . . . . 0.0 111.28 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -67.74 164.75 18.74 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.498 -0.751 . . . . 0.0 110.329 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -155.99 161.61 40.45 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.53 -159.32 24.89 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.055 1.788 . . . . 0.0 113.61 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.94 171.99 15.51 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.956 3.104 . . . . 0.0 112.85 -172.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.68 123.46 16.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.019 0.928 . . . . 0.0 111.381 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.62 -3.78 78.79 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.798 1.189 . . . . 0.0 114.584 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.72 1.41 53.4 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.908 1.354 . . . . 0.0 114.355 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -118.27 124.31 47.53 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.494 1.118 . . . . 0.0 110.884 -169.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 18.9 mt -123.62 146.78 47.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.796 2.038 . . . . 0.0 113.052 -168.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -117.43 135.09 54.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.718 1.607 . . . . 0.0 109.099 168.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -119.84 137.36 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.181 1.792 . . . . 0.0 107.831 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -134.99 161.3 35.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.128 1.371 . . . . 0.0 112.584 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 67.46 27.41 8.01 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.433 2.293 . . . . 0.0 113.92 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 67.7 mt -64.92 157.77 73.88 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.014 1.325 . . . . 0.0 112.06 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.53 147.48 91.42 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.992 2.461 . . . . 0.0 111.434 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -69.73 -8.29 46.69 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.43 -8.09 15.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.511 1.924 . . . . 0.0 114.166 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.47 124.27 23.09 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.8 1.24 . . . . 0.0 110.805 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.25 -176.27 26.39 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.481 1.039 . . . . 0.0 114.065 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.35 -36.36 82.69 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.83 0.852 . . . . 0.0 112.782 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.59 -28.36 56.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.83 0.852 . . . . 0.0 111.769 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.1 -42.11 73.13 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.655 0.661 . . . . 0.0 110.646 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.8 tp -67.03 -36.41 82.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.184 0.594 . . . . 0.0 111.797 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.11 -51.68 66.91 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.686 0.675 . . . . 0.0 110.931 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -63.51 -28.43 69.94 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.0 ttm -72.62 -29.18 63.26 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.453 1.101 . . . . 0.0 113.159 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -109.51 -18.34 13.54 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 47.3 mtm -55.4 -32.24 12.02 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -58.09 -16.33 26.7 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.661 2.908 . . . . 0.0 116.291 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -100.34 -8.35 23.46 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.48 -163.44 28.48 Favored Glycine 0 N--CA 1.47 0.906 0 C-N-CA 125.173 1.368 . . . . 0.0 114.513 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -72.4 90.58 1.3 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.749 0.82 . . . . 0.0 112.026 -173.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 79.9 t -65.42 128.92 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.714 1.206 . . . . 0.0 109.843 172.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 37.5 t -91.62 -36.61 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.94 2.096 . . . . 0.0 110.913 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.85 152.8 25.4 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.618 1.167 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -155.35 133.39 11.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.505 1.122 . . . . 0.0 110.705 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -154.45 147.99 25.19 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.398 -0.814 . . . . 0.0 112.925 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.8 t -124.68 131.4 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 126.214 1.806 . . . . 0.0 107.899 172.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -84.45 139.86 31.9 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.504 0.722 . . . . 0.0 110.962 -175.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.5 mm -117.58 137.25 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.112 1.365 . . . . 0.0 110.838 -168.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.71 128.19 33.36 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.587 1.155 . . . . 0.0 111.763 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.15 -13.91 62.41 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -97.84 -16.75 19.66 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.143 0.977 . . . . 0.0 113.098 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.1 p -131.15 -16.5 3.16 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.804 1.242 . . . . 0.0 114.16 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.6 t30 63.57 14.81 8.38 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.255 1.822 . . . . 0.0 113.168 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 90.1 mt -88.6 154.93 19.93 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.221 1.408 . . . . 0.0 111.002 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 67.3 m -73.64 135.01 43.75 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.474 0.709 . . . . 0.0 111.283 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -71.65 8.56 1.09 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.478 1.511 . . . . 0.0 114.665 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 58.4 m 68.17 17.62 9.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.514 2.326 . . . . 0.0 113.582 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -144.46 154.77 43.28 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.585 1.084 . . . . 0.0 112.758 175.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.74 -177.64 31.03 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.982 1.754 . . . . 0.0 114.087 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -134.61 145.96 49.12 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.704 2.002 . . . . 0.0 110.193 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 92.5 t -144.78 138.75 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.826 1.25 . . . . 0.0 109.236 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 64.7 p -130.47 152.24 50.08 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.211 1.004 . . . . 0.0 112.074 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -125.77 163.82 22.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.344 1.457 . . . . 0.0 113.106 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -71.33 -18.46 62.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.031 0.932 . . . . 0.0 113.048 173.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -144.6 150.77 48.37 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.078 1.351 . . . . 0.0 112.197 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.76 -29.69 59.36 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.856 3.037 . . . . 0.0 113.722 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.08 -40.25 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.811 0.844 . . . . 0.0 110.963 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 8.8 m -61.95 -34.24 75.76 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.971 0.908 . . . . 0.0 111.817 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.79 -49.27 26.16 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.88 1.272 . . . . 0.0 112.029 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -60.93 -33.91 73.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.961 0.904 . . . . 0.0 112.15 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 -30.56 71.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.412 0.685 . . . . 0.0 112.611 172.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.3 -41.54 48.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.294 0.638 . . . . 0.0 111.451 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 45.5 mt -57.88 -47.47 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.014 0.824 . . . . 0.0 110.129 174.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.08 -14.69 62.4 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.8 m -101.94 -28.47 12.37 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 91.7 mmm -114.44 -19.13 11.32 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -169.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -70.33 110.28 5.19 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.289 0.949 . . . . 0.0 109.933 173.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.37 2.91 60.18 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.369 1.462 . . . . 0.0 114.933 -172.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.17 123.47 18.71 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.427 1.613 . . . . 0.0 111.587 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -79.0 130.53 35.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.222 0.609 . . . . 0.0 110.988 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -149.49 133.18 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.11 1.364 . . . . 0.0 110.43 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.06 -99.57 0.44 Allowed Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 59.3 mtt -133.84 17.9 3.86 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.333 1.853 . . . . 0.0 112.408 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -146.23 -178.02 5.92 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.628 1.571 . . . . 0.0 112.688 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -122.32 138.84 54.38 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.992 1.317 . . . . 0.0 111.774 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 66.9 mt -70.71 160.72 32.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.032 1.333 . . . . 0.0 111.75 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -132.3 141.9 49.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.226 1.41 . . . . 0.0 109.194 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.5 t -139.42 136.14 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.505 1.122 . . . . 0.0 109.062 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -145.73 165.22 29.42 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.018 1.327 . . . . 0.0 111.044 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.48 159.88 26.23 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.861 0.864 . . . . 0.0 111.859 169.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -49.85 115.26 1.31 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.411 1.484 . . . . 0.0 112.324 171.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -168.15 154.21 7.25 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.972 2.109 . . . . 0.0 109.714 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 9.6 t -152.3 162.47 41.12 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.705 1.202 . . . . 0.0 111.16 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 65.69 4.91 3.06 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.096 2.158 . . . . 0.0 115.08 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.29 -11.29 35.6 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.138 1.375 . . . . 0.0 113.374 -174.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -79.31 -13.61 59.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.755 1.222 . . . . 0.0 113.823 -173.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 19.3 m -61.62 -21.11 64.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.745 1.218 . . . . 0.0 114.113 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -70.22 -16.16 63.02 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.532 1.133 . . . . 0.0 113.059 173.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 49.5 m -115.81 11.96 15.74 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.876 1.67 . . . . 0.0 112.954 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -72.45 165.28 54.41 Favored Glycine 0 CA--C 1.543 1.804 0 C-N-CA 124.486 1.041 . . . . 0.0 113.739 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.49 152.47 60.12 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.997 3.132 . . . . 0.0 111.963 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 32.4 t -166.66 -47.09 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.809 1.244 . . . . 0.0 111.907 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 79.7 p -163.87 165.01 23.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.363 1.465 . . . . 0.0 111.762 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 CA-C-O 118.382 -1.232 . . . . 0.0 112.844 -179.225 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 112.091 -0.404 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 8.4 m -165.18 154.72 12.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.503 1.921 . . . . 0.0 110.651 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.0 m -80.33 -10.06 59.75 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.02 165.28 36.0 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.224 1.392 . . . . 0.0 113.521 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 5.1 t -157.54 6.29 0.14 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 60.4 m 67.18 4.11 3.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.286 1.834 . . . . 0.0 115.899 172.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 141.62 -137.24 7.9 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.163 1.364 . . . . 0.0 112.849 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 43.8 tp -61.96 142.33 57.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.892 1.277 . . . . 0.0 111.672 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.4 t -158.39 168.52 26.75 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.988 1.715 . . . . 0.0 110.662 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -70.71 121.6 18.26 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.253 1.021 . . . . 0.0 110.544 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -140.87 116.21 10.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.199 1.399 . . . . 0.0 107.918 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 59.5 p -111.08 9.36 22.02 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -168.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -6.0 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.318 1.447 . . . . 0.0 114.475 -177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 139.61 -143.64 14.12 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 125.635 1.588 . . . . 0.0 112.643 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.23 -18.35 63.15 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.97 120.26 12.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.622 1.569 . . . . 0.0 110.615 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.26 -2.4 71.22 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.456 1.027 . . . . 0.0 113.375 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.0 t -77.35 165.75 24.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.156 0.978 . . . . 0.0 112.093 174.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -134.09 23.19 3.84 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.017 1.327 . . . . 0.0 110.791 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -65.75 174.73 2.2 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.903 1.281 . . . . 0.0 111.751 168.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -156.26 161.53 40.23 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.791 0.836 . . . . 0.0 112.432 168.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.35 -163.19 29.47 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.965 1.745 . . . . 0.0 113.376 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.99 172.79 13.95 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.754 2.97 . . . . 0.0 112.43 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.51 128.39 36.95 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.495 0.664 . . . . 0.0 111.342 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.6 -10.2 75.24 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.796 1.189 . . . . 0.0 113.962 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.9 -5.73 47.24 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.639 1.22 . . . . 0.0 114.218 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -112.08 123.95 51.36 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.317 1.047 . . . . 0.0 110.55 -169.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.9 mt -124.07 143.26 50.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.675 1.99 . . . . 0.0 112.549 -168.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -112.92 134.26 54.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.417 1.487 . . . . 0.0 109.073 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.01 134.17 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.346 1.858 . . . . 0.0 107.737 -171.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -132.65 158.5 42.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.878 1.271 . . . . 0.0 112.694 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 71.69 27.33 2.93 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.604 2.362 . . . . 0.0 113.747 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 76.8 mt -65.13 161.11 51.56 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.986 1.315 . . . . 0.0 111.803 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.62 149.19 91.94 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.921 2.414 . . . . 0.0 110.845 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -67.7 -20.47 65.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -88.94 -11.18 45.16 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.53 129.1 38.83 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.504 1.122 . . . . 0.0 111.886 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.12 -173.95 23.48 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.296 1.427 . . . . 0.0 112.273 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.02 -33.48 73.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.757 0.823 . . . . 0.0 112.493 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -67.84 -44.98 75.92 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.099 1.76 . . . . 0.0 111.472 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.89 -40.92 95.84 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.974 0.91 . . . . 0.0 111.528 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 30.4 tp -67.13 -38.94 86.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.267 0.627 . . . . 0.0 111.891 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 66.1 tp -63.11 -48.7 77.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.87 0.759 . . . . 0.0 111.077 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -67.88 -23.2 65.09 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.8 ttm -74.91 -25.91 59.25 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.112 0.965 . . . . 0.0 113.148 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -113.63 -16.67 12.31 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.4 mtm -54.16 -33.82 17.99 Favored Pre-proline 0 CA--C 1.549 0.914 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -58.99 -16.3 31.83 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.476 2.784 . . . . 0.0 116.296 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.12 -11.38 20.54 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 149.01 -163.06 29.07 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.931 1.253 . . . . 0.0 114.823 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -71.55 102.1 2.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.118 0.967 . . . . 0.0 112.385 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 69.7 t -80.44 128.69 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.071 1.348 . . . . 0.0 110.083 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.12 -22.44 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.956 2.502 . . . . 0.0 112.087 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 8.8 t -159.7 146.05 16.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.266 1.427 . . . . 0.0 110.341 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.58 129.39 10.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.196 1.399 . . . . 0.0 110.687 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -156.0 132.03 9.93 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.584 0.754 . . . . 0.0 112.557 -174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.9 135.14 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.486 1.514 . . . . 0.0 107.299 167.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -83.68 140.29 32.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.275 0.63 . . . . 0.0 111.295 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.2 mm -123.11 141.96 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.778 1.631 . . . . 0.0 110.306 -168.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.75 132.73 34.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.506 0.67 . . . . 0.0 112.798 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -62.73 -22.52 66.59 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -85.49 -22.68 28.09 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.019 0.928 . . . . 0.0 112.846 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 73.6 p -134.16 -17.45 2.1 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -170.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 60.66 17.28 7.37 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.028 1.731 . . . . 0.0 113.386 -169.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.7 mt -87.68 153.23 21.54 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.743 1.217 . . . . 0.0 111.05 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 56.5 m -77.18 136.24 38.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.586 0.755 . . . . 0.0 112.099 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -75.11 5.54 5.22 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.23 1.412 . . . . 0.0 114.682 -175.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.1 m 66.87 21.62 10.37 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.067 2.147 . . . . 0.0 113.207 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -146.52 156.17 43.06 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.129 0.972 . . . . 0.0 111.687 172.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.58 -177.71 29.09 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.868 1.699 . . . . 0.0 113.767 -170.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -138.58 141.16 39.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.015 2.126 . . . . 0.0 109.901 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 94.9 t -144.03 137.31 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.076 1.35 . . . . 0.0 108.867 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.0 m -131.03 148.43 52.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.474 0.71 . . . . 0.0 112.068 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -117.57 170.24 8.91 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.405 1.482 . . . . 0.0 113.287 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.52 -25.02 67.01 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.381 1.472 . . . . 0.0 113.648 170.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -160.12 162.2 24.57 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.096 1.358 . . . . 0.0 112.109 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.98 -13.52 31.65 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.332 2.021 . . . . 0.0 114.03 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 22.8 t -75.4 -45.92 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 121.032 1.742 . . . . 0.0 110.892 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.5 p -69.73 -32.52 71.11 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.811 0.844 . . . . 0.0 112.631 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -67.14 -49.0 66.37 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.365 0.666 . . . . 0.0 112.435 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -63.2 -31.71 72.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.376 -0.828 . . . . 0.0 112.056 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.79 70.47 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.7 0.682 . . . . 0.0 112.595 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.79 -42.0 51.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.717 0.689 . . . . 0.0 111.411 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.27 -47.22 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 118.914 0.779 . . . . 0.0 110.199 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -70.36 -15.45 62.86 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.0 m -99.78 -29.38 12.66 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 88.4 mmm -113.97 -19.93 11.24 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -71.68 110.6 6.34 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.441 1.019 . . . . 0.0 109.987 174.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 90.92 8.64 64.85 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.393 1.473 . . . . 0.0 114.433 -171.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.76 122.64 17.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.764 1.782 . . . . 0.0 110.568 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -74.36 131.88 41.51 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 122.063 -0.398 . . . . 0.0 110.292 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.8 tt -137.73 114.95 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.556 1.143 . . . . 0.0 108.579 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 63.21 -125.05 33.42 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -169.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.4 mmt -99.93 12.57 36.48 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.395 1.478 . . . . 0.0 113.504 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -135.41 176.82 8.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.228 1.411 . . . . 0.0 113.015 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -126.81 136.17 52.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.063 1.345 . . . . 0.0 110.946 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.18 155.96 40.13 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.854 1.262 . . . . 0.0 111.502 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.38 140.7 52.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.857 1.263 . . . . 0.0 109.46 169.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 23.4 t -139.61 136.27 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.541 1.136 . . . . 0.0 109.245 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -150.77 162.04 41.49 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.08 0.952 . . . . 0.0 112.097 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 75.4 mt -64.5 157.16 27.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.599 1.16 . . . . 0.0 113.071 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -65.51 -31.03 71.87 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.537 1.135 . . . . 0.0 113.152 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -90.06 136.29 33.14 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.072 1.349 . . . . 0.0 111.143 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 30.9 m -135.84 16.27 3.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.809 1.243 . . . . 0.0 113.232 -174.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -131.81 141.24 49.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.186 1.394 . . . . 0.0 112.488 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -154.91 122.11 5.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.569 1.548 . . . . 0.0 110.914 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -70.59 -22.22 62.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.312 1.045 . . . . 0.0 113.239 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 50.6 m -82.67 -6.24 59.27 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.986 0.915 . . . . 0.0 113.18 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt 52.77 -111.13 0.57 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.744 2.018 . . . . 0.0 113.086 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 62.7 m -150.83 155.93 40.21 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.27 1.828 . . . . 0.0 110.978 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -77.12 168.76 54.8 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 123.96 0.79 . . . . 0.0 113.671 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -75.96 -5.89 16.83 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.216 3.277 . . . . 0.0 113.913 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 24.1 p -81.09 1.87 29.76 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.52 1.528 . . . . 0.0 114.24 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 93.5 p -156.21 165.75 35.47 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.377 1.471 . . . . 0.0 112.718 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 CA-C-O 118.268 -1.296 . . . . 0.0 112.889 -178.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.996 -0.442 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 30.7 p -165.74 -54.16 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.475 1.11 . . . . 0.0 112.25 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.6 p -163.36 167.28 21.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.698 1.599 . . . . 0.0 112.214 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -77.33 147.23 32.66 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.293 0.949 . . . . 0.0 112.653 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 49.3 p -93.11 -4.96 51.37 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 44.4 m -70.8 118.6 13.78 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.917 -1.114 . . . . 0.0 112.339 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -86.91 137.81 15.05 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.431 1.015 . . . . 0.0 112.219 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 59.4 tp -163.97 121.48 1.77 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.594 1.558 . . . . 0.0 109.968 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 29.8 p -63.1 -34.38 77.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.292 1.037 . . . . 0.0 112.753 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -68.84 -8.89 47.87 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.906 1.282 . . . . 0.0 113.345 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -81.45 -13.89 57.69 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.987 -1.07 . . . . 0.0 112.439 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 52.0 m -79.7 48.87 0.97 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.151 1.38 . . . . 0.0 113.123 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.7 149.1 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.582 1.153 . . . . 0.0 113.571 -173.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 77.17 -59.93 3.56 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.56 1.552 . . . . 0.0 113.768 171.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -170.27 -38.82 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.143 1.777 . . . . 0.0 113.235 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -64.98 119.18 10.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.619 1.168 . . . . 0.0 110.816 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.6 -6.36 83.7 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.584 1.087 . . . . 0.0 113.281 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 7.6 t -86.92 160.21 18.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.461 1.131 . . . . 0.0 111.117 172.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -135.83 22.93 3.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.399 1.08 . . . . 0.0 112.477 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -68.81 173.96 4.8 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.314 -0.866 . . . . 0.0 111.676 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -148.88 158.44 44.17 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.756 0.822 . . . . 0.0 112.196 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.55 -160.95 27.99 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.994 1.759 . . . . 0.0 113.451 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.08 176.03 9.67 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.94 3.094 . . . . 0.0 112.576 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -56.32 124.67 18.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.266 1.026 . . . . 0.0 111.501 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.04 -7.64 81.27 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.811 1.196 . . . . 0.0 114.556 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.72 -5.21 54.04 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.919 1.359 . . . . 0.0 114.364 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -112.68 122.53 47.95 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.576 1.15 . . . . 0.0 110.676 -168.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.1 mt -123.32 141.65 51.77 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.562 1.945 . . . . 0.0 112.535 -168.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -111.09 134.83 52.39 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.574 1.549 . . . . 0.0 108.729 167.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.5 133.51 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.93 1.692 . . . . 0.0 107.791 -171.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -129.58 160.64 32.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.858 1.263 . . . . 0.0 112.22 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 65.8 38.37 5.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.07 1.748 . . . . 0.0 113.193 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 54.1 mt -71.59 161.45 78.45 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.104 1.362 . . . . 0.0 111.696 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.6 154.59 47.45 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.233 2.622 . . . . 0.0 111.469 168.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -68.12 -28.19 67.12 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.58 -11.19 57.66 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.83 128.25 35.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.405 1.082 . . . . 0.0 112.494 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.78 -171.55 18.29 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.796 1.665 . . . . 0.0 112.362 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -62.15 -35.51 79.02 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.838 0.855 . . . . 0.0 113.195 -174.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -74.16 -29.29 61.71 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.161 0.985 . . . . 0.0 112.089 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -76.12 -42.13 47.99 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.815 0.846 . . . . 0.0 110.695 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 32.8 tp -63.69 -38.01 89.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.359 0.664 . . . . 0.0 111.572 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.8 tp -63.69 -49.6 72.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.613 0.642 . . . . 0.0 111.116 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -68.81 -20.1 64.31 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.0 ttm -74.56 -26.85 60.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.945 0.898 . . . . 0.0 112.852 169.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -111.61 -19.44 12.51 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -172.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.3 mtm -53.72 -34.39 20.08 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -59.18 -17.31 38.25 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.505 2.803 . . . . 0.0 116.097 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.68 -10.79 21.52 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.32 -160.12 28.11 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.713 1.149 . . . . 0.0 115.033 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -74.06 96.07 2.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.15 0.98 . . . . 0.0 112.18 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.7 t -77.19 127.29 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.104 1.362 . . . . 0.0 109.677 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.53 -34.23 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.682 1.993 . . . . 0.0 111.319 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.8 m -160.07 147.37 16.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.533 1.533 . . . . 0.0 110.786 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.04 134.23 16.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.596 1.559 . . . . 0.0 110.129 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -153.64 132.65 12.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.48 0.712 . . . . 0.0 111.887 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 91.8 t -101.42 131.13 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.634 1.574 . . . . 0.0 107.169 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -78.92 138.22 37.99 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.19 0.519 . . . . 0.0 111.178 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.5 mm -120.71 137.38 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.619 1.568 . . . . 0.0 109.771 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -81.21 118.29 22.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.445 0.698 . . . . 0.0 110.569 172.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -68.05 -8.79 40.79 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -84.47 -22.92 30.11 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.161 0.985 . . . . 0.0 112.534 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 73.8 p -133.3 -14.77 2.57 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.73 1.212 . . . . 0.0 114.181 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 57.5 t30 65.28 19.01 11.59 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.701 2.0 . . . . 0.0 113.075 -172.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.0 mt -97.35 147.39 24.22 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.099 1.36 . . . . 0.0 111.591 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 50.7 m -66.94 140.09 57.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.987 0.915 . . . . 0.0 112.159 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -82.9 4.11 27.0 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.477 1.111 . . . . 0.0 113.91 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 78.5 m 65.66 22.99 11.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.271 2.229 . . . . 0.0 113.735 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -143.69 156.02 44.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.236 1.014 . . . . 0.0 111.455 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.64 -174.15 26.02 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.889 1.709 . . . . 0.0 114.006 -169.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -144.96 140.99 28.61 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.757 2.023 . . . . 0.0 109.837 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 89.0 t -145.5 135.97 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.222 1.409 . . . . 0.0 109.072 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 65.8 m -132.44 141.79 48.98 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.37 0.668 . . . . 0.0 112.378 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -111.0 169.49 8.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.598 1.559 . . . . 0.0 113.56 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.06 -23.5 65.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.941 1.696 . . . . 0.0 113.59 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -161.27 160.89 24.01 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.323 1.449 . . . . 0.0 112.05 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.85 -12.38 26.26 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.652 2.234 . . . . 0.0 114.272 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 40.6 t -77.37 -46.33 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.665 1.575 . . . . 0.0 110.494 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 21.6 m -64.78 -29.75 70.74 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.671 1.189 . . . . 0.0 111.896 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.12 -50.34 19.88 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.032 0.933 . . . . 0.0 111.934 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -59.68 -37.8 79.8 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.476 -0.765 . . . . 0.0 111.735 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.34 -28.09 64.75 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -80.44 -43.97 20.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.65 0.78 . . . . 0.0 111.898 172.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.31 -50.18 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.138 0.881 . . . . 0.0 110.523 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -74.78 -11.58 60.19 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 66.1 m -99.2 -31.4 11.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 89.7 mmm -112.35 -18.04 12.58 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -168.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -68.47 110.83 4.35 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.559 1.072 . . . . 0.0 110.489 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.71 3.8 66.03 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.959 1.743 . . . . 0.0 115.038 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.41 128.36 35.46 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.409 1.605 . . . . 0.0 111.721 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -84.77 130.37 34.69 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.227 0.611 . . . . 0.0 111.3 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.3 tt -149.64 131.02 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.212 1.405 . . . . 0.0 110.145 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.31 -96.93 0.3 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 14.7 ttt -140.78 24.45 2.21 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.151 1.78 . . . . 0.0 111.843 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -143.55 176.4 9.23 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.983 1.713 . . . . 0.0 112.125 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -126.06 133.82 51.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.393 1.077 . . . . 0.0 111.678 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 62.0 mt -66.45 160.44 24.94 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.34 1.456 . . . . 0.0 112.196 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -136.78 139.64 41.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.162 1.385 . . . . 0.0 108.925 167.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.2 t -139.33 135.69 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.497 1.119 . . . . 0.0 109.066 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -153.72 153.68 32.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.701 0.8 . . . . 0.0 111.394 -176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 82.3 mt -61.78 154.89 24.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.562 1.145 . . . . 0.0 113.206 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -61.29 119.59 8.76 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.251 1.021 . . . . 0.0 111.122 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -162.3 33.18 0.11 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.463 1.105 . . . . 0.0 112.76 -171.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 65.4 p -162.33 170.84 18.2 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.822 -1.173 . . . . 0.0 112.943 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -152.29 154.57 35.96 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.007 1.723 . . . . 0.0 111.816 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -159.68 145.53 15.86 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.061 1.344 . . . . 0.0 111.7 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 25.2 t70 62.02 33.24 17.34 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.918 1.687 . . . . 0.0 112.386 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 52.8 p -140.94 33.77 1.76 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.663 1.585 . . . . 0.0 112.748 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -152.7 141.22 20.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.762 2.025 . . . . 0.0 110.466 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 7.9 m -160.61 148.86 16.34 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.039 1.735 . . . . 0.0 110.975 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -86.95 170.65 41.85 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 124.493 1.044 . . . . 0.0 113.566 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.39 -14.67 12.96 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.962 3.108 . . . . 0.0 113.737 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 18.9 m -161.63 156.88 23.77 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.724 2.01 . . . . 0.0 110.523 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 17.9 m -79.05 -7.15 57.88 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.188 0 C-N-CA 125.597 1.57 . . . . 0.0 112.909 179.624 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 25.3 m -133.79 11.54 4.0 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 80.3 p -163.18 164.97 24.98 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.61 1.564 . . . . 0.0 112.003 -174.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.01 -86.02 1.1 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.977 1.275 . . . . 0.0 111.866 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 36.6 t -163.54 151.69 13.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.267 1.427 . . . . 0.0 111.497 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 17.5 m -84.12 -2.97 57.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.47 1.108 . . . . 0.0 113.291 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.43 151.57 45.19 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.761 1.172 . . . . 0.0 113.444 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 98.5 mt -142.43 162.57 35.13 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.518 1.927 . . . . 0.0 110.701 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 40.5 p -136.34 157.03 47.77 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.934 1.694 . . . . 0.0 111.36 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -147.06 166.15 27.73 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.196 1.798 . . . . 0.0 109.94 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -151.49 130.37 12.49 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.706 1.202 . . . . 0.0 109.871 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 9.8 t -159.81 40.45 0.19 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.279 1.031 . . . . 0.0 111.482 -172.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.76 147.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.962 -1.086 . . . . 0.0 112.982 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -86.7 167.92 39.13 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.76 1.172 . . . . 0.0 113.485 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -90.01 -15.12 32.52 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.882 1.273 . . . . 0.0 114.117 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -74.07 121.36 20.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.427 1.491 . . . . 0.0 110.613 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.8 -9.3 76.91 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.588 1.089 . . . . 0.0 113.093 -175.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 74.2 m -81.49 149.56 28.67 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.435 1.094 . . . . 0.0 110.62 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -132.85 29.53 4.12 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.211 1.004 . . . . 0.0 111.83 -170.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -71.68 176.29 4.96 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.471 -0.768 . . . . 0.0 110.907 168.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.81 157.53 42.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 168.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.92 -163.26 27.82 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 127.79 2.614 . . . . 0.0 113.775 -170.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.15 173.13 13.45 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.024 3.15 . . . . 0.0 112.759 -173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.54 124.28 18.48 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.059 0.943 . . . . 0.0 111.108 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.45 -10.48 69.13 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.783 1.182 . . . . 0.0 114.497 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.77 -0.76 47.59 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -111.57 118.14 34.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.837 1.255 . . . . 0.0 110.938 -169.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.3 mt -121.48 135.37 55.04 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.855 1.662 . . . . 0.0 112.016 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -106.16 133.29 51.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.936 1.294 . . . . 0.0 108.725 167.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.6 mm -118.08 138.39 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.092 1.757 . . . . 0.0 108.788 -169.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -140.34 161.94 36.48 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.626 1.171 . . . . 0.0 113.029 -172.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 63.83 25.96 14.2 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.474 2.31 . . . . 0.0 113.926 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.33 156.06 82.88 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.477 1.111 . . . . 0.0 111.115 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.27 145.8 91.72 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.791 2.327 . . . . 0.0 111.76 171.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -67.43 -17.43 64.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.908 0.883 . . . . 0.0 113.161 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -99.71 -8.83 23.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.829 1.252 . . . . 0.0 114.033 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.58 125.4 26.41 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.448 1.499 . . . . 0.0 111.205 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -102.68 -177.67 27.04 Favored Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.344 0.973 . . . . 0.0 113.745 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -61.76 -36.12 80.09 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.122 0.969 . . . . 0.0 112.673 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -76.44 -30.69 57.48 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.82 0.848 . . . . 0.0 111.786 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -70.73 -41.19 72.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.614 0.643 . . . . 0.0 110.685 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 28.1 tp -64.86 -38.73 91.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.559 0.744 . . . . 0.0 111.674 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.26 -50.16 71.25 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.573 0.624 . . . . 0.0 111.095 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -63.39 -27.11 69.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.3 ttm -73.31 -29.41 62.68 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.433 1.093 . . . . 0.0 113.229 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -110.22 -18.15 13.36 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 44.7 mtm -55.54 -33.05 14.71 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 171.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.75 -16.06 23.64 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.57 2.846 . . . . 0.0 116.157 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -100.73 -9.78 21.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.32 -162.11 28.39 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.988 1.28 . . . . 0.0 115.127 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -71.88 92.58 1.26 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.753 1.221 . . . . 0.0 112.38 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.23 128.38 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.816 1.246 . . . . 0.0 109.722 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 44.8 t -92.6 -34.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.909 2.084 . . . . 0.0 111.478 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.3 m -159.53 145.54 16.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 110.377 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.9 134.59 17.62 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.949 1.699 . . . . 0.0 110.208 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -154.92 136.83 14.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.63 0.772 . . . . 0.0 111.588 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.06 135.29 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.969 1.708 . . . . 0.0 107.873 169.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -82.65 137.15 34.58 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.085 0.554 . . . . 0.0 110.994 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.8 mm -118.08 136.89 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.034 1.334 . . . . 0.0 111.104 -168.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.69 129.23 36.79 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.305 1.442 . . . . 0.0 111.857 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.2 -2.78 42.61 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -173.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -102.99 -21.92 13.88 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.029 1.332 . . . . 0.0 112.046 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.5 p -130.61 -16.5 3.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.434 1.494 . . . . 0.0 114.233 -172.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 53.8 t30 65.15 15.92 10.27 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.331 1.852 . . . . 0.0 113.294 -173.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.01 159.03 15.92 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.516 1.527 . . . . 0.0 111.193 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 63.8 m -81.82 137.82 35.21 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.199 -0.938 . . . . 0.0 112.022 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.82 6.06 3.58 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 30.8 m 69.79 18.52 7.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.515 2.326 . . . . 0.0 113.406 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -145.91 156.09 43.3 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.094 0.958 . . . . 0.0 112.091 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.52 -175.29 28.28 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 126.099 1.809 . . . . 0.0 113.546 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -139.71 144.84 37.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.244 1.818 . . . . 0.0 110.262 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 81.2 t -142.84 139.82 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.514 1.526 . . . . 0.0 108.708 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 34.3 t -136.74 144.99 44.12 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.631 0.772 . . . . 0.0 112.277 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -116.44 166.02 12.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.869 1.667 . . . . 0.0 113.431 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.51 -19.3 63.73 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.663 1.185 . . . . 0.0 113.204 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -147.74 159.69 40.23 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 126.23 1.812 . . . . 0.0 110.843 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 -18.67 8.19 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.297 1.998 . . . . 0.0 113.816 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 70.7 t -72.67 -43.57 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 119.812 1.187 . . . . 0.0 111.0 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.6 p -65.8 -31.74 72.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.775 0.83 . . . . 0.0 112.427 172.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -69.51 -50.47 44.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.85 0.86 . . . . 0.0 112.327 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.89 -29.97 70.0 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.266 -0.896 . . . . 0.0 112.097 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.05 -31.25 71.64 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.606 0.639 . . . . 0.0 112.485 169.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.08 63.94 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.838 0.745 . . . . 0.0 111.834 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 30.0 mt -57.55 -49.06 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.116 0.871 . . . . 0.0 110.047 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -70.97 -15.05 62.56 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 53.1 m -99.35 -30.42 12.23 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.5 mmm -112.79 -20.69 11.53 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -69.99 112.71 6.58 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.413 1.006 . . . . 0.0 109.786 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.25 2.54 68.28 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.392 1.472 . . . . 0.0 115.268 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -65.24 123.3 19.19 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.628 1.714 . . . . 0.0 111.169 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -81.18 131.12 35.28 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.878 -0.514 . . . . 0.0 111.233 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.8 tt -138.96 85.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 122.772 1.272 . . . . 0.0 109.468 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 85.2 -125.97 7.48 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.651 1.12 . . . . 0.0 111.067 -169.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 61.6 mtt -99.41 22.16 11.08 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.664 1.586 . . . . 0.0 112.759 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -146.07 161.24 40.58 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.353 1.861 . . . . 0.0 111.862 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -121.32 130.19 53.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.566 1.146 . . . . 0.0 110.765 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 72.2 mt -63.84 159.48 19.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.331 1.453 . . . . 0.0 111.473 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -135.42 139.35 44.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.352 1.461 . . . . 0.0 109.715 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 29.2 t -139.24 136.9 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.324 1.049 . . . . 0.0 109.688 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -143.07 155.74 44.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.389 1.075 . . . . 0.0 111.488 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.29 156.8 33.32 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.851 0.86 . . . . 0.0 112.216 169.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -66.42 -36.21 82.25 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.091 0.956 . . . . 0.0 113.119 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 -104.0 117.6 34.68 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.556 1.143 . . . . 0.0 111.759 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 59.7 m -148.69 -46.75 0.15 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.032 1.333 . . . . 0.0 112.379 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -149.29 -14.35 0.29 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.541 1.136 . . . . 0.0 114.015 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -68.59 -14.84 63.28 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.6 -1.312 . . . . 0.0 114.105 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -130.38 11.59 5.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.64 1.576 . . . . 0.0 112.894 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 47.8 t -165.09 133.24 3.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.716 1.207 . . . . 0.0 112.035 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.42 3.97 41.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.331 1.052 . . . . 0.0 113.041 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 4.0 t 69.4 -170.23 0.18 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.58 1.952 . . . . 0.0 112.686 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -78.34 179.25 52.12 Favored Glycine 0 CA--C 1.543 1.833 0 C-N-CA 125.082 1.325 . . . . 0.0 114.509 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.49 156.01 33.41 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.754 3.636 . . . . 0.0 113.983 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 93.1 p -160.26 164.38 32.72 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.44 1.496 . . . . 0.0 111.833 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 18.4 m -163.89 156.12 17.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.165 1.786 . . . . 0.0 111.03 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.282 -1.288 . . . . 0.0 112.837 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 24.2 m -131.38 9.79 4.77 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -169.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 80.9 p -162.18 163.24 28.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.531 1.532 . . . . 0.0 111.533 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 77.66 -53.14 3.61 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.407 1.48 . . . . 0.0 113.54 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 71.0 m -84.72 -3.53 58.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.89 1.276 . . . . 0.0 113.21 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 10.1 m -71.0 -13.11 61.89 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.926 1.29 . . . . 0.0 114.25 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -80.31 58.65 4.63 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.707 1.622 . . . . 0.0 112.602 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.36 -11.15 59.99 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.061 1.344 . . . . 0.0 114.193 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 20.6 m -80.25 79.27 6.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.201 1.4 . . . . 0.0 109.765 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -149.1 170.94 17.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.387 1.875 . . . . 0.0 110.474 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -80.06 15.83 1.39 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.659 1.184 . . . . 0.0 112.877 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 42.6 p -83.08 8.45 12.89 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.9 1.68 . . . . 0.0 114.245 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -7.88 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.446 1.499 . . . . 0.0 114.527 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.8 -156.31 22.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.226 1.393 . . . . 0.0 113.661 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.5 73.98 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -171.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -71.56 109.84 5.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.312 1.045 . . . . 0.0 110.049 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 95.22 -3.21 66.33 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.434 1.016 . . . . 0.0 113.33 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 3.2 m -70.13 154.15 42.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.598 1.199 . . . . 0.0 110.927 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -127.81 26.37 5.87 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.643 1.177 . . . . 0.0 110.078 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -73.26 179.93 3.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.383 1.473 . . . . 0.0 110.662 168.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.83 167.08 31.55 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.587 -0.695 . . . . 0.0 112.873 168.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.24 -163.82 28.57 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 126.133 1.825 . . . . 0.0 113.892 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.35 174.61 11.83 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.019 3.146 . . . . 0.0 112.693 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -57.46 125.75 24.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.179 0.992 . . . . 0.0 111.286 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.03 71.49 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.864 1.221 . . . . 0.0 114.301 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.64 -0.54 42.8 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -113.67 123.65 50.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.422 1.089 . . . . 0.0 110.645 -169.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.9 mt -122.52 142.93 50.07 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.815 2.046 . . . . 0.0 112.861 -168.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -111.61 135.21 52.5 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.78 1.632 . . . . 0.0 108.595 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.6 mm -119.56 138.22 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.993 1.717 . . . . 0.0 108.369 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -138.8 162.27 35.18 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.597 0.759 . . . . 0.0 112.867 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 64.57 26.34 13.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.34 2.256 . . . . 0.0 113.87 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 72.1 mt -65.56 159.46 67.61 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.023 1.329 . . . . 0.0 111.823 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.71 149.38 77.39 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.065 2.51 . . . . 0.0 111.929 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -71.64 -8.4 53.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.77 1.228 . . . . 0.0 113.922 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -113.56 -6.01 13.41 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.271 2.228 . . . . 0.0 113.865 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 125.72 27.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.153 1.381 . . . . 0.0 110.869 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.67 -177.75 25.9 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.443 1.02 . . . . 0.0 113.745 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -62.4 -36.07 81.18 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.892 0.877 . . . . 0.0 112.66 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.22 -31.23 58.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.992 0.917 . . . . 0.0 111.95 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.495 0.589 . . . . 0.0 110.762 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.19 -37.06 83.02 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.286 0.635 . . . . 0.0 111.694 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -62.75 -50.17 72.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.838 0.745 . . . . 0.0 111.062 172.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -63.19 -28.08 69.8 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.427 0.691 . . . . 0.0 112.767 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.9 ttm -73.31 -28.76 62.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.478 1.111 . . . . 0.0 113.241 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -110.54 -17.47 13.42 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.0 mtm -55.29 -32.49 12.69 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -57.99 -15.48 22.61 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.66 2.907 . . . . 0.0 116.372 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -101.59 -7.94 22.3 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.07 -160.74 28.09 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.895 1.236 . . . . 0.0 114.718 171.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -72.52 95.79 1.85 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.257 1.023 . . . . 0.0 112.144 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.5 t -77.38 127.73 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.061 1.344 . . . . 0.0 109.814 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.14 -26.02 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.378 2.271 . . . . 0.0 111.788 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.6 t -154.27 144.37 21.96 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.678 1.191 . . . . 0.0 110.339 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.26 126.39 5.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.935 1.694 . . . . 0.0 110.246 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 28.9 tptt -154.83 138.01 15.66 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.427 -0.796 . . . . 0.0 111.813 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.36 135.09 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.779 1.632 . . . . 0.0 108.167 169.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -84.65 138.51 32.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.453 0.701 . . . . 0.0 111.086 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 30.6 mm -119.59 134.6 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.176 1.39 . . . . 0.0 110.348 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -82.59 126.11 31.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.947 0.899 . . . . 0.0 111.043 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -75.67 -5.93 47.96 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -87.11 -24.1 24.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.387 1.075 . . . . 0.0 112.297 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 71.2 p -133.38 -13.24 2.69 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . 0.286 8.2 p30 59.35 11.7 2.31 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.521 2.328 . . . . 0.0 114.516 -169.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 85.2 mt -84.48 155.36 22.22 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.165 1.386 . . . . 0.0 111.149 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 58.0 m -76.75 136.75 39.03 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.943 0.897 . . . . 0.0 111.397 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.31 7.08 2.43 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.8 m 67.53 18.78 10.0 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.209 2.204 . . . . 0.0 113.439 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -144.35 155.34 43.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.205 0.911 . . . . 0.0 112.124 173.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.35 -176.04 28.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.945 1.736 . . . . 0.0 113.653 -170.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -141.47 142.43 33.63 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.437 1.895 . . . . 0.0 110.077 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.8 t -143.89 141.55 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.205 1.402 . . . . 0.0 108.88 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 75.5 m -137.48 144.25 42.16 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.431 -0.793 . . . . 0.0 112.296 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -112.93 166.1 11.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.313 1.445 . . . . 0.0 113.131 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.0 -19.5 62.51 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.423 1.089 . . . . 0.0 113.078 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -148.34 153.39 40.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.589 1.556 . . . . 0.0 111.476 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.5 -17.66 11.23 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.071 2.514 . . . . 0.0 114.027 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.1 t -72.37 -40.57 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.175 0.898 . . . . 0.0 110.395 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.3 m -62.97 -32.82 74.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.866 0.866 . . . . 0.0 111.719 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.79 -49.44 25.31 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.593 1.157 . . . . 0.0 112.017 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -59.14 -38.75 80.42 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.528 -0.733 . . . . 0.0 111.964 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.01 -28.41 64.4 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -80.14 -44.47 19.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 111.899 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 43.4 mt -57.94 -49.3 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.537 1.062 . . . . 0.0 110.372 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 -74.42 -11.52 60.26 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.4 m -101.1 -29.86 11.91 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.46 -18.64 12.81 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -169.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.01 109.24 3.87 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.925 0.784 . . . . 0.0 109.737 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.72 9.98 60.68 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.392 1.472 . . . . 0.0 114.966 -171.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -64.86 124.48 22.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.051 1.926 . . . . 0.0 111.145 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -79.25 131.05 36.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.095 0.558 . . . . 0.0 110.887 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.4 tt -149.28 133.39 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.809 1.244 . . . . 0.0 110.556 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.71 -102.34 0.62 Allowed Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -129.83 17.07 5.74 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.303 1.841 . . . . 0.0 112.219 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -146.15 -176.51 5.19 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.75 1.62 . . . . 0.0 113.014 -172.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -128.23 135.97 50.41 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.065 1.346 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 56.6 mt -70.99 162.88 28.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.176 1.39 . . . . 0.0 111.933 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -133.9 147.33 51.1 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.309 1.444 . . . . 0.0 109.327 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 29.6 t -139.21 137.81 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.647 1.179 . . . . 0.0 109.386 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -141.75 160.54 39.96 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.458 1.103 . . . . 0.0 111.191 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 69.9 mt -69.31 157.95 35.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.653 0.74 . . . . 0.0 111.18 168.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -53.12 123.63 12.25 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.539 1.136 . . . . 0.0 112.334 172.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -165.48 146.18 7.03 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.55 1.94 . . . . 0.0 110.083 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 13.3 t -158.3 167.96 28.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.093 1.357 . . . . 0.0 111.416 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -143.92 13.95 1.69 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.614 1.565 . . . . 0.0 112.842 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -154.68 141.6 19.19 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.841 1.257 . . . . 0.0 112.441 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -144.66 10.15 1.39 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.219 1.408 . . . . 0.0 113.045 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 22.8 t -165.87 147.74 7.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.631 1.572 . . . . 0.0 111.108 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -132.13 25.4 4.56 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.207 1.403 . . . . 0.0 112.453 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 12.5 t -152.17 159.15 43.66 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.665 1.586 . . . . 0.0 111.216 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 154.6 -153.08 24.55 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.871 1.224 . . . . 0.0 113.154 -174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.71 -3.04 12.97 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.992 3.128 . . . . 0.0 113.908 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 74.0 m -143.11 156.29 44.77 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.755 1.622 . . . . 0.0 111.123 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 20.4 m 69.37 10.93 7.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.915 1.686 . . . . 0.0 114.857 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 C-N-CA 125.676 1.608 . . . . 0.0 113.556 176.927 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.567 0 N-CA-C 111.829 -0.509 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 16.7 m -65.22 -19.15 65.84 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -173.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 33.4 p -66.52 -10.39 44.27 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.002 1.321 . . . . 0.0 113.948 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -82.08 1.32 87.16 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.332 1.444 . . . . 0.0 114.306 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 66.3 m -131.54 152.79 50.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.482 1.513 . . . . 0.0 112.013 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 8.5 t -163.28 163.19 25.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.111 1.364 . . . . 0.0 111.312 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -86.13 176.69 48.88 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.97 1.271 . . . . 0.0 113.862 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.88 123.67 21.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.591 1.156 . . . . 0.0 110.614 177.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.0 t -72.63 -35.17 67.74 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.46 1.104 . . . . 0.0 113.76 -172.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -149.66 143.41 25.48 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.395 1.478 . . . . 0.0 109.858 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.78 21.17 12.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.69 1.196 . . . . 0.0 111.916 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 10.6 m -66.44 0.59 2.09 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.435 1.494 . . . . 0.0 114.83 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.27 -11.9 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.182 1.393 . . . . 0.0 112.956 169.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -96.51 16.05 61.71 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 126.556 2.027 . . . . 0.0 113.962 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -55.91 -39.16 71.21 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.983 1.313 . . . . 0.0 114.526 -175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -66.27 117.54 8.69 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.494 1.118 . . . . 0.0 111.432 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.61 -7.47 77.42 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.75 1.643 . . . . 0.0 113.254 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.4 t -85.08 172.37 11.31 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.376 1.088 . . . . 0.0 112.186 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.07 31.98 2.93 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.101 1.361 . . . . 0.0 111.065 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -68.74 165.75 18.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.065 0.946 . . . . 0.0 112.528 169.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.63 156.77 45.11 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.25 -169.23 29.27 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 126.156 1.836 . . . . 0.0 113.246 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.14 175.28 7.79 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.086 3.19 . . . . 0.0 112.676 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.85 121.96 11.75 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.094 0.957 . . . . 0.0 111.44 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.88 -1.73 78.56 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.862 1.22 . . . . 0.0 114.659 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.41 6.76 46.98 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.957 1.378 . . . . 0.0 114.372 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -118.36 122.12 42.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.293 1.437 . . . . 0.0 111.08 -171.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.7 140.76 52.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.439 1.896 . . . . 0.0 112.343 -169.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -110.99 133.09 53.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.889 1.676 . . . . 0.0 108.801 168.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.29 135.1 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.946 1.698 . . . . 0.0 107.884 -171.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -132.98 156.78 46.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.933 1.293 . . . . 0.0 112.585 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 74.55 27.9 1.31 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.732 2.413 . . . . 0.0 113.849 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.2 mt -64.96 157.29 76.76 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.103 1.361 . . . . 0.0 112.057 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.81 152.56 34.86 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.388 2.725 . . . . 0.0 112.126 169.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -67.21 -29.33 68.96 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.9 -9.79 56.35 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.01 129.2 39.2 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.9 1.28 . . . . 0.0 111.793 -175.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -113.74 -174.28 18.73 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.312 1.434 . . . . 0.0 113.314 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.25 -34.7 78.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.077 0.951 . . . . 0.0 112.991 -174.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -76.77 -31.56 57.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.893 0.877 . . . . 0.0 111.782 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -67.66 -41.59 83.53 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.705 0.684 . . . . 0.0 110.649 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 23.3 tp -65.59 -41.09 93.23 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.334 0.654 . . . . 0.0 111.562 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.26 -51.69 67.86 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.661 0.664 . . . . 0.0 111.37 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -63.72 -28.04 69.61 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.8 ttp -81.4 -20.39 40.56 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -109.61 -19.78 13.08 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 51.5 mtm -54.8 -31.85 10.46 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -57.34 -16.78 23.98 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.616 2.877 . . . . 0.0 116.273 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -97.71 -8.79 27.92 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.406 1.003 . . . . 0.0 113.636 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.18 -162.92 28.16 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.089 1.328 . . . . 0.0 114.67 170.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -71.03 95.01 1.15 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.437 1.095 . . . . 0.0 111.842 -173.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.1 t -73.43 129.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.027 1.331 . . . . 0.0 109.733 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 35.7 t -94.56 -33.78 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.16 2.184 . . . . 0.0 111.505 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.3 t -155.22 150.45 27.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.462 1.105 . . . . 0.0 110.836 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.29 14.86 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.178 1.391 . . . . 0.0 109.915 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -151.58 138.74 19.23 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.466 -0.771 . . . . 0.0 111.705 -168.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 85.8 t -119.32 126.99 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.534 1.534 . . . . 0.0 107.468 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -81.02 144.23 31.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.361 0.664 . . . . 0.0 111.308 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 39.4 mm -120.1 135.75 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.215 1.406 . . . . 0.0 110.362 -169.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.72 128.15 33.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.396 1.078 . . . . 0.0 111.739 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -72.68 -9.0 58.11 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -99.52 -15.46 18.65 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.229 1.012 . . . . 0.0 113.133 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 70.0 p -128.64 -19.62 3.71 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.623 1.169 . . . . 0.0 113.957 -177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 66.15 18.65 11.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.558 1.943 . . . . 0.0 112.924 -172.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 85.3 mt -101.78 156.25 17.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.348 1.459 . . . . 0.0 111.612 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 50.0 m -64.3 139.47 58.77 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.035 0.934 . . . . 0.0 112.633 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.74 2.51 19.46 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 76.3 m 65.63 22.8 11.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.912 2.085 . . . . 0.0 113.396 -172.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -146.14 155.57 42.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.004 0.922 . . . . 0.0 111.68 171.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.05 -173.43 24.63 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.749 1.643 . . . . 0.0 113.918 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -139.79 146.24 39.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.304 1.842 . . . . 0.0 110.243 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 58.1 t -143.61 138.58 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.115 1.366 . . . . 0.0 109.006 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 85.6 p -130.71 152.69 49.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.911 0.885 . . . . 0.0 112.358 175.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.73 161.86 26.36 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.933 1.293 . . . . 0.0 113.504 -174.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.65 -18.37 64.27 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.72 1.208 . . . . 0.0 112.885 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -146.16 151.24 44.08 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 125.596 1.559 . . . . 0.0 112.05 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.26 -28.16 55.66 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.035 3.157 . . . . 0.0 114.035 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.7 t -74.43 -38.46 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.958 0.903 . . . . 0.0 110.828 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 8.2 m -63.9 -31.79 73.1 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.916 0.886 . . . . 0.0 111.82 171.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.91 -48.58 29.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.403 1.081 . . . . 0.0 111.926 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -59.05 -38.97 80.62 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.383 -0.823 . . . . 0.0 111.879 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.75 -27.33 64.84 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -79.9 -44.65 20.01 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.458 171.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.56 -49.4 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.871 1.214 . . . . 0.0 110.618 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -73.87 -11.21 60.3 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.6 m -102.1 -27.71 12.76 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.5 mmm -112.47 -20.63 11.7 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -168.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.29 110.1 5.06 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.197 0.908 . . . . 0.0 109.84 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.31 1.85 62.34 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.533 1.539 . . . . 0.0 115.028 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -62.63 125.79 25.15 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.54 1.67 . . . . 0.0 111.866 -178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -79.72 125.96 30.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.592 0.757 . . . . 0.0 110.075 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt -148.18 134.27 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.058 1.343 . . . . 0.0 109.811 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.53 -120.62 23.59 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -171.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 25.0 ptp -106.87 13.42 27.79 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.675 1.59 . . . . 0.0 113.773 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -142.91 -172.75 3.73 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.217 1.407 . . . . 0.0 113.339 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -129.48 141.63 50.96 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.59 1.556 . . . . 0.0 111.403 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 75.8 mt -76.79 162.9 27.28 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.149 1.38 . . . . 0.0 112.652 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -131.51 141.91 49.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.758 1.623 . . . . 0.0 109.678 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.75 138.1 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.735 1.214 . . . . 0.0 109.392 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -147.76 142.53 26.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.815 1.246 . . . . 0.0 110.597 -169.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 41.1 mt -65.8 151.41 46.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.011 0.925 . . . . 0.0 112.308 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -52.22 119.36 4.31 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.303 1.041 . . . . 0.0 111.329 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -73.1 144.04 47.15 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.618 1.167 . . . . 0.0 113.405 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 74.0 p -167.63 157.55 10.49 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.787 2.035 . . . . 0.0 110.482 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -77.01 132.87 39.19 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.274 -0.891 . . . . 0.0 111.842 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -157.88 40.37 0.28 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.136 1.775 . . . . 0.0 109.635 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -166.5 159.14 14.15 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.348 1.859 . . . . 0.0 111.813 -166.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 6.7 t -154.47 17.13 0.47 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.705 1.202 . . . . 0.0 112.71 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -163.64 178.08 8.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.561 1.945 . . . . 0.0 112.004 -173.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.6 t -154.92 168.43 26.99 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.031 1.332 . . . . 0.0 111.331 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -159.5 -178.8 33.83 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 125.317 1.437 . . . . 0.0 114.087 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.81 155.21 53.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.087 3.191 . . . . 0.0 111.999 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 91.6 p -163.47 166.9 22.2 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.508 1.523 . . . . 0.0 111.839 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 59.1 p -161.93 157.44 23.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.888 1.275 . . . . 0.0 112.191 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 C-N-CA 124.937 1.256 . . . . 0.0 112.84 -179.461 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.546 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 39.7 m -149.71 153.13 36.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.024 1.33 . . . . 0.0 111.348 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.0 t -163.3 179.49 7.34 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.371 1.469 . . . . 0.0 111.284 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 100.17 -160.55 19.25 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.808 1.671 . . . . 0.0 113.218 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 15.5 t -161.4 164.42 29.93 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.175 1.39 . . . . 0.0 111.544 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 21.7 m -82.66 -3.94 57.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.932 1.293 . . . . 0.0 114.343 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 83.07 -143.55 22.15 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.688 1.137 . . . . 0.0 112.614 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 99.0 mt -138.75 151.87 47.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.887 1.675 . . . . 0.0 111.197 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 32.7 m -66.45 137.84 57.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.589 1.555 . . . . 0.0 110.337 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -144.68 154.11 42.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.237 1.415 . . . . 0.0 110.923 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -81.97 12.74 3.83 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.12 1.368 . . . . 0.0 112.875 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 8.5 p -76.29 59.77 1.44 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.523 1.929 . . . . 0.0 112.106 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -41.21 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.029 -1.044 . . . . 0.0 113.383 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 55.3 -110.12 1.65 Allowed Glycine 0 CA--C 1.534 1.241 0 CA-C-N 119.268 0.94 . . . . 0.0 112.176 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -84.7 -11.32 56.1 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.694 1.598 . . . . 0.0 114.667 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -69.37 122.99 20.05 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.012 1.325 . . . . 0.0 110.606 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.34 79.29 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.283 0.944 . . . . 0.0 113.086 -175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 10.1 t -75.61 162.68 28.06 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.25 1.025 . . . . 0.0 111.88 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -134.79 20.21 3.53 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.169 1.388 . . . . 0.0 111.224 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -66.83 173.67 3.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.133 0.973 . . . . 0.0 111.484 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.47 167.1 29.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 167.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -94.81 -167.14 36.2 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.113 1.34 . . . . 0.0 113.638 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.6 171.06 13.78 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.358 2.705 . . . . 0.0 111.521 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.94 123.27 15.24 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.641 0.777 . . . . 0.0 111.259 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.79 -9.66 70.76 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.725 1.155 . . . . 0.0 114.276 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.07 -6.25 54.06 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.895 1.347 . . . . 0.0 113.686 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.3 118.54 36.2 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.282 2.233 . . . . 0.0 111.404 -174.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 22.0 mt -119.68 136.63 54.33 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.386 1.875 . . . . 0.0 111.989 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -109.69 131.99 54.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.451 1.5 . . . . 0.0 108.796 168.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.56 135.33 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.938 1.695 . . . . 0.0 107.951 -171.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -131.42 160.4 35.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.247 1.419 . . . . 0.0 112.687 -175.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 68.27 28.26 6.39 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.496 2.318 . . . . 0.0 113.601 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 52.9 mt -65.69 155.24 86.65 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.491 1.116 . . . . 0.0 111.727 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.21 143.19 94.13 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.047 2.498 . . . . 0.0 112.575 172.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -62.69 -6.9 3.98 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.791 2.036 . . . . 0.0 114.845 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -113.14 -9.04 13.55 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.58 1.952 . . . . 0.0 114.241 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.44 134.03 47.41 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.635 1.174 . . . . 0.0 112.287 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.42 -172.7 18.9 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.663 1.601 . . . . 0.0 112.447 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -63.53 -34.66 78.27 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -172.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -77.09 -28.31 54.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.145 0.578 . . . . 0.0 112.448 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -69.95 -41.79 74.08 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.586 0.63 . . . . 0.0 110.796 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 31.8 tp -65.56 -37.6 87.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.491 0.716 . . . . 0.0 111.811 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.72 -50.4 67.07 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.709 0.686 . . . . 0.0 111.462 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -63.42 -26.33 68.69 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.409 0.684 . . . . 0.0 112.551 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 48.1 ttm -73.95 -28.79 61.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.169 0.988 . . . . 0.0 113.373 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -109.84 -18.52 13.39 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.6 mtm -56.16 -32.61 13.51 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -57.63 -16.23 23.63 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.578 2.852 . . . . 0.0 116.165 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -100.28 -9.7 22.08 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.7 -163.35 28.55 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.087 1.327 . . . . 0.0 114.957 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -70.37 99.82 1.64 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.335 1.054 . . . . 0.0 112.542 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 85.5 t -79.35 128.54 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.163 1.385 . . . . 0.0 110.038 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 56.0 t -98.97 -24.33 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.568 2.347 . . . . 0.0 111.787 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 9.4 t -156.98 144.27 18.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.762 1.225 . . . . 0.0 110.711 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.36 130.3 12.52 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.158 1.383 . . . . 0.0 110.89 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -156.11 132.85 10.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.578 0.751 . . . . 0.0 112.657 -174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 64.8 t -102.12 134.71 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.683 1.593 . . . . 0.0 106.943 167.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.83 140.75 30.95 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.293 0.637 . . . . 0.0 110.423 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 17.1 mt -131.05 136.21 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.776 1.23 . . . . 0.0 110.541 -169.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.3 133.51 45.04 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.355 1.462 . . . . 0.0 112.233 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -82.1 -1.94 50.35 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -172.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -109.54 -19.17 13.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.55 1.14 . . . . 0.0 112.716 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.9 p -126.29 -17.7 5.13 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.434 1.494 . . . . 0.0 114.079 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 64.16 18.91 11.53 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.253 1.821 . . . . 0.0 113.197 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 86.7 mt -91.79 145.48 24.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.603 1.561 . . . . 0.0 110.587 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 88.6 p -61.92 144.61 54.75 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.247 1.022 . . . . 0.0 112.244 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -81.2 6.81 12.84 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.9 m 63.82 21.32 12.61 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.017 2.127 . . . . 0.0 113.119 -170.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.84 155.14 43.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.109 0.868 . . . . 0.0 112.4 173.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.56 179.83 31.22 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.926 1.727 . . . . 0.0 113.513 -170.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -137.04 142.22 42.46 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.549 1.94 . . . . 0.0 110.228 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 84.8 t -141.7 142.98 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.137 1.375 . . . . 0.0 108.608 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 18.3 m -136.86 148.81 47.31 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -115.35 171.59 7.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.546 1.539 . . . . 0.0 113.165 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.49 -23.71 66.09 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.42 1.488 . . . . 0.0 113.427 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -161.33 161.13 23.65 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.199 1.4 . . . . 0.0 112.104 -172.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.08 -13.77 34.27 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.504 2.136 . . . . 0.0 114.082 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.34 -46.01 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 121.043 1.747 . . . . 0.0 110.608 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 45.6 m -65.93 -30.66 71.28 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.312 1.045 . . . . 0.0 111.924 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.37 -48.4 28.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.04 0.936 . . . . 0.0 111.981 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -61.68 -32.29 72.46 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.523 -0.736 . . . . 0.0 112.094 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.71 71.76 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.46 -42.95 41.96 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.564 0.746 . . . . 0.0 111.732 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.7 mt -58.42 -46.67 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 118.798 0.727 . . . . 0.0 110.274 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.48 -12.52 61.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 66.6 m -103.54 -29.85 10.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 87.6 mmm -114.29 -18.71 11.52 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -168.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -70.87 111.48 6.32 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.42 1.009 . . . . 0.0 110.191 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.24 0.53 63.23 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.719 1.628 . . . . 0.0 114.953 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.12 122.74 16.85 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.403 1.601 . . . . 0.0 111.251 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -75.64 131.95 40.27 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 110.631 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.0 tt -139.55 106.81 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.011 1.324 . . . . 0.0 108.757 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 67.23 -124.32 22.41 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -169.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 25.5 mmt -99.62 13.57 33.05 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.428 1.491 . . . . 0.0 113.371 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -140.58 170.59 15.5 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.676 1.59 . . . . 0.0 112.717 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -121.22 134.69 55.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.004 1.322 . . . . 0.0 111.282 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.47 155.58 37.17 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.051 1.341 . . . . 0.0 111.547 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -130.3 141.9 50.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.935 1.294 . . . . 0.0 109.143 168.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.4 t -139.0 132.95 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.454 1.102 . . . . 0.0 109.169 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -143.85 154.95 43.91 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.514 1.126 . . . . 0.0 111.232 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 60.4 mt -66.95 160.12 27.02 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.527 0.731 . . . . 0.0 112.722 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -71.61 71.53 0.71 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.102 1.361 . . . . 0.0 110.388 167.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -165.16 146.99 7.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.94 1.696 . . . . 0.0 111.366 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 49.7 m 68.03 78.42 0.23 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.368 1.867 . . . . 0.0 113.164 172.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -65.71 -27.84 68.62 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -162.16 145.64 11.88 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.676 1.59 . . . . 0.0 111.346 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -130.92 3.12 4.4 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.103 1.761 . . . . 0.0 112.716 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 58.5 m -111.6 27.76 9.37 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.945 1.698 . . . . 0.0 112.27 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -56.79 -29.38 62.62 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.209 1.404 . . . . 0.0 113.768 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 37.2 m -106.65 16.97 23.88 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.607 1.563 . . . . 0.0 112.486 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 96.78 170.58 34.13 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.009 1.766 . . . . 0.0 112.324 -169.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.88 142.81 35.74 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.628 2.885 . . . . 0.0 110.952 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 65.6 m -100.77 3.25 41.99 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.112 0.965 . . . . 0.0 113.546 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 67.4 m -146.59 149.76 34.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.919 1.688 . . . . 0.0 111.477 -174.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.311 -1.271 . . . . 0.0 112.789 179.38 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.603 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 30.6 m 70.13 -34.23 0.28 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 127.92 2.488 . . . . 0.0 114.91 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 72.4 m -142.1 143.68 33.16 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.12 2.168 . . . . 0.0 109.782 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 71.78 -129.73 16.48 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.633 0.635 . . . . 0.0 111.734 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 77.5 p -159.31 155.74 27.39 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.293 1.437 . . . . 0.0 111.57 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 28.6 p -164.57 138.15 5.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.477 1.111 . . . . 0.0 112.041 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -107.11 171.82 17.23 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.413 1.482 . . . . 0.0 112.995 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 90.8 mt -142.29 134.77 27.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.671 1.589 . . . . 0.0 110.627 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 18.8 p -70.71 136.97 49.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.344 1.458 . . . . 0.0 110.467 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -141.36 143.03 33.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.993 1.317 . . . . 0.0 110.408 -169.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.36 25.07 0.41 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.067 1.347 . . . . 0.0 112.029 -171.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 32.9 p -90.67 14.18 14.06 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.829 1.652 . . . . 0.0 114.401 -169.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.87 143.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.866 1.266 . . . . 0.0 112.818 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -86.95 120.61 5.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.135 0.874 . . . . 0.0 113.031 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.83 -51.5 0.39 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.045 2.938 . . . . 0.0 116.46 169.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.4 115.29 5.51 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.912 1.285 . . . . 0.0 110.481 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 94.88 -5.45 69.14 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.992 1.282 . . . . 0.0 113.442 -175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 36.2 t -79.7 143.55 34.48 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.574 1.187 . . . . 0.0 111.341 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -118.93 15.25 13.38 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.852 1.261 . . . . 0.0 111.755 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -66.33 173.64 3.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.807 0.843 . . . . 0.0 111.655 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -153.43 160.34 42.57 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.6 -161.62 29.03 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 128.243 2.83 . . . . 0.0 113.365 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 169.01 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.68 2.92 . . . . 0.0 112.49 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -59.36 127.09 30.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.41 0.684 . . . . 0.0 111.145 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.36 -11.18 70.68 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.92 1.248 . . . . 0.0 114.01 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.86 -4.49 46.9 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.722 1.261 . . . . 0.0 114.118 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -108.29 118.21 36.18 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.118 1.367 . . . . 0.0 110.93 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.7 mt -120.19 132.0 55.21 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.175 1.79 . . . . 0.0 111.861 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -103.04 133.2 48.56 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.785 1.234 . . . . 0.0 108.557 167.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.3 mm -118.16 135.65 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.771 1.629 . . . . 0.0 108.26 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -133.93 160.45 37.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.574 1.15 . . . . 0.0 112.308 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 62.62 33.94 15.36 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.477 1.911 . . . . 0.0 113.282 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 45.2 mt -70.03 164.68 50.07 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.659 1.584 . . . . 0.0 111.455 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.03 141.47 94.36 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.702 2.268 . . . . 0.0 110.888 168.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -67.86 -8.29 35.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.959 1.304 . . . . 0.0 113.962 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.52 -9.2 16.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.424 1.889 . . . . 0.0 114.144 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.3 130.85 43.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.138 1.375 . . . . 0.0 111.643 -175.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -101.96 -179.63 27.69 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.367 0.984 . . . . 0.0 113.582 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.15 -33.69 74.98 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.149 0.98 . . . . 0.0 112.326 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -73.56 -40.81 63.65 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.989 1.716 . . . . 0.0 110.917 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -64.77 -41.38 95.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.708 0.803 . . . . 0.0 111.351 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.0 tp -67.0 -37.7 84.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.277 0.631 . . . . 0.0 111.858 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.63 -49.88 73.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.758 0.708 . . . . 0.0 110.943 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -63.39 -27.56 69.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.608 0.763 . . . . 0.0 112.851 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.5 ttm -72.45 -32.06 65.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.231 1.012 . . . . 0.0 113.051 173.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -107.38 -18.49 13.85 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -171.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 44.4 mtm -55.61 -33.49 18.09 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -57.77 -16.72 26.44 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.556 2.837 . . . . 0.0 115.992 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -99.23 -10.85 21.89 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.47 -154.36 25.88 Favored Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.411 1.005 . . . . 0.0 115.494 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -74.49 82.46 1.97 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.528 1.131 . . . . 0.0 112.962 -169.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.46 128.39 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.551 1.14 . . . . 0.0 109.951 172.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 73.5 t -94.13 -37.77 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.801 2.04 . . . . 0.0 110.85 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 63.3 m -151.29 146.01 25.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.859 1.263 . . . . 0.0 110.807 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.53 134.66 14.96 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.247 1.419 . . . . 0.0 110.402 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -155.6 136.26 13.42 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.692 0.797 . . . . 0.0 111.839 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.17 134.78 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.922 1.689 . . . . 0.0 107.734 169.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -82.17 136.54 35.12 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.033 0.533 . . . . 0.0 110.925 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 30.7 mm -119.68 137.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.285 1.434 . . . . 0.0 110.51 -169.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -73.24 131.27 41.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.783 1.233 . . . . 0.0 112.127 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -75.04 -13.57 60.51 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -104.07 -28.32 11.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.294 1.038 . . . . 0.0 112.642 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 77.8 p -117.3 -15.55 10.38 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.255 1.422 . . . . 0.0 114.057 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 25.1 m120 63.76 15.53 9.09 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.124 1.77 . . . . 0.0 113.495 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.74 154.6 21.5 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.421 1.488 . . . . 0.0 110.979 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 51.0 m -80.87 134.13 35.7 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.492 -0.755 . . . . 0.0 111.16 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.58 5.79 2.83 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -173.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.1 m 67.33 20.49 10.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.387 2.275 . . . . 0.0 113.061 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -145.02 156.18 43.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.854 0.862 . . . . 0.0 111.711 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.0 -174.86 28.26 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.906 1.717 . . . . 0.0 113.736 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -142.06 144.25 33.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.181 1.792 . . . . 0.0 110.196 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 98.8 t -141.97 142.72 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.499 1.519 . . . . 0.0 108.482 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 37.9 t -139.98 142.44 36.31 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.567 -0.708 . . . . 0.0 112.106 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.69 168.2 9.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.808 1.643 . . . . 0.0 113.422 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.17 -22.89 66.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.616 1.567 . . . . 0.0 113.282 170.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -160.07 157.69 25.47 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.232 1.413 . . . . 0.0 112.19 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.25 -15.65 39.16 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.629 2.219 . . . . 0.0 113.794 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.52 -43.72 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.53 1.514 . . . . 0.0 110.535 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.4 m -68.7 -31.26 70.22 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 112.072 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -75.84 -47.43 25.62 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.808 0.843 . . . . 0.0 112.474 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -62.47 -31.32 72.04 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.5 -0.75 . . . . 0.0 111.981 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.44 -30.92 71.95 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.312 0.645 . . . . 0.0 112.632 172.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.46 -42.59 43.24 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.447 0.699 . . . . 0.0 111.879 175.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.52 -46.08 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 118.738 0.699 . . . . 0.0 110.065 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -72.16 -12.46 61.19 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.6 m -104.02 -30.95 9.95 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.7 mmm -111.86 -18.04 12.78 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -70.06 112.1 6.2 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.429 1.013 . . . . 0.0 110.755 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.87 71.5 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.038 1.78 . . . . 0.0 114.94 -173.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -61.47 124.07 19.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.189 1.495 . . . . 0.0 111.331 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -78.39 131.0 36.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.215 0.531 . . . . 0.0 110.42 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.9 tt -136.7 104.84 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.027 1.331 . . . . 0.0 108.493 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.68 -121.52 20.03 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.1 mmt -99.87 9.95 42.12 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.418 1.487 . . . . 0.0 113.89 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -133.04 164.86 26.07 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.234 1.413 . . . . 0.0 112.557 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -120.83 131.89 54.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.743 1.217 . . . . 0.0 111.122 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.96 158.86 24.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.211 1.404 . . . . 0.0 112.224 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -136.85 141.99 42.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.069 1.348 . . . . 0.0 109.063 167.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.7 t -138.29 136.73 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.421 1.089 . . . . 0.0 108.95 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -149.13 151.28 34.11 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.774 0.83 . . . . 0.0 110.829 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.7 mt -60.24 156.65 15.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.931 0.872 . . . . 0.0 112.805 170.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.19 -23.28 66.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.359 1.064 . . . . 0.0 113.175 169.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -139.05 117.58 12.12 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.904 1.681 . . . . 0.0 110.719 -173.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 45.7 m -154.17 128.79 9.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.459 1.504 . . . . 0.0 110.011 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -144.24 146.04 32.42 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.481 1.512 . . . . 0.0 110.897 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -130.5 -7.2 4.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 23.6 t70 68.73 -42.91 0.49 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 129.101 2.96 . . . . 0.0 114.964 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 73.3 p -92.19 -6.73 50.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.576 1.55 . . . . 0.0 113.881 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -162.18 163.22 28.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.853 1.661 . . . . 0.0 112.811 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 24.6 p -85.17 157.88 20.53 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.307 1.443 . . . . 0.0 112.95 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -83.06 173.03 51.95 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.422 1.011 . . . . 0.0 113.574 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.86 151.61 40.48 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.07 3.18 . . . . 0.0 111.811 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 78.9 p -162.62 169.04 20.81 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.018 1.327 . . . . 0.0 112.09 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 10.5 m -151.94 150.62 30.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.8 1.64 . . . . 0.0 110.783 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.222 -1.321 . . . . 0.0 112.936 179.427 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 89.5 p -164.33 177.3 8.38 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.601 1.56 . . . . 0.0 111.429 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.1 m -74.09 -7.41 52.44 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -89.96 141.62 16.11 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.076 1.322 . . . . 0.0 112.596 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 74.3 p -92.06 -14.15 29.76 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 42.9 m 65.15 5.37 2.99 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.923 2.089 . . . . 0.0 114.949 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -80.57 127.65 8.04 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.687 1.137 . . . . 0.0 112.317 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 92.3 mt -146.87 145.25 29.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.586 1.954 . . . . 0.0 110.009 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 85.0 m -142.7 130.17 21.22 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.689 1.595 . . . . 0.0 109.542 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -161.39 131.13 4.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.788 1.635 . . . . 0.0 108.732 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -112.61 -3.47 14.32 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 23.6 m -66.64 -13.74 61.56 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.793 -1.192 . . . . 0.0 114.193 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 1.8 pp -66.02 -4.13 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.482 2.313 . . . . 0.0 114.897 -171.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -69.96 -22.32 77.07 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.864 169.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -166.19 -47.05 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -73.79 111.97 9.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.474 1.109 . . . . 0.0 111.999 -170.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.86 -3.71 84.82 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.613 1.577 . . . . 0.0 112.911 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.8 m -78.01 163.68 25.73 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.0 1.32 . . . . 0.0 111.991 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -125.26 33.12 5.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.746 1.218 . . . . 0.0 110.657 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -69.4 171.59 8.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.83 1.252 . . . . 0.0 110.74 168.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -158.83 165.41 34.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.474 0.709 . . . . 0.0 112.903 168.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -102.57 -165.23 26.29 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 126.074 1.797 . . . . 0.0 113.876 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.73 179.74 5.69 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.259 3.306 . . . . 0.0 112.702 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -54.63 124.3 15.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.538 1.135 . . . . 0.0 111.738 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.84 -6.32 83.64 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.775 1.179 . . . . 0.0 114.547 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.62 -3.15 55.44 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.765 1.283 . . . . 0.0 114.362 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -115.39 128.36 56.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.343 1.057 . . . . 0.0 111.005 -169.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 23.0 mt -126.01 143.1 51.23 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.041 2.136 . . . . 0.0 112.483 -168.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -110.65 135.59 51.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.693 1.597 . . . . 0.0 108.499 167.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.66 135.56 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.707 1.603 . . . . 0.0 107.905 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -131.84 160.59 35.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.872 1.269 . . . . 0.0 112.771 -176.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 69.76 27.74 4.55 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.732 2.413 . . . . 0.0 113.858 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.7 mt -66.59 158.52 78.69 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 124.916 1.286 . . . . 0.0 112.133 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.24 147.26 96.08 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.972 2.448 . . . . 0.0 111.299 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -70.97 -9.06 57.24 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.25 -8.29 17.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.505 1.922 . . . . 0.0 114.035 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.8 124.79 24.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.869 1.268 . . . . 0.0 110.741 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.23 -173.97 24.25 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.54 1.067 . . . . 0.0 113.914 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -70.07 -35.22 74.06 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -172.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -74.95 -28.64 60.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.477 0.711 . . . . 0.0 111.641 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -70.39 -43.14 70.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.236 0.614 . . . . 0.0 110.698 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.18 -35.81 80.46 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.069 0.548 . . . . 0.0 111.764 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.7 tp -62.07 -51.01 69.7 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.84 0.746 . . . . 0.0 110.913 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -68.07 -22.81 64.91 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.4 ttm -73.93 -28.76 61.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.316 1.046 . . . . 0.0 112.888 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -109.86 -17.85 13.54 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.6 mtm -54.28 -33.62 17.07 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 170.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -58.95 -15.94 29.81 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.569 2.846 . . . . 0.0 116.229 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -101.48 -9.3 21.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.59 -158.93 27.88 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.831 1.205 . . . . 0.0 114.884 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -75.0 94.42 2.85 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.084 0.954 . . . . 0.0 112.172 -170.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 96.2 t -74.27 131.48 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.972 1.309 . . . . 0.0 110.445 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 34.1 t -106.75 -20.9 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 128.082 2.553 . . . . 0.0 112.06 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.8 t -160.26 148.3 16.62 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.659 1.184 . . . . 0.0 110.657 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -159.91 124.46 3.86 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.143 1.377 . . . . 0.0 110.573 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -155.16 146.78 23.16 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.129 -0.982 . . . . 0.0 112.695 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 23.9 t -119.42 131.03 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.036 1.734 . . . . 0.0 107.763 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -81.87 137.07 35.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.111 0.564 . . . . 0.0 110.54 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 53.9 mt -130.39 141.07 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.59 1.556 . . . . 0.0 109.764 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -84.54 126.35 33.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.438 0.695 . . . . 0.0 111.27 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.78 -16.44 61.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -83.35 -19.98 35.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.227 1.011 . . . . 0.0 112.995 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.0 p -133.53 -19.54 2.12 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 57.4 t30 62.9 17.84 10.32 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.19 1.796 . . . . 0.0 112.989 -171.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 94.2 mt -94.12 145.55 24.61 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.106 1.362 . . . . 0.0 111.055 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 66.4 m -72.22 133.57 45.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.094 0.958 . . . . 0.0 112.024 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -74.07 9.86 1.43 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.567 1.547 . . . . 0.0 114.522 -174.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 57.0 m 68.47 19.11 8.88 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.441 2.296 . . . . 0.0 113.69 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -145.56 154.34 42.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.453 1.024 . . . . 0.0 112.534 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.2 -176.1 27.01 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.282 1.896 . . . . 0.0 113.509 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -143.49 143.65 31.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.354 1.862 . . . . 0.0 110.068 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 80.7 t -142.53 147.48 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.442 1.497 . . . . 0.0 108.815 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.1 m -139.92 152.18 46.18 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.668 0.787 . . . . 0.0 112.003 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -121.24 169.02 10.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.535 1.534 . . . . 0.0 113.126 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.71 -22.53 65.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.081 1.353 . . . . 0.0 113.356 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -160.7 158.07 24.29 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.304 1.441 . . . . 0.0 112.306 -171.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.24 -16.04 43.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.656 2.238 . . . . 0.0 113.969 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.27 -44.31 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.595 1.543 . . . . 0.0 110.569 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.7 m -68.58 -31.47 70.68 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.01 0.924 . . . . 0.0 111.91 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.22 -48.47 34.75 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.931 0.892 . . . . 0.0 112.071 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -62.59 -32.89 73.96 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.436 -0.79 . . . . 0.0 111.882 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.65 -29.42 70.42 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.88 -42.3 33.84 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.525 0.73 . . . . 0.0 111.439 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.7 mt -58.5 -46.32 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 118.859 0.754 . . . . 0.0 110.201 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -71.18 -13.02 61.79 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.4 m -104.17 -27.78 11.85 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.5 mmm -115.34 -19.23 10.81 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -169.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -70.93 109.96 5.37 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.177 0.899 . . . . 0.0 109.903 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 97.18 2.36 59.2 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.619 1.58 . . . . 0.0 114.978 -171.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -62.04 125.06 22.55 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.574 1.687 . . . . 0.0 111.699 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -80.73 129.98 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.387 0.675 . . . . 0.0 110.965 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt -149.51 133.93 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.866 1.266 . . . . 0.0 110.492 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.87 -99.46 0.42 Allowed Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.722 0.677 . . . . 0.0 111.574 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 89.9 mtp -133.88 18.86 3.82 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.469 1.907 . . . . 0.0 112.287 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -146.27 -176.6 5.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.703 1.601 . . . . 0.0 112.783 -171.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.42 138.05 52.88 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.01 1.324 . . . . 0.0 111.582 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 69.1 mt -72.29 159.43 34.06 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.177 1.391 . . . . 0.0 111.992 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -129.17 141.92 51.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.178 1.391 . . . . 0.0 109.24 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 25.2 t -139.46 135.56 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.587 1.155 . . . . 0.0 109.144 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -155.97 151.06 26.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.195 0.598 . . . . 0.0 111.938 -172.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.04 152.41 40.34 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -63.07 -16.67 60.7 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.799 1.239 . . . . 0.0 113.104 169.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 29.7 ttt85 -58.71 -39.09 79.79 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.09 -1.007 . . . . 0.0 111.619 171.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 15.0 m -73.12 -10.87 60.24 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -84.35 -8.38 59.02 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.048 1.339 . . . . 0.0 112.313 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -135.01 -12.19 2.21 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.533 1.533 . . . . 0.0 114.563 -170.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -157.41 163.02 38.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.741 2.017 . . . . 0.0 110.459 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.8 p -153.07 -0.39 0.25 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -66.38 142.48 57.6 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.792 -1.192 . . . . 0.0 112.713 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.5 t -166.8 169.14 13.59 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.251 1.421 . . . . 0.0 111.444 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -164.83 167.08 38.4 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.429 1.49 . . . . 0.0 113.529 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.51 154.1 44.8 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.959 3.106 . . . . 0.0 111.669 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 34.8 p -84.33 -4.42 58.86 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.647 1.179 . . . . 0.0 114.107 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 67.6 m -147.83 149.54 32.51 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.381 1.872 . . . . 0.0 111.207 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 CA-C-O 118.253 -1.304 . . . . 0.0 112.926 178.826 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 36.7 p -70.3 -15.33 62.88 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.9 p -81.03 -1.36 43.7 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.958 1.703 . . . . 0.0 113.883 170.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.55 -168.17 18.3 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.91 1.719 . . . . 0.0 113.416 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 18.4 m -168.98 164.35 11.46 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.714 2.405 . . . . 0.0 110.37 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 15.1 m -72.96 -8.63 56.55 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 65.87 10.99 53.14 Favored Glycine 0 N--CA 1.476 1.321 0 C-N-CA 125.229 1.395 . . . . 0.0 115.79 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 7.7 mp 63.23 15.1 8.33 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 127.024 2.13 . . . . 0.0 112.246 -169.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 42.1 m -76.18 -35.96 58.89 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.108 1.363 . . . . 0.0 111.951 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -83.65 75.21 10.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.946 0.899 . . . . 0.0 110.557 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -128.62 11.66 6.26 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.138 1.375 . . . . 0.0 112.407 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 66.2 p -148.97 137.1 20.83 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.021 1.728 . . . . 0.0 109.288 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.95 149.67 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.107 1.363 . . . . 0.0 111.63 -168.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -80.72 61.37 4.51 Favored Glycine 0 N--CA 1.471 1.001 0 C-N-CA 124.894 1.235 . . . . 0.0 112.222 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.98 -40.36 0.45 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 129.033 2.933 . . . . 0.0 114.487 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -69.53 124.08 22.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.511 1.525 . . . . 0.0 111.287 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.65 6.48 70.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.747 1.641 . . . . 0.0 113.256 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.3 t -80.02 163.47 24.19 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.391 1.076 . . . . 0.0 113.224 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -126.99 8.73 6.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.917 1.287 . . . . 0.0 112.243 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -68.3 166.8 15.74 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.342 -0.849 . . . . 0.0 111.966 168.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.01 165.85 34.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.319 1.048 . . . . 0.0 112.267 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.63 -161.41 25.01 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 126.007 1.765 . . . . 0.0 113.976 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.26 177.64 8.01 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.098 3.199 . . . . 0.0 112.749 -174.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.9 126.83 28.8 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.107 0.963 . . . . 0.0 111.408 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.02 -7.27 82.59 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.042 1.306 . . . . 0.0 114.463 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.59 -2.11 45.55 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -114.8 122.22 45.68 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.27 1.028 . . . . 0.0 110.775 -168.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.7 mt -121.92 138.22 54.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.39 1.876 . . . . 0.0 111.971 -168.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -108.85 135.01 50.76 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.099 1.359 . . . . 0.0 108.834 167.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.95 135.31 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.978 1.711 . . . . 0.0 107.833 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -133.56 159.34 40.74 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.783 1.233 . . . . 0.0 112.434 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 68.5 30.58 5.19 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.218 2.207 . . . . 0.0 113.234 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.29 156.12 86.04 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.355 1.062 . . . . 0.0 111.556 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.71 148.41 74.49 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.183 2.589 . . . . 0.0 111.639 169.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -66.62 -19.36 65.75 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.45 -10.14 39.02 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -176.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.29 136.85 57.08 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.568 1.147 . . . . 0.0 113.203 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -113.11 -178.77 19.5 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.548 1.547 . . . . 0.0 112.799 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -64.48 -32.06 73.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.016 0.926 . . . . 0.0 113.131 -174.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -72.57 -35.21 67.92 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.08 0.952 . . . . 0.0 111.65 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -67.45 -41.69 84.31 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.737 0.699 . . . . 0.0 110.934 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.96 -36.53 78.0 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.101 0.56 . . . . 0.0 112.126 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 64.8 tp -64.08 -51.25 64.94 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.711 0.687 . . . . 0.0 111.097 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -65.47 -29.02 69.63 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.328 0.651 . . . . 0.0 112.274 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 47.0 ttm -67.85 -29.95 69.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.35 1.06 . . . . 0.0 113.006 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -106.24 -14.06 15.23 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.9 mtt -50.3 -37.64 30.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -61.06 -18.77 59.89 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.212 2.608 . . . . 0.0 115.75 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -97.4 -10.34 25.68 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.39 -159.37 27.73 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 125.217 1.389 . . . . 0.0 114.64 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -74.15 85.8 1.87 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.461 1.105 . . . . 0.0 112.436 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.18 125.89 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.134 0.974 . . . . 0.0 109.281 169.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.83 -33.68 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.146 1.779 . . . . 0.0 110.864 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 19.4 m -159.44 145.48 16.22 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.498 1.519 . . . . 0.0 110.875 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.78 143.74 24.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.582 1.553 . . . . 0.0 110.826 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -159.06 142.66 14.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.089 0.955 . . . . 0.0 112.947 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.97 138.88 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.136 1.774 . . . . 0.0 107.166 169.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -83.46 127.56 33.8 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 47.3 mm -115.51 138.46 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.987 1.315 . . . . 0.0 111.191 -168.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -71.92 127.8 33.73 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.994 1.318 . . . . 0.0 111.507 174.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -72.45 -11.43 60.67 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -173.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -104.54 -34.23 8.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.48 1.112 . . . . 0.0 112.272 -176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 -17.59 14.13 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 66.57 16.91 10.54 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.502 1.921 . . . . 0.0 113.14 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 90.2 mt -93.98 162.7 13.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.502 1.521 . . . . 0.0 111.787 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 36.1 t -66.65 138.57 57.53 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.631 -0.668 . . . . 0.0 111.923 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -75.97 3.55 10.03 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.241 1.016 . . . . 0.0 112.949 169.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 28.3 m 75.78 20.56 1.78 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.388 2.675 . . . . 0.0 113.179 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.52 158.02 43.8 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.816 0.846 . . . . 0.0 112.168 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.63 -173.7 28.44 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.979 1.752 . . . . 0.0 113.757 -170.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -147.09 140.44 25.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.592 1.957 . . . . 0.0 110.041 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 71.7 t -146.29 137.49 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.346 1.458 . . . . 0.0 109.278 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.0 m -135.56 141.72 45.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.638 0.775 . . . . 0.0 112.681 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -110.37 170.78 7.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.315 1.846 . . . . 0.0 112.183 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.72 -2.21 45.93 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -157.6 157.3 29.83 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 126.023 1.729 . . . . 0.0 111.887 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.06 -12.61 15.99 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.281 1.987 . . . . 0.0 113.899 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.9 t -79.28 -44.29 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.891 1.678 . . . . 0.0 110.648 -174.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 40.6 m -63.55 -31.96 73.28 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.339 1.056 . . . . 0.0 111.875 171.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -71.43 -51.47 23.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.088 0.955 . . . . 0.0 111.741 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -66.85 -29.66 69.63 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.312 -0.868 . . . . 0.0 112.241 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.44 71.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.791 0.723 . . . . 0.0 112.733 170.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.91 -41.71 61.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.78 0.718 . . . . 0.0 111.466 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 38.1 mt -56.59 -49.29 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 118.964 0.802 . . . . 0.0 110.308 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -70.45 -12.27 61.46 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.5 m -104.06 -28.0 11.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.7 mmm -116.43 -18.09 10.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -70.6 112.2 6.67 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.416 1.007 . . . . 0.0 110.113 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.57 3.22 64.77 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.953 1.74 . . . . 0.0 114.815 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.71 125.43 23.93 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.332 1.566 . . . . 0.0 111.355 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -86.15 130.04 34.65 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.034 0.533 . . . . 0.0 111.066 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.8 tt -149.51 130.95 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.3 1.44 . . . . 0.0 110.081 -173.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.53 -98.91 0.43 Allowed Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -173.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 75.3 mtm -137.11 20.35 2.99 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.377 1.871 . . . . 0.0 112.272 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.35 174.55 11.02 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.698 1.599 . . . . 0.0 112.522 -173.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -124.32 132.76 53.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.356 1.062 . . . . 0.0 111.703 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 60.8 mt -69.58 154.5 41.9 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.051 1.34 . . . . 0.0 112.343 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -124.17 138.98 54.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.639 1.176 . . . . 0.0 108.156 166.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 33.1 t -135.23 135.23 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.362 1.065 . . . . 0.0 108.212 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -152.02 146.66 25.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.277 0.631 . . . . 0.0 111.593 -169.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.75 157.77 29.37 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.862 0.865 . . . . 0.0 112.821 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -76.13 56.72 1.04 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.282 1.433 . . . . 0.0 110.581 168.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -161.02 132.72 5.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.785 1.634 . . . . 0.0 111.227 -169.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 66.9 p -155.9 7.51 0.22 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.054 1.341 . . . . 0.0 113.619 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -161.3 155.87 23.19 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.393 1.877 . . . . 0.0 110.717 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -148.38 144.87 27.79 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.671 1.189 . . . . 0.0 111.73 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -149.26 23.85 0.92 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 112.63 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 18.2 m -159.09 129.85 6.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.233 1.813 . . . . 0.0 110.181 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.28 24.86 14.83 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.271 1.428 . . . . 0.0 113.002 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 18.3 m -68.27 -13.72 62.46 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.184 1.394 . . . . 0.0 114.646 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 91.97 172.35 42.1 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.452 1.501 . . . . 0.0 114.144 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.7 162.56 32.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.344 3.363 . . . . 0.0 112.001 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 49.3 p -81.71 -1.55 47.35 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.734 1.213 . . . . 0.0 114.26 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 10.5 t -163.54 160.09 22.71 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.242 1.817 . . . . 0.0 111.121 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.277 1.418 . . . . 0.0 112.945 -178.074 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.544 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 18.9 m -81.86 -8.08 59.66 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -173.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.0 t -161.59 154.87 21.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.691 1.596 . . . . 0.0 111.114 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -96.82 167.71 24.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.191 1.377 . . . . 0.0 113.888 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 49.0 m -136.23 15.49 3.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.96 1.304 . . . . 0.0 112.798 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 83.4 p -164.22 174.22 11.45 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.766 1.626 . . . . 0.0 111.987 -170.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 92.1 -23.0 28.95 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.28 1.419 . . . . 0.0 114.703 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 8.2 mp 66.15 -179.17 0.2 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.409 2.284 . . . . 0.0 112.613 173.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 36.8 p -61.86 -16.86 53.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.827 1.651 . . . . 0.0 114.531 -172.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -63.19 -17.67 62.66 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.728 1.211 . . . . 0.0 112.635 171.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -98.34 -0.96 42.76 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.55 1.14 . . . . 0.0 112.686 172.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 16.3 m -100.31 9.6 42.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.319 1.448 . . . . 0.0 112.957 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 39.0 pt -75.78 148.96 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.304 1.442 . . . . 0.0 113.355 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -85.82 163.39 36.58 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.685 1.136 . . . . 0.0 112.645 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -73.11 -37.56 66.64 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.95 119.32 12.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.501 1.12 . . . . 0.0 111.563 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.67 3.28 86.28 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.608 1.575 . . . . 0.0 113.652 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 17.1 t -84.8 174.63 9.72 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.225 1.013 . . . . 0.0 112.514 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -132.77 21.36 4.21 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.067 1.747 . . . . 0.0 110.852 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -61.83 161.28 10.55 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.001 0.92 . . . . 0.0 112.6 168.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.56 155.62 45.02 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.04 -170.48 32.35 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.155 1.836 . . . . 0.0 113.301 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -70.03 177.43 5.77 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.151 3.234 . . . . 0.0 112.558 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.13 125.76 24.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.866 0.866 . . . . 0.0 111.198 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.23 -7.46 75.75 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.99 1.281 . . . . 0.0 114.609 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -103.55 8.7 37.69 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -117.96 123.95 47.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.03 1.332 . . . . 0.0 110.709 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 30.7 mt -124.64 140.4 52.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.351 1.86 . . . . 0.0 112.531 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -111.19 133.72 53.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.445 1.498 . . . . 0.0 109.147 168.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.29 137.33 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 126.108 1.763 . . . . 0.0 107.935 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -134.04 161.63 34.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.459 1.504 . . . . 0.0 112.051 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 63.01 33.28 14.92 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.233 1.813 . . . . 0.0 113.307 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 52.9 mt -65.75 159.07 71.63 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.296 1.038 . . . . 0.0 111.01 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -55.46 144.42 73.35 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.89 2.394 . . . . 0.0 111.967 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -55.69 -11.9 1.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.811 2.444 . . . . 0.0 115.587 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -131.05 0.74 4.22 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.294 1.838 . . . . 0.0 114.264 -169.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.04 133.64 51.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.604 1.562 . . . . 0.0 111.363 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.32 -179.86 23.91 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.899 1.238 . . . . 0.0 113.563 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -65.41 -32.45 74.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.046 0.938 . . . . 0.0 112.541 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -74.68 -39.96 61.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.828 1.651 . . . . 0.0 110.876 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -62.13 -44.36 96.81 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.93 0.892 . . . . 0.0 111.015 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 26.4 tp -66.16 -43.09 87.97 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.156 0.582 . . . . 0.0 111.803 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.4 tp -57.21 -54.17 49.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 111.211 175.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -73.96 -20.88 60.22 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.7 ttp -76.97 -22.29 53.43 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.037 0.835 . . . . 0.0 113.03 170.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -102.97 -15.59 16.08 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.964 1.305 . . . . 0.0 113.872 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 36.1 mtt -48.21 -37.86 17.68 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -62.41 -17.62 58.67 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.108 2.538 . . . . 0.0 115.488 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -97.04 -10.43 26.15 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.94 0.896 . . . . 0.0 113.327 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.41 -163.91 28.72 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.405 1.478 . . . . 0.0 114.449 171.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.12 100.61 2.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.932 0.893 . . . . 0.0 111.896 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.6 t -76.19 129.14 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.911 1.284 . . . . 0.0 110.191 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 42.1 t -94.63 -33.6 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.742 2.017 . . . . 0.0 111.541 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 8.6 t -155.75 152.96 29.15 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.96 1.304 . . . . 0.0 110.748 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.91 130.8 8.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.387 1.475 . . . . 0.0 110.351 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -153.95 144.93 22.71 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.465 -0.772 . . . . 0.0 112.544 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.31 131.46 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.203 1.801 . . . . 0.0 107.229 170.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -79.01 138.91 38.24 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.39 0.614 . . . . 0.0 111.11 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 35.6 mm -121.53 145.54 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.451 1.5 . . . . 0.0 110.601 -168.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -76.25 128.41 34.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.897 1.279 . . . . 0.0 111.866 171.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.73 -14.95 62.64 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -110.46 -29.96 7.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.623 1.169 . . . . 0.0 112.979 -174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 65.7 p -108.71 -15.09 14.48 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.327 1.051 . . . . 0.0 113.692 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 25.2 m120 64.92 17.19 10.93 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.33 1.852 . . . . 0.0 113.443 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 88.4 mt -89.24 151.76 21.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.277 1.431 . . . . 0.0 111.753 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 61.3 m -74.99 134.98 41.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.724 0.81 . . . . 0.0 111.893 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -82.05 3.75 25.58 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.082 1.353 . . . . 0.0 114.454 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 34.5 m 69.15 20.16 7.7 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.966 2.107 . . . . 0.0 113.626 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -144.43 156.33 44.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.184 0.994 . . . . 0.0 111.444 172.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.54 -175.36 28.38 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.715 1.626 . . . . 0.0 114.103 -169.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -139.3 146.67 40.63 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.571 1.948 . . . . 0.0 110.049 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 64.2 t -144.94 144.09 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.165 1.386 . . . . 0.0 109.188 174.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 95.7 p -137.16 155.12 49.96 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.389 -0.819 . . . . 0.0 112.884 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -126.82 162.24 26.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.321 1.448 . . . . 0.0 113.462 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.5 -19.78 64.55 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.277 1.031 . . . . 0.0 113.252 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -147.68 153.71 43.43 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.721 1.608 . . . . 0.0 111.066 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.61 -17.53 11.16 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.896 2.397 . . . . 0.0 113.785 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 90.8 t -71.45 -39.6 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.314 0.961 . . . . 0.0 110.333 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 7.8 m -62.44 -34.37 76.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.041 0.936 . . . . 0.0 111.77 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.01 -48.2 38.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.583 1.153 . . . . 0.0 111.97 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -59.3 -38.75 81.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.673 0.789 . . . . 0.0 111.895 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.95 -29.16 70.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.587 0.755 . . . . 0.0 112.957 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.91 -43.38 45.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.626 0.648 . . . . 0.0 111.098 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.4 mt -58.24 -47.39 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.272 0.942 . . . . 0.0 110.246 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -67.14 -17.93 65.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.327 1.051 . . . . 0.0 113.589 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.7 m -104.41 -23.66 13.15 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.5 mmt -112.49 -22.52 10.78 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.686 1.194 . . . . 0.0 113.542 -171.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -70.9 112.52 7.14 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 120.014 1.279 . . . . 0.0 110.831 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 88.15 1.88 81.23 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.587 1.565 . . . . 0.0 114.694 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.88 125.31 23.24 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.937 1.369 . . . . 0.0 111.3 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -77.35 131.71 38.21 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.34 0.59 . . . . 0.0 110.37 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 18.8 tt -138.25 98.65 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.394 1.477 . . . . 0.0 108.093 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.0 -122.66 11.78 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -168.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 92.7 mtp -100.03 11.91 38.17 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.382 1.473 . . . . 0.0 113.574 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -134.64 168.2 19.42 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.58 1.552 . . . . 0.0 112.537 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -124.17 137.05 54.59 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.809 1.244 . . . . 0.0 111.536 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.53 163.91 26.83 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.183 1.393 . . . . 0.0 112.574 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -137.33 139.68 41.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.863 1.665 . . . . 0.0 108.693 167.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.42 140.34 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.39 1.076 . . . . 0.0 109.881 -175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -149.19 154.28 38.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.683 1.193 . . . . 0.0 110.643 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.06 159.23 14.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.957 0.884 . . . . 0.0 111.562 167.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.37 109.35 1.12 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.553 1.141 . . . . 0.0 110.18 168.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 65.02 167.46 0.18 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.836 2.054 . . . . 0.0 112.443 -171.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 73.9 p -160.79 161.63 32.09 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.989 -1.069 . . . . 0.0 112.671 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -157.55 135.98 11.21 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.771 1.629 . . . . 0.0 110.484 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -161.08 149.23 15.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.847 1.259 . . . . 0.0 111.861 -175.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -144.82 16.65 1.6 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.165 1.386 . . . . 0.0 112.666 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 32.5 t -169.49 137.25 1.79 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.278 1.431 . . . . 0.0 111.636 -175.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -78.61 36.17 0.25 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.99 1.316 . . . . 0.0 112.942 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.4 t -161.56 172.0 17.11 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.561 1.944 . . . . 0.0 111.164 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 86.86 -164.96 36.02 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 124.821 1.201 . . . . 0.0 113.159 -174.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.76 147.92 51.47 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.698 2.932 . . . . 0.0 111.725 -176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 20.7 t -165.43 168.86 16.26 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.621 1.568 . . . . 0.0 111.132 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 50.4 m -86.72 -13.23 45.95 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.102 0.961 . . . . 0.0 113.54 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 125.444 1.497 . . . . 0.0 112.82 -176.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 11.6 m -162.98 148.09 11.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.347 1.859 . . . . 0.0 110.63 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 52.7 p -94.69 -4.37 47.67 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 176.62 -165.36 35.57 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.061 1.315 . . . . 0.0 113.871 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 4.3 m -163.02 156.0 19.21 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.669 1.988 . . . . 0.0 110.806 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 7.8 t -161.71 175.45 11.99 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.954 1.302 . . . . 0.0 111.678 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -100.95 -149.75 23.49 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.98 1.752 . . . . 0.0 112.731 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 5.5 tp -89.81 17.59 6.5 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.333 1.453 . . . . 0.0 113.626 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 72.5 p 52.62 -90.39 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.372 3.069 . . . . 0.0 112.916 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -141.85 14.93 2.11 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.217 1.807 . . . . 0.0 111.35 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -87.86 2.17 52.12 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.819 -1.176 . . . . 0.0 112.495 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 25.2 p -75.24 9.36 2.1 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.28 1.832 . . . . 0.0 114.203 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 1.9 pp -81.7 -6.18 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.796 1.639 . . . . 0.0 114.164 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -97.2 -155.98 30.42 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.687 1.613 . . . . 0.0 112.426 174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.02 -35.79 80.69 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.17 -0.606 . . . . 0.0 112.36 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.97 121.02 14.15 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.919 1.288 . . . . 0.0 111.288 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.25 -0.88 84.06 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.5 1.524 . . . . 0.0 113.537 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.1 t -79.53 166.0 22.4 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.177 0.989 . . . . 0.0 112.881 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -128.68 18.1 6.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.665 1.586 . . . . 0.0 111.156 174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -64.62 167.25 7.48 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.999 0.92 . . . . 0.0 111.672 167.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -153.43 154.98 35.48 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.664 0.786 . . . . 0.0 112.187 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.57 -154.72 23.72 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.393 1.473 . . . . 0.0 113.153 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -67.35 161.1 44.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.188 2.592 . . . . 0.0 111.494 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.49 124.58 21.31 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.982 0.513 . . . . 0.0 110.678 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.6 -16.51 44.19 Favored Glycine 0 N--CA 1.473 1.132 0 C-N-CA 124.985 1.278 . . . . 0.0 113.454 -171.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.71 21.93 8.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.35 1.46 . . . . 0.0 112.716 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.94 116.23 21.17 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.298 1.439 . . . . 0.0 110.449 -167.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.5 mt -123.67 138.97 54.43 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.855 1.662 . . . . 0.0 112.361 -169.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.96 134.21 52.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.311 1.444 . . . . 0.0 108.99 167.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -118.51 135.74 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.089 1.755 . . . . 0.0 107.758 -172.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -134.32 158.99 42.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.035 1.334 . . . . 0.0 112.526 -174.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 70.75 27.47 3.61 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.892 2.477 . . . . 0.0 113.749 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.81 157.03 81.58 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.652 1.181 . . . . 0.0 112.038 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -59.36 150.82 72.5 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.001 2.467 . . . . 0.0 111.741 169.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -71.07 -10.3 59.53 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.509 1.123 . . . . 0.0 113.901 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.84 -6.97 15.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.949 2.1 . . . . 0.0 113.817 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.33 123.31 21.39 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.079 1.351 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -102.48 -176.81 27.35 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.405 1.002 . . . . 0.0 113.809 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -65.71 -34.7 78.8 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.793 0.837 . . . . 0.0 112.791 -175.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -77.58 -29.7 52.21 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.868 0.867 . . . . 0.0 111.807 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -68.4 -42.91 78.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.87 0.759 . . . . 0.0 110.657 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.5 tp -65.49 -40.27 92.88 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.184 0.593 . . . . 0.0 111.525 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 62.4 tp -61.19 -52.14 66.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.569 0.622 . . . . 0.0 111.313 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -64.37 -27.1 68.78 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.9 ttp -81.21 -20.15 41.71 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -110.3 -20.55 12.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 48.5 mtm -55.05 -31.57 9.86 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 169.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -57.28 -16.5 22.6 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.63 2.887 . . . . 0.0 116.106 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -98.26 -9.66 25.2 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.246 0.93 . . . . 0.0 113.437 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.79 -159.29 27.9 Favored Glycine 0 N--CA 1.469 0.892 0 C-N-CA 125.075 1.322 . . . . 0.0 115.047 170.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.0 90.71 1.51 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.3 1.04 . . . . 0.0 112.278 -171.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 86.1 t -71.58 130.47 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.762 1.225 . . . . 0.0 110.112 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 53.4 t -100.78 -27.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.286 2.235 . . . . 0.0 111.389 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 20.9 t -156.33 146.32 21.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.48 1.112 . . . . 0.0 110.657 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.63 132.36 9.53 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.573 1.549 . . . . 0.0 110.434 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -156.51 147.95 22.48 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.299 -0.876 . . . . 0.0 113.016 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.72 135.66 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.433 1.893 . . . . 0.0 107.646 173.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -85.22 137.06 33.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.41 0.684 . . . . 0.0 110.392 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 15.8 mt -131.85 137.49 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.301 1.44 . . . . 0.0 109.836 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -85.24 128.0 34.51 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.754 0.822 . . . . 0.0 111.897 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.41 -12.27 59.83 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.36 -20.75 31.46 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.097 0.959 . . . . 0.0 112.593 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 69.6 p -134.11 -18.97 2.01 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -171.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.6 t30 62.86 19.28 11.42 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.046 1.739 . . . . 0.0 112.657 -169.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.19 146.32 26.99 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.169 1.387 . . . . 0.0 111.159 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 66.0 m -72.24 136.97 46.5 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.551 1.141 . . . . 0.0 112.232 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -76.65 9.7 2.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.654 1.582 . . . . 0.0 114.289 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 55.5 m 69.72 19.16 7.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.53 2.332 . . . . 0.0 113.894 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -146.9 156.93 43.47 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.442 1.019 . . . . 0.0 112.528 173.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.81 -174.63 30.89 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.789 1.662 . . . . 0.0 113.702 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -138.99 147.48 42.21 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.333 1.853 . . . . 0.0 110.421 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.4 t -143.58 145.02 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.486 1.514 . . . . 0.0 108.865 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.5 t -143.47 147.99 35.38 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.416 -0.802 . . . . 0.0 112.647 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -117.85 167.17 11.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.154 1.782 . . . . 0.0 113.066 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.37 -13.58 62.14 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.143 1.377 . . . . 0.0 113.63 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -158.86 158.27 28.99 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 126.206 1.803 . . . . 0.0 111.664 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.98 -10.86 19.76 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.347 2.031 . . . . 0.0 113.844 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 29.0 t -77.1 -43.11 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 120.882 1.673 . . . . 0.0 110.555 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 27.2 m -64.86 -31.29 72.46 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.672 1.189 . . . . 0.0 111.773 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.75 -49.32 31.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.035 0.934 . . . . 0.0 111.76 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -61.76 -33.88 74.86 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.388 -0.82 . . . . 0.0 111.987 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.03 -29.63 70.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.318 0.647 . . . . 0.0 112.72 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.68 -41.53 45.09 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.704 0.684 . . . . 0.0 111.086 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 51.4 mt -57.99 -46.8 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 119.388 0.995 . . . . 0.0 110.208 174.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -70.87 -14.25 62.32 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 51.6 m -103.95 -26.6 12.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.9 mmm -114.69 -20.22 10.76 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -168.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -70.93 109.94 5.36 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.295 0.952 . . . . 0.0 109.765 173.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.46 2.4 61.8 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.443 1.497 . . . . 0.0 114.907 -171.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -63.94 126.42 27.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.489 1.645 . . . . 0.0 111.703 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -80.44 125.73 30.31 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.595 0.758 . . . . 0.0 110.203 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.5 tt -145.74 134.75 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.075 1.35 . . . . 0.0 109.953 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.93 -118.62 15.65 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 28.7 ptm -108.99 13.33 24.74 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.797 1.639 . . . . 0.0 113.843 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -143.66 -176.23 4.88 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.271 1.429 . . . . 0.0 113.243 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -124.37 142.12 51.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.539 1.535 . . . . 0.0 111.801 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.1 mt -76.7 161.64 28.35 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.297 1.439 . . . . 0.0 112.751 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -128.89 141.03 51.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.554 1.542 . . . . 0.0 108.709 167.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.4 t -138.47 136.82 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.481 1.112 . . . . 0.0 109.16 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -152.1 151.17 30.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.979 0.912 . . . . 0.0 111.056 -172.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.7 155.41 22.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.03 0.919 . . . . 0.0 112.899 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -56.89 131.56 49.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.759 1.224 . . . . 0.0 111.901 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -102.95 131.16 50.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.976 1.311 . . . . 0.0 111.334 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 51.9 p -93.34 173.85 7.5 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.692 1.997 . . . . 0.0 113.067 175.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 71.31 11.05 6.74 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.219 1.808 . . . . 0.0 115.311 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -151.22 147.26 26.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.813 1.245 . . . . 0.0 112.604 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -154.58 155.45 34.78 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.62 1.968 . . . . 0.0 110.68 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 22.5 m -76.76 -5.81 49.66 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -66.95 137.54 56.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.892 1.277 . . . . 0.0 112.348 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.3 t -152.61 -177.2 6.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.965 1.706 . . . . 0.0 110.63 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 93.36 171.86 39.79 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 125.639 1.59 . . . . 0.0 113.737 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.41 158.74 40.44 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.158 3.238 . . . . 0.0 112.254 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 26.0 t -164.34 153.92 13.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.572 1.549 . . . . 0.0 111.045 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 30.9 m -82.68 -6.75 59.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.135 1.35 . . . . 0.0 113.018 179.896 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 112.125 -0.39 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 95.8 p -163.85 176.12 9.78 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.423 1.489 . . . . 0.0 111.683 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 47.6 p -82.86 0.76 42.61 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.843 1.257 . . . . 0.0 114.24 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -77.93 155.48 42.73 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.802 1.192 . . . . 0.0 113.558 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 19.4 m -89.62 -3.5 58.24 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 50.0 m 65.11 -0.66 1.03 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.721 2.008 . . . . 0.0 115.913 171.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.79 11.74 84.36 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.934 1.254 . . . . 0.0 114.356 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 56.7 tp -74.04 110.84 8.65 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.61 1.205 . . . . 0.0 111.417 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.2 m -61.52 -24.56 66.7 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.389 1.875 . . . . 0.0 113.816 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -62.11 -12.14 17.9 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.084 1.354 . . . . 0.0 113.421 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -79.59 -3.07 45.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.661 1.185 . . . . 0.0 112.906 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 15.5 t -116.97 140.83 49.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.403 1.481 . . . . 0.0 111.157 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.89 151.58 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.065 1.746 . . . . 0.0 111.257 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -132.68 -114.78 1.59 Allowed Glycine 0 N--CA 1.47 0.918 0 C-N-CA 125.361 1.458 . . . . 0.0 112.426 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.48 -51.07 2.7 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 112.892 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.46 122.49 18.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.207 1.003 . . . . 0.0 111.005 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.68 -6.61 82.27 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.343 1.449 . . . . 0.0 113.293 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 66.2 m -98.42 131.4 44.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.242 1.417 . . . . 0.0 110.067 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -103.74 38.51 1.8 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.186 0.995 . . . . 0.0 112.254 -170.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -74.24 -177.44 3.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.667 0.787 . . . . 0.0 110.877 168.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.42 166.63 31.77 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 169.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.77 -165.48 29.28 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.158 1.837 . . . . 0.0 113.572 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.44 171.32 16.44 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.031 3.154 . . . . 0.0 112.47 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.98 126.62 28.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.663 0.785 . . . . 0.0 111.334 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.79 -11.71 71.49 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.8 1.19 . . . . 0.0 114.027 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.82 -1.44 57.35 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.659 1.229 . . . . 0.0 113.963 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -113.4 125.04 53.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.941 1.296 . . . . 0.0 111.458 -169.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.0 mt -124.71 140.23 53.12 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.756 2.022 . . . . 0.0 111.751 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -110.84 132.25 54.36 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.09 1.356 . . . . 0.0 108.594 167.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.67 134.96 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.982 1.713 . . . . 0.0 107.602 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.8 160.34 37.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.242 1.417 . . . . 0.0 112.292 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 69.66 28.88 4.36 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.555 2.342 . . . . 0.0 113.693 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 58.5 mt -68.58 161.2 72.37 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.653 1.181 . . . . 0.0 111.417 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.68 151.1 78.66 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.96 2.44 . . . . 0.0 111.259 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -72.06 -9.07 57.89 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.692 1.197 . . . . 0.0 113.959 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -112.76 -6.72 13.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.256 2.222 . . . . 0.0 113.838 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 130.15 42.29 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.167 1.387 . . . . 0.0 110.898 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.77 178.9 25.16 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.387 0.994 . . . . 0.0 113.842 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -64.6 -33.97 77.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.725 0.81 . . . . 0.0 112.58 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.4 -31.17 57.81 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.087 0.955 . . . . 0.0 111.812 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -66.99 -42.68 84.63 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.821 0.737 . . . . 0.0 110.652 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.55 -39.87 88.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.357 0.663 . . . . 0.0 111.745 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.17 -52.08 65.26 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.641 0.655 . . . . 0.0 111.31 174.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -63.72 -28.01 69.59 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.7 ttp -80.61 -19.93 44.35 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -111.19 -19.48 12.67 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.3 mtm -55.05 -31.73 10.33 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -57.52 -16.74 24.95 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.579 2.853 . . . . 0.0 116.25 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -97.51 -9.53 26.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.41 -162.32 28.21 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.17 1.367 . . . . 0.0 114.348 172.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -72.8 88.14 1.31 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.642 0.777 . . . . 0.0 112.182 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.5 t -65.27 127.41 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.363 1.065 . . . . 0.0 109.403 170.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 45.5 t -91.64 -38.86 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.671 1.988 . . . . 0.0 110.841 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.61 149.52 23.89 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.641 1.176 . . . . 0.0 111.181 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.39 140.29 20.07 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.345 1.458 . . . . 0.0 110.738 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -155.8 140.14 16.68 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.474 -0.766 . . . . 0.0 111.788 -169.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.47 130.8 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.548 1.539 . . . . 0.0 107.498 168.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -84.34 141.76 30.66 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.32 0.648 . . . . 0.0 111.172 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 42.5 mm -118.15 134.9 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.235 1.414 . . . . 0.0 110.269 -169.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -82.26 128.0 33.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.927 0.891 . . . . 0.0 111.781 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -67.66 -12.04 59.59 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -89.99 -21.31 22.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.417 1.087 . . . . 0.0 112.835 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 76.3 p -137.64 -17.76 1.27 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -169.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 64.73 15.06 9.54 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.287 1.835 . . . . 0.0 113.17 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.54 161.18 15.06 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.382 1.473 . . . . 0.0 111.082 175.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 64.5 m -76.65 136.09 39.15 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.66 -0.65 . . . . 0.0 111.561 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.3 4.9 2.53 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -174.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.9 m 67.11 19.76 10.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.863 2.065 . . . . 0.0 113.115 -172.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -146.81 155.25 42.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.864 0.865 . . . . 0.0 112.311 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.88 -175.6 27.99 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.152 1.834 . . . . 0.0 113.559 -170.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -136.25 145.5 45.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.716 2.006 . . . . 0.0 110.285 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 61.4 t -143.27 141.14 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.318 1.447 . . . . 0.0 108.529 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 37.3 p -137.53 146.7 44.45 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.027 0.931 . . . . 0.0 112.18 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -119.82 169.29 10.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.178 1.391 . . . . 0.0 113.223 -174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.03 -23.75 66.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.972 1.309 . . . . 0.0 113.26 169.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -160.0 157.93 25.96 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.24 1.416 . . . . 0.0 112.394 -171.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.13 -15.14 42.47 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.765 2.31 . . . . 0.0 114.026 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.18 -44.78 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 120.754 1.615 . . . . 0.0 110.679 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 57.4 m -68.06 -30.97 70.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.991 0.917 . . . . 0.0 111.886 174.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.64 42.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.659 0.784 . . . . 0.0 111.81 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -58.57 -39.24 79.77 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.487 -0.758 . . . . 0.0 111.947 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.84 -28.76 69.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -79.14 -44.27 22.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.705 0.684 . . . . 0.0 111.386 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 49.4 mt -57.07 -47.53 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.523 1.056 . . . . 0.0 110.151 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -74.66 -10.86 59.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.199 0.999 . . . . 0.0 113.227 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -104.28 -26.55 12.44 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.7 mmm -113.12 -19.86 11.69 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -168.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -70.9 111.19 6.12 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 119.385 0.993 . . . . 0.0 109.954 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.48 2.55 65.45 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.142 1.83 . . . . 0.0 115.172 -171.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.06 124.99 23.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.256 1.528 . . . . 0.0 111.543 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -73.5 131.12 41.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.852 0.296 . . . . 0.0 110.594 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.0 tt -137.24 109.88 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.311 1.044 . . . . 0.0 108.325 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 63.09 -118.43 13.95 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -168.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 62.7 mtt -99.96 -1.97 35.81 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.057 1.343 . . . . 0.0 113.623 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -95.39 168.2 10.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.658 1.183 . . . . 0.0 112.697 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -128.85 125.71 38.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.219 1.408 . . . . 0.0 108.515 166.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 79.7 mt -68.81 160.98 29.5 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.349 1.06 . . . . 0.0 112.079 -176.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -126.2 141.39 51.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.636 1.574 . . . . 0.0 108.638 168.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.07 136.45 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.121 0.968 . . . . 0.0 109.418 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -149.83 146.1 26.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.178 0.991 . . . . 0.0 111.279 -172.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.74 150.17 47.83 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.786 0.834 . . . . 0.0 113.236 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.27 -31.05 72.11 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.568 0.747 . . . . 0.0 111.322 168.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -77.63 82.75 4.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.695 1.598 . . . . 0.0 110.186 170.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 80.4 p -161.14 164.42 30.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.064 1.745 . . . . 0.0 111.025 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -69.99 151.69 45.29 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -169.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -110.97 11.97 22.17 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.807 2.043 . . . . 0.0 113.276 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -156.05 166.96 31.92 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.686 2.394 . . . . 0.0 109.458 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 7.4 m 68.01 20.23 9.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.031 1.732 . . . . 0.0 112.903 -173.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -73.96 -3.67 30.49 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -168.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 77.4 p -161.52 160.22 28.83 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.954 1.702 . . . . 0.0 111.432 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 163.86 -146.83 11.97 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.02 1.295 . . . . 0.0 112.527 -175.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.18 -14.95 20.61 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.118 2.546 . . . . 0.0 113.404 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 60.8 p -116.01 0.56 13.07 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.095 1.358 . . . . 0.0 114.29 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 19.9 t -166.44 144.66 5.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.249 1.42 . . . . 0.0 111.549 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.347 -1.252 . . . . 0.0 112.872 -179.802 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 19.2 m -83.29 -7.22 59.62 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.5 t -162.93 165.13 25.44 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.839 1.656 . . . . 0.0 111.122 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 82.05 -165.39 45.3 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.944 1.259 . . . . 0.0 113.565 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 79.1 p -163.44 162.63 24.87 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.57 1.548 . . . . 0.0 111.645 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 77.6 p -163.51 164.11 24.46 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.895 1.278 . . . . 0.0 112.306 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -91.09 -146.32 16.84 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.189 1.376 . . . . 0.0 112.925 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 61.5 tp -150.77 130.5 13.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.197 1.399 . . . . 0.0 110.461 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 73.6 p -146.75 174.4 11.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.842 2.057 . . . . 0.0 110.353 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -125.55 44.85 2.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.211 1.405 . . . . 0.0 109.629 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -128.18 13.68 6.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.377 1.471 . . . . 0.0 112.362 -170.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 10.6 m -73.59 26.59 0.07 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.851 2.061 . . . . 0.0 115.291 -169.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 34.0 pt -73.24 140.45 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.712 -1.242 . . . . 0.0 112.578 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -132.98 20.16 4.31 Favored Glycine 0 N--CA 1.474 1.228 0 C-N-CA 125.158 1.361 . . . . 0.0 114.764 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.09 99.2 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.254 1.027 . . . . 0.0 113.73 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -68.64 118.8 12.11 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.652 1.181 . . . . 0.0 110.399 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.76 -3.24 74.08 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.194 0.902 . . . . 0.0 113.211 -176.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.1 t -98.35 163.8 12.55 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.356 1.062 . . . . 0.0 111.62 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -134.4 18.06 3.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.947 1.299 . . . . 0.0 112.216 -170.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.52 169.59 3.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.461 1.104 . . . . 0.0 111.783 168.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.41 158.9 44.32 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.838 -1.164 . . . . 0.0 111.855 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.72 -162.08 26.92 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.903 1.716 . . . . 0.0 113.401 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.46 171.23 14.51 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.822 3.015 . . . . 0.0 112.628 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.31 121.09 9.94 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.084 0.954 . . . . 0.0 111.359 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.11 -4.0 73.84 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.949 1.261 . . . . 0.0 114.675 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.15 2.71 55.92 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.002 1.401 . . . . 0.0 114.173 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -118.35 125.66 50.5 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.721 1.208 . . . . 0.0 111.343 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.47 137.45 54.79 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.477 1.911 . . . . 0.0 112.026 -169.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.64 133.88 50.63 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.155 1.382 . . . . 0.0 108.352 167.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 9.3 mm -117.53 136.41 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.641 1.576 . . . . 0.0 108.517 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -135.37 161.5 35.26 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.114 0.965 . . . . 0.0 112.569 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 62.03 36.62 15.36 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.334 1.854 . . . . 0.0 113.299 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 46.0 mt -70.93 162.92 69.29 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.052 1.341 . . . . 0.0 111.392 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.87 149.06 90.32 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.04 2.493 . . . . 0.0 111.231 168.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -71.07 -10.45 59.78 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -104.1 -9.53 18.67 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.473 1.909 . . . . 0.0 114.27 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.28 126.94 31.14 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.608 1.163 . . . . 0.0 111.211 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.22 -174.79 24.31 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.961 1.267 . . . . 0.0 112.9 171.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -62.51 -34.6 77.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.743 0.817 . . . . 0.0 112.925 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -77.55 -30.52 52.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.856 0.862 . . . . 0.0 112.001 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -70.1 -40.43 74.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.606 0.639 . . . . 0.0 110.615 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 23.4 tp -66.42 -39.23 88.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.342 0.657 . . . . 0.0 111.601 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 64.1 tp -61.61 -49.67 75.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.81 0.732 . . . . 0.0 111.053 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -68.64 -23.02 64.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.7 ttm -73.56 -29.88 62.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.021 0.929 . . . . 0.0 113.002 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -109.23 -17.8 13.75 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -171.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.0 mtm -53.61 -33.09 12.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -59.53 -15.36 30.2 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.479 2.786 . . . . 0.0 116.475 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -102.48 -10.69 19.15 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -175.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 154.09 -169.45 32.58 Favored Glycine 0 N--CA 1.469 0.882 0 C-N-CA 125.089 1.328 . . . . 0.0 113.991 174.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -73.93 99.68 3.32 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.14 -0.624 . . . . 0.0 110.991 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.7 t -72.2 125.73 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.22 1.008 . . . . 0.0 109.336 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 37.3 t -86.64 -36.12 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.363 1.865 . . . . 0.0 111.017 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.7 m -161.22 151.59 17.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.213 1.805 . . . . 0.0 110.47 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.14 134.22 15.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.523 1.529 . . . . 0.0 110.225 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -153.36 135.5 14.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.392 0.677 . . . . 0.0 112.08 -174.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.7 t -106.73 135.02 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.205 1.802 . . . . 0.0 107.086 168.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.58 140.43 32.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.249 0.62 . . . . 0.0 111.171 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.5 mm -120.88 137.7 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.166 1.386 . . . . 0.0 110.917 -168.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.09 133.13 42.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.183 1.393 . . . . 0.0 112.47 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -77.99 -7.09 56.38 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -172.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -111.92 -18.85 12.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.517 1.127 . . . . 0.0 113.063 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.2 p -126.37 -15.3 5.69 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.34 1.456 . . . . 0.0 113.982 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 53.3 t30 64.17 16.0 9.72 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.082 1.753 . . . . 0.0 113.355 -175.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.09 153.98 20.83 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.413 1.485 . . . . 0.0 111.216 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 63.0 m -76.47 134.46 39.52 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.538 -0.726 . . . . 0.0 111.603 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.02 3.54 8.22 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 64.1 m 69.11 20.03 7.8 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.167 2.187 . . . . 0.0 113.614 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.27 156.86 44.83 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.898 0.879 . . . . 0.0 112.063 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.1 -172.01 26.74 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.664 1.602 . . . . 0.0 114.316 -169.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -144.32 144.89 31.68 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.491 1.916 . . . . 0.0 110.127 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 78.9 t -144.88 139.08 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.529 1.532 . . . . 0.0 109.049 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 77.8 p -134.43 153.39 51.94 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.913 0.885 . . . . 0.0 112.66 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -128.65 167.57 17.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.86 1.264 . . . . 0.0 114.179 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -67.57 -21.48 65.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.487 1.515 . . . . 0.0 114.607 172.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -152.4 156.48 33.56 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.526 1.531 . . . . 0.0 111.931 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -63.37 -29.77 72.38 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.652 2.901 . . . . 0.0 113.415 174.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.8 -39.57 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.001 0.921 . . . . 0.0 110.865 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 16.3 m -58.92 -35.61 73.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.089 0.955 . . . . 0.0 111.61 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -76.95 -48.41 18.18 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.237 1.415 . . . . 0.0 112.576 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -61.18 -32.21 71.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.321 1.048 . . . . 0.0 112.367 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.15 72.22 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.305 0.642 . . . . 0.0 112.64 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.81 33.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.532 0.733 . . . . 0.0 111.841 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 38.6 mt -58.01 -46.5 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.121 0.873 . . . . 0.0 110.235 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -72.39 -12.81 61.28 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.9 m -103.9 -30.4 10.36 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 83.9 mmm -112.84 -18.75 12.2 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -169.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -70.16 111.97 6.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.66 1.118 . . . . 0.0 110.496 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.24 1.76 69.11 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.744 1.64 . . . . 0.0 114.821 -173.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.13 124.72 21.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.255 1.528 . . . . 0.0 111.636 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -80.27 127.48 32.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.603 0.761 . . . . 0.0 110.19 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.2 tt -148.57 132.36 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.953 1.301 . . . . 0.0 109.793 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.8 -120.37 22.13 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -173.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.17 16.0 24.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.625 1.57 . . . . 0.0 113.008 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -139.01 -176.4 4.49 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.415 1.486 . . . . 0.0 113.341 -170.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -132.48 136.56 46.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.643 1.577 . . . . 0.0 110.942 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 53.3 mt -68.14 161.65 26.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.19 1.396 . . . . 0.0 112.485 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -137.55 142.61 41.37 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.668 1.587 . . . . 0.0 109.161 167.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 34.6 t -139.31 133.11 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.591 1.156 . . . . 0.0 109.019 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -142.25 151.92 42.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.195 0.998 . . . . 0.0 111.482 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 58.9 mt -66.36 152.8 44.28 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.938 0.875 . . . . 0.0 113.151 172.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -66.91 140.26 57.76 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.536 1.134 . . . . 0.0 111.534 169.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -137.11 130.12 30.74 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.886 1.674 . . . . 0.0 110.822 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 10.3 t -168.65 168.93 10.51 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.121 1.768 . . . . 0.0 111.003 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -138.36 -42.32 0.5 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.378 1.471 . . . . 0.0 112.767 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -168.21 154.13 7.12 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.561 1.944 . . . . 0.0 111.549 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -113.83 -0.05 14.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.815 1.646 . . . . 0.0 113.502 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 74.4 p -169.6 172.98 6.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.491 1.916 . . . . 0.0 111.195 -169.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -144.47 -12.78 0.6 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.725 1.61 . . . . 0.0 114.174 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 7.7 t -151.1 177.2 10.42 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.618 1.167 . . . . 0.0 112.959 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -88.96 -101.44 1.01 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.994 1.759 . . . . 0.0 111.486 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.9 99.46 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.375 2.717 . . . . 0.0 109.016 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 35.9 t -173.11 169.21 4.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.65 1.58 . . . . 0.0 110.835 -168.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 51.8 p -76.64 -9.53 58.73 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.028 -1.045 . . . . 0.0 112.229 167.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.339 0 C-N-CA 128.042 2.734 . . . . 0.0 111.933 176.612 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.617 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 29.2 p -68.96 -16.61 63.78 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.1 p -70.7 -10.59 59.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.052 1.341 . . . . 0.0 113.736 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -86.07 8.15 74.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.595 1.569 . . . . 0.0 114.134 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 8.4 t -157.64 -171.86 3.73 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.481 1.513 . . . . 0.0 111.567 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 45.5 m -80.37 54.09 1.94 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.022 1.729 . . . . 0.0 112.427 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.44 -14.61 79.35 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.801 1.191 . . . . 0.0 115.002 -174.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 62.8 tp -83.24 123.78 29.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.732 1.213 . . . . 0.0 110.202 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 76.2 p -73.42 -32.62 64.52 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.559 1.144 . . . . 0.0 113.277 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 67.28 18.06 10.26 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.693 1.997 . . . . 0.0 112.517 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -92.59 -7.31 47.45 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.01 -1.056 . . . . 0.0 113.766 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 78.5 p -94.34 11.9 28.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.165 1.386 . . . . 0.0 113.526 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 16.8 pt -86.0 169.03 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.785 1.634 . . . . 0.0 113.038 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.12 131.32 7.26 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.194 1.378 . . . . 0.0 111.547 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.18 -60.1 0.42 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.997 2.519 . . . . 0.0 110.746 -169.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.02 116.55 7.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.923 1.289 . . . . 0.0 110.181 169.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.0 -9.08 67.29 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.452 1.501 . . . . 0.0 113.173 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.6 m -76.52 158.67 31.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.168 0.987 . . . . 0.0 110.078 169.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -139.86 31.51 2.02 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.379 -0.826 . . . . 0.0 112.133 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -69.33 174.15 5.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.548 0.739 . . . . 0.0 111.007 167.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.78 160.59 43.43 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.92 -160.19 26.56 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.982 1.753 . . . . 0.0 113.453 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.23 172.41 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.899 3.066 . . . . 0.0 112.862 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -59.18 120.63 9.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.419 1.088 . . . . 0.0 110.917 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.01 -3.53 70.32 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.003 1.287 . . . . 0.0 114.708 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.18 0.86 51.74 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.975 1.388 . . . . 0.0 114.421 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -117.15 123.54 46.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.645 1.178 . . . . 0.0 111.271 -169.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.0 mt -123.6 141.51 51.94 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.532 1.933 . . . . 0.0 112.525 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -111.61 134.19 53.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.784 1.634 . . . . 0.0 108.463 167.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.87 135.64 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.733 1.613 . . . . 0.0 107.832 -172.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -131.55 162.42 30.34 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.128 1.371 . . . . 0.0 111.92 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 63.02 37.06 12.0 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.465 1.906 . . . . 0.0 113.273 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 54.6 mt -70.11 161.62 74.47 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.792 1.237 . . . . 0.0 112.083 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.99 154.14 58.88 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.418 2.746 . . . . 0.0 111.123 168.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -75.51 -19.91 59.06 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -96.76 -6.38 36.36 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.57 1.548 . . . . 0.0 114.207 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.01 128.12 35.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.862 1.265 . . . . 0.0 111.819 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -107.26 -177.56 22.67 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.963 1.268 . . . . 0.0 113.506 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.46 -34.2 77.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.11 0.964 . . . . 0.0 112.703 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -75.97 -27.24 57.41 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.402 1.081 . . . . 0.0 111.676 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -75.5 -42.29 53.17 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.881 0.872 . . . . 0.0 110.723 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 27.1 tp -64.76 -36.63 84.91 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.334 0.653 . . . . 0.0 111.686 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.4 -51.22 69.64 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.417 0.553 . . . . 0.0 110.702 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -69.01 -20.99 64.16 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.7 ttm -73.98 -26.95 60.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.108 0.963 . . . . 0.0 112.817 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -113.03 -18.29 12.23 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.9 mtm -53.24 -34.03 16.77 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 170.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -59.44 -16.88 37.75 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.559 2.839 . . . . 0.0 116.215 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -100.2 -9.01 22.92 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.408 1.004 . . . . 0.0 113.664 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.78 -163.37 28.57 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.981 1.277 . . . . 0.0 114.75 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -70.68 96.53 1.23 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.311 1.044 . . . . 0.0 112.285 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 80.3 t -74.85 128.43 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.089 1.355 . . . . 0.0 109.881 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 38.7 t -88.69 -36.78 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.57 1.948 . . . . 0.0 111.045 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.8 m -160.25 150.73 18.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.511 1.525 . . . . 0.0 110.814 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.4 130.39 11.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.232 1.813 . . . . 0.0 109.637 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -152.71 144.73 23.76 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.539 -0.726 . . . . 0.0 112.854 -171.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.0 t -119.18 135.93 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.554 1.942 . . . . 0.0 108.219 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -85.19 131.94 34.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.539 0.736 . . . . 0.0 109.853 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 44.1 mm -114.43 135.74 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.723 1.209 . . . . 0.0 111.316 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.28 131.88 43.3 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.437 1.495 . . . . 0.0 111.938 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -82.04 -2.0 50.28 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -171.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -108.52 -27.63 9.78 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.672 1.189 . . . . 0.0 112.297 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.2 p -119.28 -15.31 9.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.292 1.437 . . . . 0.0 114.236 -174.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 51.6 t30 63.79 15.25 8.9 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.063 1.745 . . . . 0.0 113.271 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.9 mt -86.96 160.58 18.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.496 1.518 . . . . 0.0 111.315 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 27.4 t -62.08 138.69 58.42 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.68 -0.638 . . . . 0.0 110.867 168.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -72.34 2.65 5.74 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 66.5 m 73.52 20.36 3.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.265 2.626 . . . . 0.0 113.003 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -146.38 155.68 42.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.678 0.791 . . . . 0.0 112.394 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.38 -173.95 29.57 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.968 1.747 . . . . 0.0 113.675 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -140.94 145.67 36.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.406 1.883 . . . . 0.0 110.141 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.1 t -145.36 139.18 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.155 1.382 . . . . 0.0 109.279 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.1 p -133.38 149.06 51.86 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.327 1.051 . . . . 0.0 112.328 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -121.55 163.34 19.03 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.099 1.359 . . . . 0.0 113.323 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.27 -18.2 63.12 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.293 1.037 . . . . 0.0 113.073 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -145.52 151.78 47.8 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.273 1.429 . . . . 0.0 112.182 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.91 -29.34 58.09 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.829 3.019 . . . . 0.0 113.868 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.45 -40.97 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.705 0.802 . . . . 0.0 110.916 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.1 m -62.06 -33.27 74.09 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.856 0.862 . . . . 0.0 111.918 173.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.72 -49.26 21.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.993 1.317 . . . . 0.0 112.129 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -60.99 -33.65 73.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.062 0.945 . . . . 0.0 112.126 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.11 -31.05 72.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.358 0.663 . . . . 0.0 112.642 172.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.36 -41.53 47.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.344 0.658 . . . . 0.0 111.68 175.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 40.2 mt -58.14 -47.29 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.03 0.832 . . . . 0.0 110.153 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.24 -14.27 62.18 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.9 m -102.18 -29.78 11.52 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 86.1 mmm -113.32 -18.04 12.15 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -169.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -70.26 111.78 6.12 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.491 1.041 . . . . 0.0 110.551 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.93 1.75 67.27 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.885 1.707 . . . . 0.0 114.77 -173.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.9 124.43 20.46 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.215 1.507 . . . . 0.0 111.615 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -80.39 127.71 32.71 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.613 0.765 . . . . 0.0 110.175 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.5 tt -148.31 131.99 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.888 1.275 . . . . 0.0 109.713 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.74 -118.78 14.95 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -173.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -109.71 16.36 22.16 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.871 1.668 . . . . 0.0 112.624 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -138.98 -176.46 4.5 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.615 1.566 . . . . 0.0 113.173 -171.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -132.5 137.24 47.12 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.528 1.531 . . . . 0.0 110.941 173.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 59.5 mt -68.96 161.01 29.77 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.978 1.311 . . . . 0.0 112.328 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.96 141.21 42.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.435 1.494 . . . . 0.0 108.967 168.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.35 138.2 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.532 1.133 . . . . 0.0 109.302 -175.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -151.02 152.76 33.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.241 1.016 . . . . 0.0 110.757 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.32 157.63 16.13 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.6 0.76 . . . . 0.0 112.778 170.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -53.69 134.1 41.81 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.942 1.297 . . . . 0.0 112.673 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -103.5 9.34 37.65 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.676 1.59 . . . . 0.0 114.617 -171.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 69.0 m -138.52 152.03 47.88 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.376 1.47 . . . . 0.0 111.205 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -138.29 156.26 47.82 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.936 1.294 . . . . 0.0 112.424 -174.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -71.87 167.77 19.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.874 1.27 . . . . 0.0 112.902 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -153.14 128.48 9.87 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.986 1.314 . . . . 0.0 110.4 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 53.5 p -69.87 -19.57 63.43 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -171.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -72.64 -4.72 32.7 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 44.8 m -113.69 12.29 18.35 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.922 1.689 . . . . 0.0 112.713 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -82.19 -171.1 45.9 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.326 1.441 . . . . 0.0 114.253 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.98 -10.93 30.43 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.772 2.981 . . . . 0.0 113.796 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 24.8 p -73.35 -8.5 56.14 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.949 1.3 . . . . 0.0 113.841 170.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 94.5 p -136.76 3.78 2.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.084 1.354 . . . . 0.0 114.263 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.197 0 CA-C-O 118.2 -1.333 . . . . 0.0 113.247 178.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.587 0 CA-C-O 121.29 0.567 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.35 -6.53 81.71 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.66 1.6 . . . . 0.0 113.168 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 4.2 t -82.63 157.29 23.47 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.455 1.128 . . . . 0.0 113.421 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -128.54 13.87 6.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.994 1.318 . . . . 0.0 112.26 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -70.62 176.08 4.41 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.377 -0.827 . . . . 0.0 110.195 167.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.48 157.46 39.87 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.263 -0.898 . . . . 0.0 112.355 168.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.82 -157.39 22.72 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.339 1.447 . . . . 0.0 113.235 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.92 160.61 43.31 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.197 2.598 . . . . 0.0 111.488 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.04 124.33 20.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.103 0.561 . . . . 0.0 110.983 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.58 -8.74 60.27 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.024 1.297 . . . . 0.0 113.68 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.85 22.1 7.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.168 1.387 . . . . 0.0 112.646 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.7 118.6 25.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.413 1.485 . . . . 0.0 110.084 -167.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 27.9 mt -125.33 141.95 51.78 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.106 1.763 . . . . 0.0 112.659 -168.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -114.54 134.06 55.32 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.382 1.473 . . . . 0.0 109.283 168.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.56 134.71 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.318 1.847 . . . . 0.0 107.884 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -133.08 158.62 42.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.743 1.217 . . . . 0.0 112.87 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 73.2 26.86 2.05 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.984 2.513 . . . . 0.0 113.528 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.45 149.6 97.9 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.599 1.16 . . . . 0.0 111.373 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -58.32 149.87 70.78 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.247 2.631 . . . . 0.0 112.454 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -69.23 -9.72 54.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.63 -11.32 23.73 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.969 1.708 . . . . 0.0 114.168 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.07 126.34 30.31 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.261 1.024 . . . . 0.0 111.549 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -108.3 -171.65 21.47 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.545 1.545 . . . . 0.0 112.096 169.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.73 -32.56 74.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.047 0.939 . . . . 0.0 113.145 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -78.5 -30.38 47.18 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.993 0.917 . . . . 0.0 112.079 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -70.55 -40.78 73.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.71 0.686 . . . . 0.0 110.632 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 28.6 tp -65.63 -37.66 87.22 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.382 0.673 . . . . 0.0 111.838 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 65.1 tp -62.52 -51.71 66.33 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.702 0.683 . . . . 0.0 111.253 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -63.92 -30.78 71.84 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.1 0.56 . . . . 0.0 112.423 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.0 ttm -68.57 -29.45 67.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.345 1.058 . . . . 0.0 113.11 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -106.36 -13.23 15.43 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 29.7 mtt -49.66 -37.36 23.26 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -61.78 -17.73 56.65 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.127 2.552 . . . . 0.0 116.015 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -99.67 -7.82 25.18 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.49 -163.73 28.46 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.326 1.441 . . . . 0.0 114.44 171.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -72.52 97.78 2.17 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.054 0.942 . . . . 0.0 111.853 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.6 t -74.55 126.93 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.56 1.144 . . . . 0.0 109.815 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 39.9 t -91.06 -36.47 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.437 1.895 . . . . 0.0 111.032 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 53.6 m -149.81 147.77 28.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.737 1.215 . . . . 0.0 110.92 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.14 136.48 20.11 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.237 1.815 . . . . 0.0 109.013 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -153.74 138.32 16.88 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.556 -0.715 . . . . 0.0 111.656 -168.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.58 128.36 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.214 1.406 . . . . 0.0 107.976 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 123.607 0.763 . . . . 0.0 110.85 -177.059 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 35.3 m 64.97 20.1 12.02 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.996 2.118 . . . . 0.0 112.973 -171.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -147.35 156.07 42.57 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.143 0.977 . . . . 0.0 112.033 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.52 -177.55 27.99 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 126.008 1.766 . . . . 0.0 113.605 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -135.18 146.68 48.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.521 1.928 . . . . 0.0 110.133 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.9 t -143.22 144.86 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.309 1.443 . . . . 0.0 108.719 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 8.1 t -143.65 146.85 33.55 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.455 -0.778 . . . . 0.0 112.37 173.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -115.87 165.42 13.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.138 1.775 . . . . 0.0 113.128 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.0 -18.43 64.72 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.371 1.069 . . . . 0.0 113.281 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -145.27 149.59 41.91 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.122 1.369 . . . . 0.0 112.16 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.29 -28.08 55.47 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.757 2.971 . . . . 0.0 113.774 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.36 -38.67 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.879 0.872 . . . . 0.0 110.896 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 9.9 m -62.68 -34.63 77.52 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.966 0.906 . . . . 0.0 111.707 171.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.71 -48.14 41.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.54 1.136 . . . . 0.0 111.964 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -60.67 -34.32 74.15 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 112.16 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.0 -30.01 70.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.431 0.693 . . . . 0.0 112.696 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.73 -41.49 53.22 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.349 0.66 . . . . 0.0 111.491 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.9 -48.07 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.896 0.771 . . . . 0.0 110.12 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.58 -14.23 62.41 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -102.76 -29.07 11.71 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 92.2 mmm -114.54 -19.14 11.27 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -169.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -70.81 111.28 6.12 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.277 0.944 . . . . 0.0 109.951 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 97.46 1.36 59.14 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.682 1.61 . . . . 0.0 114.841 -172.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -64.62 120.36 12.24 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.676 1.738 . . . . 0.0 111.173 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -76.78 131.93 38.97 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.976 0.417 . . . . 0.0 110.452 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.1 tt . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 124.492 1.117 . . . . 0.0 109.018 179.127 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.81 150.54 47.7 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.169 1.388 . . . . 0.0 111.591 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -121.22 141.99 50.33 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.64 1.176 . . . . 0.0 108.777 168.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.26 133.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.364 1.066 . . . . 0.0 108.82 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -142.53 157.69 44.47 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.563 1.145 . . . . 0.0 111.075 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.47 156.98 30.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.821 0.819 . . . . 0.0 112.132 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 CA--C 1.545 0.754 0 C-N-CA 124.54 1.136 . . . . 0.0 112.189 171.855 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.477 0 CA-C-O 120.828 0.347 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.29 84.64 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.373 0.987 . . . . 0.0 113.347 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.3 t -85.47 173.82 9.96 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.002 0.901 . . . . 0.0 111.411 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -139.7 28.53 2.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.392 1.477 . . . . 0.0 110.846 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -66.98 164.16 18.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.982 0.913 . . . . 0.0 112.684 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.7 154.66 37.82 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.73 -160.38 26.77 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.101 1.81 . . . . 0.0 113.473 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.08 171.74 15.29 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.907 3.071 . . . . 0.0 112.576 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.45 122.34 13.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.069 0.948 . . . . 0.0 111.337 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.63 -4.33 75.91 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.844 1.212 . . . . 0.0 114.587 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.66 1.56 53.63 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.069 1.434 . . . . 0.0 114.39 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -116.98 125.17 50.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.899 1.28 . . . . 0.0 111.162 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.3 mt -124.22 140.29 53.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.528 1.931 . . . . 0.0 112.403 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -110.8 133.38 53.4 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.506 1.522 . . . . 0.0 108.52 167.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.5 mm -117.05 139.23 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.98 1.712 . . . . 0.0 108.71 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -140.65 160.89 39.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.335 1.054 . . . . 0.0 113.131 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 66.52 26.81 9.86 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.832 2.453 . . . . 0.0 114.037 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 68.4 mt -66.14 155.9 86.15 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.595 1.158 . . . . 0.0 112.219 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -59.95 148.76 87.54 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.291 2.661 . . . . 0.0 111.953 171.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.71 -19.17 65.7 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -91.93 -10.04 40.93 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.033 1.333 . . . . 0.0 114.556 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.1 134.36 51.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.272 1.029 . . . . 0.0 112.495 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.62 -176.78 19.76 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.402 1.477 . . . . 0.0 112.213 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -62.25 -32.49 73.2 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -78.13 -29.57 48.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.967 0.907 . . . . 0.0 112.268 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -70.45 -40.33 73.79 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.741 0.7 . . . . 0.0 110.692 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.37 -36.71 79.6 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.953 0.501 . . . . 0.0 111.745 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -62.27 -49.7 74.65 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.917 0.78 . . . . 0.0 110.947 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -67.96 -22.97 65.01 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.7 ttm -73.96 -27.82 61.18 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.024 0.93 . . . . 0.0 113.108 171.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -112.58 -16.37 12.85 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -171.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.7 mtm -53.92 -33.92 18.0 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -59.15 -16.17 32.13 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.492 2.794 . . . . 0.0 116.325 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -99.85 -10.22 22.0 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.42 -159.66 28.08 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 124.657 1.122 . . . . 0.0 114.909 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.34 92.83 1.85 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.201 1.0 . . . . 0.0 112.201 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.5 t -72.1 128.12 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.951 1.3 . . . . 0.0 110.018 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.93 -31.9 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.126 2.17 . . . . 0.0 111.494 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.9 t -157.64 151.12 23.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.458 1.103 . . . . 0.0 110.916 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.06 132.15 14.36 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.246 1.418 . . . . 0.0 110.19 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -153.68 132.44 12.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.43 0.692 . . . . 0.0 112.005 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 64.0 t -103.25 135.03 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.653 1.581 . . . . 0.0 107.27 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.352 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 58.3 m 74.27 18.99 2.95 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.575 2.75 . . . . 0.0 113.206 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.15 156.77 43.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.991 0.814 . . . . 0.0 112.382 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.93 -175.16 28.54 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.85 1.69 . . . . 0.0 113.708 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -141.57 144.25 34.15 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.542 1.937 . . . . 0.0 110.111 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.1 t -144.33 140.67 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.203 1.401 . . . . 0.0 108.765 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 88.3 p -135.8 153.1 51.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.648 0.779 . . . . 0.0 112.36 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -126.6 164.89 20.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.213 1.405 . . . . 0.0 113.078 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.98 -10.88 59.78 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.488 1.115 . . . . 0.0 113.007 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.74 145.51 28.3 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.062 1.345 . . . . 0.0 111.744 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.69 -29.78 69.38 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.464 2.776 . . . . 0.0 113.718 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.14 -41.57 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.815 0.846 . . . . 0.0 111.382 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.4 p -66.83 -31.13 71.54 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.605 0.762 . . . . 0.0 112.377 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -68.9 -49.8 55.02 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.769 0.828 . . . . 0.0 111.849 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -58.93 -39.37 81.38 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.582 -0.699 . . . . 0.0 111.941 175.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.44 -28.82 65.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 174.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.65 -43.66 30.67 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.652 0.66 . . . . 0.0 112.036 171.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.1 mt -58.12 -49.96 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 119.479 1.036 . . . . 0.0 110.408 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -73.79 -11.71 60.47 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.5 m -100.1 -30.65 11.83 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.5 mmm -111.66 -19.77 12.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -169.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.71 111.54 5.56 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.286 0.948 . . . . 0.0 109.903 173.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.01 3.31 65.76 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.404 1.478 . . . . 0.0 115.104 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -63.86 124.28 21.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.438 1.619 . . . . 0.0 111.258 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -81.04 131.3 35.3 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.263 0.554 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.2 tt . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 125.247 1.419 . . . . 0.0 108.447 -178.179 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 120.691 0.281 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.2 mt -68.12 160.5 28.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.276 1.43 . . . . 0.0 111.787 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -133.14 143.4 49.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.246 1.418 . . . . 0.0 109.67 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 30.1 t -138.44 136.02 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.648 1.179 . . . . 0.0 109.172 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -140.71 154.9 46.53 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.451 1.101 . . . . 0.0 111.173 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.15 155.64 38.24 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 122.317 1.056 . . . . 0.0 111.802 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 CA--C 1.546 0.822 0 C-N-CA 123.709 0.804 . . . . 0.0 111.162 169.868 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.27 0.557 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.81 -6.79 82.73 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.517 1.532 . . . . 0.0 113.272 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 6.8 t -84.03 158.0 21.62 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.676 1.238 . . . . 0.0 112.64 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -128.78 14.39 6.41 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.041 1.336 . . . . 0.0 112.34 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -68.13 177.16 2.35 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.394 -0.816 . . . . 0.0 110.349 167.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -154.74 157.66 38.36 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.235 -0.916 . . . . 0.0 112.079 168.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.59 -158.42 24.17 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.176 1.37 . . . . 0.0 113.314 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.31 160.73 43.85 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.216 2.611 . . . . 0.0 111.439 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.87 123.4 18.39 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.828 -0.545 . . . . 0.0 110.928 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.96 -9.07 58.0 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.013 1.292 . . . . 0.0 113.752 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.17 20.19 10.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.169 1.387 . . . . 0.0 112.728 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 120.38 30.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.434 1.493 . . . . 0.0 110.052 -167.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.92 139.77 53.52 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.239 1.815 . . . . 0.0 112.372 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -112.14 133.37 54.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.213 1.405 . . . . 0.0 108.993 167.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -118.46 136.08 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.19 1.796 . . . . 0.0 107.748 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -133.55 160.77 36.48 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.185 1.394 . . . . 0.0 112.404 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 67.49 30.34 6.82 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.266 2.226 . . . . 0.0 113.478 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.38 155.65 90.34 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.889 0.876 . . . . 0.0 111.257 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.68 151.91 52.27 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.291 2.661 . . . . 0.0 111.981 169.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -70.48 -15.28 62.79 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.329 1.052 . . . . 0.0 113.517 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -102.89 -4.75 24.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.482 1.913 . . . . 0.0 114.29 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.29 134.51 52.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.925 1.29 . . . . 0.0 112.105 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -111.27 -179.14 20.25 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.105 1.336 . . . . 0.0 113.147 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -66.99 -31.84 72.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.455 0.702 . . . . 0.0 112.838 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -73.18 -35.89 66.47 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.353 1.061 . . . . 0.0 112.003 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -64.95 -41.69 95.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.909 0.484 . . . . 0.0 110.857 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -69.44 -42.2 75.27 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.973 -0.537 . . . . 0.0 112.035 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.1 tp -58.64 -54.81 42.91 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.742 0.701 . . . . 0.0 111.501 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -75.58 -15.53 60.35 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -170.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.4 ttp -80.71 -20.76 42.14 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.125 0.97 . . . . 0.0 112.738 169.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -105.71 -15.33 14.99 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.553 1.541 . . . . 0.0 114.013 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 37.1 mtt -47.89 -37.37 13.46 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 168.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -62.07 -16.9 53.21 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.976 2.451 . . . . 0.0 115.696 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -99.37 -8.34 24.95 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.94 0.896 . . . . 0.0 113.327 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 148.48 -167.28 29.14 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.324 1.44 . . . . 0.0 114.447 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -75.06 97.42 3.41 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.615 1.166 . . . . 0.0 112.792 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.25 132.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.558 1.543 . . . . 0.0 110.263 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.66 -35.41 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 127.07 2.148 . . . . 0.0 111.39 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 24.0 m -150.77 147.41 27.27 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.19 1.396 . . . . 0.0 110.896 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.26 134.19 14.88 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.846 1.658 . . . . 0.0 109.187 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -154.27 136.61 14.92 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.727 -0.608 . . . . 0.0 111.805 -168.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 84.1 t -112.62 132.08 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.238 1.415 . . . . 0.0 107.926 169.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.985 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 64.0 mttm . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 23.3 m 75.06 19.3 2.35 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.166 2.586 . . . . 0.0 113.074 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -149.21 158.48 44.22 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.618 0.767 . . . . 0.0 112.051 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.55 -177.67 31.85 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.696 1.617 . . . . 0.0 113.599 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -137.42 145.77 43.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.392 1.877 . . . . 0.0 110.021 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 94.9 t -143.41 143.91 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.204 1.402 . . . . 0.0 108.532 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 8.1 t -143.77 145.61 32.51 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.394 -0.816 . . . . 0.0 112.146 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -114.74 167.5 10.71 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.41 1.884 . . . . 0.0 112.225 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.63 -16.89 63.46 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -144.86 149.51 43.06 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.967 1.307 . . . . 0.0 112.168 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.91 -27.88 58.58 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.721 2.947 . . . . 0.0 113.66 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.46 -40.27 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.884 0.873 . . . . 0.0 110.927 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 15.3 m -62.73 -33.49 75.25 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.687 0.795 . . . . 0.0 111.833 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.14 -47.34 36.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.731 1.212 . . . . 0.0 112.083 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -61.17 -34.83 75.68 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.125 0.97 . . . . 0.0 112.041 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.39 70.4 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.476 0.711 . . . . 0.0 112.803 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.06 47.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.26 0.624 . . . . 0.0 111.163 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.05 -46.85 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 119.335 0.97 . . . . 0.0 110.304 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -69.85 -14.6 62.83 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.0 m -104.21 -26.48 12.5 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.7 mmm -115.08 -19.28 10.94 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -71.02 110.5 5.75 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.321 0.964 . . . . 0.0 110.186 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.73 2.34 65.11 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.766 1.65 . . . . 0.0 114.857 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -61.16 123.97 19.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.453 1.626 . . . . 0.0 111.669 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -78.37 131.3 36.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.128 0.489 . . . . 0.0 110.412 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.1 tt . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 125.043 1.337 . . . . 0.0 108.852 -178.354 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 111.587 0.218 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.74 161.59 29.49 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.118 1.367 . . . . 0.0 112.588 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -130.97 141.55 50.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.596 1.558 . . . . 0.0 108.781 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.02 138.46 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.392 1.077 . . . . 0.0 109.43 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -147.5 151.13 35.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.548 1.139 . . . . 0.0 110.791 -174.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.33 157.54 25.88 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.914 0.864 . . . . 0.0 111.787 168.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 CA--C 1.548 0.873 0 C-N-CA 124.523 1.129 . . . . 0.0 113.26 170.32 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 120.841 0.353 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 87.44 -5.2 85.44 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.922 1.249 . . . . 0.0 113.375 -176.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 40.4 m -78.21 158.52 28.96 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.902 1.281 . . . . 0.0 111.371 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -131.7 27.79 4.62 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.441 1.096 . . . . 0.0 112.086 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -71.95 171.03 12.55 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.386 -0.822 . . . . 0.0 110.47 167.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.09 156.23 35.48 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 169.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -87.43 -158.44 32.72 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.898 1.713 . . . . 0.0 114.172 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.7 165.84 26.25 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.544 2.829 . . . . 0.0 111.625 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.95 125.72 24.76 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.597 -0.689 . . . . 0.0 111.274 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.5 -6.64 68.15 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.75 1.167 . . . . 0.0 113.689 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.81 18.41 14.55 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.211 1.404 . . . . 0.0 112.824 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.25 119.95 27.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.519 1.527 . . . . 0.0 109.779 -168.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 33.5 mt -124.86 133.9 52.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.122 1.769 . . . . 0.0 112.087 -168.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -105.11 134.25 48.52 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.964 1.306 . . . . 0.0 108.673 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 9.4 mm -118.24 137.72 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.897 1.679 . . . . 0.0 108.526 -169.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -137.06 161.68 35.42 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.487 1.115 . . . . 0.0 112.492 -175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 62.57 34.39 15.15 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.259 1.824 . . . . 0.0 113.14 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.23 158.46 86.61 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.218 1.407 . . . . 0.0 111.818 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.85 142.6 99.15 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.82 2.347 . . . . 0.0 111.26 169.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -68.44 -9.18 46.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.519 1.127 . . . . 0.0 113.644 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -98.53 -10.79 22.98 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.826 1.65 . . . . 0.0 113.922 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.54 132.31 40.64 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.937 1.295 . . . . 0.0 112.132 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.69 -172.62 18.72 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.282 1.42 . . . . 0.0 113.274 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -67.64 -34.43 76.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.953 0.901 . . . . 0.0 113.219 -172.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -77.81 -30.89 51.41 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.542 0.737 . . . . 0.0 111.756 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -67.01 -43.5 82.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.16 0.584 . . . . 0.0 110.396 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 26.5 tp -65.48 -43.27 90.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.291 0.637 . . . . 0.0 111.636 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.53 -54.1 50.72 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.599 0.76 . . . . 0.0 111.259 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -73.95 -20.72 60.27 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.8 ttp -76.59 -22.61 54.0 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.031 0.832 . . . . 0.0 113.016 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -102.77 -16.3 16.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.077 1.351 . . . . 0.0 113.754 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 36.6 mtt -47.63 -38.03 15.23 Favored Pre-proline 0 CA--C 1.552 1.035 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -62.26 -17.73 58.63 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.158 2.572 . . . . 0.0 115.54 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -97.7 -9.94 25.85 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.0 0.92 . . . . 0.0 113.325 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.38 -164.17 28.39 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.371 1.462 . . . . 0.0 114.518 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.69 100.63 2.87 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.972 0.909 . . . . 0.0 111.874 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.3 t -76.73 127.09 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.876 1.27 . . . . 0.0 109.874 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 43.0 t -86.86 -35.51 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.502 1.921 . . . . 0.0 111.246 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.8 m -161.79 151.21 16.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.736 1.614 . . . . 0.0 110.636 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.91 132.97 12.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.07 1.748 . . . . 0.0 109.977 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -154.22 148.32 25.78 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.49 130.14 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 126.699 2.0 . . . . 0.0 107.685 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 111.511 -175.38 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 83.0 m 62.87 22.03 13.18 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.652 1.981 . . . . 0.0 113.364 -172.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -141.76 155.48 45.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.116 0.966 . . . . 0.0 111.67 172.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.27 -172.33 24.35 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.831 1.681 . . . . 0.0 113.912 -169.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -143.75 147.36 34.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.945 1.698 . . . . 0.0 110.257 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 59.7 t -144.0 145.65 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.765 1.626 . . . . 0.0 108.976 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.2 t -143.14 151.81 41.1 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.216 -0.927 . . . . 0.0 112.55 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -120.94 164.64 16.39 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.015 1.726 . . . . 0.0 113.247 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.11 -18.67 64.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.347 1.059 . . . . 0.0 113.143 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -145.28 150.21 44.02 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.118 1.367 . . . . 0.0 112.222 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.71 -29.22 60.0 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.797 2.998 . . . . 0.0 113.845 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.58 -38.4 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.779 0.832 . . . . 0.0 110.852 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.3 m -62.54 -35.19 78.65 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.003 0.921 . . . . 0.0 111.695 171.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.42 -47.83 46.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.571 1.148 . . . . 0.0 112.007 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -60.28 -35.46 75.6 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.03 0.932 . . . . 0.0 112.113 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.03 71.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.566 0.746 . . . . 0.0 112.685 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.92 56.01 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.298 0.639 . . . . 0.0 111.196 174.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.48 -46.62 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 119.434 1.015 . . . . 0.0 110.362 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -69.6 -15.82 63.28 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.1 m -104.54 -23.12 13.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.5 mmt -113.37 -22.89 10.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.898 1.279 . . . . 0.0 113.626 -171.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -71.41 113.44 8.45 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.974 1.261 . . . . 0.0 110.698 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.68 4.13 83.03 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.554 1.55 . . . . 0.0 114.626 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -63.34 126.47 27.56 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.904 1.352 . . . . 0.0 111.171 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -85.04 130.93 34.53 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.115 0.566 . . . . 0.0 110.866 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.6 tt . . . . . 0 CA--C 1.536 0.413 0 C-N-CA 125.425 1.49 . . . . 0.0 109.799 -170.292 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.4 mt -68.72 163.35 24.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.405 1.482 . . . . 0.0 112.618 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -139.57 142.33 37.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.417 1.487 . . . . 0.0 108.83 168.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.46 139.79 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.314 1.046 . . . . 0.0 109.452 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -144.86 148.13 33.61 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.316 1.046 . . . . 0.0 110.931 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.24 155.33 28.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.962 0.887 . . . . 0.0 112.256 168.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.6 tttt . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 124.358 1.063 . . . . 0.0 111.058 168.998 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 121.156 0.503 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.25 -3.37 85.51 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.195 1.855 . . . . 0.0 113.889 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 38.8 t -74.69 156.03 37.1 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.667 1.187 . . . . 0.0 112.498 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -118.43 10.34 12.66 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.016 1.326 . . . . 0.0 112.519 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -64.95 165.43 10.89 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.268 -0.895 . . . . 0.0 112.273 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.66 163.83 36.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.205 1.002 . . . . 0.0 112.433 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -102.42 -161.51 26.17 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 126.102 1.81 . . . . 0.0 113.685 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.73 178.98 6.45 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.055 3.17 . . . . 0.0 112.791 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -54.68 123.88 14.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.796 1.238 . . . . 0.0 111.696 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.33 -5.06 85.72 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.692 1.139 . . . . 0.0 114.694 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.22 -3.38 53.87 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.808 1.304 . . . . 0.0 114.439 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -114.49 124.68 52.51 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.51 1.124 . . . . 0.0 111.263 -168.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.8 mt -124.68 141.85 51.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.625 1.97 . . . . 0.0 112.69 -168.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -112.18 134.58 53.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.588 1.555 . . . . 0.0 109.035 168.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.31 136.24 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.932 1.693 . . . . 0.0 108.249 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -134.23 159.9 39.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.879 1.272 . . . . 0.0 112.865 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 70.45 27.72 3.86 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.945 2.498 . . . . 0.0 113.898 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.89 155.45 86.64 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.828 1.251 . . . . 0.0 112.054 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.48 150.3 69.29 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.019 2.48 . . . . 0.0 111.557 168.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -69.83 -11.82 61.16 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.447 1.099 . . . . 0.0 113.709 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.08 -7.61 16.82 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.895 2.078 . . . . 0.0 113.799 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.47 116.68 14.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.09 1.356 . . . . 0.0 110.429 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -99.28 -175.7 31.55 Favored Glycine 0 N--CA 1.467 0.757 0 C-N-CA 124.19 0.9 . . . . 0.0 113.743 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.14 -35.45 78.8 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.477 1.111 . . . . 0.0 112.631 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -77.52 -31.05 53.21 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.081 0.953 . . . . 0.0 111.981 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -70.82 -41.6 71.36 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.791 0.723 . . . . 0.0 110.715 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.5 tp -64.61 -42.28 95.65 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.217 0.607 . . . . 0.0 111.144 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.88 -51.01 71.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.325 0.65 . . . . 0.0 111.229 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -71.24 -20.07 62.28 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.5 ttp -82.92 -21.63 34.11 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.043 0.838 . . . . 0.0 113.044 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -106.17 -23.23 12.64 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.1 mtm -54.3 -33.02 13.24 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 170.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -58.09 -18.22 35.33 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.627 2.885 . . . . 0.0 115.787 174.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -94.82 -12.16 27.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.231 0.923 . . . . 0.0 113.41 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.8 -157.78 27.47 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.926 1.251 . . . . 0.0 115.027 170.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -74.06 84.23 1.79 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.261 1.024 . . . . 0.0 112.757 -169.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 84.8 t -66.79 127.87 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.872 1.269 . . . . 0.0 109.707 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 55.6 t -91.46 -35.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.011 1.724 . . . . 0.0 110.978 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 27.5 m -158.73 147.36 18.54 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.528 1.531 . . . . 0.0 110.854 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.46 140.28 20.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.828 1.651 . . . . 0.0 110.439 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -154.41 149.22 26.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.635 0.774 . . . . 0.0 112.887 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.89 137.19 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.428 1.891 . . . . 0.0 108.535 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 123.845 0.858 . . . . 0.0 110.692 -178.855 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 50.6 m 71.33 18.28 5.65 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.602 2.361 . . . . 0.0 113.935 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -145.15 154.79 42.82 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.504 1.047 . . . . 0.0 112.357 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.01 -172.34 25.98 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.948 1.737 . . . . 0.0 113.608 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -148.77 141.59 24.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.986 1.714 . . . . 0.0 109.95 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 61.3 t -146.22 136.32 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.908 1.283 . . . . 0.0 109.31 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 68.3 m -134.23 140.43 46.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.618 0.767 . . . . 0.0 112.293 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -110.08 168.85 9.13 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.804 1.642 . . . . 0.0 113.145 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.51 -21.15 66.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.401 1.481 . . . . 0.0 113.295 169.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -160.94 157.42 22.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.24 1.416 . . . . 0.0 112.378 -171.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.9 -16.09 40.88 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.7 2.267 . . . . 0.0 113.936 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.82 -44.19 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 120.459 1.481 . . . . 0.0 110.459 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.8 m -69.21 -30.91 69.18 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.967 0.907 . . . . 0.0 112.114 174.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -75.03 -47.13 30.57 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.851 0.86 . . . . 0.0 112.327 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -62.69 -32.57 73.68 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.469 -0.769 . . . . 0.0 111.806 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.59 70.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.14 -43.35 34.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.27 0.628 . . . . 0.0 111.174 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.03 -45.71 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.07 0.85 . . . . 0.0 110.351 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -70.76 -14.87 62.59 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.4 m -104.33 -22.94 13.27 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 2.1 mmt -114.15 -24.18 9.11 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 113.768 -170.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -71.69 112.48 7.83 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.687 1.13 . . . . 0.0 110.348 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.73 3.01 74.74 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.473 1.511 . . . . 0.0 114.683 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -64.41 127.68 32.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.11 1.455 . . . . 0.0 111.291 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -85.96 129.6 34.79 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.048 0.539 . . . . 0.0 110.951 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.6 tt . . . . . 0 CA--C 1.537 0.449 0 C-N-CA 125.545 1.538 . . . . 0.0 110.108 -173.356 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 120.701 0.286 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.39 162.04 30.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.287 1.435 . . . . 0.0 112.521 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -130.91 139.17 50.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.232 1.413 . . . . 0.0 109.079 168.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 32.0 t -139.3 134.42 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.393 1.077 . . . . 0.0 109.259 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -146.71 159.35 43.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.023 0.929 . . . . 0.0 112.24 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 62.0 mt -66.38 152.71 44.49 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.095 0.958 . . . . 0.0 112.866 173.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 124.033 0.933 . . . . 0.0 110.614 168.47 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 120.878 0.371 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 87.14 0.02 85.54 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.269 1.414 . . . . 0.0 113.563 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.4 t -98.43 170.51 8.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.303 1.052 . . . . 0.0 111.898 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -132.42 32.35 3.94 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.179 1.392 . . . . 0.0 111.28 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -67.74 164.75 18.74 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.498 -0.751 . . . . 0.0 110.329 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -155.99 161.61 40.45 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.53 -159.32 24.89 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.055 1.788 . . . . 0.0 113.61 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.94 171.99 15.51 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.956 3.104 . . . . 0.0 112.85 -172.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.68 123.46 16.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.019 0.928 . . . . 0.0 111.381 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.62 -3.78 78.79 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.798 1.189 . . . . 0.0 114.584 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.72 1.41 53.4 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.908 1.354 . . . . 0.0 114.355 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -118.27 124.31 47.53 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.494 1.118 . . . . 0.0 110.884 -169.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 18.9 mt -123.62 146.78 47.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.796 2.038 . . . . 0.0 113.052 -168.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -117.43 135.09 54.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.718 1.607 . . . . 0.0 109.099 168.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -119.84 137.36 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.181 1.792 . . . . 0.0 107.831 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -134.99 161.3 35.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.128 1.371 . . . . 0.0 112.584 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 67.46 27.41 8.01 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.433 2.293 . . . . 0.0 113.92 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 67.7 mt -64.92 157.77 73.88 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.014 1.325 . . . . 0.0 112.06 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.53 147.48 91.42 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.992 2.461 . . . . 0.0 111.434 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -69.73 -8.29 46.69 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.43 -8.09 15.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.511 1.924 . . . . 0.0 114.166 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.47 124.27 23.09 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.8 1.24 . . . . 0.0 110.805 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.25 -176.27 26.39 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.481 1.039 . . . . 0.0 114.065 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.35 -36.36 82.69 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.83 0.852 . . . . 0.0 112.782 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.59 -28.36 56.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.83 0.852 . . . . 0.0 111.769 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.1 -42.11 73.13 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.655 0.661 . . . . 0.0 110.646 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.8 tp -67.03 -36.41 82.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.184 0.594 . . . . 0.0 111.797 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.11 -51.68 66.91 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.686 0.675 . . . . 0.0 110.931 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -63.51 -28.43 69.94 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.0 ttm -72.62 -29.18 63.26 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.453 1.101 . . . . 0.0 113.159 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -109.51 -18.34 13.54 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 47.3 mtm -55.4 -32.24 12.02 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -58.09 -16.33 26.7 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.661 2.908 . . . . 0.0 116.291 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -100.34 -8.35 23.46 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.48 -163.44 28.48 Favored Glycine 0 N--CA 1.47 0.906 0 C-N-CA 125.173 1.368 . . . . 0.0 114.513 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -72.4 90.58 1.3 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.749 0.82 . . . . 0.0 112.026 -173.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 79.9 t -65.42 128.92 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.714 1.206 . . . . 0.0 109.843 172.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 37.5 t -91.62 -36.61 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.94 2.096 . . . . 0.0 110.913 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.85 152.8 25.4 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.618 1.167 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -155.35 133.39 11.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.505 1.122 . . . . 0.0 110.705 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -154.45 147.99 25.19 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.398 -0.814 . . . . 0.0 112.925 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.8 t -124.68 131.4 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 126.214 1.806 . . . . 0.0 107.899 172.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 CA--C 1.538 0.508 0 C-N-CA 123.504 0.722 . . . . 0.0 110.962 -175.824 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.549 0.92 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 58.4 m 68.17 17.62 9.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.514 2.326 . . . . 0.0 113.582 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -144.46 154.77 43.28 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.585 1.084 . . . . 0.0 112.758 175.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.74 -177.64 31.03 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.982 1.754 . . . . 0.0 114.087 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -134.61 145.96 49.12 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.704 2.002 . . . . 0.0 110.193 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 92.5 t -144.78 138.75 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.826 1.25 . . . . 0.0 109.236 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 64.7 p -130.47 152.24 50.08 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.211 1.004 . . . . 0.0 112.074 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -125.77 163.82 22.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.344 1.457 . . . . 0.0 113.106 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -71.33 -18.46 62.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.031 0.932 . . . . 0.0 113.048 173.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -144.6 150.77 48.37 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.078 1.351 . . . . 0.0 112.197 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.76 -29.69 59.36 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.856 3.037 . . . . 0.0 113.722 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.08 -40.25 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.811 0.844 . . . . 0.0 110.963 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 8.8 m -61.95 -34.24 75.76 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.971 0.908 . . . . 0.0 111.817 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.79 -49.27 26.16 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.88 1.272 . . . . 0.0 112.029 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -60.93 -33.91 73.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.961 0.904 . . . . 0.0 112.15 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 -30.56 71.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.412 0.685 . . . . 0.0 112.611 172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.3 -41.54 48.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.294 0.638 . . . . 0.0 111.451 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 45.5 mt -57.88 -47.47 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.014 0.824 . . . . 0.0 110.129 174.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.08 -14.69 62.4 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.8 m -101.94 -28.47 12.37 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 91.7 mmm -114.44 -19.13 11.32 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -169.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -70.33 110.28 5.19 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.289 0.949 . . . . 0.0 109.933 173.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.37 2.91 60.18 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.369 1.462 . . . . 0.0 114.933 -172.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.17 123.47 18.71 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.427 1.613 . . . . 0.0 111.587 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -79.0 130.53 35.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.222 0.609 . . . . 0.0 110.988 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 125.11 1.364 . . . . 0.0 110.43 -178.339 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 66.9 mt -70.71 160.72 32.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.032 1.333 . . . . 0.0 111.75 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -132.3 141.9 49.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.226 1.41 . . . . 0.0 109.194 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.5 t -139.42 136.14 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.505 1.122 . . . . 0.0 109.062 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -145.73 165.22 29.42 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.018 1.327 . . . . 0.0 111.044 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.48 159.88 26.23 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.861 0.864 . . . . 0.0 111.859 169.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.0 tttt . . . . . 0 CA--C 1.547 0.856 0 C-N-CA 125.411 1.484 . . . . 0.0 112.324 171.491 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 120.984 0.421 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.26 -2.4 71.22 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.456 1.027 . . . . 0.0 113.375 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.0 t -77.35 165.75 24.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.156 0.978 . . . . 0.0 112.093 174.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -134.09 23.19 3.84 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.017 1.327 . . . . 0.0 110.791 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -65.75 174.73 2.2 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.903 1.281 . . . . 0.0 111.751 168.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -156.26 161.53 40.23 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.791 0.836 . . . . 0.0 112.432 168.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.35 -163.19 29.47 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.965 1.745 . . . . 0.0 113.376 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.99 172.79 13.95 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.754 2.97 . . . . 0.0 112.43 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.51 128.39 36.95 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.495 0.664 . . . . 0.0 111.342 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.6 -10.2 75.24 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.796 1.189 . . . . 0.0 113.962 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.9 -5.73 47.24 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.639 1.22 . . . . 0.0 114.218 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -112.08 123.95 51.36 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.317 1.047 . . . . 0.0 110.55 -169.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.9 mt -124.07 143.26 50.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.675 1.99 . . . . 0.0 112.549 -168.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -112.92 134.26 54.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.417 1.487 . . . . 0.0 109.073 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.01 134.17 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.346 1.858 . . . . 0.0 107.737 -171.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -132.65 158.5 42.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.878 1.271 . . . . 0.0 112.694 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 71.69 27.33 2.93 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.604 2.362 . . . . 0.0 113.747 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 76.8 mt -65.13 161.11 51.56 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.986 1.315 . . . . 0.0 111.803 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.62 149.19 91.94 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.921 2.414 . . . . 0.0 110.845 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -67.7 -20.47 65.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -88.94 -11.18 45.16 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.53 129.1 38.83 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.504 1.122 . . . . 0.0 111.886 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.12 -173.95 23.48 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.296 1.427 . . . . 0.0 112.273 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.02 -33.48 73.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.757 0.823 . . . . 0.0 112.493 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -67.84 -44.98 75.92 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.099 1.76 . . . . 0.0 111.472 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.89 -40.92 95.84 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.974 0.91 . . . . 0.0 111.528 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 30.4 tp -67.13 -38.94 86.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.267 0.627 . . . . 0.0 111.891 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 66.1 tp -63.11 -48.7 77.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.87 0.759 . . . . 0.0 111.077 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -67.88 -23.2 65.09 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.8 ttm -74.91 -25.91 59.25 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.112 0.965 . . . . 0.0 113.148 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -113.63 -16.67 12.31 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.4 mtm -54.16 -33.82 17.99 Favored Pre-proline 0 CA--C 1.549 0.914 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -58.99 -16.3 31.83 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.476 2.784 . . . . 0.0 116.296 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.12 -11.38 20.54 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 149.01 -163.06 29.07 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.931 1.253 . . . . 0.0 114.823 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -71.55 102.1 2.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.118 0.967 . . . . 0.0 112.385 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 69.7 t -80.44 128.69 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.071 1.348 . . . . 0.0 110.083 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.12 -22.44 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.956 2.502 . . . . 0.0 112.087 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 8.8 t -159.7 146.05 16.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.266 1.427 . . . . 0.0 110.341 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.58 129.39 10.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.196 1.399 . . . . 0.0 110.687 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -156.0 132.03 9.93 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.584 0.754 . . . . 0.0 112.557 -174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.9 135.14 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.486 1.514 . . . . 0.0 107.299 167.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 123.275 0.63 . . . . 0.0 111.295 -178.095 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 57.9 mttm . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.1 m 66.87 21.62 10.37 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.067 2.147 . . . . 0.0 113.207 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -146.52 156.17 43.06 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.129 0.972 . . . . 0.0 111.687 172.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.58 -177.71 29.09 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.868 1.699 . . . . 0.0 113.767 -170.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -138.58 141.16 39.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.015 2.126 . . . . 0.0 109.901 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 94.9 t -144.03 137.31 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.076 1.35 . . . . 0.0 108.867 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.0 m -131.03 148.43 52.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.474 0.71 . . . . 0.0 112.068 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -117.57 170.24 8.91 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.405 1.482 . . . . 0.0 113.287 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.52 -25.02 67.01 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.381 1.472 . . . . 0.0 113.648 170.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -160.12 162.2 24.57 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.096 1.358 . . . . 0.0 112.109 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.98 -13.52 31.65 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.332 2.021 . . . . 0.0 114.03 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 22.8 t -75.4 -45.92 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 121.032 1.742 . . . . 0.0 110.892 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.5 p -69.73 -32.52 71.11 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.811 0.844 . . . . 0.0 112.631 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -67.14 -49.0 66.37 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.365 0.666 . . . . 0.0 112.435 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -63.2 -31.71 72.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.376 -0.828 . . . . 0.0 112.056 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.79 70.47 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.7 0.682 . . . . 0.0 112.595 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.79 -42.0 51.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.717 0.689 . . . . 0.0 111.411 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.27 -47.22 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 118.914 0.779 . . . . 0.0 110.199 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -70.36 -15.45 62.86 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.0 m -99.78 -29.38 12.66 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 88.4 mmm -113.97 -19.93 11.24 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -71.68 110.6 6.34 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.441 1.019 . . . . 0.0 109.987 174.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 90.92 8.64 64.85 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.393 1.473 . . . . 0.0 114.433 -171.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.76 122.64 17.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.764 1.782 . . . . 0.0 110.568 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -74.36 131.88 41.51 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 122.063 -0.398 . . . . 0.0 110.292 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 124.556 1.143 . . . . 0.0 108.579 173.906 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.691 0.282 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.18 155.96 40.13 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.854 1.262 . . . . 0.0 111.502 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.38 140.7 52.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.857 1.263 . . . . 0.0 109.46 169.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 23.4 t -139.61 136.27 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.541 1.136 . . . . 0.0 109.245 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -150.77 162.04 41.49 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.08 0.952 . . . . 0.0 112.097 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 75.4 mt -64.5 157.16 27.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.599 1.16 . . . . 0.0 113.071 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 CA--C 1.548 0.866 0 C-N-CA 124.537 1.135 . . . . 0.0 113.152 169.708 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.6 -6.36 83.7 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.584 1.087 . . . . 0.0 113.281 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 7.6 t -86.92 160.21 18.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.461 1.131 . . . . 0.0 111.117 172.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -135.83 22.93 3.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.399 1.08 . . . . 0.0 112.477 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -68.81 173.96 4.8 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.314 -0.866 . . . . 0.0 111.676 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -148.88 158.44 44.17 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.756 0.822 . . . . 0.0 112.196 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.55 -160.95 27.99 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.994 1.759 . . . . 0.0 113.451 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.08 176.03 9.67 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.94 3.094 . . . . 0.0 112.576 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -56.32 124.67 18.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.266 1.026 . . . . 0.0 111.501 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.04 -7.64 81.27 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.811 1.196 . . . . 0.0 114.556 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.72 -5.21 54.04 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.919 1.359 . . . . 0.0 114.364 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -112.68 122.53 47.95 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.576 1.15 . . . . 0.0 110.676 -168.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.1 mt -123.32 141.65 51.77 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.562 1.945 . . . . 0.0 112.535 -168.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -111.09 134.83 52.39 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.574 1.549 . . . . 0.0 108.729 167.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.5 133.51 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.93 1.692 . . . . 0.0 107.791 -171.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -129.58 160.64 32.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.858 1.263 . . . . 0.0 112.22 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 65.8 38.37 5.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.07 1.748 . . . . 0.0 113.193 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 54.1 mt -71.59 161.45 78.45 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.104 1.362 . . . . 0.0 111.696 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.6 154.59 47.45 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.233 2.622 . . . . 0.0 111.469 168.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -68.12 -28.19 67.12 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.58 -11.19 57.66 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.83 128.25 35.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.405 1.082 . . . . 0.0 112.494 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.78 -171.55 18.29 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.796 1.665 . . . . 0.0 112.362 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -62.15 -35.51 79.02 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.838 0.855 . . . . 0.0 113.195 -174.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -74.16 -29.29 61.71 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.161 0.985 . . . . 0.0 112.089 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -76.12 -42.13 47.99 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.815 0.846 . . . . 0.0 110.695 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 32.8 tp -63.69 -38.01 89.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.359 0.664 . . . . 0.0 111.572 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.8 tp -63.69 -49.6 72.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.613 0.642 . . . . 0.0 111.116 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -68.81 -20.1 64.31 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.0 ttm -74.56 -26.85 60.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.945 0.898 . . . . 0.0 112.852 169.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -111.61 -19.44 12.51 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -172.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.3 mtm -53.72 -34.39 20.08 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -59.18 -17.31 38.25 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.505 2.803 . . . . 0.0 116.097 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.68 -10.79 21.52 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.32 -160.12 28.11 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.713 1.149 . . . . 0.0 115.033 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -74.06 96.07 2.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.15 0.98 . . . . 0.0 112.18 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.7 t -77.19 127.29 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.104 1.362 . . . . 0.0 109.677 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.53 -34.23 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.682 1.993 . . . . 0.0 111.319 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.8 m -160.07 147.37 16.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.533 1.533 . . . . 0.0 110.786 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.04 134.23 16.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.596 1.559 . . . . 0.0 110.129 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -153.64 132.65 12.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.48 0.712 . . . . 0.0 111.887 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 91.8 t -101.42 131.13 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.634 1.574 . . . . 0.0 107.169 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.19 0.519 . . . . 0.0 111.178 -177.318 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 78.5 m 65.66 22.99 11.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.271 2.229 . . . . 0.0 113.735 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -143.69 156.02 44.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.236 1.014 . . . . 0.0 111.455 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.64 -174.15 26.02 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.889 1.709 . . . . 0.0 114.006 -169.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -144.96 140.99 28.61 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.757 2.023 . . . . 0.0 109.837 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 89.0 t -145.5 135.97 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.222 1.409 . . . . 0.0 109.072 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 65.8 m -132.44 141.79 48.98 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.37 0.668 . . . . 0.0 112.378 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -111.0 169.49 8.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.598 1.559 . . . . 0.0 113.56 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.06 -23.5 65.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.941 1.696 . . . . 0.0 113.59 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -161.27 160.89 24.01 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.323 1.449 . . . . 0.0 112.05 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.85 -12.38 26.26 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.652 2.234 . . . . 0.0 114.272 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 40.6 t -77.37 -46.33 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.665 1.575 . . . . 0.0 110.494 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 21.6 m -64.78 -29.75 70.74 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.671 1.189 . . . . 0.0 111.896 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.12 -50.34 19.88 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.032 0.933 . . . . 0.0 111.934 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -59.68 -37.8 79.8 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.476 -0.765 . . . . 0.0 111.735 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.34 -28.09 64.75 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -80.44 -43.97 20.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.65 0.78 . . . . 0.0 111.898 172.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.31 -50.18 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.138 0.881 . . . . 0.0 110.523 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -74.78 -11.58 60.19 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 66.1 m -99.2 -31.4 11.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 89.7 mmm -112.35 -18.04 12.58 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -168.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -68.47 110.83 4.35 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.559 1.072 . . . . 0.0 110.489 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.71 3.8 66.03 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.959 1.743 . . . . 0.0 115.038 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.41 128.36 35.46 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.409 1.605 . . . . 0.0 111.721 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -84.77 130.37 34.69 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.227 0.611 . . . . 0.0 111.3 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.3 tt . . . . . 0 N--CA 1.468 0.446 0 C-N-CA 125.212 1.405 . . . . 0.0 110.145 -173.745 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 62.0 mt -66.45 160.44 24.94 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.34 1.456 . . . . 0.0 112.196 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -136.78 139.64 41.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.162 1.385 . . . . 0.0 108.925 167.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.2 t -139.33 135.69 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.497 1.119 . . . . 0.0 109.066 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -153.72 153.68 32.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.701 0.8 . . . . 0.0 111.394 -176.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 82.3 mt -61.78 154.89 24.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.562 1.145 . . . . 0.0 113.206 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.8 tttt . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 124.251 1.021 . . . . 0.0 111.122 169.753 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.8 -9.3 76.91 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.588 1.089 . . . . 0.0 113.093 -175.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 74.2 m -81.49 149.56 28.67 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.435 1.094 . . . . 0.0 110.62 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -132.85 29.53 4.12 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.211 1.004 . . . . 0.0 111.83 -170.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -71.68 176.29 4.96 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.471 -0.768 . . . . 0.0 110.907 168.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.81 157.53 42.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 168.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.92 -163.26 27.82 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 127.79 2.614 . . . . 0.0 113.775 -170.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.15 173.13 13.45 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.024 3.15 . . . . 0.0 112.759 -173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.54 124.28 18.48 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.059 0.943 . . . . 0.0 111.108 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.45 -10.48 69.13 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.783 1.182 . . . . 0.0 114.497 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.77 -0.76 47.59 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -111.57 118.14 34.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.837 1.255 . . . . 0.0 110.938 -169.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.3 mt -121.48 135.37 55.04 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.855 1.662 . . . . 0.0 112.016 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -106.16 133.29 51.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.936 1.294 . . . . 0.0 108.725 167.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.6 mm -118.08 138.39 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.092 1.757 . . . . 0.0 108.788 -169.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -140.34 161.94 36.48 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.626 1.171 . . . . 0.0 113.029 -172.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 63.83 25.96 14.2 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.474 2.31 . . . . 0.0 113.926 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.33 156.06 82.88 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.477 1.111 . . . . 0.0 111.115 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.27 145.8 91.72 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.791 2.327 . . . . 0.0 111.76 171.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -67.43 -17.43 64.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.908 0.883 . . . . 0.0 113.161 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -99.71 -8.83 23.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.829 1.252 . . . . 0.0 114.033 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.58 125.4 26.41 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.448 1.499 . . . . 0.0 111.205 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -102.68 -177.67 27.04 Favored Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.344 0.973 . . . . 0.0 113.745 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -61.76 -36.12 80.09 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.122 0.969 . . . . 0.0 112.673 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -76.44 -30.69 57.48 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.82 0.848 . . . . 0.0 111.786 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -70.73 -41.19 72.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.614 0.643 . . . . 0.0 110.685 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 28.1 tp -64.86 -38.73 91.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.559 0.744 . . . . 0.0 111.674 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.26 -50.16 71.25 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.573 0.624 . . . . 0.0 111.095 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -63.39 -27.11 69.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.3 ttm -73.31 -29.41 62.68 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.433 1.093 . . . . 0.0 113.229 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -110.22 -18.15 13.36 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 44.7 mtm -55.54 -33.05 14.71 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 171.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.75 -16.06 23.64 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.57 2.846 . . . . 0.0 116.157 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -100.73 -9.78 21.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.32 -162.11 28.39 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.988 1.28 . . . . 0.0 115.127 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -71.88 92.58 1.26 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.753 1.221 . . . . 0.0 112.38 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.23 128.38 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.816 1.246 . . . . 0.0 109.722 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 44.8 t -92.6 -34.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.909 2.084 . . . . 0.0 111.478 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.3 m -159.53 145.54 16.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 110.377 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.9 134.59 17.62 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.949 1.699 . . . . 0.0 110.208 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -154.92 136.83 14.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.63 0.772 . . . . 0.0 111.588 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.06 135.29 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.969 1.708 . . . . 0.0 107.873 169.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 123.085 0.554 . . . . 0.0 110.994 -179.078 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 30.8 m 69.79 18.52 7.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.515 2.326 . . . . 0.0 113.406 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -145.91 156.09 43.3 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.094 0.958 . . . . 0.0 112.091 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.52 -175.29 28.28 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 126.099 1.809 . . . . 0.0 113.546 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -139.71 144.84 37.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.244 1.818 . . . . 0.0 110.262 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 81.2 t -142.84 139.82 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.514 1.526 . . . . 0.0 108.708 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 34.3 t -136.74 144.99 44.12 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.631 0.772 . . . . 0.0 112.277 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -116.44 166.02 12.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.869 1.667 . . . . 0.0 113.431 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.51 -19.3 63.73 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.663 1.185 . . . . 0.0 113.204 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -147.74 159.69 40.23 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 126.23 1.812 . . . . 0.0 110.843 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 -18.67 8.19 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.297 1.998 . . . . 0.0 113.816 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 70.7 t -72.67 -43.57 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 119.812 1.187 . . . . 0.0 111.0 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.6 p -65.8 -31.74 72.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.775 0.83 . . . . 0.0 112.427 172.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -69.51 -50.47 44.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.85 0.86 . . . . 0.0 112.327 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.89 -29.97 70.0 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.266 -0.896 . . . . 0.0 112.097 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.05 -31.25 71.64 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.606 0.639 . . . . 0.0 112.485 169.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.08 63.94 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.838 0.745 . . . . 0.0 111.834 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 30.0 mt -57.55 -49.06 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.116 0.871 . . . . 0.0 110.047 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -70.97 -15.05 62.56 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 53.1 m -99.35 -30.42 12.23 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.5 mmm -112.79 -20.69 11.53 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -69.99 112.71 6.58 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.413 1.006 . . . . 0.0 109.786 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.25 2.54 68.28 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.392 1.472 . . . . 0.0 115.268 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -65.24 123.3 19.19 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.628 1.714 . . . . 0.0 111.169 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -81.18 131.12 35.28 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.878 -0.514 . . . . 0.0 111.233 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.8 tt . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 122.772 1.272 . . . . 0.0 109.468 -178.815 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.755 0.312 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 72.2 mt -63.84 159.48 19.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.331 1.453 . . . . 0.0 111.473 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -135.42 139.35 44.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.352 1.461 . . . . 0.0 109.715 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 29.2 t -139.24 136.9 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.324 1.049 . . . . 0.0 109.688 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -143.07 155.74 44.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.389 1.075 . . . . 0.0 111.488 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.29 156.8 33.32 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.851 0.86 . . . . 0.0 112.216 169.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.091 0.956 . . . . 0.0 113.119 172.506 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 120.931 0.396 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 95.22 -3.21 66.33 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.434 1.016 . . . . 0.0 113.33 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 3.2 m -70.13 154.15 42.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.598 1.199 . . . . 0.0 110.927 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -127.81 26.37 5.87 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.643 1.177 . . . . 0.0 110.078 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -73.26 179.93 3.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.383 1.473 . . . . 0.0 110.662 168.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.83 167.08 31.55 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.587 -0.695 . . . . 0.0 112.873 168.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.24 -163.82 28.57 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 126.133 1.825 . . . . 0.0 113.892 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.35 174.61 11.83 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.019 3.146 . . . . 0.0 112.693 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -57.46 125.75 24.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.179 0.992 . . . . 0.0 111.286 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.03 71.49 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.864 1.221 . . . . 0.0 114.301 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.64 -0.54 42.8 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -113.67 123.65 50.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.422 1.089 . . . . 0.0 110.645 -169.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.9 mt -122.52 142.93 50.07 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.815 2.046 . . . . 0.0 112.861 -168.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -111.61 135.21 52.5 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.78 1.632 . . . . 0.0 108.595 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.6 mm -119.56 138.22 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.993 1.717 . . . . 0.0 108.369 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -138.8 162.27 35.18 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.597 0.759 . . . . 0.0 112.867 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 64.57 26.34 13.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.34 2.256 . . . . 0.0 113.87 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 72.1 mt -65.56 159.46 67.61 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.023 1.329 . . . . 0.0 111.823 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.71 149.38 77.39 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.065 2.51 . . . . 0.0 111.929 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -71.64 -8.4 53.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.77 1.228 . . . . 0.0 113.922 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -113.56 -6.01 13.41 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.271 2.228 . . . . 0.0 113.865 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 125.72 27.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.153 1.381 . . . . 0.0 110.869 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.67 -177.75 25.9 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.443 1.02 . . . . 0.0 113.745 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -62.4 -36.07 81.18 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.892 0.877 . . . . 0.0 112.66 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.22 -31.23 58.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.992 0.917 . . . . 0.0 111.95 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.495 0.589 . . . . 0.0 110.762 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.19 -37.06 83.02 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.286 0.635 . . . . 0.0 111.694 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -62.75 -50.17 72.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.838 0.745 . . . . 0.0 111.062 172.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -63.19 -28.08 69.8 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.427 0.691 . . . . 0.0 112.767 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.9 ttm -73.31 -28.76 62.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.478 1.111 . . . . 0.0 113.241 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -110.54 -17.47 13.42 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.0 mtm -55.29 -32.49 12.69 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -57.99 -15.48 22.61 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.66 2.907 . . . . 0.0 116.372 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -101.59 -7.94 22.3 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.07 -160.74 28.09 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.895 1.236 . . . . 0.0 114.718 171.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -72.52 95.79 1.85 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.257 1.023 . . . . 0.0 112.144 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.5 t -77.38 127.73 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.061 1.344 . . . . 0.0 109.814 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.14 -26.02 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.378 2.271 . . . . 0.0 111.788 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.6 t -154.27 144.37 21.96 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.678 1.191 . . . . 0.0 110.339 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.26 126.39 5.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.935 1.694 . . . . 0.0 110.246 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 28.9 tptt -154.83 138.01 15.66 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.427 -0.796 . . . . 0.0 111.813 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.36 135.09 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.779 1.632 . . . . 0.0 108.167 169.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 123.453 0.701 . . . . 0.0 111.086 -178.419 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.8 m 67.53 18.78 10.0 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.209 2.204 . . . . 0.0 113.439 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -144.35 155.34 43.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.205 0.911 . . . . 0.0 112.124 173.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.35 -176.04 28.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.945 1.736 . . . . 0.0 113.653 -170.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -141.47 142.43 33.63 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.437 1.895 . . . . 0.0 110.077 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.8 t -143.89 141.55 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.205 1.402 . . . . 0.0 108.88 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 75.5 m -137.48 144.25 42.16 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.431 -0.793 . . . . 0.0 112.296 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -112.93 166.1 11.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.313 1.445 . . . . 0.0 113.131 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.0 -19.5 62.51 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.423 1.089 . . . . 0.0 113.078 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -148.34 153.39 40.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.589 1.556 . . . . 0.0 111.476 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.5 -17.66 11.23 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.071 2.514 . . . . 0.0 114.027 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.1 t -72.37 -40.57 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.175 0.898 . . . . 0.0 110.395 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.3 m -62.97 -32.82 74.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.866 0.866 . . . . 0.0 111.719 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.79 -49.44 25.31 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.593 1.157 . . . . 0.0 112.017 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -59.14 -38.75 80.42 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.528 -0.733 . . . . 0.0 111.964 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.01 -28.41 64.4 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -80.14 -44.47 19.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 111.899 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 43.4 mt -57.94 -49.3 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.537 1.062 . . . . 0.0 110.372 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 -74.42 -11.52 60.26 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.4 m -101.1 -29.86 11.91 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.46 -18.64 12.81 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -169.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.01 109.24 3.87 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.925 0.784 . . . . 0.0 109.737 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.72 9.98 60.68 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.392 1.472 . . . . 0.0 114.966 -171.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -64.86 124.48 22.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.051 1.926 . . . . 0.0 111.145 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -79.25 131.05 36.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.095 0.558 . . . . 0.0 110.887 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.4 tt . . . . . 0 N--CA 1.472 0.64 0 C-N-CA 124.809 1.244 . . . . 0.0 110.556 -179.086 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 . . . . . 0 N--CA 1.474 0.725 0 CA-C-O 120.577 0.227 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 56.6 mt -70.99 162.88 28.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.176 1.39 . . . . 0.0 111.933 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -133.9 147.33 51.1 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.309 1.444 . . . . 0.0 109.327 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 29.6 t -139.21 137.81 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.647 1.179 . . . . 0.0 109.386 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -141.75 160.54 39.96 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.458 1.103 . . . . 0.0 111.191 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 69.9 mt -69.31 157.95 35.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.653 0.74 . . . . 0.0 111.18 168.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 124.539 1.136 . . . . 0.0 112.334 172.516 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.319 0.58 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.61 -7.47 77.42 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.75 1.643 . . . . 0.0 113.254 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.4 t -85.08 172.37 11.31 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.376 1.088 . . . . 0.0 112.186 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.07 31.98 2.93 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.101 1.361 . . . . 0.0 111.065 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -68.74 165.75 18.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.065 0.946 . . . . 0.0 112.528 169.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.63 156.77 45.11 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.25 -169.23 29.27 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 126.156 1.836 . . . . 0.0 113.246 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.14 175.28 7.79 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.086 3.19 . . . . 0.0 112.676 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.85 121.96 11.75 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.094 0.957 . . . . 0.0 111.44 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.88 -1.73 78.56 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.862 1.22 . . . . 0.0 114.659 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.41 6.76 46.98 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.957 1.378 . . . . 0.0 114.372 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -118.36 122.12 42.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.293 1.437 . . . . 0.0 111.08 -171.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.7 140.76 52.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.439 1.896 . . . . 0.0 112.343 -169.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -110.99 133.09 53.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.889 1.676 . . . . 0.0 108.801 168.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.29 135.1 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.946 1.698 . . . . 0.0 107.884 -171.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -132.98 156.78 46.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.933 1.293 . . . . 0.0 112.585 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 74.55 27.9 1.31 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.732 2.413 . . . . 0.0 113.849 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.2 mt -64.96 157.29 76.76 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.103 1.361 . . . . 0.0 112.057 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.81 152.56 34.86 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.388 2.725 . . . . 0.0 112.126 169.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -67.21 -29.33 68.96 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.9 -9.79 56.35 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.01 129.2 39.2 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.9 1.28 . . . . 0.0 111.793 -175.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -113.74 -174.28 18.73 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.312 1.434 . . . . 0.0 113.314 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.25 -34.7 78.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.077 0.951 . . . . 0.0 112.991 -174.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -76.77 -31.56 57.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.893 0.877 . . . . 0.0 111.782 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -67.66 -41.59 83.53 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.705 0.684 . . . . 0.0 110.649 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 23.3 tp -65.59 -41.09 93.23 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.334 0.654 . . . . 0.0 111.562 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.26 -51.69 67.86 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.661 0.664 . . . . 0.0 111.37 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -63.72 -28.04 69.61 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.8 ttp -81.4 -20.39 40.56 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -109.61 -19.78 13.08 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 51.5 mtm -54.8 -31.85 10.46 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -57.34 -16.78 23.98 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.616 2.877 . . . . 0.0 116.273 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -97.71 -8.79 27.92 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.406 1.003 . . . . 0.0 113.636 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.18 -162.92 28.16 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.089 1.328 . . . . 0.0 114.67 170.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -71.03 95.01 1.15 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.437 1.095 . . . . 0.0 111.842 -173.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.1 t -73.43 129.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.027 1.331 . . . . 0.0 109.733 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 35.7 t -94.56 -33.78 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.16 2.184 . . . . 0.0 111.505 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.3 t -155.22 150.45 27.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.462 1.105 . . . . 0.0 110.836 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.29 14.86 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.178 1.391 . . . . 0.0 109.915 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -151.58 138.74 19.23 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.466 -0.771 . . . . 0.0 111.705 -168.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 85.8 t -119.32 126.99 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.534 1.534 . . . . 0.0 107.468 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 123.361 0.664 . . . . 0.0 111.308 -174.627 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.549 0.939 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 76.3 m 65.63 22.8 11.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.912 2.085 . . . . 0.0 113.396 -172.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -146.14 155.57 42.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.004 0.922 . . . . 0.0 111.68 171.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.05 -173.43 24.63 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.749 1.643 . . . . 0.0 113.918 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -139.79 146.24 39.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.304 1.842 . . . . 0.0 110.243 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 58.1 t -143.61 138.58 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.115 1.366 . . . . 0.0 109.006 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 85.6 p -130.71 152.69 49.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.911 0.885 . . . . 0.0 112.358 175.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.73 161.86 26.36 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.933 1.293 . . . . 0.0 113.504 -174.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.65 -18.37 64.27 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.72 1.208 . . . . 0.0 112.885 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -146.16 151.24 44.08 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 125.596 1.559 . . . . 0.0 112.05 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.26 -28.16 55.66 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.035 3.157 . . . . 0.0 114.035 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.7 t -74.43 -38.46 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.958 0.903 . . . . 0.0 110.828 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 8.2 m -63.9 -31.79 73.1 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.916 0.886 . . . . 0.0 111.82 171.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.91 -48.58 29.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.403 1.081 . . . . 0.0 111.926 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -59.05 -38.97 80.62 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.383 -0.823 . . . . 0.0 111.879 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.75 -27.33 64.84 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -79.9 -44.65 20.01 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.458 171.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.56 -49.4 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.871 1.214 . . . . 0.0 110.618 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -73.87 -11.21 60.3 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.6 m -102.1 -27.71 12.76 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.5 mmm -112.47 -20.63 11.7 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -168.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.29 110.1 5.06 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.197 0.908 . . . . 0.0 109.84 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.31 1.85 62.34 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.533 1.539 . . . . 0.0 115.028 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -62.63 125.79 25.15 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.54 1.67 . . . . 0.0 111.866 -178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -79.72 125.96 30.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.592 0.757 . . . . 0.0 110.075 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt . . . . . 0 N--CA 1.469 0.504 0 C-N-CA 125.058 1.343 . . . . 0.0 109.811 -177.708 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 120.569 0.223 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 75.8 mt -76.79 162.9 27.28 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.149 1.38 . . . . 0.0 112.652 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -131.51 141.91 49.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.758 1.623 . . . . 0.0 109.678 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.75 138.1 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.735 1.214 . . . . 0.0 109.392 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -147.76 142.53 26.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.815 1.246 . . . . 0.0 110.597 -169.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 41.1 mt -65.8 151.41 46.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.011 0.925 . . . . 0.0 112.308 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.5 tttt . . . . . 0 CA--C 1.547 0.85 0 C-N-CA 124.303 1.041 . . . . 0.0 111.329 170.934 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.869 0.366 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.34 79.29 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.283 0.944 . . . . 0.0 113.086 -175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 10.1 t -75.61 162.68 28.06 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.25 1.025 . . . . 0.0 111.88 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -134.79 20.21 3.53 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.169 1.388 . . . . 0.0 111.224 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -66.83 173.67 3.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.133 0.973 . . . . 0.0 111.484 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.47 167.1 29.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 167.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -94.81 -167.14 36.2 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.113 1.34 . . . . 0.0 113.638 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.6 171.06 13.78 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.358 2.705 . . . . 0.0 111.521 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.94 123.27 15.24 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.641 0.777 . . . . 0.0 111.259 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.79 -9.66 70.76 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.725 1.155 . . . . 0.0 114.276 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.07 -6.25 54.06 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.895 1.347 . . . . 0.0 113.686 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.3 118.54 36.2 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.282 2.233 . . . . 0.0 111.404 -174.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 22.0 mt -119.68 136.63 54.33 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.386 1.875 . . . . 0.0 111.989 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -109.69 131.99 54.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.451 1.5 . . . . 0.0 108.796 168.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.56 135.33 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.938 1.695 . . . . 0.0 107.951 -171.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -131.42 160.4 35.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.247 1.419 . . . . 0.0 112.687 -175.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 68.27 28.26 6.39 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.496 2.318 . . . . 0.0 113.601 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 52.9 mt -65.69 155.24 86.65 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.491 1.116 . . . . 0.0 111.727 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.21 143.19 94.13 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.047 2.498 . . . . 0.0 112.575 172.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -62.69 -6.9 3.98 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.791 2.036 . . . . 0.0 114.845 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -113.14 -9.04 13.55 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.58 1.952 . . . . 0.0 114.241 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.44 134.03 47.41 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.635 1.174 . . . . 0.0 112.287 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.42 -172.7 18.9 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.663 1.601 . . . . 0.0 112.447 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -63.53 -34.66 78.27 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -172.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -77.09 -28.31 54.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.145 0.578 . . . . 0.0 112.448 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -69.95 -41.79 74.08 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.586 0.63 . . . . 0.0 110.796 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 31.8 tp -65.56 -37.6 87.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.491 0.716 . . . . 0.0 111.811 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.72 -50.4 67.07 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.709 0.686 . . . . 0.0 111.462 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -63.42 -26.33 68.69 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.409 0.684 . . . . 0.0 112.551 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 48.1 ttm -73.95 -28.79 61.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.169 0.988 . . . . 0.0 113.373 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -109.84 -18.52 13.39 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.6 mtm -56.16 -32.61 13.51 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -57.63 -16.23 23.63 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.578 2.852 . . . . 0.0 116.165 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -100.28 -9.7 22.08 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.7 -163.35 28.55 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.087 1.327 . . . . 0.0 114.957 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -70.37 99.82 1.64 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.335 1.054 . . . . 0.0 112.542 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 85.5 t -79.35 128.54 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.163 1.385 . . . . 0.0 110.038 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 56.0 t -98.97 -24.33 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.568 2.347 . . . . 0.0 111.787 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 9.4 t -156.98 144.27 18.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.762 1.225 . . . . 0.0 110.711 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.36 130.3 12.52 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.158 1.383 . . . . 0.0 110.89 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -156.11 132.85 10.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.578 0.751 . . . . 0.0 112.657 -174.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 64.8 t -102.12 134.71 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.683 1.593 . . . . 0.0 106.943 167.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 123.293 0.637 . . . . 0.0 110.423 178.137 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.9 m 63.82 21.32 12.61 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.017 2.127 . . . . 0.0 113.119 -170.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.84 155.14 43.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.109 0.868 . . . . 0.0 112.4 173.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.56 179.83 31.22 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.926 1.727 . . . . 0.0 113.513 -170.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -137.04 142.22 42.46 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.549 1.94 . . . . 0.0 110.228 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 84.8 t -141.7 142.98 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.137 1.375 . . . . 0.0 108.608 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 18.3 m -136.86 148.81 47.31 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -115.35 171.59 7.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.546 1.539 . . . . 0.0 113.165 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.49 -23.71 66.09 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.42 1.488 . . . . 0.0 113.427 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -161.33 161.13 23.65 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.199 1.4 . . . . 0.0 112.104 -172.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.08 -13.77 34.27 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.504 2.136 . . . . 0.0 114.082 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.34 -46.01 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 121.043 1.747 . . . . 0.0 110.608 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 45.6 m -65.93 -30.66 71.28 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.312 1.045 . . . . 0.0 111.924 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.37 -48.4 28.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.04 0.936 . . . . 0.0 111.981 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -61.68 -32.29 72.46 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.523 -0.736 . . . . 0.0 112.094 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.71 71.76 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.46 -42.95 41.96 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.564 0.746 . . . . 0.0 111.732 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.7 mt -58.42 -46.67 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 118.798 0.727 . . . . 0.0 110.274 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.48 -12.52 61.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 66.6 m -103.54 -29.85 10.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 87.6 mmm -114.29 -18.71 11.52 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -168.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -70.87 111.48 6.32 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.42 1.009 . . . . 0.0 110.191 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.24 0.53 63.23 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.719 1.628 . . . . 0.0 114.953 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.12 122.74 16.85 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.403 1.601 . . . . 0.0 111.251 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -75.64 131.95 40.27 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 110.631 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.0 tt . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 125.011 1.324 . . . . 0.0 108.757 176.975 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 . . . . . 0 N--CA 1.473 0.706 0 CA-C-O 120.477 0.179 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.47 155.58 37.17 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.051 1.341 . . . . 0.0 111.547 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -130.3 141.9 50.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.935 1.294 . . . . 0.0 109.143 168.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.4 t -139.0 132.95 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.454 1.102 . . . . 0.0 109.169 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -143.85 154.95 43.91 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.514 1.126 . . . . 0.0 111.232 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 60.4 mt -66.95 160.12 27.02 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.527 0.731 . . . . 0.0 112.722 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 78.1 tttt . . . . . 0 CA--C 1.555 1.154 0 C-N-CA 125.102 1.361 . . . . 0.0 110.388 167.466 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 120.979 0.418 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 94.88 -5.45 69.14 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.992 1.282 . . . . 0.0 113.442 -175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 36.2 t -79.7 143.55 34.48 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.574 1.187 . . . . 0.0 111.341 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -118.93 15.25 13.38 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.852 1.261 . . . . 0.0 111.755 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -66.33 173.64 3.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.807 0.843 . . . . 0.0 111.655 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -153.43 160.34 42.57 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.6 -161.62 29.03 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 128.243 2.83 . . . . 0.0 113.365 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 169.01 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.68 2.92 . . . . 0.0 112.49 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -59.36 127.09 30.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.41 0.684 . . . . 0.0 111.145 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.36 -11.18 70.68 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.92 1.248 . . . . 0.0 114.01 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.86 -4.49 46.9 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.722 1.261 . . . . 0.0 114.118 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -108.29 118.21 36.18 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.118 1.367 . . . . 0.0 110.93 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.7 mt -120.19 132.0 55.21 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.175 1.79 . . . . 0.0 111.861 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -103.04 133.2 48.56 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.785 1.234 . . . . 0.0 108.557 167.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.3 mm -118.16 135.65 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.771 1.629 . . . . 0.0 108.26 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -133.93 160.45 37.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.574 1.15 . . . . 0.0 112.308 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 62.62 33.94 15.36 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.477 1.911 . . . . 0.0 113.282 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 45.2 mt -70.03 164.68 50.07 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.659 1.584 . . . . 0.0 111.455 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.03 141.47 94.36 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.702 2.268 . . . . 0.0 110.888 168.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -67.86 -8.29 35.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.959 1.304 . . . . 0.0 113.962 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.52 -9.2 16.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.424 1.889 . . . . 0.0 114.144 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.3 130.85 43.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.138 1.375 . . . . 0.0 111.643 -175.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -101.96 -179.63 27.69 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.367 0.984 . . . . 0.0 113.582 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.15 -33.69 74.98 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.149 0.98 . . . . 0.0 112.326 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -73.56 -40.81 63.65 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.989 1.716 . . . . 0.0 110.917 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -64.77 -41.38 95.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.708 0.803 . . . . 0.0 111.351 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.0 tp -67.0 -37.7 84.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.277 0.631 . . . . 0.0 111.858 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.63 -49.88 73.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.758 0.708 . . . . 0.0 110.943 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -63.39 -27.56 69.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.608 0.763 . . . . 0.0 112.851 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.5 ttm -72.45 -32.06 65.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.231 1.012 . . . . 0.0 113.051 173.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -107.38 -18.49 13.85 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -171.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 44.4 mtm -55.61 -33.49 18.09 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -57.77 -16.72 26.44 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.556 2.837 . . . . 0.0 115.992 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -99.23 -10.85 21.89 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.47 -154.36 25.88 Favored Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.411 1.005 . . . . 0.0 115.494 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -74.49 82.46 1.97 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.528 1.131 . . . . 0.0 112.962 -169.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.46 128.39 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.551 1.14 . . . . 0.0 109.951 172.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 73.5 t -94.13 -37.77 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.801 2.04 . . . . 0.0 110.85 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 63.3 m -151.29 146.01 25.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.859 1.263 . . . . 0.0 110.807 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.53 134.66 14.96 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.247 1.419 . . . . 0.0 110.402 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -155.6 136.26 13.42 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.692 0.797 . . . . 0.0 111.839 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.17 134.78 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.922 1.689 . . . . 0.0 107.734 169.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 123.033 0.533 . . . . 0.0 110.925 -179.358 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 CA--C 1.547 0.864 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.1 m 67.33 20.49 10.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.387 2.275 . . . . 0.0 113.061 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -145.02 156.18 43.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.854 0.862 . . . . 0.0 111.711 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.0 -174.86 28.26 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.906 1.717 . . . . 0.0 113.736 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -142.06 144.25 33.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.181 1.792 . . . . 0.0 110.196 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 98.8 t -141.97 142.72 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.499 1.519 . . . . 0.0 108.482 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 37.9 t -139.98 142.44 36.31 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.567 -0.708 . . . . 0.0 112.106 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.69 168.2 9.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.808 1.643 . . . . 0.0 113.422 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.17 -22.89 66.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.616 1.567 . . . . 0.0 113.282 170.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -160.07 157.69 25.47 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.232 1.413 . . . . 0.0 112.19 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.25 -15.65 39.16 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.629 2.219 . . . . 0.0 113.794 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.52 -43.72 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.53 1.514 . . . . 0.0 110.535 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.4 m -68.7 -31.26 70.22 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 112.072 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -75.84 -47.43 25.62 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.808 0.843 . . . . 0.0 112.474 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -62.47 -31.32 72.04 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.5 -0.75 . . . . 0.0 111.981 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.44 -30.92 71.95 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.312 0.645 . . . . 0.0 112.632 172.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.46 -42.59 43.24 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.447 0.699 . . . . 0.0 111.879 175.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.52 -46.08 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 118.738 0.699 . . . . 0.0 110.065 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -72.16 -12.46 61.19 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.6 m -104.02 -30.95 9.95 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.7 mmm -111.86 -18.04 12.78 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -70.06 112.1 6.2 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.429 1.013 . . . . 0.0 110.755 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.87 71.5 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.038 1.78 . . . . 0.0 114.94 -173.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -61.47 124.07 19.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.189 1.495 . . . . 0.0 111.331 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -78.39 131.0 36.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.215 0.531 . . . . 0.0 110.42 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 125.027 1.331 . . . . 0.0 108.493 177.261 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 119.951 -0.071 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.96 158.86 24.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.211 1.404 . . . . 0.0 112.224 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -136.85 141.99 42.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.069 1.348 . . . . 0.0 109.063 167.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.7 t -138.29 136.73 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.421 1.089 . . . . 0.0 108.95 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -149.13 151.28 34.11 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.774 0.83 . . . . 0.0 110.829 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.7 mt -60.24 156.65 15.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.931 0.872 . . . . 0.0 112.805 170.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 CA--C 1.548 0.877 0 C-N-CA 124.359 1.064 . . . . 0.0 113.175 169.707 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.561 0 CA-C-O 121.59 0.709 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.86 -3.71 84.82 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.613 1.577 . . . . 0.0 112.911 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.8 m -78.01 163.68 25.73 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.0 1.32 . . . . 0.0 111.991 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -125.26 33.12 5.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.746 1.218 . . . . 0.0 110.657 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -69.4 171.59 8.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.83 1.252 . . . . 0.0 110.74 168.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -158.83 165.41 34.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.474 0.709 . . . . 0.0 112.903 168.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -102.57 -165.23 26.29 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 126.074 1.797 . . . . 0.0 113.876 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.73 179.74 5.69 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.259 3.306 . . . . 0.0 112.702 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -54.63 124.3 15.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.538 1.135 . . . . 0.0 111.738 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.84 -6.32 83.64 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.775 1.179 . . . . 0.0 114.547 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.62 -3.15 55.44 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.765 1.283 . . . . 0.0 114.362 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -115.39 128.36 56.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.343 1.057 . . . . 0.0 111.005 -169.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 23.0 mt -126.01 143.1 51.23 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.041 2.136 . . . . 0.0 112.483 -168.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -110.65 135.59 51.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.693 1.597 . . . . 0.0 108.499 167.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.66 135.56 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.707 1.603 . . . . 0.0 107.905 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -131.84 160.59 35.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.872 1.269 . . . . 0.0 112.771 -176.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 69.76 27.74 4.55 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.732 2.413 . . . . 0.0 113.858 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.7 mt -66.59 158.52 78.69 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 124.916 1.286 . . . . 0.0 112.133 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.24 147.26 96.08 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.972 2.448 . . . . 0.0 111.299 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -70.97 -9.06 57.24 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.25 -8.29 17.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.505 1.922 . . . . 0.0 114.035 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.8 124.79 24.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.869 1.268 . . . . 0.0 110.741 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.23 -173.97 24.25 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.54 1.067 . . . . 0.0 113.914 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -70.07 -35.22 74.06 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -172.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -74.95 -28.64 60.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.477 0.711 . . . . 0.0 111.641 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -70.39 -43.14 70.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.236 0.614 . . . . 0.0 110.698 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.18 -35.81 80.46 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.069 0.548 . . . . 0.0 111.764 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.7 tp -62.07 -51.01 69.7 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.84 0.746 . . . . 0.0 110.913 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -68.07 -22.81 64.91 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.4 ttm -73.93 -28.76 61.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.316 1.046 . . . . 0.0 112.888 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -109.86 -17.85 13.54 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.6 mtm -54.28 -33.62 17.07 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 170.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -58.95 -15.94 29.81 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.569 2.846 . . . . 0.0 116.229 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -101.48 -9.3 21.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.59 -158.93 27.88 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.831 1.205 . . . . 0.0 114.884 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -75.0 94.42 2.85 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.084 0.954 . . . . 0.0 112.172 -170.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 96.2 t -74.27 131.48 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.972 1.309 . . . . 0.0 110.445 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 34.1 t -106.75 -20.9 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 128.082 2.553 . . . . 0.0 112.06 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.8 t -160.26 148.3 16.62 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.659 1.184 . . . . 0.0 110.657 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -159.91 124.46 3.86 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.143 1.377 . . . . 0.0 110.573 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -155.16 146.78 23.16 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.129 -0.982 . . . . 0.0 112.695 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 23.9 t -119.42 131.03 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.036 1.734 . . . . 0.0 107.763 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 123.111 0.564 . . . . 0.0 110.54 -177.497 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 57.0 m 68.47 19.11 8.88 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.441 2.296 . . . . 0.0 113.69 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -145.56 154.34 42.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.453 1.024 . . . . 0.0 112.534 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.2 -176.1 27.01 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.282 1.896 . . . . 0.0 113.509 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -143.49 143.65 31.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.354 1.862 . . . . 0.0 110.068 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 80.7 t -142.53 147.48 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.442 1.497 . . . . 0.0 108.815 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.1 m -139.92 152.18 46.18 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.668 0.787 . . . . 0.0 112.003 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -121.24 169.02 10.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.535 1.534 . . . . 0.0 113.126 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.71 -22.53 65.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.081 1.353 . . . . 0.0 113.356 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -160.7 158.07 24.29 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.304 1.441 . . . . 0.0 112.306 -171.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.24 -16.04 43.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.656 2.238 . . . . 0.0 113.969 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.27 -44.31 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.595 1.543 . . . . 0.0 110.569 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.7 m -68.58 -31.47 70.68 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.01 0.924 . . . . 0.0 111.91 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.22 -48.47 34.75 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.931 0.892 . . . . 0.0 112.071 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -62.59 -32.89 73.96 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.436 -0.79 . . . . 0.0 111.882 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.65 -29.42 70.42 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.88 -42.3 33.84 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.525 0.73 . . . . 0.0 111.439 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.7 mt -58.5 -46.32 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 118.859 0.754 . . . . 0.0 110.201 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -71.18 -13.02 61.79 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.4 m -104.17 -27.78 11.85 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.5 mmm -115.34 -19.23 10.81 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -169.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -70.93 109.96 5.37 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.177 0.899 . . . . 0.0 109.903 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 97.18 2.36 59.2 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.619 1.58 . . . . 0.0 114.978 -171.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -62.04 125.06 22.55 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.574 1.687 . . . . 0.0 111.699 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -80.73 129.98 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.387 0.675 . . . . 0.0 110.965 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt . . . . . 0 N--CA 1.471 0.589 0 C-N-CA 124.866 1.266 . . . . 0.0 110.492 -178.12 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 120.556 0.217 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 69.1 mt -72.29 159.43 34.06 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.177 1.391 . . . . 0.0 111.992 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -129.17 141.92 51.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.178 1.391 . . . . 0.0 109.24 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 25.2 t -139.46 135.56 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.587 1.155 . . . . 0.0 109.144 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -155.97 151.06 26.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.195 0.598 . . . . 0.0 111.938 -172.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.04 152.41 40.34 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 79.4 tttt . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 124.799 1.239 . . . . 0.0 113.104 169.195 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 120.896 0.379 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.65 6.48 70.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.747 1.641 . . . . 0.0 113.256 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.3 t -80.02 163.47 24.19 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.391 1.076 . . . . 0.0 113.224 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -126.99 8.73 6.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.917 1.287 . . . . 0.0 112.243 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -68.3 166.8 15.74 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.342 -0.849 . . . . 0.0 111.966 168.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.01 165.85 34.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.319 1.048 . . . . 0.0 112.267 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.63 -161.41 25.01 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 126.007 1.765 . . . . 0.0 113.976 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.26 177.64 8.01 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.098 3.199 . . . . 0.0 112.749 -174.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.9 126.83 28.8 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.107 0.963 . . . . 0.0 111.408 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.02 -7.27 82.59 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.042 1.306 . . . . 0.0 114.463 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.59 -2.11 45.55 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -114.8 122.22 45.68 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.27 1.028 . . . . 0.0 110.775 -168.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.7 mt -121.92 138.22 54.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.39 1.876 . . . . 0.0 111.971 -168.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -108.85 135.01 50.76 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.099 1.359 . . . . 0.0 108.834 167.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.95 135.31 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.978 1.711 . . . . 0.0 107.833 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -133.56 159.34 40.74 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.783 1.233 . . . . 0.0 112.434 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 68.5 30.58 5.19 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.218 2.207 . . . . 0.0 113.234 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.29 156.12 86.04 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.355 1.062 . . . . 0.0 111.556 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.71 148.41 74.49 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.183 2.589 . . . . 0.0 111.639 169.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -66.62 -19.36 65.75 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.45 -10.14 39.02 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -176.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.29 136.85 57.08 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.568 1.147 . . . . 0.0 113.203 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -113.11 -178.77 19.5 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.548 1.547 . . . . 0.0 112.799 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -64.48 -32.06 73.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.016 0.926 . . . . 0.0 113.131 -174.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -72.57 -35.21 67.92 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.08 0.952 . . . . 0.0 111.65 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -67.45 -41.69 84.31 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.737 0.699 . . . . 0.0 110.934 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.96 -36.53 78.0 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.101 0.56 . . . . 0.0 112.126 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 64.8 tp -64.08 -51.25 64.94 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.711 0.687 . . . . 0.0 111.097 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -65.47 -29.02 69.63 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.328 0.651 . . . . 0.0 112.274 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 47.0 ttm -67.85 -29.95 69.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.35 1.06 . . . . 0.0 113.006 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -106.24 -14.06 15.23 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.9 mtt -50.3 -37.64 30.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -61.06 -18.77 59.89 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.212 2.608 . . . . 0.0 115.75 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -97.4 -10.34 25.68 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.39 -159.37 27.73 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 125.217 1.389 . . . . 0.0 114.64 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -74.15 85.8 1.87 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.461 1.105 . . . . 0.0 112.436 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.18 125.89 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.134 0.974 . . . . 0.0 109.281 169.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.83 -33.68 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.146 1.779 . . . . 0.0 110.864 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 19.4 m -159.44 145.48 16.22 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.498 1.519 . . . . 0.0 110.875 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.78 143.74 24.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.582 1.553 . . . . 0.0 110.826 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -159.06 142.66 14.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.089 0.955 . . . . 0.0 112.947 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.97 138.88 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.136 1.774 . . . . 0.0 107.166 169.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.083 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 28.3 m 75.78 20.56 1.78 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.388 2.675 . . . . 0.0 113.179 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.52 158.02 43.8 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.816 0.846 . . . . 0.0 112.168 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.63 -173.7 28.44 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.979 1.752 . . . . 0.0 113.757 -170.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -147.09 140.44 25.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.592 1.957 . . . . 0.0 110.041 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 71.7 t -146.29 137.49 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.346 1.458 . . . . 0.0 109.278 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.0 m -135.56 141.72 45.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.638 0.775 . . . . 0.0 112.681 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -110.37 170.78 7.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.315 1.846 . . . . 0.0 112.183 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.72 -2.21 45.93 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -157.6 157.3 29.83 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 126.023 1.729 . . . . 0.0 111.887 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.06 -12.61 15.99 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.281 1.987 . . . . 0.0 113.899 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.9 t -79.28 -44.29 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.891 1.678 . . . . 0.0 110.648 -174.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 40.6 m -63.55 -31.96 73.28 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.339 1.056 . . . . 0.0 111.875 171.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -71.43 -51.47 23.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.088 0.955 . . . . 0.0 111.741 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -66.85 -29.66 69.63 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.312 -0.868 . . . . 0.0 112.241 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.44 71.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.791 0.723 . . . . 0.0 112.733 170.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.91 -41.71 61.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.78 0.718 . . . . 0.0 111.466 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 38.1 mt -56.59 -49.29 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 118.964 0.802 . . . . 0.0 110.308 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -70.45 -12.27 61.46 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.5 m -104.06 -28.0 11.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.7 mmm -116.43 -18.09 10.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -70.6 112.2 6.67 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.416 1.007 . . . . 0.0 110.113 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.57 3.22 64.77 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.953 1.74 . . . . 0.0 114.815 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.71 125.43 23.93 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.332 1.566 . . . . 0.0 111.355 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -86.15 130.04 34.65 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.034 0.533 . . . . 0.0 111.066 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.8 tt . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 125.3 1.44 . . . . 0.0 110.081 -173.626 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 60.8 mt -69.58 154.5 41.9 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.051 1.34 . . . . 0.0 112.343 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -124.17 138.98 54.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.639 1.176 . . . . 0.0 108.156 166.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 33.1 t -135.23 135.23 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.362 1.065 . . . . 0.0 108.212 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -152.02 146.66 25.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.277 0.631 . . . . 0.0 111.593 -169.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.75 157.77 29.37 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.862 0.865 . . . . 0.0 112.821 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 75.5 tttt . . . . . 0 CA--C 1.555 1.15 0 C-N-CA 125.282 1.433 . . . . 0.0 110.581 168.132 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 121.082 0.468 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.67 3.28 86.28 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.608 1.575 . . . . 0.0 113.652 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 17.1 t -84.8 174.63 9.72 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.225 1.013 . . . . 0.0 112.514 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -132.77 21.36 4.21 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.067 1.747 . . . . 0.0 110.852 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -61.83 161.28 10.55 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.001 0.92 . . . . 0.0 112.6 168.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.56 155.62 45.02 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.04 -170.48 32.35 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.155 1.836 . . . . 0.0 113.301 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -70.03 177.43 5.77 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.151 3.234 . . . . 0.0 112.558 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.13 125.76 24.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.866 0.866 . . . . 0.0 111.198 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.23 -7.46 75.75 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.99 1.281 . . . . 0.0 114.609 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -103.55 8.7 37.69 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -117.96 123.95 47.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.03 1.332 . . . . 0.0 110.709 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 30.7 mt -124.64 140.4 52.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.351 1.86 . . . . 0.0 112.531 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -111.19 133.72 53.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.445 1.498 . . . . 0.0 109.147 168.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.29 137.33 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 126.108 1.763 . . . . 0.0 107.935 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -134.04 161.63 34.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.459 1.504 . . . . 0.0 112.051 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 63.01 33.28 14.92 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.233 1.813 . . . . 0.0 113.307 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 52.9 mt -65.75 159.07 71.63 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.296 1.038 . . . . 0.0 111.01 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -55.46 144.42 73.35 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.89 2.394 . . . . 0.0 111.967 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -55.69 -11.9 1.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.811 2.444 . . . . 0.0 115.587 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -131.05 0.74 4.22 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.294 1.838 . . . . 0.0 114.264 -169.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.04 133.64 51.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.604 1.562 . . . . 0.0 111.363 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.32 -179.86 23.91 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.899 1.238 . . . . 0.0 113.563 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -65.41 -32.45 74.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.046 0.938 . . . . 0.0 112.541 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -74.68 -39.96 61.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.828 1.651 . . . . 0.0 110.876 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -62.13 -44.36 96.81 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.93 0.892 . . . . 0.0 111.015 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 26.4 tp -66.16 -43.09 87.97 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.156 0.582 . . . . 0.0 111.803 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.4 tp -57.21 -54.17 49.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 111.211 175.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -73.96 -20.88 60.22 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.7 ttp -76.97 -22.29 53.43 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.037 0.835 . . . . 0.0 113.03 170.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -102.97 -15.59 16.08 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.964 1.305 . . . . 0.0 113.872 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 36.1 mtt -48.21 -37.86 17.68 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -62.41 -17.62 58.67 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.108 2.538 . . . . 0.0 115.488 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -97.04 -10.43 26.15 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.94 0.896 . . . . 0.0 113.327 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.41 -163.91 28.72 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.405 1.478 . . . . 0.0 114.449 171.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.12 100.61 2.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.932 0.893 . . . . 0.0 111.896 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.6 t -76.19 129.14 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.911 1.284 . . . . 0.0 110.191 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 42.1 t -94.63 -33.6 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.742 2.017 . . . . 0.0 111.541 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 8.6 t -155.75 152.96 29.15 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.96 1.304 . . . . 0.0 110.748 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.91 130.8 8.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.387 1.475 . . . . 0.0 110.351 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -153.95 144.93 22.71 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.465 -0.772 . . . . 0.0 112.544 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.31 131.46 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.203 1.801 . . . . 0.0 107.229 170.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 CA--C 1.537 0.451 0 CA-C-O 121.39 0.614 . . . . 0.0 111.11 -177.628 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 73.1 mttt . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 34.5 m 69.15 20.16 7.7 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.966 2.107 . . . . 0.0 113.626 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -144.43 156.33 44.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.184 0.994 . . . . 0.0 111.444 172.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.54 -175.36 28.38 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.715 1.626 . . . . 0.0 114.103 -169.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -139.3 146.67 40.63 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.571 1.948 . . . . 0.0 110.049 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 64.2 t -144.94 144.09 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.165 1.386 . . . . 0.0 109.188 174.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 95.7 p -137.16 155.12 49.96 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.389 -0.819 . . . . 0.0 112.884 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -126.82 162.24 26.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.321 1.448 . . . . 0.0 113.462 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.5 -19.78 64.55 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.277 1.031 . . . . 0.0 113.252 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -147.68 153.71 43.43 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.721 1.608 . . . . 0.0 111.066 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.61 -17.53 11.16 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.896 2.397 . . . . 0.0 113.785 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 90.8 t -71.45 -39.6 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.314 0.961 . . . . 0.0 110.333 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 7.8 m -62.44 -34.37 76.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.041 0.936 . . . . 0.0 111.77 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.01 -48.2 38.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.583 1.153 . . . . 0.0 111.97 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -59.3 -38.75 81.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.673 0.789 . . . . 0.0 111.895 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.95 -29.16 70.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.587 0.755 . . . . 0.0 112.957 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.91 -43.38 45.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.626 0.648 . . . . 0.0 111.098 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.4 mt -58.24 -47.39 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.272 0.942 . . . . 0.0 110.246 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -67.14 -17.93 65.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.327 1.051 . . . . 0.0 113.589 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.7 m -104.41 -23.66 13.15 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.5 mmt -112.49 -22.52 10.78 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.686 1.194 . . . . 0.0 113.542 -171.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -70.9 112.52 7.14 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 120.014 1.279 . . . . 0.0 110.831 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 88.15 1.88 81.23 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.587 1.565 . . . . 0.0 114.694 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.88 125.31 23.24 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.937 1.369 . . . . 0.0 111.3 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -77.35 131.71 38.21 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.34 0.59 . . . . 0.0 110.37 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 18.8 tt . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 125.394 1.477 . . . . 0.0 108.093 -178.746 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.53 163.91 26.83 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.183 1.393 . . . . 0.0 112.574 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -137.33 139.68 41.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.863 1.665 . . . . 0.0 108.693 167.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.42 140.34 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.39 1.076 . . . . 0.0 109.881 -175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -149.19 154.28 38.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.683 1.193 . . . . 0.0 110.643 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.06 159.23 14.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.957 0.884 . . . . 0.0 111.562 167.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 CA--C 1.546 0.812 0 C-N-CA 124.553 1.141 . . . . 0.0 110.18 168.511 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.754 0.311 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.25 -0.88 84.06 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.5 1.524 . . . . 0.0 113.537 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.1 t -79.53 166.0 22.4 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.177 0.989 . . . . 0.0 112.881 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -128.68 18.1 6.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.665 1.586 . . . . 0.0 111.156 174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -64.62 167.25 7.48 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.999 0.92 . . . . 0.0 111.672 167.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -153.43 154.98 35.48 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.664 0.786 . . . . 0.0 112.187 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.57 -154.72 23.72 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.393 1.473 . . . . 0.0 113.153 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -67.35 161.1 44.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.188 2.592 . . . . 0.0 111.494 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.49 124.58 21.31 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.982 0.513 . . . . 0.0 110.678 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.6 -16.51 44.19 Favored Glycine 0 N--CA 1.473 1.132 0 C-N-CA 124.985 1.278 . . . . 0.0 113.454 -171.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.71 21.93 8.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.35 1.46 . . . . 0.0 112.716 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.94 116.23 21.17 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.298 1.439 . . . . 0.0 110.449 -167.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.5 mt -123.67 138.97 54.43 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.855 1.662 . . . . 0.0 112.361 -169.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.96 134.21 52.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.311 1.444 . . . . 0.0 108.99 167.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -118.51 135.74 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.089 1.755 . . . . 0.0 107.758 -172.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -134.32 158.99 42.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.035 1.334 . . . . 0.0 112.526 -174.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 70.75 27.47 3.61 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.892 2.477 . . . . 0.0 113.749 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.81 157.03 81.58 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.652 1.181 . . . . 0.0 112.038 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -59.36 150.82 72.5 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.001 2.467 . . . . 0.0 111.741 169.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -71.07 -10.3 59.53 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.509 1.123 . . . . 0.0 113.901 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.84 -6.97 15.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.949 2.1 . . . . 0.0 113.817 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.33 123.31 21.39 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.079 1.351 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -102.48 -176.81 27.35 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.405 1.002 . . . . 0.0 113.809 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -65.71 -34.7 78.8 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.793 0.837 . . . . 0.0 112.791 -175.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -77.58 -29.7 52.21 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.868 0.867 . . . . 0.0 111.807 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -68.4 -42.91 78.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.87 0.759 . . . . 0.0 110.657 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.5 tp -65.49 -40.27 92.88 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.184 0.593 . . . . 0.0 111.525 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 62.4 tp -61.19 -52.14 66.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.569 0.622 . . . . 0.0 111.313 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -64.37 -27.1 68.78 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.9 ttp -81.21 -20.15 41.71 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -110.3 -20.55 12.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 48.5 mtm -55.05 -31.57 9.86 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 169.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -57.28 -16.5 22.6 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.63 2.887 . . . . 0.0 116.106 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -98.26 -9.66 25.2 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.246 0.93 . . . . 0.0 113.437 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.79 -159.29 27.9 Favored Glycine 0 N--CA 1.469 0.892 0 C-N-CA 125.075 1.322 . . . . 0.0 115.047 170.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.0 90.71 1.51 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.3 1.04 . . . . 0.0 112.278 -171.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 86.1 t -71.58 130.47 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.762 1.225 . . . . 0.0 110.112 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 53.4 t -100.78 -27.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.286 2.235 . . . . 0.0 111.389 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 20.9 t -156.33 146.32 21.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.48 1.112 . . . . 0.0 110.657 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.63 132.36 9.53 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.573 1.549 . . . . 0.0 110.434 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -156.51 147.95 22.48 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.299 -0.876 . . . . 0.0 113.016 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.72 135.66 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.433 1.893 . . . . 0.0 107.646 173.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 123.41 0.684 . . . . 0.0 110.392 -179.969 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 55.5 m 69.72 19.16 7.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.53 2.332 . . . . 0.0 113.894 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -146.9 156.93 43.47 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.442 1.019 . . . . 0.0 112.528 173.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.81 -174.63 30.89 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.789 1.662 . . . . 0.0 113.702 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -138.99 147.48 42.21 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.333 1.853 . . . . 0.0 110.421 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.4 t -143.58 145.02 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.486 1.514 . . . . 0.0 108.865 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.5 t -143.47 147.99 35.38 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.416 -0.802 . . . . 0.0 112.647 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -117.85 167.17 11.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.154 1.782 . . . . 0.0 113.066 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.37 -13.58 62.14 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.143 1.377 . . . . 0.0 113.63 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -158.86 158.27 28.99 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 126.206 1.803 . . . . 0.0 111.664 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.98 -10.86 19.76 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.347 2.031 . . . . 0.0 113.844 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 29.0 t -77.1 -43.11 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 120.882 1.673 . . . . 0.0 110.555 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 27.2 m -64.86 -31.29 72.46 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.672 1.189 . . . . 0.0 111.773 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.75 -49.32 31.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.035 0.934 . . . . 0.0 111.76 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -61.76 -33.88 74.86 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.388 -0.82 . . . . 0.0 111.987 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.03 -29.63 70.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.318 0.647 . . . . 0.0 112.72 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.68 -41.53 45.09 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.704 0.684 . . . . 0.0 111.086 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 51.4 mt -57.99 -46.8 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 119.388 0.995 . . . . 0.0 110.208 174.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -70.87 -14.25 62.32 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 51.6 m -103.95 -26.6 12.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.9 mmm -114.69 -20.22 10.76 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -168.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -70.93 109.94 5.36 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.295 0.952 . . . . 0.0 109.765 173.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.46 2.4 61.8 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.443 1.497 . . . . 0.0 114.907 -171.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -63.94 126.42 27.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.489 1.645 . . . . 0.0 111.703 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -80.44 125.73 30.31 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.595 0.758 . . . . 0.0 110.203 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.5 tt . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 125.075 1.35 . . . . 0.0 109.953 -178.852 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.1 mt -76.7 161.64 28.35 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.297 1.439 . . . . 0.0 112.751 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -128.89 141.03 51.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.554 1.542 . . . . 0.0 108.709 167.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.4 t -138.47 136.82 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.481 1.112 . . . . 0.0 109.16 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -152.1 151.17 30.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.979 0.912 . . . . 0.0 111.056 -172.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.7 155.41 22.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.03 0.919 . . . . 0.0 112.899 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 CA--C 1.546 0.797 0 C-N-CA 124.759 1.224 . . . . 0.0 111.901 169.783 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 121.11 0.481 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.68 -6.61 82.27 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.343 1.449 . . . . 0.0 113.293 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 66.2 m -98.42 131.4 44.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.242 1.417 . . . . 0.0 110.067 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -103.74 38.51 1.8 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.186 0.995 . . . . 0.0 112.254 -170.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -74.24 -177.44 3.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.667 0.787 . . . . 0.0 110.877 168.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.42 166.63 31.77 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 169.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.77 -165.48 29.28 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.158 1.837 . . . . 0.0 113.572 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.44 171.32 16.44 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.031 3.154 . . . . 0.0 112.47 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.98 126.62 28.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.663 0.785 . . . . 0.0 111.334 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.79 -11.71 71.49 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.8 1.19 . . . . 0.0 114.027 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.82 -1.44 57.35 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.659 1.229 . . . . 0.0 113.963 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -113.4 125.04 53.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.941 1.296 . . . . 0.0 111.458 -169.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.0 mt -124.71 140.23 53.12 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.756 2.022 . . . . 0.0 111.751 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -110.84 132.25 54.36 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.09 1.356 . . . . 0.0 108.594 167.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.67 134.96 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.982 1.713 . . . . 0.0 107.602 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.8 160.34 37.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.242 1.417 . . . . 0.0 112.292 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 69.66 28.88 4.36 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.555 2.342 . . . . 0.0 113.693 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 58.5 mt -68.58 161.2 72.37 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.653 1.181 . . . . 0.0 111.417 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.68 151.1 78.66 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.96 2.44 . . . . 0.0 111.259 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -72.06 -9.07 57.89 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.692 1.197 . . . . 0.0 113.959 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -112.76 -6.72 13.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.256 2.222 . . . . 0.0 113.838 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 130.15 42.29 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.167 1.387 . . . . 0.0 110.898 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.77 178.9 25.16 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.387 0.994 . . . . 0.0 113.842 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -64.6 -33.97 77.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.725 0.81 . . . . 0.0 112.58 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.4 -31.17 57.81 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.087 0.955 . . . . 0.0 111.812 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -66.99 -42.68 84.63 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.821 0.737 . . . . 0.0 110.652 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.55 -39.87 88.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.357 0.663 . . . . 0.0 111.745 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.17 -52.08 65.26 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.641 0.655 . . . . 0.0 111.31 174.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -63.72 -28.01 69.59 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.7 ttp -80.61 -19.93 44.35 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -111.19 -19.48 12.67 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.3 mtm -55.05 -31.73 10.33 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -57.52 -16.74 24.95 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.579 2.853 . . . . 0.0 116.25 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -97.51 -9.53 26.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.41 -162.32 28.21 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.17 1.367 . . . . 0.0 114.348 172.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -72.8 88.14 1.31 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.642 0.777 . . . . 0.0 112.182 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.5 t -65.27 127.41 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.363 1.065 . . . . 0.0 109.403 170.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 45.5 t -91.64 -38.86 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.671 1.988 . . . . 0.0 110.841 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.61 149.52 23.89 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.641 1.176 . . . . 0.0 111.181 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.39 140.29 20.07 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.345 1.458 . . . . 0.0 110.738 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -155.8 140.14 16.68 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.474 -0.766 . . . . 0.0 111.788 -169.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.47 130.8 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.548 1.539 . . . . 0.0 107.498 168.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 . . . . . 0 CA--C 1.537 0.447 0 C-N-CA 123.32 0.648 . . . . 0.0 111.172 -176.255 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 CA--C 1.549 0.91 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.9 m 67.11 19.76 10.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.863 2.065 . . . . 0.0 113.115 -172.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -146.81 155.25 42.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.864 0.865 . . . . 0.0 112.311 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.88 -175.6 27.99 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.152 1.834 . . . . 0.0 113.559 -170.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -136.25 145.5 45.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.716 2.006 . . . . 0.0 110.285 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 61.4 t -143.27 141.14 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.318 1.447 . . . . 0.0 108.529 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 37.3 p -137.53 146.7 44.45 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.027 0.931 . . . . 0.0 112.18 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -119.82 169.29 10.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.178 1.391 . . . . 0.0 113.223 -174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.03 -23.75 66.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.972 1.309 . . . . 0.0 113.26 169.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -160.0 157.93 25.96 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.24 1.416 . . . . 0.0 112.394 -171.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.13 -15.14 42.47 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.765 2.31 . . . . 0.0 114.026 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.18 -44.78 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 120.754 1.615 . . . . 0.0 110.679 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 57.4 m -68.06 -30.97 70.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.991 0.917 . . . . 0.0 111.886 174.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.64 42.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.659 0.784 . . . . 0.0 111.81 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -58.57 -39.24 79.77 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.487 -0.758 . . . . 0.0 111.947 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.84 -28.76 69.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -79.14 -44.27 22.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.705 0.684 . . . . 0.0 111.386 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 49.4 mt -57.07 -47.53 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.523 1.056 . . . . 0.0 110.151 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -74.66 -10.86 59.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.199 0.999 . . . . 0.0 113.227 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -104.28 -26.55 12.44 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.7 mmm -113.12 -19.86 11.69 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -168.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -70.9 111.19 6.12 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 119.385 0.993 . . . . 0.0 109.954 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.48 2.55 65.45 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.142 1.83 . . . . 0.0 115.172 -171.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.06 124.99 23.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.256 1.528 . . . . 0.0 111.543 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -73.5 131.12 41.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.852 0.296 . . . . 0.0 110.594 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.0 tt . . . . . 0 N--CA 1.467 0.408 0 C-N-CA 124.311 1.044 . . . . 0.0 108.325 175.118 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 79.7 mt -68.81 160.98 29.5 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.349 1.06 . . . . 0.0 112.079 -176.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -126.2 141.39 51.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.636 1.574 . . . . 0.0 108.638 168.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.07 136.45 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.121 0.968 . . . . 0.0 109.418 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -149.83 146.1 26.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.178 0.991 . . . . 0.0 111.279 -172.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.74 150.17 47.83 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.786 0.834 . . . . 0.0 113.236 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.5 tttt . . . . . 0 CA--C 1.546 0.822 0 C-N-CA 123.568 0.747 . . . . 0.0 111.322 168.395 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 120.806 0.336 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.76 -3.24 74.08 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.194 0.902 . . . . 0.0 113.211 -176.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.1 t -98.35 163.8 12.55 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.356 1.062 . . . . 0.0 111.62 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -134.4 18.06 3.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.947 1.299 . . . . 0.0 112.216 -170.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.52 169.59 3.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.461 1.104 . . . . 0.0 111.783 168.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.41 158.9 44.32 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.838 -1.164 . . . . 0.0 111.855 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.72 -162.08 26.92 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.903 1.716 . . . . 0.0 113.401 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.46 171.23 14.51 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.822 3.015 . . . . 0.0 112.628 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.31 121.09 9.94 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.084 0.954 . . . . 0.0 111.359 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.11 -4.0 73.84 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.949 1.261 . . . . 0.0 114.675 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.15 2.71 55.92 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.002 1.401 . . . . 0.0 114.173 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -118.35 125.66 50.5 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.721 1.208 . . . . 0.0 111.343 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.47 137.45 54.79 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.477 1.911 . . . . 0.0 112.026 -169.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.64 133.88 50.63 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.155 1.382 . . . . 0.0 108.352 167.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 9.3 mm -117.53 136.41 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.641 1.576 . . . . 0.0 108.517 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -135.37 161.5 35.26 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.114 0.965 . . . . 0.0 112.569 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 62.03 36.62 15.36 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.334 1.854 . . . . 0.0 113.299 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 46.0 mt -70.93 162.92 69.29 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.052 1.341 . . . . 0.0 111.392 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.87 149.06 90.32 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.04 2.493 . . . . 0.0 111.231 168.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -71.07 -10.45 59.78 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -104.1 -9.53 18.67 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.473 1.909 . . . . 0.0 114.27 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.28 126.94 31.14 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.608 1.163 . . . . 0.0 111.211 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.22 -174.79 24.31 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.961 1.267 . . . . 0.0 112.9 171.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -62.51 -34.6 77.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.743 0.817 . . . . 0.0 112.925 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -77.55 -30.52 52.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.856 0.862 . . . . 0.0 112.001 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -70.1 -40.43 74.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.606 0.639 . . . . 0.0 110.615 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 23.4 tp -66.42 -39.23 88.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.342 0.657 . . . . 0.0 111.601 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 64.1 tp -61.61 -49.67 75.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.81 0.732 . . . . 0.0 111.053 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -68.64 -23.02 64.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.7 ttm -73.56 -29.88 62.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.021 0.929 . . . . 0.0 113.002 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -109.23 -17.8 13.75 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -171.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.0 mtm -53.61 -33.09 12.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -59.53 -15.36 30.2 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.479 2.786 . . . . 0.0 116.475 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -102.48 -10.69 19.15 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -175.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 154.09 -169.45 32.58 Favored Glycine 0 N--CA 1.469 0.882 0 C-N-CA 125.089 1.328 . . . . 0.0 113.991 174.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -73.93 99.68 3.32 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.14 -0.624 . . . . 0.0 110.991 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.7 t -72.2 125.73 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.22 1.008 . . . . 0.0 109.336 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 37.3 t -86.64 -36.12 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.363 1.865 . . . . 0.0 111.017 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.7 m -161.22 151.59 17.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.213 1.805 . . . . 0.0 110.47 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.14 134.22 15.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.523 1.529 . . . . 0.0 110.225 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -153.36 135.5 14.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.392 0.677 . . . . 0.0 112.08 -174.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.7 t -106.73 135.02 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.205 1.802 . . . . 0.0 107.086 168.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 123.249 0.62 . . . . 0.0 111.171 -178.766 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 64.1 m 69.11 20.03 7.8 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.167 2.187 . . . . 0.0 113.614 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.27 156.86 44.83 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.898 0.879 . . . . 0.0 112.063 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.1 -172.01 26.74 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.664 1.602 . . . . 0.0 114.316 -169.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -144.32 144.89 31.68 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.491 1.916 . . . . 0.0 110.127 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 78.9 t -144.88 139.08 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.529 1.532 . . . . 0.0 109.049 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 77.8 p -134.43 153.39 51.94 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.913 0.885 . . . . 0.0 112.66 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -128.65 167.57 17.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.86 1.264 . . . . 0.0 114.179 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -67.57 -21.48 65.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.487 1.515 . . . . 0.0 114.607 172.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -152.4 156.48 33.56 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.526 1.531 . . . . 0.0 111.931 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -63.37 -29.77 72.38 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.652 2.901 . . . . 0.0 113.415 174.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.8 -39.57 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.001 0.921 . . . . 0.0 110.865 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 16.3 m -58.92 -35.61 73.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.089 0.955 . . . . 0.0 111.61 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -76.95 -48.41 18.18 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.237 1.415 . . . . 0.0 112.576 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -61.18 -32.21 71.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.321 1.048 . . . . 0.0 112.367 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.15 72.22 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.305 0.642 . . . . 0.0 112.64 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.81 33.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.532 0.733 . . . . 0.0 111.841 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 38.6 mt -58.01 -46.5 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.121 0.873 . . . . 0.0 110.235 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -72.39 -12.81 61.28 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.9 m -103.9 -30.4 10.36 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 83.9 mmm -112.84 -18.75 12.2 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -169.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -70.16 111.97 6.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.66 1.118 . . . . 0.0 110.496 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.24 1.76 69.11 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.744 1.64 . . . . 0.0 114.821 -173.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.13 124.72 21.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.255 1.528 . . . . 0.0 111.636 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -80.27 127.48 32.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.603 0.761 . . . . 0.0 110.19 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 N--CA 1.467 0.408 0 C-N-CA 124.953 1.301 . . . . 0.0 109.793 -176.389 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 119.862 -0.114 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 53.3 mt -68.14 161.65 26.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.19 1.396 . . . . 0.0 112.485 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -137.55 142.61 41.37 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.668 1.587 . . . . 0.0 109.161 167.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 34.6 t -139.31 133.11 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.591 1.156 . . . . 0.0 109.019 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -142.25 151.92 42.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.195 0.998 . . . . 0.0 111.482 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 58.9 mt -66.36 152.8 44.28 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.938 0.875 . . . . 0.0 113.151 172.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.0 tttt . . . . . 0 CA--C 1.547 0.861 0 C-N-CA 124.536 1.134 . . . . 0.0 111.534 169.07 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 120.898 0.38 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.0 -9.08 67.29 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.452 1.501 . . . . 0.0 113.173 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.6 m -76.52 158.67 31.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.168 0.987 . . . . 0.0 110.078 169.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -139.86 31.51 2.02 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.379 -0.826 . . . . 0.0 112.133 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -69.33 174.15 5.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.548 0.739 . . . . 0.0 111.007 167.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.78 160.59 43.43 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.92 -160.19 26.56 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.982 1.753 . . . . 0.0 113.453 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.23 172.41 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.899 3.066 . . . . 0.0 112.862 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -59.18 120.63 9.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.419 1.088 . . . . 0.0 110.917 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.01 -3.53 70.32 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.003 1.287 . . . . 0.0 114.708 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.18 0.86 51.74 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.975 1.388 . . . . 0.0 114.421 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -117.15 123.54 46.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.645 1.178 . . . . 0.0 111.271 -169.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.0 mt -123.6 141.51 51.94 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.532 1.933 . . . . 0.0 112.525 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -111.61 134.19 53.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.784 1.634 . . . . 0.0 108.463 167.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.87 135.64 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.733 1.613 . . . . 0.0 107.832 -172.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -131.55 162.42 30.34 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.128 1.371 . . . . 0.0 111.92 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 63.02 37.06 12.0 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.465 1.906 . . . . 0.0 113.273 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 54.6 mt -70.11 161.62 74.47 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.792 1.237 . . . . 0.0 112.083 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.99 154.14 58.88 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.418 2.746 . . . . 0.0 111.123 168.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -75.51 -19.91 59.06 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -96.76 -6.38 36.36 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.57 1.548 . . . . 0.0 114.207 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.01 128.12 35.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.862 1.265 . . . . 0.0 111.819 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -107.26 -177.56 22.67 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.963 1.268 . . . . 0.0 113.506 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.46 -34.2 77.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.11 0.964 . . . . 0.0 112.703 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -75.97 -27.24 57.41 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.402 1.081 . . . . 0.0 111.676 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -75.5 -42.29 53.17 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.881 0.872 . . . . 0.0 110.723 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 27.1 tp -64.76 -36.63 84.91 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.334 0.653 . . . . 0.0 111.686 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.4 -51.22 69.64 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.417 0.553 . . . . 0.0 110.702 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -69.01 -20.99 64.16 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.7 ttm -73.98 -26.95 60.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.108 0.963 . . . . 0.0 112.817 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -113.03 -18.29 12.23 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.9 mtm -53.24 -34.03 16.77 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 170.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -59.44 -16.88 37.75 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.559 2.839 . . . . 0.0 116.215 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -100.2 -9.01 22.92 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.408 1.004 . . . . 0.0 113.664 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.78 -163.37 28.57 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.981 1.277 . . . . 0.0 114.75 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -70.68 96.53 1.23 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.311 1.044 . . . . 0.0 112.285 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 80.3 t -74.85 128.43 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.089 1.355 . . . . 0.0 109.881 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 38.7 t -88.69 -36.78 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.57 1.948 . . . . 0.0 111.045 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.8 m -160.25 150.73 18.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.511 1.525 . . . . 0.0 110.814 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.4 130.39 11.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.232 1.813 . . . . 0.0 109.637 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -152.71 144.73 23.76 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.539 -0.726 . . . . 0.0 112.854 -171.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.0 t -119.18 135.93 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.554 1.942 . . . . 0.0 108.219 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 123.539 0.736 . . . . 0.0 109.853 177.439 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 66.5 m 73.52 20.36 3.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.265 2.626 . . . . 0.0 113.003 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -146.38 155.68 42.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.678 0.791 . . . . 0.0 112.394 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.38 -173.95 29.57 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.968 1.747 . . . . 0.0 113.675 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -140.94 145.67 36.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.406 1.883 . . . . 0.0 110.141 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.1 t -145.36 139.18 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.155 1.382 . . . . 0.0 109.279 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.1 p -133.38 149.06 51.86 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.327 1.051 . . . . 0.0 112.328 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -121.55 163.34 19.03 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.099 1.359 . . . . 0.0 113.323 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.27 -18.2 63.12 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.293 1.037 . . . . 0.0 113.073 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -145.52 151.78 47.8 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.273 1.429 . . . . 0.0 112.182 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.91 -29.34 58.09 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.829 3.019 . . . . 0.0 113.868 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.45 -40.97 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.705 0.802 . . . . 0.0 110.916 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.1 m -62.06 -33.27 74.09 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.856 0.862 . . . . 0.0 111.918 173.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.72 -49.26 21.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.993 1.317 . . . . 0.0 112.129 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -60.99 -33.65 73.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.062 0.945 . . . . 0.0 112.126 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.11 -31.05 72.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.358 0.663 . . . . 0.0 112.642 172.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.36 -41.53 47.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.344 0.658 . . . . 0.0 111.68 175.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 40.2 mt -58.14 -47.29 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.03 0.832 . . . . 0.0 110.153 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.24 -14.27 62.18 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.9 m -102.18 -29.78 11.52 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 86.1 mmm -113.32 -18.04 12.15 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -169.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -70.26 111.78 6.12 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.491 1.041 . . . . 0.0 110.551 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.93 1.75 67.27 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.885 1.707 . . . . 0.0 114.77 -173.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.9 124.43 20.46 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.215 1.507 . . . . 0.0 111.615 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -80.39 127.71 32.71 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.613 0.765 . . . . 0.0 110.175 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.5 tt . . . . . 0 N--CA 1.468 0.466 0 C-N-CA 124.888 1.275 . . . . 0.0 109.713 -176.188 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 119.923 -0.084 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 59.5 mt -68.96 161.01 29.77 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.978 1.311 . . . . 0.0 112.328 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.96 141.21 42.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.435 1.494 . . . . 0.0 108.967 168.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.35 138.2 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.532 1.133 . . . . 0.0 109.302 -175.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -151.02 152.76 33.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.241 1.016 . . . . 0.0 110.757 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.32 157.63 16.13 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.6 0.76 . . . . 0.0 112.778 170.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.1 tttt . . . . . 0 CA--C 1.55 0.949 0 C-N-CA 124.942 1.297 . . . . 0.0 112.673 172.178 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 17.4 m 71.66 -0.47 3.15 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.443 1.897 . . . . 0.0 115.514 171.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.3 t -166.6 157.48 12.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.34 1.856 . . . . 0.0 110.676 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -129.96 151.02 19.23 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.454 1.502 . . . . 0.0 112.76 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 57.3 p -83.88 -15.73 47.04 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 42.2 m -132.45 10.01 4.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.367 1.467 . . . . 0.0 113.302 -175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 165.49 -164.12 37.06 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.102 1.334 . . . . 0.0 113.701 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.58 170.08 23.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.98 1.712 . . . . 0.0 112.026 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 79.4 p -79.99 173.17 12.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.534 1.534 . . . . 0.0 112.093 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -78.53 12.24 2.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.616 1.166 . . . . 0.0 113.07 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -70.55 -9.39 56.64 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.905 -1.122 . . . . 0.0 113.468 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 32.7 m -64.27 6.49 0.19 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.015 1.726 . . . . 0.0 115.01 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 2.2 pp -76.73 -9.92 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.576 1.551 . . . . 0.0 113.135 169.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -83.5 -138.28 3.42 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.778 1.656 . . . . 0.0 111.485 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -99.33 -59.87 1.64 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.363 0.665 . . . . 0.0 112.357 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.46 128.01 34.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.078 0.951 . . . . 0.0 111.423 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.35 -6.53 81.71 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.66 1.6 . . . . 0.0 113.168 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 4.2 t -82.63 157.29 23.47 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.455 1.128 . . . . 0.0 113.421 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -128.54 13.87 6.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.994 1.318 . . . . 0.0 112.26 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -70.62 176.08 4.41 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.377 -0.827 . . . . 0.0 110.195 167.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.48 157.46 39.87 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.263 -0.898 . . . . 0.0 112.355 168.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.82 -157.39 22.72 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.339 1.447 . . . . 0.0 113.235 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.92 160.61 43.31 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.197 2.598 . . . . 0.0 111.488 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.04 124.33 20.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.103 0.561 . . . . 0.0 110.983 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.58 -8.74 60.27 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.024 1.297 . . . . 0.0 113.68 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.85 22.1 7.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.168 1.387 . . . . 0.0 112.646 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.7 118.6 25.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.413 1.485 . . . . 0.0 110.084 -167.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 27.9 mt -125.33 141.95 51.78 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.106 1.763 . . . . 0.0 112.659 -168.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -114.54 134.06 55.32 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.382 1.473 . . . . 0.0 109.283 168.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.56 134.71 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.318 1.847 . . . . 0.0 107.884 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -133.08 158.62 42.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.743 1.217 . . . . 0.0 112.87 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 73.2 26.86 2.05 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.984 2.513 . . . . 0.0 113.528 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.45 149.6 97.9 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.599 1.16 . . . . 0.0 111.373 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -58.32 149.87 70.78 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.247 2.631 . . . . 0.0 112.454 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -69.23 -9.72 54.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.63 -11.32 23.73 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.969 1.708 . . . . 0.0 114.168 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.07 126.34 30.31 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.261 1.024 . . . . 0.0 111.549 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -108.3 -171.65 21.47 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.545 1.545 . . . . 0.0 112.096 169.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.73 -32.56 74.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.047 0.939 . . . . 0.0 113.145 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -78.5 -30.38 47.18 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.993 0.917 . . . . 0.0 112.079 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -70.55 -40.78 73.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.71 0.686 . . . . 0.0 110.632 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 28.6 tp -65.63 -37.66 87.22 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.382 0.673 . . . . 0.0 111.838 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 65.1 tp -62.52 -51.71 66.33 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.702 0.683 . . . . 0.0 111.253 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -63.92 -30.78 71.84 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.1 0.56 . . . . 0.0 112.423 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.0 ttm -68.57 -29.45 67.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.345 1.058 . . . . 0.0 113.11 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -106.36 -13.23 15.43 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 29.7 mtt -49.66 -37.36 23.26 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -61.78 -17.73 56.65 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.127 2.552 . . . . 0.0 116.015 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -99.67 -7.82 25.18 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.49 -163.73 28.46 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.326 1.441 . . . . 0.0 114.44 171.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -72.52 97.78 2.17 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.054 0.942 . . . . 0.0 111.853 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.6 t -74.55 126.93 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.56 1.144 . . . . 0.0 109.815 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 39.9 t -91.06 -36.47 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.437 1.895 . . . . 0.0 111.032 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 53.6 m -149.81 147.77 28.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.737 1.215 . . . . 0.0 110.92 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.14 136.48 20.11 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.237 1.815 . . . . 0.0 109.013 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -153.74 138.32 16.88 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.556 -0.715 . . . . 0.0 111.656 -168.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.58 128.36 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.214 1.406 . . . . 0.0 107.976 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -82.24 142.84 31.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.607 0.763 . . . . 0.0 110.85 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 37.8 mm -120.45 133.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.994 1.318 . . . . 0.0 110.339 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -76.32 125.91 30.04 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.35 1.06 . . . . 0.0 110.951 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -76.08 -7.29 54.4 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -172.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -98.93 -17.1 18.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.388 1.075 . . . . 0.0 112.904 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 60.9 p -129.57 -16.85 3.77 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.745 1.218 . . . . 0.0 114.144 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 21.9 m120 64.33 14.46 8.77 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.648 1.979 . . . . 0.0 113.363 -173.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 80.7 mt -89.15 156.34 18.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.362 1.465 . . . . 0.0 110.779 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 67.5 p -69.49 144.62 53.15 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.065 0.936 . . . . 0.0 112.149 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -76.42 5.41 7.26 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 35.3 m 64.97 20.1 12.02 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.996 2.118 . . . . 0.0 112.973 -171.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -147.35 156.07 42.57 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.143 0.977 . . . . 0.0 112.033 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.52 -177.55 27.99 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 126.008 1.766 . . . . 0.0 113.605 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -135.18 146.68 48.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.521 1.928 . . . . 0.0 110.133 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.9 t -143.22 144.86 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.309 1.443 . . . . 0.0 108.719 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 8.1 t -143.65 146.85 33.55 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.455 -0.778 . . . . 0.0 112.37 173.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -115.87 165.42 13.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.138 1.775 . . . . 0.0 113.128 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.0 -18.43 64.72 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.371 1.069 . . . . 0.0 113.281 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -145.27 149.59 41.91 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.122 1.369 . . . . 0.0 112.16 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.29 -28.08 55.47 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.757 2.971 . . . . 0.0 113.774 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.36 -38.67 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.879 0.872 . . . . 0.0 110.896 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 9.9 m -62.68 -34.63 77.52 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.966 0.906 . . . . 0.0 111.707 171.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.71 -48.14 41.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.54 1.136 . . . . 0.0 111.964 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -60.67 -34.32 74.15 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 112.16 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.0 -30.01 70.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.431 0.693 . . . . 0.0 112.696 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.73 -41.49 53.22 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.349 0.66 . . . . 0.0 111.491 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.9 -48.07 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.896 0.771 . . . . 0.0 110.12 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.58 -14.23 62.41 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -102.76 -29.07 11.71 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 92.2 mmm -114.54 -19.14 11.27 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -169.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -70.81 111.28 6.12 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.277 0.944 . . . . 0.0 109.951 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 97.46 1.36 59.14 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.682 1.61 . . . . 0.0 114.841 -172.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -64.62 120.36 12.24 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.676 1.738 . . . . 0.0 111.173 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -76.78 131.93 38.97 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.976 0.417 . . . . 0.0 110.452 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.1 tt -139.56 93.18 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.492 1.117 . . . . 0.0 109.018 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 81.41 -124.3 6.39 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -169.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 62.4 mtt -99.22 7.73 45.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.915 1.286 . . . . 0.0 113.694 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.04 170.39 15.79 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.684 1.594 . . . . 0.0 112.74 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -119.46 138.4 53.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.999 1.32 . . . . 0.0 112.018 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.81 150.54 47.7 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.169 1.388 . . . . 0.0 111.591 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -121.22 141.99 50.33 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.64 1.176 . . . . 0.0 108.777 168.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.26 133.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.364 1.066 . . . . 0.0 108.82 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -142.53 157.69 44.47 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.563 1.145 . . . . 0.0 111.075 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.47 156.98 30.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.821 0.819 . . . . 0.0 112.132 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -58.79 121.95 12.36 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.54 1.136 . . . . 0.0 112.189 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -79.98 138.59 37.1 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.755 1.222 . . . . 0.0 110.272 171.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 7.0 t -163.52 176.72 9.46 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.138 1.375 . . . . 0.0 111.245 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -69.97 155.02 41.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.634 1.174 . . . . 0.0 112.517 176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -142.21 157.41 44.88 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.689 1.595 . . . . 0.0 111.496 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -151.95 -33.13 0.14 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.855 1.262 . . . . 0.0 113.218 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 33.0 p -76.84 -5.37 48.06 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.761 1.224 . . . . 0.0 113.743 171.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -157.37 146.89 20.24 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.713 2.005 . . . . 0.0 110.511 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 37.3 p -80.94 -10.14 59.75 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 170.55 -172.97 44.36 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.727 1.156 . . . . 0.0 114.052 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.59 -11.91 20.41 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.93 3.087 . . . . 0.0 114.036 -176.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 19.8 m 68.43 3.92 4.0 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.296 1.838 . . . . 0.0 114.79 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 10.7 t -163.2 159.77 23.28 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.328 1.851 . . . . 0.0 110.998 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 C-N-CA 125.256 1.408 . . . . 0.0 112.843 -177.848 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.479 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.3 m -66.32 -18.32 65.28 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 52.8 p -90.99 -8.62 48.67 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.19 1.396 . . . . 0.0 113.879 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 75.95 -43.24 1.67 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.824 1.678 . . . . 0.0 113.692 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 22.5 t -166.22 154.4 10.57 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.531 1.932 . . . . 0.0 110.932 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 4.6 m -78.78 -3.37 44.05 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 108.3 -162.02 13.19 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.843 1.687 . . . . 0.0 112.791 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 43.2 tp -60.31 -29.99 69.21 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.082 0.953 . . . . 0.0 113.464 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 37.0 p -67.95 -10.91 57.19 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.672 1.589 . . . . 0.0 113.971 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 6.96 38.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.538 1.535 . . . . 0.0 111.655 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -141.39 -53.69 0.46 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.927 1.291 . . . . 0.0 111.642 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 50.4 m -107.02 109.24 21.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.316 1.047 . . . . 0.0 110.156 -171.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.57 152.74 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.534 1.534 . . . . 0.0 111.625 -171.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -90.89 130.76 10.44 Favored Glycine 0 N--CA 1.471 1.016 0 C-N-CA 124.379 0.99 . . . . 0.0 111.994 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -79.79 -36.99 36.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.857 0.863 . . . . 0.0 113.076 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -68.37 121.7 16.83 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.742 1.217 . . . . 0.0 110.623 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.29 84.64 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.373 0.987 . . . . 0.0 113.347 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.3 t -85.47 173.82 9.96 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.002 0.901 . . . . 0.0 111.411 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -139.7 28.53 2.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.392 1.477 . . . . 0.0 110.846 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -66.98 164.16 18.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.982 0.913 . . . . 0.0 112.684 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.7 154.66 37.82 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.73 -160.38 26.77 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.101 1.81 . . . . 0.0 113.473 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.08 171.74 15.29 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.907 3.071 . . . . 0.0 112.576 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.45 122.34 13.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.069 0.948 . . . . 0.0 111.337 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.63 -4.33 75.91 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.844 1.212 . . . . 0.0 114.587 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.66 1.56 53.63 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.069 1.434 . . . . 0.0 114.39 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -116.98 125.17 50.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.899 1.28 . . . . 0.0 111.162 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.3 mt -124.22 140.29 53.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.528 1.931 . . . . 0.0 112.403 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -110.8 133.38 53.4 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.506 1.522 . . . . 0.0 108.52 167.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.5 mm -117.05 139.23 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.98 1.712 . . . . 0.0 108.71 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -140.65 160.89 39.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.335 1.054 . . . . 0.0 113.131 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 66.52 26.81 9.86 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.832 2.453 . . . . 0.0 114.037 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 68.4 mt -66.14 155.9 86.15 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.595 1.158 . . . . 0.0 112.219 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -59.95 148.76 87.54 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.291 2.661 . . . . 0.0 111.953 171.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.71 -19.17 65.7 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -91.93 -10.04 40.93 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.033 1.333 . . . . 0.0 114.556 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.1 134.36 51.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.272 1.029 . . . . 0.0 112.495 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.62 -176.78 19.76 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.402 1.477 . . . . 0.0 112.213 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -62.25 -32.49 73.2 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -78.13 -29.57 48.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.967 0.907 . . . . 0.0 112.268 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -70.45 -40.33 73.79 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.741 0.7 . . . . 0.0 110.692 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.37 -36.71 79.6 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.953 0.501 . . . . 0.0 111.745 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -62.27 -49.7 74.65 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.917 0.78 . . . . 0.0 110.947 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -67.96 -22.97 65.01 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.7 ttm -73.96 -27.82 61.18 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.024 0.93 . . . . 0.0 113.108 171.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -112.58 -16.37 12.85 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -171.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.7 mtm -53.92 -33.92 18.0 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -59.15 -16.17 32.13 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.492 2.794 . . . . 0.0 116.325 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -99.85 -10.22 22.0 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.42 -159.66 28.08 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 124.657 1.122 . . . . 0.0 114.909 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.34 92.83 1.85 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.201 1.0 . . . . 0.0 112.201 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.5 t -72.1 128.12 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.951 1.3 . . . . 0.0 110.018 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.93 -31.9 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.126 2.17 . . . . 0.0 111.494 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.9 t -157.64 151.12 23.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.458 1.103 . . . . 0.0 110.916 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.06 132.15 14.36 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.246 1.418 . . . . 0.0 110.19 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -153.68 132.44 12.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.43 0.692 . . . . 0.0 112.005 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 64.0 t -103.25 135.03 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.653 1.581 . . . . 0.0 107.27 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -82.64 127.71 33.64 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 48.3 mt -127.64 140.67 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.287 1.435 . . . . 0.0 110.15 -168.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -84.71 126.82 33.73 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.73 0.812 . . . . 0.0 111.366 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -66.78 -11.78 56.3 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -84.8 -21.15 30.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.126 0.97 . . . . 0.0 112.632 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 73.7 p -133.53 -18.75 2.17 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -172.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 58.6 t30 62.4 19.26 10.99 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.135 1.774 . . . . 0.0 112.857 -171.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.3 mt -95.34 149.15 21.67 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.153 1.381 . . . . 0.0 111.402 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.7 t -56.77 136.75 55.29 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.324 1.049 . . . . 0.0 111.615 169.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -75.38 5.37 5.81 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.393 1.077 . . . . 0.0 113.085 170.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 58.3 m 74.27 18.99 2.95 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.575 2.75 . . . . 0.0 113.206 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.15 156.77 43.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.991 0.814 . . . . 0.0 112.382 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.93 -175.16 28.54 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.85 1.69 . . . . 0.0 113.708 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -141.57 144.25 34.15 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.542 1.937 . . . . 0.0 110.111 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.1 t -144.33 140.67 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.203 1.401 . . . . 0.0 108.765 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 88.3 p -135.8 153.1 51.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.648 0.779 . . . . 0.0 112.36 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -126.6 164.89 20.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.213 1.405 . . . . 0.0 113.078 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.98 -10.88 59.78 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.488 1.115 . . . . 0.0 113.007 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.74 145.51 28.3 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.062 1.345 . . . . 0.0 111.744 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.69 -29.78 69.38 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.464 2.776 . . . . 0.0 113.718 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.14 -41.57 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.815 0.846 . . . . 0.0 111.382 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.4 p -66.83 -31.13 71.54 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.605 0.762 . . . . 0.0 112.377 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -68.9 -49.8 55.02 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.769 0.828 . . . . 0.0 111.849 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -58.93 -39.37 81.38 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.582 -0.699 . . . . 0.0 111.941 175.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.44 -28.82 65.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 174.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.65 -43.66 30.67 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.652 0.66 . . . . 0.0 112.036 171.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.1 mt -58.12 -49.96 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 119.479 1.036 . . . . 0.0 110.408 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -73.79 -11.71 60.47 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.5 m -100.1 -30.65 11.83 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.5 mmm -111.66 -19.77 12.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -169.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.71 111.54 5.56 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.286 0.948 . . . . 0.0 109.903 173.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.01 3.31 65.76 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.404 1.478 . . . . 0.0 115.104 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -63.86 124.28 21.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.438 1.619 . . . . 0.0 111.258 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -81.04 131.3 35.3 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.263 0.554 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.2 tt -141.89 109.83 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.247 1.419 . . . . 0.0 108.447 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.88 -122.48 22.04 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -169.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.56 13.26 34.96 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.351 1.46 . . . . 0.0 113.501 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -142.05 173.15 11.78 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.742 1.217 . . . . 0.0 113.382 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -123.44 133.4 54.07 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.968 1.307 . . . . 0.0 111.417 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.2 mt -68.12 160.5 28.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.276 1.43 . . . . 0.0 111.787 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -133.14 143.4 49.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.246 1.418 . . . . 0.0 109.67 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 30.1 t -138.44 136.02 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.648 1.179 . . . . 0.0 109.172 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -140.71 154.9 46.53 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.451 1.101 . . . . 0.0 111.173 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.15 155.64 38.24 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 122.317 1.056 . . . . 0.0 111.802 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -58.47 128.18 35.85 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.709 0.804 . . . . 0.0 111.162 169.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 72.58 20.06 3.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.551 1.94 . . . . 0.0 114.338 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 38.6 m -65.51 152.87 42.98 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.513 -1.367 . . . . 0.0 112.614 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -137.34 157.85 45.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.643 1.577 . . . . 0.0 111.847 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -158.63 146.22 17.91 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.246 1.418 . . . . 0.0 111.556 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -156.92 149.15 23.05 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.82 1.648 . . . . 0.0 111.018 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 65.5 p -113.02 5.27 17.12 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -171.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -140.81 -21.23 0.8 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -170.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 71.8 m -76.45 149.6 36.8 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.679 1.127 . . . . 0.0 112.282 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -163.39 178.44 38.97 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 124.74 1.162 . . . . 0.0 114.009 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.96 162.77 36.65 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.225 3.283 . . . . 0.0 111.969 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 48.5 p -76.94 0.93 19.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.865 1.266 . . . . 0.0 113.94 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 15.6 m -72.3 -8.89 57.34 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.679 1.592 . . . . 0.0 114.708 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.242 1.401 . . . . 0.0 112.985 179.319 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 36.5 t -163.09 150.02 12.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.981 1.312 . . . . 0.0 111.393 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 53.1 p -85.31 -5.63 59.3 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.762 1.225 . . . . 0.0 113.336 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -76.08 0.43 62.87 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.274 1.416 . . . . 0.0 115.332 -174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 23.9 m -73.85 -4.46 34.97 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.093 1.357 . . . . 0.0 114.207 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.2 t -159.32 166.13 31.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.792 1.637 . . . . 0.0 111.303 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 76.82 -140.87 25.58 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.469 1.033 . . . . 0.0 112.945 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -158.94 168.53 26.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.345 1.858 . . . . 0.0 111.681 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.0 p -99.08 173.27 6.9 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.845 1.258 . . . . 0.0 111.497 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -100.82 15.14 29.41 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.992 1.317 . . . . 0.0 110.458 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.95 -17.34 5.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.681 1.192 . . . . 0.0 113.688 -170.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 56.9 p -78.53 2.49 18.94 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.89 -10.55 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.487 1.515 . . . . 0.0 113.914 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -74.21 154.43 47.82 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.77 1.176 . . . . 0.0 112.041 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -102.23 -49.79 3.8 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -172.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.22 120.25 12.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.103 0.961 . . . . 0.0 111.262 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.81 -6.79 82.73 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.517 1.532 . . . . 0.0 113.272 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 6.8 t -84.03 158.0 21.62 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.676 1.238 . . . . 0.0 112.64 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -128.78 14.39 6.41 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.041 1.336 . . . . 0.0 112.34 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -68.13 177.16 2.35 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.394 -0.816 . . . . 0.0 110.349 167.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -154.74 157.66 38.36 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.235 -0.916 . . . . 0.0 112.079 168.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.59 -158.42 24.17 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.176 1.37 . . . . 0.0 113.314 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.31 160.73 43.85 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.216 2.611 . . . . 0.0 111.439 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.87 123.4 18.39 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.828 -0.545 . . . . 0.0 110.928 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.96 -9.07 58.0 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.013 1.292 . . . . 0.0 113.752 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.17 20.19 10.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.169 1.387 . . . . 0.0 112.728 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 120.38 30.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.434 1.493 . . . . 0.0 110.052 -167.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.92 139.77 53.52 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.239 1.815 . . . . 0.0 112.372 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -112.14 133.37 54.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.213 1.405 . . . . 0.0 108.993 167.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -118.46 136.08 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.19 1.796 . . . . 0.0 107.748 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -133.55 160.77 36.48 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.185 1.394 . . . . 0.0 112.404 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 67.49 30.34 6.82 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.266 2.226 . . . . 0.0 113.478 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.38 155.65 90.34 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.889 0.876 . . . . 0.0 111.257 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.68 151.91 52.27 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.291 2.661 . . . . 0.0 111.981 169.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -70.48 -15.28 62.79 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.329 1.052 . . . . 0.0 113.517 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -102.89 -4.75 24.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.482 1.913 . . . . 0.0 114.29 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.29 134.51 52.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.925 1.29 . . . . 0.0 112.105 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -111.27 -179.14 20.25 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.105 1.336 . . . . 0.0 113.147 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -66.99 -31.84 72.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.455 0.702 . . . . 0.0 112.838 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -73.18 -35.89 66.47 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.353 1.061 . . . . 0.0 112.003 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -64.95 -41.69 95.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.909 0.484 . . . . 0.0 110.857 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -69.44 -42.2 75.27 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.973 -0.537 . . . . 0.0 112.035 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.1 tp -58.64 -54.81 42.91 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.742 0.701 . . . . 0.0 111.501 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -75.58 -15.53 60.35 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -170.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.4 ttp -80.71 -20.76 42.14 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.125 0.97 . . . . 0.0 112.738 169.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -105.71 -15.33 14.99 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.553 1.541 . . . . 0.0 114.013 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 37.1 mtt -47.89 -37.37 13.46 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 168.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -62.07 -16.9 53.21 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.976 2.451 . . . . 0.0 115.696 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -99.37 -8.34 24.95 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.94 0.896 . . . . 0.0 113.327 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 148.48 -167.28 29.14 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.324 1.44 . . . . 0.0 114.447 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -75.06 97.42 3.41 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.615 1.166 . . . . 0.0 112.792 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.25 132.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.558 1.543 . . . . 0.0 110.263 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.66 -35.41 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 127.07 2.148 . . . . 0.0 111.39 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 24.0 m -150.77 147.41 27.27 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.19 1.396 . . . . 0.0 110.896 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.26 134.19 14.88 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.846 1.658 . . . . 0.0 109.187 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -154.27 136.61 14.92 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.727 -0.608 . . . . 0.0 111.805 -168.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 84.1 t -112.62 132.08 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.238 1.415 . . . . 0.0 107.926 169.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -79.29 126.73 31.17 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 50.5 mt -131.36 141.25 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.386 1.475 . . . . 0.0 110.073 -169.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -86.48 130.59 34.44 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.654 0.782 . . . . 0.0 112.0 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.97 -12.66 61.18 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -85.4 -20.34 30.0 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.05 0.94 . . . . 0.0 112.694 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.6 p -133.9 -20.68 1.96 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.583 1.153 . . . . 0.0 114.039 -172.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 62.96 19.13 11.4 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.355 1.862 . . . . 0.0 113.045 -171.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.61 148.99 21.59 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.006 1.323 . . . . 0.0 111.464 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.0 t -59.22 136.38 57.94 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.298 1.039 . . . . 0.0 111.85 170.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -76.18 6.72 5.02 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.795 1.238 . . . . 0.0 113.307 170.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 23.3 m 75.06 19.3 2.35 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.166 2.586 . . . . 0.0 113.074 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -149.21 158.48 44.22 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.618 0.767 . . . . 0.0 112.051 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.55 -177.67 31.85 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.696 1.617 . . . . 0.0 113.599 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -137.42 145.77 43.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.392 1.877 . . . . 0.0 110.021 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 94.9 t -143.41 143.91 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.204 1.402 . . . . 0.0 108.532 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 8.1 t -143.77 145.61 32.51 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.394 -0.816 . . . . 0.0 112.146 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -114.74 167.5 10.71 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.41 1.884 . . . . 0.0 112.225 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.63 -16.89 63.46 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -144.86 149.51 43.06 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.967 1.307 . . . . 0.0 112.168 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.91 -27.88 58.58 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.721 2.947 . . . . 0.0 113.66 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.46 -40.27 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.884 0.873 . . . . 0.0 110.927 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 15.3 m -62.73 -33.49 75.25 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.687 0.795 . . . . 0.0 111.833 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.14 -47.34 36.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.731 1.212 . . . . 0.0 112.083 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -61.17 -34.83 75.68 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.125 0.97 . . . . 0.0 112.041 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.39 70.4 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.476 0.711 . . . . 0.0 112.803 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.06 47.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.26 0.624 . . . . 0.0 111.163 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.05 -46.85 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 119.335 0.97 . . . . 0.0 110.304 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -69.85 -14.6 62.83 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.0 m -104.21 -26.48 12.5 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.7 mmm -115.08 -19.28 10.94 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -71.02 110.5 5.75 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.321 0.964 . . . . 0.0 110.186 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.73 2.34 65.11 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.766 1.65 . . . . 0.0 114.857 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -61.16 123.97 19.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.453 1.626 . . . . 0.0 111.669 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -78.37 131.3 36.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.128 0.489 . . . . 0.0 110.412 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.1 tt -135.29 86.79 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.043 1.337 . . . . 0.0 108.852 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 74.8 -118.19 5.64 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -169.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -99.79 12.9 35.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.446 1.498 . . . . 0.0 113.454 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -139.8 166.81 23.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.784 1.634 . . . . 0.0 112.533 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -122.94 138.01 54.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.882 1.273 . . . . 0.0 111.587 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.74 161.59 29.49 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.118 1.367 . . . . 0.0 112.588 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -130.97 141.55 50.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.596 1.558 . . . . 0.0 108.781 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.02 138.46 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.392 1.077 . . . . 0.0 109.43 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -147.5 151.13 35.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.548 1.139 . . . . 0.0 110.791 -174.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.33 157.54 25.88 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.914 0.864 . . . . 0.0 111.787 168.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -65.61 -27.68 68.58 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.523 1.129 . . . . 0.0 113.26 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -162.81 153.36 16.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.96 1.704 . . . . 0.0 110.796 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 74.1 p -145.27 157.84 43.97 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.604 1.562 . . . . 0.0 110.9 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -109.92 -3.53 16.52 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -162.19 151.68 15.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.786 1.635 . . . . 0.0 112.064 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -123.72 7.16 8.79 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.17 1.788 . . . . 0.0 113.081 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 59.1 m -148.94 157.92 43.79 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.716 2.006 . . . . 0.0 111.36 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 45.0 tttp 76.36 133.29 0.05 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.677 2.791 . . . . 0.0 113.887 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 67.5 m -149.86 151.77 34.01 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.836 1.654 . . . . 0.0 110.742 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 80.18 -141.66 23.39 Favored Glycine 0 CA--C 1.542 1.755 0 CA-C-O 118.519 -1.156 . . . . 0.0 112.671 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -76.61 176.26 10.31 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.881 3.054 . . . . 0.0 111.881 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.6 m -59.94 -25.95 65.58 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.981 0.912 . . . . 0.0 113.276 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 21.9 m -86.23 -2.04 58.01 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.278 1.431 . . . . 0.0 113.786 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.634 1.587 . . . . 0.0 113.892 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.039 -0.424 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 29.4 t -163.58 158.05 20.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.337 1.455 . . . . 0.0 111.234 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 53.6 p -82.14 -11.63 58.63 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.344 1.058 . . . . 0.0 113.133 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -89.24 150.63 21.48 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.192 1.377 . . . . 0.0 112.123 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 77.7 p -167.96 -46.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.657 1.183 . . . . 0.0 112.87 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 80.7 p -165.89 168.28 15.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.411 1.484 . . . . 0.0 111.782 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -177.73 164.03 32.78 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.265 0.936 . . . . 0.0 113.715 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.27 149.02 45.3 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.708 1.603 . . . . 0.0 110.278 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 24.2 p -144.43 145.33 31.85 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.29 1.836 . . . . 0.0 110.355 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -140.89 89.72 2.28 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 109.3 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -163.56 145.32 9.46 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.388 1.475 . . . . 0.0 110.064 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 22.7 t -159.93 118.82 2.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.898 1.279 . . . . 0.0 109.923 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.74 -3.83 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 84.19 143.43 5.8 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.176 1.37 . . . . 0.0 113.011 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 67.87 -54.13 0.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.824 2.85 . . . . 0.0 113.629 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -68.39 113.17 5.73 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.965 1.306 . . . . 0.0 110.3 173.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 87.44 -5.2 85.44 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.922 1.249 . . . . 0.0 113.375 -176.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 40.4 m -78.21 158.52 28.96 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.902 1.281 . . . . 0.0 111.371 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -131.7 27.79 4.62 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.441 1.096 . . . . 0.0 112.086 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -71.95 171.03 12.55 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.386 -0.822 . . . . 0.0 110.47 167.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.09 156.23 35.48 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 169.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -87.43 -158.44 32.72 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.898 1.713 . . . . 0.0 114.172 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.7 165.84 26.25 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.544 2.829 . . . . 0.0 111.625 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.95 125.72 24.76 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.597 -0.689 . . . . 0.0 111.274 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.5 -6.64 68.15 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.75 1.167 . . . . 0.0 113.689 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.81 18.41 14.55 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.211 1.404 . . . . 0.0 112.824 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.25 119.95 27.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.519 1.527 . . . . 0.0 109.779 -168.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 33.5 mt -124.86 133.9 52.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.122 1.769 . . . . 0.0 112.087 -168.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -105.11 134.25 48.52 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.964 1.306 . . . . 0.0 108.673 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 9.4 mm -118.24 137.72 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.897 1.679 . . . . 0.0 108.526 -169.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -137.06 161.68 35.42 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.487 1.115 . . . . 0.0 112.492 -175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 62.57 34.39 15.15 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.259 1.824 . . . . 0.0 113.14 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.23 158.46 86.61 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.218 1.407 . . . . 0.0 111.818 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.85 142.6 99.15 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.82 2.347 . . . . 0.0 111.26 169.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -68.44 -9.18 46.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.519 1.127 . . . . 0.0 113.644 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -98.53 -10.79 22.98 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.826 1.65 . . . . 0.0 113.922 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.54 132.31 40.64 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.937 1.295 . . . . 0.0 112.132 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.69 -172.62 18.72 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.282 1.42 . . . . 0.0 113.274 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -67.64 -34.43 76.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.953 0.901 . . . . 0.0 113.219 -172.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -77.81 -30.89 51.41 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.542 0.737 . . . . 0.0 111.756 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -67.01 -43.5 82.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.16 0.584 . . . . 0.0 110.396 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 26.5 tp -65.48 -43.27 90.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.291 0.637 . . . . 0.0 111.636 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.53 -54.1 50.72 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.599 0.76 . . . . 0.0 111.259 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -73.95 -20.72 60.27 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.8 ttp -76.59 -22.61 54.0 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.031 0.832 . . . . 0.0 113.016 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -102.77 -16.3 16.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.077 1.351 . . . . 0.0 113.754 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 36.6 mtt -47.63 -38.03 15.23 Favored Pre-proline 0 CA--C 1.552 1.035 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -62.26 -17.73 58.63 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.158 2.572 . . . . 0.0 115.54 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -97.7 -9.94 25.85 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.0 0.92 . . . . 0.0 113.325 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.38 -164.17 28.39 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.371 1.462 . . . . 0.0 114.518 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.69 100.63 2.87 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.972 0.909 . . . . 0.0 111.874 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.3 t -76.73 127.09 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.876 1.27 . . . . 0.0 109.874 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 43.0 t -86.86 -35.51 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.502 1.921 . . . . 0.0 111.246 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.8 m -161.79 151.21 16.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.736 1.614 . . . . 0.0 110.636 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.91 132.97 12.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.07 1.748 . . . . 0.0 109.977 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -154.22 148.32 25.78 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.49 130.14 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 126.699 2.0 . . . . 0.0 107.685 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -83.39 143.77 30.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 111.511 -175.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 37.5 mm -121.2 135.87 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.513 1.525 . . . . 0.0 110.004 -169.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -82.38 124.86 30.4 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.834 0.854 . . . . 0.0 111.419 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -69.52 -7.6 39.66 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -90.98 -17.89 25.57 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.602 1.161 . . . . 0.0 112.777 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 79.7 p -137.43 -19.32 1.24 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 40.4 t30 66.17 14.86 9.85 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.388 1.875 . . . . 0.0 113.262 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.78 155.89 16.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.276 1.43 . . . . 0.0 110.664 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 89.8 p -72.97 146.8 45.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.277 1.036 . . . . 0.0 112.675 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -81.15 3.5 23.36 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.454 1.101 . . . . 0.0 113.886 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 83.0 m 62.87 22.03 13.18 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.652 1.981 . . . . 0.0 113.364 -172.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -141.76 155.48 45.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.116 0.966 . . . . 0.0 111.67 172.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.27 -172.33 24.35 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.831 1.681 . . . . 0.0 113.912 -169.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -143.75 147.36 34.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.945 1.698 . . . . 0.0 110.257 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 59.7 t -144.0 145.65 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.765 1.626 . . . . 0.0 108.976 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.2 t -143.14 151.81 41.1 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.216 -0.927 . . . . 0.0 112.55 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -120.94 164.64 16.39 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.015 1.726 . . . . 0.0 113.247 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.11 -18.67 64.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.347 1.059 . . . . 0.0 113.143 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -145.28 150.21 44.02 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.118 1.367 . . . . 0.0 112.222 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.71 -29.22 60.0 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.797 2.998 . . . . 0.0 113.845 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.58 -38.4 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.779 0.832 . . . . 0.0 110.852 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.3 m -62.54 -35.19 78.65 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.003 0.921 . . . . 0.0 111.695 171.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.42 -47.83 46.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.571 1.148 . . . . 0.0 112.007 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -60.28 -35.46 75.6 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.03 0.932 . . . . 0.0 112.113 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.03 71.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.566 0.746 . . . . 0.0 112.685 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.92 56.01 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.298 0.639 . . . . 0.0 111.196 174.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.48 -46.62 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 119.434 1.015 . . . . 0.0 110.362 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -69.6 -15.82 63.28 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.1 m -104.54 -23.12 13.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.5 mmt -113.37 -22.89 10.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.898 1.279 . . . . 0.0 113.626 -171.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -71.41 113.44 8.45 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.974 1.261 . . . . 0.0 110.698 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.68 4.13 83.03 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.554 1.55 . . . . 0.0 114.626 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -63.34 126.47 27.56 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.904 1.352 . . . . 0.0 111.171 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -85.04 130.93 34.53 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.115 0.566 . . . . 0.0 110.866 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.6 tt -149.46 126.89 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.425 1.49 . . . . 0.0 109.799 -170.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.0 -98.86 0.32 Allowed Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -173.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 89.0 mtp -136.31 19.66 3.16 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.404 1.881 . . . . 0.0 112.322 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -138.48 175.5 9.52 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.758 1.623 . . . . 0.0 112.282 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -125.69 132.93 52.31 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.334 1.053 . . . . 0.0 111.517 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.4 mt -68.72 163.35 24.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.405 1.482 . . . . 0.0 112.618 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -139.57 142.33 37.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.417 1.487 . . . . 0.0 108.83 168.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.46 139.79 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.314 1.046 . . . . 0.0 109.452 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -144.86 148.13 33.61 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.316 1.046 . . . . 0.0 110.931 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.24 155.33 28.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.962 0.887 . . . . 0.0 112.256 168.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -65.1 137.8 57.9 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.358 1.063 . . . . 0.0 111.058 168.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -63.02 -40.94 99.24 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.471 1.108 . . . . 0.0 113.864 -170.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 10.4 t -168.78 166.79 11.43 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.682 1.593 . . . . 0.0 110.709 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -135.22 119.83 18.18 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.261 1.425 . . . . 0.0 111.329 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -84.63 -17.71 37.78 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.19 0.996 . . . . 0.0 113.093 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -83.42 97.72 9.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.135 1.774 . . . . 0.0 110.492 173.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 18.0 t -166.58 151.5 7.79 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.197 1.399 . . . . 0.0 111.628 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -159.39 154.17 24.59 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.198 1.799 . . . . 0.0 110.718 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 32.6 p -72.31 -8.19 53.57 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 173.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 110.69 -107.88 2.32 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.518 1.533 . . . . 0.0 112.486 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.78 170.29 19.96 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.79 2.993 . . . . 0.0 112.553 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 74.5 m -141.72 144.95 34.31 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.575 1.55 . . . . 0.0 110.945 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 16.0 m -78.0 -5.09 50.18 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -171.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.209 0 C-N-CA 125.527 1.536 . . . . 0.0 112.945 -178.832 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 36.8 p -71.38 -16.0 62.4 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.306 -1.114 . . . . 0.0 113.794 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 42.2 p -85.44 -3.42 58.85 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.905 1.682 . . . . 0.0 113.971 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 127.5 179.05 15.61 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.786 1.66 . . . . 0.0 114.053 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 57.9 p -113.17 2.61 15.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.517 1.527 . . . . 0.0 114.144 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 91.9 p -161.37 167.35 25.89 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.445 1.498 . . . . 0.0 112.174 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -155.48 171.18 33.54 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.021 1.296 . . . . 0.0 113.673 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -151.66 14.75 0.66 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.243 1.417 . . . . 0.0 114.118 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 46.3 p -140.54 170.51 15.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.937 2.095 . . . . 0.0 110.794 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -150.15 139.46 21.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.965 1.306 . . . . 0.0 109.742 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -106.22 9.79 32.02 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.245 1.018 . . . . 0.0 113.201 -171.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 3.4 m -77.54 7.02 6.04 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.058 1.343 . . . . 0.0 114.426 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.21 -13.11 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.139 1.376 . . . . 0.0 113.982 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -138.85 146.62 18.39 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.37 1.938 . . . . 0.0 110.934 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.76 -34.44 71.83 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -71.37 120.83 17.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.437 1.095 . . . . 0.0 111.52 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.25 -3.37 85.51 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.195 1.855 . . . . 0.0 113.889 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 38.8 t -74.69 156.03 37.1 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.667 1.187 . . . . 0.0 112.498 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -118.43 10.34 12.66 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.016 1.326 . . . . 0.0 112.519 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -64.95 165.43 10.89 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.268 -0.895 . . . . 0.0 112.273 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.66 163.83 36.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.205 1.002 . . . . 0.0 112.433 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -102.42 -161.51 26.17 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 126.102 1.81 . . . . 0.0 113.685 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.73 178.98 6.45 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.055 3.17 . . . . 0.0 112.791 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -54.68 123.88 14.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.796 1.238 . . . . 0.0 111.696 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.33 -5.06 85.72 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.692 1.139 . . . . 0.0 114.694 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.22 -3.38 53.87 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.808 1.304 . . . . 0.0 114.439 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -114.49 124.68 52.51 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.51 1.124 . . . . 0.0 111.263 -168.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.8 mt -124.68 141.85 51.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.625 1.97 . . . . 0.0 112.69 -168.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -112.18 134.58 53.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.588 1.555 . . . . 0.0 109.035 168.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.31 136.24 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.932 1.693 . . . . 0.0 108.249 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -134.23 159.9 39.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.879 1.272 . . . . 0.0 112.865 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 70.45 27.72 3.86 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.945 2.498 . . . . 0.0 113.898 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.89 155.45 86.64 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.828 1.251 . . . . 0.0 112.054 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.48 150.3 69.29 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.019 2.48 . . . . 0.0 111.557 168.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -69.83 -11.82 61.16 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.447 1.099 . . . . 0.0 113.709 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.08 -7.61 16.82 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.895 2.078 . . . . 0.0 113.799 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.47 116.68 14.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.09 1.356 . . . . 0.0 110.429 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -99.28 -175.7 31.55 Favored Glycine 0 N--CA 1.467 0.757 0 C-N-CA 124.19 0.9 . . . . 0.0 113.743 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.14 -35.45 78.8 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.477 1.111 . . . . 0.0 112.631 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -77.52 -31.05 53.21 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.081 0.953 . . . . 0.0 111.981 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -70.82 -41.6 71.36 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.791 0.723 . . . . 0.0 110.715 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.5 tp -64.61 -42.28 95.65 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.217 0.607 . . . . 0.0 111.144 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.88 -51.01 71.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.325 0.65 . . . . 0.0 111.229 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -71.24 -20.07 62.28 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.5 ttp -82.92 -21.63 34.11 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.043 0.838 . . . . 0.0 113.044 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -106.17 -23.23 12.64 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.1 mtm -54.3 -33.02 13.24 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 170.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -58.09 -18.22 35.33 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.627 2.885 . . . . 0.0 115.787 174.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -94.82 -12.16 27.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.231 0.923 . . . . 0.0 113.41 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.8 -157.78 27.47 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.926 1.251 . . . . 0.0 115.027 170.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -74.06 84.23 1.79 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.261 1.024 . . . . 0.0 112.757 -169.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 84.8 t -66.79 127.87 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.872 1.269 . . . . 0.0 109.707 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 55.6 t -91.46 -35.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.011 1.724 . . . . 0.0 110.978 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 27.5 m -158.73 147.36 18.54 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.528 1.531 . . . . 0.0 110.854 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.46 140.28 20.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.828 1.651 . . . . 0.0 110.439 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -154.41 149.22 26.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.635 0.774 . . . . 0.0 112.887 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.89 137.19 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.428 1.891 . . . . 0.0 108.535 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -86.9 134.98 33.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.845 0.858 . . . . 0.0 110.692 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 30.7 mm -119.16 139.55 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.445 1.498 . . . . 0.0 110.42 -169.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.5 126.24 34.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.007 0.923 . . . . 0.0 111.571 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -65.05 -18.17 65.07 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -80.38 -23.21 40.63 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.171 -0.955 . . . . 0.0 112.828 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 76.4 p -133.81 -16.86 2.24 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 56.7 t30 63.37 16.83 9.82 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.294 1.838 . . . . 0.0 112.816 -169.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.1 mt -95.55 156.75 16.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.2 1.4 . . . . 0.0 111.213 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 58.8 m -77.09 137.99 39.26 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.468 1.107 . . . . 0.0 112.082 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -75.33 8.8 2.47 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.343 1.457 . . . . 0.0 114.402 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 50.6 m 71.33 18.28 5.65 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.602 2.361 . . . . 0.0 113.935 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -145.15 154.79 42.82 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.504 1.047 . . . . 0.0 112.357 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.01 -172.34 25.98 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.948 1.737 . . . . 0.0 113.608 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -148.77 141.59 24.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.986 1.714 . . . . 0.0 109.95 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 61.3 t -146.22 136.32 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.908 1.283 . . . . 0.0 109.31 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 68.3 m -134.23 140.43 46.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.618 0.767 . . . . 0.0 112.293 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -110.08 168.85 9.13 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.804 1.642 . . . . 0.0 113.145 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.51 -21.15 66.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.401 1.481 . . . . 0.0 113.295 169.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -160.94 157.42 22.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.24 1.416 . . . . 0.0 112.378 -171.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.9 -16.09 40.88 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.7 2.267 . . . . 0.0 113.936 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.82 -44.19 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 120.459 1.481 . . . . 0.0 110.459 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.8 m -69.21 -30.91 69.18 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.967 0.907 . . . . 0.0 112.114 174.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -75.03 -47.13 30.57 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.851 0.86 . . . . 0.0 112.327 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -62.69 -32.57 73.68 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.469 -0.769 . . . . 0.0 111.806 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.59 70.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.14 -43.35 34.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.27 0.628 . . . . 0.0 111.174 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.03 -45.71 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.07 0.85 . . . . 0.0 110.351 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -70.76 -14.87 62.59 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.4 m -104.33 -22.94 13.27 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 2.1 mmt -114.15 -24.18 9.11 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 113.768 -170.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -71.69 112.48 7.83 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.687 1.13 . . . . 0.0 110.348 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.73 3.01 74.74 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.473 1.511 . . . . 0.0 114.683 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -64.41 127.68 32.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.11 1.455 . . . . 0.0 111.291 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -85.96 129.6 34.79 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.048 0.539 . . . . 0.0 110.951 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.6 tt -149.27 131.68 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.545 1.538 . . . . 0.0 110.108 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 68.33 -93.93 0.31 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 121.622 -0.674 . . . . 0.0 111.521 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 28.5 ptm -141.05 16.16 2.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.244 1.818 . . . . 0.0 113.101 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -145.12 177.98 8.39 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.431 1.492 . . . . 0.0 112.623 -172.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -122.91 133.9 54.38 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.51 1.124 . . . . 0.0 111.723 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.39 162.04 30.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.287 1.435 . . . . 0.0 112.521 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -130.91 139.17 50.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.232 1.413 . . . . 0.0 109.079 168.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 32.0 t -139.3 134.42 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.393 1.077 . . . . 0.0 109.259 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -146.71 159.35 43.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.023 0.929 . . . . 0.0 112.24 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 62.0 mt -66.38 152.71 44.49 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.095 0.958 . . . . 0.0 112.866 173.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -59.38 138.33 57.68 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.033 0.933 . . . . 0.0 110.614 168.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -59.61 141.67 54.48 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.562 0.745 . . . . 0.0 112.181 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 21.0 t -163.81 176.19 9.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.374 1.87 . . . . 0.0 109.6 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.71 -20.21 60.6 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.61 -1.306 . . . . 0.0 113.72 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -85.32 -15.04 44.61 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.112 1.765 . . . . 0.0 113.774 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -132.8 -10.08 3.09 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -168.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 19.5 m -83.33 81.88 8.52 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.795 1.238 . . . . 0.0 109.707 171.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -132.03 159.81 37.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.948 1.299 . . . . 0.0 113.196 -168.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 36.5 p -79.35 173.17 12.85 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.573 1.549 . . . . 0.0 113.437 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -76.62 177.16 51.84 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 124.711 1.148 . . . . 0.0 114.334 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.46 -8.45 17.22 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.278 3.319 . . . . 0.0 114.428 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 81.4 p -161.32 162.43 30.89 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.121 1.368 . . . . 0.0 111.819 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 78.0 p -144.65 5.94 1.21 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.136 1.35 . . . . 0.0 112.823 -179.438 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.8 m -67.85 -12.13 60.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -171.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 85.6 p -79.21 -10.1 59.73 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.072 1.349 . . . . 0.0 113.802 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 64.94 17.05 62.65 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.122 0.868 . . . . 0.0 113.176 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 20.6 m 72.01 10.26 6.1 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.242 2.217 . . . . 0.0 113.343 -169.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.7 t 68.23 -167.73 0.19 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.622 1.969 . . . . 0.0 113.535 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 89.75 -176.36 42.72 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.623 1.582 . . . . 0.0 113.479 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 49.0 tp -82.25 130.4 35.09 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.528 1.131 . . . . 0.0 111.052 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 62.3 p -134.0 30.21 3.68 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.949 1.7 . . . . 0.0 112.424 -174.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -54.85 -17.56 3.75 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.655 1.982 . . . . 0.0 116.344 -169.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -145.69 11.22 1.25 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.885 1.274 . . . . 0.0 112.858 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 16.4 m -73.81 -4.25 33.57 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.92 -1.112 . . . . 0.0 113.785 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.79 -11.36 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.247 2.219 . . . . 0.0 113.541 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -87.24 177.83 47.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.112 1.339 . . . . 0.0 112.926 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -156.51 -59.64 0.09 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.363 1.065 . . . . 0.0 111.968 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -64.76 114.93 4.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.898 0.879 . . . . 0.0 110.781 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 87.14 0.02 85.54 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.269 1.414 . . . . 0.0 113.563 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.4 t -98.43 170.51 8.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.303 1.052 . . . . 0.0 111.898 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -132.42 32.35 3.94 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.179 1.392 . . . . 0.0 111.28 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -67.74 164.75 18.74 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.498 -0.751 . . . . 0.0 110.329 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -155.99 161.61 40.45 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.53 -159.32 24.89 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.055 1.788 . . . . 0.0 113.61 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.94 171.99 15.51 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.956 3.104 . . . . 0.0 112.85 -172.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.68 123.46 16.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.019 0.928 . . . . 0.0 111.381 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.62 -3.78 78.79 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.798 1.189 . . . . 0.0 114.584 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.72 1.41 53.4 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.908 1.354 . . . . 0.0 114.355 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -118.27 124.31 47.53 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.494 1.118 . . . . 0.0 110.884 -169.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 18.9 mt -123.62 146.78 47.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.796 2.038 . . . . 0.0 113.052 -168.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -117.43 135.09 54.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.718 1.607 . . . . 0.0 109.099 168.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -119.84 137.36 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.181 1.792 . . . . 0.0 107.831 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -134.99 161.3 35.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.128 1.371 . . . . 0.0 112.584 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 67.46 27.41 8.01 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.433 2.293 . . . . 0.0 113.92 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 67.7 mt -64.92 157.77 73.88 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.014 1.325 . . . . 0.0 112.06 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.53 147.48 91.42 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.992 2.461 . . . . 0.0 111.434 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -69.73 -8.29 46.69 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.43 -8.09 15.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.511 1.924 . . . . 0.0 114.166 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.47 124.27 23.09 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.8 1.24 . . . . 0.0 110.805 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.25 -176.27 26.39 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.481 1.039 . . . . 0.0 114.065 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.35 -36.36 82.69 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.83 0.852 . . . . 0.0 112.782 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.59 -28.36 56.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.83 0.852 . . . . 0.0 111.769 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.1 -42.11 73.13 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.655 0.661 . . . . 0.0 110.646 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.8 tp -67.03 -36.41 82.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.184 0.594 . . . . 0.0 111.797 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.11 -51.68 66.91 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.686 0.675 . . . . 0.0 110.931 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -63.51 -28.43 69.94 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.0 ttm -72.62 -29.18 63.26 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.453 1.101 . . . . 0.0 113.159 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -109.51 -18.34 13.54 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 47.3 mtm -55.4 -32.24 12.02 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -58.09 -16.33 26.7 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.661 2.908 . . . . 0.0 116.291 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -100.34 -8.35 23.46 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.48 -163.44 28.48 Favored Glycine 0 N--CA 1.47 0.906 0 C-N-CA 125.173 1.368 . . . . 0.0 114.513 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -72.4 90.58 1.3 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.749 0.82 . . . . 0.0 112.026 -173.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 79.9 t -65.42 128.92 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.714 1.206 . . . . 0.0 109.843 172.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 37.5 t -91.62 -36.61 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.94 2.096 . . . . 0.0 110.913 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.85 152.8 25.4 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.618 1.167 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -155.35 133.39 11.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.505 1.122 . . . . 0.0 110.705 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -154.45 147.99 25.19 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.398 -0.814 . . . . 0.0 112.925 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.8 t -124.68 131.4 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 126.214 1.806 . . . . 0.0 107.899 172.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -84.45 139.86 31.9 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.504 0.722 . . . . 0.0 110.962 -175.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.5 mm -117.58 137.25 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.112 1.365 . . . . 0.0 110.838 -168.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.71 128.19 33.36 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.587 1.155 . . . . 0.0 111.763 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.15 -13.91 62.41 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -97.84 -16.75 19.66 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.143 0.977 . . . . 0.0 113.098 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.1 p -131.15 -16.5 3.16 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.804 1.242 . . . . 0.0 114.16 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.6 t30 63.57 14.81 8.38 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.255 1.822 . . . . 0.0 113.168 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 90.1 mt -88.6 154.93 19.93 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.221 1.408 . . . . 0.0 111.002 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 67.3 m -73.64 135.01 43.75 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.474 0.709 . . . . 0.0 111.283 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -71.65 8.56 1.09 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.478 1.511 . . . . 0.0 114.665 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 58.4 m 68.17 17.62 9.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.514 2.326 . . . . 0.0 113.582 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -144.46 154.77 43.28 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.585 1.084 . . . . 0.0 112.758 175.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.74 -177.64 31.03 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.982 1.754 . . . . 0.0 114.087 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -134.61 145.96 49.12 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.704 2.002 . . . . 0.0 110.193 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 92.5 t -144.78 138.75 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.826 1.25 . . . . 0.0 109.236 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 64.7 p -130.47 152.24 50.08 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.211 1.004 . . . . 0.0 112.074 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -125.77 163.82 22.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.344 1.457 . . . . 0.0 113.106 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -71.33 -18.46 62.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.031 0.932 . . . . 0.0 113.048 173.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -144.6 150.77 48.37 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.078 1.351 . . . . 0.0 112.197 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.76 -29.69 59.36 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.856 3.037 . . . . 0.0 113.722 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.08 -40.25 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.811 0.844 . . . . 0.0 110.963 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 8.8 m -61.95 -34.24 75.76 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.971 0.908 . . . . 0.0 111.817 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.79 -49.27 26.16 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.88 1.272 . . . . 0.0 112.029 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -60.93 -33.91 73.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.961 0.904 . . . . 0.0 112.15 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 -30.56 71.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.412 0.685 . . . . 0.0 112.611 172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.3 -41.54 48.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.294 0.638 . . . . 0.0 111.451 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 45.5 mt -57.88 -47.47 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.014 0.824 . . . . 0.0 110.129 174.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.08 -14.69 62.4 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.8 m -101.94 -28.47 12.37 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 91.7 mmm -114.44 -19.13 11.32 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -169.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -70.33 110.28 5.19 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.289 0.949 . . . . 0.0 109.933 173.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.37 2.91 60.18 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.369 1.462 . . . . 0.0 114.933 -172.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.17 123.47 18.71 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.427 1.613 . . . . 0.0 111.587 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -79.0 130.53 35.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.222 0.609 . . . . 0.0 110.988 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -149.49 133.18 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.11 1.364 . . . . 0.0 110.43 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.06 -99.57 0.44 Allowed Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 59.3 mtt -133.84 17.9 3.86 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.333 1.853 . . . . 0.0 112.408 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -146.23 -178.02 5.92 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.628 1.571 . . . . 0.0 112.688 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -122.32 138.84 54.38 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.992 1.317 . . . . 0.0 111.774 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 66.9 mt -70.71 160.72 32.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.032 1.333 . . . . 0.0 111.75 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -132.3 141.9 49.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.226 1.41 . . . . 0.0 109.194 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.5 t -139.42 136.14 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.505 1.122 . . . . 0.0 109.062 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -145.73 165.22 29.42 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.018 1.327 . . . . 0.0 111.044 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.48 159.88 26.23 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.861 0.864 . . . . 0.0 111.859 169.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -49.85 115.26 1.31 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.411 1.484 . . . . 0.0 112.324 171.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -168.15 154.21 7.25 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.972 2.109 . . . . 0.0 109.714 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 9.6 t -152.3 162.47 41.12 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.705 1.202 . . . . 0.0 111.16 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 65.69 4.91 3.06 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.096 2.158 . . . . 0.0 115.08 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.29 -11.29 35.6 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.138 1.375 . . . . 0.0 113.374 -174.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -79.31 -13.61 59.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.755 1.222 . . . . 0.0 113.823 -173.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 19.3 m -61.62 -21.11 64.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.745 1.218 . . . . 0.0 114.113 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -70.22 -16.16 63.02 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.532 1.133 . . . . 0.0 113.059 173.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 49.5 m -115.81 11.96 15.74 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.876 1.67 . . . . 0.0 112.954 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -72.45 165.28 54.41 Favored Glycine 0 CA--C 1.543 1.804 0 C-N-CA 124.486 1.041 . . . . 0.0 113.739 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.49 152.47 60.12 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.997 3.132 . . . . 0.0 111.963 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 32.4 t -166.66 -47.09 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.809 1.244 . . . . 0.0 111.907 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 79.7 p -163.87 165.01 23.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.363 1.465 . . . . 0.0 111.762 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 CA-C-O 118.382 -1.232 . . . . 0.0 112.844 -179.225 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 112.091 -0.404 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 8.4 m -165.18 154.72 12.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.503 1.921 . . . . 0.0 110.651 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.0 m -80.33 -10.06 59.75 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.02 165.28 36.0 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.224 1.392 . . . . 0.0 113.521 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 5.1 t -157.54 6.29 0.14 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 60.4 m 67.18 4.11 3.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.286 1.834 . . . . 0.0 115.899 172.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 141.62 -137.24 7.9 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.163 1.364 . . . . 0.0 112.849 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 43.8 tp -61.96 142.33 57.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.892 1.277 . . . . 0.0 111.672 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.4 t -158.39 168.52 26.75 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.988 1.715 . . . . 0.0 110.662 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -70.71 121.6 18.26 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.253 1.021 . . . . 0.0 110.544 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -140.87 116.21 10.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.199 1.399 . . . . 0.0 107.918 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 59.5 p -111.08 9.36 22.02 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -168.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.402 ' H ' HD13 ' A' ' 388' ' ' ILE . 0.2 OUTLIER -78.87 -6.0 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.318 1.447 . . . . 0.0 114.475 -177.109 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 139.61 -143.64 14.12 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 125.635 1.588 . . . . 0.0 112.643 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.23 -18.35 63.15 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.97 120.26 12.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.622 1.569 . . . . 0.0 110.615 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.26 -2.4 71.22 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.456 1.027 . . . . 0.0 113.375 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.0 t -77.35 165.75 24.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.156 0.978 . . . . 0.0 112.093 174.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -134.09 23.19 3.84 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.017 1.327 . . . . 0.0 110.791 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -65.75 174.73 2.2 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.903 1.281 . . . . 0.0 111.751 168.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -156.26 161.53 40.23 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.791 0.836 . . . . 0.0 112.432 168.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.35 -163.19 29.47 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.965 1.745 . . . . 0.0 113.376 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.99 172.79 13.95 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.754 2.97 . . . . 0.0 112.43 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.51 128.39 36.95 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.495 0.664 . . . . 0.0 111.342 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.6 -10.2 75.24 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.796 1.189 . . . . 0.0 113.962 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.9 -5.73 47.24 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.639 1.22 . . . . 0.0 114.218 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -112.08 123.95 51.36 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.317 1.047 . . . . 0.0 110.55 -169.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.9 mt -124.07 143.26 50.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.675 1.99 . . . . 0.0 112.549 -168.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -112.92 134.26 54.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.417 1.487 . . . . 0.0 109.073 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.01 134.17 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.346 1.858 . . . . 0.0 107.737 -171.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -132.65 158.5 42.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.878 1.271 . . . . 0.0 112.694 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 71.69 27.33 2.93 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.604 2.362 . . . . 0.0 113.747 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 76.8 mt -65.13 161.11 51.56 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.986 1.315 . . . . 0.0 111.803 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.62 149.19 91.94 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.921 2.414 . . . . 0.0 110.845 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -67.7 -20.47 65.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -88.94 -11.18 45.16 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.53 129.1 38.83 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.504 1.122 . . . . 0.0 111.886 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.12 -173.95 23.48 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.296 1.427 . . . . 0.0 112.273 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.02 -33.48 73.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.757 0.823 . . . . 0.0 112.493 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -67.84 -44.98 75.92 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.099 1.76 . . . . 0.0 111.472 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.89 -40.92 95.84 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.974 0.91 . . . . 0.0 111.528 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 30.4 tp -67.13 -38.94 86.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.267 0.627 . . . . 0.0 111.891 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 66.1 tp -63.11 -48.7 77.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.87 0.759 . . . . 0.0 111.077 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -67.88 -23.2 65.09 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.8 ttm -74.91 -25.91 59.25 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.112 0.965 . . . . 0.0 113.148 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -113.63 -16.67 12.31 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.4 mtm -54.16 -33.82 17.99 Favored Pre-proline 0 CA--C 1.549 0.914 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -58.99 -16.3 31.83 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.476 2.784 . . . . 0.0 116.296 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.12 -11.38 20.54 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 149.01 -163.06 29.07 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.931 1.253 . . . . 0.0 114.823 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -71.55 102.1 2.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.118 0.967 . . . . 0.0 112.385 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 69.7 t -80.44 128.69 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.071 1.348 . . . . 0.0 110.083 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.12 -22.44 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.956 2.502 . . . . 0.0 112.087 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 8.8 t -159.7 146.05 16.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.266 1.427 . . . . 0.0 110.341 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.58 129.39 10.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.196 1.399 . . . . 0.0 110.687 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -156.0 132.03 9.93 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.584 0.754 . . . . 0.0 112.557 -174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.9 135.14 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.486 1.514 . . . . 0.0 107.299 167.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -83.68 140.29 32.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.275 0.63 . . . . 0.0 111.295 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.2 mm -123.11 141.96 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.778 1.631 . . . . 0.0 110.306 -168.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.75 132.73 34.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.506 0.67 . . . . 0.0 112.798 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -62.73 -22.52 66.59 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -85.49 -22.68 28.09 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.019 0.928 . . . . 0.0 112.846 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 73.6 p -134.16 -17.45 2.1 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -170.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 60.66 17.28 7.37 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.028 1.731 . . . . 0.0 113.386 -169.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.7 mt -87.68 153.23 21.54 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.743 1.217 . . . . 0.0 111.05 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 56.5 m -77.18 136.24 38.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.586 0.755 . . . . 0.0 112.099 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -75.11 5.54 5.22 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.23 1.412 . . . . 0.0 114.682 -175.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.1 m 66.87 21.62 10.37 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.067 2.147 . . . . 0.0 113.207 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -146.52 156.17 43.06 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.129 0.972 . . . . 0.0 111.687 172.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.58 -177.71 29.09 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.868 1.699 . . . . 0.0 113.767 -170.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -138.58 141.16 39.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.015 2.126 . . . . 0.0 109.901 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 94.9 t -144.03 137.31 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.076 1.35 . . . . 0.0 108.867 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.0 m -131.03 148.43 52.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.474 0.71 . . . . 0.0 112.068 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -117.57 170.24 8.91 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.405 1.482 . . . . 0.0 113.287 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.52 -25.02 67.01 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.381 1.472 . . . . 0.0 113.648 170.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -160.12 162.2 24.57 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.096 1.358 . . . . 0.0 112.109 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.98 -13.52 31.65 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.332 2.021 . . . . 0.0 114.03 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 22.8 t -75.4 -45.92 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 121.032 1.742 . . . . 0.0 110.892 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.5 p -69.73 -32.52 71.11 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.811 0.844 . . . . 0.0 112.631 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -67.14 -49.0 66.37 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.365 0.666 . . . . 0.0 112.435 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -63.2 -31.71 72.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.376 -0.828 . . . . 0.0 112.056 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.79 70.47 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.7 0.682 . . . . 0.0 112.595 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.79 -42.0 51.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.717 0.689 . . . . 0.0 111.411 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.27 -47.22 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 118.914 0.779 . . . . 0.0 110.199 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -70.36 -15.45 62.86 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.0 m -99.78 -29.38 12.66 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 88.4 mmm -113.97 -19.93 11.24 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -71.68 110.6 6.34 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.441 1.019 . . . . 0.0 109.987 174.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 90.92 8.64 64.85 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.393 1.473 . . . . 0.0 114.433 -171.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.76 122.64 17.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.764 1.782 . . . . 0.0 110.568 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -74.36 131.88 41.51 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 122.063 -0.398 . . . . 0.0 110.292 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.8 tt -137.73 114.95 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.556 1.143 . . . . 0.0 108.579 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 63.21 -125.05 33.42 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -169.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.4 mmt -99.93 12.57 36.48 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.395 1.478 . . . . 0.0 113.504 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -135.41 176.82 8.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.228 1.411 . . . . 0.0 113.015 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -126.81 136.17 52.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.063 1.345 . . . . 0.0 110.946 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.18 155.96 40.13 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.854 1.262 . . . . 0.0 111.502 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.38 140.7 52.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.857 1.263 . . . . 0.0 109.46 169.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 23.4 t -139.61 136.27 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.541 1.136 . . . . 0.0 109.245 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -150.77 162.04 41.49 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.08 0.952 . . . . 0.0 112.097 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 75.4 mt -64.5 157.16 27.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.599 1.16 . . . . 0.0 113.071 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -65.51 -31.03 71.87 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.537 1.135 . . . . 0.0 113.152 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -90.06 136.29 33.14 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.072 1.349 . . . . 0.0 111.143 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 30.9 m -135.84 16.27 3.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.809 1.243 . . . . 0.0 113.232 -174.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -131.81 141.24 49.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.186 1.394 . . . . 0.0 112.488 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -154.91 122.11 5.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.569 1.548 . . . . 0.0 110.914 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -70.59 -22.22 62.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.312 1.045 . . . . 0.0 113.239 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 50.6 m -82.67 -6.24 59.27 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.986 0.915 . . . . 0.0 113.18 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt 52.77 -111.13 0.57 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.744 2.018 . . . . 0.0 113.086 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 62.7 m -150.83 155.93 40.21 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.27 1.828 . . . . 0.0 110.978 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -77.12 168.76 54.8 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 123.96 0.79 . . . . 0.0 113.671 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -75.96 -5.89 16.83 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.216 3.277 . . . . 0.0 113.913 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 24.1 p -81.09 1.87 29.76 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.52 1.528 . . . . 0.0 114.24 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 93.5 p -156.21 165.75 35.47 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.377 1.471 . . . . 0.0 112.718 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 CA-C-O 118.268 -1.296 . . . . 0.0 112.889 -178.929 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.996 -0.442 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 30.7 p -165.74 -54.16 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.475 1.11 . . . . 0.0 112.25 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.6 p -163.36 167.28 21.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.698 1.599 . . . . 0.0 112.214 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -77.33 147.23 32.66 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.293 0.949 . . . . 0.0 112.653 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 49.3 p -93.11 -4.96 51.37 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 44.4 m -70.8 118.6 13.78 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.917 -1.114 . . . . 0.0 112.339 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -86.91 137.81 15.05 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.431 1.015 . . . . 0.0 112.219 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 59.4 tp -163.97 121.48 1.77 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.594 1.558 . . . . 0.0 109.968 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 29.8 p -63.1 -34.38 77.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.292 1.037 . . . . 0.0 112.753 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -68.84 -8.89 47.87 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.906 1.282 . . . . 0.0 113.345 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -81.45 -13.89 57.69 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.987 -1.07 . . . . 0.0 112.439 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 52.0 m -79.7 48.87 0.97 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.151 1.38 . . . . 0.0 113.123 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.7 149.1 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.582 1.153 . . . . 0.0 113.571 -173.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 77.17 -59.93 3.56 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.56 1.552 . . . . 0.0 113.768 171.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -170.27 -38.82 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.143 1.777 . . . . 0.0 113.235 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -64.98 119.18 10.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.619 1.168 . . . . 0.0 110.816 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.6 -6.36 83.7 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.584 1.087 . . . . 0.0 113.281 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 7.6 t -86.92 160.21 18.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.461 1.131 . . . . 0.0 111.117 172.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -135.83 22.93 3.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.399 1.08 . . . . 0.0 112.477 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -68.81 173.96 4.8 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.314 -0.866 . . . . 0.0 111.676 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -148.88 158.44 44.17 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.756 0.822 . . . . 0.0 112.196 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.55 -160.95 27.99 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.994 1.759 . . . . 0.0 113.451 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.08 176.03 9.67 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.94 3.094 . . . . 0.0 112.576 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -56.32 124.67 18.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.266 1.026 . . . . 0.0 111.501 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.04 -7.64 81.27 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.811 1.196 . . . . 0.0 114.556 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.72 -5.21 54.04 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.919 1.359 . . . . 0.0 114.364 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -112.68 122.53 47.95 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.576 1.15 . . . . 0.0 110.676 -168.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.1 mt -123.32 141.65 51.77 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.562 1.945 . . . . 0.0 112.535 -168.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -111.09 134.83 52.39 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.574 1.549 . . . . 0.0 108.729 167.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.5 133.51 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.93 1.692 . . . . 0.0 107.791 -171.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -129.58 160.64 32.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.858 1.263 . . . . 0.0 112.22 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 65.8 38.37 5.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.07 1.748 . . . . 0.0 113.193 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 54.1 mt -71.59 161.45 78.45 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.104 1.362 . . . . 0.0 111.696 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.6 154.59 47.45 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.233 2.622 . . . . 0.0 111.469 168.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -68.12 -28.19 67.12 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.58 -11.19 57.66 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.83 128.25 35.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.405 1.082 . . . . 0.0 112.494 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.78 -171.55 18.29 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.796 1.665 . . . . 0.0 112.362 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -62.15 -35.51 79.02 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.838 0.855 . . . . 0.0 113.195 -174.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -74.16 -29.29 61.71 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.161 0.985 . . . . 0.0 112.089 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -76.12 -42.13 47.99 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.815 0.846 . . . . 0.0 110.695 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 32.8 tp -63.69 -38.01 89.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.359 0.664 . . . . 0.0 111.572 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.8 tp -63.69 -49.6 72.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.613 0.642 . . . . 0.0 111.116 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -68.81 -20.1 64.31 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.0 ttm -74.56 -26.85 60.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.945 0.898 . . . . 0.0 112.852 169.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -111.61 -19.44 12.51 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -172.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.3 mtm -53.72 -34.39 20.08 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -59.18 -17.31 38.25 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.505 2.803 . . . . 0.0 116.097 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.68 -10.79 21.52 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.32 -160.12 28.11 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.713 1.149 . . . . 0.0 115.033 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -74.06 96.07 2.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.15 0.98 . . . . 0.0 112.18 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.7 t -77.19 127.29 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.104 1.362 . . . . 0.0 109.677 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.53 -34.23 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.682 1.993 . . . . 0.0 111.319 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.8 m -160.07 147.37 16.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.533 1.533 . . . . 0.0 110.786 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.04 134.23 16.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.596 1.559 . . . . 0.0 110.129 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -153.64 132.65 12.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.48 0.712 . . . . 0.0 111.887 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 91.8 t -101.42 131.13 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.634 1.574 . . . . 0.0 107.169 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -78.92 138.22 37.99 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.19 0.519 . . . . 0.0 111.178 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.5 mm -120.71 137.38 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.619 1.568 . . . . 0.0 109.771 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -81.21 118.29 22.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.445 0.698 . . . . 0.0 110.569 172.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -68.05 -8.79 40.79 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -84.47 -22.92 30.11 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.161 0.985 . . . . 0.0 112.534 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 73.8 p -133.3 -14.77 2.57 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.73 1.212 . . . . 0.0 114.181 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 57.5 t30 65.28 19.01 11.59 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.701 2.0 . . . . 0.0 113.075 -172.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.0 mt -97.35 147.39 24.22 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.099 1.36 . . . . 0.0 111.591 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 50.7 m -66.94 140.09 57.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.987 0.915 . . . . 0.0 112.159 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -82.9 4.11 27.0 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.477 1.111 . . . . 0.0 113.91 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 78.5 m 65.66 22.99 11.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.271 2.229 . . . . 0.0 113.735 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -143.69 156.02 44.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.236 1.014 . . . . 0.0 111.455 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.64 -174.15 26.02 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.889 1.709 . . . . 0.0 114.006 -169.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -144.96 140.99 28.61 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.757 2.023 . . . . 0.0 109.837 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 89.0 t -145.5 135.97 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.222 1.409 . . . . 0.0 109.072 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 65.8 m -132.44 141.79 48.98 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.37 0.668 . . . . 0.0 112.378 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -111.0 169.49 8.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.598 1.559 . . . . 0.0 113.56 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.06 -23.5 65.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.941 1.696 . . . . 0.0 113.59 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -161.27 160.89 24.01 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.323 1.449 . . . . 0.0 112.05 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.85 -12.38 26.26 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.652 2.234 . . . . 0.0 114.272 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 40.6 t -77.37 -46.33 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.665 1.575 . . . . 0.0 110.494 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 21.6 m -64.78 -29.75 70.74 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.671 1.189 . . . . 0.0 111.896 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.12 -50.34 19.88 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.032 0.933 . . . . 0.0 111.934 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -59.68 -37.8 79.8 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.476 -0.765 . . . . 0.0 111.735 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.34 -28.09 64.75 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -80.44 -43.97 20.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.65 0.78 . . . . 0.0 111.898 172.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.31 -50.18 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.138 0.881 . . . . 0.0 110.523 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -74.78 -11.58 60.19 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 66.1 m -99.2 -31.4 11.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 89.7 mmm -112.35 -18.04 12.58 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -168.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -68.47 110.83 4.35 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.559 1.072 . . . . 0.0 110.489 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.71 3.8 66.03 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.959 1.743 . . . . 0.0 115.038 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.41 128.36 35.46 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.409 1.605 . . . . 0.0 111.721 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -84.77 130.37 34.69 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.227 0.611 . . . . 0.0 111.3 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.3 tt -149.64 131.02 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.212 1.405 . . . . 0.0 110.145 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.31 -96.93 0.3 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 14.7 ttt -140.78 24.45 2.21 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.151 1.78 . . . . 0.0 111.843 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -143.55 176.4 9.23 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.983 1.713 . . . . 0.0 112.125 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -126.06 133.82 51.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.393 1.077 . . . . 0.0 111.678 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 62.0 mt -66.45 160.44 24.94 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.34 1.456 . . . . 0.0 112.196 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -136.78 139.64 41.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.162 1.385 . . . . 0.0 108.925 167.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.2 t -139.33 135.69 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.497 1.119 . . . . 0.0 109.066 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -153.72 153.68 32.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.701 0.8 . . . . 0.0 111.394 -176.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 82.3 mt -61.78 154.89 24.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.562 1.145 . . . . 0.0 113.206 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -61.29 119.59 8.76 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.251 1.021 . . . . 0.0 111.122 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -162.3 33.18 0.11 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.463 1.105 . . . . 0.0 112.76 -171.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 65.4 p -162.33 170.84 18.2 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.822 -1.173 . . . . 0.0 112.943 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -152.29 154.57 35.96 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.007 1.723 . . . . 0.0 111.816 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -159.68 145.53 15.86 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.061 1.344 . . . . 0.0 111.7 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 25.2 t70 62.02 33.24 17.34 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.918 1.687 . . . . 0.0 112.386 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 52.8 p -140.94 33.77 1.76 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.663 1.585 . . . . 0.0 112.748 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -152.7 141.22 20.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.762 2.025 . . . . 0.0 110.466 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 7.9 m -160.61 148.86 16.34 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.039 1.735 . . . . 0.0 110.975 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -86.95 170.65 41.85 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 124.493 1.044 . . . . 0.0 113.566 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.39 -14.67 12.96 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.962 3.108 . . . . 0.0 113.737 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 18.9 m -161.63 156.88 23.77 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.724 2.01 . . . . 0.0 110.523 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 17.9 m -79.05 -7.15 57.88 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.188 0 C-N-CA 125.597 1.57 . . . . 0.0 112.909 179.624 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 25.3 m -133.79 11.54 4.0 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 80.3 p -163.18 164.97 24.98 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.61 1.564 . . . . 0.0 112.003 -174.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.01 -86.02 1.1 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.977 1.275 . . . . 0.0 111.866 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 36.6 t -163.54 151.69 13.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.267 1.427 . . . . 0.0 111.497 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 17.5 m -84.12 -2.97 57.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.47 1.108 . . . . 0.0 113.291 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.43 151.57 45.19 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.761 1.172 . . . . 0.0 113.444 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 98.5 mt -142.43 162.57 35.13 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.518 1.927 . . . . 0.0 110.701 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 40.5 p -136.34 157.03 47.77 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.934 1.694 . . . . 0.0 111.36 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -147.06 166.15 27.73 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.196 1.798 . . . . 0.0 109.94 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -151.49 130.37 12.49 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.706 1.202 . . . . 0.0 109.871 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 9.8 t -159.81 40.45 0.19 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.279 1.031 . . . . 0.0 111.482 -172.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.76 147.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.962 -1.086 . . . . 0.0 112.982 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -86.7 167.92 39.13 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.76 1.172 . . . . 0.0 113.485 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -90.01 -15.12 32.52 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.882 1.273 . . . . 0.0 114.117 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -74.07 121.36 20.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.427 1.491 . . . . 0.0 110.613 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.8 -9.3 76.91 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.588 1.089 . . . . 0.0 113.093 -175.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 74.2 m -81.49 149.56 28.67 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.435 1.094 . . . . 0.0 110.62 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -132.85 29.53 4.12 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.211 1.004 . . . . 0.0 111.83 -170.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -71.68 176.29 4.96 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.471 -0.768 . . . . 0.0 110.907 168.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.81 157.53 42.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 168.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.92 -163.26 27.82 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 127.79 2.614 . . . . 0.0 113.775 -170.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.15 173.13 13.45 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.024 3.15 . . . . 0.0 112.759 -173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.54 124.28 18.48 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.059 0.943 . . . . 0.0 111.108 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.45 -10.48 69.13 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.783 1.182 . . . . 0.0 114.497 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.77 -0.76 47.59 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -111.57 118.14 34.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.837 1.255 . . . . 0.0 110.938 -169.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.3 mt -121.48 135.37 55.04 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.855 1.662 . . . . 0.0 112.016 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -106.16 133.29 51.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.936 1.294 . . . . 0.0 108.725 167.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.6 mm -118.08 138.39 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.092 1.757 . . . . 0.0 108.788 -169.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -140.34 161.94 36.48 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.626 1.171 . . . . 0.0 113.029 -172.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 63.83 25.96 14.2 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.474 2.31 . . . . 0.0 113.926 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.33 156.06 82.88 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.477 1.111 . . . . 0.0 111.115 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.27 145.8 91.72 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.791 2.327 . . . . 0.0 111.76 171.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -67.43 -17.43 64.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.908 0.883 . . . . 0.0 113.161 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -99.71 -8.83 23.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.829 1.252 . . . . 0.0 114.033 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.58 125.4 26.41 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.448 1.499 . . . . 0.0 111.205 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -102.68 -177.67 27.04 Favored Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.344 0.973 . . . . 0.0 113.745 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -61.76 -36.12 80.09 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.122 0.969 . . . . 0.0 112.673 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -76.44 -30.69 57.48 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.82 0.848 . . . . 0.0 111.786 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -70.73 -41.19 72.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.614 0.643 . . . . 0.0 110.685 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 28.1 tp -64.86 -38.73 91.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.559 0.744 . . . . 0.0 111.674 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.26 -50.16 71.25 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.573 0.624 . . . . 0.0 111.095 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -63.39 -27.11 69.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.3 ttm -73.31 -29.41 62.68 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.433 1.093 . . . . 0.0 113.229 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -110.22 -18.15 13.36 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 44.7 mtm -55.54 -33.05 14.71 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 171.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.75 -16.06 23.64 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.57 2.846 . . . . 0.0 116.157 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -100.73 -9.78 21.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.32 -162.11 28.39 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.988 1.28 . . . . 0.0 115.127 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -71.88 92.58 1.26 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.753 1.221 . . . . 0.0 112.38 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.23 128.38 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.816 1.246 . . . . 0.0 109.722 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 44.8 t -92.6 -34.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.909 2.084 . . . . 0.0 111.478 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.3 m -159.53 145.54 16.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 110.377 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.9 134.59 17.62 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.949 1.699 . . . . 0.0 110.208 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -154.92 136.83 14.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.63 0.772 . . . . 0.0 111.588 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.06 135.29 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.969 1.708 . . . . 0.0 107.873 169.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -82.65 137.15 34.58 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.085 0.554 . . . . 0.0 110.994 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.8 mm -118.08 136.89 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.034 1.334 . . . . 0.0 111.104 -168.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.69 129.23 36.79 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.305 1.442 . . . . 0.0 111.857 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.2 -2.78 42.61 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -173.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -102.99 -21.92 13.88 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.029 1.332 . . . . 0.0 112.046 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.5 p -130.61 -16.5 3.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.434 1.494 . . . . 0.0 114.233 -172.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 53.8 t30 65.15 15.92 10.27 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.331 1.852 . . . . 0.0 113.294 -173.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.01 159.03 15.92 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.516 1.527 . . . . 0.0 111.193 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 63.8 m -81.82 137.82 35.21 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.199 -0.938 . . . . 0.0 112.022 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.82 6.06 3.58 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 30.8 m 69.79 18.52 7.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.515 2.326 . . . . 0.0 113.406 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -145.91 156.09 43.3 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.094 0.958 . . . . 0.0 112.091 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.52 -175.29 28.28 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 126.099 1.809 . . . . 0.0 113.546 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -139.71 144.84 37.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.244 1.818 . . . . 0.0 110.262 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 81.2 t -142.84 139.82 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.514 1.526 . . . . 0.0 108.708 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 34.3 t -136.74 144.99 44.12 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.631 0.772 . . . . 0.0 112.277 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -116.44 166.02 12.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.869 1.667 . . . . 0.0 113.431 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.51 -19.3 63.73 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.663 1.185 . . . . 0.0 113.204 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -147.74 159.69 40.23 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 126.23 1.812 . . . . 0.0 110.843 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 -18.67 8.19 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.297 1.998 . . . . 0.0 113.816 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 70.7 t -72.67 -43.57 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 119.812 1.187 . . . . 0.0 111.0 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.6 p -65.8 -31.74 72.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.775 0.83 . . . . 0.0 112.427 172.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -69.51 -50.47 44.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.85 0.86 . . . . 0.0 112.327 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.89 -29.97 70.0 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.266 -0.896 . . . . 0.0 112.097 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.05 -31.25 71.64 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.606 0.639 . . . . 0.0 112.485 169.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.08 63.94 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.838 0.745 . . . . 0.0 111.834 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 30.0 mt -57.55 -49.06 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.116 0.871 . . . . 0.0 110.047 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -70.97 -15.05 62.56 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 53.1 m -99.35 -30.42 12.23 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.5 mmm -112.79 -20.69 11.53 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -69.99 112.71 6.58 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.413 1.006 . . . . 0.0 109.786 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.25 2.54 68.28 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.392 1.472 . . . . 0.0 115.268 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -65.24 123.3 19.19 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.628 1.714 . . . . 0.0 111.169 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -81.18 131.12 35.28 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.878 -0.514 . . . . 0.0 111.233 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.8 tt -138.96 85.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 122.772 1.272 . . . . 0.0 109.468 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 85.2 -125.97 7.48 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.651 1.12 . . . . 0.0 111.067 -169.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 61.6 mtt -99.41 22.16 11.08 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.664 1.586 . . . . 0.0 112.759 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -146.07 161.24 40.58 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.353 1.861 . . . . 0.0 111.862 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -121.32 130.19 53.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.566 1.146 . . . . 0.0 110.765 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 72.2 mt -63.84 159.48 19.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.331 1.453 . . . . 0.0 111.473 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -135.42 139.35 44.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.352 1.461 . . . . 0.0 109.715 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 29.2 t -139.24 136.9 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.324 1.049 . . . . 0.0 109.688 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -143.07 155.74 44.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.389 1.075 . . . . 0.0 111.488 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.29 156.8 33.32 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.851 0.86 . . . . 0.0 112.216 169.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -66.42 -36.21 82.25 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.091 0.956 . . . . 0.0 113.119 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 -104.0 117.6 34.68 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.556 1.143 . . . . 0.0 111.759 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 59.7 m -148.69 -46.75 0.15 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.032 1.333 . . . . 0.0 112.379 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -149.29 -14.35 0.29 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.541 1.136 . . . . 0.0 114.015 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -68.59 -14.84 63.28 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.6 -1.312 . . . . 0.0 114.105 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -130.38 11.59 5.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.64 1.576 . . . . 0.0 112.894 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 47.8 t -165.09 133.24 3.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.716 1.207 . . . . 0.0 112.035 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.42 3.97 41.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.331 1.052 . . . . 0.0 113.041 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 4.0 t 69.4 -170.23 0.18 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.58 1.952 . . . . 0.0 112.686 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -78.34 179.25 52.12 Favored Glycine 0 CA--C 1.543 1.833 0 C-N-CA 125.082 1.325 . . . . 0.0 114.509 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.49 156.01 33.41 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.754 3.636 . . . . 0.0 113.983 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 93.1 p -160.26 164.38 32.72 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.44 1.496 . . . . 0.0 111.833 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 18.4 m -163.89 156.12 17.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.165 1.786 . . . . 0.0 111.03 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.282 -1.288 . . . . 0.0 112.837 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 24.2 m -131.38 9.79 4.77 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -169.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 80.9 p -162.18 163.24 28.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.531 1.532 . . . . 0.0 111.533 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 77.66 -53.14 3.61 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.407 1.48 . . . . 0.0 113.54 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 71.0 m -84.72 -3.53 58.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.89 1.276 . . . . 0.0 113.21 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 10.1 m -71.0 -13.11 61.89 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.926 1.29 . . . . 0.0 114.25 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -80.31 58.65 4.63 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.707 1.622 . . . . 0.0 112.602 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.36 -11.15 59.99 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.061 1.344 . . . . 0.0 114.193 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 20.6 m -80.25 79.27 6.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.201 1.4 . . . . 0.0 109.765 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -149.1 170.94 17.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.387 1.875 . . . . 0.0 110.474 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -80.06 15.83 1.39 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.659 1.184 . . . . 0.0 112.877 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 42.6 p -83.08 8.45 12.89 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.9 1.68 . . . . 0.0 114.245 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -7.88 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.446 1.499 . . . . 0.0 114.527 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.8 -156.31 22.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.226 1.393 . . . . 0.0 113.661 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.5 73.98 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -171.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -71.56 109.84 5.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.312 1.045 . . . . 0.0 110.049 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 95.22 -3.21 66.33 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.434 1.016 . . . . 0.0 113.33 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 3.2 m -70.13 154.15 42.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.598 1.199 . . . . 0.0 110.927 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -127.81 26.37 5.87 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.643 1.177 . . . . 0.0 110.078 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -73.26 179.93 3.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.383 1.473 . . . . 0.0 110.662 168.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.83 167.08 31.55 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.587 -0.695 . . . . 0.0 112.873 168.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.24 -163.82 28.57 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 126.133 1.825 . . . . 0.0 113.892 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.35 174.61 11.83 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.019 3.146 . . . . 0.0 112.693 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -57.46 125.75 24.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.179 0.992 . . . . 0.0 111.286 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.03 71.49 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.864 1.221 . . . . 0.0 114.301 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.64 -0.54 42.8 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -113.67 123.65 50.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.422 1.089 . . . . 0.0 110.645 -169.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.9 mt -122.52 142.93 50.07 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.815 2.046 . . . . 0.0 112.861 -168.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -111.61 135.21 52.5 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.78 1.632 . . . . 0.0 108.595 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.6 mm -119.56 138.22 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.993 1.717 . . . . 0.0 108.369 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -138.8 162.27 35.18 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.597 0.759 . . . . 0.0 112.867 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 64.57 26.34 13.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.34 2.256 . . . . 0.0 113.87 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 72.1 mt -65.56 159.46 67.61 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.023 1.329 . . . . 0.0 111.823 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.71 149.38 77.39 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.065 2.51 . . . . 0.0 111.929 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -71.64 -8.4 53.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.77 1.228 . . . . 0.0 113.922 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -113.56 -6.01 13.41 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.271 2.228 . . . . 0.0 113.865 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 125.72 27.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.153 1.381 . . . . 0.0 110.869 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.67 -177.75 25.9 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.443 1.02 . . . . 0.0 113.745 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -62.4 -36.07 81.18 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.892 0.877 . . . . 0.0 112.66 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.22 -31.23 58.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.992 0.917 . . . . 0.0 111.95 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.495 0.589 . . . . 0.0 110.762 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.19 -37.06 83.02 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.286 0.635 . . . . 0.0 111.694 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -62.75 -50.17 72.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.838 0.745 . . . . 0.0 111.062 172.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -63.19 -28.08 69.8 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.427 0.691 . . . . 0.0 112.767 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.9 ttm -73.31 -28.76 62.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.478 1.111 . . . . 0.0 113.241 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -110.54 -17.47 13.42 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.0 mtm -55.29 -32.49 12.69 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -57.99 -15.48 22.61 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.66 2.907 . . . . 0.0 116.372 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -101.59 -7.94 22.3 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.07 -160.74 28.09 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.895 1.236 . . . . 0.0 114.718 171.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -72.52 95.79 1.85 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.257 1.023 . . . . 0.0 112.144 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.5 t -77.38 127.73 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.061 1.344 . . . . 0.0 109.814 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.14 -26.02 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.378 2.271 . . . . 0.0 111.788 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.6 t -154.27 144.37 21.96 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.678 1.191 . . . . 0.0 110.339 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.26 126.39 5.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.935 1.694 . . . . 0.0 110.246 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 28.9 tptt -154.83 138.01 15.66 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.427 -0.796 . . . . 0.0 111.813 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.36 135.09 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.779 1.632 . . . . 0.0 108.167 169.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -84.65 138.51 32.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.453 0.701 . . . . 0.0 111.086 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 30.6 mm -119.59 134.6 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.176 1.39 . . . . 0.0 110.348 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -82.59 126.11 31.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.947 0.899 . . . . 0.0 111.043 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -75.67 -5.93 47.96 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -87.11 -24.1 24.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.387 1.075 . . . . 0.0 112.297 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 71.2 p -133.38 -13.24 2.69 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . 0.286 8.2 p30 59.35 11.7 2.31 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.521 2.328 . . . . 0.0 114.516 -169.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 85.2 mt -84.48 155.36 22.22 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.165 1.386 . . . . 0.0 111.149 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 58.0 m -76.75 136.75 39.03 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.943 0.897 . . . . 0.0 111.397 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.31 7.08 2.43 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.8 m 67.53 18.78 10.0 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.209 2.204 . . . . 0.0 113.439 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -144.35 155.34 43.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.205 0.911 . . . . 0.0 112.124 173.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.35 -176.04 28.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.945 1.736 . . . . 0.0 113.653 -170.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -141.47 142.43 33.63 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.437 1.895 . . . . 0.0 110.077 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.8 t -143.89 141.55 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.205 1.402 . . . . 0.0 108.88 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 75.5 m -137.48 144.25 42.16 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.431 -0.793 . . . . 0.0 112.296 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -112.93 166.1 11.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.313 1.445 . . . . 0.0 113.131 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.0 -19.5 62.51 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.423 1.089 . . . . 0.0 113.078 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -148.34 153.39 40.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.589 1.556 . . . . 0.0 111.476 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.5 -17.66 11.23 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.071 2.514 . . . . 0.0 114.027 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.1 t -72.37 -40.57 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.175 0.898 . . . . 0.0 110.395 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.3 m -62.97 -32.82 74.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.866 0.866 . . . . 0.0 111.719 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.79 -49.44 25.31 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.593 1.157 . . . . 0.0 112.017 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -59.14 -38.75 80.42 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.528 -0.733 . . . . 0.0 111.964 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.01 -28.41 64.4 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -80.14 -44.47 19.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 111.899 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 43.4 mt -57.94 -49.3 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.537 1.062 . . . . 0.0 110.372 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 -74.42 -11.52 60.26 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.4 m -101.1 -29.86 11.91 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.46 -18.64 12.81 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -169.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.01 109.24 3.87 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.925 0.784 . . . . 0.0 109.737 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.72 9.98 60.68 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.392 1.472 . . . . 0.0 114.966 -171.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -64.86 124.48 22.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.051 1.926 . . . . 0.0 111.145 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -79.25 131.05 36.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.095 0.558 . . . . 0.0 110.887 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.4 tt -149.28 133.39 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.809 1.244 . . . . 0.0 110.556 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.71 -102.34 0.62 Allowed Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -129.83 17.07 5.74 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.303 1.841 . . . . 0.0 112.219 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -146.15 -176.51 5.19 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.75 1.62 . . . . 0.0 113.014 -172.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -128.23 135.97 50.41 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.065 1.346 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 56.6 mt -70.99 162.88 28.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.176 1.39 . . . . 0.0 111.933 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -133.9 147.33 51.1 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.309 1.444 . . . . 0.0 109.327 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 29.6 t -139.21 137.81 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.647 1.179 . . . . 0.0 109.386 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -141.75 160.54 39.96 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.458 1.103 . . . . 0.0 111.191 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 69.9 mt -69.31 157.95 35.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.653 0.74 . . . . 0.0 111.18 168.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -53.12 123.63 12.25 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.539 1.136 . . . . 0.0 112.334 172.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -165.48 146.18 7.03 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.55 1.94 . . . . 0.0 110.083 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 13.3 t -158.3 167.96 28.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.093 1.357 . . . . 0.0 111.416 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -143.92 13.95 1.69 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.614 1.565 . . . . 0.0 112.842 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -154.68 141.6 19.19 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.841 1.257 . . . . 0.0 112.441 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -144.66 10.15 1.39 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.219 1.408 . . . . 0.0 113.045 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 22.8 t -165.87 147.74 7.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.631 1.572 . . . . 0.0 111.108 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -132.13 25.4 4.56 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.207 1.403 . . . . 0.0 112.453 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 12.5 t -152.17 159.15 43.66 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.665 1.586 . . . . 0.0 111.216 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 154.6 -153.08 24.55 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.871 1.224 . . . . 0.0 113.154 -174.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.71 -3.04 12.97 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.992 3.128 . . . . 0.0 113.908 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 74.0 m -143.11 156.29 44.77 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.755 1.622 . . . . 0.0 111.123 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 20.4 m 69.37 10.93 7.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.915 1.686 . . . . 0.0 114.857 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 C-N-CA 125.676 1.608 . . . . 0.0 113.556 176.927 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.567 0 N-CA-C 111.829 -0.509 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 16.7 m -65.22 -19.15 65.84 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -173.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 33.4 p -66.52 -10.39 44.27 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.002 1.321 . . . . 0.0 113.948 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -82.08 1.32 87.16 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.332 1.444 . . . . 0.0 114.306 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 66.3 m -131.54 152.79 50.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.482 1.513 . . . . 0.0 112.013 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 8.5 t -163.28 163.19 25.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.111 1.364 . . . . 0.0 111.312 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -86.13 176.69 48.88 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.97 1.271 . . . . 0.0 113.862 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.88 123.67 21.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.591 1.156 . . . . 0.0 110.614 177.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.0 t -72.63 -35.17 67.74 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.46 1.104 . . . . 0.0 113.76 -172.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -149.66 143.41 25.48 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.395 1.478 . . . . 0.0 109.858 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.78 21.17 12.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.69 1.196 . . . . 0.0 111.916 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 10.6 m -66.44 0.59 2.09 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.435 1.494 . . . . 0.0 114.83 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.27 -11.9 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.182 1.393 . . . . 0.0 112.956 169.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -96.51 16.05 61.71 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 126.556 2.027 . . . . 0.0 113.962 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -55.91 -39.16 71.21 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.983 1.313 . . . . 0.0 114.526 -175.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -66.27 117.54 8.69 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.494 1.118 . . . . 0.0 111.432 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.61 -7.47 77.42 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.75 1.643 . . . . 0.0 113.254 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.4 t -85.08 172.37 11.31 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.376 1.088 . . . . 0.0 112.186 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.07 31.98 2.93 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.101 1.361 . . . . 0.0 111.065 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -68.74 165.75 18.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.065 0.946 . . . . 0.0 112.528 169.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.63 156.77 45.11 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.25 -169.23 29.27 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 126.156 1.836 . . . . 0.0 113.246 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.14 175.28 7.79 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.086 3.19 . . . . 0.0 112.676 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.85 121.96 11.75 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.094 0.957 . . . . 0.0 111.44 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.88 -1.73 78.56 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.862 1.22 . . . . 0.0 114.659 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.41 6.76 46.98 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.957 1.378 . . . . 0.0 114.372 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -118.36 122.12 42.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.293 1.437 . . . . 0.0 111.08 -171.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.7 140.76 52.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.439 1.896 . . . . 0.0 112.343 -169.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -110.99 133.09 53.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.889 1.676 . . . . 0.0 108.801 168.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.29 135.1 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.946 1.698 . . . . 0.0 107.884 -171.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -132.98 156.78 46.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.933 1.293 . . . . 0.0 112.585 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 74.55 27.9 1.31 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.732 2.413 . . . . 0.0 113.849 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.2 mt -64.96 157.29 76.76 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.103 1.361 . . . . 0.0 112.057 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.81 152.56 34.86 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.388 2.725 . . . . 0.0 112.126 169.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -67.21 -29.33 68.96 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.9 -9.79 56.35 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.01 129.2 39.2 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.9 1.28 . . . . 0.0 111.793 -175.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -113.74 -174.28 18.73 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.312 1.434 . . . . 0.0 113.314 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.25 -34.7 78.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.077 0.951 . . . . 0.0 112.991 -174.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -76.77 -31.56 57.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.893 0.877 . . . . 0.0 111.782 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -67.66 -41.59 83.53 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.705 0.684 . . . . 0.0 110.649 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 23.3 tp -65.59 -41.09 93.23 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.334 0.654 . . . . 0.0 111.562 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.26 -51.69 67.86 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.661 0.664 . . . . 0.0 111.37 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -63.72 -28.04 69.61 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.8 ttp -81.4 -20.39 40.56 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -109.61 -19.78 13.08 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 51.5 mtm -54.8 -31.85 10.46 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -57.34 -16.78 23.98 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.616 2.877 . . . . 0.0 116.273 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -97.71 -8.79 27.92 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.406 1.003 . . . . 0.0 113.636 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.18 -162.92 28.16 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.089 1.328 . . . . 0.0 114.67 170.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -71.03 95.01 1.15 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.437 1.095 . . . . 0.0 111.842 -173.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.1 t -73.43 129.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.027 1.331 . . . . 0.0 109.733 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 35.7 t -94.56 -33.78 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.16 2.184 . . . . 0.0 111.505 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.3 t -155.22 150.45 27.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.462 1.105 . . . . 0.0 110.836 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.29 14.86 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.178 1.391 . . . . 0.0 109.915 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -151.58 138.74 19.23 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.466 -0.771 . . . . 0.0 111.705 -168.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 85.8 t -119.32 126.99 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.534 1.534 . . . . 0.0 107.468 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -81.02 144.23 31.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.361 0.664 . . . . 0.0 111.308 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 39.4 mm -120.1 135.75 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.215 1.406 . . . . 0.0 110.362 -169.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.72 128.15 33.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.396 1.078 . . . . 0.0 111.739 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -72.68 -9.0 58.11 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -99.52 -15.46 18.65 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.229 1.012 . . . . 0.0 113.133 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 70.0 p -128.64 -19.62 3.71 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.623 1.169 . . . . 0.0 113.957 -177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 66.15 18.65 11.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.558 1.943 . . . . 0.0 112.924 -172.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 85.3 mt -101.78 156.25 17.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.348 1.459 . . . . 0.0 111.612 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 50.0 m -64.3 139.47 58.77 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.035 0.934 . . . . 0.0 112.633 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.74 2.51 19.46 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 76.3 m 65.63 22.8 11.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.912 2.085 . . . . 0.0 113.396 -172.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -146.14 155.57 42.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.004 0.922 . . . . 0.0 111.68 171.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.05 -173.43 24.63 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.749 1.643 . . . . 0.0 113.918 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -139.79 146.24 39.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.304 1.842 . . . . 0.0 110.243 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 58.1 t -143.61 138.58 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.115 1.366 . . . . 0.0 109.006 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 85.6 p -130.71 152.69 49.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.911 0.885 . . . . 0.0 112.358 175.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.73 161.86 26.36 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.933 1.293 . . . . 0.0 113.504 -174.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.65 -18.37 64.27 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.72 1.208 . . . . 0.0 112.885 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -146.16 151.24 44.08 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 125.596 1.559 . . . . 0.0 112.05 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.26 -28.16 55.66 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.035 3.157 . . . . 0.0 114.035 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.7 t -74.43 -38.46 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.958 0.903 . . . . 0.0 110.828 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 8.2 m -63.9 -31.79 73.1 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.916 0.886 . . . . 0.0 111.82 171.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.91 -48.58 29.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.403 1.081 . . . . 0.0 111.926 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -59.05 -38.97 80.62 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.383 -0.823 . . . . 0.0 111.879 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.75 -27.33 64.84 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -79.9 -44.65 20.01 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.458 171.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.56 -49.4 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.871 1.214 . . . . 0.0 110.618 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -73.87 -11.21 60.3 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.6 m -102.1 -27.71 12.76 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.5 mmm -112.47 -20.63 11.7 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -168.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.29 110.1 5.06 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.197 0.908 . . . . 0.0 109.84 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.31 1.85 62.34 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.533 1.539 . . . . 0.0 115.028 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -62.63 125.79 25.15 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.54 1.67 . . . . 0.0 111.866 -178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -79.72 125.96 30.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.592 0.757 . . . . 0.0 110.075 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt -148.18 134.27 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.058 1.343 . . . . 0.0 109.811 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.53 -120.62 23.59 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -171.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 25.0 ptp -106.87 13.42 27.79 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.675 1.59 . . . . 0.0 113.773 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -142.91 -172.75 3.73 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.217 1.407 . . . . 0.0 113.339 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -129.48 141.63 50.96 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.59 1.556 . . . . 0.0 111.403 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 75.8 mt -76.79 162.9 27.28 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.149 1.38 . . . . 0.0 112.652 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -131.51 141.91 49.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.758 1.623 . . . . 0.0 109.678 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.75 138.1 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.735 1.214 . . . . 0.0 109.392 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -147.76 142.53 26.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.815 1.246 . . . . 0.0 110.597 -169.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 41.1 mt -65.8 151.41 46.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.011 0.925 . . . . 0.0 112.308 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -52.22 119.36 4.31 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.303 1.041 . . . . 0.0 111.329 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -73.1 144.04 47.15 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.618 1.167 . . . . 0.0 113.405 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 74.0 p -167.63 157.55 10.49 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.787 2.035 . . . . 0.0 110.482 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -77.01 132.87 39.19 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.274 -0.891 . . . . 0.0 111.842 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -157.88 40.37 0.28 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.136 1.775 . . . . 0.0 109.635 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -166.5 159.14 14.15 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.348 1.859 . . . . 0.0 111.813 -166.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 6.7 t -154.47 17.13 0.47 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.705 1.202 . . . . 0.0 112.71 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -163.64 178.08 8.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.561 1.945 . . . . 0.0 112.004 -173.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.6 t -154.92 168.43 26.99 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.031 1.332 . . . . 0.0 111.331 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -159.5 -178.8 33.83 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 125.317 1.437 . . . . 0.0 114.087 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.81 155.21 53.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.087 3.191 . . . . 0.0 111.999 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 91.6 p -163.47 166.9 22.2 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.508 1.523 . . . . 0.0 111.839 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 59.1 p -161.93 157.44 23.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.888 1.275 . . . . 0.0 112.191 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 C-N-CA 124.937 1.256 . . . . 0.0 112.84 -179.461 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.546 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 39.7 m -149.71 153.13 36.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.024 1.33 . . . . 0.0 111.348 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.0 t -163.3 179.49 7.34 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.371 1.469 . . . . 0.0 111.284 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 100.17 -160.55 19.25 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.808 1.671 . . . . 0.0 113.218 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 15.5 t -161.4 164.42 29.93 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.175 1.39 . . . . 0.0 111.544 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 21.7 m -82.66 -3.94 57.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.932 1.293 . . . . 0.0 114.343 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 83.07 -143.55 22.15 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.688 1.137 . . . . 0.0 112.614 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 99.0 mt -138.75 151.87 47.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.887 1.675 . . . . 0.0 111.197 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 32.7 m -66.45 137.84 57.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.589 1.555 . . . . 0.0 110.337 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -144.68 154.11 42.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.237 1.415 . . . . 0.0 110.923 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -81.97 12.74 3.83 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.12 1.368 . . . . 0.0 112.875 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 8.5 p -76.29 59.77 1.44 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.523 1.929 . . . . 0.0 112.106 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -41.21 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.029 -1.044 . . . . 0.0 113.383 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 55.3 -110.12 1.65 Allowed Glycine 0 CA--C 1.534 1.241 0 CA-C-N 119.268 0.94 . . . . 0.0 112.176 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -84.7 -11.32 56.1 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.694 1.598 . . . . 0.0 114.667 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -69.37 122.99 20.05 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.012 1.325 . . . . 0.0 110.606 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.34 79.29 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.283 0.944 . . . . 0.0 113.086 -175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 10.1 t -75.61 162.68 28.06 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.25 1.025 . . . . 0.0 111.88 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -134.79 20.21 3.53 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.169 1.388 . . . . 0.0 111.224 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -66.83 173.67 3.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.133 0.973 . . . . 0.0 111.484 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.47 167.1 29.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 167.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -94.81 -167.14 36.2 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.113 1.34 . . . . 0.0 113.638 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.6 171.06 13.78 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.358 2.705 . . . . 0.0 111.521 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.94 123.27 15.24 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.641 0.777 . . . . 0.0 111.259 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.79 -9.66 70.76 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.725 1.155 . . . . 0.0 114.276 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.07 -6.25 54.06 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.895 1.347 . . . . 0.0 113.686 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.3 118.54 36.2 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.282 2.233 . . . . 0.0 111.404 -174.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 22.0 mt -119.68 136.63 54.33 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.386 1.875 . . . . 0.0 111.989 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -109.69 131.99 54.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.451 1.5 . . . . 0.0 108.796 168.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.56 135.33 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.938 1.695 . . . . 0.0 107.951 -171.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -131.42 160.4 35.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.247 1.419 . . . . 0.0 112.687 -175.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 68.27 28.26 6.39 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.496 2.318 . . . . 0.0 113.601 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 52.9 mt -65.69 155.24 86.65 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.491 1.116 . . . . 0.0 111.727 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.21 143.19 94.13 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.047 2.498 . . . . 0.0 112.575 172.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -62.69 -6.9 3.98 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.791 2.036 . . . . 0.0 114.845 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -113.14 -9.04 13.55 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.58 1.952 . . . . 0.0 114.241 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.44 134.03 47.41 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.635 1.174 . . . . 0.0 112.287 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.42 -172.7 18.9 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.663 1.601 . . . . 0.0 112.447 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -63.53 -34.66 78.27 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -172.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -77.09 -28.31 54.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.145 0.578 . . . . 0.0 112.448 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -69.95 -41.79 74.08 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.586 0.63 . . . . 0.0 110.796 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 31.8 tp -65.56 -37.6 87.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.491 0.716 . . . . 0.0 111.811 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.72 -50.4 67.07 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.709 0.686 . . . . 0.0 111.462 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -63.42 -26.33 68.69 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.409 0.684 . . . . 0.0 112.551 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 48.1 ttm -73.95 -28.79 61.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.169 0.988 . . . . 0.0 113.373 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -109.84 -18.52 13.39 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.6 mtm -56.16 -32.61 13.51 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -57.63 -16.23 23.63 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.578 2.852 . . . . 0.0 116.165 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -100.28 -9.7 22.08 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.7 -163.35 28.55 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.087 1.327 . . . . 0.0 114.957 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -70.37 99.82 1.64 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.335 1.054 . . . . 0.0 112.542 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 85.5 t -79.35 128.54 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.163 1.385 . . . . 0.0 110.038 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 56.0 t -98.97 -24.33 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.568 2.347 . . . . 0.0 111.787 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 9.4 t -156.98 144.27 18.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.762 1.225 . . . . 0.0 110.711 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.36 130.3 12.52 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.158 1.383 . . . . 0.0 110.89 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -156.11 132.85 10.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.578 0.751 . . . . 0.0 112.657 -174.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 64.8 t -102.12 134.71 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.683 1.593 . . . . 0.0 106.943 167.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.83 140.75 30.95 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.293 0.637 . . . . 0.0 110.423 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 17.1 mt -131.05 136.21 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.776 1.23 . . . . 0.0 110.541 -169.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.3 133.51 45.04 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.355 1.462 . . . . 0.0 112.233 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -82.1 -1.94 50.35 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -172.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -109.54 -19.17 13.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.55 1.14 . . . . 0.0 112.716 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.9 p -126.29 -17.7 5.13 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.434 1.494 . . . . 0.0 114.079 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 64.16 18.91 11.53 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.253 1.821 . . . . 0.0 113.197 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 86.7 mt -91.79 145.48 24.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.603 1.561 . . . . 0.0 110.587 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 88.6 p -61.92 144.61 54.75 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.247 1.022 . . . . 0.0 112.244 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -81.2 6.81 12.84 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.9 m 63.82 21.32 12.61 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.017 2.127 . . . . 0.0 113.119 -170.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.84 155.14 43.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.109 0.868 . . . . 0.0 112.4 173.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.56 179.83 31.22 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.926 1.727 . . . . 0.0 113.513 -170.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -137.04 142.22 42.46 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.549 1.94 . . . . 0.0 110.228 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 84.8 t -141.7 142.98 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.137 1.375 . . . . 0.0 108.608 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 18.3 m -136.86 148.81 47.31 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -115.35 171.59 7.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.546 1.539 . . . . 0.0 113.165 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.49 -23.71 66.09 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.42 1.488 . . . . 0.0 113.427 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -161.33 161.13 23.65 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.199 1.4 . . . . 0.0 112.104 -172.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.08 -13.77 34.27 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.504 2.136 . . . . 0.0 114.082 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.34 -46.01 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 121.043 1.747 . . . . 0.0 110.608 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 45.6 m -65.93 -30.66 71.28 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.312 1.045 . . . . 0.0 111.924 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.37 -48.4 28.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.04 0.936 . . . . 0.0 111.981 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -61.68 -32.29 72.46 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.523 -0.736 . . . . 0.0 112.094 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.71 71.76 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.46 -42.95 41.96 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.564 0.746 . . . . 0.0 111.732 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.7 mt -58.42 -46.67 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 118.798 0.727 . . . . 0.0 110.274 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.48 -12.52 61.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 66.6 m -103.54 -29.85 10.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 87.6 mmm -114.29 -18.71 11.52 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -168.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -70.87 111.48 6.32 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.42 1.009 . . . . 0.0 110.191 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.24 0.53 63.23 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.719 1.628 . . . . 0.0 114.953 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.12 122.74 16.85 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.403 1.601 . . . . 0.0 111.251 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -75.64 131.95 40.27 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 110.631 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.0 tt -139.55 106.81 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.011 1.324 . . . . 0.0 108.757 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 67.23 -124.32 22.41 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -169.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 25.5 mmt -99.62 13.57 33.05 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.428 1.491 . . . . 0.0 113.371 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -140.58 170.59 15.5 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.676 1.59 . . . . 0.0 112.717 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -121.22 134.69 55.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.004 1.322 . . . . 0.0 111.282 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.47 155.58 37.17 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.051 1.341 . . . . 0.0 111.547 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -130.3 141.9 50.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.935 1.294 . . . . 0.0 109.143 168.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.4 t -139.0 132.95 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.454 1.102 . . . . 0.0 109.169 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -143.85 154.95 43.91 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.514 1.126 . . . . 0.0 111.232 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 60.4 mt -66.95 160.12 27.02 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.527 0.731 . . . . 0.0 112.722 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -71.61 71.53 0.71 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.102 1.361 . . . . 0.0 110.388 167.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -165.16 146.99 7.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.94 1.696 . . . . 0.0 111.366 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 49.7 m 68.03 78.42 0.23 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.368 1.867 . . . . 0.0 113.164 172.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -65.71 -27.84 68.62 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -162.16 145.64 11.88 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.676 1.59 . . . . 0.0 111.346 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -130.92 3.12 4.4 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.103 1.761 . . . . 0.0 112.716 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 58.5 m -111.6 27.76 9.37 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.945 1.698 . . . . 0.0 112.27 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -56.79 -29.38 62.62 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.209 1.404 . . . . 0.0 113.768 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 37.2 m -106.65 16.97 23.88 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.607 1.563 . . . . 0.0 112.486 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 96.78 170.58 34.13 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.009 1.766 . . . . 0.0 112.324 -169.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.88 142.81 35.74 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.628 2.885 . . . . 0.0 110.952 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 65.6 m -100.77 3.25 41.99 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.112 0.965 . . . . 0.0 113.546 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 67.4 m -146.59 149.76 34.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.919 1.688 . . . . 0.0 111.477 -174.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.311 -1.271 . . . . 0.0 112.789 179.38 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 376' ' ' GLY . . . . . 0.516 ' N ' ' HG ' ' A' ' 381' ' ' SER . . . . . . . . 0 N--CA 1.48 1.603 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 30.6 m 70.13 -34.23 0.28 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 127.92 2.488 . . . . 0.0 114.91 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 72.4 m -142.1 143.68 33.16 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.12 2.168 . . . . 0.0 109.782 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 71.78 -129.73 16.48 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.633 0.635 . . . . 0.0 111.734 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 77.5 p -159.31 155.74 27.39 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.293 1.437 . . . . 0.0 111.57 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.516 ' HG ' ' N ' ' A' ' 376' ' ' GLY . 28.6 p -164.57 138.15 5.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.477 1.111 . . . . 0.0 112.041 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -107.11 171.82 17.23 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.413 1.482 . . . . 0.0 112.995 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 90.8 mt -142.29 134.77 27.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.671 1.589 . . . . 0.0 110.627 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 18.8 p -70.71 136.97 49.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.344 1.458 . . . . 0.0 110.467 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -141.36 143.03 33.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.993 1.317 . . . . 0.0 110.408 -169.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.36 25.07 0.41 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.067 1.347 . . . . 0.0 112.029 -171.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 32.9 p -90.67 14.18 14.06 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.829 1.652 . . . . 0.0 114.401 -169.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.87 143.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.866 1.266 . . . . 0.0 112.818 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -86.95 120.61 5.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.135 0.874 . . . . 0.0 113.031 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.83 -51.5 0.39 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.045 2.938 . . . . 0.0 116.46 169.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.4 115.29 5.51 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.912 1.285 . . . . 0.0 110.481 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 94.88 -5.45 69.14 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.992 1.282 . . . . 0.0 113.442 -175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 36.2 t -79.7 143.55 34.48 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.574 1.187 . . . . 0.0 111.341 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -118.93 15.25 13.38 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.852 1.261 . . . . 0.0 111.755 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -66.33 173.64 3.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.807 0.843 . . . . 0.0 111.655 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -153.43 160.34 42.57 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.6 -161.62 29.03 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 128.243 2.83 . . . . 0.0 113.365 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 169.01 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.68 2.92 . . . . 0.0 112.49 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -59.36 127.09 30.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.41 0.684 . . . . 0.0 111.145 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.36 -11.18 70.68 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.92 1.248 . . . . 0.0 114.01 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.86 -4.49 46.9 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.722 1.261 . . . . 0.0 114.118 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -108.29 118.21 36.18 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.118 1.367 . . . . 0.0 110.93 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.7 mt -120.19 132.0 55.21 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.175 1.79 . . . . 0.0 111.861 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -103.04 133.2 48.56 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.785 1.234 . . . . 0.0 108.557 167.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.3 mm -118.16 135.65 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.771 1.629 . . . . 0.0 108.26 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -133.93 160.45 37.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.574 1.15 . . . . 0.0 112.308 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 62.62 33.94 15.36 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.477 1.911 . . . . 0.0 113.282 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 45.2 mt -70.03 164.68 50.07 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.659 1.584 . . . . 0.0 111.455 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.03 141.47 94.36 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.702 2.268 . . . . 0.0 110.888 168.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -67.86 -8.29 35.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.959 1.304 . . . . 0.0 113.962 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.52 -9.2 16.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.424 1.889 . . . . 0.0 114.144 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.3 130.85 43.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.138 1.375 . . . . 0.0 111.643 -175.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -101.96 -179.63 27.69 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.367 0.984 . . . . 0.0 113.582 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.15 -33.69 74.98 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.149 0.98 . . . . 0.0 112.326 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -73.56 -40.81 63.65 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.989 1.716 . . . . 0.0 110.917 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -64.77 -41.38 95.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.708 0.803 . . . . 0.0 111.351 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.0 tp -67.0 -37.7 84.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.277 0.631 . . . . 0.0 111.858 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.63 -49.88 73.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.758 0.708 . . . . 0.0 110.943 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -63.39 -27.56 69.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.608 0.763 . . . . 0.0 112.851 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.5 ttm -72.45 -32.06 65.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.231 1.012 . . . . 0.0 113.051 173.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -107.38 -18.49 13.85 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -171.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 44.4 mtm -55.61 -33.49 18.09 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -57.77 -16.72 26.44 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.556 2.837 . . . . 0.0 115.992 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -99.23 -10.85 21.89 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.47 -154.36 25.88 Favored Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.411 1.005 . . . . 0.0 115.494 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -74.49 82.46 1.97 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.528 1.131 . . . . 0.0 112.962 -169.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.46 128.39 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.551 1.14 . . . . 0.0 109.951 172.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 73.5 t -94.13 -37.77 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.801 2.04 . . . . 0.0 110.85 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 63.3 m -151.29 146.01 25.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.859 1.263 . . . . 0.0 110.807 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.53 134.66 14.96 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.247 1.419 . . . . 0.0 110.402 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -155.6 136.26 13.42 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.692 0.797 . . . . 0.0 111.839 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.17 134.78 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.922 1.689 . . . . 0.0 107.734 169.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -82.17 136.54 35.12 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.033 0.533 . . . . 0.0 110.925 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 30.7 mm -119.68 137.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.285 1.434 . . . . 0.0 110.51 -169.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -73.24 131.27 41.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.783 1.233 . . . . 0.0 112.127 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -75.04 -13.57 60.51 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -104.07 -28.32 11.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.294 1.038 . . . . 0.0 112.642 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 77.8 p -117.3 -15.55 10.38 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.255 1.422 . . . . 0.0 114.057 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 25.1 m120 63.76 15.53 9.09 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.124 1.77 . . . . 0.0 113.495 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.74 154.6 21.5 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.421 1.488 . . . . 0.0 110.979 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 51.0 m -80.87 134.13 35.7 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.492 -0.755 . . . . 0.0 111.16 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.58 5.79 2.83 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -173.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.1 m 67.33 20.49 10.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.387 2.275 . . . . 0.0 113.061 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -145.02 156.18 43.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.854 0.862 . . . . 0.0 111.711 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.0 -174.86 28.26 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.906 1.717 . . . . 0.0 113.736 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -142.06 144.25 33.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.181 1.792 . . . . 0.0 110.196 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 98.8 t -141.97 142.72 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.499 1.519 . . . . 0.0 108.482 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 37.9 t -139.98 142.44 36.31 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.567 -0.708 . . . . 0.0 112.106 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.69 168.2 9.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.808 1.643 . . . . 0.0 113.422 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.17 -22.89 66.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.616 1.567 . . . . 0.0 113.282 170.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -160.07 157.69 25.47 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.232 1.413 . . . . 0.0 112.19 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.25 -15.65 39.16 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.629 2.219 . . . . 0.0 113.794 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.52 -43.72 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.53 1.514 . . . . 0.0 110.535 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.4 m -68.7 -31.26 70.22 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 112.072 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -75.84 -47.43 25.62 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.808 0.843 . . . . 0.0 112.474 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -62.47 -31.32 72.04 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.5 -0.75 . . . . 0.0 111.981 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.44 -30.92 71.95 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.312 0.645 . . . . 0.0 112.632 172.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.46 -42.59 43.24 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.447 0.699 . . . . 0.0 111.879 175.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.52 -46.08 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 118.738 0.699 . . . . 0.0 110.065 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -72.16 -12.46 61.19 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.6 m -104.02 -30.95 9.95 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.7 mmm -111.86 -18.04 12.78 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -70.06 112.1 6.2 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.429 1.013 . . . . 0.0 110.755 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.87 71.5 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.038 1.78 . . . . 0.0 114.94 -173.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -61.47 124.07 19.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.189 1.495 . . . . 0.0 111.331 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -78.39 131.0 36.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.215 0.531 . . . . 0.0 110.42 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.9 tt -136.7 104.84 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.027 1.331 . . . . 0.0 108.493 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.68 -121.52 20.03 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.1 mmt -99.87 9.95 42.12 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.418 1.487 . . . . 0.0 113.89 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -133.04 164.86 26.07 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.234 1.413 . . . . 0.0 112.557 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -120.83 131.89 54.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.743 1.217 . . . . 0.0 111.122 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.96 158.86 24.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.211 1.404 . . . . 0.0 112.224 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -136.85 141.99 42.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.069 1.348 . . . . 0.0 109.063 167.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.7 t -138.29 136.73 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.421 1.089 . . . . 0.0 108.95 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -149.13 151.28 34.11 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.774 0.83 . . . . 0.0 110.829 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.7 mt -60.24 156.65 15.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.931 0.872 . . . . 0.0 112.805 170.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.19 -23.28 66.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.359 1.064 . . . . 0.0 113.175 169.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -139.05 117.58 12.12 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.904 1.681 . . . . 0.0 110.719 -173.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 45.7 m -154.17 128.79 9.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.459 1.504 . . . . 0.0 110.011 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -144.24 146.04 32.42 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.481 1.512 . . . . 0.0 110.897 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -130.5 -7.2 4.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 23.6 t70 68.73 -42.91 0.49 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 129.101 2.96 . . . . 0.0 114.964 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 73.3 p -92.19 -6.73 50.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.576 1.55 . . . . 0.0 113.881 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -162.18 163.22 28.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.853 1.661 . . . . 0.0 112.811 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 24.6 p -85.17 157.88 20.53 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.307 1.443 . . . . 0.0 112.95 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -83.06 173.03 51.95 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.422 1.011 . . . . 0.0 113.574 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.86 151.61 40.48 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.07 3.18 . . . . 0.0 111.811 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 78.9 p -162.62 169.04 20.81 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.018 1.327 . . . . 0.0 112.09 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 10.5 m -151.94 150.62 30.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.8 1.64 . . . . 0.0 110.783 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.222 -1.321 . . . . 0.0 112.936 179.427 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 89.5 p -164.33 177.3 8.38 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.601 1.56 . . . . 0.0 111.429 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.1 m -74.09 -7.41 52.44 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -89.96 141.62 16.11 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.076 1.322 . . . . 0.0 112.596 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 74.3 p -92.06 -14.15 29.76 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 42.9 m 65.15 5.37 2.99 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.923 2.089 . . . . 0.0 114.949 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -80.57 127.65 8.04 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.687 1.137 . . . . 0.0 112.317 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 92.3 mt -146.87 145.25 29.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.586 1.954 . . . . 0.0 110.009 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 85.0 m -142.7 130.17 21.22 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.689 1.595 . . . . 0.0 109.542 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -161.39 131.13 4.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.788 1.635 . . . . 0.0 108.732 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -112.61 -3.47 14.32 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 23.6 m -66.64 -13.74 61.56 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.793 -1.192 . . . . 0.0 114.193 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 1.8 pp -66.02 -4.13 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.482 2.313 . . . . 0.0 114.897 -171.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -69.96 -22.32 77.07 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.864 169.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -166.19 -47.05 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -73.79 111.97 9.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.474 1.109 . . . . 0.0 111.999 -170.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.86 -3.71 84.82 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.613 1.577 . . . . 0.0 112.911 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.8 m -78.01 163.68 25.73 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.0 1.32 . . . . 0.0 111.991 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -125.26 33.12 5.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.746 1.218 . . . . 0.0 110.657 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -69.4 171.59 8.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.83 1.252 . . . . 0.0 110.74 168.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -158.83 165.41 34.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.474 0.709 . . . . 0.0 112.903 168.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -102.57 -165.23 26.29 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 126.074 1.797 . . . . 0.0 113.876 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.73 179.74 5.69 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.259 3.306 . . . . 0.0 112.702 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -54.63 124.3 15.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.538 1.135 . . . . 0.0 111.738 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.84 -6.32 83.64 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.775 1.179 . . . . 0.0 114.547 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.62 -3.15 55.44 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.765 1.283 . . . . 0.0 114.362 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -115.39 128.36 56.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.343 1.057 . . . . 0.0 111.005 -169.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 23.0 mt -126.01 143.1 51.23 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.041 2.136 . . . . 0.0 112.483 -168.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -110.65 135.59 51.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.693 1.597 . . . . 0.0 108.499 167.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.66 135.56 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.707 1.603 . . . . 0.0 107.905 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -131.84 160.59 35.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.872 1.269 . . . . 0.0 112.771 -176.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 69.76 27.74 4.55 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.732 2.413 . . . . 0.0 113.858 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.7 mt -66.59 158.52 78.69 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 124.916 1.286 . . . . 0.0 112.133 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.24 147.26 96.08 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.972 2.448 . . . . 0.0 111.299 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -70.97 -9.06 57.24 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.25 -8.29 17.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.505 1.922 . . . . 0.0 114.035 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.8 124.79 24.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.869 1.268 . . . . 0.0 110.741 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.23 -173.97 24.25 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.54 1.067 . . . . 0.0 113.914 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -70.07 -35.22 74.06 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -172.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -74.95 -28.64 60.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.477 0.711 . . . . 0.0 111.641 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -70.39 -43.14 70.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.236 0.614 . . . . 0.0 110.698 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.18 -35.81 80.46 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.069 0.548 . . . . 0.0 111.764 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.7 tp -62.07 -51.01 69.7 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.84 0.746 . . . . 0.0 110.913 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -68.07 -22.81 64.91 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.4 ttm -73.93 -28.76 61.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.316 1.046 . . . . 0.0 112.888 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -109.86 -17.85 13.54 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.6 mtm -54.28 -33.62 17.07 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 170.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -58.95 -15.94 29.81 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.569 2.846 . . . . 0.0 116.229 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -101.48 -9.3 21.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.59 -158.93 27.88 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.831 1.205 . . . . 0.0 114.884 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -75.0 94.42 2.85 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.084 0.954 . . . . 0.0 112.172 -170.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 96.2 t -74.27 131.48 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.972 1.309 . . . . 0.0 110.445 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 34.1 t -106.75 -20.9 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 128.082 2.553 . . . . 0.0 112.06 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.8 t -160.26 148.3 16.62 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.659 1.184 . . . . 0.0 110.657 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -159.91 124.46 3.86 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.143 1.377 . . . . 0.0 110.573 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -155.16 146.78 23.16 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.129 -0.982 . . . . 0.0 112.695 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 23.9 t -119.42 131.03 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.036 1.734 . . . . 0.0 107.763 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -81.87 137.07 35.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.111 0.564 . . . . 0.0 110.54 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 53.9 mt -130.39 141.07 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.59 1.556 . . . . 0.0 109.764 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -84.54 126.35 33.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.438 0.695 . . . . 0.0 111.27 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.78 -16.44 61.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -83.35 -19.98 35.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.227 1.011 . . . . 0.0 112.995 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.0 p -133.53 -19.54 2.12 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 57.4 t30 62.9 17.84 10.32 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.19 1.796 . . . . 0.0 112.989 -171.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 94.2 mt -94.12 145.55 24.61 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.106 1.362 . . . . 0.0 111.055 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 66.4 m -72.22 133.57 45.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.094 0.958 . . . . 0.0 112.024 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -74.07 9.86 1.43 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.567 1.547 . . . . 0.0 114.522 -174.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 57.0 m 68.47 19.11 8.88 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.441 2.296 . . . . 0.0 113.69 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -145.56 154.34 42.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.453 1.024 . . . . 0.0 112.534 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.2 -176.1 27.01 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.282 1.896 . . . . 0.0 113.509 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -143.49 143.65 31.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.354 1.862 . . . . 0.0 110.068 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 80.7 t -142.53 147.48 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.442 1.497 . . . . 0.0 108.815 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.1 m -139.92 152.18 46.18 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.668 0.787 . . . . 0.0 112.003 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -121.24 169.02 10.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.535 1.534 . . . . 0.0 113.126 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.71 -22.53 65.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.081 1.353 . . . . 0.0 113.356 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -160.7 158.07 24.29 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.304 1.441 . . . . 0.0 112.306 -171.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.24 -16.04 43.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.656 2.238 . . . . 0.0 113.969 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.27 -44.31 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.595 1.543 . . . . 0.0 110.569 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.7 m -68.58 -31.47 70.68 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.01 0.924 . . . . 0.0 111.91 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.22 -48.47 34.75 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.931 0.892 . . . . 0.0 112.071 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -62.59 -32.89 73.96 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.436 -0.79 . . . . 0.0 111.882 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.65 -29.42 70.42 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.88 -42.3 33.84 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.525 0.73 . . . . 0.0 111.439 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.7 mt -58.5 -46.32 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 118.859 0.754 . . . . 0.0 110.201 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -71.18 -13.02 61.79 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.4 m -104.17 -27.78 11.85 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.5 mmm -115.34 -19.23 10.81 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -169.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -70.93 109.96 5.37 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.177 0.899 . . . . 0.0 109.903 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 97.18 2.36 59.2 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.619 1.58 . . . . 0.0 114.978 -171.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -62.04 125.06 22.55 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.574 1.687 . . . . 0.0 111.699 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -80.73 129.98 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.387 0.675 . . . . 0.0 110.965 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt -149.51 133.93 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.866 1.266 . . . . 0.0 110.492 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.87 -99.46 0.42 Allowed Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.722 0.677 . . . . 0.0 111.574 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 89.9 mtp -133.88 18.86 3.82 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.469 1.907 . . . . 0.0 112.287 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -146.27 -176.6 5.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.703 1.601 . . . . 0.0 112.783 -171.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.42 138.05 52.88 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.01 1.324 . . . . 0.0 111.582 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 69.1 mt -72.29 159.43 34.06 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.177 1.391 . . . . 0.0 111.992 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -129.17 141.92 51.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.178 1.391 . . . . 0.0 109.24 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 25.2 t -139.46 135.56 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.587 1.155 . . . . 0.0 109.144 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -155.97 151.06 26.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.195 0.598 . . . . 0.0 111.938 -172.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.04 152.41 40.34 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -63.07 -16.67 60.7 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.799 1.239 . . . . 0.0 113.104 169.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 29.7 ttt85 -58.71 -39.09 79.79 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.09 -1.007 . . . . 0.0 111.619 171.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 15.0 m -73.12 -10.87 60.24 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -84.35 -8.38 59.02 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.048 1.339 . . . . 0.0 112.313 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -135.01 -12.19 2.21 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.533 1.533 . . . . 0.0 114.563 -170.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -157.41 163.02 38.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.741 2.017 . . . . 0.0 110.459 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.8 p -153.07 -0.39 0.25 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -66.38 142.48 57.6 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.792 -1.192 . . . . 0.0 112.713 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.5 t -166.8 169.14 13.59 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.251 1.421 . . . . 0.0 111.444 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -164.83 167.08 38.4 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.429 1.49 . . . . 0.0 113.529 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.51 154.1 44.8 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.959 3.106 . . . . 0.0 111.669 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 34.8 p -84.33 -4.42 58.86 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.647 1.179 . . . . 0.0 114.107 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 67.6 m -147.83 149.54 32.51 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.381 1.872 . . . . 0.0 111.207 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 CA-C-O 118.253 -1.304 . . . . 0.0 112.926 178.826 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 36.7 p -70.3 -15.33 62.88 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.9 p -81.03 -1.36 43.7 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.958 1.703 . . . . 0.0 113.883 170.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.55 -168.17 18.3 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.91 1.719 . . . . 0.0 113.416 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 18.4 m -168.98 164.35 11.46 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.714 2.405 . . . . 0.0 110.37 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 15.1 m -72.96 -8.63 56.55 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 65.87 10.99 53.14 Favored Glycine 0 N--CA 1.476 1.321 0 C-N-CA 125.229 1.395 . . . . 0.0 115.79 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 7.7 mp 63.23 15.1 8.33 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 127.024 2.13 . . . . 0.0 112.246 -169.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 42.1 m -76.18 -35.96 58.89 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.108 1.363 . . . . 0.0 111.951 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -83.65 75.21 10.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.946 0.899 . . . . 0.0 110.557 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -128.62 11.66 6.26 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.138 1.375 . . . . 0.0 112.407 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 66.2 p -148.97 137.1 20.83 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.021 1.728 . . . . 0.0 109.288 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.95 149.67 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.107 1.363 . . . . 0.0 111.63 -168.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -80.72 61.37 4.51 Favored Glycine 0 N--CA 1.471 1.001 0 C-N-CA 124.894 1.235 . . . . 0.0 112.222 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.98 -40.36 0.45 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 129.033 2.933 . . . . 0.0 114.487 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -69.53 124.08 22.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.511 1.525 . . . . 0.0 111.287 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.65 6.48 70.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.747 1.641 . . . . 0.0 113.256 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.3 t -80.02 163.47 24.19 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.391 1.076 . . . . 0.0 113.224 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -126.99 8.73 6.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.917 1.287 . . . . 0.0 112.243 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -68.3 166.8 15.74 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.342 -0.849 . . . . 0.0 111.966 168.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.01 165.85 34.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.319 1.048 . . . . 0.0 112.267 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.63 -161.41 25.01 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 126.007 1.765 . . . . 0.0 113.976 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.26 177.64 8.01 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.098 3.199 . . . . 0.0 112.749 -174.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.9 126.83 28.8 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.107 0.963 . . . . 0.0 111.408 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.02 -7.27 82.59 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.042 1.306 . . . . 0.0 114.463 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.59 -2.11 45.55 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -114.8 122.22 45.68 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.27 1.028 . . . . 0.0 110.775 -168.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.7 mt -121.92 138.22 54.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.39 1.876 . . . . 0.0 111.971 -168.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -108.85 135.01 50.76 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.099 1.359 . . . . 0.0 108.834 167.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.95 135.31 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.978 1.711 . . . . 0.0 107.833 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -133.56 159.34 40.74 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.783 1.233 . . . . 0.0 112.434 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 68.5 30.58 5.19 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.218 2.207 . . . . 0.0 113.234 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.29 156.12 86.04 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.355 1.062 . . . . 0.0 111.556 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.71 148.41 74.49 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.183 2.589 . . . . 0.0 111.639 169.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -66.62 -19.36 65.75 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.45 -10.14 39.02 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -176.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.29 136.85 57.08 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.568 1.147 . . . . 0.0 113.203 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -113.11 -178.77 19.5 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.548 1.547 . . . . 0.0 112.799 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -64.48 -32.06 73.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.016 0.926 . . . . 0.0 113.131 -174.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -72.57 -35.21 67.92 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.08 0.952 . . . . 0.0 111.65 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -67.45 -41.69 84.31 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.737 0.699 . . . . 0.0 110.934 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.96 -36.53 78.0 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.101 0.56 . . . . 0.0 112.126 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 64.8 tp -64.08 -51.25 64.94 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.711 0.687 . . . . 0.0 111.097 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -65.47 -29.02 69.63 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.328 0.651 . . . . 0.0 112.274 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 47.0 ttm -67.85 -29.95 69.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.35 1.06 . . . . 0.0 113.006 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -106.24 -14.06 15.23 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.9 mtt -50.3 -37.64 30.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -61.06 -18.77 59.89 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.212 2.608 . . . . 0.0 115.75 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -97.4 -10.34 25.68 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.39 -159.37 27.73 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 125.217 1.389 . . . . 0.0 114.64 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -74.15 85.8 1.87 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.461 1.105 . . . . 0.0 112.436 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.18 125.89 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.134 0.974 . . . . 0.0 109.281 169.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.83 -33.68 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.146 1.779 . . . . 0.0 110.864 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 19.4 m -159.44 145.48 16.22 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.498 1.519 . . . . 0.0 110.875 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.78 143.74 24.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.582 1.553 . . . . 0.0 110.826 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -159.06 142.66 14.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.089 0.955 . . . . 0.0 112.947 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.97 138.88 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.136 1.774 . . . . 0.0 107.166 169.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -83.46 127.56 33.8 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 47.3 mm -115.51 138.46 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.987 1.315 . . . . 0.0 111.191 -168.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -71.92 127.8 33.73 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.994 1.318 . . . . 0.0 111.507 174.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -72.45 -11.43 60.67 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -173.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -104.54 -34.23 8.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.48 1.112 . . . . 0.0 112.272 -176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 -17.59 14.13 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 66.57 16.91 10.54 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.502 1.921 . . . . 0.0 113.14 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 90.2 mt -93.98 162.7 13.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.502 1.521 . . . . 0.0 111.787 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 36.1 t -66.65 138.57 57.53 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.631 -0.668 . . . . 0.0 111.923 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -75.97 3.55 10.03 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.241 1.016 . . . . 0.0 112.949 169.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 28.3 m 75.78 20.56 1.78 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.388 2.675 . . . . 0.0 113.179 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.52 158.02 43.8 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.816 0.846 . . . . 0.0 112.168 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.63 -173.7 28.44 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.979 1.752 . . . . 0.0 113.757 -170.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -147.09 140.44 25.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.592 1.957 . . . . 0.0 110.041 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 71.7 t -146.29 137.49 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.346 1.458 . . . . 0.0 109.278 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.0 m -135.56 141.72 45.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.638 0.775 . . . . 0.0 112.681 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -110.37 170.78 7.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.315 1.846 . . . . 0.0 112.183 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.72 -2.21 45.93 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -157.6 157.3 29.83 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 126.023 1.729 . . . . 0.0 111.887 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.06 -12.61 15.99 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.281 1.987 . . . . 0.0 113.899 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.9 t -79.28 -44.29 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.891 1.678 . . . . 0.0 110.648 -174.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 40.6 m -63.55 -31.96 73.28 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.339 1.056 . . . . 0.0 111.875 171.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -71.43 -51.47 23.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.088 0.955 . . . . 0.0 111.741 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -66.85 -29.66 69.63 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.312 -0.868 . . . . 0.0 112.241 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.44 71.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.791 0.723 . . . . 0.0 112.733 170.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.91 -41.71 61.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.78 0.718 . . . . 0.0 111.466 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 38.1 mt -56.59 -49.29 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 118.964 0.802 . . . . 0.0 110.308 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -70.45 -12.27 61.46 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.5 m -104.06 -28.0 11.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.7 mmm -116.43 -18.09 10.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -70.6 112.2 6.67 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.416 1.007 . . . . 0.0 110.113 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.57 3.22 64.77 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.953 1.74 . . . . 0.0 114.815 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.71 125.43 23.93 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.332 1.566 . . . . 0.0 111.355 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -86.15 130.04 34.65 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.034 0.533 . . . . 0.0 111.066 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.8 tt -149.51 130.95 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.3 1.44 . . . . 0.0 110.081 -173.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.53 -98.91 0.43 Allowed Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -173.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 75.3 mtm -137.11 20.35 2.99 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.377 1.871 . . . . 0.0 112.272 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.35 174.55 11.02 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.698 1.599 . . . . 0.0 112.522 -173.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -124.32 132.76 53.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.356 1.062 . . . . 0.0 111.703 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 60.8 mt -69.58 154.5 41.9 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.051 1.34 . . . . 0.0 112.343 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -124.17 138.98 54.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.639 1.176 . . . . 0.0 108.156 166.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 33.1 t -135.23 135.23 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.362 1.065 . . . . 0.0 108.212 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -152.02 146.66 25.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.277 0.631 . . . . 0.0 111.593 -169.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.75 157.77 29.37 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.862 0.865 . . . . 0.0 112.821 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -76.13 56.72 1.04 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.282 1.433 . . . . 0.0 110.581 168.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -161.02 132.72 5.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.785 1.634 . . . . 0.0 111.227 -169.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 66.9 p -155.9 7.51 0.22 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.054 1.341 . . . . 0.0 113.619 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -161.3 155.87 23.19 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.393 1.877 . . . . 0.0 110.717 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -148.38 144.87 27.79 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.671 1.189 . . . . 0.0 111.73 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -149.26 23.85 0.92 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 112.63 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 18.2 m -159.09 129.85 6.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.233 1.813 . . . . 0.0 110.181 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.28 24.86 14.83 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.271 1.428 . . . . 0.0 113.002 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 18.3 m -68.27 -13.72 62.46 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.184 1.394 . . . . 0.0 114.646 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 91.97 172.35 42.1 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.452 1.501 . . . . 0.0 114.144 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.7 162.56 32.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.344 3.363 . . . . 0.0 112.001 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 49.3 p -81.71 -1.55 47.35 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.734 1.213 . . . . 0.0 114.26 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 10.5 t -163.54 160.09 22.71 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.242 1.817 . . . . 0.0 111.121 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.277 1.418 . . . . 0.0 112.945 -178.074 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.544 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 18.9 m -81.86 -8.08 59.66 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -173.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.0 t -161.59 154.87 21.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.691 1.596 . . . . 0.0 111.114 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -96.82 167.71 24.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.191 1.377 . . . . 0.0 113.888 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 49.0 m -136.23 15.49 3.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.96 1.304 . . . . 0.0 112.798 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 83.4 p -164.22 174.22 11.45 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.766 1.626 . . . . 0.0 111.987 -170.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 92.1 -23.0 28.95 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.28 1.419 . . . . 0.0 114.703 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 8.2 mp 66.15 -179.17 0.2 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.409 2.284 . . . . 0.0 112.613 173.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 36.8 p -61.86 -16.86 53.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.827 1.651 . . . . 0.0 114.531 -172.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -63.19 -17.67 62.66 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.728 1.211 . . . . 0.0 112.635 171.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -98.34 -0.96 42.76 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.55 1.14 . . . . 0.0 112.686 172.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 16.3 m -100.31 9.6 42.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.319 1.448 . . . . 0.0 112.957 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 39.0 pt -75.78 148.96 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.304 1.442 . . . . 0.0 113.355 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -85.82 163.39 36.58 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.685 1.136 . . . . 0.0 112.645 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -73.11 -37.56 66.64 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.95 119.32 12.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.501 1.12 . . . . 0.0 111.563 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.67 3.28 86.28 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.608 1.575 . . . . 0.0 113.652 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 17.1 t -84.8 174.63 9.72 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.225 1.013 . . . . 0.0 112.514 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -132.77 21.36 4.21 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.067 1.747 . . . . 0.0 110.852 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -61.83 161.28 10.55 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.001 0.92 . . . . 0.0 112.6 168.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.56 155.62 45.02 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.04 -170.48 32.35 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.155 1.836 . . . . 0.0 113.301 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -70.03 177.43 5.77 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.151 3.234 . . . . 0.0 112.558 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.13 125.76 24.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.866 0.866 . . . . 0.0 111.198 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.23 -7.46 75.75 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.99 1.281 . . . . 0.0 114.609 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -103.55 8.7 37.69 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -117.96 123.95 47.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.03 1.332 . . . . 0.0 110.709 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 30.7 mt -124.64 140.4 52.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.351 1.86 . . . . 0.0 112.531 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -111.19 133.72 53.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.445 1.498 . . . . 0.0 109.147 168.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.29 137.33 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 126.108 1.763 . . . . 0.0 107.935 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -134.04 161.63 34.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.459 1.504 . . . . 0.0 112.051 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 63.01 33.28 14.92 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.233 1.813 . . . . 0.0 113.307 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 52.9 mt -65.75 159.07 71.63 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.296 1.038 . . . . 0.0 111.01 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -55.46 144.42 73.35 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.89 2.394 . . . . 0.0 111.967 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -55.69 -11.9 1.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.811 2.444 . . . . 0.0 115.587 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -131.05 0.74 4.22 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.294 1.838 . . . . 0.0 114.264 -169.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.04 133.64 51.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.604 1.562 . . . . 0.0 111.363 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.32 -179.86 23.91 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.899 1.238 . . . . 0.0 113.563 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -65.41 -32.45 74.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.046 0.938 . . . . 0.0 112.541 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -74.68 -39.96 61.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.828 1.651 . . . . 0.0 110.876 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -62.13 -44.36 96.81 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.93 0.892 . . . . 0.0 111.015 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 26.4 tp -66.16 -43.09 87.97 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.156 0.582 . . . . 0.0 111.803 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.4 tp -57.21 -54.17 49.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 111.211 175.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -73.96 -20.88 60.22 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.7 ttp -76.97 -22.29 53.43 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.037 0.835 . . . . 0.0 113.03 170.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -102.97 -15.59 16.08 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.964 1.305 . . . . 0.0 113.872 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 36.1 mtt -48.21 -37.86 17.68 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -62.41 -17.62 58.67 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.108 2.538 . . . . 0.0 115.488 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -97.04 -10.43 26.15 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.94 0.896 . . . . 0.0 113.327 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.41 -163.91 28.72 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.405 1.478 . . . . 0.0 114.449 171.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.12 100.61 2.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.932 0.893 . . . . 0.0 111.896 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.6 t -76.19 129.14 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.911 1.284 . . . . 0.0 110.191 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 42.1 t -94.63 -33.6 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.742 2.017 . . . . 0.0 111.541 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 8.6 t -155.75 152.96 29.15 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.96 1.304 . . . . 0.0 110.748 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.91 130.8 8.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.387 1.475 . . . . 0.0 110.351 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -153.95 144.93 22.71 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.465 -0.772 . . . . 0.0 112.544 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.31 131.46 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.203 1.801 . . . . 0.0 107.229 170.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -79.01 138.91 38.24 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.39 0.614 . . . . 0.0 111.11 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 35.6 mm -121.53 145.54 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.451 1.5 . . . . 0.0 110.601 -168.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -76.25 128.41 34.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.897 1.279 . . . . 0.0 111.866 171.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.73 -14.95 62.64 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -110.46 -29.96 7.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.623 1.169 . . . . 0.0 112.979 -174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 65.7 p -108.71 -15.09 14.48 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.327 1.051 . . . . 0.0 113.692 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 25.2 m120 64.92 17.19 10.93 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.33 1.852 . . . . 0.0 113.443 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 88.4 mt -89.24 151.76 21.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.277 1.431 . . . . 0.0 111.753 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 61.3 m -74.99 134.98 41.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.724 0.81 . . . . 0.0 111.893 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -82.05 3.75 25.58 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.082 1.353 . . . . 0.0 114.454 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 34.5 m 69.15 20.16 7.7 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.966 2.107 . . . . 0.0 113.626 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -144.43 156.33 44.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.184 0.994 . . . . 0.0 111.444 172.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.54 -175.36 28.38 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.715 1.626 . . . . 0.0 114.103 -169.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -139.3 146.67 40.63 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.571 1.948 . . . . 0.0 110.049 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 64.2 t -144.94 144.09 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.165 1.386 . . . . 0.0 109.188 174.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 95.7 p -137.16 155.12 49.96 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.389 -0.819 . . . . 0.0 112.884 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -126.82 162.24 26.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.321 1.448 . . . . 0.0 113.462 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.5 -19.78 64.55 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.277 1.031 . . . . 0.0 113.252 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -147.68 153.71 43.43 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.721 1.608 . . . . 0.0 111.066 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.61 -17.53 11.16 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.896 2.397 . . . . 0.0 113.785 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 90.8 t -71.45 -39.6 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.314 0.961 . . . . 0.0 110.333 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 7.8 m -62.44 -34.37 76.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.041 0.936 . . . . 0.0 111.77 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.01 -48.2 38.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.583 1.153 . . . . 0.0 111.97 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -59.3 -38.75 81.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.673 0.789 . . . . 0.0 111.895 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.95 -29.16 70.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.587 0.755 . . . . 0.0 112.957 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.91 -43.38 45.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.626 0.648 . . . . 0.0 111.098 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.4 mt -58.24 -47.39 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.272 0.942 . . . . 0.0 110.246 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -67.14 -17.93 65.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.327 1.051 . . . . 0.0 113.589 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.7 m -104.41 -23.66 13.15 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.5 mmt -112.49 -22.52 10.78 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.686 1.194 . . . . 0.0 113.542 -171.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -70.9 112.52 7.14 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 120.014 1.279 . . . . 0.0 110.831 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 88.15 1.88 81.23 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.587 1.565 . . . . 0.0 114.694 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.88 125.31 23.24 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.937 1.369 . . . . 0.0 111.3 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -77.35 131.71 38.21 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.34 0.59 . . . . 0.0 110.37 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 18.8 tt -138.25 98.65 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.394 1.477 . . . . 0.0 108.093 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.0 -122.66 11.78 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -168.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 92.7 mtp -100.03 11.91 38.17 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.382 1.473 . . . . 0.0 113.574 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -134.64 168.2 19.42 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.58 1.552 . . . . 0.0 112.537 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -124.17 137.05 54.59 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.809 1.244 . . . . 0.0 111.536 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.53 163.91 26.83 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.183 1.393 . . . . 0.0 112.574 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -137.33 139.68 41.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.863 1.665 . . . . 0.0 108.693 167.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.42 140.34 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.39 1.076 . . . . 0.0 109.881 -175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -149.19 154.28 38.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.683 1.193 . . . . 0.0 110.643 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.06 159.23 14.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.957 0.884 . . . . 0.0 111.562 167.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.37 109.35 1.12 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.553 1.141 . . . . 0.0 110.18 168.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 65.02 167.46 0.18 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.836 2.054 . . . . 0.0 112.443 -171.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 73.9 p -160.79 161.63 32.09 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.989 -1.069 . . . . 0.0 112.671 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -157.55 135.98 11.21 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.771 1.629 . . . . 0.0 110.484 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -161.08 149.23 15.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.847 1.259 . . . . 0.0 111.861 -175.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -144.82 16.65 1.6 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.165 1.386 . . . . 0.0 112.666 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 32.5 t -169.49 137.25 1.79 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.278 1.431 . . . . 0.0 111.636 -175.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -78.61 36.17 0.25 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.99 1.316 . . . . 0.0 112.942 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.4 t -161.56 172.0 17.11 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.561 1.944 . . . . 0.0 111.164 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 86.86 -164.96 36.02 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 124.821 1.201 . . . . 0.0 113.159 -174.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.76 147.92 51.47 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.698 2.932 . . . . 0.0 111.725 -176.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 20.7 t -165.43 168.86 16.26 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.621 1.568 . . . . 0.0 111.132 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 50.4 m -86.72 -13.23 45.95 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.102 0.961 . . . . 0.0 113.54 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 125.444 1.497 . . . . 0.0 112.82 -176.932 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 11.6 m -162.98 148.09 11.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.347 1.859 . . . . 0.0 110.63 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 52.7 p -94.69 -4.37 47.67 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 176.62 -165.36 35.57 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.061 1.315 . . . . 0.0 113.871 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 4.3 m -163.02 156.0 19.21 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.669 1.988 . . . . 0.0 110.806 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 7.8 t -161.71 175.45 11.99 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.954 1.302 . . . . 0.0 111.678 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -100.95 -149.75 23.49 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.98 1.752 . . . . 0.0 112.731 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 5.5 tp -89.81 17.59 6.5 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.333 1.453 . . . . 0.0 113.626 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 72.5 p 52.62 -90.39 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.372 3.069 . . . . 0.0 112.916 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -141.85 14.93 2.11 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.217 1.807 . . . . 0.0 111.35 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -87.86 2.17 52.12 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.819 -1.176 . . . . 0.0 112.495 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 25.2 p -75.24 9.36 2.1 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.28 1.832 . . . . 0.0 114.203 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 1.9 pp -81.7 -6.18 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.796 1.639 . . . . 0.0 114.164 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -97.2 -155.98 30.42 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.687 1.613 . . . . 0.0 112.426 174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.02 -35.79 80.69 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.17 -0.606 . . . . 0.0 112.36 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.97 121.02 14.15 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.919 1.288 . . . . 0.0 111.288 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.25 -0.88 84.06 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.5 1.524 . . . . 0.0 113.537 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.1 t -79.53 166.0 22.4 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.177 0.989 . . . . 0.0 112.881 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -128.68 18.1 6.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.665 1.586 . . . . 0.0 111.156 174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -64.62 167.25 7.48 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.999 0.92 . . . . 0.0 111.672 167.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -153.43 154.98 35.48 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.664 0.786 . . . . 0.0 112.187 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.57 -154.72 23.72 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.393 1.473 . . . . 0.0 113.153 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -67.35 161.1 44.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.188 2.592 . . . . 0.0 111.494 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.49 124.58 21.31 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.982 0.513 . . . . 0.0 110.678 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.6 -16.51 44.19 Favored Glycine 0 N--CA 1.473 1.132 0 C-N-CA 124.985 1.278 . . . . 0.0 113.454 -171.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.71 21.93 8.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.35 1.46 . . . . 0.0 112.716 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.94 116.23 21.17 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.298 1.439 . . . . 0.0 110.449 -167.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.5 mt -123.67 138.97 54.43 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.855 1.662 . . . . 0.0 112.361 -169.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.96 134.21 52.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.311 1.444 . . . . 0.0 108.99 167.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -118.51 135.74 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.089 1.755 . . . . 0.0 107.758 -172.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -134.32 158.99 42.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.035 1.334 . . . . 0.0 112.526 -174.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 70.75 27.47 3.61 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.892 2.477 . . . . 0.0 113.749 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.81 157.03 81.58 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.652 1.181 . . . . 0.0 112.038 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -59.36 150.82 72.5 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.001 2.467 . . . . 0.0 111.741 169.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -71.07 -10.3 59.53 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.509 1.123 . . . . 0.0 113.901 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.84 -6.97 15.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.949 2.1 . . . . 0.0 113.817 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.33 123.31 21.39 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.079 1.351 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -102.48 -176.81 27.35 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.405 1.002 . . . . 0.0 113.809 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -65.71 -34.7 78.8 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.793 0.837 . . . . 0.0 112.791 -175.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -77.58 -29.7 52.21 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.868 0.867 . . . . 0.0 111.807 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -68.4 -42.91 78.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.87 0.759 . . . . 0.0 110.657 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.5 tp -65.49 -40.27 92.88 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.184 0.593 . . . . 0.0 111.525 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 62.4 tp -61.19 -52.14 66.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.569 0.622 . . . . 0.0 111.313 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -64.37 -27.1 68.78 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.9 ttp -81.21 -20.15 41.71 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -110.3 -20.55 12.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 48.5 mtm -55.05 -31.57 9.86 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 169.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -57.28 -16.5 22.6 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.63 2.887 . . . . 0.0 116.106 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -98.26 -9.66 25.2 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.246 0.93 . . . . 0.0 113.437 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.79 -159.29 27.9 Favored Glycine 0 N--CA 1.469 0.892 0 C-N-CA 125.075 1.322 . . . . 0.0 115.047 170.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.0 90.71 1.51 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.3 1.04 . . . . 0.0 112.278 -171.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 86.1 t -71.58 130.47 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.762 1.225 . . . . 0.0 110.112 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 53.4 t -100.78 -27.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.286 2.235 . . . . 0.0 111.389 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 20.9 t -156.33 146.32 21.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.48 1.112 . . . . 0.0 110.657 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.63 132.36 9.53 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.573 1.549 . . . . 0.0 110.434 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -156.51 147.95 22.48 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.299 -0.876 . . . . 0.0 113.016 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.72 135.66 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.433 1.893 . . . . 0.0 107.646 173.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -85.22 137.06 33.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.41 0.684 . . . . 0.0 110.392 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 15.8 mt -131.85 137.49 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.301 1.44 . . . . 0.0 109.836 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -85.24 128.0 34.51 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.754 0.822 . . . . 0.0 111.897 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.41 -12.27 59.83 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.36 -20.75 31.46 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.097 0.959 . . . . 0.0 112.593 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 69.6 p -134.11 -18.97 2.01 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -171.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.6 t30 62.86 19.28 11.42 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.046 1.739 . . . . 0.0 112.657 -169.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.19 146.32 26.99 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.169 1.387 . . . . 0.0 111.159 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 66.0 m -72.24 136.97 46.5 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.551 1.141 . . . . 0.0 112.232 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -76.65 9.7 2.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.654 1.582 . . . . 0.0 114.289 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 55.5 m 69.72 19.16 7.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.53 2.332 . . . . 0.0 113.894 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -146.9 156.93 43.47 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.442 1.019 . . . . 0.0 112.528 173.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.81 -174.63 30.89 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.789 1.662 . . . . 0.0 113.702 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -138.99 147.48 42.21 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.333 1.853 . . . . 0.0 110.421 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.4 t -143.58 145.02 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.486 1.514 . . . . 0.0 108.865 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.5 t -143.47 147.99 35.38 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.416 -0.802 . . . . 0.0 112.647 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -117.85 167.17 11.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.154 1.782 . . . . 0.0 113.066 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.37 -13.58 62.14 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.143 1.377 . . . . 0.0 113.63 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -158.86 158.27 28.99 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 126.206 1.803 . . . . 0.0 111.664 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.98 -10.86 19.76 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.347 2.031 . . . . 0.0 113.844 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 29.0 t -77.1 -43.11 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 120.882 1.673 . . . . 0.0 110.555 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 27.2 m -64.86 -31.29 72.46 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.672 1.189 . . . . 0.0 111.773 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.75 -49.32 31.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.035 0.934 . . . . 0.0 111.76 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -61.76 -33.88 74.86 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.388 -0.82 . . . . 0.0 111.987 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.03 -29.63 70.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.318 0.647 . . . . 0.0 112.72 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.68 -41.53 45.09 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.704 0.684 . . . . 0.0 111.086 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 51.4 mt -57.99 -46.8 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 119.388 0.995 . . . . 0.0 110.208 174.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -70.87 -14.25 62.32 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 51.6 m -103.95 -26.6 12.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.9 mmm -114.69 -20.22 10.76 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -168.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -70.93 109.94 5.36 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.295 0.952 . . . . 0.0 109.765 173.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.46 2.4 61.8 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.443 1.497 . . . . 0.0 114.907 -171.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -63.94 126.42 27.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.489 1.645 . . . . 0.0 111.703 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -80.44 125.73 30.31 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.595 0.758 . . . . 0.0 110.203 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.5 tt -145.74 134.75 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.075 1.35 . . . . 0.0 109.953 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.93 -118.62 15.65 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 28.7 ptm -108.99 13.33 24.74 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.797 1.639 . . . . 0.0 113.843 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -143.66 -176.23 4.88 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.271 1.429 . . . . 0.0 113.243 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -124.37 142.12 51.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.539 1.535 . . . . 0.0 111.801 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.1 mt -76.7 161.64 28.35 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.297 1.439 . . . . 0.0 112.751 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -128.89 141.03 51.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.554 1.542 . . . . 0.0 108.709 167.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.4 t -138.47 136.82 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.481 1.112 . . . . 0.0 109.16 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -152.1 151.17 30.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.979 0.912 . . . . 0.0 111.056 -172.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.7 155.41 22.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.03 0.919 . . . . 0.0 112.899 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -56.89 131.56 49.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.759 1.224 . . . . 0.0 111.901 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -102.95 131.16 50.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.976 1.311 . . . . 0.0 111.334 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 51.9 p -93.34 173.85 7.5 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.692 1.997 . . . . 0.0 113.067 175.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 71.31 11.05 6.74 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.219 1.808 . . . . 0.0 115.311 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -151.22 147.26 26.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.813 1.245 . . . . 0.0 112.604 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -154.58 155.45 34.78 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.62 1.968 . . . . 0.0 110.68 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 22.5 m -76.76 -5.81 49.66 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -66.95 137.54 56.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.892 1.277 . . . . 0.0 112.348 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.3 t -152.61 -177.2 6.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.965 1.706 . . . . 0.0 110.63 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 93.36 171.86 39.79 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 125.639 1.59 . . . . 0.0 113.737 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.41 158.74 40.44 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.158 3.238 . . . . 0.0 112.254 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 26.0 t -164.34 153.92 13.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.572 1.549 . . . . 0.0 111.045 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 30.9 m -82.68 -6.75 59.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.135 1.35 . . . . 0.0 113.018 179.896 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 112.125 -0.39 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 95.8 p -163.85 176.12 9.78 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.423 1.489 . . . . 0.0 111.683 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 47.6 p -82.86 0.76 42.61 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.843 1.257 . . . . 0.0 114.24 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -77.93 155.48 42.73 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.802 1.192 . . . . 0.0 113.558 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 19.4 m -89.62 -3.5 58.24 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 50.0 m 65.11 -0.66 1.03 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.721 2.008 . . . . 0.0 115.913 171.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.79 11.74 84.36 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.934 1.254 . . . . 0.0 114.356 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 56.7 tp -74.04 110.84 8.65 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.61 1.205 . . . . 0.0 111.417 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.2 m -61.52 -24.56 66.7 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.389 1.875 . . . . 0.0 113.816 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -62.11 -12.14 17.9 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.084 1.354 . . . . 0.0 113.421 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -79.59 -3.07 45.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.661 1.185 . . . . 0.0 112.906 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 15.5 t -116.97 140.83 49.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.403 1.481 . . . . 0.0 111.157 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.89 151.58 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.065 1.746 . . . . 0.0 111.257 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -132.68 -114.78 1.59 Allowed Glycine 0 N--CA 1.47 0.918 0 C-N-CA 125.361 1.458 . . . . 0.0 112.426 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.48 -51.07 2.7 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 112.892 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.46 122.49 18.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.207 1.003 . . . . 0.0 111.005 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.68 -6.61 82.27 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.343 1.449 . . . . 0.0 113.293 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 66.2 m -98.42 131.4 44.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.242 1.417 . . . . 0.0 110.067 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -103.74 38.51 1.8 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.186 0.995 . . . . 0.0 112.254 -170.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -74.24 -177.44 3.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.667 0.787 . . . . 0.0 110.877 168.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.42 166.63 31.77 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 169.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.77 -165.48 29.28 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.158 1.837 . . . . 0.0 113.572 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.44 171.32 16.44 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.031 3.154 . . . . 0.0 112.47 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.98 126.62 28.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.663 0.785 . . . . 0.0 111.334 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.79 -11.71 71.49 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.8 1.19 . . . . 0.0 114.027 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.82 -1.44 57.35 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.659 1.229 . . . . 0.0 113.963 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -113.4 125.04 53.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.941 1.296 . . . . 0.0 111.458 -169.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.0 mt -124.71 140.23 53.12 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.756 2.022 . . . . 0.0 111.751 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -110.84 132.25 54.36 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.09 1.356 . . . . 0.0 108.594 167.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.67 134.96 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.982 1.713 . . . . 0.0 107.602 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.8 160.34 37.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.242 1.417 . . . . 0.0 112.292 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 69.66 28.88 4.36 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.555 2.342 . . . . 0.0 113.693 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 58.5 mt -68.58 161.2 72.37 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.653 1.181 . . . . 0.0 111.417 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.68 151.1 78.66 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.96 2.44 . . . . 0.0 111.259 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -72.06 -9.07 57.89 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.692 1.197 . . . . 0.0 113.959 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -112.76 -6.72 13.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.256 2.222 . . . . 0.0 113.838 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 130.15 42.29 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.167 1.387 . . . . 0.0 110.898 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.77 178.9 25.16 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.387 0.994 . . . . 0.0 113.842 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -64.6 -33.97 77.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.725 0.81 . . . . 0.0 112.58 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.4 -31.17 57.81 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.087 0.955 . . . . 0.0 111.812 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -66.99 -42.68 84.63 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.821 0.737 . . . . 0.0 110.652 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.55 -39.87 88.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.357 0.663 . . . . 0.0 111.745 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.17 -52.08 65.26 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.641 0.655 . . . . 0.0 111.31 174.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -63.72 -28.01 69.59 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.7 ttp -80.61 -19.93 44.35 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -111.19 -19.48 12.67 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.3 mtm -55.05 -31.73 10.33 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -57.52 -16.74 24.95 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.579 2.853 . . . . 0.0 116.25 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -97.51 -9.53 26.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.41 -162.32 28.21 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.17 1.367 . . . . 0.0 114.348 172.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -72.8 88.14 1.31 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.642 0.777 . . . . 0.0 112.182 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.5 t -65.27 127.41 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.363 1.065 . . . . 0.0 109.403 170.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 45.5 t -91.64 -38.86 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.671 1.988 . . . . 0.0 110.841 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.61 149.52 23.89 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.641 1.176 . . . . 0.0 111.181 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.39 140.29 20.07 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.345 1.458 . . . . 0.0 110.738 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -155.8 140.14 16.68 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.474 -0.766 . . . . 0.0 111.788 -169.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.47 130.8 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.548 1.539 . . . . 0.0 107.498 168.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -84.34 141.76 30.66 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.32 0.648 . . . . 0.0 111.172 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 42.5 mm -118.15 134.9 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.235 1.414 . . . . 0.0 110.269 -169.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -82.26 128.0 33.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.927 0.891 . . . . 0.0 111.781 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -67.66 -12.04 59.59 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -89.99 -21.31 22.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.417 1.087 . . . . 0.0 112.835 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 76.3 p -137.64 -17.76 1.27 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -169.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 64.73 15.06 9.54 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.287 1.835 . . . . 0.0 113.17 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.54 161.18 15.06 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.382 1.473 . . . . 0.0 111.082 175.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 64.5 m -76.65 136.09 39.15 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.66 -0.65 . . . . 0.0 111.561 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.3 4.9 2.53 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -174.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.9 m 67.11 19.76 10.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.863 2.065 . . . . 0.0 113.115 -172.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -146.81 155.25 42.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.864 0.865 . . . . 0.0 112.311 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.88 -175.6 27.99 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.152 1.834 . . . . 0.0 113.559 -170.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -136.25 145.5 45.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.716 2.006 . . . . 0.0 110.285 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 61.4 t -143.27 141.14 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.318 1.447 . . . . 0.0 108.529 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 37.3 p -137.53 146.7 44.45 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.027 0.931 . . . . 0.0 112.18 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -119.82 169.29 10.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.178 1.391 . . . . 0.0 113.223 -174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.03 -23.75 66.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.972 1.309 . . . . 0.0 113.26 169.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -160.0 157.93 25.96 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.24 1.416 . . . . 0.0 112.394 -171.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.13 -15.14 42.47 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.765 2.31 . . . . 0.0 114.026 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.18 -44.78 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 120.754 1.615 . . . . 0.0 110.679 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 57.4 m -68.06 -30.97 70.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.991 0.917 . . . . 0.0 111.886 174.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.64 42.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.659 0.784 . . . . 0.0 111.81 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -58.57 -39.24 79.77 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.487 -0.758 . . . . 0.0 111.947 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.84 -28.76 69.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -79.14 -44.27 22.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.705 0.684 . . . . 0.0 111.386 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 49.4 mt -57.07 -47.53 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.523 1.056 . . . . 0.0 110.151 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -74.66 -10.86 59.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.199 0.999 . . . . 0.0 113.227 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -104.28 -26.55 12.44 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.7 mmm -113.12 -19.86 11.69 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -168.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -70.9 111.19 6.12 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 119.385 0.993 . . . . 0.0 109.954 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.48 2.55 65.45 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.142 1.83 . . . . 0.0 115.172 -171.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.06 124.99 23.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.256 1.528 . . . . 0.0 111.543 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -73.5 131.12 41.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.852 0.296 . . . . 0.0 110.594 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.0 tt -137.24 109.88 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.311 1.044 . . . . 0.0 108.325 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 63.09 -118.43 13.95 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -168.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 62.7 mtt -99.96 -1.97 35.81 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.057 1.343 . . . . 0.0 113.623 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -95.39 168.2 10.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.658 1.183 . . . . 0.0 112.697 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -128.85 125.71 38.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.219 1.408 . . . . 0.0 108.515 166.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 79.7 mt -68.81 160.98 29.5 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.349 1.06 . . . . 0.0 112.079 -176.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -126.2 141.39 51.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.636 1.574 . . . . 0.0 108.638 168.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.07 136.45 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.121 0.968 . . . . 0.0 109.418 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -149.83 146.1 26.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.178 0.991 . . . . 0.0 111.279 -172.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.74 150.17 47.83 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.786 0.834 . . . . 0.0 113.236 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.27 -31.05 72.11 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.568 0.747 . . . . 0.0 111.322 168.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -77.63 82.75 4.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.695 1.598 . . . . 0.0 110.186 170.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 80.4 p -161.14 164.42 30.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.064 1.745 . . . . 0.0 111.025 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -69.99 151.69 45.29 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -169.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -110.97 11.97 22.17 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.807 2.043 . . . . 0.0 113.276 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -156.05 166.96 31.92 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.686 2.394 . . . . 0.0 109.458 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 7.4 m 68.01 20.23 9.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.031 1.732 . . . . 0.0 112.903 -173.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -73.96 -3.67 30.49 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -168.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 77.4 p -161.52 160.22 28.83 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.954 1.702 . . . . 0.0 111.432 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 163.86 -146.83 11.97 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.02 1.295 . . . . 0.0 112.527 -175.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.18 -14.95 20.61 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.118 2.546 . . . . 0.0 113.404 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 60.8 p -116.01 0.56 13.07 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.095 1.358 . . . . 0.0 114.29 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 19.9 t -166.44 144.66 5.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.249 1.42 . . . . 0.0 111.549 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.347 -1.252 . . . . 0.0 112.872 -179.802 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 19.2 m -83.29 -7.22 59.62 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.5 t -162.93 165.13 25.44 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.839 1.656 . . . . 0.0 111.122 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 82.05 -165.39 45.3 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.944 1.259 . . . . 0.0 113.565 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 79.1 p -163.44 162.63 24.87 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.57 1.548 . . . . 0.0 111.645 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 77.6 p -163.51 164.11 24.46 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.895 1.278 . . . . 0.0 112.306 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -91.09 -146.32 16.84 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.189 1.376 . . . . 0.0 112.925 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 61.5 tp -150.77 130.5 13.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.197 1.399 . . . . 0.0 110.461 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 73.6 p -146.75 174.4 11.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.842 2.057 . . . . 0.0 110.353 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -125.55 44.85 2.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.211 1.405 . . . . 0.0 109.629 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -128.18 13.68 6.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.377 1.471 . . . . 0.0 112.362 -170.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 10.6 m -73.59 26.59 0.07 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.851 2.061 . . . . 0.0 115.291 -169.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 34.0 pt -73.24 140.45 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.712 -1.242 . . . . 0.0 112.578 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -132.98 20.16 4.31 Favored Glycine 0 N--CA 1.474 1.228 0 C-N-CA 125.158 1.361 . . . . 0.0 114.764 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.09 99.2 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.254 1.027 . . . . 0.0 113.73 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -68.64 118.8 12.11 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.652 1.181 . . . . 0.0 110.399 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.76 -3.24 74.08 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.194 0.902 . . . . 0.0 113.211 -176.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.1 t -98.35 163.8 12.55 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.356 1.062 . . . . 0.0 111.62 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -134.4 18.06 3.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.947 1.299 . . . . 0.0 112.216 -170.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.52 169.59 3.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.461 1.104 . . . . 0.0 111.783 168.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.41 158.9 44.32 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.838 -1.164 . . . . 0.0 111.855 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.72 -162.08 26.92 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.903 1.716 . . . . 0.0 113.401 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.46 171.23 14.51 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.822 3.015 . . . . 0.0 112.628 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.31 121.09 9.94 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.084 0.954 . . . . 0.0 111.359 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.11 -4.0 73.84 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.949 1.261 . . . . 0.0 114.675 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.15 2.71 55.92 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.002 1.401 . . . . 0.0 114.173 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -118.35 125.66 50.5 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.721 1.208 . . . . 0.0 111.343 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.47 137.45 54.79 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.477 1.911 . . . . 0.0 112.026 -169.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.64 133.88 50.63 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.155 1.382 . . . . 0.0 108.352 167.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 9.3 mm -117.53 136.41 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.641 1.576 . . . . 0.0 108.517 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -135.37 161.5 35.26 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.114 0.965 . . . . 0.0 112.569 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 62.03 36.62 15.36 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.334 1.854 . . . . 0.0 113.299 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 46.0 mt -70.93 162.92 69.29 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.052 1.341 . . . . 0.0 111.392 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.87 149.06 90.32 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.04 2.493 . . . . 0.0 111.231 168.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -71.07 -10.45 59.78 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -104.1 -9.53 18.67 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.473 1.909 . . . . 0.0 114.27 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.28 126.94 31.14 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.608 1.163 . . . . 0.0 111.211 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.22 -174.79 24.31 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.961 1.267 . . . . 0.0 112.9 171.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -62.51 -34.6 77.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.743 0.817 . . . . 0.0 112.925 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -77.55 -30.52 52.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.856 0.862 . . . . 0.0 112.001 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -70.1 -40.43 74.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.606 0.639 . . . . 0.0 110.615 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 23.4 tp -66.42 -39.23 88.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.342 0.657 . . . . 0.0 111.601 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 64.1 tp -61.61 -49.67 75.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.81 0.732 . . . . 0.0 111.053 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -68.64 -23.02 64.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.7 ttm -73.56 -29.88 62.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.021 0.929 . . . . 0.0 113.002 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -109.23 -17.8 13.75 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -171.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.0 mtm -53.61 -33.09 12.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -59.53 -15.36 30.2 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.479 2.786 . . . . 0.0 116.475 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -102.48 -10.69 19.15 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -175.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 154.09 -169.45 32.58 Favored Glycine 0 N--CA 1.469 0.882 0 C-N-CA 125.089 1.328 . . . . 0.0 113.991 174.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -73.93 99.68 3.32 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.14 -0.624 . . . . 0.0 110.991 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.7 t -72.2 125.73 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.22 1.008 . . . . 0.0 109.336 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 37.3 t -86.64 -36.12 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.363 1.865 . . . . 0.0 111.017 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.7 m -161.22 151.59 17.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.213 1.805 . . . . 0.0 110.47 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.14 134.22 15.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.523 1.529 . . . . 0.0 110.225 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -153.36 135.5 14.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.392 0.677 . . . . 0.0 112.08 -174.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.7 t -106.73 135.02 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.205 1.802 . . . . 0.0 107.086 168.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.58 140.43 32.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.249 0.62 . . . . 0.0 111.171 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.5 mm -120.88 137.7 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.166 1.386 . . . . 0.0 110.917 -168.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.09 133.13 42.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.183 1.393 . . . . 0.0 112.47 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -77.99 -7.09 56.38 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -172.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -111.92 -18.85 12.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.517 1.127 . . . . 0.0 113.063 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.2 p -126.37 -15.3 5.69 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.34 1.456 . . . . 0.0 113.982 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 53.3 t30 64.17 16.0 9.72 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.082 1.753 . . . . 0.0 113.355 -175.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.09 153.98 20.83 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.413 1.485 . . . . 0.0 111.216 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 63.0 m -76.47 134.46 39.52 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.538 -0.726 . . . . 0.0 111.603 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.02 3.54 8.22 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 64.1 m 69.11 20.03 7.8 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.167 2.187 . . . . 0.0 113.614 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.27 156.86 44.83 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.898 0.879 . . . . 0.0 112.063 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.1 -172.01 26.74 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.664 1.602 . . . . 0.0 114.316 -169.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -144.32 144.89 31.68 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.491 1.916 . . . . 0.0 110.127 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 78.9 t -144.88 139.08 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.529 1.532 . . . . 0.0 109.049 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 77.8 p -134.43 153.39 51.94 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.913 0.885 . . . . 0.0 112.66 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -128.65 167.57 17.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.86 1.264 . . . . 0.0 114.179 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -67.57 -21.48 65.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.487 1.515 . . . . 0.0 114.607 172.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -152.4 156.48 33.56 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.526 1.531 . . . . 0.0 111.931 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -63.37 -29.77 72.38 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.652 2.901 . . . . 0.0 113.415 174.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.8 -39.57 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.001 0.921 . . . . 0.0 110.865 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 16.3 m -58.92 -35.61 73.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.089 0.955 . . . . 0.0 111.61 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -76.95 -48.41 18.18 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.237 1.415 . . . . 0.0 112.576 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -61.18 -32.21 71.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.321 1.048 . . . . 0.0 112.367 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.15 72.22 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.305 0.642 . . . . 0.0 112.64 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.81 33.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.532 0.733 . . . . 0.0 111.841 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 38.6 mt -58.01 -46.5 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.121 0.873 . . . . 0.0 110.235 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -72.39 -12.81 61.28 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.9 m -103.9 -30.4 10.36 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 83.9 mmm -112.84 -18.75 12.2 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -169.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -70.16 111.97 6.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.66 1.118 . . . . 0.0 110.496 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.24 1.76 69.11 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.744 1.64 . . . . 0.0 114.821 -173.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.13 124.72 21.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.255 1.528 . . . . 0.0 111.636 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -80.27 127.48 32.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.603 0.761 . . . . 0.0 110.19 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.2 tt -148.57 132.36 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.953 1.301 . . . . 0.0 109.793 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.8 -120.37 22.13 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -173.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.17 16.0 24.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.625 1.57 . . . . 0.0 113.008 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -139.01 -176.4 4.49 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.415 1.486 . . . . 0.0 113.341 -170.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -132.48 136.56 46.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.643 1.577 . . . . 0.0 110.942 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 53.3 mt -68.14 161.65 26.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.19 1.396 . . . . 0.0 112.485 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -137.55 142.61 41.37 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.668 1.587 . . . . 0.0 109.161 167.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 34.6 t -139.31 133.11 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.591 1.156 . . . . 0.0 109.019 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -142.25 151.92 42.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.195 0.998 . . . . 0.0 111.482 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 58.9 mt -66.36 152.8 44.28 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.938 0.875 . . . . 0.0 113.151 172.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -66.91 140.26 57.76 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.536 1.134 . . . . 0.0 111.534 169.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -137.11 130.12 30.74 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.886 1.674 . . . . 0.0 110.822 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 10.3 t -168.65 168.93 10.51 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.121 1.768 . . . . 0.0 111.003 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -138.36 -42.32 0.5 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.378 1.471 . . . . 0.0 112.767 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -168.21 154.13 7.12 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.561 1.944 . . . . 0.0 111.549 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -113.83 -0.05 14.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.815 1.646 . . . . 0.0 113.502 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 74.4 p -169.6 172.98 6.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.491 1.916 . . . . 0.0 111.195 -169.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -144.47 -12.78 0.6 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.725 1.61 . . . . 0.0 114.174 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 7.7 t -151.1 177.2 10.42 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.618 1.167 . . . . 0.0 112.959 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -88.96 -101.44 1.01 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.994 1.759 . . . . 0.0 111.486 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.9 99.46 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.375 2.717 . . . . 0.0 109.016 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 35.9 t -173.11 169.21 4.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.65 1.58 . . . . 0.0 110.835 -168.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 51.8 p -76.64 -9.53 58.73 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.028 -1.045 . . . . 0.0 112.229 167.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.339 0 C-N-CA 128.042 2.734 . . . . 0.0 111.933 176.612 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.617 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 29.2 p -68.96 -16.61 63.78 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.1 p -70.7 -10.59 59.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.052 1.341 . . . . 0.0 113.736 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -86.07 8.15 74.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.595 1.569 . . . . 0.0 114.134 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 8.4 t -157.64 -171.86 3.73 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.481 1.513 . . . . 0.0 111.567 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 45.5 m -80.37 54.09 1.94 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.022 1.729 . . . . 0.0 112.427 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.44 -14.61 79.35 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.801 1.191 . . . . 0.0 115.002 -174.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 62.8 tp -83.24 123.78 29.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.732 1.213 . . . . 0.0 110.202 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 76.2 p -73.42 -32.62 64.52 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.559 1.144 . . . . 0.0 113.277 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 67.28 18.06 10.26 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.693 1.997 . . . . 0.0 112.517 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -92.59 -7.31 47.45 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.01 -1.056 . . . . 0.0 113.766 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 78.5 p -94.34 11.9 28.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.165 1.386 . . . . 0.0 113.526 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 16.8 pt -86.0 169.03 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.785 1.634 . . . . 0.0 113.038 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.12 131.32 7.26 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.194 1.378 . . . . 0.0 111.547 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.18 -60.1 0.42 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.997 2.519 . . . . 0.0 110.746 -169.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.02 116.55 7.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.923 1.289 . . . . 0.0 110.181 169.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.0 -9.08 67.29 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.452 1.501 . . . . 0.0 113.173 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.6 m -76.52 158.67 31.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.168 0.987 . . . . 0.0 110.078 169.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -139.86 31.51 2.02 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.379 -0.826 . . . . 0.0 112.133 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -69.33 174.15 5.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.548 0.739 . . . . 0.0 111.007 167.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.78 160.59 43.43 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.92 -160.19 26.56 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.982 1.753 . . . . 0.0 113.453 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.23 172.41 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.899 3.066 . . . . 0.0 112.862 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -59.18 120.63 9.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.419 1.088 . . . . 0.0 110.917 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.01 -3.53 70.32 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.003 1.287 . . . . 0.0 114.708 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.18 0.86 51.74 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.975 1.388 . . . . 0.0 114.421 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -117.15 123.54 46.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.645 1.178 . . . . 0.0 111.271 -169.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.0 mt -123.6 141.51 51.94 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.532 1.933 . . . . 0.0 112.525 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -111.61 134.19 53.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.784 1.634 . . . . 0.0 108.463 167.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.87 135.64 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.733 1.613 . . . . 0.0 107.832 -172.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -131.55 162.42 30.34 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.128 1.371 . . . . 0.0 111.92 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 63.02 37.06 12.0 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.465 1.906 . . . . 0.0 113.273 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 54.6 mt -70.11 161.62 74.47 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.792 1.237 . . . . 0.0 112.083 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.99 154.14 58.88 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.418 2.746 . . . . 0.0 111.123 168.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -75.51 -19.91 59.06 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -96.76 -6.38 36.36 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.57 1.548 . . . . 0.0 114.207 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.01 128.12 35.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.862 1.265 . . . . 0.0 111.819 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -107.26 -177.56 22.67 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.963 1.268 . . . . 0.0 113.506 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.46 -34.2 77.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.11 0.964 . . . . 0.0 112.703 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -75.97 -27.24 57.41 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.402 1.081 . . . . 0.0 111.676 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -75.5 -42.29 53.17 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.881 0.872 . . . . 0.0 110.723 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 27.1 tp -64.76 -36.63 84.91 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.334 0.653 . . . . 0.0 111.686 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.4 -51.22 69.64 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.417 0.553 . . . . 0.0 110.702 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -69.01 -20.99 64.16 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.7 ttm -73.98 -26.95 60.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.108 0.963 . . . . 0.0 112.817 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -113.03 -18.29 12.23 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.9 mtm -53.24 -34.03 16.77 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 170.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -59.44 -16.88 37.75 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.559 2.839 . . . . 0.0 116.215 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -100.2 -9.01 22.92 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.408 1.004 . . . . 0.0 113.664 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.78 -163.37 28.57 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.981 1.277 . . . . 0.0 114.75 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -70.68 96.53 1.23 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.311 1.044 . . . . 0.0 112.285 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 80.3 t -74.85 128.43 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.089 1.355 . . . . 0.0 109.881 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 38.7 t -88.69 -36.78 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.57 1.948 . . . . 0.0 111.045 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.8 m -160.25 150.73 18.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.511 1.525 . . . . 0.0 110.814 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.4 130.39 11.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.232 1.813 . . . . 0.0 109.637 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -152.71 144.73 23.76 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.539 -0.726 . . . . 0.0 112.854 -171.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.0 t -119.18 135.93 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.554 1.942 . . . . 0.0 108.219 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -85.19 131.94 34.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.539 0.736 . . . . 0.0 109.853 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 44.1 mm -114.43 135.74 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.723 1.209 . . . . 0.0 111.316 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.28 131.88 43.3 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.437 1.495 . . . . 0.0 111.938 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -82.04 -2.0 50.28 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -171.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -108.52 -27.63 9.78 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.672 1.189 . . . . 0.0 112.297 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.2 p -119.28 -15.31 9.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.292 1.437 . . . . 0.0 114.236 -174.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 51.6 t30 63.79 15.25 8.9 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.063 1.745 . . . . 0.0 113.271 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.9 mt -86.96 160.58 18.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.496 1.518 . . . . 0.0 111.315 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 27.4 t -62.08 138.69 58.42 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.68 -0.638 . . . . 0.0 110.867 168.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -72.34 2.65 5.74 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 66.5 m 73.52 20.36 3.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.265 2.626 . . . . 0.0 113.003 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -146.38 155.68 42.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.678 0.791 . . . . 0.0 112.394 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.38 -173.95 29.57 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.968 1.747 . . . . 0.0 113.675 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -140.94 145.67 36.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.406 1.883 . . . . 0.0 110.141 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.1 t -145.36 139.18 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.155 1.382 . . . . 0.0 109.279 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.1 p -133.38 149.06 51.86 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.327 1.051 . . . . 0.0 112.328 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -121.55 163.34 19.03 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.099 1.359 . . . . 0.0 113.323 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.27 -18.2 63.12 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.293 1.037 . . . . 0.0 113.073 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -145.52 151.78 47.8 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.273 1.429 . . . . 0.0 112.182 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.91 -29.34 58.09 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.829 3.019 . . . . 0.0 113.868 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.45 -40.97 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.705 0.802 . . . . 0.0 110.916 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.1 m -62.06 -33.27 74.09 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.856 0.862 . . . . 0.0 111.918 173.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.72 -49.26 21.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.993 1.317 . . . . 0.0 112.129 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -60.99 -33.65 73.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.062 0.945 . . . . 0.0 112.126 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.11 -31.05 72.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.358 0.663 . . . . 0.0 112.642 172.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.36 -41.53 47.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.344 0.658 . . . . 0.0 111.68 175.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 40.2 mt -58.14 -47.29 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.03 0.832 . . . . 0.0 110.153 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.24 -14.27 62.18 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.9 m -102.18 -29.78 11.52 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 86.1 mmm -113.32 -18.04 12.15 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -169.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -70.26 111.78 6.12 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.491 1.041 . . . . 0.0 110.551 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.93 1.75 67.27 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.885 1.707 . . . . 0.0 114.77 -173.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.9 124.43 20.46 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.215 1.507 . . . . 0.0 111.615 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -80.39 127.71 32.71 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.613 0.765 . . . . 0.0 110.175 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.5 tt -148.31 131.99 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.888 1.275 . . . . 0.0 109.713 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.74 -118.78 14.95 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -173.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -109.71 16.36 22.16 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.871 1.668 . . . . 0.0 112.624 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -138.98 -176.46 4.5 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.615 1.566 . . . . 0.0 113.173 -171.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -132.5 137.24 47.12 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.528 1.531 . . . . 0.0 110.941 173.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 59.5 mt -68.96 161.01 29.77 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.978 1.311 . . . . 0.0 112.328 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.96 141.21 42.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.435 1.494 . . . . 0.0 108.967 168.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.35 138.2 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.532 1.133 . . . . 0.0 109.302 -175.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -151.02 152.76 33.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.241 1.016 . . . . 0.0 110.757 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.32 157.63 16.13 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.6 0.76 . . . . 0.0 112.778 170.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -53.69 134.1 41.81 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.942 1.297 . . . . 0.0 112.673 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -103.5 9.34 37.65 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.676 1.59 . . . . 0.0 114.617 -171.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 69.0 m -138.52 152.03 47.88 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.376 1.47 . . . . 0.0 111.205 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -138.29 156.26 47.82 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.936 1.294 . . . . 0.0 112.424 -174.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -71.87 167.77 19.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.874 1.27 . . . . 0.0 112.902 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -153.14 128.48 9.87 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.986 1.314 . . . . 0.0 110.4 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 53.5 p -69.87 -19.57 63.43 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -171.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -72.64 -4.72 32.7 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 44.8 m -113.69 12.29 18.35 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.922 1.689 . . . . 0.0 112.713 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -82.19 -171.1 45.9 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.326 1.441 . . . . 0.0 114.253 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.98 -10.93 30.43 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.772 2.981 . . . . 0.0 113.796 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 24.8 p -73.35 -8.5 56.14 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.949 1.3 . . . . 0.0 113.841 170.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 94.5 p -136.76 3.78 2.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.084 1.354 . . . . 0.0 114.263 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.197 0 CA-C-O 118.2 -1.333 . . . . 0.0 113.247 178.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.587 0 CA-C-O 121.29 0.567 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.35 -6.53 81.71 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.66 1.6 . . . . 0.0 113.168 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 4.2 t -82.63 157.29 23.47 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.455 1.128 . . . . 0.0 113.421 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -128.54 13.87 6.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.994 1.318 . . . . 0.0 112.26 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -70.62 176.08 4.41 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.377 -0.827 . . . . 0.0 110.195 167.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.48 157.46 39.87 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.263 -0.898 . . . . 0.0 112.355 168.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.82 -157.39 22.72 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.339 1.447 . . . . 0.0 113.235 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.92 160.61 43.31 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.197 2.598 . . . . 0.0 111.488 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.04 124.33 20.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.103 0.561 . . . . 0.0 110.983 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.58 -8.74 60.27 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.024 1.297 . . . . 0.0 113.68 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.85 22.1 7.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.168 1.387 . . . . 0.0 112.646 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.7 118.6 25.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.413 1.485 . . . . 0.0 110.084 -167.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 27.9 mt -125.33 141.95 51.78 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.106 1.763 . . . . 0.0 112.659 -168.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -114.54 134.06 55.32 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.382 1.473 . . . . 0.0 109.283 168.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.56 134.71 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.318 1.847 . . . . 0.0 107.884 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -133.08 158.62 42.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.743 1.217 . . . . 0.0 112.87 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 73.2 26.86 2.05 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.984 2.513 . . . . 0.0 113.528 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.45 149.6 97.9 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.599 1.16 . . . . 0.0 111.373 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -58.32 149.87 70.78 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.247 2.631 . . . . 0.0 112.454 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -69.23 -9.72 54.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.63 -11.32 23.73 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.969 1.708 . . . . 0.0 114.168 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.07 126.34 30.31 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.261 1.024 . . . . 0.0 111.549 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -108.3 -171.65 21.47 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.545 1.545 . . . . 0.0 112.096 169.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.73 -32.56 74.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.047 0.939 . . . . 0.0 113.145 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -78.5 -30.38 47.18 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.993 0.917 . . . . 0.0 112.079 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -70.55 -40.78 73.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.71 0.686 . . . . 0.0 110.632 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 28.6 tp -65.63 -37.66 87.22 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.382 0.673 . . . . 0.0 111.838 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 65.1 tp -62.52 -51.71 66.33 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.702 0.683 . . . . 0.0 111.253 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -63.92 -30.78 71.84 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.1 0.56 . . . . 0.0 112.423 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.0 ttm -68.57 -29.45 67.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.345 1.058 . . . . 0.0 113.11 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -106.36 -13.23 15.43 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 29.7 mtt -49.66 -37.36 23.26 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -61.78 -17.73 56.65 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.127 2.552 . . . . 0.0 116.015 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -99.67 -7.82 25.18 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.49 -163.73 28.46 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.326 1.441 . . . . 0.0 114.44 171.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -72.52 97.78 2.17 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.054 0.942 . . . . 0.0 111.853 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.6 t -74.55 126.93 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.56 1.144 . . . . 0.0 109.815 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 39.9 t -91.06 -36.47 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.437 1.895 . . . . 0.0 111.032 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 53.6 m -149.81 147.77 28.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.737 1.215 . . . . 0.0 110.92 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.14 136.48 20.11 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.237 1.815 . . . . 0.0 109.013 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -153.74 138.32 16.88 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.556 -0.715 . . . . 0.0 111.656 -168.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.58 128.36 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.214 1.406 . . . . 0.0 107.976 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 123.607 0.763 . . . . 0.0 110.85 -177.059 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 35.3 m 64.97 20.1 12.02 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.996 2.118 . . . . 0.0 112.973 -171.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -147.35 156.07 42.57 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.143 0.977 . . . . 0.0 112.033 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.52 -177.55 27.99 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 126.008 1.766 . . . . 0.0 113.605 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -135.18 146.68 48.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.521 1.928 . . . . 0.0 110.133 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.9 t -143.22 144.86 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.309 1.443 . . . . 0.0 108.719 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 8.1 t -143.65 146.85 33.55 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.455 -0.778 . . . . 0.0 112.37 173.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -115.87 165.42 13.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.138 1.775 . . . . 0.0 113.128 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.0 -18.43 64.72 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.371 1.069 . . . . 0.0 113.281 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -145.27 149.59 41.91 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.122 1.369 . . . . 0.0 112.16 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.29 -28.08 55.47 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.757 2.971 . . . . 0.0 113.774 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.36 -38.67 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.879 0.872 . . . . 0.0 110.896 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 9.9 m -62.68 -34.63 77.52 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.966 0.906 . . . . 0.0 111.707 171.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.71 -48.14 41.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.54 1.136 . . . . 0.0 111.964 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -60.67 -34.32 74.15 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 112.16 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.0 -30.01 70.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.431 0.693 . . . . 0.0 112.696 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.73 -41.49 53.22 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.349 0.66 . . . . 0.0 111.491 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.9 -48.07 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.896 0.771 . . . . 0.0 110.12 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.58 -14.23 62.41 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -102.76 -29.07 11.71 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 92.2 mmm -114.54 -19.14 11.27 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -169.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -70.81 111.28 6.12 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.277 0.944 . . . . 0.0 109.951 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 97.46 1.36 59.14 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.682 1.61 . . . . 0.0 114.841 -172.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -64.62 120.36 12.24 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.676 1.738 . . . . 0.0 111.173 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -76.78 131.93 38.97 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.976 0.417 . . . . 0.0 110.452 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.1 tt . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 124.492 1.117 . . . . 0.0 109.018 179.127 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.81 150.54 47.7 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.169 1.388 . . . . 0.0 111.591 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -121.22 141.99 50.33 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.64 1.176 . . . . 0.0 108.777 168.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.26 133.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.364 1.066 . . . . 0.0 108.82 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -142.53 157.69 44.47 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.563 1.145 . . . . 0.0 111.075 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.47 156.98 30.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.821 0.819 . . . . 0.0 112.132 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 CA--C 1.545 0.754 0 C-N-CA 124.54 1.136 . . . . 0.0 112.189 171.855 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.477 0 CA-C-O 120.828 0.347 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.29 84.64 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.373 0.987 . . . . 0.0 113.347 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.3 t -85.47 173.82 9.96 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.002 0.901 . . . . 0.0 111.411 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -139.7 28.53 2.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.392 1.477 . . . . 0.0 110.846 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -66.98 164.16 18.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.982 0.913 . . . . 0.0 112.684 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.7 154.66 37.82 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.73 -160.38 26.77 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.101 1.81 . . . . 0.0 113.473 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.08 171.74 15.29 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.907 3.071 . . . . 0.0 112.576 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.45 122.34 13.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.069 0.948 . . . . 0.0 111.337 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.63 -4.33 75.91 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.844 1.212 . . . . 0.0 114.587 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.66 1.56 53.63 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.069 1.434 . . . . 0.0 114.39 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -116.98 125.17 50.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.899 1.28 . . . . 0.0 111.162 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.3 mt -124.22 140.29 53.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.528 1.931 . . . . 0.0 112.403 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -110.8 133.38 53.4 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.506 1.522 . . . . 0.0 108.52 167.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.5 mm -117.05 139.23 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.98 1.712 . . . . 0.0 108.71 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -140.65 160.89 39.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.335 1.054 . . . . 0.0 113.131 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 66.52 26.81 9.86 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.832 2.453 . . . . 0.0 114.037 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 68.4 mt -66.14 155.9 86.15 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.595 1.158 . . . . 0.0 112.219 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -59.95 148.76 87.54 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.291 2.661 . . . . 0.0 111.953 171.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.71 -19.17 65.7 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -91.93 -10.04 40.93 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.033 1.333 . . . . 0.0 114.556 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.1 134.36 51.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.272 1.029 . . . . 0.0 112.495 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.62 -176.78 19.76 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.402 1.477 . . . . 0.0 112.213 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -62.25 -32.49 73.2 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -78.13 -29.57 48.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.967 0.907 . . . . 0.0 112.268 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -70.45 -40.33 73.79 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.741 0.7 . . . . 0.0 110.692 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.37 -36.71 79.6 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.953 0.501 . . . . 0.0 111.745 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -62.27 -49.7 74.65 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.917 0.78 . . . . 0.0 110.947 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -67.96 -22.97 65.01 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.7 ttm -73.96 -27.82 61.18 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.024 0.93 . . . . 0.0 113.108 171.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -112.58 -16.37 12.85 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -171.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.7 mtm -53.92 -33.92 18.0 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -59.15 -16.17 32.13 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.492 2.794 . . . . 0.0 116.325 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -99.85 -10.22 22.0 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.42 -159.66 28.08 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 124.657 1.122 . . . . 0.0 114.909 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.34 92.83 1.85 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.201 1.0 . . . . 0.0 112.201 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.5 t -72.1 128.12 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.951 1.3 . . . . 0.0 110.018 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.93 -31.9 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.126 2.17 . . . . 0.0 111.494 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.9 t -157.64 151.12 23.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.458 1.103 . . . . 0.0 110.916 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.06 132.15 14.36 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.246 1.418 . . . . 0.0 110.19 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -153.68 132.44 12.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.43 0.692 . . . . 0.0 112.005 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 64.0 t -103.25 135.03 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.653 1.581 . . . . 0.0 107.27 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.352 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 58.3 m 74.27 18.99 2.95 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.575 2.75 . . . . 0.0 113.206 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.15 156.77 43.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.991 0.814 . . . . 0.0 112.382 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.93 -175.16 28.54 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.85 1.69 . . . . 0.0 113.708 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -141.57 144.25 34.15 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.542 1.937 . . . . 0.0 110.111 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.1 t -144.33 140.67 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.203 1.401 . . . . 0.0 108.765 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 88.3 p -135.8 153.1 51.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.648 0.779 . . . . 0.0 112.36 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -126.6 164.89 20.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.213 1.405 . . . . 0.0 113.078 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.98 -10.88 59.78 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.488 1.115 . . . . 0.0 113.007 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.74 145.51 28.3 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.062 1.345 . . . . 0.0 111.744 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.69 -29.78 69.38 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.464 2.776 . . . . 0.0 113.718 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.14 -41.57 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.815 0.846 . . . . 0.0 111.382 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.4 p -66.83 -31.13 71.54 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.605 0.762 . . . . 0.0 112.377 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -68.9 -49.8 55.02 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.769 0.828 . . . . 0.0 111.849 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -58.93 -39.37 81.38 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.582 -0.699 . . . . 0.0 111.941 175.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.44 -28.82 65.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 174.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.65 -43.66 30.67 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.652 0.66 . . . . 0.0 112.036 171.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.1 mt -58.12 -49.96 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 119.479 1.036 . . . . 0.0 110.408 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -73.79 -11.71 60.47 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.5 m -100.1 -30.65 11.83 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.5 mmm -111.66 -19.77 12.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -169.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.71 111.54 5.56 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.286 0.948 . . . . 0.0 109.903 173.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.01 3.31 65.76 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.404 1.478 . . . . 0.0 115.104 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -63.86 124.28 21.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.438 1.619 . . . . 0.0 111.258 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -81.04 131.3 35.3 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.263 0.554 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.2 tt . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 125.247 1.419 . . . . 0.0 108.447 -178.179 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 120.691 0.281 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.2 mt -68.12 160.5 28.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.276 1.43 . . . . 0.0 111.787 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -133.14 143.4 49.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.246 1.418 . . . . 0.0 109.67 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 30.1 t -138.44 136.02 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.648 1.179 . . . . 0.0 109.172 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -140.71 154.9 46.53 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.451 1.101 . . . . 0.0 111.173 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.15 155.64 38.24 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 122.317 1.056 . . . . 0.0 111.802 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 CA--C 1.546 0.822 0 C-N-CA 123.709 0.804 . . . . 0.0 111.162 169.868 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.27 0.557 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.81 -6.79 82.73 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.517 1.532 . . . . 0.0 113.272 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 6.8 t -84.03 158.0 21.62 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.676 1.238 . . . . 0.0 112.64 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -128.78 14.39 6.41 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.041 1.336 . . . . 0.0 112.34 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -68.13 177.16 2.35 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.394 -0.816 . . . . 0.0 110.349 167.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -154.74 157.66 38.36 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.235 -0.916 . . . . 0.0 112.079 168.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.59 -158.42 24.17 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.176 1.37 . . . . 0.0 113.314 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.31 160.73 43.85 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.216 2.611 . . . . 0.0 111.439 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.87 123.4 18.39 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.828 -0.545 . . . . 0.0 110.928 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.96 -9.07 58.0 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.013 1.292 . . . . 0.0 113.752 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.17 20.19 10.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.169 1.387 . . . . 0.0 112.728 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 120.38 30.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.434 1.493 . . . . 0.0 110.052 -167.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.92 139.77 53.52 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.239 1.815 . . . . 0.0 112.372 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -112.14 133.37 54.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.213 1.405 . . . . 0.0 108.993 167.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -118.46 136.08 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.19 1.796 . . . . 0.0 107.748 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -133.55 160.77 36.48 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.185 1.394 . . . . 0.0 112.404 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 67.49 30.34 6.82 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.266 2.226 . . . . 0.0 113.478 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.38 155.65 90.34 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.889 0.876 . . . . 0.0 111.257 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.68 151.91 52.27 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.291 2.661 . . . . 0.0 111.981 169.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -70.48 -15.28 62.79 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.329 1.052 . . . . 0.0 113.517 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -102.89 -4.75 24.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.482 1.913 . . . . 0.0 114.29 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.29 134.51 52.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.925 1.29 . . . . 0.0 112.105 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -111.27 -179.14 20.25 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.105 1.336 . . . . 0.0 113.147 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -66.99 -31.84 72.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.455 0.702 . . . . 0.0 112.838 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -73.18 -35.89 66.47 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.353 1.061 . . . . 0.0 112.003 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -64.95 -41.69 95.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.909 0.484 . . . . 0.0 110.857 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -69.44 -42.2 75.27 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.973 -0.537 . . . . 0.0 112.035 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.1 tp -58.64 -54.81 42.91 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.742 0.701 . . . . 0.0 111.501 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -75.58 -15.53 60.35 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -170.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.4 ttp -80.71 -20.76 42.14 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.125 0.97 . . . . 0.0 112.738 169.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -105.71 -15.33 14.99 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.553 1.541 . . . . 0.0 114.013 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 37.1 mtt -47.89 -37.37 13.46 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 168.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -62.07 -16.9 53.21 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.976 2.451 . . . . 0.0 115.696 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -99.37 -8.34 24.95 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.94 0.896 . . . . 0.0 113.327 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 148.48 -167.28 29.14 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.324 1.44 . . . . 0.0 114.447 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -75.06 97.42 3.41 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.615 1.166 . . . . 0.0 112.792 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.25 132.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.558 1.543 . . . . 0.0 110.263 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.66 -35.41 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 127.07 2.148 . . . . 0.0 111.39 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 24.0 m -150.77 147.41 27.27 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.19 1.396 . . . . 0.0 110.896 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.26 134.19 14.88 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.846 1.658 . . . . 0.0 109.187 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -154.27 136.61 14.92 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.727 -0.608 . . . . 0.0 111.805 -168.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 84.1 t -112.62 132.08 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.238 1.415 . . . . 0.0 107.926 169.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 64.0 mttm . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 23.3 m 75.06 19.3 2.35 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.166 2.586 . . . . 0.0 113.074 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -149.21 158.48 44.22 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.618 0.767 . . . . 0.0 112.051 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.55 -177.67 31.85 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.696 1.617 . . . . 0.0 113.599 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -137.42 145.77 43.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.392 1.877 . . . . 0.0 110.021 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 94.9 t -143.41 143.91 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.204 1.402 . . . . 0.0 108.532 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 8.1 t -143.77 145.61 32.51 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.394 -0.816 . . . . 0.0 112.146 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -114.74 167.5 10.71 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.41 1.884 . . . . 0.0 112.225 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.63 -16.89 63.46 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -144.86 149.51 43.06 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.967 1.307 . . . . 0.0 112.168 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.91 -27.88 58.58 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.721 2.947 . . . . 0.0 113.66 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.46 -40.27 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.884 0.873 . . . . 0.0 110.927 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 15.3 m -62.73 -33.49 75.25 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.687 0.795 . . . . 0.0 111.833 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.14 -47.34 36.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.731 1.212 . . . . 0.0 112.083 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -61.17 -34.83 75.68 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.125 0.97 . . . . 0.0 112.041 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.39 70.4 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.476 0.711 . . . . 0.0 112.803 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.06 47.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.26 0.624 . . . . 0.0 111.163 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.05 -46.85 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 119.335 0.97 . . . . 0.0 110.304 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -69.85 -14.6 62.83 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.0 m -104.21 -26.48 12.5 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.7 mmm -115.08 -19.28 10.94 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -71.02 110.5 5.75 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.321 0.964 . . . . 0.0 110.186 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.73 2.34 65.11 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.766 1.65 . . . . 0.0 114.857 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -61.16 123.97 19.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.453 1.626 . . . . 0.0 111.669 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -78.37 131.3 36.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.128 0.489 . . . . 0.0 110.412 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.1 tt . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 125.043 1.337 . . . . 0.0 108.852 -178.354 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 111.587 0.218 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.74 161.59 29.49 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.118 1.367 . . . . 0.0 112.588 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -130.97 141.55 50.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.596 1.558 . . . . 0.0 108.781 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.02 138.46 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.392 1.077 . . . . 0.0 109.43 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -147.5 151.13 35.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.548 1.139 . . . . 0.0 110.791 -174.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.33 157.54 25.88 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.914 0.864 . . . . 0.0 111.787 168.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 CA--C 1.548 0.873 0 C-N-CA 124.523 1.129 . . . . 0.0 113.26 170.32 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 120.841 0.353 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 87.44 -5.2 85.44 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.922 1.249 . . . . 0.0 113.375 -176.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 40.4 m -78.21 158.52 28.96 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.902 1.281 . . . . 0.0 111.371 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -131.7 27.79 4.62 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.441 1.096 . . . . 0.0 112.086 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -71.95 171.03 12.55 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.386 -0.822 . . . . 0.0 110.47 167.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.09 156.23 35.48 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 169.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -87.43 -158.44 32.72 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.898 1.713 . . . . 0.0 114.172 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.7 165.84 26.25 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.544 2.829 . . . . 0.0 111.625 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.95 125.72 24.76 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.597 -0.689 . . . . 0.0 111.274 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.5 -6.64 68.15 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.75 1.167 . . . . 0.0 113.689 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.81 18.41 14.55 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.211 1.404 . . . . 0.0 112.824 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.25 119.95 27.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.519 1.527 . . . . 0.0 109.779 -168.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 33.5 mt -124.86 133.9 52.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.122 1.769 . . . . 0.0 112.087 -168.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -105.11 134.25 48.52 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.964 1.306 . . . . 0.0 108.673 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 9.4 mm -118.24 137.72 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.897 1.679 . . . . 0.0 108.526 -169.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -137.06 161.68 35.42 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.487 1.115 . . . . 0.0 112.492 -175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 62.57 34.39 15.15 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.259 1.824 . . . . 0.0 113.14 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.23 158.46 86.61 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.218 1.407 . . . . 0.0 111.818 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.85 142.6 99.15 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.82 2.347 . . . . 0.0 111.26 169.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -68.44 -9.18 46.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.519 1.127 . . . . 0.0 113.644 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -98.53 -10.79 22.98 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.826 1.65 . . . . 0.0 113.922 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.54 132.31 40.64 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.937 1.295 . . . . 0.0 112.132 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.69 -172.62 18.72 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.282 1.42 . . . . 0.0 113.274 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -67.64 -34.43 76.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.953 0.901 . . . . 0.0 113.219 -172.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -77.81 -30.89 51.41 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.542 0.737 . . . . 0.0 111.756 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -67.01 -43.5 82.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.16 0.584 . . . . 0.0 110.396 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 26.5 tp -65.48 -43.27 90.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.291 0.637 . . . . 0.0 111.636 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.53 -54.1 50.72 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.599 0.76 . . . . 0.0 111.259 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -73.95 -20.72 60.27 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.8 ttp -76.59 -22.61 54.0 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.031 0.832 . . . . 0.0 113.016 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -102.77 -16.3 16.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.077 1.351 . . . . 0.0 113.754 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 36.6 mtt -47.63 -38.03 15.23 Favored Pre-proline 0 CA--C 1.552 1.035 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -62.26 -17.73 58.63 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.158 2.572 . . . . 0.0 115.54 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -97.7 -9.94 25.85 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.0 0.92 . . . . 0.0 113.325 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.38 -164.17 28.39 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.371 1.462 . . . . 0.0 114.518 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.69 100.63 2.87 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.972 0.909 . . . . 0.0 111.874 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.3 t -76.73 127.09 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.876 1.27 . . . . 0.0 109.874 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 43.0 t -86.86 -35.51 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.502 1.921 . . . . 0.0 111.246 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.8 m -161.79 151.21 16.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.736 1.614 . . . . 0.0 110.636 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.91 132.97 12.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.07 1.748 . . . . 0.0 109.977 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -154.22 148.32 25.78 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.49 130.14 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 126.699 2.0 . . . . 0.0 107.685 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 111.511 -175.38 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 83.0 m 62.87 22.03 13.18 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.652 1.981 . . . . 0.0 113.364 -172.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -141.76 155.48 45.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.116 0.966 . . . . 0.0 111.67 172.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.27 -172.33 24.35 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.831 1.681 . . . . 0.0 113.912 -169.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -143.75 147.36 34.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.945 1.698 . . . . 0.0 110.257 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 59.7 t -144.0 145.65 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.765 1.626 . . . . 0.0 108.976 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.2 t -143.14 151.81 41.1 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.216 -0.927 . . . . 0.0 112.55 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -120.94 164.64 16.39 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.015 1.726 . . . . 0.0 113.247 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.11 -18.67 64.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.347 1.059 . . . . 0.0 113.143 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -145.28 150.21 44.02 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.118 1.367 . . . . 0.0 112.222 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.71 -29.22 60.0 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.797 2.998 . . . . 0.0 113.845 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.58 -38.4 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.779 0.832 . . . . 0.0 110.852 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.3 m -62.54 -35.19 78.65 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.003 0.921 . . . . 0.0 111.695 171.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.42 -47.83 46.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.571 1.148 . . . . 0.0 112.007 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -60.28 -35.46 75.6 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.03 0.932 . . . . 0.0 112.113 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.03 71.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.566 0.746 . . . . 0.0 112.685 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.92 56.01 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.298 0.639 . . . . 0.0 111.196 174.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.48 -46.62 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 119.434 1.015 . . . . 0.0 110.362 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -69.6 -15.82 63.28 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.1 m -104.54 -23.12 13.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.5 mmt -113.37 -22.89 10.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.898 1.279 . . . . 0.0 113.626 -171.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -71.41 113.44 8.45 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.974 1.261 . . . . 0.0 110.698 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.68 4.13 83.03 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.554 1.55 . . . . 0.0 114.626 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -63.34 126.47 27.56 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.904 1.352 . . . . 0.0 111.171 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -85.04 130.93 34.53 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.115 0.566 . . . . 0.0 110.866 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.6 tt . . . . . 0 CA--C 1.536 0.413 0 C-N-CA 125.425 1.49 . . . . 0.0 109.799 -170.292 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.4 mt -68.72 163.35 24.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.405 1.482 . . . . 0.0 112.618 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -139.57 142.33 37.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.417 1.487 . . . . 0.0 108.83 168.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.46 139.79 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.314 1.046 . . . . 0.0 109.452 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -144.86 148.13 33.61 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.316 1.046 . . . . 0.0 110.931 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.24 155.33 28.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.962 0.887 . . . . 0.0 112.256 168.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.6 tttt . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 124.358 1.063 . . . . 0.0 111.058 168.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 121.156 0.503 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.25 -3.37 85.51 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.195 1.855 . . . . 0.0 113.889 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 38.8 t -74.69 156.03 37.1 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.667 1.187 . . . . 0.0 112.498 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -118.43 10.34 12.66 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.016 1.326 . . . . 0.0 112.519 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -64.95 165.43 10.89 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.268 -0.895 . . . . 0.0 112.273 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.66 163.83 36.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.205 1.002 . . . . 0.0 112.433 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -102.42 -161.51 26.17 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 126.102 1.81 . . . . 0.0 113.685 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.73 178.98 6.45 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.055 3.17 . . . . 0.0 112.791 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -54.68 123.88 14.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.796 1.238 . . . . 0.0 111.696 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.33 -5.06 85.72 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.692 1.139 . . . . 0.0 114.694 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.22 -3.38 53.87 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.808 1.304 . . . . 0.0 114.439 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -114.49 124.68 52.51 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.51 1.124 . . . . 0.0 111.263 -168.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.8 mt -124.68 141.85 51.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.625 1.97 . . . . 0.0 112.69 -168.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -112.18 134.58 53.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.588 1.555 . . . . 0.0 109.035 168.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.31 136.24 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.932 1.693 . . . . 0.0 108.249 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -134.23 159.9 39.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.879 1.272 . . . . 0.0 112.865 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 70.45 27.72 3.86 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.945 2.498 . . . . 0.0 113.898 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.89 155.45 86.64 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.828 1.251 . . . . 0.0 112.054 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.48 150.3 69.29 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.019 2.48 . . . . 0.0 111.557 168.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -69.83 -11.82 61.16 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.447 1.099 . . . . 0.0 113.709 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.08 -7.61 16.82 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.895 2.078 . . . . 0.0 113.799 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.47 116.68 14.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.09 1.356 . . . . 0.0 110.429 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -99.28 -175.7 31.55 Favored Glycine 0 N--CA 1.467 0.757 0 C-N-CA 124.19 0.9 . . . . 0.0 113.743 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.14 -35.45 78.8 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.477 1.111 . . . . 0.0 112.631 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -77.52 -31.05 53.21 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.081 0.953 . . . . 0.0 111.981 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -70.82 -41.6 71.36 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.791 0.723 . . . . 0.0 110.715 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.5 tp -64.61 -42.28 95.65 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.217 0.607 . . . . 0.0 111.144 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.88 -51.01 71.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.325 0.65 . . . . 0.0 111.229 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -71.24 -20.07 62.28 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.5 ttp -82.92 -21.63 34.11 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.043 0.838 . . . . 0.0 113.044 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -106.17 -23.23 12.64 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.1 mtm -54.3 -33.02 13.24 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 170.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -58.09 -18.22 35.33 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.627 2.885 . . . . 0.0 115.787 174.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -94.82 -12.16 27.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.231 0.923 . . . . 0.0 113.41 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.8 -157.78 27.47 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.926 1.251 . . . . 0.0 115.027 170.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -74.06 84.23 1.79 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.261 1.024 . . . . 0.0 112.757 -169.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 84.8 t -66.79 127.87 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.872 1.269 . . . . 0.0 109.707 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 55.6 t -91.46 -35.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.011 1.724 . . . . 0.0 110.978 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 27.5 m -158.73 147.36 18.54 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.528 1.531 . . . . 0.0 110.854 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.46 140.28 20.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.828 1.651 . . . . 0.0 110.439 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -154.41 149.22 26.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.635 0.774 . . . . 0.0 112.887 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.89 137.19 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.428 1.891 . . . . 0.0 108.535 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 123.845 0.858 . . . . 0.0 110.692 -178.855 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 50.6 m 71.33 18.28 5.65 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.602 2.361 . . . . 0.0 113.935 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -145.15 154.79 42.82 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.504 1.047 . . . . 0.0 112.357 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.01 -172.34 25.98 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.948 1.737 . . . . 0.0 113.608 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -148.77 141.59 24.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.986 1.714 . . . . 0.0 109.95 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 61.3 t -146.22 136.32 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.908 1.283 . . . . 0.0 109.31 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 68.3 m -134.23 140.43 46.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.618 0.767 . . . . 0.0 112.293 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -110.08 168.85 9.13 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.804 1.642 . . . . 0.0 113.145 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.51 -21.15 66.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.401 1.481 . . . . 0.0 113.295 169.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -160.94 157.42 22.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.24 1.416 . . . . 0.0 112.378 -171.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.9 -16.09 40.88 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.7 2.267 . . . . 0.0 113.936 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.82 -44.19 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 120.459 1.481 . . . . 0.0 110.459 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.8 m -69.21 -30.91 69.18 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.967 0.907 . . . . 0.0 112.114 174.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -75.03 -47.13 30.57 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.851 0.86 . . . . 0.0 112.327 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -62.69 -32.57 73.68 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.469 -0.769 . . . . 0.0 111.806 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.59 70.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.14 -43.35 34.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.27 0.628 . . . . 0.0 111.174 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.03 -45.71 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.07 0.85 . . . . 0.0 110.351 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -70.76 -14.87 62.59 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.4 m -104.33 -22.94 13.27 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 2.1 mmt -114.15 -24.18 9.11 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 113.768 -170.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -71.69 112.48 7.83 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.687 1.13 . . . . 0.0 110.348 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.73 3.01 74.74 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.473 1.511 . . . . 0.0 114.683 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -64.41 127.68 32.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.11 1.455 . . . . 0.0 111.291 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -85.96 129.6 34.79 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.048 0.539 . . . . 0.0 110.951 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.6 tt . . . . . 0 CA--C 1.537 0.449 0 C-N-CA 125.545 1.538 . . . . 0.0 110.108 -173.356 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 120.701 0.286 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.39 162.04 30.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.287 1.435 . . . . 0.0 112.521 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -130.91 139.17 50.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.232 1.413 . . . . 0.0 109.079 168.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 32.0 t -139.3 134.42 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.393 1.077 . . . . 0.0 109.259 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -146.71 159.35 43.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.023 0.929 . . . . 0.0 112.24 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 62.0 mt -66.38 152.71 44.49 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.095 0.958 . . . . 0.0 112.866 173.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 124.033 0.933 . . . . 0.0 110.614 168.47 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 120.878 0.371 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 87.14 0.02 85.54 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.269 1.414 . . . . 0.0 113.563 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.4 t -98.43 170.51 8.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.303 1.052 . . . . 0.0 111.898 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -132.42 32.35 3.94 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.179 1.392 . . . . 0.0 111.28 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -67.74 164.75 18.74 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.498 -0.751 . . . . 0.0 110.329 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -155.99 161.61 40.45 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.53 -159.32 24.89 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.055 1.788 . . . . 0.0 113.61 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.94 171.99 15.51 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.956 3.104 . . . . 0.0 112.85 -172.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.68 123.46 16.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.019 0.928 . . . . 0.0 111.381 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.62 -3.78 78.79 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.798 1.189 . . . . 0.0 114.584 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.72 1.41 53.4 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.908 1.354 . . . . 0.0 114.355 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -118.27 124.31 47.53 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.494 1.118 . . . . 0.0 110.884 -169.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 18.9 mt -123.62 146.78 47.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.796 2.038 . . . . 0.0 113.052 -168.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -117.43 135.09 54.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.718 1.607 . . . . 0.0 109.099 168.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -119.84 137.36 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.181 1.792 . . . . 0.0 107.831 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -134.99 161.3 35.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.128 1.371 . . . . 0.0 112.584 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 67.46 27.41 8.01 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.433 2.293 . . . . 0.0 113.92 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 67.7 mt -64.92 157.77 73.88 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.014 1.325 . . . . 0.0 112.06 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.53 147.48 91.42 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.992 2.461 . . . . 0.0 111.434 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -69.73 -8.29 46.69 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.43 -8.09 15.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.511 1.924 . . . . 0.0 114.166 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.47 124.27 23.09 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.8 1.24 . . . . 0.0 110.805 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.25 -176.27 26.39 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.481 1.039 . . . . 0.0 114.065 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.35 -36.36 82.69 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.83 0.852 . . . . 0.0 112.782 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.59 -28.36 56.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.83 0.852 . . . . 0.0 111.769 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.1 -42.11 73.13 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.655 0.661 . . . . 0.0 110.646 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.8 tp -67.03 -36.41 82.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.184 0.594 . . . . 0.0 111.797 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.11 -51.68 66.91 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.686 0.675 . . . . 0.0 110.931 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -63.51 -28.43 69.94 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.0 ttm -72.62 -29.18 63.26 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.453 1.101 . . . . 0.0 113.159 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -109.51 -18.34 13.54 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 47.3 mtm -55.4 -32.24 12.02 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -58.09 -16.33 26.7 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.661 2.908 . . . . 0.0 116.291 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -100.34 -8.35 23.46 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.48 -163.44 28.48 Favored Glycine 0 N--CA 1.47 0.906 0 C-N-CA 125.173 1.368 . . . . 0.0 114.513 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -72.4 90.58 1.3 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.749 0.82 . . . . 0.0 112.026 -173.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 79.9 t -65.42 128.92 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.714 1.206 . . . . 0.0 109.843 172.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 37.5 t -91.62 -36.61 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.94 2.096 . . . . 0.0 110.913 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.85 152.8 25.4 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.618 1.167 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -155.35 133.39 11.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.505 1.122 . . . . 0.0 110.705 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -154.45 147.99 25.19 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.398 -0.814 . . . . 0.0 112.925 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.8 t -124.68 131.4 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 126.214 1.806 . . . . 0.0 107.899 172.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 CA--C 1.538 0.508 0 C-N-CA 123.504 0.722 . . . . 0.0 110.962 -175.824 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.549 0.92 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 58.4 m 68.17 17.62 9.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.514 2.326 . . . . 0.0 113.582 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -144.46 154.77 43.28 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.585 1.084 . . . . 0.0 112.758 175.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.74 -177.64 31.03 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.982 1.754 . . . . 0.0 114.087 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -134.61 145.96 49.12 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.704 2.002 . . . . 0.0 110.193 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 92.5 t -144.78 138.75 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.826 1.25 . . . . 0.0 109.236 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 64.7 p -130.47 152.24 50.08 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.211 1.004 . . . . 0.0 112.074 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -125.77 163.82 22.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.344 1.457 . . . . 0.0 113.106 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -71.33 -18.46 62.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.031 0.932 . . . . 0.0 113.048 173.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -144.6 150.77 48.37 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.078 1.351 . . . . 0.0 112.197 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.76 -29.69 59.36 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.856 3.037 . . . . 0.0 113.722 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.08 -40.25 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.811 0.844 . . . . 0.0 110.963 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 8.8 m -61.95 -34.24 75.76 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.971 0.908 . . . . 0.0 111.817 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.79 -49.27 26.16 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.88 1.272 . . . . 0.0 112.029 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -60.93 -33.91 73.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.961 0.904 . . . . 0.0 112.15 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 -30.56 71.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.412 0.685 . . . . 0.0 112.611 172.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.3 -41.54 48.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.294 0.638 . . . . 0.0 111.451 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 45.5 mt -57.88 -47.47 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.014 0.824 . . . . 0.0 110.129 174.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.08 -14.69 62.4 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.8 m -101.94 -28.47 12.37 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 91.7 mmm -114.44 -19.13 11.32 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -169.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -70.33 110.28 5.19 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.289 0.949 . . . . 0.0 109.933 173.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.37 2.91 60.18 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.369 1.462 . . . . 0.0 114.933 -172.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.17 123.47 18.71 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.427 1.613 . . . . 0.0 111.587 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -79.0 130.53 35.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.222 0.609 . . . . 0.0 110.988 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 125.11 1.364 . . . . 0.0 110.43 -178.339 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 66.9 mt -70.71 160.72 32.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.032 1.333 . . . . 0.0 111.75 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -132.3 141.9 49.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.226 1.41 . . . . 0.0 109.194 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.5 t -139.42 136.14 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.505 1.122 . . . . 0.0 109.062 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -145.73 165.22 29.42 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.018 1.327 . . . . 0.0 111.044 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.48 159.88 26.23 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.861 0.864 . . . . 0.0 111.859 169.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.0 tttt . . . . . 0 CA--C 1.547 0.856 0 C-N-CA 125.411 1.484 . . . . 0.0 112.324 171.491 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 120.984 0.421 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.26 -2.4 71.22 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.456 1.027 . . . . 0.0 113.375 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.0 t -77.35 165.75 24.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.156 0.978 . . . . 0.0 112.093 174.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -134.09 23.19 3.84 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.017 1.327 . . . . 0.0 110.791 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -65.75 174.73 2.2 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.903 1.281 . . . . 0.0 111.751 168.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -156.26 161.53 40.23 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.791 0.836 . . . . 0.0 112.432 168.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.35 -163.19 29.47 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.965 1.745 . . . . 0.0 113.376 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.99 172.79 13.95 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.754 2.97 . . . . 0.0 112.43 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.51 128.39 36.95 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.495 0.664 . . . . 0.0 111.342 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.6 -10.2 75.24 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.796 1.189 . . . . 0.0 113.962 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.9 -5.73 47.24 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.639 1.22 . . . . 0.0 114.218 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -112.08 123.95 51.36 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.317 1.047 . . . . 0.0 110.55 -169.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.9 mt -124.07 143.26 50.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.675 1.99 . . . . 0.0 112.549 -168.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -112.92 134.26 54.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.417 1.487 . . . . 0.0 109.073 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.01 134.17 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.346 1.858 . . . . 0.0 107.737 -171.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -132.65 158.5 42.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.878 1.271 . . . . 0.0 112.694 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 71.69 27.33 2.93 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.604 2.362 . . . . 0.0 113.747 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 76.8 mt -65.13 161.11 51.56 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.986 1.315 . . . . 0.0 111.803 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.62 149.19 91.94 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.921 2.414 . . . . 0.0 110.845 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -67.7 -20.47 65.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -88.94 -11.18 45.16 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.53 129.1 38.83 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.504 1.122 . . . . 0.0 111.886 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.12 -173.95 23.48 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.296 1.427 . . . . 0.0 112.273 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.02 -33.48 73.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.757 0.823 . . . . 0.0 112.493 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -67.84 -44.98 75.92 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.099 1.76 . . . . 0.0 111.472 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.89 -40.92 95.84 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.974 0.91 . . . . 0.0 111.528 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 30.4 tp -67.13 -38.94 86.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.267 0.627 . . . . 0.0 111.891 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 66.1 tp -63.11 -48.7 77.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.87 0.759 . . . . 0.0 111.077 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -67.88 -23.2 65.09 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.8 ttm -74.91 -25.91 59.25 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.112 0.965 . . . . 0.0 113.148 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -113.63 -16.67 12.31 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.4 mtm -54.16 -33.82 17.99 Favored Pre-proline 0 CA--C 1.549 0.914 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -58.99 -16.3 31.83 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.476 2.784 . . . . 0.0 116.296 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.12 -11.38 20.54 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 149.01 -163.06 29.07 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.931 1.253 . . . . 0.0 114.823 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -71.55 102.1 2.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.118 0.967 . . . . 0.0 112.385 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 69.7 t -80.44 128.69 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.071 1.348 . . . . 0.0 110.083 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.12 -22.44 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.956 2.502 . . . . 0.0 112.087 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 8.8 t -159.7 146.05 16.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.266 1.427 . . . . 0.0 110.341 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.58 129.39 10.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.196 1.399 . . . . 0.0 110.687 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -156.0 132.03 9.93 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.584 0.754 . . . . 0.0 112.557 -174.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.9 135.14 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.486 1.514 . . . . 0.0 107.299 167.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 123.275 0.63 . . . . 0.0 111.295 -178.095 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 57.9 mttm . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.1 m 66.87 21.62 10.37 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.067 2.147 . . . . 0.0 113.207 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -146.52 156.17 43.06 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.129 0.972 . . . . 0.0 111.687 172.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.58 -177.71 29.09 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.868 1.699 . . . . 0.0 113.767 -170.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -138.58 141.16 39.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.015 2.126 . . . . 0.0 109.901 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 94.9 t -144.03 137.31 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.076 1.35 . . . . 0.0 108.867 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.0 m -131.03 148.43 52.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.474 0.71 . . . . 0.0 112.068 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -117.57 170.24 8.91 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.405 1.482 . . . . 0.0 113.287 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.52 -25.02 67.01 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.381 1.472 . . . . 0.0 113.648 170.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -160.12 162.2 24.57 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.096 1.358 . . . . 0.0 112.109 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.98 -13.52 31.65 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.332 2.021 . . . . 0.0 114.03 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 22.8 t -75.4 -45.92 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 121.032 1.742 . . . . 0.0 110.892 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.5 p -69.73 -32.52 71.11 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.811 0.844 . . . . 0.0 112.631 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -67.14 -49.0 66.37 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.365 0.666 . . . . 0.0 112.435 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -63.2 -31.71 72.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.376 -0.828 . . . . 0.0 112.056 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.79 70.47 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.7 0.682 . . . . 0.0 112.595 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.79 -42.0 51.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.717 0.689 . . . . 0.0 111.411 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.27 -47.22 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 118.914 0.779 . . . . 0.0 110.199 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -70.36 -15.45 62.86 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.0 m -99.78 -29.38 12.66 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 88.4 mmm -113.97 -19.93 11.24 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -71.68 110.6 6.34 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.441 1.019 . . . . 0.0 109.987 174.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 90.92 8.64 64.85 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.393 1.473 . . . . 0.0 114.433 -171.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.76 122.64 17.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.764 1.782 . . . . 0.0 110.568 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -74.36 131.88 41.51 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 122.063 -0.398 . . . . 0.0 110.292 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 124.556 1.143 . . . . 0.0 108.579 173.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.691 0.282 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.18 155.96 40.13 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.854 1.262 . . . . 0.0 111.502 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.38 140.7 52.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.857 1.263 . . . . 0.0 109.46 169.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 23.4 t -139.61 136.27 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.541 1.136 . . . . 0.0 109.245 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -150.77 162.04 41.49 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.08 0.952 . . . . 0.0 112.097 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 75.4 mt -64.5 157.16 27.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.599 1.16 . . . . 0.0 113.071 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 CA--C 1.548 0.866 0 C-N-CA 124.537 1.135 . . . . 0.0 113.152 169.708 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.6 -6.36 83.7 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.584 1.087 . . . . 0.0 113.281 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 7.6 t -86.92 160.21 18.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.461 1.131 . . . . 0.0 111.117 172.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -135.83 22.93 3.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.399 1.08 . . . . 0.0 112.477 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -68.81 173.96 4.8 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.314 -0.866 . . . . 0.0 111.676 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -148.88 158.44 44.17 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.756 0.822 . . . . 0.0 112.196 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.55 -160.95 27.99 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.994 1.759 . . . . 0.0 113.451 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.08 176.03 9.67 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.94 3.094 . . . . 0.0 112.576 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -56.32 124.67 18.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.266 1.026 . . . . 0.0 111.501 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.04 -7.64 81.27 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.811 1.196 . . . . 0.0 114.556 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.72 -5.21 54.04 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.919 1.359 . . . . 0.0 114.364 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -112.68 122.53 47.95 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.576 1.15 . . . . 0.0 110.676 -168.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.1 mt -123.32 141.65 51.77 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.562 1.945 . . . . 0.0 112.535 -168.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -111.09 134.83 52.39 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.574 1.549 . . . . 0.0 108.729 167.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.5 133.51 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.93 1.692 . . . . 0.0 107.791 -171.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -129.58 160.64 32.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.858 1.263 . . . . 0.0 112.22 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 65.8 38.37 5.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.07 1.748 . . . . 0.0 113.193 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 54.1 mt -71.59 161.45 78.45 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.104 1.362 . . . . 0.0 111.696 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.6 154.59 47.45 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.233 2.622 . . . . 0.0 111.469 168.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -68.12 -28.19 67.12 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.58 -11.19 57.66 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.83 128.25 35.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.405 1.082 . . . . 0.0 112.494 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.78 -171.55 18.29 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.796 1.665 . . . . 0.0 112.362 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -62.15 -35.51 79.02 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.838 0.855 . . . . 0.0 113.195 -174.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -74.16 -29.29 61.71 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.161 0.985 . . . . 0.0 112.089 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -76.12 -42.13 47.99 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.815 0.846 . . . . 0.0 110.695 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 32.8 tp -63.69 -38.01 89.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.359 0.664 . . . . 0.0 111.572 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.8 tp -63.69 -49.6 72.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.613 0.642 . . . . 0.0 111.116 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -68.81 -20.1 64.31 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.0 ttm -74.56 -26.85 60.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.945 0.898 . . . . 0.0 112.852 169.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -111.61 -19.44 12.51 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -172.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.3 mtm -53.72 -34.39 20.08 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -59.18 -17.31 38.25 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.505 2.803 . . . . 0.0 116.097 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.68 -10.79 21.52 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.32 -160.12 28.11 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.713 1.149 . . . . 0.0 115.033 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -74.06 96.07 2.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.15 0.98 . . . . 0.0 112.18 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.7 t -77.19 127.29 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.104 1.362 . . . . 0.0 109.677 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.53 -34.23 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.682 1.993 . . . . 0.0 111.319 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.8 m -160.07 147.37 16.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.533 1.533 . . . . 0.0 110.786 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.04 134.23 16.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.596 1.559 . . . . 0.0 110.129 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -153.64 132.65 12.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.48 0.712 . . . . 0.0 111.887 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 91.8 t -101.42 131.13 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.634 1.574 . . . . 0.0 107.169 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.19 0.519 . . . . 0.0 111.178 -177.318 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 78.5 m 65.66 22.99 11.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.271 2.229 . . . . 0.0 113.735 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -143.69 156.02 44.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.236 1.014 . . . . 0.0 111.455 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.64 -174.15 26.02 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.889 1.709 . . . . 0.0 114.006 -169.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -144.96 140.99 28.61 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.757 2.023 . . . . 0.0 109.837 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 89.0 t -145.5 135.97 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.222 1.409 . . . . 0.0 109.072 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 65.8 m -132.44 141.79 48.98 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.37 0.668 . . . . 0.0 112.378 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -111.0 169.49 8.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.598 1.559 . . . . 0.0 113.56 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.06 -23.5 65.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.941 1.696 . . . . 0.0 113.59 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -161.27 160.89 24.01 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.323 1.449 . . . . 0.0 112.05 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.85 -12.38 26.26 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.652 2.234 . . . . 0.0 114.272 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 40.6 t -77.37 -46.33 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.665 1.575 . . . . 0.0 110.494 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 21.6 m -64.78 -29.75 70.74 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.671 1.189 . . . . 0.0 111.896 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.12 -50.34 19.88 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.032 0.933 . . . . 0.0 111.934 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -59.68 -37.8 79.8 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.476 -0.765 . . . . 0.0 111.735 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.34 -28.09 64.75 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -80.44 -43.97 20.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.65 0.78 . . . . 0.0 111.898 172.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.31 -50.18 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.138 0.881 . . . . 0.0 110.523 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -74.78 -11.58 60.19 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 66.1 m -99.2 -31.4 11.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 89.7 mmm -112.35 -18.04 12.58 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -168.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -68.47 110.83 4.35 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.559 1.072 . . . . 0.0 110.489 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.71 3.8 66.03 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.959 1.743 . . . . 0.0 115.038 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.41 128.36 35.46 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.409 1.605 . . . . 0.0 111.721 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -84.77 130.37 34.69 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.227 0.611 . . . . 0.0 111.3 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.3 tt . . . . . 0 N--CA 1.468 0.446 0 C-N-CA 125.212 1.405 . . . . 0.0 110.145 -173.745 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 62.0 mt -66.45 160.44 24.94 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.34 1.456 . . . . 0.0 112.196 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -136.78 139.64 41.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.162 1.385 . . . . 0.0 108.925 167.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.2 t -139.33 135.69 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.497 1.119 . . . . 0.0 109.066 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -153.72 153.68 32.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.701 0.8 . . . . 0.0 111.394 -176.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 82.3 mt -61.78 154.89 24.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.562 1.145 . . . . 0.0 113.206 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.8 tttt . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 124.251 1.021 . . . . 0.0 111.122 169.753 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.8 -9.3 76.91 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.588 1.089 . . . . 0.0 113.093 -175.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 74.2 m -81.49 149.56 28.67 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.435 1.094 . . . . 0.0 110.62 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -132.85 29.53 4.12 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.211 1.004 . . . . 0.0 111.83 -170.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -71.68 176.29 4.96 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.471 -0.768 . . . . 0.0 110.907 168.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.81 157.53 42.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 168.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.92 -163.26 27.82 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 127.79 2.614 . . . . 0.0 113.775 -170.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.15 173.13 13.45 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.024 3.15 . . . . 0.0 112.759 -173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.54 124.28 18.48 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.059 0.943 . . . . 0.0 111.108 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.45 -10.48 69.13 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.783 1.182 . . . . 0.0 114.497 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.77 -0.76 47.59 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -111.57 118.14 34.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.837 1.255 . . . . 0.0 110.938 -169.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.3 mt -121.48 135.37 55.04 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.855 1.662 . . . . 0.0 112.016 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -106.16 133.29 51.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.936 1.294 . . . . 0.0 108.725 167.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.6 mm -118.08 138.39 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.092 1.757 . . . . 0.0 108.788 -169.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -140.34 161.94 36.48 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.626 1.171 . . . . 0.0 113.029 -172.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 63.83 25.96 14.2 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.474 2.31 . . . . 0.0 113.926 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.33 156.06 82.88 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.477 1.111 . . . . 0.0 111.115 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.27 145.8 91.72 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.791 2.327 . . . . 0.0 111.76 171.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -67.43 -17.43 64.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.908 0.883 . . . . 0.0 113.161 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -99.71 -8.83 23.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.829 1.252 . . . . 0.0 114.033 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.58 125.4 26.41 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.448 1.499 . . . . 0.0 111.205 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -102.68 -177.67 27.04 Favored Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.344 0.973 . . . . 0.0 113.745 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -61.76 -36.12 80.09 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.122 0.969 . . . . 0.0 112.673 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -76.44 -30.69 57.48 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.82 0.848 . . . . 0.0 111.786 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -70.73 -41.19 72.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.614 0.643 . . . . 0.0 110.685 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 28.1 tp -64.86 -38.73 91.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.559 0.744 . . . . 0.0 111.674 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.26 -50.16 71.25 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.573 0.624 . . . . 0.0 111.095 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -63.39 -27.11 69.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.3 ttm -73.31 -29.41 62.68 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.433 1.093 . . . . 0.0 113.229 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -110.22 -18.15 13.36 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 44.7 mtm -55.54 -33.05 14.71 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 171.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.75 -16.06 23.64 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.57 2.846 . . . . 0.0 116.157 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -100.73 -9.78 21.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.32 -162.11 28.39 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.988 1.28 . . . . 0.0 115.127 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -71.88 92.58 1.26 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.753 1.221 . . . . 0.0 112.38 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.23 128.38 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.816 1.246 . . . . 0.0 109.722 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 44.8 t -92.6 -34.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.909 2.084 . . . . 0.0 111.478 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.3 m -159.53 145.54 16.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 110.377 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.9 134.59 17.62 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.949 1.699 . . . . 0.0 110.208 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -154.92 136.83 14.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.63 0.772 . . . . 0.0 111.588 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.06 135.29 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.969 1.708 . . . . 0.0 107.873 169.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 123.085 0.554 . . . . 0.0 110.994 -179.078 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 30.8 m 69.79 18.52 7.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.515 2.326 . . . . 0.0 113.406 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -145.91 156.09 43.3 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.094 0.958 . . . . 0.0 112.091 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.52 -175.29 28.28 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 126.099 1.809 . . . . 0.0 113.546 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -139.71 144.84 37.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.244 1.818 . . . . 0.0 110.262 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 81.2 t -142.84 139.82 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.514 1.526 . . . . 0.0 108.708 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 34.3 t -136.74 144.99 44.12 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.631 0.772 . . . . 0.0 112.277 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -116.44 166.02 12.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.869 1.667 . . . . 0.0 113.431 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.51 -19.3 63.73 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.663 1.185 . . . . 0.0 113.204 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -147.74 159.69 40.23 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 126.23 1.812 . . . . 0.0 110.843 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 -18.67 8.19 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.297 1.998 . . . . 0.0 113.816 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 70.7 t -72.67 -43.57 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 119.812 1.187 . . . . 0.0 111.0 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.6 p -65.8 -31.74 72.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.775 0.83 . . . . 0.0 112.427 172.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -69.51 -50.47 44.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.85 0.86 . . . . 0.0 112.327 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.89 -29.97 70.0 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.266 -0.896 . . . . 0.0 112.097 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.05 -31.25 71.64 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.606 0.639 . . . . 0.0 112.485 169.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.08 63.94 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.838 0.745 . . . . 0.0 111.834 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 30.0 mt -57.55 -49.06 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.116 0.871 . . . . 0.0 110.047 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -70.97 -15.05 62.56 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 53.1 m -99.35 -30.42 12.23 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.5 mmm -112.79 -20.69 11.53 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -69.99 112.71 6.58 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.413 1.006 . . . . 0.0 109.786 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.25 2.54 68.28 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.392 1.472 . . . . 0.0 115.268 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -65.24 123.3 19.19 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.628 1.714 . . . . 0.0 111.169 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -81.18 131.12 35.28 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.878 -0.514 . . . . 0.0 111.233 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.8 tt . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 122.772 1.272 . . . . 0.0 109.468 -178.815 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.755 0.312 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 72.2 mt -63.84 159.48 19.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.331 1.453 . . . . 0.0 111.473 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -135.42 139.35 44.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.352 1.461 . . . . 0.0 109.715 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 29.2 t -139.24 136.9 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.324 1.049 . . . . 0.0 109.688 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -143.07 155.74 44.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.389 1.075 . . . . 0.0 111.488 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.29 156.8 33.32 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.851 0.86 . . . . 0.0 112.216 169.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.091 0.956 . . . . 0.0 113.119 172.506 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 120.931 0.396 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 95.22 -3.21 66.33 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.434 1.016 . . . . 0.0 113.33 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 3.2 m -70.13 154.15 42.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.598 1.199 . . . . 0.0 110.927 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -127.81 26.37 5.87 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.643 1.177 . . . . 0.0 110.078 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -73.26 179.93 3.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.383 1.473 . . . . 0.0 110.662 168.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.83 167.08 31.55 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.587 -0.695 . . . . 0.0 112.873 168.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.24 -163.82 28.57 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 126.133 1.825 . . . . 0.0 113.892 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.35 174.61 11.83 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.019 3.146 . . . . 0.0 112.693 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -57.46 125.75 24.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.179 0.992 . . . . 0.0 111.286 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.03 71.49 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.864 1.221 . . . . 0.0 114.301 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.64 -0.54 42.8 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -113.67 123.65 50.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.422 1.089 . . . . 0.0 110.645 -169.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.9 mt -122.52 142.93 50.07 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.815 2.046 . . . . 0.0 112.861 -168.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -111.61 135.21 52.5 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.78 1.632 . . . . 0.0 108.595 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.6 mm -119.56 138.22 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.993 1.717 . . . . 0.0 108.369 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -138.8 162.27 35.18 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.597 0.759 . . . . 0.0 112.867 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 64.57 26.34 13.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.34 2.256 . . . . 0.0 113.87 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 72.1 mt -65.56 159.46 67.61 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.023 1.329 . . . . 0.0 111.823 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.71 149.38 77.39 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.065 2.51 . . . . 0.0 111.929 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -71.64 -8.4 53.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.77 1.228 . . . . 0.0 113.922 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -113.56 -6.01 13.41 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.271 2.228 . . . . 0.0 113.865 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 125.72 27.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.153 1.381 . . . . 0.0 110.869 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.67 -177.75 25.9 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.443 1.02 . . . . 0.0 113.745 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -62.4 -36.07 81.18 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.892 0.877 . . . . 0.0 112.66 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.22 -31.23 58.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.992 0.917 . . . . 0.0 111.95 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.495 0.589 . . . . 0.0 110.762 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.19 -37.06 83.02 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.286 0.635 . . . . 0.0 111.694 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -62.75 -50.17 72.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.838 0.745 . . . . 0.0 111.062 172.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -63.19 -28.08 69.8 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.427 0.691 . . . . 0.0 112.767 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.9 ttm -73.31 -28.76 62.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.478 1.111 . . . . 0.0 113.241 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -110.54 -17.47 13.42 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.0 mtm -55.29 -32.49 12.69 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -57.99 -15.48 22.61 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.66 2.907 . . . . 0.0 116.372 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -101.59 -7.94 22.3 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.07 -160.74 28.09 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.895 1.236 . . . . 0.0 114.718 171.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -72.52 95.79 1.85 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.257 1.023 . . . . 0.0 112.144 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.5 t -77.38 127.73 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.061 1.344 . . . . 0.0 109.814 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.14 -26.02 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.378 2.271 . . . . 0.0 111.788 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.6 t -154.27 144.37 21.96 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.678 1.191 . . . . 0.0 110.339 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.26 126.39 5.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.935 1.694 . . . . 0.0 110.246 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 28.9 tptt -154.83 138.01 15.66 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.427 -0.796 . . . . 0.0 111.813 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.36 135.09 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.779 1.632 . . . . 0.0 108.167 169.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 123.453 0.701 . . . . 0.0 111.086 -178.419 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.8 m 67.53 18.78 10.0 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.209 2.204 . . . . 0.0 113.439 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -144.35 155.34 43.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.205 0.911 . . . . 0.0 112.124 173.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.35 -176.04 28.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.945 1.736 . . . . 0.0 113.653 -170.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -141.47 142.43 33.63 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.437 1.895 . . . . 0.0 110.077 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.8 t -143.89 141.55 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.205 1.402 . . . . 0.0 108.88 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 75.5 m -137.48 144.25 42.16 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.431 -0.793 . . . . 0.0 112.296 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -112.93 166.1 11.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.313 1.445 . . . . 0.0 113.131 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.0 -19.5 62.51 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.423 1.089 . . . . 0.0 113.078 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -148.34 153.39 40.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.589 1.556 . . . . 0.0 111.476 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.5 -17.66 11.23 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.071 2.514 . . . . 0.0 114.027 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.1 t -72.37 -40.57 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.175 0.898 . . . . 0.0 110.395 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.3 m -62.97 -32.82 74.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.866 0.866 . . . . 0.0 111.719 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.79 -49.44 25.31 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.593 1.157 . . . . 0.0 112.017 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -59.14 -38.75 80.42 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.528 -0.733 . . . . 0.0 111.964 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.01 -28.41 64.4 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -80.14 -44.47 19.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 111.899 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 43.4 mt -57.94 -49.3 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.537 1.062 . . . . 0.0 110.372 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 -74.42 -11.52 60.26 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.4 m -101.1 -29.86 11.91 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.46 -18.64 12.81 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -169.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.01 109.24 3.87 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.925 0.784 . . . . 0.0 109.737 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.72 9.98 60.68 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.392 1.472 . . . . 0.0 114.966 -171.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -64.86 124.48 22.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.051 1.926 . . . . 0.0 111.145 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -79.25 131.05 36.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.095 0.558 . . . . 0.0 110.887 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.4 tt . . . . . 0 N--CA 1.472 0.64 0 C-N-CA 124.809 1.244 . . . . 0.0 110.556 -179.086 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 . . . . . 0 N--CA 1.474 0.725 0 CA-C-O 120.577 0.227 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 56.6 mt -70.99 162.88 28.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.176 1.39 . . . . 0.0 111.933 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -133.9 147.33 51.1 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.309 1.444 . . . . 0.0 109.327 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 29.6 t -139.21 137.81 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.647 1.179 . . . . 0.0 109.386 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -141.75 160.54 39.96 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.458 1.103 . . . . 0.0 111.191 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 69.9 mt -69.31 157.95 35.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.653 0.74 . . . . 0.0 111.18 168.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 124.539 1.136 . . . . 0.0 112.334 172.516 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.319 0.58 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.61 -7.47 77.42 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.75 1.643 . . . . 0.0 113.254 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.4 t -85.08 172.37 11.31 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.376 1.088 . . . . 0.0 112.186 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.07 31.98 2.93 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.101 1.361 . . . . 0.0 111.065 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -68.74 165.75 18.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.065 0.946 . . . . 0.0 112.528 169.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.63 156.77 45.11 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.25 -169.23 29.27 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 126.156 1.836 . . . . 0.0 113.246 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.14 175.28 7.79 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.086 3.19 . . . . 0.0 112.676 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.85 121.96 11.75 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.094 0.957 . . . . 0.0 111.44 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.88 -1.73 78.56 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.862 1.22 . . . . 0.0 114.659 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.41 6.76 46.98 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.957 1.378 . . . . 0.0 114.372 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -118.36 122.12 42.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.293 1.437 . . . . 0.0 111.08 -171.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.7 140.76 52.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.439 1.896 . . . . 0.0 112.343 -169.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -110.99 133.09 53.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.889 1.676 . . . . 0.0 108.801 168.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.29 135.1 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.946 1.698 . . . . 0.0 107.884 -171.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -132.98 156.78 46.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.933 1.293 . . . . 0.0 112.585 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 74.55 27.9 1.31 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.732 2.413 . . . . 0.0 113.849 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.2 mt -64.96 157.29 76.76 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.103 1.361 . . . . 0.0 112.057 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.81 152.56 34.86 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.388 2.725 . . . . 0.0 112.126 169.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -67.21 -29.33 68.96 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.9 -9.79 56.35 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.01 129.2 39.2 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.9 1.28 . . . . 0.0 111.793 -175.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -113.74 -174.28 18.73 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.312 1.434 . . . . 0.0 113.314 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.25 -34.7 78.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.077 0.951 . . . . 0.0 112.991 -174.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -76.77 -31.56 57.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.893 0.877 . . . . 0.0 111.782 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -67.66 -41.59 83.53 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.705 0.684 . . . . 0.0 110.649 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 23.3 tp -65.59 -41.09 93.23 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.334 0.654 . . . . 0.0 111.562 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.26 -51.69 67.86 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.661 0.664 . . . . 0.0 111.37 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -63.72 -28.04 69.61 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.8 ttp -81.4 -20.39 40.56 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -109.61 -19.78 13.08 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 51.5 mtm -54.8 -31.85 10.46 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -57.34 -16.78 23.98 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.616 2.877 . . . . 0.0 116.273 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -97.71 -8.79 27.92 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.406 1.003 . . . . 0.0 113.636 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.18 -162.92 28.16 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.089 1.328 . . . . 0.0 114.67 170.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -71.03 95.01 1.15 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.437 1.095 . . . . 0.0 111.842 -173.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.1 t -73.43 129.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.027 1.331 . . . . 0.0 109.733 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 35.7 t -94.56 -33.78 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.16 2.184 . . . . 0.0 111.505 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.3 t -155.22 150.45 27.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.462 1.105 . . . . 0.0 110.836 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.29 14.86 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.178 1.391 . . . . 0.0 109.915 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -151.58 138.74 19.23 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.466 -0.771 . . . . 0.0 111.705 -168.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 85.8 t -119.32 126.99 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.534 1.534 . . . . 0.0 107.468 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 123.361 0.664 . . . . 0.0 111.308 -174.627 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.549 0.939 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 76.3 m 65.63 22.8 11.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.912 2.085 . . . . 0.0 113.396 -172.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -146.14 155.57 42.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.004 0.922 . . . . 0.0 111.68 171.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.05 -173.43 24.63 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.749 1.643 . . . . 0.0 113.918 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -139.79 146.24 39.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.304 1.842 . . . . 0.0 110.243 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 58.1 t -143.61 138.58 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.115 1.366 . . . . 0.0 109.006 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 85.6 p -130.71 152.69 49.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.911 0.885 . . . . 0.0 112.358 175.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.73 161.86 26.36 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.933 1.293 . . . . 0.0 113.504 -174.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.65 -18.37 64.27 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.72 1.208 . . . . 0.0 112.885 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -146.16 151.24 44.08 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 125.596 1.559 . . . . 0.0 112.05 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.26 -28.16 55.66 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.035 3.157 . . . . 0.0 114.035 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.7 t -74.43 -38.46 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.958 0.903 . . . . 0.0 110.828 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 8.2 m -63.9 -31.79 73.1 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.916 0.886 . . . . 0.0 111.82 171.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.91 -48.58 29.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.403 1.081 . . . . 0.0 111.926 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -59.05 -38.97 80.62 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.383 -0.823 . . . . 0.0 111.879 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.75 -27.33 64.84 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -79.9 -44.65 20.01 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.458 171.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.56 -49.4 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.871 1.214 . . . . 0.0 110.618 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -73.87 -11.21 60.3 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.6 m -102.1 -27.71 12.76 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.5 mmm -112.47 -20.63 11.7 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -168.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.29 110.1 5.06 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.197 0.908 . . . . 0.0 109.84 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.31 1.85 62.34 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.533 1.539 . . . . 0.0 115.028 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -62.63 125.79 25.15 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.54 1.67 . . . . 0.0 111.866 -178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -79.72 125.96 30.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.592 0.757 . . . . 0.0 110.075 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt . . . . . 0 N--CA 1.469 0.504 0 C-N-CA 125.058 1.343 . . . . 0.0 109.811 -177.708 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 120.569 0.223 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 75.8 mt -76.79 162.9 27.28 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.149 1.38 . . . . 0.0 112.652 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -131.51 141.91 49.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.758 1.623 . . . . 0.0 109.678 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.75 138.1 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.735 1.214 . . . . 0.0 109.392 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -147.76 142.53 26.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.815 1.246 . . . . 0.0 110.597 -169.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 41.1 mt -65.8 151.41 46.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.011 0.925 . . . . 0.0 112.308 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.5 tttt . . . . . 0 CA--C 1.547 0.85 0 C-N-CA 124.303 1.041 . . . . 0.0 111.329 170.934 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.869 0.366 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.34 79.29 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.283 0.944 . . . . 0.0 113.086 -175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 10.1 t -75.61 162.68 28.06 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.25 1.025 . . . . 0.0 111.88 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -134.79 20.21 3.53 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.169 1.388 . . . . 0.0 111.224 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -66.83 173.67 3.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.133 0.973 . . . . 0.0 111.484 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.47 167.1 29.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 167.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -94.81 -167.14 36.2 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.113 1.34 . . . . 0.0 113.638 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.6 171.06 13.78 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.358 2.705 . . . . 0.0 111.521 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.94 123.27 15.24 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.641 0.777 . . . . 0.0 111.259 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.79 -9.66 70.76 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.725 1.155 . . . . 0.0 114.276 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.07 -6.25 54.06 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.895 1.347 . . . . 0.0 113.686 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.3 118.54 36.2 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.282 2.233 . . . . 0.0 111.404 -174.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 22.0 mt -119.68 136.63 54.33 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.386 1.875 . . . . 0.0 111.989 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -109.69 131.99 54.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.451 1.5 . . . . 0.0 108.796 168.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.56 135.33 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.938 1.695 . . . . 0.0 107.951 -171.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -131.42 160.4 35.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.247 1.419 . . . . 0.0 112.687 -175.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 68.27 28.26 6.39 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.496 2.318 . . . . 0.0 113.601 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 52.9 mt -65.69 155.24 86.65 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.491 1.116 . . . . 0.0 111.727 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.21 143.19 94.13 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.047 2.498 . . . . 0.0 112.575 172.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -62.69 -6.9 3.98 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.791 2.036 . . . . 0.0 114.845 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -113.14 -9.04 13.55 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.58 1.952 . . . . 0.0 114.241 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.44 134.03 47.41 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.635 1.174 . . . . 0.0 112.287 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.42 -172.7 18.9 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.663 1.601 . . . . 0.0 112.447 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -63.53 -34.66 78.27 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -172.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -77.09 -28.31 54.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.145 0.578 . . . . 0.0 112.448 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -69.95 -41.79 74.08 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.586 0.63 . . . . 0.0 110.796 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 31.8 tp -65.56 -37.6 87.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.491 0.716 . . . . 0.0 111.811 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.72 -50.4 67.07 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.709 0.686 . . . . 0.0 111.462 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -63.42 -26.33 68.69 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.409 0.684 . . . . 0.0 112.551 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 48.1 ttm -73.95 -28.79 61.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.169 0.988 . . . . 0.0 113.373 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -109.84 -18.52 13.39 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.6 mtm -56.16 -32.61 13.51 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -57.63 -16.23 23.63 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.578 2.852 . . . . 0.0 116.165 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -100.28 -9.7 22.08 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.7 -163.35 28.55 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.087 1.327 . . . . 0.0 114.957 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -70.37 99.82 1.64 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.335 1.054 . . . . 0.0 112.542 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 85.5 t -79.35 128.54 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.163 1.385 . . . . 0.0 110.038 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 56.0 t -98.97 -24.33 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.568 2.347 . . . . 0.0 111.787 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 9.4 t -156.98 144.27 18.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.762 1.225 . . . . 0.0 110.711 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.36 130.3 12.52 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.158 1.383 . . . . 0.0 110.89 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -156.11 132.85 10.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.578 0.751 . . . . 0.0 112.657 -174.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 64.8 t -102.12 134.71 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.683 1.593 . . . . 0.0 106.943 167.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 123.293 0.637 . . . . 0.0 110.423 178.137 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.9 m 63.82 21.32 12.61 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.017 2.127 . . . . 0.0 113.119 -170.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.84 155.14 43.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.109 0.868 . . . . 0.0 112.4 173.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.56 179.83 31.22 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.926 1.727 . . . . 0.0 113.513 -170.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -137.04 142.22 42.46 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.549 1.94 . . . . 0.0 110.228 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 84.8 t -141.7 142.98 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.137 1.375 . . . . 0.0 108.608 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 18.3 m -136.86 148.81 47.31 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -115.35 171.59 7.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.546 1.539 . . . . 0.0 113.165 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.49 -23.71 66.09 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.42 1.488 . . . . 0.0 113.427 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -161.33 161.13 23.65 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.199 1.4 . . . . 0.0 112.104 -172.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.08 -13.77 34.27 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.504 2.136 . . . . 0.0 114.082 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.34 -46.01 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 121.043 1.747 . . . . 0.0 110.608 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 45.6 m -65.93 -30.66 71.28 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.312 1.045 . . . . 0.0 111.924 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.37 -48.4 28.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.04 0.936 . . . . 0.0 111.981 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -61.68 -32.29 72.46 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.523 -0.736 . . . . 0.0 112.094 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.71 71.76 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.46 -42.95 41.96 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.564 0.746 . . . . 0.0 111.732 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.7 mt -58.42 -46.67 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 118.798 0.727 . . . . 0.0 110.274 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.48 -12.52 61.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 66.6 m -103.54 -29.85 10.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 87.6 mmm -114.29 -18.71 11.52 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -168.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -70.87 111.48 6.32 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.42 1.009 . . . . 0.0 110.191 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.24 0.53 63.23 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.719 1.628 . . . . 0.0 114.953 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.12 122.74 16.85 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.403 1.601 . . . . 0.0 111.251 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -75.64 131.95 40.27 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 110.631 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.0 tt . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 125.011 1.324 . . . . 0.0 108.757 176.975 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 . . . . . 0 N--CA 1.473 0.706 0 CA-C-O 120.477 0.179 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.47 155.58 37.17 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.051 1.341 . . . . 0.0 111.547 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -130.3 141.9 50.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.935 1.294 . . . . 0.0 109.143 168.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.4 t -139.0 132.95 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.454 1.102 . . . . 0.0 109.169 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -143.85 154.95 43.91 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.514 1.126 . . . . 0.0 111.232 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 60.4 mt -66.95 160.12 27.02 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.527 0.731 . . . . 0.0 112.722 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 78.1 tttt . . . . . 0 CA--C 1.555 1.154 0 C-N-CA 125.102 1.361 . . . . 0.0 110.388 167.466 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 120.979 0.418 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 94.88 -5.45 69.14 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.992 1.282 . . . . 0.0 113.442 -175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 36.2 t -79.7 143.55 34.48 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.574 1.187 . . . . 0.0 111.341 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -118.93 15.25 13.38 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.852 1.261 . . . . 0.0 111.755 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -66.33 173.64 3.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.807 0.843 . . . . 0.0 111.655 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -153.43 160.34 42.57 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.6 -161.62 29.03 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 128.243 2.83 . . . . 0.0 113.365 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 169.01 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.68 2.92 . . . . 0.0 112.49 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -59.36 127.09 30.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.41 0.684 . . . . 0.0 111.145 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.36 -11.18 70.68 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.92 1.248 . . . . 0.0 114.01 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.86 -4.49 46.9 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.722 1.261 . . . . 0.0 114.118 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -108.29 118.21 36.18 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.118 1.367 . . . . 0.0 110.93 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.7 mt -120.19 132.0 55.21 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.175 1.79 . . . . 0.0 111.861 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -103.04 133.2 48.56 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.785 1.234 . . . . 0.0 108.557 167.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.3 mm -118.16 135.65 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.771 1.629 . . . . 0.0 108.26 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -133.93 160.45 37.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.574 1.15 . . . . 0.0 112.308 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 62.62 33.94 15.36 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.477 1.911 . . . . 0.0 113.282 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 45.2 mt -70.03 164.68 50.07 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.659 1.584 . . . . 0.0 111.455 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.03 141.47 94.36 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.702 2.268 . . . . 0.0 110.888 168.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -67.86 -8.29 35.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.959 1.304 . . . . 0.0 113.962 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.52 -9.2 16.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.424 1.889 . . . . 0.0 114.144 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.3 130.85 43.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.138 1.375 . . . . 0.0 111.643 -175.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -101.96 -179.63 27.69 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.367 0.984 . . . . 0.0 113.582 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.15 -33.69 74.98 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.149 0.98 . . . . 0.0 112.326 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -73.56 -40.81 63.65 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.989 1.716 . . . . 0.0 110.917 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -64.77 -41.38 95.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.708 0.803 . . . . 0.0 111.351 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.0 tp -67.0 -37.7 84.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.277 0.631 . . . . 0.0 111.858 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.63 -49.88 73.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.758 0.708 . . . . 0.0 110.943 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -63.39 -27.56 69.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.608 0.763 . . . . 0.0 112.851 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.5 ttm -72.45 -32.06 65.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.231 1.012 . . . . 0.0 113.051 173.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -107.38 -18.49 13.85 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -171.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 44.4 mtm -55.61 -33.49 18.09 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -57.77 -16.72 26.44 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.556 2.837 . . . . 0.0 115.992 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -99.23 -10.85 21.89 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.47 -154.36 25.88 Favored Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.411 1.005 . . . . 0.0 115.494 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -74.49 82.46 1.97 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.528 1.131 . . . . 0.0 112.962 -169.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.46 128.39 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.551 1.14 . . . . 0.0 109.951 172.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 73.5 t -94.13 -37.77 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.801 2.04 . . . . 0.0 110.85 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 63.3 m -151.29 146.01 25.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.859 1.263 . . . . 0.0 110.807 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.53 134.66 14.96 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.247 1.419 . . . . 0.0 110.402 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -155.6 136.26 13.42 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.692 0.797 . . . . 0.0 111.839 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.17 134.78 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.922 1.689 . . . . 0.0 107.734 169.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 123.033 0.533 . . . . 0.0 110.925 -179.358 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 CA--C 1.547 0.864 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.1 m 67.33 20.49 10.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.387 2.275 . . . . 0.0 113.061 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -145.02 156.18 43.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.854 0.862 . . . . 0.0 111.711 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.0 -174.86 28.26 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.906 1.717 . . . . 0.0 113.736 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -142.06 144.25 33.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.181 1.792 . . . . 0.0 110.196 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 98.8 t -141.97 142.72 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.499 1.519 . . . . 0.0 108.482 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 37.9 t -139.98 142.44 36.31 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.567 -0.708 . . . . 0.0 112.106 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.69 168.2 9.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.808 1.643 . . . . 0.0 113.422 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.17 -22.89 66.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.616 1.567 . . . . 0.0 113.282 170.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -160.07 157.69 25.47 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.232 1.413 . . . . 0.0 112.19 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.25 -15.65 39.16 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.629 2.219 . . . . 0.0 113.794 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.52 -43.72 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.53 1.514 . . . . 0.0 110.535 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.4 m -68.7 -31.26 70.22 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 112.072 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -75.84 -47.43 25.62 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.808 0.843 . . . . 0.0 112.474 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -62.47 -31.32 72.04 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.5 -0.75 . . . . 0.0 111.981 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.44 -30.92 71.95 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.312 0.645 . . . . 0.0 112.632 172.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.46 -42.59 43.24 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.447 0.699 . . . . 0.0 111.879 175.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.52 -46.08 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 118.738 0.699 . . . . 0.0 110.065 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -72.16 -12.46 61.19 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.6 m -104.02 -30.95 9.95 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.7 mmm -111.86 -18.04 12.78 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -70.06 112.1 6.2 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.429 1.013 . . . . 0.0 110.755 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.87 71.5 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.038 1.78 . . . . 0.0 114.94 -173.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -61.47 124.07 19.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.189 1.495 . . . . 0.0 111.331 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -78.39 131.0 36.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.215 0.531 . . . . 0.0 110.42 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 125.027 1.331 . . . . 0.0 108.493 177.261 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 119.951 -0.071 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.96 158.86 24.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.211 1.404 . . . . 0.0 112.224 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -136.85 141.99 42.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.069 1.348 . . . . 0.0 109.063 167.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.7 t -138.29 136.73 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.421 1.089 . . . . 0.0 108.95 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -149.13 151.28 34.11 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.774 0.83 . . . . 0.0 110.829 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.7 mt -60.24 156.65 15.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.931 0.872 . . . . 0.0 112.805 170.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 CA--C 1.548 0.877 0 C-N-CA 124.359 1.064 . . . . 0.0 113.175 169.707 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.561 0 CA-C-O 121.59 0.709 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.86 -3.71 84.82 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.613 1.577 . . . . 0.0 112.911 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.8 m -78.01 163.68 25.73 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.0 1.32 . . . . 0.0 111.991 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -125.26 33.12 5.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.746 1.218 . . . . 0.0 110.657 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -69.4 171.59 8.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.83 1.252 . . . . 0.0 110.74 168.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -158.83 165.41 34.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.474 0.709 . . . . 0.0 112.903 168.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -102.57 -165.23 26.29 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 126.074 1.797 . . . . 0.0 113.876 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.73 179.74 5.69 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.259 3.306 . . . . 0.0 112.702 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -54.63 124.3 15.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.538 1.135 . . . . 0.0 111.738 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.84 -6.32 83.64 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.775 1.179 . . . . 0.0 114.547 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.62 -3.15 55.44 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.765 1.283 . . . . 0.0 114.362 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -115.39 128.36 56.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.343 1.057 . . . . 0.0 111.005 -169.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 23.0 mt -126.01 143.1 51.23 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.041 2.136 . . . . 0.0 112.483 -168.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -110.65 135.59 51.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.693 1.597 . . . . 0.0 108.499 167.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.66 135.56 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.707 1.603 . . . . 0.0 107.905 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -131.84 160.59 35.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.872 1.269 . . . . 0.0 112.771 -176.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 69.76 27.74 4.55 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.732 2.413 . . . . 0.0 113.858 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.7 mt -66.59 158.52 78.69 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 124.916 1.286 . . . . 0.0 112.133 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.24 147.26 96.08 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.972 2.448 . . . . 0.0 111.299 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -70.97 -9.06 57.24 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.25 -8.29 17.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.505 1.922 . . . . 0.0 114.035 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.8 124.79 24.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.869 1.268 . . . . 0.0 110.741 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.23 -173.97 24.25 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.54 1.067 . . . . 0.0 113.914 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -70.07 -35.22 74.06 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -172.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -74.95 -28.64 60.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.477 0.711 . . . . 0.0 111.641 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -70.39 -43.14 70.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.236 0.614 . . . . 0.0 110.698 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.18 -35.81 80.46 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.069 0.548 . . . . 0.0 111.764 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.7 tp -62.07 -51.01 69.7 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.84 0.746 . . . . 0.0 110.913 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -68.07 -22.81 64.91 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.4 ttm -73.93 -28.76 61.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.316 1.046 . . . . 0.0 112.888 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -109.86 -17.85 13.54 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.6 mtm -54.28 -33.62 17.07 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 170.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -58.95 -15.94 29.81 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.569 2.846 . . . . 0.0 116.229 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -101.48 -9.3 21.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.59 -158.93 27.88 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.831 1.205 . . . . 0.0 114.884 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -75.0 94.42 2.85 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.084 0.954 . . . . 0.0 112.172 -170.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 96.2 t -74.27 131.48 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.972 1.309 . . . . 0.0 110.445 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 34.1 t -106.75 -20.9 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 128.082 2.553 . . . . 0.0 112.06 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.8 t -160.26 148.3 16.62 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.659 1.184 . . . . 0.0 110.657 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -159.91 124.46 3.86 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.143 1.377 . . . . 0.0 110.573 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -155.16 146.78 23.16 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.129 -0.982 . . . . 0.0 112.695 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 23.9 t -119.42 131.03 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.036 1.734 . . . . 0.0 107.763 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 123.111 0.564 . . . . 0.0 110.54 -177.497 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 57.0 m 68.47 19.11 8.88 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.441 2.296 . . . . 0.0 113.69 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -145.56 154.34 42.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.453 1.024 . . . . 0.0 112.534 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.2 -176.1 27.01 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.282 1.896 . . . . 0.0 113.509 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -143.49 143.65 31.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.354 1.862 . . . . 0.0 110.068 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 80.7 t -142.53 147.48 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.442 1.497 . . . . 0.0 108.815 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.1 m -139.92 152.18 46.18 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.668 0.787 . . . . 0.0 112.003 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -121.24 169.02 10.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.535 1.534 . . . . 0.0 113.126 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.71 -22.53 65.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.081 1.353 . . . . 0.0 113.356 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -160.7 158.07 24.29 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.304 1.441 . . . . 0.0 112.306 -171.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.24 -16.04 43.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.656 2.238 . . . . 0.0 113.969 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.27 -44.31 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.595 1.543 . . . . 0.0 110.569 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.7 m -68.58 -31.47 70.68 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.01 0.924 . . . . 0.0 111.91 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.22 -48.47 34.75 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.931 0.892 . . . . 0.0 112.071 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -62.59 -32.89 73.96 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.436 -0.79 . . . . 0.0 111.882 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.65 -29.42 70.42 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.88 -42.3 33.84 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.525 0.73 . . . . 0.0 111.439 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.7 mt -58.5 -46.32 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 118.859 0.754 . . . . 0.0 110.201 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -71.18 -13.02 61.79 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.4 m -104.17 -27.78 11.85 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.5 mmm -115.34 -19.23 10.81 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -169.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -70.93 109.96 5.37 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.177 0.899 . . . . 0.0 109.903 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 97.18 2.36 59.2 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.619 1.58 . . . . 0.0 114.978 -171.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -62.04 125.06 22.55 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.574 1.687 . . . . 0.0 111.699 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -80.73 129.98 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.387 0.675 . . . . 0.0 110.965 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt . . . . . 0 N--CA 1.471 0.589 0 C-N-CA 124.866 1.266 . . . . 0.0 110.492 -178.12 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 120.556 0.217 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 69.1 mt -72.29 159.43 34.06 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.177 1.391 . . . . 0.0 111.992 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -129.17 141.92 51.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.178 1.391 . . . . 0.0 109.24 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 25.2 t -139.46 135.56 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.587 1.155 . . . . 0.0 109.144 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -155.97 151.06 26.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.195 0.598 . . . . 0.0 111.938 -172.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.04 152.41 40.34 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 79.4 tttt . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 124.799 1.239 . . . . 0.0 113.104 169.195 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 120.896 0.379 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.65 6.48 70.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.747 1.641 . . . . 0.0 113.256 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.3 t -80.02 163.47 24.19 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.391 1.076 . . . . 0.0 113.224 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -126.99 8.73 6.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.917 1.287 . . . . 0.0 112.243 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -68.3 166.8 15.74 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.342 -0.849 . . . . 0.0 111.966 168.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.01 165.85 34.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.319 1.048 . . . . 0.0 112.267 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.63 -161.41 25.01 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 126.007 1.765 . . . . 0.0 113.976 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.26 177.64 8.01 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.098 3.199 . . . . 0.0 112.749 -174.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.9 126.83 28.8 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.107 0.963 . . . . 0.0 111.408 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.02 -7.27 82.59 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.042 1.306 . . . . 0.0 114.463 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.59 -2.11 45.55 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -114.8 122.22 45.68 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.27 1.028 . . . . 0.0 110.775 -168.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.7 mt -121.92 138.22 54.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.39 1.876 . . . . 0.0 111.971 -168.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -108.85 135.01 50.76 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.099 1.359 . . . . 0.0 108.834 167.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.95 135.31 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.978 1.711 . . . . 0.0 107.833 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -133.56 159.34 40.74 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.783 1.233 . . . . 0.0 112.434 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 68.5 30.58 5.19 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.218 2.207 . . . . 0.0 113.234 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.29 156.12 86.04 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.355 1.062 . . . . 0.0 111.556 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.71 148.41 74.49 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.183 2.589 . . . . 0.0 111.639 169.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -66.62 -19.36 65.75 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.45 -10.14 39.02 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -176.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.29 136.85 57.08 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.568 1.147 . . . . 0.0 113.203 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -113.11 -178.77 19.5 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.548 1.547 . . . . 0.0 112.799 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -64.48 -32.06 73.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.016 0.926 . . . . 0.0 113.131 -174.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -72.57 -35.21 67.92 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.08 0.952 . . . . 0.0 111.65 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -67.45 -41.69 84.31 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.737 0.699 . . . . 0.0 110.934 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.96 -36.53 78.0 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.101 0.56 . . . . 0.0 112.126 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 64.8 tp -64.08 -51.25 64.94 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.711 0.687 . . . . 0.0 111.097 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -65.47 -29.02 69.63 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.328 0.651 . . . . 0.0 112.274 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 47.0 ttm -67.85 -29.95 69.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.35 1.06 . . . . 0.0 113.006 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -106.24 -14.06 15.23 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.9 mtt -50.3 -37.64 30.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -61.06 -18.77 59.89 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.212 2.608 . . . . 0.0 115.75 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -97.4 -10.34 25.68 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.39 -159.37 27.73 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 125.217 1.389 . . . . 0.0 114.64 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -74.15 85.8 1.87 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.461 1.105 . . . . 0.0 112.436 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.18 125.89 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.134 0.974 . . . . 0.0 109.281 169.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.83 -33.68 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.146 1.779 . . . . 0.0 110.864 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 19.4 m -159.44 145.48 16.22 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.498 1.519 . . . . 0.0 110.875 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.78 143.74 24.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.582 1.553 . . . . 0.0 110.826 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -159.06 142.66 14.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.089 0.955 . . . . 0.0 112.947 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.97 138.88 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.136 1.774 . . . . 0.0 107.166 169.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.083 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 28.3 m 75.78 20.56 1.78 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.388 2.675 . . . . 0.0 113.179 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.52 158.02 43.8 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.816 0.846 . . . . 0.0 112.168 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.63 -173.7 28.44 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.979 1.752 . . . . 0.0 113.757 -170.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -147.09 140.44 25.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.592 1.957 . . . . 0.0 110.041 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 71.7 t -146.29 137.49 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.346 1.458 . . . . 0.0 109.278 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.0 m -135.56 141.72 45.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.638 0.775 . . . . 0.0 112.681 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -110.37 170.78 7.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.315 1.846 . . . . 0.0 112.183 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.72 -2.21 45.93 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -157.6 157.3 29.83 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 126.023 1.729 . . . . 0.0 111.887 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.06 -12.61 15.99 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.281 1.987 . . . . 0.0 113.899 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.9 t -79.28 -44.29 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.891 1.678 . . . . 0.0 110.648 -174.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 40.6 m -63.55 -31.96 73.28 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.339 1.056 . . . . 0.0 111.875 171.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -71.43 -51.47 23.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.088 0.955 . . . . 0.0 111.741 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -66.85 -29.66 69.63 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.312 -0.868 . . . . 0.0 112.241 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.44 71.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.791 0.723 . . . . 0.0 112.733 170.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.91 -41.71 61.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.78 0.718 . . . . 0.0 111.466 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 38.1 mt -56.59 -49.29 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 118.964 0.802 . . . . 0.0 110.308 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -70.45 -12.27 61.46 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.5 m -104.06 -28.0 11.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.7 mmm -116.43 -18.09 10.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -70.6 112.2 6.67 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.416 1.007 . . . . 0.0 110.113 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.57 3.22 64.77 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.953 1.74 . . . . 0.0 114.815 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.71 125.43 23.93 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.332 1.566 . . . . 0.0 111.355 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -86.15 130.04 34.65 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.034 0.533 . . . . 0.0 111.066 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.8 tt . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 125.3 1.44 . . . . 0.0 110.081 -173.626 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 60.8 mt -69.58 154.5 41.9 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.051 1.34 . . . . 0.0 112.343 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -124.17 138.98 54.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.639 1.176 . . . . 0.0 108.156 166.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 33.1 t -135.23 135.23 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.362 1.065 . . . . 0.0 108.212 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -152.02 146.66 25.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.277 0.631 . . . . 0.0 111.593 -169.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.75 157.77 29.37 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.862 0.865 . . . . 0.0 112.821 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 75.5 tttt . . . . . 0 CA--C 1.555 1.15 0 C-N-CA 125.282 1.433 . . . . 0.0 110.581 168.132 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 121.082 0.468 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.67 3.28 86.28 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.608 1.575 . . . . 0.0 113.652 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 17.1 t -84.8 174.63 9.72 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.225 1.013 . . . . 0.0 112.514 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -132.77 21.36 4.21 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.067 1.747 . . . . 0.0 110.852 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -61.83 161.28 10.55 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.001 0.92 . . . . 0.0 112.6 168.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.56 155.62 45.02 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.04 -170.48 32.35 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.155 1.836 . . . . 0.0 113.301 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -70.03 177.43 5.77 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.151 3.234 . . . . 0.0 112.558 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.13 125.76 24.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.866 0.866 . . . . 0.0 111.198 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.23 -7.46 75.75 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.99 1.281 . . . . 0.0 114.609 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -103.55 8.7 37.69 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -117.96 123.95 47.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.03 1.332 . . . . 0.0 110.709 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 30.7 mt -124.64 140.4 52.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.351 1.86 . . . . 0.0 112.531 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -111.19 133.72 53.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.445 1.498 . . . . 0.0 109.147 168.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.29 137.33 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 126.108 1.763 . . . . 0.0 107.935 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -134.04 161.63 34.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.459 1.504 . . . . 0.0 112.051 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 63.01 33.28 14.92 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.233 1.813 . . . . 0.0 113.307 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 52.9 mt -65.75 159.07 71.63 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.296 1.038 . . . . 0.0 111.01 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -55.46 144.42 73.35 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.89 2.394 . . . . 0.0 111.967 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -55.69 -11.9 1.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.811 2.444 . . . . 0.0 115.587 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -131.05 0.74 4.22 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.294 1.838 . . . . 0.0 114.264 -169.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.04 133.64 51.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.604 1.562 . . . . 0.0 111.363 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.32 -179.86 23.91 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.899 1.238 . . . . 0.0 113.563 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -65.41 -32.45 74.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.046 0.938 . . . . 0.0 112.541 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -74.68 -39.96 61.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.828 1.651 . . . . 0.0 110.876 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -62.13 -44.36 96.81 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.93 0.892 . . . . 0.0 111.015 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 26.4 tp -66.16 -43.09 87.97 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.156 0.582 . . . . 0.0 111.803 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.4 tp -57.21 -54.17 49.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 111.211 175.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -73.96 -20.88 60.22 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.7 ttp -76.97 -22.29 53.43 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.037 0.835 . . . . 0.0 113.03 170.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -102.97 -15.59 16.08 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.964 1.305 . . . . 0.0 113.872 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 36.1 mtt -48.21 -37.86 17.68 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -62.41 -17.62 58.67 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.108 2.538 . . . . 0.0 115.488 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -97.04 -10.43 26.15 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.94 0.896 . . . . 0.0 113.327 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.41 -163.91 28.72 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.405 1.478 . . . . 0.0 114.449 171.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.12 100.61 2.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.932 0.893 . . . . 0.0 111.896 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.6 t -76.19 129.14 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.911 1.284 . . . . 0.0 110.191 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 42.1 t -94.63 -33.6 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.742 2.017 . . . . 0.0 111.541 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 8.6 t -155.75 152.96 29.15 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.96 1.304 . . . . 0.0 110.748 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.91 130.8 8.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.387 1.475 . . . . 0.0 110.351 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -153.95 144.93 22.71 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.465 -0.772 . . . . 0.0 112.544 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.31 131.46 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.203 1.801 . . . . 0.0 107.229 170.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 CA--C 1.537 0.451 0 CA-C-O 121.39 0.614 . . . . 0.0 111.11 -177.628 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 73.1 mttt . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 34.5 m 69.15 20.16 7.7 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.966 2.107 . . . . 0.0 113.626 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -144.43 156.33 44.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.184 0.994 . . . . 0.0 111.444 172.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.54 -175.36 28.38 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.715 1.626 . . . . 0.0 114.103 -169.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -139.3 146.67 40.63 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.571 1.948 . . . . 0.0 110.049 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 64.2 t -144.94 144.09 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.165 1.386 . . . . 0.0 109.188 174.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 95.7 p -137.16 155.12 49.96 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.389 -0.819 . . . . 0.0 112.884 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -126.82 162.24 26.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.321 1.448 . . . . 0.0 113.462 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.5 -19.78 64.55 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.277 1.031 . . . . 0.0 113.252 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -147.68 153.71 43.43 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.721 1.608 . . . . 0.0 111.066 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.61 -17.53 11.16 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.896 2.397 . . . . 0.0 113.785 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 90.8 t -71.45 -39.6 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.314 0.961 . . . . 0.0 110.333 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 7.8 m -62.44 -34.37 76.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.041 0.936 . . . . 0.0 111.77 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.01 -48.2 38.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.583 1.153 . . . . 0.0 111.97 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -59.3 -38.75 81.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.673 0.789 . . . . 0.0 111.895 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.95 -29.16 70.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.587 0.755 . . . . 0.0 112.957 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.91 -43.38 45.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.626 0.648 . . . . 0.0 111.098 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.4 mt -58.24 -47.39 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.272 0.942 . . . . 0.0 110.246 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -67.14 -17.93 65.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.327 1.051 . . . . 0.0 113.589 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.7 m -104.41 -23.66 13.15 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.5 mmt -112.49 -22.52 10.78 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.686 1.194 . . . . 0.0 113.542 -171.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -70.9 112.52 7.14 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 120.014 1.279 . . . . 0.0 110.831 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 88.15 1.88 81.23 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.587 1.565 . . . . 0.0 114.694 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.88 125.31 23.24 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.937 1.369 . . . . 0.0 111.3 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -77.35 131.71 38.21 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.34 0.59 . . . . 0.0 110.37 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 18.8 tt . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 125.394 1.477 . . . . 0.0 108.093 -178.746 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.53 163.91 26.83 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.183 1.393 . . . . 0.0 112.574 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -137.33 139.68 41.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.863 1.665 . . . . 0.0 108.693 167.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.42 140.34 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.39 1.076 . . . . 0.0 109.881 -175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -149.19 154.28 38.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.683 1.193 . . . . 0.0 110.643 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.06 159.23 14.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.957 0.884 . . . . 0.0 111.562 167.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 CA--C 1.546 0.812 0 C-N-CA 124.553 1.141 . . . . 0.0 110.18 168.511 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.754 0.311 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.25 -0.88 84.06 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.5 1.524 . . . . 0.0 113.537 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.1 t -79.53 166.0 22.4 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.177 0.989 . . . . 0.0 112.881 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -128.68 18.1 6.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.665 1.586 . . . . 0.0 111.156 174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -64.62 167.25 7.48 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.999 0.92 . . . . 0.0 111.672 167.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -153.43 154.98 35.48 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.664 0.786 . . . . 0.0 112.187 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.57 -154.72 23.72 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.393 1.473 . . . . 0.0 113.153 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -67.35 161.1 44.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.188 2.592 . . . . 0.0 111.494 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.49 124.58 21.31 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.982 0.513 . . . . 0.0 110.678 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.6 -16.51 44.19 Favored Glycine 0 N--CA 1.473 1.132 0 C-N-CA 124.985 1.278 . . . . 0.0 113.454 -171.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.71 21.93 8.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.35 1.46 . . . . 0.0 112.716 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.94 116.23 21.17 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.298 1.439 . . . . 0.0 110.449 -167.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.5 mt -123.67 138.97 54.43 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.855 1.662 . . . . 0.0 112.361 -169.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.96 134.21 52.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.311 1.444 . . . . 0.0 108.99 167.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -118.51 135.74 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.089 1.755 . . . . 0.0 107.758 -172.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -134.32 158.99 42.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.035 1.334 . . . . 0.0 112.526 -174.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 70.75 27.47 3.61 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.892 2.477 . . . . 0.0 113.749 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.81 157.03 81.58 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.652 1.181 . . . . 0.0 112.038 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -59.36 150.82 72.5 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.001 2.467 . . . . 0.0 111.741 169.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -71.07 -10.3 59.53 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.509 1.123 . . . . 0.0 113.901 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.84 -6.97 15.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.949 2.1 . . . . 0.0 113.817 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.33 123.31 21.39 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.079 1.351 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -102.48 -176.81 27.35 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.405 1.002 . . . . 0.0 113.809 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -65.71 -34.7 78.8 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.793 0.837 . . . . 0.0 112.791 -175.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -77.58 -29.7 52.21 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.868 0.867 . . . . 0.0 111.807 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -68.4 -42.91 78.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.87 0.759 . . . . 0.0 110.657 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.5 tp -65.49 -40.27 92.88 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.184 0.593 . . . . 0.0 111.525 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 62.4 tp -61.19 -52.14 66.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.569 0.622 . . . . 0.0 111.313 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -64.37 -27.1 68.78 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.9 ttp -81.21 -20.15 41.71 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -110.3 -20.55 12.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 48.5 mtm -55.05 -31.57 9.86 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 169.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -57.28 -16.5 22.6 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.63 2.887 . . . . 0.0 116.106 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -98.26 -9.66 25.2 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.246 0.93 . . . . 0.0 113.437 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.79 -159.29 27.9 Favored Glycine 0 N--CA 1.469 0.892 0 C-N-CA 125.075 1.322 . . . . 0.0 115.047 170.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.0 90.71 1.51 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.3 1.04 . . . . 0.0 112.278 -171.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 86.1 t -71.58 130.47 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.762 1.225 . . . . 0.0 110.112 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 53.4 t -100.78 -27.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.286 2.235 . . . . 0.0 111.389 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 20.9 t -156.33 146.32 21.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.48 1.112 . . . . 0.0 110.657 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.63 132.36 9.53 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.573 1.549 . . . . 0.0 110.434 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -156.51 147.95 22.48 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.299 -0.876 . . . . 0.0 113.016 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.72 135.66 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.433 1.893 . . . . 0.0 107.646 173.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 123.41 0.684 . . . . 0.0 110.392 -179.969 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 55.5 m 69.72 19.16 7.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.53 2.332 . . . . 0.0 113.894 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -146.9 156.93 43.47 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.442 1.019 . . . . 0.0 112.528 173.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.81 -174.63 30.89 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.789 1.662 . . . . 0.0 113.702 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -138.99 147.48 42.21 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.333 1.853 . . . . 0.0 110.421 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.4 t -143.58 145.02 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.486 1.514 . . . . 0.0 108.865 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.5 t -143.47 147.99 35.38 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.416 -0.802 . . . . 0.0 112.647 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -117.85 167.17 11.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.154 1.782 . . . . 0.0 113.066 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.37 -13.58 62.14 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.143 1.377 . . . . 0.0 113.63 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -158.86 158.27 28.99 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 126.206 1.803 . . . . 0.0 111.664 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.98 -10.86 19.76 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.347 2.031 . . . . 0.0 113.844 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 29.0 t -77.1 -43.11 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 120.882 1.673 . . . . 0.0 110.555 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 27.2 m -64.86 -31.29 72.46 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.672 1.189 . . . . 0.0 111.773 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.75 -49.32 31.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.035 0.934 . . . . 0.0 111.76 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -61.76 -33.88 74.86 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.388 -0.82 . . . . 0.0 111.987 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.03 -29.63 70.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.318 0.647 . . . . 0.0 112.72 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.68 -41.53 45.09 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.704 0.684 . . . . 0.0 111.086 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 51.4 mt -57.99 -46.8 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 119.388 0.995 . . . . 0.0 110.208 174.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -70.87 -14.25 62.32 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 51.6 m -103.95 -26.6 12.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.9 mmm -114.69 -20.22 10.76 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -168.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -70.93 109.94 5.36 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.295 0.952 . . . . 0.0 109.765 173.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.46 2.4 61.8 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.443 1.497 . . . . 0.0 114.907 -171.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -63.94 126.42 27.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.489 1.645 . . . . 0.0 111.703 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -80.44 125.73 30.31 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.595 0.758 . . . . 0.0 110.203 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.5 tt . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 125.075 1.35 . . . . 0.0 109.953 -178.852 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.1 mt -76.7 161.64 28.35 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.297 1.439 . . . . 0.0 112.751 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -128.89 141.03 51.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.554 1.542 . . . . 0.0 108.709 167.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.4 t -138.47 136.82 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.481 1.112 . . . . 0.0 109.16 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -152.1 151.17 30.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.979 0.912 . . . . 0.0 111.056 -172.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.7 155.41 22.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.03 0.919 . . . . 0.0 112.899 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 CA--C 1.546 0.797 0 C-N-CA 124.759 1.224 . . . . 0.0 111.901 169.783 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 121.11 0.481 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.68 -6.61 82.27 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.343 1.449 . . . . 0.0 113.293 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 66.2 m -98.42 131.4 44.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.242 1.417 . . . . 0.0 110.067 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -103.74 38.51 1.8 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.186 0.995 . . . . 0.0 112.254 -170.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -74.24 -177.44 3.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.667 0.787 . . . . 0.0 110.877 168.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.42 166.63 31.77 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 169.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.77 -165.48 29.28 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.158 1.837 . . . . 0.0 113.572 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.44 171.32 16.44 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.031 3.154 . . . . 0.0 112.47 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.98 126.62 28.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.663 0.785 . . . . 0.0 111.334 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.79 -11.71 71.49 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.8 1.19 . . . . 0.0 114.027 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.82 -1.44 57.35 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.659 1.229 . . . . 0.0 113.963 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -113.4 125.04 53.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.941 1.296 . . . . 0.0 111.458 -169.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.0 mt -124.71 140.23 53.12 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.756 2.022 . . . . 0.0 111.751 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -110.84 132.25 54.36 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.09 1.356 . . . . 0.0 108.594 167.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.67 134.96 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.982 1.713 . . . . 0.0 107.602 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.8 160.34 37.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.242 1.417 . . . . 0.0 112.292 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 69.66 28.88 4.36 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.555 2.342 . . . . 0.0 113.693 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 58.5 mt -68.58 161.2 72.37 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.653 1.181 . . . . 0.0 111.417 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.68 151.1 78.66 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.96 2.44 . . . . 0.0 111.259 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -72.06 -9.07 57.89 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.692 1.197 . . . . 0.0 113.959 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -112.76 -6.72 13.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.256 2.222 . . . . 0.0 113.838 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 130.15 42.29 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.167 1.387 . . . . 0.0 110.898 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.77 178.9 25.16 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.387 0.994 . . . . 0.0 113.842 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -64.6 -33.97 77.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.725 0.81 . . . . 0.0 112.58 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.4 -31.17 57.81 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.087 0.955 . . . . 0.0 111.812 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -66.99 -42.68 84.63 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.821 0.737 . . . . 0.0 110.652 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.55 -39.87 88.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.357 0.663 . . . . 0.0 111.745 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.17 -52.08 65.26 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.641 0.655 . . . . 0.0 111.31 174.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -63.72 -28.01 69.59 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.7 ttp -80.61 -19.93 44.35 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -111.19 -19.48 12.67 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.3 mtm -55.05 -31.73 10.33 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -57.52 -16.74 24.95 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.579 2.853 . . . . 0.0 116.25 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -97.51 -9.53 26.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.41 -162.32 28.21 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.17 1.367 . . . . 0.0 114.348 172.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -72.8 88.14 1.31 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.642 0.777 . . . . 0.0 112.182 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.5 t -65.27 127.41 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.363 1.065 . . . . 0.0 109.403 170.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 45.5 t -91.64 -38.86 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.671 1.988 . . . . 0.0 110.841 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.61 149.52 23.89 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.641 1.176 . . . . 0.0 111.181 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.39 140.29 20.07 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.345 1.458 . . . . 0.0 110.738 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -155.8 140.14 16.68 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.474 -0.766 . . . . 0.0 111.788 -169.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.47 130.8 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.548 1.539 . . . . 0.0 107.498 168.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 . . . . . 0 CA--C 1.537 0.447 0 C-N-CA 123.32 0.648 . . . . 0.0 111.172 -176.255 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 CA--C 1.549 0.91 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.9 m 67.11 19.76 10.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.863 2.065 . . . . 0.0 113.115 -172.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -146.81 155.25 42.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.864 0.865 . . . . 0.0 112.311 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.88 -175.6 27.99 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.152 1.834 . . . . 0.0 113.559 -170.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -136.25 145.5 45.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.716 2.006 . . . . 0.0 110.285 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 61.4 t -143.27 141.14 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.318 1.447 . . . . 0.0 108.529 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 37.3 p -137.53 146.7 44.45 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.027 0.931 . . . . 0.0 112.18 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -119.82 169.29 10.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.178 1.391 . . . . 0.0 113.223 -174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.03 -23.75 66.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.972 1.309 . . . . 0.0 113.26 169.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -160.0 157.93 25.96 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.24 1.416 . . . . 0.0 112.394 -171.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.13 -15.14 42.47 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.765 2.31 . . . . 0.0 114.026 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.18 -44.78 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 120.754 1.615 . . . . 0.0 110.679 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 57.4 m -68.06 -30.97 70.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.991 0.917 . . . . 0.0 111.886 174.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.64 42.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.659 0.784 . . . . 0.0 111.81 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -58.57 -39.24 79.77 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.487 -0.758 . . . . 0.0 111.947 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.84 -28.76 69.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -79.14 -44.27 22.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.705 0.684 . . . . 0.0 111.386 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 49.4 mt -57.07 -47.53 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.523 1.056 . . . . 0.0 110.151 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -74.66 -10.86 59.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.199 0.999 . . . . 0.0 113.227 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -104.28 -26.55 12.44 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.7 mmm -113.12 -19.86 11.69 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -168.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -70.9 111.19 6.12 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 119.385 0.993 . . . . 0.0 109.954 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.48 2.55 65.45 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.142 1.83 . . . . 0.0 115.172 -171.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.06 124.99 23.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.256 1.528 . . . . 0.0 111.543 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -73.5 131.12 41.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.852 0.296 . . . . 0.0 110.594 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.0 tt . . . . . 0 N--CA 1.467 0.408 0 C-N-CA 124.311 1.044 . . . . 0.0 108.325 175.118 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 79.7 mt -68.81 160.98 29.5 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.349 1.06 . . . . 0.0 112.079 -176.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -126.2 141.39 51.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.636 1.574 . . . . 0.0 108.638 168.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.07 136.45 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.121 0.968 . . . . 0.0 109.418 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -149.83 146.1 26.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.178 0.991 . . . . 0.0 111.279 -172.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.74 150.17 47.83 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.786 0.834 . . . . 0.0 113.236 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.5 tttt . . . . . 0 CA--C 1.546 0.822 0 C-N-CA 123.568 0.747 . . . . 0.0 111.322 168.395 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 120.806 0.336 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.76 -3.24 74.08 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.194 0.902 . . . . 0.0 113.211 -176.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.1 t -98.35 163.8 12.55 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.356 1.062 . . . . 0.0 111.62 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -134.4 18.06 3.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.947 1.299 . . . . 0.0 112.216 -170.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.52 169.59 3.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.461 1.104 . . . . 0.0 111.783 168.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.41 158.9 44.32 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.838 -1.164 . . . . 0.0 111.855 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.72 -162.08 26.92 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.903 1.716 . . . . 0.0 113.401 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.46 171.23 14.51 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.822 3.015 . . . . 0.0 112.628 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.31 121.09 9.94 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.084 0.954 . . . . 0.0 111.359 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.11 -4.0 73.84 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.949 1.261 . . . . 0.0 114.675 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.15 2.71 55.92 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.002 1.401 . . . . 0.0 114.173 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -118.35 125.66 50.5 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.721 1.208 . . . . 0.0 111.343 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.47 137.45 54.79 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.477 1.911 . . . . 0.0 112.026 -169.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.64 133.88 50.63 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.155 1.382 . . . . 0.0 108.352 167.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 9.3 mm -117.53 136.41 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.641 1.576 . . . . 0.0 108.517 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -135.37 161.5 35.26 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.114 0.965 . . . . 0.0 112.569 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 62.03 36.62 15.36 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.334 1.854 . . . . 0.0 113.299 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 46.0 mt -70.93 162.92 69.29 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.052 1.341 . . . . 0.0 111.392 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.87 149.06 90.32 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.04 2.493 . . . . 0.0 111.231 168.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -71.07 -10.45 59.78 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -104.1 -9.53 18.67 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.473 1.909 . . . . 0.0 114.27 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.28 126.94 31.14 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.608 1.163 . . . . 0.0 111.211 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.22 -174.79 24.31 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.961 1.267 . . . . 0.0 112.9 171.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -62.51 -34.6 77.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.743 0.817 . . . . 0.0 112.925 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -77.55 -30.52 52.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.856 0.862 . . . . 0.0 112.001 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -70.1 -40.43 74.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.606 0.639 . . . . 0.0 110.615 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 23.4 tp -66.42 -39.23 88.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.342 0.657 . . . . 0.0 111.601 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 64.1 tp -61.61 -49.67 75.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.81 0.732 . . . . 0.0 111.053 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -68.64 -23.02 64.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.7 ttm -73.56 -29.88 62.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.021 0.929 . . . . 0.0 113.002 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -109.23 -17.8 13.75 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -171.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.0 mtm -53.61 -33.09 12.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -59.53 -15.36 30.2 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.479 2.786 . . . . 0.0 116.475 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -102.48 -10.69 19.15 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -175.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 154.09 -169.45 32.58 Favored Glycine 0 N--CA 1.469 0.882 0 C-N-CA 125.089 1.328 . . . . 0.0 113.991 174.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -73.93 99.68 3.32 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.14 -0.624 . . . . 0.0 110.991 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.7 t -72.2 125.73 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.22 1.008 . . . . 0.0 109.336 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 37.3 t -86.64 -36.12 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.363 1.865 . . . . 0.0 111.017 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.7 m -161.22 151.59 17.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.213 1.805 . . . . 0.0 110.47 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.14 134.22 15.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.523 1.529 . . . . 0.0 110.225 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -153.36 135.5 14.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.392 0.677 . . . . 0.0 112.08 -174.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.7 t -106.73 135.02 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.205 1.802 . . . . 0.0 107.086 168.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 123.249 0.62 . . . . 0.0 111.171 -178.766 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 64.1 m 69.11 20.03 7.8 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.167 2.187 . . . . 0.0 113.614 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.27 156.86 44.83 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.898 0.879 . . . . 0.0 112.063 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.1 -172.01 26.74 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.664 1.602 . . . . 0.0 114.316 -169.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -144.32 144.89 31.68 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.491 1.916 . . . . 0.0 110.127 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 78.9 t -144.88 139.08 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.529 1.532 . . . . 0.0 109.049 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 77.8 p -134.43 153.39 51.94 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.913 0.885 . . . . 0.0 112.66 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -128.65 167.57 17.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.86 1.264 . . . . 0.0 114.179 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -67.57 -21.48 65.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.487 1.515 . . . . 0.0 114.607 172.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -152.4 156.48 33.56 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.526 1.531 . . . . 0.0 111.931 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -63.37 -29.77 72.38 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.652 2.901 . . . . 0.0 113.415 174.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.8 -39.57 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.001 0.921 . . . . 0.0 110.865 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 16.3 m -58.92 -35.61 73.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.089 0.955 . . . . 0.0 111.61 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -76.95 -48.41 18.18 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.237 1.415 . . . . 0.0 112.576 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -61.18 -32.21 71.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.321 1.048 . . . . 0.0 112.367 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.15 72.22 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.305 0.642 . . . . 0.0 112.64 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.81 33.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.532 0.733 . . . . 0.0 111.841 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 38.6 mt -58.01 -46.5 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.121 0.873 . . . . 0.0 110.235 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -72.39 -12.81 61.28 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.9 m -103.9 -30.4 10.36 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 83.9 mmm -112.84 -18.75 12.2 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -169.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -70.16 111.97 6.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.66 1.118 . . . . 0.0 110.496 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.24 1.76 69.11 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.744 1.64 . . . . 0.0 114.821 -173.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.13 124.72 21.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.255 1.528 . . . . 0.0 111.636 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -80.27 127.48 32.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.603 0.761 . . . . 0.0 110.19 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 N--CA 1.467 0.408 0 C-N-CA 124.953 1.301 . . . . 0.0 109.793 -176.389 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 119.862 -0.114 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 53.3 mt -68.14 161.65 26.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.19 1.396 . . . . 0.0 112.485 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -137.55 142.61 41.37 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.668 1.587 . . . . 0.0 109.161 167.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 34.6 t -139.31 133.11 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.591 1.156 . . . . 0.0 109.019 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -142.25 151.92 42.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.195 0.998 . . . . 0.0 111.482 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 58.9 mt -66.36 152.8 44.28 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.938 0.875 . . . . 0.0 113.151 172.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.0 tttt . . . . . 0 CA--C 1.547 0.861 0 C-N-CA 124.536 1.134 . . . . 0.0 111.534 169.07 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 120.898 0.38 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.0 -9.08 67.29 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.452 1.501 . . . . 0.0 113.173 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.6 m -76.52 158.67 31.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.168 0.987 . . . . 0.0 110.078 169.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -139.86 31.51 2.02 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.379 -0.826 . . . . 0.0 112.133 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -69.33 174.15 5.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.548 0.739 . . . . 0.0 111.007 167.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.78 160.59 43.43 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.92 -160.19 26.56 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.982 1.753 . . . . 0.0 113.453 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.23 172.41 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.899 3.066 . . . . 0.0 112.862 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -59.18 120.63 9.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.419 1.088 . . . . 0.0 110.917 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.01 -3.53 70.32 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.003 1.287 . . . . 0.0 114.708 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.18 0.86 51.74 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.975 1.388 . . . . 0.0 114.421 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -117.15 123.54 46.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.645 1.178 . . . . 0.0 111.271 -169.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.0 mt -123.6 141.51 51.94 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.532 1.933 . . . . 0.0 112.525 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -111.61 134.19 53.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.784 1.634 . . . . 0.0 108.463 167.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.87 135.64 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.733 1.613 . . . . 0.0 107.832 -172.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -131.55 162.42 30.34 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.128 1.371 . . . . 0.0 111.92 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 63.02 37.06 12.0 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.465 1.906 . . . . 0.0 113.273 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 54.6 mt -70.11 161.62 74.47 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.792 1.237 . . . . 0.0 112.083 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.99 154.14 58.88 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.418 2.746 . . . . 0.0 111.123 168.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -75.51 -19.91 59.06 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -96.76 -6.38 36.36 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.57 1.548 . . . . 0.0 114.207 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.01 128.12 35.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.862 1.265 . . . . 0.0 111.819 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -107.26 -177.56 22.67 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.963 1.268 . . . . 0.0 113.506 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.46 -34.2 77.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.11 0.964 . . . . 0.0 112.703 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -75.97 -27.24 57.41 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.402 1.081 . . . . 0.0 111.676 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -75.5 -42.29 53.17 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.881 0.872 . . . . 0.0 110.723 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 27.1 tp -64.76 -36.63 84.91 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.334 0.653 . . . . 0.0 111.686 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.4 -51.22 69.64 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.417 0.553 . . . . 0.0 110.702 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -69.01 -20.99 64.16 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.7 ttm -73.98 -26.95 60.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.108 0.963 . . . . 0.0 112.817 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -113.03 -18.29 12.23 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.9 mtm -53.24 -34.03 16.77 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 170.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -59.44 -16.88 37.75 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.559 2.839 . . . . 0.0 116.215 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -100.2 -9.01 22.92 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.408 1.004 . . . . 0.0 113.664 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.78 -163.37 28.57 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.981 1.277 . . . . 0.0 114.75 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -70.68 96.53 1.23 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.311 1.044 . . . . 0.0 112.285 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 80.3 t -74.85 128.43 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.089 1.355 . . . . 0.0 109.881 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 38.7 t -88.69 -36.78 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.57 1.948 . . . . 0.0 111.045 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.8 m -160.25 150.73 18.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.511 1.525 . . . . 0.0 110.814 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.4 130.39 11.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.232 1.813 . . . . 0.0 109.637 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -152.71 144.73 23.76 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.539 -0.726 . . . . 0.0 112.854 -171.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.0 t -119.18 135.93 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.554 1.942 . . . . 0.0 108.219 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 123.539 0.736 . . . . 0.0 109.853 177.439 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 66.5 m 73.52 20.36 3.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.265 2.626 . . . . 0.0 113.003 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -146.38 155.68 42.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.678 0.791 . . . . 0.0 112.394 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.38 -173.95 29.57 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.968 1.747 . . . . 0.0 113.675 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -140.94 145.67 36.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.406 1.883 . . . . 0.0 110.141 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.1 t -145.36 139.18 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.155 1.382 . . . . 0.0 109.279 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.1 p -133.38 149.06 51.86 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.327 1.051 . . . . 0.0 112.328 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -121.55 163.34 19.03 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.099 1.359 . . . . 0.0 113.323 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.27 -18.2 63.12 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.293 1.037 . . . . 0.0 113.073 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -145.52 151.78 47.8 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.273 1.429 . . . . 0.0 112.182 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.91 -29.34 58.09 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.829 3.019 . . . . 0.0 113.868 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.45 -40.97 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.705 0.802 . . . . 0.0 110.916 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.1 m -62.06 -33.27 74.09 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.856 0.862 . . . . 0.0 111.918 173.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.72 -49.26 21.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.993 1.317 . . . . 0.0 112.129 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -60.99 -33.65 73.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.062 0.945 . . . . 0.0 112.126 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.11 -31.05 72.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.358 0.663 . . . . 0.0 112.642 172.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.36 -41.53 47.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.344 0.658 . . . . 0.0 111.68 175.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 40.2 mt -58.14 -47.29 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.03 0.832 . . . . 0.0 110.153 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.24 -14.27 62.18 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.9 m -102.18 -29.78 11.52 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 86.1 mmm -113.32 -18.04 12.15 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -169.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -70.26 111.78 6.12 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.491 1.041 . . . . 0.0 110.551 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.93 1.75 67.27 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.885 1.707 . . . . 0.0 114.77 -173.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.9 124.43 20.46 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.215 1.507 . . . . 0.0 111.615 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -80.39 127.71 32.71 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.613 0.765 . . . . 0.0 110.175 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.5 tt . . . . . 0 N--CA 1.468 0.466 0 C-N-CA 124.888 1.275 . . . . 0.0 109.713 -176.188 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 119.923 -0.084 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 59.5 mt -68.96 161.01 29.77 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.978 1.311 . . . . 0.0 112.328 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.96 141.21 42.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.435 1.494 . . . . 0.0 108.967 168.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.35 138.2 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.532 1.133 . . . . 0.0 109.302 -175.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -151.02 152.76 33.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.241 1.016 . . . . 0.0 110.757 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.32 157.63 16.13 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.6 0.76 . . . . 0.0 112.778 170.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.1 tttt . . . . . 0 CA--C 1.55 0.949 0 C-N-CA 124.942 1.297 . . . . 0.0 112.673 172.178 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 17.4 m 71.66 -0.47 3.15 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.443 1.897 . . . . 0.0 115.514 171.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.3 t -166.6 157.48 12.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.34 1.856 . . . . 0.0 110.676 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -129.96 151.02 19.23 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.454 1.502 . . . . 0.0 112.76 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 57.3 p -83.88 -15.73 47.04 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 42.2 m -132.45 10.01 4.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.367 1.467 . . . . 0.0 113.302 -175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 165.49 -164.12 37.06 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.102 1.334 . . . . 0.0 113.701 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.58 170.08 23.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.98 1.712 . . . . 0.0 112.026 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 79.4 p -79.99 173.17 12.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.534 1.534 . . . . 0.0 112.093 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -78.53 12.24 2.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.616 1.166 . . . . 0.0 113.07 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -70.55 -9.39 56.64 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.905 -1.122 . . . . 0.0 113.468 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 32.7 m -64.27 6.49 0.19 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.015 1.726 . . . . 0.0 115.01 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 2.2 pp -76.73 -9.92 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.576 1.551 . . . . 0.0 113.135 169.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -83.5 -138.28 3.42 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.778 1.656 . . . . 0.0 111.485 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -99.33 -59.87 1.64 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.363 0.665 . . . . 0.0 112.357 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.46 128.01 34.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.078 0.951 . . . . 0.0 111.423 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.35 -6.53 81.71 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.66 1.6 . . . . 0.0 113.168 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 4.2 t -82.63 157.29 23.47 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.455 1.128 . . . . 0.0 113.421 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -128.54 13.87 6.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.994 1.318 . . . . 0.0 112.26 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -70.62 176.08 4.41 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.377 -0.827 . . . . 0.0 110.195 167.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.48 157.46 39.87 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.263 -0.898 . . . . 0.0 112.355 168.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.82 -157.39 22.72 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.339 1.447 . . . . 0.0 113.235 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.92 160.61 43.31 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.197 2.598 . . . . 0.0 111.488 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.04 124.33 20.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.103 0.561 . . . . 0.0 110.983 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.58 -8.74 60.27 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.024 1.297 . . . . 0.0 113.68 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.85 22.1 7.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.168 1.387 . . . . 0.0 112.646 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.7 118.6 25.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.413 1.485 . . . . 0.0 110.084 -167.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 27.9 mt -125.33 141.95 51.78 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.106 1.763 . . . . 0.0 112.659 -168.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -114.54 134.06 55.32 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.382 1.473 . . . . 0.0 109.283 168.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.56 134.71 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.318 1.847 . . . . 0.0 107.884 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -133.08 158.62 42.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.743 1.217 . . . . 0.0 112.87 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 73.2 26.86 2.05 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.984 2.513 . . . . 0.0 113.528 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.45 149.6 97.9 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.599 1.16 . . . . 0.0 111.373 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -58.32 149.87 70.78 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.247 2.631 . . . . 0.0 112.454 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -69.23 -9.72 54.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.63 -11.32 23.73 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.969 1.708 . . . . 0.0 114.168 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.07 126.34 30.31 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.261 1.024 . . . . 0.0 111.549 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -108.3 -171.65 21.47 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.545 1.545 . . . . 0.0 112.096 169.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.73 -32.56 74.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.047 0.939 . . . . 0.0 113.145 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -78.5 -30.38 47.18 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.993 0.917 . . . . 0.0 112.079 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -70.55 -40.78 73.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.71 0.686 . . . . 0.0 110.632 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 28.6 tp -65.63 -37.66 87.22 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.382 0.673 . . . . 0.0 111.838 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 65.1 tp -62.52 -51.71 66.33 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.702 0.683 . . . . 0.0 111.253 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -63.92 -30.78 71.84 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.1 0.56 . . . . 0.0 112.423 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.0 ttm -68.57 -29.45 67.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.345 1.058 . . . . 0.0 113.11 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -106.36 -13.23 15.43 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 29.7 mtt -49.66 -37.36 23.26 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -61.78 -17.73 56.65 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.127 2.552 . . . . 0.0 116.015 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -99.67 -7.82 25.18 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.49 -163.73 28.46 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.326 1.441 . . . . 0.0 114.44 171.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -72.52 97.78 2.17 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.054 0.942 . . . . 0.0 111.853 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.6 t -74.55 126.93 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.56 1.144 . . . . 0.0 109.815 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 39.9 t -91.06 -36.47 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.437 1.895 . . . . 0.0 111.032 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 53.6 m -149.81 147.77 28.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.737 1.215 . . . . 0.0 110.92 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.14 136.48 20.11 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.237 1.815 . . . . 0.0 109.013 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -153.74 138.32 16.88 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.556 -0.715 . . . . 0.0 111.656 -168.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.58 128.36 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.214 1.406 . . . . 0.0 107.976 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -82.24 142.84 31.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.607 0.763 . . . . 0.0 110.85 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 37.8 mm -120.45 133.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.994 1.318 . . . . 0.0 110.339 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -76.32 125.91 30.04 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.35 1.06 . . . . 0.0 110.951 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -76.08 -7.29 54.4 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -172.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -98.93 -17.1 18.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.388 1.075 . . . . 0.0 112.904 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 60.9 p -129.57 -16.85 3.77 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.745 1.218 . . . . 0.0 114.144 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 21.9 m120 64.33 14.46 8.77 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.648 1.979 . . . . 0.0 113.363 -173.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 80.7 mt -89.15 156.34 18.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.362 1.465 . . . . 0.0 110.779 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 67.5 p -69.49 144.62 53.15 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.065 0.936 . . . . 0.0 112.149 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -76.42 5.41 7.26 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 35.3 m 64.97 20.1 12.02 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.996 2.118 . . . . 0.0 112.973 -171.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -147.35 156.07 42.57 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.143 0.977 . . . . 0.0 112.033 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.52 -177.55 27.99 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 126.008 1.766 . . . . 0.0 113.605 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -135.18 146.68 48.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.521 1.928 . . . . 0.0 110.133 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.9 t -143.22 144.86 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.309 1.443 . . . . 0.0 108.719 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 8.1 t -143.65 146.85 33.55 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.455 -0.778 . . . . 0.0 112.37 173.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -115.87 165.42 13.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.138 1.775 . . . . 0.0 113.128 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.0 -18.43 64.72 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.371 1.069 . . . . 0.0 113.281 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -145.27 149.59 41.91 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.122 1.369 . . . . 0.0 112.16 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.29 -28.08 55.47 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.757 2.971 . . . . 0.0 113.774 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.36 -38.67 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.879 0.872 . . . . 0.0 110.896 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 9.9 m -62.68 -34.63 77.52 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.966 0.906 . . . . 0.0 111.707 171.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.71 -48.14 41.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.54 1.136 . . . . 0.0 111.964 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -60.67 -34.32 74.15 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 112.16 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.0 -30.01 70.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.431 0.693 . . . . 0.0 112.696 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.73 -41.49 53.22 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.349 0.66 . . . . 0.0 111.491 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.9 -48.07 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.896 0.771 . . . . 0.0 110.12 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.58 -14.23 62.41 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -102.76 -29.07 11.71 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 92.2 mmm -114.54 -19.14 11.27 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -169.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -70.81 111.28 6.12 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.277 0.944 . . . . 0.0 109.951 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 97.46 1.36 59.14 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.682 1.61 . . . . 0.0 114.841 -172.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -64.62 120.36 12.24 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.676 1.738 . . . . 0.0 111.173 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -76.78 131.93 38.97 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.976 0.417 . . . . 0.0 110.452 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.1 tt -139.56 93.18 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.492 1.117 . . . . 0.0 109.018 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 81.41 -124.3 6.39 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -169.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 62.4 mtt -99.22 7.73 45.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.915 1.286 . . . . 0.0 113.694 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.04 170.39 15.79 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.684 1.594 . . . . 0.0 112.74 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -119.46 138.4 53.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.999 1.32 . . . . 0.0 112.018 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.81 150.54 47.7 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.169 1.388 . . . . 0.0 111.591 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -121.22 141.99 50.33 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.64 1.176 . . . . 0.0 108.777 168.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.26 133.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.364 1.066 . . . . 0.0 108.82 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -142.53 157.69 44.47 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.563 1.145 . . . . 0.0 111.075 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.47 156.98 30.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.821 0.819 . . . . 0.0 112.132 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -58.79 121.95 12.36 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.54 1.136 . . . . 0.0 112.189 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -79.98 138.59 37.1 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.755 1.222 . . . . 0.0 110.272 171.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 7.0 t -163.52 176.72 9.46 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.138 1.375 . . . . 0.0 111.245 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -69.97 155.02 41.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.634 1.174 . . . . 0.0 112.517 176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -142.21 157.41 44.88 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.689 1.595 . . . . 0.0 111.496 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -151.95 -33.13 0.14 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.855 1.262 . . . . 0.0 113.218 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 33.0 p -76.84 -5.37 48.06 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.761 1.224 . . . . 0.0 113.743 171.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -157.37 146.89 20.24 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.713 2.005 . . . . 0.0 110.511 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 37.3 p -80.94 -10.14 59.75 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 170.55 -172.97 44.36 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.727 1.156 . . . . 0.0 114.052 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.59 -11.91 20.41 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.93 3.087 . . . . 0.0 114.036 -176.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 19.8 m 68.43 3.92 4.0 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.296 1.838 . . . . 0.0 114.79 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 10.7 t -163.2 159.77 23.28 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.328 1.851 . . . . 0.0 110.998 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 C-N-CA 125.256 1.408 . . . . 0.0 112.843 -177.848 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.479 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.3 m -66.32 -18.32 65.28 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 52.8 p -90.99 -8.62 48.67 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.19 1.396 . . . . 0.0 113.879 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 75.95 -43.24 1.67 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.824 1.678 . . . . 0.0 113.692 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 22.5 t -166.22 154.4 10.57 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.531 1.932 . . . . 0.0 110.932 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 4.6 m -78.78 -3.37 44.05 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 108.3 -162.02 13.19 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.843 1.687 . . . . 0.0 112.791 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 43.2 tp -60.31 -29.99 69.21 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.082 0.953 . . . . 0.0 113.464 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 37.0 p -67.95 -10.91 57.19 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.672 1.589 . . . . 0.0 113.971 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 6.96 38.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.538 1.535 . . . . 0.0 111.655 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -141.39 -53.69 0.46 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.927 1.291 . . . . 0.0 111.642 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 50.4 m -107.02 109.24 21.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.316 1.047 . . . . 0.0 110.156 -171.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.57 152.74 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.534 1.534 . . . . 0.0 111.625 -171.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -90.89 130.76 10.44 Favored Glycine 0 N--CA 1.471 1.016 0 C-N-CA 124.379 0.99 . . . . 0.0 111.994 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -79.79 -36.99 36.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.857 0.863 . . . . 0.0 113.076 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -68.37 121.7 16.83 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.742 1.217 . . . . 0.0 110.623 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.29 84.64 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.373 0.987 . . . . 0.0 113.347 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.3 t -85.47 173.82 9.96 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.002 0.901 . . . . 0.0 111.411 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -139.7 28.53 2.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.392 1.477 . . . . 0.0 110.846 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -66.98 164.16 18.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.982 0.913 . . . . 0.0 112.684 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.7 154.66 37.82 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.73 -160.38 26.77 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.101 1.81 . . . . 0.0 113.473 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.08 171.74 15.29 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.907 3.071 . . . . 0.0 112.576 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.45 122.34 13.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.069 0.948 . . . . 0.0 111.337 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.63 -4.33 75.91 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.844 1.212 . . . . 0.0 114.587 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.66 1.56 53.63 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.069 1.434 . . . . 0.0 114.39 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -116.98 125.17 50.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.899 1.28 . . . . 0.0 111.162 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.3 mt -124.22 140.29 53.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.528 1.931 . . . . 0.0 112.403 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -110.8 133.38 53.4 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.506 1.522 . . . . 0.0 108.52 167.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.5 mm -117.05 139.23 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.98 1.712 . . . . 0.0 108.71 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -140.65 160.89 39.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.335 1.054 . . . . 0.0 113.131 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 66.52 26.81 9.86 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.832 2.453 . . . . 0.0 114.037 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 68.4 mt -66.14 155.9 86.15 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.595 1.158 . . . . 0.0 112.219 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -59.95 148.76 87.54 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.291 2.661 . . . . 0.0 111.953 171.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.71 -19.17 65.7 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -91.93 -10.04 40.93 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.033 1.333 . . . . 0.0 114.556 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.1 134.36 51.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.272 1.029 . . . . 0.0 112.495 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.62 -176.78 19.76 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.402 1.477 . . . . 0.0 112.213 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -62.25 -32.49 73.2 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -78.13 -29.57 48.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.967 0.907 . . . . 0.0 112.268 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -70.45 -40.33 73.79 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.741 0.7 . . . . 0.0 110.692 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.37 -36.71 79.6 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.953 0.501 . . . . 0.0 111.745 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -62.27 -49.7 74.65 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.917 0.78 . . . . 0.0 110.947 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -67.96 -22.97 65.01 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.7 ttm -73.96 -27.82 61.18 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.024 0.93 . . . . 0.0 113.108 171.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -112.58 -16.37 12.85 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -171.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.7 mtm -53.92 -33.92 18.0 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 170.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -59.15 -16.17 32.13 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.492 2.794 . . . . 0.0 116.325 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -99.85 -10.22 22.0 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.42 -159.66 28.08 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 124.657 1.122 . . . . 0.0 114.909 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.34 92.83 1.85 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.201 1.0 . . . . 0.0 112.201 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.5 t -72.1 128.12 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.951 1.3 . . . . 0.0 110.018 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.93 -31.9 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.126 2.17 . . . . 0.0 111.494 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.9 t -157.64 151.12 23.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.458 1.103 . . . . 0.0 110.916 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.06 132.15 14.36 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.246 1.418 . . . . 0.0 110.19 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -153.68 132.44 12.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.43 0.692 . . . . 0.0 112.005 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 64.0 t -103.25 135.03 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.653 1.581 . . . . 0.0 107.27 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -82.64 127.71 33.64 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 48.3 mt -127.64 140.67 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.287 1.435 . . . . 0.0 110.15 -168.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -84.71 126.82 33.73 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.73 0.812 . . . . 0.0 111.366 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -66.78 -11.78 56.3 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -84.8 -21.15 30.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.126 0.97 . . . . 0.0 112.632 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 73.7 p -133.53 -18.75 2.17 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -172.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 58.6 t30 62.4 19.26 10.99 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.135 1.774 . . . . 0.0 112.857 -171.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.3 mt -95.34 149.15 21.67 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.153 1.381 . . . . 0.0 111.402 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.7 t -56.77 136.75 55.29 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.324 1.049 . . . . 0.0 111.615 169.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -75.38 5.37 5.81 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.393 1.077 . . . . 0.0 113.085 170.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 58.3 m 74.27 18.99 2.95 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.575 2.75 . . . . 0.0 113.206 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.15 156.77 43.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.991 0.814 . . . . 0.0 112.382 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.93 -175.16 28.54 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.85 1.69 . . . . 0.0 113.708 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -141.57 144.25 34.15 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.542 1.937 . . . . 0.0 110.111 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.1 t -144.33 140.67 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.203 1.401 . . . . 0.0 108.765 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 88.3 p -135.8 153.1 51.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.648 0.779 . . . . 0.0 112.36 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -126.6 164.89 20.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.213 1.405 . . . . 0.0 113.078 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.98 -10.88 59.78 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.488 1.115 . . . . 0.0 113.007 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.74 145.51 28.3 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.062 1.345 . . . . 0.0 111.744 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.69 -29.78 69.38 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.464 2.776 . . . . 0.0 113.718 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.14 -41.57 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.815 0.846 . . . . 0.0 111.382 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.4 p -66.83 -31.13 71.54 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.605 0.762 . . . . 0.0 112.377 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -68.9 -49.8 55.02 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.769 0.828 . . . . 0.0 111.849 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -58.93 -39.37 81.38 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.582 -0.699 . . . . 0.0 111.941 175.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.44 -28.82 65.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 174.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.65 -43.66 30.67 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.652 0.66 . . . . 0.0 112.036 171.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.1 mt -58.12 -49.96 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 119.479 1.036 . . . . 0.0 110.408 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -73.79 -11.71 60.47 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.5 m -100.1 -30.65 11.83 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.5 mmm -111.66 -19.77 12.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -169.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.71 111.54 5.56 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.286 0.948 . . . . 0.0 109.903 173.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.01 3.31 65.76 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.404 1.478 . . . . 0.0 115.104 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -63.86 124.28 21.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.438 1.619 . . . . 0.0 111.258 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -81.04 131.3 35.3 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.263 0.554 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.2 tt -141.89 109.83 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.247 1.419 . . . . 0.0 108.447 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.88 -122.48 22.04 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -169.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.56 13.26 34.96 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.351 1.46 . . . . 0.0 113.501 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -142.05 173.15 11.78 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.742 1.217 . . . . 0.0 113.382 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -123.44 133.4 54.07 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.968 1.307 . . . . 0.0 111.417 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.2 mt -68.12 160.5 28.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.276 1.43 . . . . 0.0 111.787 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -133.14 143.4 49.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.246 1.418 . . . . 0.0 109.67 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 30.1 t -138.44 136.02 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.648 1.179 . . . . 0.0 109.172 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -140.71 154.9 46.53 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.451 1.101 . . . . 0.0 111.173 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.15 155.64 38.24 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 122.317 1.056 . . . . 0.0 111.802 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -58.47 128.18 35.85 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.709 0.804 . . . . 0.0 111.162 169.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 72.58 20.06 3.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.551 1.94 . . . . 0.0 114.338 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 38.6 m -65.51 152.87 42.98 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.513 -1.367 . . . . 0.0 112.614 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -137.34 157.85 45.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.643 1.577 . . . . 0.0 111.847 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -158.63 146.22 17.91 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.246 1.418 . . . . 0.0 111.556 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -156.92 149.15 23.05 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.82 1.648 . . . . 0.0 111.018 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 65.5 p -113.02 5.27 17.12 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -171.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -140.81 -21.23 0.8 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -170.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 71.8 m -76.45 149.6 36.8 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.679 1.127 . . . . 0.0 112.282 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -163.39 178.44 38.97 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 124.74 1.162 . . . . 0.0 114.009 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.96 162.77 36.65 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.225 3.283 . . . . 0.0 111.969 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 48.5 p -76.94 0.93 19.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.865 1.266 . . . . 0.0 113.94 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 15.6 m -72.3 -8.89 57.34 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.679 1.592 . . . . 0.0 114.708 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.242 1.401 . . . . 0.0 112.985 179.319 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 36.5 t -163.09 150.02 12.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.981 1.312 . . . . 0.0 111.393 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 53.1 p -85.31 -5.63 59.3 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.762 1.225 . . . . 0.0 113.336 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -76.08 0.43 62.87 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.274 1.416 . . . . 0.0 115.332 -174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 23.9 m -73.85 -4.46 34.97 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.093 1.357 . . . . 0.0 114.207 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 9.2 t -159.32 166.13 31.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.792 1.637 . . . . 0.0 111.303 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 76.82 -140.87 25.58 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.469 1.033 . . . . 0.0 112.945 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -158.94 168.53 26.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.345 1.858 . . . . 0.0 111.681 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.0 p -99.08 173.27 6.9 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.845 1.258 . . . . 0.0 111.497 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -100.82 15.14 29.41 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.992 1.317 . . . . 0.0 110.458 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.95 -17.34 5.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.681 1.192 . . . . 0.0 113.688 -170.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 56.9 p -78.53 2.49 18.94 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.89 -10.55 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.487 1.515 . . . . 0.0 113.914 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -74.21 154.43 47.82 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.77 1.176 . . . . 0.0 112.041 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -102.23 -49.79 3.8 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -172.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.22 120.25 12.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.103 0.961 . . . . 0.0 111.262 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.81 -6.79 82.73 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.517 1.532 . . . . 0.0 113.272 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 6.8 t -84.03 158.0 21.62 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.676 1.238 . . . . 0.0 112.64 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -128.78 14.39 6.41 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.041 1.336 . . . . 0.0 112.34 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -68.13 177.16 2.35 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.394 -0.816 . . . . 0.0 110.349 167.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -154.74 157.66 38.36 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.235 -0.916 . . . . 0.0 112.079 168.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.59 -158.42 24.17 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.176 1.37 . . . . 0.0 113.314 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.31 160.73 43.85 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.216 2.611 . . . . 0.0 111.439 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.87 123.4 18.39 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.828 -0.545 . . . . 0.0 110.928 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.96 -9.07 58.0 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.013 1.292 . . . . 0.0 113.752 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.17 20.19 10.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.169 1.387 . . . . 0.0 112.728 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 120.38 30.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.434 1.493 . . . . 0.0 110.052 -167.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.92 139.77 53.52 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.239 1.815 . . . . 0.0 112.372 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -112.14 133.37 54.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.213 1.405 . . . . 0.0 108.993 167.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -118.46 136.08 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.19 1.796 . . . . 0.0 107.748 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -133.55 160.77 36.48 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.185 1.394 . . . . 0.0 112.404 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 67.49 30.34 6.82 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.266 2.226 . . . . 0.0 113.478 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.38 155.65 90.34 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.889 0.876 . . . . 0.0 111.257 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.68 151.91 52.27 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.291 2.661 . . . . 0.0 111.981 169.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -70.48 -15.28 62.79 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.329 1.052 . . . . 0.0 113.517 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -102.89 -4.75 24.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.482 1.913 . . . . 0.0 114.29 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.29 134.51 52.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.925 1.29 . . . . 0.0 112.105 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -111.27 -179.14 20.25 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.105 1.336 . . . . 0.0 113.147 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -66.99 -31.84 72.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.455 0.702 . . . . 0.0 112.838 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -73.18 -35.89 66.47 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.353 1.061 . . . . 0.0 112.003 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -64.95 -41.69 95.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.909 0.484 . . . . 0.0 110.857 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -69.44 -42.2 75.27 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.973 -0.537 . . . . 0.0 112.035 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.1 tp -58.64 -54.81 42.91 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.742 0.701 . . . . 0.0 111.501 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -75.58 -15.53 60.35 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -170.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.4 ttp -80.71 -20.76 42.14 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.125 0.97 . . . . 0.0 112.738 169.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -105.71 -15.33 14.99 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.553 1.541 . . . . 0.0 114.013 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 37.1 mtt -47.89 -37.37 13.46 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 168.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -62.07 -16.9 53.21 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.976 2.451 . . . . 0.0 115.696 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -99.37 -8.34 24.95 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.94 0.896 . . . . 0.0 113.327 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 148.48 -167.28 29.14 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.324 1.44 . . . . 0.0 114.447 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -75.06 97.42 3.41 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.615 1.166 . . . . 0.0 112.792 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.25 132.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.558 1.543 . . . . 0.0 110.263 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.66 -35.41 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 127.07 2.148 . . . . 0.0 111.39 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 24.0 m -150.77 147.41 27.27 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.19 1.396 . . . . 0.0 110.896 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.26 134.19 14.88 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.846 1.658 . . . . 0.0 109.187 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -154.27 136.61 14.92 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.727 -0.608 . . . . 0.0 111.805 -168.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 84.1 t -112.62 132.08 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.238 1.415 . . . . 0.0 107.926 169.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -79.29 126.73 31.17 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 50.5 mt -131.36 141.25 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.386 1.475 . . . . 0.0 110.073 -169.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -86.48 130.59 34.44 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.654 0.782 . . . . 0.0 112.0 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.97 -12.66 61.18 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -85.4 -20.34 30.0 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.05 0.94 . . . . 0.0 112.694 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.6 p -133.9 -20.68 1.96 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.583 1.153 . . . . 0.0 114.039 -172.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 62.96 19.13 11.4 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.355 1.862 . . . . 0.0 113.045 -171.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.61 148.99 21.59 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.006 1.323 . . . . 0.0 111.464 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.0 t -59.22 136.38 57.94 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.298 1.039 . . . . 0.0 111.85 170.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -76.18 6.72 5.02 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.795 1.238 . . . . 0.0 113.307 170.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 23.3 m 75.06 19.3 2.35 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.166 2.586 . . . . 0.0 113.074 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -149.21 158.48 44.22 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.618 0.767 . . . . 0.0 112.051 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.55 -177.67 31.85 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.696 1.617 . . . . 0.0 113.599 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -137.42 145.77 43.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.392 1.877 . . . . 0.0 110.021 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 94.9 t -143.41 143.91 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.204 1.402 . . . . 0.0 108.532 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 8.1 t -143.77 145.61 32.51 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.394 -0.816 . . . . 0.0 112.146 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -114.74 167.5 10.71 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.41 1.884 . . . . 0.0 112.225 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.63 -16.89 63.46 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -144.86 149.51 43.06 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.967 1.307 . . . . 0.0 112.168 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.91 -27.88 58.58 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.721 2.947 . . . . 0.0 113.66 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.46 -40.27 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.884 0.873 . . . . 0.0 110.927 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 15.3 m -62.73 -33.49 75.25 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.687 0.795 . . . . 0.0 111.833 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.14 -47.34 36.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.731 1.212 . . . . 0.0 112.083 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -61.17 -34.83 75.68 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.125 0.97 . . . . 0.0 112.041 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.39 70.4 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.476 0.711 . . . . 0.0 112.803 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.06 47.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.26 0.624 . . . . 0.0 111.163 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.05 -46.85 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 119.335 0.97 . . . . 0.0 110.304 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -69.85 -14.6 62.83 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.0 m -104.21 -26.48 12.5 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.7 mmm -115.08 -19.28 10.94 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -71.02 110.5 5.75 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.321 0.964 . . . . 0.0 110.186 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.73 2.34 65.11 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.766 1.65 . . . . 0.0 114.857 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -61.16 123.97 19.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.453 1.626 . . . . 0.0 111.669 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -78.37 131.3 36.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.128 0.489 . . . . 0.0 110.412 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.1 tt -135.29 86.79 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.043 1.337 . . . . 0.0 108.852 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 74.8 -118.19 5.64 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -169.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -99.79 12.9 35.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.446 1.498 . . . . 0.0 113.454 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -139.8 166.81 23.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.784 1.634 . . . . 0.0 112.533 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -122.94 138.01 54.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.882 1.273 . . . . 0.0 111.587 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.74 161.59 29.49 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.118 1.367 . . . . 0.0 112.588 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -130.97 141.55 50.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.596 1.558 . . . . 0.0 108.781 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.02 138.46 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.392 1.077 . . . . 0.0 109.43 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -147.5 151.13 35.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.548 1.139 . . . . 0.0 110.791 -174.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.33 157.54 25.88 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.914 0.864 . . . . 0.0 111.787 168.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -65.61 -27.68 68.58 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.523 1.129 . . . . 0.0 113.26 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -162.81 153.36 16.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.96 1.704 . . . . 0.0 110.796 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 74.1 p -145.27 157.84 43.97 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.604 1.562 . . . . 0.0 110.9 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -109.92 -3.53 16.52 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -162.19 151.68 15.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.786 1.635 . . . . 0.0 112.064 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -123.72 7.16 8.79 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.17 1.788 . . . . 0.0 113.081 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 59.1 m -148.94 157.92 43.79 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.716 2.006 . . . . 0.0 111.36 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 45.0 tttp 76.36 133.29 0.05 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.677 2.791 . . . . 0.0 113.887 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 67.5 m -149.86 151.77 34.01 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.836 1.654 . . . . 0.0 110.742 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 80.18 -141.66 23.39 Favored Glycine 0 CA--C 1.542 1.755 0 CA-C-O 118.519 -1.156 . . . . 0.0 112.671 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -76.61 176.26 10.31 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.881 3.054 . . . . 0.0 111.881 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.6 m -59.94 -25.95 65.58 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.981 0.912 . . . . 0.0 113.276 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 21.9 m -86.23 -2.04 58.01 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.278 1.431 . . . . 0.0 113.786 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.634 1.587 . . . . 0.0 113.892 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.039 -0.424 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 29.4 t -163.58 158.05 20.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.337 1.455 . . . . 0.0 111.234 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 53.6 p -82.14 -11.63 58.63 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.344 1.058 . . . . 0.0 113.133 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -89.24 150.63 21.48 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.192 1.377 . . . . 0.0 112.123 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 77.7 p -167.96 -46.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.657 1.183 . . . . 0.0 112.87 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 80.7 p -165.89 168.28 15.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.411 1.484 . . . . 0.0 111.782 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -177.73 164.03 32.78 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.265 0.936 . . . . 0.0 113.715 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.27 149.02 45.3 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.708 1.603 . . . . 0.0 110.278 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 24.2 p -144.43 145.33 31.85 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.29 1.836 . . . . 0.0 110.355 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -140.89 89.72 2.28 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 109.3 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -163.56 145.32 9.46 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.388 1.475 . . . . 0.0 110.064 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 22.7 t -159.93 118.82 2.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.898 1.279 . . . . 0.0 109.923 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.74 -3.83 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 84.19 143.43 5.8 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.176 1.37 . . . . 0.0 113.011 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 67.87 -54.13 0.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.824 2.85 . . . . 0.0 113.629 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -68.39 113.17 5.73 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.965 1.306 . . . . 0.0 110.3 173.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 87.44 -5.2 85.44 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.922 1.249 . . . . 0.0 113.375 -176.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 40.4 m -78.21 158.52 28.96 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.902 1.281 . . . . 0.0 111.371 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -131.7 27.79 4.62 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.441 1.096 . . . . 0.0 112.086 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -71.95 171.03 12.55 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.386 -0.822 . . . . 0.0 110.47 167.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.09 156.23 35.48 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 169.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -87.43 -158.44 32.72 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.898 1.713 . . . . 0.0 114.172 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.7 165.84 26.25 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.544 2.829 . . . . 0.0 111.625 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.95 125.72 24.76 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.597 -0.689 . . . . 0.0 111.274 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.5 -6.64 68.15 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.75 1.167 . . . . 0.0 113.689 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.81 18.41 14.55 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.211 1.404 . . . . 0.0 112.824 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.25 119.95 27.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.519 1.527 . . . . 0.0 109.779 -168.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 33.5 mt -124.86 133.9 52.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.122 1.769 . . . . 0.0 112.087 -168.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -105.11 134.25 48.52 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.964 1.306 . . . . 0.0 108.673 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 9.4 mm -118.24 137.72 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.897 1.679 . . . . 0.0 108.526 -169.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -137.06 161.68 35.42 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.487 1.115 . . . . 0.0 112.492 -175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 62.57 34.39 15.15 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.259 1.824 . . . . 0.0 113.14 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 35.9 mt -69.23 158.46 86.61 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.218 1.407 . . . . 0.0 111.818 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.85 142.6 99.15 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.82 2.347 . . . . 0.0 111.26 169.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -68.44 -9.18 46.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.519 1.127 . . . . 0.0 113.644 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -98.53 -10.79 22.98 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.826 1.65 . . . . 0.0 113.922 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.54 132.31 40.64 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.937 1.295 . . . . 0.0 112.132 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.69 -172.62 18.72 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.282 1.42 . . . . 0.0 113.274 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -67.64 -34.43 76.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.953 0.901 . . . . 0.0 113.219 -172.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -77.81 -30.89 51.41 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.542 0.737 . . . . 0.0 111.756 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -67.01 -43.5 82.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.16 0.584 . . . . 0.0 110.396 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 26.5 tp -65.48 -43.27 90.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.291 0.637 . . . . 0.0 111.636 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.53 -54.1 50.72 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.599 0.76 . . . . 0.0 111.259 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -73.95 -20.72 60.27 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.8 ttp -76.59 -22.61 54.0 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.031 0.832 . . . . 0.0 113.016 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -102.77 -16.3 16.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.077 1.351 . . . . 0.0 113.754 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 36.6 mtt -47.63 -38.03 15.23 Favored Pre-proline 0 CA--C 1.552 1.035 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -62.26 -17.73 58.63 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.158 2.572 . . . . 0.0 115.54 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -97.7 -9.94 25.85 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.0 0.92 . . . . 0.0 113.325 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.38 -164.17 28.39 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.371 1.462 . . . . 0.0 114.518 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.69 100.63 2.87 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.972 0.909 . . . . 0.0 111.874 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.3 t -76.73 127.09 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.876 1.27 . . . . 0.0 109.874 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 43.0 t -86.86 -35.51 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.502 1.921 . . . . 0.0 111.246 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.8 m -161.79 151.21 16.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.736 1.614 . . . . 0.0 110.636 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.91 132.97 12.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.07 1.748 . . . . 0.0 109.977 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -154.22 148.32 25.78 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.49 130.14 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 126.699 2.0 . . . . 0.0 107.685 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -83.39 143.77 30.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 111.511 -175.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 37.5 mm -121.2 135.87 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.513 1.525 . . . . 0.0 110.004 -169.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -82.38 124.86 30.4 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.834 0.854 . . . . 0.0 111.419 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -69.52 -7.6 39.66 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -90.98 -17.89 25.57 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.602 1.161 . . . . 0.0 112.777 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 79.7 p -137.43 -19.32 1.24 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 40.4 t30 66.17 14.86 9.85 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.388 1.875 . . . . 0.0 113.262 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.78 155.89 16.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.276 1.43 . . . . 0.0 110.664 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 89.8 p -72.97 146.8 45.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.277 1.036 . . . . 0.0 112.675 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -81.15 3.5 23.36 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.454 1.101 . . . . 0.0 113.886 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 83.0 m 62.87 22.03 13.18 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.652 1.981 . . . . 0.0 113.364 -172.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -141.76 155.48 45.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.116 0.966 . . . . 0.0 111.67 172.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.27 -172.33 24.35 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.831 1.681 . . . . 0.0 113.912 -169.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -143.75 147.36 34.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.945 1.698 . . . . 0.0 110.257 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 59.7 t -144.0 145.65 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.765 1.626 . . . . 0.0 108.976 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.2 t -143.14 151.81 41.1 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.216 -0.927 . . . . 0.0 112.55 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -120.94 164.64 16.39 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.015 1.726 . . . . 0.0 113.247 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.11 -18.67 64.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.347 1.059 . . . . 0.0 113.143 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -145.28 150.21 44.02 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.118 1.367 . . . . 0.0 112.222 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.71 -29.22 60.0 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.797 2.998 . . . . 0.0 113.845 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.58 -38.4 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.779 0.832 . . . . 0.0 110.852 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.3 m -62.54 -35.19 78.65 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.003 0.921 . . . . 0.0 111.695 171.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.42 -47.83 46.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.571 1.148 . . . . 0.0 112.007 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -60.28 -35.46 75.6 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.03 0.932 . . . . 0.0 112.113 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.03 71.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.566 0.746 . . . . 0.0 112.685 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.92 56.01 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.298 0.639 . . . . 0.0 111.196 174.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.48 -46.62 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 119.434 1.015 . . . . 0.0 110.362 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -69.6 -15.82 63.28 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.1 m -104.54 -23.12 13.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.5 mmt -113.37 -22.89 10.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.898 1.279 . . . . 0.0 113.626 -171.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -71.41 113.44 8.45 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.974 1.261 . . . . 0.0 110.698 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.68 4.13 83.03 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.554 1.55 . . . . 0.0 114.626 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -63.34 126.47 27.56 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.904 1.352 . . . . 0.0 111.171 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -85.04 130.93 34.53 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.115 0.566 . . . . 0.0 110.866 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.6 tt -149.46 126.89 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.425 1.49 . . . . 0.0 109.799 -170.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.0 -98.86 0.32 Allowed Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -173.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 89.0 mtp -136.31 19.66 3.16 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.404 1.881 . . . . 0.0 112.322 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -138.48 175.5 9.52 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.758 1.623 . . . . 0.0 112.282 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -125.69 132.93 52.31 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.334 1.053 . . . . 0.0 111.517 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.4 mt -68.72 163.35 24.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.405 1.482 . . . . 0.0 112.618 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -139.57 142.33 37.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.417 1.487 . . . . 0.0 108.83 168.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.46 139.79 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.314 1.046 . . . . 0.0 109.452 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -144.86 148.13 33.61 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.316 1.046 . . . . 0.0 110.931 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.24 155.33 28.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.962 0.887 . . . . 0.0 112.256 168.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -65.1 137.8 57.9 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.358 1.063 . . . . 0.0 111.058 168.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -63.02 -40.94 99.24 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.471 1.108 . . . . 0.0 113.864 -170.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 10.4 t -168.78 166.79 11.43 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.682 1.593 . . . . 0.0 110.709 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -135.22 119.83 18.18 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.261 1.425 . . . . 0.0 111.329 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -84.63 -17.71 37.78 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.19 0.996 . . . . 0.0 113.093 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -83.42 97.72 9.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.135 1.774 . . . . 0.0 110.492 173.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 18.0 t -166.58 151.5 7.79 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.197 1.399 . . . . 0.0 111.628 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -159.39 154.17 24.59 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.198 1.799 . . . . 0.0 110.718 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 32.6 p -72.31 -8.19 53.57 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 173.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 110.69 -107.88 2.32 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.518 1.533 . . . . 0.0 112.486 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.78 170.29 19.96 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.79 2.993 . . . . 0.0 112.553 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 74.5 m -141.72 144.95 34.31 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.575 1.55 . . . . 0.0 110.945 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 16.0 m -78.0 -5.09 50.18 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -171.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.209 0 C-N-CA 125.527 1.536 . . . . 0.0 112.945 -178.832 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 36.8 p -71.38 -16.0 62.4 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.306 -1.114 . . . . 0.0 113.794 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 42.2 p -85.44 -3.42 58.85 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.905 1.682 . . . . 0.0 113.971 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 127.5 179.05 15.61 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.786 1.66 . . . . 0.0 114.053 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 57.9 p -113.17 2.61 15.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.517 1.527 . . . . 0.0 114.144 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 91.9 p -161.37 167.35 25.89 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.445 1.498 . . . . 0.0 112.174 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -155.48 171.18 33.54 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.021 1.296 . . . . 0.0 113.673 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -151.66 14.75 0.66 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.243 1.417 . . . . 0.0 114.118 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 46.3 p -140.54 170.51 15.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.937 2.095 . . . . 0.0 110.794 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -150.15 139.46 21.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.965 1.306 . . . . 0.0 109.742 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -106.22 9.79 32.02 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.245 1.018 . . . . 0.0 113.201 -171.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 3.4 m -77.54 7.02 6.04 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.058 1.343 . . . . 0.0 114.426 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.21 -13.11 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.139 1.376 . . . . 0.0 113.982 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -138.85 146.62 18.39 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.37 1.938 . . . . 0.0 110.934 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.76 -34.44 71.83 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -71.37 120.83 17.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.437 1.095 . . . . 0.0 111.52 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.25 -3.37 85.51 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.195 1.855 . . . . 0.0 113.889 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 38.8 t -74.69 156.03 37.1 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.667 1.187 . . . . 0.0 112.498 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -118.43 10.34 12.66 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.016 1.326 . . . . 0.0 112.519 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -64.95 165.43 10.89 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.268 -0.895 . . . . 0.0 112.273 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.66 163.83 36.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.205 1.002 . . . . 0.0 112.433 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -102.42 -161.51 26.17 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 126.102 1.81 . . . . 0.0 113.685 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.73 178.98 6.45 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.055 3.17 . . . . 0.0 112.791 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -54.68 123.88 14.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.796 1.238 . . . . 0.0 111.696 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.33 -5.06 85.72 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.692 1.139 . . . . 0.0 114.694 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.22 -3.38 53.87 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.808 1.304 . . . . 0.0 114.439 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -114.49 124.68 52.51 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.51 1.124 . . . . 0.0 111.263 -168.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.8 mt -124.68 141.85 51.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.625 1.97 . . . . 0.0 112.69 -168.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -112.18 134.58 53.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.588 1.555 . . . . 0.0 109.035 168.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.31 136.24 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.932 1.693 . . . . 0.0 108.249 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -134.23 159.9 39.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.879 1.272 . . . . 0.0 112.865 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 70.45 27.72 3.86 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.945 2.498 . . . . 0.0 113.898 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.89 155.45 86.64 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.828 1.251 . . . . 0.0 112.054 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.48 150.3 69.29 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.019 2.48 . . . . 0.0 111.557 168.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -69.83 -11.82 61.16 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.447 1.099 . . . . 0.0 113.709 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.08 -7.61 16.82 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.895 2.078 . . . . 0.0 113.799 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.47 116.68 14.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.09 1.356 . . . . 0.0 110.429 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -99.28 -175.7 31.55 Favored Glycine 0 N--CA 1.467 0.757 0 C-N-CA 124.19 0.9 . . . . 0.0 113.743 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.14 -35.45 78.8 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.477 1.111 . . . . 0.0 112.631 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -77.52 -31.05 53.21 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.081 0.953 . . . . 0.0 111.981 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -70.82 -41.6 71.36 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.791 0.723 . . . . 0.0 110.715 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.5 tp -64.61 -42.28 95.65 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.217 0.607 . . . . 0.0 111.144 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.88 -51.01 71.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.325 0.65 . . . . 0.0 111.229 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -71.24 -20.07 62.28 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.5 ttp -82.92 -21.63 34.11 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.043 0.838 . . . . 0.0 113.044 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -106.17 -23.23 12.64 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.1 mtm -54.3 -33.02 13.24 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 170.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -58.09 -18.22 35.33 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.627 2.885 . . . . 0.0 115.787 174.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -94.82 -12.16 27.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.231 0.923 . . . . 0.0 113.41 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.8 -157.78 27.47 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.926 1.251 . . . . 0.0 115.027 170.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -74.06 84.23 1.79 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.261 1.024 . . . . 0.0 112.757 -169.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 84.8 t -66.79 127.87 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.872 1.269 . . . . 0.0 109.707 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 55.6 t -91.46 -35.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.011 1.724 . . . . 0.0 110.978 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 27.5 m -158.73 147.36 18.54 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.528 1.531 . . . . 0.0 110.854 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.46 140.28 20.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.828 1.651 . . . . 0.0 110.439 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -154.41 149.22 26.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.635 0.774 . . . . 0.0 112.887 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.89 137.19 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.428 1.891 . . . . 0.0 108.535 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -86.9 134.98 33.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.845 0.858 . . . . 0.0 110.692 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 30.7 mm -119.16 139.55 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.445 1.498 . . . . 0.0 110.42 -169.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.5 126.24 34.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.007 0.923 . . . . 0.0 111.571 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -65.05 -18.17 65.07 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -80.38 -23.21 40.63 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.171 -0.955 . . . . 0.0 112.828 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 76.4 p -133.81 -16.86 2.24 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 56.7 t30 63.37 16.83 9.82 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.294 1.838 . . . . 0.0 112.816 -169.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.1 mt -95.55 156.75 16.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.2 1.4 . . . . 0.0 111.213 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 58.8 m -77.09 137.99 39.26 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.468 1.107 . . . . 0.0 112.082 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -75.33 8.8 2.47 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.343 1.457 . . . . 0.0 114.402 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 50.6 m 71.33 18.28 5.65 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.602 2.361 . . . . 0.0 113.935 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -145.15 154.79 42.82 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.504 1.047 . . . . 0.0 112.357 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.01 -172.34 25.98 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.948 1.737 . . . . 0.0 113.608 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -148.77 141.59 24.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.986 1.714 . . . . 0.0 109.95 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 61.3 t -146.22 136.32 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.908 1.283 . . . . 0.0 109.31 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 68.3 m -134.23 140.43 46.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.618 0.767 . . . . 0.0 112.293 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -110.08 168.85 9.13 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.804 1.642 . . . . 0.0 113.145 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.51 -21.15 66.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.401 1.481 . . . . 0.0 113.295 169.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -160.94 157.42 22.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.24 1.416 . . . . 0.0 112.378 -171.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.9 -16.09 40.88 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.7 2.267 . . . . 0.0 113.936 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.82 -44.19 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 120.459 1.481 . . . . 0.0 110.459 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.8 m -69.21 -30.91 69.18 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.967 0.907 . . . . 0.0 112.114 174.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -75.03 -47.13 30.57 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.851 0.86 . . . . 0.0 112.327 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -62.69 -32.57 73.68 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.469 -0.769 . . . . 0.0 111.806 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.59 70.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.14 -43.35 34.35 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.27 0.628 . . . . 0.0 111.174 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.03 -45.71 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.07 0.85 . . . . 0.0 110.351 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -70.76 -14.87 62.59 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.4 m -104.33 -22.94 13.27 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 2.1 mmt -114.15 -24.18 9.11 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 113.768 -170.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -71.69 112.48 7.83 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.687 1.13 . . . . 0.0 110.348 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.73 3.01 74.74 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.473 1.511 . . . . 0.0 114.683 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -64.41 127.68 32.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.11 1.455 . . . . 0.0 111.291 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -85.96 129.6 34.79 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.048 0.539 . . . . 0.0 110.951 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.6 tt -149.27 131.68 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.545 1.538 . . . . 0.0 110.108 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 68.33 -93.93 0.31 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 121.622 -0.674 . . . . 0.0 111.521 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 28.5 ptm -141.05 16.16 2.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.244 1.818 . . . . 0.0 113.101 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -145.12 177.98 8.39 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.431 1.492 . . . . 0.0 112.623 -172.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -122.91 133.9 54.38 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.51 1.124 . . . . 0.0 111.723 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.39 162.04 30.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.287 1.435 . . . . 0.0 112.521 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -130.91 139.17 50.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.232 1.413 . . . . 0.0 109.079 168.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 32.0 t -139.3 134.42 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.393 1.077 . . . . 0.0 109.259 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -146.71 159.35 43.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.023 0.929 . . . . 0.0 112.24 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 62.0 mt -66.38 152.71 44.49 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.095 0.958 . . . . 0.0 112.866 173.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -59.38 138.33 57.68 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.033 0.933 . . . . 0.0 110.614 168.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -59.61 141.67 54.48 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.562 0.745 . . . . 0.0 112.181 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 21.0 t -163.81 176.19 9.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.374 1.87 . . . . 0.0 109.6 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.71 -20.21 60.6 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.61 -1.306 . . . . 0.0 113.72 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -85.32 -15.04 44.61 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.112 1.765 . . . . 0.0 113.774 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -132.8 -10.08 3.09 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -168.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 19.5 m -83.33 81.88 8.52 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.795 1.238 . . . . 0.0 109.707 171.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -132.03 159.81 37.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.948 1.299 . . . . 0.0 113.196 -168.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 36.5 p -79.35 173.17 12.85 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.573 1.549 . . . . 0.0 113.437 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -76.62 177.16 51.84 Favored Glycine 0 CA--C 1.542 1.75 0 C-N-CA 124.711 1.148 . . . . 0.0 114.334 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.46 -8.45 17.22 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.278 3.319 . . . . 0.0 114.428 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 81.4 p -161.32 162.43 30.89 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.121 1.368 . . . . 0.0 111.819 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 78.0 p -144.65 5.94 1.21 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.136 1.35 . . . . 0.0 112.823 -179.438 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.8 m -67.85 -12.13 60.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -171.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 85.6 p -79.21 -10.1 59.73 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.072 1.349 . . . . 0.0 113.802 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 64.94 17.05 62.65 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.122 0.868 . . . . 0.0 113.176 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 20.6 m 72.01 10.26 6.1 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.242 2.217 . . . . 0.0 113.343 -169.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.7 t 68.23 -167.73 0.19 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.622 1.969 . . . . 0.0 113.535 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 89.75 -176.36 42.72 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.623 1.582 . . . . 0.0 113.479 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 49.0 tp -82.25 130.4 35.09 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.528 1.131 . . . . 0.0 111.052 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 62.3 p -134.0 30.21 3.68 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.949 1.7 . . . . 0.0 112.424 -174.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -54.85 -17.56 3.75 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.655 1.982 . . . . 0.0 116.344 -169.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -145.69 11.22 1.25 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.885 1.274 . . . . 0.0 112.858 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 16.4 m -73.81 -4.25 33.57 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.92 -1.112 . . . . 0.0 113.785 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.79 -11.36 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.247 2.219 . . . . 0.0 113.541 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -87.24 177.83 47.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.112 1.339 . . . . 0.0 112.926 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -156.51 -59.64 0.09 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.363 1.065 . . . . 0.0 111.968 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -64.76 114.93 4.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.898 0.879 . . . . 0.0 110.781 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 87.14 0.02 85.54 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.269 1.414 . . . . 0.0 113.563 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.4 t -98.43 170.51 8.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.303 1.052 . . . . 0.0 111.898 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -132.42 32.35 3.94 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.179 1.392 . . . . 0.0 111.28 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -67.74 164.75 18.74 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.498 -0.751 . . . . 0.0 110.329 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -155.99 161.61 40.45 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.53 -159.32 24.89 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.055 1.788 . . . . 0.0 113.61 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.94 171.99 15.51 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.956 3.104 . . . . 0.0 112.85 -172.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.68 123.46 16.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.019 0.928 . . . . 0.0 111.381 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.62 -3.78 78.79 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.798 1.189 . . . . 0.0 114.584 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.72 1.41 53.4 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.908 1.354 . . . . 0.0 114.355 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -118.27 124.31 47.53 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.494 1.118 . . . . 0.0 110.884 -169.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 18.9 mt -123.62 146.78 47.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.796 2.038 . . . . 0.0 113.052 -168.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -117.43 135.09 54.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.718 1.607 . . . . 0.0 109.099 168.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -119.84 137.36 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.181 1.792 . . . . 0.0 107.831 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -134.99 161.3 35.68 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.128 1.371 . . . . 0.0 112.584 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 67.46 27.41 8.01 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.433 2.293 . . . . 0.0 113.92 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 67.7 mt -64.92 157.77 73.88 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.014 1.325 . . . . 0.0 112.06 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.53 147.48 91.42 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.992 2.461 . . . . 0.0 111.434 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -69.73 -8.29 46.69 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.43 -8.09 15.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.511 1.924 . . . . 0.0 114.166 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.47 124.27 23.09 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.8 1.24 . . . . 0.0 110.805 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.25 -176.27 26.39 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 124.481 1.039 . . . . 0.0 114.065 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.35 -36.36 82.69 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.83 0.852 . . . . 0.0 112.782 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.59 -28.36 56.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.83 0.852 . . . . 0.0 111.769 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.1 -42.11 73.13 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.655 0.661 . . . . 0.0 110.646 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.8 tp -67.03 -36.41 82.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.184 0.594 . . . . 0.0 111.797 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.11 -51.68 66.91 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.686 0.675 . . . . 0.0 110.931 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -63.51 -28.43 69.94 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.0 ttm -72.62 -29.18 63.26 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.453 1.101 . . . . 0.0 113.159 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -109.51 -18.34 13.54 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 47.3 mtm -55.4 -32.24 12.02 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -58.09 -16.33 26.7 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.661 2.908 . . . . 0.0 116.291 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -100.34 -8.35 23.46 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.48 -163.44 28.48 Favored Glycine 0 N--CA 1.47 0.906 0 C-N-CA 125.173 1.368 . . . . 0.0 114.513 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -72.4 90.58 1.3 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.749 0.82 . . . . 0.0 112.026 -173.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 79.9 t -65.42 128.92 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.714 1.206 . . . . 0.0 109.843 172.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 37.5 t -91.62 -36.61 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.94 2.096 . . . . 0.0 110.913 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.85 152.8 25.4 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.618 1.167 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -155.35 133.39 11.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.505 1.122 . . . . 0.0 110.705 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -154.45 147.99 25.19 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.398 -0.814 . . . . 0.0 112.925 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.8 t -124.68 131.4 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 126.214 1.806 . . . . 0.0 107.899 172.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -84.45 139.86 31.9 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.504 0.722 . . . . 0.0 110.962 -175.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.5 mm -117.58 137.25 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.112 1.365 . . . . 0.0 110.838 -168.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.71 128.19 33.36 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.587 1.155 . . . . 0.0 111.763 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.15 -13.91 62.41 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -97.84 -16.75 19.66 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.143 0.977 . . . . 0.0 113.098 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.1 p -131.15 -16.5 3.16 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.804 1.242 . . . . 0.0 114.16 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.6 t30 63.57 14.81 8.38 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.255 1.822 . . . . 0.0 113.168 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 90.1 mt -88.6 154.93 19.93 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.221 1.408 . . . . 0.0 111.002 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 67.3 m -73.64 135.01 43.75 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.474 0.709 . . . . 0.0 111.283 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -71.65 8.56 1.09 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.478 1.511 . . . . 0.0 114.665 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 58.4 m 68.17 17.62 9.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.514 2.326 . . . . 0.0 113.582 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -144.46 154.77 43.28 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.585 1.084 . . . . 0.0 112.758 175.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.74 -177.64 31.03 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.982 1.754 . . . . 0.0 114.087 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -134.61 145.96 49.12 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.704 2.002 . . . . 0.0 110.193 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 92.5 t -144.78 138.75 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.826 1.25 . . . . 0.0 109.236 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 64.7 p -130.47 152.24 50.08 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.211 1.004 . . . . 0.0 112.074 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -125.77 163.82 22.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.344 1.457 . . . . 0.0 113.106 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -71.33 -18.46 62.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.031 0.932 . . . . 0.0 113.048 173.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -144.6 150.77 48.37 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.078 1.351 . . . . 0.0 112.197 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.76 -29.69 59.36 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.856 3.037 . . . . 0.0 113.722 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.08 -40.25 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.811 0.844 . . . . 0.0 110.963 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 8.8 m -61.95 -34.24 75.76 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.971 0.908 . . . . 0.0 111.817 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.79 -49.27 26.16 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.88 1.272 . . . . 0.0 112.029 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -60.93 -33.91 73.89 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.961 0.904 . . . . 0.0 112.15 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 -30.56 71.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.412 0.685 . . . . 0.0 112.611 172.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.3 -41.54 48.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.294 0.638 . . . . 0.0 111.451 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 45.5 mt -57.88 -47.47 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.014 0.824 . . . . 0.0 110.129 174.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.08 -14.69 62.4 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.8 m -101.94 -28.47 12.37 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 91.7 mmm -114.44 -19.13 11.32 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -169.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -70.33 110.28 5.19 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.289 0.949 . . . . 0.0 109.933 173.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.37 2.91 60.18 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.369 1.462 . . . . 0.0 114.933 -172.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.17 123.47 18.71 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.427 1.613 . . . . 0.0 111.587 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -79.0 130.53 35.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.222 0.609 . . . . 0.0 110.988 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -149.49 133.18 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.11 1.364 . . . . 0.0 110.43 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.06 -99.57 0.44 Allowed Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 59.3 mtt -133.84 17.9 3.86 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.333 1.853 . . . . 0.0 112.408 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -146.23 -178.02 5.92 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.628 1.571 . . . . 0.0 112.688 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -122.32 138.84 54.38 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.992 1.317 . . . . 0.0 111.774 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 66.9 mt -70.71 160.72 32.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.032 1.333 . . . . 0.0 111.75 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -132.3 141.9 49.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.226 1.41 . . . . 0.0 109.194 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.5 t -139.42 136.14 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.505 1.122 . . . . 0.0 109.062 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -145.73 165.22 29.42 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.018 1.327 . . . . 0.0 111.044 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.48 159.88 26.23 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.861 0.864 . . . . 0.0 111.859 169.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -49.85 115.26 1.31 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.411 1.484 . . . . 0.0 112.324 171.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -168.15 154.21 7.25 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.972 2.109 . . . . 0.0 109.714 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 9.6 t -152.3 162.47 41.12 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.705 1.202 . . . . 0.0 111.16 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 65.69 4.91 3.06 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.096 2.158 . . . . 0.0 115.08 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.29 -11.29 35.6 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.138 1.375 . . . . 0.0 113.374 -174.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -79.31 -13.61 59.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.755 1.222 . . . . 0.0 113.823 -173.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 19.3 m -61.62 -21.11 64.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.745 1.218 . . . . 0.0 114.113 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -70.22 -16.16 63.02 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.532 1.133 . . . . 0.0 113.059 173.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 49.5 m -115.81 11.96 15.74 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.876 1.67 . . . . 0.0 112.954 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -72.45 165.28 54.41 Favored Glycine 0 CA--C 1.543 1.804 0 C-N-CA 124.486 1.041 . . . . 0.0 113.739 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.49 152.47 60.12 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.997 3.132 . . . . 0.0 111.963 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 32.4 t -166.66 -47.09 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.809 1.244 . . . . 0.0 111.907 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 79.7 p -163.87 165.01 23.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.363 1.465 . . . . 0.0 111.762 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 CA-C-O 118.382 -1.232 . . . . 0.0 112.844 -179.225 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 112.091 -0.404 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 8.4 m -165.18 154.72 12.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.503 1.921 . . . . 0.0 110.651 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.0 m -80.33 -10.06 59.75 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.02 165.28 36.0 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.224 1.392 . . . . 0.0 113.521 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 5.1 t -157.54 6.29 0.14 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 60.4 m 67.18 4.11 3.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.286 1.834 . . . . 0.0 115.899 172.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 141.62 -137.24 7.9 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.163 1.364 . . . . 0.0 112.849 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 43.8 tp -61.96 142.33 57.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.892 1.277 . . . . 0.0 111.672 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.4 t -158.39 168.52 26.75 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.988 1.715 . . . . 0.0 110.662 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -70.71 121.6 18.26 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.253 1.021 . . . . 0.0 110.544 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -140.87 116.21 10.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.199 1.399 . . . . 0.0 107.918 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 59.5 p -111.08 9.36 22.02 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -168.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.402 ' H ' HD13 ' A' ' 388' ' ' ILE . 0.2 OUTLIER -78.87 -6.0 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.318 1.447 . . . . 0.0 114.475 -177.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 139.61 -143.64 14.12 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 125.635 1.588 . . . . 0.0 112.643 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.23 -18.35 63.15 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.97 120.26 12.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.622 1.569 . . . . 0.0 110.615 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.26 -2.4 71.22 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.456 1.027 . . . . 0.0 113.375 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.0 t -77.35 165.75 24.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.156 0.978 . . . . 0.0 112.093 174.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -134.09 23.19 3.84 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.017 1.327 . . . . 0.0 110.791 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -65.75 174.73 2.2 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.903 1.281 . . . . 0.0 111.751 168.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -156.26 161.53 40.23 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.791 0.836 . . . . 0.0 112.432 168.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.35 -163.19 29.47 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.965 1.745 . . . . 0.0 113.376 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.99 172.79 13.95 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.754 2.97 . . . . 0.0 112.43 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.51 128.39 36.95 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.495 0.664 . . . . 0.0 111.342 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.6 -10.2 75.24 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.796 1.189 . . . . 0.0 113.962 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.9 -5.73 47.24 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.639 1.22 . . . . 0.0 114.218 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -112.08 123.95 51.36 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.317 1.047 . . . . 0.0 110.55 -169.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.9 mt -124.07 143.26 50.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.675 1.99 . . . . 0.0 112.549 -168.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -112.92 134.26 54.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.417 1.487 . . . . 0.0 109.073 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.01 134.17 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.346 1.858 . . . . 0.0 107.737 -171.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -132.65 158.5 42.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.878 1.271 . . . . 0.0 112.694 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 71.69 27.33 2.93 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.604 2.362 . . . . 0.0 113.747 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 76.8 mt -65.13 161.11 51.56 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.986 1.315 . . . . 0.0 111.803 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.62 149.19 91.94 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.921 2.414 . . . . 0.0 110.845 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -67.7 -20.47 65.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -88.94 -11.18 45.16 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -67.53 129.1 38.83 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.504 1.122 . . . . 0.0 111.886 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.12 -173.95 23.48 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.296 1.427 . . . . 0.0 112.273 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.02 -33.48 73.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.757 0.823 . . . . 0.0 112.493 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -67.84 -44.98 75.92 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.099 1.76 . . . . 0.0 111.472 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.89 -40.92 95.84 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.974 0.91 . . . . 0.0 111.528 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 30.4 tp -67.13 -38.94 86.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.267 0.627 . . . . 0.0 111.891 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 66.1 tp -63.11 -48.7 77.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.87 0.759 . . . . 0.0 111.077 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -67.88 -23.2 65.09 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.8 ttm -74.91 -25.91 59.25 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.112 0.965 . . . . 0.0 113.148 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -113.63 -16.67 12.31 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.4 mtm -54.16 -33.82 17.99 Favored Pre-proline 0 CA--C 1.549 0.914 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -58.99 -16.3 31.83 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.476 2.784 . . . . 0.0 116.296 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.12 -11.38 20.54 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 149.01 -163.06 29.07 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.931 1.253 . . . . 0.0 114.823 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -71.55 102.1 2.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.118 0.967 . . . . 0.0 112.385 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 69.7 t -80.44 128.69 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.071 1.348 . . . . 0.0 110.083 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.12 -22.44 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.956 2.502 . . . . 0.0 112.087 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 8.8 t -159.7 146.05 16.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.266 1.427 . . . . 0.0 110.341 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.58 129.39 10.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.196 1.399 . . . . 0.0 110.687 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -156.0 132.03 9.93 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.584 0.754 . . . . 0.0 112.557 -174.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.9 135.14 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.486 1.514 . . . . 0.0 107.299 167.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -83.68 140.29 32.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.275 0.63 . . . . 0.0 111.295 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.2 mm -123.11 141.96 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.778 1.631 . . . . 0.0 110.306 -168.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.75 132.73 34.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.506 0.67 . . . . 0.0 112.798 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -62.73 -22.52 66.59 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -85.49 -22.68 28.09 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.019 0.928 . . . . 0.0 112.846 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 73.6 p -134.16 -17.45 2.1 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -170.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 60.66 17.28 7.37 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.028 1.731 . . . . 0.0 113.386 -169.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.7 mt -87.68 153.23 21.54 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.743 1.217 . . . . 0.0 111.05 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 56.5 m -77.18 136.24 38.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.586 0.755 . . . . 0.0 112.099 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -75.11 5.54 5.22 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.23 1.412 . . . . 0.0 114.682 -175.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.1 m 66.87 21.62 10.37 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.067 2.147 . . . . 0.0 113.207 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -146.52 156.17 43.06 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.129 0.972 . . . . 0.0 111.687 172.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.58 -177.71 29.09 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.868 1.699 . . . . 0.0 113.767 -170.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -138.58 141.16 39.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.015 2.126 . . . . 0.0 109.901 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 94.9 t -144.03 137.31 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.076 1.35 . . . . 0.0 108.867 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.0 m -131.03 148.43 52.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.474 0.71 . . . . 0.0 112.068 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -117.57 170.24 8.91 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.405 1.482 . . . . 0.0 113.287 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.52 -25.02 67.01 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.381 1.472 . . . . 0.0 113.648 170.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -160.12 162.2 24.57 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.096 1.358 . . . . 0.0 112.109 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.98 -13.52 31.65 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.332 2.021 . . . . 0.0 114.03 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 22.8 t -75.4 -45.92 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 121.032 1.742 . . . . 0.0 110.892 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.5 p -69.73 -32.52 71.11 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.811 0.844 . . . . 0.0 112.631 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -67.14 -49.0 66.37 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.365 0.666 . . . . 0.0 112.435 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -63.2 -31.71 72.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.376 -0.828 . . . . 0.0 112.056 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.79 70.47 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.7 0.682 . . . . 0.0 112.595 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.79 -42.0 51.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.717 0.689 . . . . 0.0 111.411 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.27 -47.22 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 118.914 0.779 . . . . 0.0 110.199 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -70.36 -15.45 62.86 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.0 m -99.78 -29.38 12.66 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 88.4 mmm -113.97 -19.93 11.24 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -168.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -71.68 110.6 6.34 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.441 1.019 . . . . 0.0 109.987 174.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 90.92 8.64 64.85 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.393 1.473 . . . . 0.0 114.433 -171.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.76 122.64 17.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.764 1.782 . . . . 0.0 110.568 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -74.36 131.88 41.51 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 122.063 -0.398 . . . . 0.0 110.292 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.8 tt -137.73 114.95 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.556 1.143 . . . . 0.0 108.579 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 63.21 -125.05 33.42 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -169.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.4 mmt -99.93 12.57 36.48 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.395 1.478 . . . . 0.0 113.504 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -135.41 176.82 8.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.228 1.411 . . . . 0.0 113.015 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -126.81 136.17 52.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.063 1.345 . . . . 0.0 110.946 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.18 155.96 40.13 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.854 1.262 . . . . 0.0 111.502 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.38 140.7 52.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.857 1.263 . . . . 0.0 109.46 169.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 23.4 t -139.61 136.27 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.541 1.136 . . . . 0.0 109.245 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -150.77 162.04 41.49 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.08 0.952 . . . . 0.0 112.097 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 75.4 mt -64.5 157.16 27.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.599 1.16 . . . . 0.0 113.071 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -65.51 -31.03 71.87 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.537 1.135 . . . . 0.0 113.152 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -90.06 136.29 33.14 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.072 1.349 . . . . 0.0 111.143 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 30.9 m -135.84 16.27 3.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.809 1.243 . . . . 0.0 113.232 -174.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -131.81 141.24 49.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.186 1.394 . . . . 0.0 112.488 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -154.91 122.11 5.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.569 1.548 . . . . 0.0 110.914 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -70.59 -22.22 62.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.312 1.045 . . . . 0.0 113.239 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 50.6 m -82.67 -6.24 59.27 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.986 0.915 . . . . 0.0 113.18 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt 52.77 -111.13 0.57 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.744 2.018 . . . . 0.0 113.086 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 62.7 m -150.83 155.93 40.21 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.27 1.828 . . . . 0.0 110.978 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -77.12 168.76 54.8 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 123.96 0.79 . . . . 0.0 113.671 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -75.96 -5.89 16.83 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.216 3.277 . . . . 0.0 113.913 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 24.1 p -81.09 1.87 29.76 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.52 1.528 . . . . 0.0 114.24 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 93.5 p -156.21 165.75 35.47 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.377 1.471 . . . . 0.0 112.718 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 CA-C-O 118.268 -1.296 . . . . 0.0 112.889 -178.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.996 -0.442 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 30.7 p -165.74 -54.16 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.475 1.11 . . . . 0.0 112.25 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.6 p -163.36 167.28 21.95 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.698 1.599 . . . . 0.0 112.214 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -77.33 147.23 32.66 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.293 0.949 . . . . 0.0 112.653 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 49.3 p -93.11 -4.96 51.37 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 44.4 m -70.8 118.6 13.78 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.917 -1.114 . . . . 0.0 112.339 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -86.91 137.81 15.05 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.431 1.015 . . . . 0.0 112.219 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 59.4 tp -163.97 121.48 1.77 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.594 1.558 . . . . 0.0 109.968 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 29.8 p -63.1 -34.38 77.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.292 1.037 . . . . 0.0 112.753 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -68.84 -8.89 47.87 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.906 1.282 . . . . 0.0 113.345 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -81.45 -13.89 57.69 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.987 -1.07 . . . . 0.0 112.439 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 52.0 m -79.7 48.87 0.97 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.151 1.38 . . . . 0.0 113.123 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.7 149.1 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.582 1.153 . . . . 0.0 113.571 -173.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 77.17 -59.93 3.56 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.56 1.552 . . . . 0.0 113.768 171.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -170.27 -38.82 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.143 1.777 . . . . 0.0 113.235 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -64.98 119.18 10.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.619 1.168 . . . . 0.0 110.816 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.6 -6.36 83.7 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.584 1.087 . . . . 0.0 113.281 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 7.6 t -86.92 160.21 18.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.461 1.131 . . . . 0.0 111.117 172.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -135.83 22.93 3.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.399 1.08 . . . . 0.0 112.477 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -68.81 173.96 4.8 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.314 -0.866 . . . . 0.0 111.676 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -148.88 158.44 44.17 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.756 0.822 . . . . 0.0 112.196 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.55 -160.95 27.99 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.994 1.759 . . . . 0.0 113.451 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.08 176.03 9.67 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.94 3.094 . . . . 0.0 112.576 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -56.32 124.67 18.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.266 1.026 . . . . 0.0 111.501 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.04 -7.64 81.27 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.811 1.196 . . . . 0.0 114.556 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.72 -5.21 54.04 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.919 1.359 . . . . 0.0 114.364 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -112.68 122.53 47.95 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.576 1.15 . . . . 0.0 110.676 -168.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.1 mt -123.32 141.65 51.77 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.562 1.945 . . . . 0.0 112.535 -168.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -111.09 134.83 52.39 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.574 1.549 . . . . 0.0 108.729 167.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.5 133.51 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.93 1.692 . . . . 0.0 107.791 -171.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -129.58 160.64 32.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.858 1.263 . . . . 0.0 112.22 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 65.8 38.37 5.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.07 1.748 . . . . 0.0 113.193 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 54.1 mt -71.59 161.45 78.45 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.104 1.362 . . . . 0.0 111.696 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.6 154.59 47.45 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.233 2.622 . . . . 0.0 111.469 168.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -68.12 -28.19 67.12 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.58 -11.19 57.66 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.83 128.25 35.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.405 1.082 . . . . 0.0 112.494 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.78 -171.55 18.29 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.796 1.665 . . . . 0.0 112.362 169.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -62.15 -35.51 79.02 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.838 0.855 . . . . 0.0 113.195 -174.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -74.16 -29.29 61.71 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.161 0.985 . . . . 0.0 112.089 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -76.12 -42.13 47.99 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.815 0.846 . . . . 0.0 110.695 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 32.8 tp -63.69 -38.01 89.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.359 0.664 . . . . 0.0 111.572 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.8 tp -63.69 -49.6 72.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.613 0.642 . . . . 0.0 111.116 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -68.81 -20.1 64.31 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.0 ttm -74.56 -26.85 60.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.945 0.898 . . . . 0.0 112.852 169.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -111.61 -19.44 12.51 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -172.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.3 mtm -53.72 -34.39 20.08 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -59.18 -17.31 38.25 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.505 2.803 . . . . 0.0 116.097 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.68 -10.79 21.52 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.32 -160.12 28.11 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.713 1.149 . . . . 0.0 115.033 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -74.06 96.07 2.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.15 0.98 . . . . 0.0 112.18 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.7 t -77.19 127.29 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.104 1.362 . . . . 0.0 109.677 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.53 -34.23 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.682 1.993 . . . . 0.0 111.319 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.8 m -160.07 147.37 16.37 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.533 1.533 . . . . 0.0 110.786 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.04 134.23 16.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.596 1.559 . . . . 0.0 110.129 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -153.64 132.65 12.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.48 0.712 . . . . 0.0 111.887 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 91.8 t -101.42 131.13 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.634 1.574 . . . . 0.0 107.169 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -78.92 138.22 37.99 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.19 0.519 . . . . 0.0 111.178 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.5 mm -120.71 137.38 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.619 1.568 . . . . 0.0 109.771 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -81.21 118.29 22.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.445 0.698 . . . . 0.0 110.569 172.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -68.05 -8.79 40.79 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -84.47 -22.92 30.11 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.161 0.985 . . . . 0.0 112.534 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 73.8 p -133.3 -14.77 2.57 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.73 1.212 . . . . 0.0 114.181 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 57.5 t30 65.28 19.01 11.59 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.701 2.0 . . . . 0.0 113.075 -172.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.0 mt -97.35 147.39 24.22 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.099 1.36 . . . . 0.0 111.591 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 50.7 m -66.94 140.09 57.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.987 0.915 . . . . 0.0 112.159 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -82.9 4.11 27.0 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.477 1.111 . . . . 0.0 113.91 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 78.5 m 65.66 22.99 11.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.271 2.229 . . . . 0.0 113.735 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -143.69 156.02 44.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.236 1.014 . . . . 0.0 111.455 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.64 -174.15 26.02 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.889 1.709 . . . . 0.0 114.006 -169.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -144.96 140.99 28.61 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.757 2.023 . . . . 0.0 109.837 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 89.0 t -145.5 135.97 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.222 1.409 . . . . 0.0 109.072 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 65.8 m -132.44 141.79 48.98 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.37 0.668 . . . . 0.0 112.378 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -111.0 169.49 8.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.598 1.559 . . . . 0.0 113.56 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.06 -23.5 65.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.941 1.696 . . . . 0.0 113.59 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -161.27 160.89 24.01 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.323 1.449 . . . . 0.0 112.05 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.85 -12.38 26.26 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.652 2.234 . . . . 0.0 114.272 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 40.6 t -77.37 -46.33 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.665 1.575 . . . . 0.0 110.494 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 21.6 m -64.78 -29.75 70.74 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.671 1.189 . . . . 0.0 111.896 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.12 -50.34 19.88 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.032 0.933 . . . . 0.0 111.934 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -59.68 -37.8 79.8 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.476 -0.765 . . . . 0.0 111.735 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.34 -28.09 64.75 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -80.44 -43.97 20.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.65 0.78 . . . . 0.0 111.898 172.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.31 -50.18 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.138 0.881 . . . . 0.0 110.523 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -74.78 -11.58 60.19 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 66.1 m -99.2 -31.4 11.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 89.7 mmm -112.35 -18.04 12.58 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -168.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -68.47 110.83 4.35 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.559 1.072 . . . . 0.0 110.489 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.71 3.8 66.03 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.959 1.743 . . . . 0.0 115.038 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.41 128.36 35.46 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.409 1.605 . . . . 0.0 111.721 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -84.77 130.37 34.69 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.227 0.611 . . . . 0.0 111.3 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.3 tt -149.64 131.02 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.212 1.405 . . . . 0.0 110.145 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.31 -96.93 0.3 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 14.7 ttt -140.78 24.45 2.21 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.151 1.78 . . . . 0.0 111.843 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -143.55 176.4 9.23 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.983 1.713 . . . . 0.0 112.125 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -126.06 133.82 51.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.393 1.077 . . . . 0.0 111.678 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 62.0 mt -66.45 160.44 24.94 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.34 1.456 . . . . 0.0 112.196 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -136.78 139.64 41.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.162 1.385 . . . . 0.0 108.925 167.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.2 t -139.33 135.69 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.497 1.119 . . . . 0.0 109.066 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -153.72 153.68 32.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.701 0.8 . . . . 0.0 111.394 -176.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 82.3 mt -61.78 154.89 24.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.562 1.145 . . . . 0.0 113.206 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -61.29 119.59 8.76 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.251 1.021 . . . . 0.0 111.122 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -162.3 33.18 0.11 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.463 1.105 . . . . 0.0 112.76 -171.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 65.4 p -162.33 170.84 18.2 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.822 -1.173 . . . . 0.0 112.943 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -152.29 154.57 35.96 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.007 1.723 . . . . 0.0 111.816 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -159.68 145.53 15.86 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.061 1.344 . . . . 0.0 111.7 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 25.2 t70 62.02 33.24 17.34 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.918 1.687 . . . . 0.0 112.386 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 52.8 p -140.94 33.77 1.76 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.663 1.585 . . . . 0.0 112.748 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -152.7 141.22 20.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.762 2.025 . . . . 0.0 110.466 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 7.9 m -160.61 148.86 16.34 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.039 1.735 . . . . 0.0 110.975 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -86.95 170.65 41.85 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 124.493 1.044 . . . . 0.0 113.566 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.39 -14.67 12.96 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.962 3.108 . . . . 0.0 113.737 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 18.9 m -161.63 156.88 23.77 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.724 2.01 . . . . 0.0 110.523 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 17.9 m -79.05 -7.15 57.88 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.188 0 C-N-CA 125.597 1.57 . . . . 0.0 112.909 179.624 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 25.3 m -133.79 11.54 4.0 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 80.3 p -163.18 164.97 24.98 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.61 1.564 . . . . 0.0 112.003 -174.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.01 -86.02 1.1 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.977 1.275 . . . . 0.0 111.866 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 36.6 t -163.54 151.69 13.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.267 1.427 . . . . 0.0 111.497 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 17.5 m -84.12 -2.97 57.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.47 1.108 . . . . 0.0 113.291 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.43 151.57 45.19 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.761 1.172 . . . . 0.0 113.444 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 98.5 mt -142.43 162.57 35.13 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.518 1.927 . . . . 0.0 110.701 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 40.5 p -136.34 157.03 47.77 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.934 1.694 . . . . 0.0 111.36 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -147.06 166.15 27.73 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.196 1.798 . . . . 0.0 109.94 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -151.49 130.37 12.49 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.706 1.202 . . . . 0.0 109.871 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 9.8 t -159.81 40.45 0.19 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.279 1.031 . . . . 0.0 111.482 -172.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.76 147.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.962 -1.086 . . . . 0.0 112.982 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -86.7 167.92 39.13 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.76 1.172 . . . . 0.0 113.485 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -90.01 -15.12 32.52 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.882 1.273 . . . . 0.0 114.117 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -74.07 121.36 20.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.427 1.491 . . . . 0.0 110.613 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.8 -9.3 76.91 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.588 1.089 . . . . 0.0 113.093 -175.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 74.2 m -81.49 149.56 28.67 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.435 1.094 . . . . 0.0 110.62 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -132.85 29.53 4.12 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.211 1.004 . . . . 0.0 111.83 -170.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -71.68 176.29 4.96 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.471 -0.768 . . . . 0.0 110.907 168.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.81 157.53 42.05 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 168.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.92 -163.26 27.82 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 127.79 2.614 . . . . 0.0 113.775 -170.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.15 173.13 13.45 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.024 3.15 . . . . 0.0 112.759 -173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.54 124.28 18.48 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.059 0.943 . . . . 0.0 111.108 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.45 -10.48 69.13 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.783 1.182 . . . . 0.0 114.497 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.77 -0.76 47.59 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -111.57 118.14 34.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.837 1.255 . . . . 0.0 110.938 -169.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.3 mt -121.48 135.37 55.04 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.855 1.662 . . . . 0.0 112.016 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -106.16 133.29 51.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.936 1.294 . . . . 0.0 108.725 167.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.6 mm -118.08 138.39 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.092 1.757 . . . . 0.0 108.788 -169.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -140.34 161.94 36.48 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.626 1.171 . . . . 0.0 113.029 -172.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 63.83 25.96 14.2 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.474 2.31 . . . . 0.0 113.926 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.33 156.06 82.88 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.477 1.111 . . . . 0.0 111.115 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.27 145.8 91.72 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.791 2.327 . . . . 0.0 111.76 171.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -67.43 -17.43 64.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.908 0.883 . . . . 0.0 113.161 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -99.71 -8.83 23.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.829 1.252 . . . . 0.0 114.033 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.58 125.4 26.41 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.448 1.499 . . . . 0.0 111.205 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -102.68 -177.67 27.04 Favored Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.344 0.973 . . . . 0.0 113.745 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -61.76 -36.12 80.09 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.122 0.969 . . . . 0.0 112.673 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -76.44 -30.69 57.48 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.82 0.848 . . . . 0.0 111.786 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -70.73 -41.19 72.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.614 0.643 . . . . 0.0 110.685 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 28.1 tp -64.86 -38.73 91.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.559 0.744 . . . . 0.0 111.674 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.26 -50.16 71.25 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.573 0.624 . . . . 0.0 111.095 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -63.39 -27.11 69.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.3 ttm -73.31 -29.41 62.68 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.433 1.093 . . . . 0.0 113.229 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -110.22 -18.15 13.36 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 44.7 mtm -55.54 -33.05 14.71 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 171.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.75 -16.06 23.64 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.57 2.846 . . . . 0.0 116.157 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -100.73 -9.78 21.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.32 -162.11 28.39 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.988 1.28 . . . . 0.0 115.127 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -71.88 92.58 1.26 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.753 1.221 . . . . 0.0 112.38 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.23 128.38 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.816 1.246 . . . . 0.0 109.722 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 44.8 t -92.6 -34.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.909 2.084 . . . . 0.0 111.478 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.3 m -159.53 145.54 16.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 110.377 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.9 134.59 17.62 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.949 1.699 . . . . 0.0 110.208 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -154.92 136.83 14.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.63 0.772 . . . . 0.0 111.588 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.06 135.29 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.969 1.708 . . . . 0.0 107.873 169.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -82.65 137.15 34.58 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.085 0.554 . . . . 0.0 110.994 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.8 mm -118.08 136.89 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.034 1.334 . . . . 0.0 111.104 -168.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.69 129.23 36.79 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.305 1.442 . . . . 0.0 111.857 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.2 -2.78 42.61 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -173.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -102.99 -21.92 13.88 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.029 1.332 . . . . 0.0 112.046 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.5 p -130.61 -16.5 3.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.434 1.494 . . . . 0.0 114.233 -172.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 53.8 t30 65.15 15.92 10.27 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.331 1.852 . . . . 0.0 113.294 -173.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.01 159.03 15.92 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.516 1.527 . . . . 0.0 111.193 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 63.8 m -81.82 137.82 35.21 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.199 -0.938 . . . . 0.0 112.022 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.82 6.06 3.58 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 30.8 m 69.79 18.52 7.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.515 2.326 . . . . 0.0 113.406 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -145.91 156.09 43.3 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.094 0.958 . . . . 0.0 112.091 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.52 -175.29 28.28 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 126.099 1.809 . . . . 0.0 113.546 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -139.71 144.84 37.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.244 1.818 . . . . 0.0 110.262 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 81.2 t -142.84 139.82 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.514 1.526 . . . . 0.0 108.708 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 34.3 t -136.74 144.99 44.12 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.631 0.772 . . . . 0.0 112.277 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -116.44 166.02 12.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.869 1.667 . . . . 0.0 113.431 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.51 -19.3 63.73 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.663 1.185 . . . . 0.0 113.204 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -147.74 159.69 40.23 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 126.23 1.812 . . . . 0.0 110.843 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 -18.67 8.19 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.297 1.998 . . . . 0.0 113.816 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 70.7 t -72.67 -43.57 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 119.812 1.187 . . . . 0.0 111.0 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.6 p -65.8 -31.74 72.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.775 0.83 . . . . 0.0 112.427 172.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -69.51 -50.47 44.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.85 0.86 . . . . 0.0 112.327 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.89 -29.97 70.0 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.266 -0.896 . . . . 0.0 112.097 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.05 -31.25 71.64 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.606 0.639 . . . . 0.0 112.485 169.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.08 63.94 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.838 0.745 . . . . 0.0 111.834 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 30.0 mt -57.55 -49.06 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.116 0.871 . . . . 0.0 110.047 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -70.97 -15.05 62.56 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 53.1 m -99.35 -30.42 12.23 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.5 mmm -112.79 -20.69 11.53 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -69.99 112.71 6.58 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.413 1.006 . . . . 0.0 109.786 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.25 2.54 68.28 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.392 1.472 . . . . 0.0 115.268 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -65.24 123.3 19.19 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.628 1.714 . . . . 0.0 111.169 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -81.18 131.12 35.28 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.878 -0.514 . . . . 0.0 111.233 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.8 tt -138.96 85.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 122.772 1.272 . . . . 0.0 109.468 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 85.2 -125.97 7.48 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.651 1.12 . . . . 0.0 111.067 -169.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 61.6 mtt -99.41 22.16 11.08 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.664 1.586 . . . . 0.0 112.759 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -146.07 161.24 40.58 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.353 1.861 . . . . 0.0 111.862 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -121.32 130.19 53.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.566 1.146 . . . . 0.0 110.765 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 72.2 mt -63.84 159.48 19.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.331 1.453 . . . . 0.0 111.473 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -135.42 139.35 44.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.352 1.461 . . . . 0.0 109.715 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 29.2 t -139.24 136.9 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.324 1.049 . . . . 0.0 109.688 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -143.07 155.74 44.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.389 1.075 . . . . 0.0 111.488 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.29 156.8 33.32 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.851 0.86 . . . . 0.0 112.216 169.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -66.42 -36.21 82.25 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.091 0.956 . . . . 0.0 113.119 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 -104.0 117.6 34.68 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.556 1.143 . . . . 0.0 111.759 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 59.7 m -148.69 -46.75 0.15 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.032 1.333 . . . . 0.0 112.379 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -149.29 -14.35 0.29 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.541 1.136 . . . . 0.0 114.015 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -68.59 -14.84 63.28 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.6 -1.312 . . . . 0.0 114.105 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -130.38 11.59 5.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.64 1.576 . . . . 0.0 112.894 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 47.8 t -165.09 133.24 3.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.716 1.207 . . . . 0.0 112.035 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.42 3.97 41.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.331 1.052 . . . . 0.0 113.041 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 4.0 t 69.4 -170.23 0.18 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.58 1.952 . . . . 0.0 112.686 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -78.34 179.25 52.12 Favored Glycine 0 CA--C 1.543 1.833 0 C-N-CA 125.082 1.325 . . . . 0.0 114.509 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.49 156.01 33.41 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.754 3.636 . . . . 0.0 113.983 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 93.1 p -160.26 164.38 32.72 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.44 1.496 . . . . 0.0 111.833 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 18.4 m -163.89 156.12 17.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.165 1.786 . . . . 0.0 111.03 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.282 -1.288 . . . . 0.0 112.837 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 24.2 m -131.38 9.79 4.77 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -169.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 80.9 p -162.18 163.24 28.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.531 1.532 . . . . 0.0 111.533 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 77.66 -53.14 3.61 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.407 1.48 . . . . 0.0 113.54 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 71.0 m -84.72 -3.53 58.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.89 1.276 . . . . 0.0 113.21 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 10.1 m -71.0 -13.11 61.89 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.926 1.29 . . . . 0.0 114.25 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -80.31 58.65 4.63 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.707 1.622 . . . . 0.0 112.602 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.36 -11.15 59.99 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.061 1.344 . . . . 0.0 114.193 -174.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 20.6 m -80.25 79.27 6.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.201 1.4 . . . . 0.0 109.765 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -149.1 170.94 17.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.387 1.875 . . . . 0.0 110.474 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -80.06 15.83 1.39 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.659 1.184 . . . . 0.0 112.877 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 42.6 p -83.08 8.45 12.89 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.9 1.68 . . . . 0.0 114.245 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -7.88 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.446 1.499 . . . . 0.0 114.527 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.8 -156.31 22.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.226 1.393 . . . . 0.0 113.661 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.5 73.98 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -171.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -71.56 109.84 5.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.312 1.045 . . . . 0.0 110.049 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 95.22 -3.21 66.33 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.434 1.016 . . . . 0.0 113.33 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 3.2 m -70.13 154.15 42.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.598 1.199 . . . . 0.0 110.927 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -127.81 26.37 5.87 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.643 1.177 . . . . 0.0 110.078 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -73.26 179.93 3.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.383 1.473 . . . . 0.0 110.662 168.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.83 167.08 31.55 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.587 -0.695 . . . . 0.0 112.873 168.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.24 -163.82 28.57 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 126.133 1.825 . . . . 0.0 113.892 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.35 174.61 11.83 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.019 3.146 . . . . 0.0 112.693 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -57.46 125.75 24.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.179 0.992 . . . . 0.0 111.286 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.03 71.49 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.864 1.221 . . . . 0.0 114.301 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.64 -0.54 42.8 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -113.67 123.65 50.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.422 1.089 . . . . 0.0 110.645 -169.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.9 mt -122.52 142.93 50.07 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.815 2.046 . . . . 0.0 112.861 -168.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -111.61 135.21 52.5 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.78 1.632 . . . . 0.0 108.595 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.6 mm -119.56 138.22 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.993 1.717 . . . . 0.0 108.369 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -138.8 162.27 35.18 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.597 0.759 . . . . 0.0 112.867 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 64.57 26.34 13.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.34 2.256 . . . . 0.0 113.87 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 72.1 mt -65.56 159.46 67.61 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.023 1.329 . . . . 0.0 111.823 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.71 149.38 77.39 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.065 2.51 . . . . 0.0 111.929 169.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -71.64 -8.4 53.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.77 1.228 . . . . 0.0 113.922 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -113.56 -6.01 13.41 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.271 2.228 . . . . 0.0 113.865 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 125.72 27.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.153 1.381 . . . . 0.0 110.869 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.67 -177.75 25.9 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.443 1.02 . . . . 0.0 113.745 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -62.4 -36.07 81.18 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.892 0.877 . . . . 0.0 112.66 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.22 -31.23 58.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.992 0.917 . . . . 0.0 111.95 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -70.03 -40.57 75.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.495 0.589 . . . . 0.0 110.762 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.19 -37.06 83.02 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.286 0.635 . . . . 0.0 111.694 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -62.75 -50.17 72.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.838 0.745 . . . . 0.0 111.062 172.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -63.19 -28.08 69.8 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.427 0.691 . . . . 0.0 112.767 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.9 ttm -73.31 -28.76 62.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.478 1.111 . . . . 0.0 113.241 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -110.54 -17.47 13.42 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.0 mtm -55.29 -32.49 12.69 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -57.99 -15.48 22.61 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.66 2.907 . . . . 0.0 116.372 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -101.59 -7.94 22.3 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.07 -160.74 28.09 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.895 1.236 . . . . 0.0 114.718 171.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -72.52 95.79 1.85 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.257 1.023 . . . . 0.0 112.144 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.5 t -77.38 127.73 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.061 1.344 . . . . 0.0 109.814 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.14 -26.02 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.378 2.271 . . . . 0.0 111.788 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.6 t -154.27 144.37 21.96 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.678 1.191 . . . . 0.0 110.339 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.26 126.39 5.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.935 1.694 . . . . 0.0 110.246 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 28.9 tptt -154.83 138.01 15.66 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.427 -0.796 . . . . 0.0 111.813 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.36 135.09 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.779 1.632 . . . . 0.0 108.167 169.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -84.65 138.51 32.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.453 0.701 . . . . 0.0 111.086 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 30.6 mm -119.59 134.6 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.176 1.39 . . . . 0.0 110.348 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -82.59 126.11 31.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.947 0.899 . . . . 0.0 111.043 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -75.67 -5.93 47.96 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -87.11 -24.1 24.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.387 1.075 . . . . 0.0 112.297 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 71.2 p -133.38 -13.24 2.69 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . 0.286 8.2 p30 59.35 11.7 2.31 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.521 2.328 . . . . 0.0 114.516 -169.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 85.2 mt -84.48 155.36 22.22 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.165 1.386 . . . . 0.0 111.149 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 58.0 m -76.75 136.75 39.03 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.943 0.897 . . . . 0.0 111.397 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.31 7.08 2.43 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.8 m 67.53 18.78 10.0 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.209 2.204 . . . . 0.0 113.439 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -144.35 155.34 43.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.205 0.911 . . . . 0.0 112.124 173.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.35 -176.04 28.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.945 1.736 . . . . 0.0 113.653 -170.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -141.47 142.43 33.63 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.437 1.895 . . . . 0.0 110.077 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.8 t -143.89 141.55 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.205 1.402 . . . . 0.0 108.88 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 75.5 m -137.48 144.25 42.16 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.431 -0.793 . . . . 0.0 112.296 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -112.93 166.1 11.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.313 1.445 . . . . 0.0 113.131 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.0 -19.5 62.51 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.423 1.089 . . . . 0.0 113.078 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -148.34 153.39 40.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.589 1.556 . . . . 0.0 111.476 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.5 -17.66 11.23 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.071 2.514 . . . . 0.0 114.027 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.1 t -72.37 -40.57 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.175 0.898 . . . . 0.0 110.395 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.3 m -62.97 -32.82 74.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.866 0.866 . . . . 0.0 111.719 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.79 -49.44 25.31 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.593 1.157 . . . . 0.0 112.017 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -59.14 -38.75 80.42 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.528 -0.733 . . . . 0.0 111.964 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.01 -28.41 64.4 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -80.14 -44.47 19.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 111.899 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 43.4 mt -57.94 -49.3 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.537 1.062 . . . . 0.0 110.372 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 -74.42 -11.52 60.26 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.4 m -101.1 -29.86 11.91 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.46 -18.64 12.81 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -169.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.01 109.24 3.87 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.925 0.784 . . . . 0.0 109.737 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.72 9.98 60.68 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.392 1.472 . . . . 0.0 114.966 -171.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -64.86 124.48 22.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.051 1.926 . . . . 0.0 111.145 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -79.25 131.05 36.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.095 0.558 . . . . 0.0 110.887 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.4 tt -149.28 133.39 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.809 1.244 . . . . 0.0 110.556 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.71 -102.34 0.62 Allowed Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -129.83 17.07 5.74 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.303 1.841 . . . . 0.0 112.219 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -146.15 -176.51 5.19 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.75 1.62 . . . . 0.0 113.014 -172.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -128.23 135.97 50.41 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.065 1.346 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 56.6 mt -70.99 162.88 28.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.176 1.39 . . . . 0.0 111.933 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -133.9 147.33 51.1 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.309 1.444 . . . . 0.0 109.327 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 29.6 t -139.21 137.81 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.647 1.179 . . . . 0.0 109.386 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -141.75 160.54 39.96 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.458 1.103 . . . . 0.0 111.191 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 69.9 mt -69.31 157.95 35.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.653 0.74 . . . . 0.0 111.18 168.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -53.12 123.63 12.25 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.539 1.136 . . . . 0.0 112.334 172.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -165.48 146.18 7.03 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.55 1.94 . . . . 0.0 110.083 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 13.3 t -158.3 167.96 28.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.093 1.357 . . . . 0.0 111.416 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -143.92 13.95 1.69 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.614 1.565 . . . . 0.0 112.842 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -154.68 141.6 19.19 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.841 1.257 . . . . 0.0 112.441 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -144.66 10.15 1.39 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.219 1.408 . . . . 0.0 113.045 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 22.8 t -165.87 147.74 7.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.631 1.572 . . . . 0.0 111.108 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -132.13 25.4 4.56 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.207 1.403 . . . . 0.0 112.453 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 12.5 t -152.17 159.15 43.66 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.665 1.586 . . . . 0.0 111.216 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 154.6 -153.08 24.55 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.871 1.224 . . . . 0.0 113.154 -174.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.71 -3.04 12.97 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.992 3.128 . . . . 0.0 113.908 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 74.0 m -143.11 156.29 44.77 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.755 1.622 . . . . 0.0 111.123 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 20.4 m 69.37 10.93 7.96 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.915 1.686 . . . . 0.0 114.857 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 C-N-CA 125.676 1.608 . . . . 0.0 113.556 176.927 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.567 0 N-CA-C 111.829 -0.509 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 16.7 m -65.22 -19.15 65.84 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -173.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 33.4 p -66.52 -10.39 44.27 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.002 1.321 . . . . 0.0 113.948 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -82.08 1.32 87.16 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.332 1.444 . . . . 0.0 114.306 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 66.3 m -131.54 152.79 50.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.482 1.513 . . . . 0.0 112.013 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 8.5 t -163.28 163.19 25.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.111 1.364 . . . . 0.0 111.312 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -86.13 176.69 48.88 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.97 1.271 . . . . 0.0 113.862 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.88 123.67 21.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.591 1.156 . . . . 0.0 110.614 177.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.0 t -72.63 -35.17 67.74 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.46 1.104 . . . . 0.0 113.76 -172.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -149.66 143.41 25.48 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.395 1.478 . . . . 0.0 109.858 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.78 21.17 12.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.69 1.196 . . . . 0.0 111.916 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 10.6 m -66.44 0.59 2.09 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.435 1.494 . . . . 0.0 114.83 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.27 -11.9 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.182 1.393 . . . . 0.0 112.956 169.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -96.51 16.05 61.71 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 126.556 2.027 . . . . 0.0 113.962 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -55.91 -39.16 71.21 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.983 1.313 . . . . 0.0 114.526 -175.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -66.27 117.54 8.69 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.494 1.118 . . . . 0.0 111.432 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.61 -7.47 77.42 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.75 1.643 . . . . 0.0 113.254 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.4 t -85.08 172.37 11.31 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.376 1.088 . . . . 0.0 112.186 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.07 31.98 2.93 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.101 1.361 . . . . 0.0 111.065 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -68.74 165.75 18.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.065 0.946 . . . . 0.0 112.528 169.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.63 156.77 45.11 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.25 -169.23 29.27 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 126.156 1.836 . . . . 0.0 113.246 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.14 175.28 7.79 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.086 3.19 . . . . 0.0 112.676 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.85 121.96 11.75 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.094 0.957 . . . . 0.0 111.44 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.88 -1.73 78.56 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.862 1.22 . . . . 0.0 114.659 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.41 6.76 46.98 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.957 1.378 . . . . 0.0 114.372 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -118.36 122.12 42.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.293 1.437 . . . . 0.0 111.08 -171.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.7 140.76 52.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.439 1.896 . . . . 0.0 112.343 -169.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -110.99 133.09 53.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.889 1.676 . . . . 0.0 108.801 168.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.29 135.1 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.946 1.698 . . . . 0.0 107.884 -171.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -132.98 156.78 46.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.933 1.293 . . . . 0.0 112.585 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 74.55 27.9 1.31 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.732 2.413 . . . . 0.0 113.849 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.2 mt -64.96 157.29 76.76 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.103 1.361 . . . . 0.0 112.057 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.81 152.56 34.86 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.388 2.725 . . . . 0.0 112.126 169.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -67.21 -29.33 68.96 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.9 -9.79 56.35 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.01 129.2 39.2 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.9 1.28 . . . . 0.0 111.793 -175.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -113.74 -174.28 18.73 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.312 1.434 . . . . 0.0 113.314 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.25 -34.7 78.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.077 0.951 . . . . 0.0 112.991 -174.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -76.77 -31.56 57.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.893 0.877 . . . . 0.0 111.782 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -67.66 -41.59 83.53 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.705 0.684 . . . . 0.0 110.649 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 23.3 tp -65.59 -41.09 93.23 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.334 0.654 . . . . 0.0 111.562 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.26 -51.69 67.86 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.661 0.664 . . . . 0.0 111.37 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -63.72 -28.04 69.61 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.8 ttp -81.4 -20.39 40.56 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -109.61 -19.78 13.08 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 51.5 mtm -54.8 -31.85 10.46 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -57.34 -16.78 23.98 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.616 2.877 . . . . 0.0 116.273 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -97.71 -8.79 27.92 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.406 1.003 . . . . 0.0 113.636 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.18 -162.92 28.16 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.089 1.328 . . . . 0.0 114.67 170.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -71.03 95.01 1.15 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.437 1.095 . . . . 0.0 111.842 -173.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.1 t -73.43 129.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.027 1.331 . . . . 0.0 109.733 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 35.7 t -94.56 -33.78 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.16 2.184 . . . . 0.0 111.505 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.3 t -155.22 150.45 27.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.462 1.105 . . . . 0.0 110.836 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.29 14.86 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.178 1.391 . . . . 0.0 109.915 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -151.58 138.74 19.23 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.466 -0.771 . . . . 0.0 111.705 -168.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 85.8 t -119.32 126.99 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.534 1.534 . . . . 0.0 107.468 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -81.02 144.23 31.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.361 0.664 . . . . 0.0 111.308 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 39.4 mm -120.1 135.75 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.215 1.406 . . . . 0.0 110.362 -169.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.72 128.15 33.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.396 1.078 . . . . 0.0 111.739 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -72.68 -9.0 58.11 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -99.52 -15.46 18.65 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.229 1.012 . . . . 0.0 113.133 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 70.0 p -128.64 -19.62 3.71 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.623 1.169 . . . . 0.0 113.957 -177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 66.15 18.65 11.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.558 1.943 . . . . 0.0 112.924 -172.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 85.3 mt -101.78 156.25 17.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.348 1.459 . . . . 0.0 111.612 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 50.0 m -64.3 139.47 58.77 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.035 0.934 . . . . 0.0 112.633 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.74 2.51 19.46 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 76.3 m 65.63 22.8 11.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.912 2.085 . . . . 0.0 113.396 -172.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -146.14 155.57 42.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.004 0.922 . . . . 0.0 111.68 171.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.05 -173.43 24.63 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.749 1.643 . . . . 0.0 113.918 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -139.79 146.24 39.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.304 1.842 . . . . 0.0 110.243 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 58.1 t -143.61 138.58 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.115 1.366 . . . . 0.0 109.006 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 85.6 p -130.71 152.69 49.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.911 0.885 . . . . 0.0 112.358 175.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.73 161.86 26.36 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.933 1.293 . . . . 0.0 113.504 -174.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.65 -18.37 64.27 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.72 1.208 . . . . 0.0 112.885 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -146.16 151.24 44.08 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 125.596 1.559 . . . . 0.0 112.05 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.26 -28.16 55.66 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.035 3.157 . . . . 0.0 114.035 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.7 t -74.43 -38.46 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.958 0.903 . . . . 0.0 110.828 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 8.2 m -63.9 -31.79 73.1 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.916 0.886 . . . . 0.0 111.82 171.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.91 -48.58 29.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.403 1.081 . . . . 0.0 111.926 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -59.05 -38.97 80.62 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.383 -0.823 . . . . 0.0 111.879 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -58.75 -27.33 64.84 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -79.9 -44.65 20.01 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.458 171.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.56 -49.4 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.871 1.214 . . . . 0.0 110.618 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -73.87 -11.21 60.3 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.6 m -102.1 -27.71 12.76 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.5 mmm -112.47 -20.63 11.7 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -168.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.29 110.1 5.06 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.197 0.908 . . . . 0.0 109.84 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.31 1.85 62.34 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.533 1.539 . . . . 0.0 115.028 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -62.63 125.79 25.15 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.54 1.67 . . . . 0.0 111.866 -178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -79.72 125.96 30.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.592 0.757 . . . . 0.0 110.075 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt -148.18 134.27 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.058 1.343 . . . . 0.0 109.811 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.53 -120.62 23.59 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -171.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 25.0 ptp -106.87 13.42 27.79 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.675 1.59 . . . . 0.0 113.773 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -142.91 -172.75 3.73 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.217 1.407 . . . . 0.0 113.339 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -129.48 141.63 50.96 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.59 1.556 . . . . 0.0 111.403 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 75.8 mt -76.79 162.9 27.28 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.149 1.38 . . . . 0.0 112.652 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -131.51 141.91 49.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.758 1.623 . . . . 0.0 109.678 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.75 138.1 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.735 1.214 . . . . 0.0 109.392 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -147.76 142.53 26.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.815 1.246 . . . . 0.0 110.597 -169.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 41.1 mt -65.8 151.41 46.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.011 0.925 . . . . 0.0 112.308 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -52.22 119.36 4.31 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.303 1.041 . . . . 0.0 111.329 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -73.1 144.04 47.15 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.618 1.167 . . . . 0.0 113.405 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 74.0 p -167.63 157.55 10.49 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.787 2.035 . . . . 0.0 110.482 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -77.01 132.87 39.19 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.274 -0.891 . . . . 0.0 111.842 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -157.88 40.37 0.28 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.136 1.775 . . . . 0.0 109.635 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -166.5 159.14 14.15 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.348 1.859 . . . . 0.0 111.813 -166.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 6.7 t -154.47 17.13 0.47 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.705 1.202 . . . . 0.0 112.71 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -163.64 178.08 8.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.561 1.945 . . . . 0.0 112.004 -173.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.6 t -154.92 168.43 26.99 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.031 1.332 . . . . 0.0 111.331 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -159.5 -178.8 33.83 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 125.317 1.437 . . . . 0.0 114.087 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.81 155.21 53.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.087 3.191 . . . . 0.0 111.999 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 91.6 p -163.47 166.9 22.2 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.508 1.523 . . . . 0.0 111.839 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 59.1 p -161.93 157.44 23.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.888 1.275 . . . . 0.0 112.191 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 C-N-CA 124.937 1.256 . . . . 0.0 112.84 -179.461 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.546 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 39.7 m -149.71 153.13 36.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.024 1.33 . . . . 0.0 111.348 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.0 t -163.3 179.49 7.34 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.371 1.469 . . . . 0.0 111.284 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 100.17 -160.55 19.25 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.808 1.671 . . . . 0.0 113.218 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 15.5 t -161.4 164.42 29.93 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.175 1.39 . . . . 0.0 111.544 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 21.7 m -82.66 -3.94 57.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.932 1.293 . . . . 0.0 114.343 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 83.07 -143.55 22.15 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.688 1.137 . . . . 0.0 112.614 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 99.0 mt -138.75 151.87 47.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.887 1.675 . . . . 0.0 111.197 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 32.7 m -66.45 137.84 57.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.589 1.555 . . . . 0.0 110.337 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -144.68 154.11 42.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.237 1.415 . . . . 0.0 110.923 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -81.97 12.74 3.83 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.12 1.368 . . . . 0.0 112.875 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 8.5 p -76.29 59.77 1.44 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.523 1.929 . . . . 0.0 112.106 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -41.21 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.029 -1.044 . . . . 0.0 113.383 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 55.3 -110.12 1.65 Allowed Glycine 0 CA--C 1.534 1.241 0 CA-C-N 119.268 0.94 . . . . 0.0 112.176 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -84.7 -11.32 56.1 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.694 1.598 . . . . 0.0 114.667 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -69.37 122.99 20.05 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.012 1.325 . . . . 0.0 110.606 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.34 79.29 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.283 0.944 . . . . 0.0 113.086 -175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 10.1 t -75.61 162.68 28.06 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.25 1.025 . . . . 0.0 111.88 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -134.79 20.21 3.53 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.169 1.388 . . . . 0.0 111.224 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -66.83 173.67 3.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.133 0.973 . . . . 0.0 111.484 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.47 167.1 29.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 167.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -94.81 -167.14 36.2 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.113 1.34 . . . . 0.0 113.638 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.6 171.06 13.78 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.358 2.705 . . . . 0.0 111.521 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.94 123.27 15.24 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.641 0.777 . . . . 0.0 111.259 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.79 -9.66 70.76 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.725 1.155 . . . . 0.0 114.276 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.07 -6.25 54.06 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.895 1.347 . . . . 0.0 113.686 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.3 118.54 36.2 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.282 2.233 . . . . 0.0 111.404 -174.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 22.0 mt -119.68 136.63 54.33 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.386 1.875 . . . . 0.0 111.989 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -109.69 131.99 54.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.451 1.5 . . . . 0.0 108.796 168.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.56 135.33 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.938 1.695 . . . . 0.0 107.951 -171.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -131.42 160.4 35.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.247 1.419 . . . . 0.0 112.687 -175.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 68.27 28.26 6.39 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.496 2.318 . . . . 0.0 113.601 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 52.9 mt -65.69 155.24 86.65 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.491 1.116 . . . . 0.0 111.727 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.21 143.19 94.13 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.047 2.498 . . . . 0.0 112.575 172.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -62.69 -6.9 3.98 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.791 2.036 . . . . 0.0 114.845 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -113.14 -9.04 13.55 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.58 1.952 . . . . 0.0 114.241 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.44 134.03 47.41 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.635 1.174 . . . . 0.0 112.287 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -112.42 -172.7 18.9 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.663 1.601 . . . . 0.0 112.447 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -63.53 -34.66 78.27 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -172.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -77.09 -28.31 54.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.145 0.578 . . . . 0.0 112.448 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -69.95 -41.79 74.08 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.586 0.63 . . . . 0.0 110.796 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 31.8 tp -65.56 -37.6 87.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.491 0.716 . . . . 0.0 111.811 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.72 -50.4 67.07 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.709 0.686 . . . . 0.0 111.462 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -63.42 -26.33 68.69 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.409 0.684 . . . . 0.0 112.551 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 48.1 ttm -73.95 -28.79 61.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.169 0.988 . . . . 0.0 113.373 173.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -109.84 -18.52 13.39 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.6 mtm -56.16 -32.61 13.51 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -57.63 -16.23 23.63 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.578 2.852 . . . . 0.0 116.165 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -100.28 -9.7 22.08 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.7 -163.35 28.55 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.087 1.327 . . . . 0.0 114.957 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -70.37 99.82 1.64 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.335 1.054 . . . . 0.0 112.542 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 85.5 t -79.35 128.54 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.163 1.385 . . . . 0.0 110.038 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 56.0 t -98.97 -24.33 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.568 2.347 . . . . 0.0 111.787 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 9.4 t -156.98 144.27 18.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.762 1.225 . . . . 0.0 110.711 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -151.36 130.3 12.52 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.158 1.383 . . . . 0.0 110.89 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -156.11 132.85 10.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.578 0.751 . . . . 0.0 112.657 -174.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 64.8 t -102.12 134.71 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.683 1.593 . . . . 0.0 106.943 167.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.83 140.75 30.95 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.293 0.637 . . . . 0.0 110.423 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 17.1 mt -131.05 136.21 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.776 1.23 . . . . 0.0 110.541 -169.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.3 133.51 45.04 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.355 1.462 . . . . 0.0 112.233 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -82.1 -1.94 50.35 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -172.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -109.54 -19.17 13.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.55 1.14 . . . . 0.0 112.716 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.9 p -126.29 -17.7 5.13 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.434 1.494 . . . . 0.0 114.079 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 64.16 18.91 11.53 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.253 1.821 . . . . 0.0 113.197 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 86.7 mt -91.79 145.48 24.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.603 1.561 . . . . 0.0 110.587 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 88.6 p -61.92 144.61 54.75 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.247 1.022 . . . . 0.0 112.244 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -81.2 6.81 12.84 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.9 m 63.82 21.32 12.61 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.017 2.127 . . . . 0.0 113.119 -170.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.84 155.14 43.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.109 0.868 . . . . 0.0 112.4 173.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.56 179.83 31.22 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.926 1.727 . . . . 0.0 113.513 -170.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -137.04 142.22 42.46 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.549 1.94 . . . . 0.0 110.228 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 84.8 t -141.7 142.98 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.137 1.375 . . . . 0.0 108.608 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 18.3 m -136.86 148.81 47.31 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -115.35 171.59 7.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.546 1.539 . . . . 0.0 113.165 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.49 -23.71 66.09 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.42 1.488 . . . . 0.0 113.427 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -161.33 161.13 23.65 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.199 1.4 . . . . 0.0 112.104 -172.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.08 -13.77 34.27 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.504 2.136 . . . . 0.0 114.082 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.34 -46.01 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 121.043 1.747 . . . . 0.0 110.608 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 45.6 m -65.93 -30.66 71.28 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.312 1.045 . . . . 0.0 111.924 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.37 -48.4 28.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.04 0.936 . . . . 0.0 111.981 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -61.68 -32.29 72.46 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.523 -0.736 . . . . 0.0 112.094 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.71 71.76 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.46 -42.95 41.96 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.564 0.746 . . . . 0.0 111.732 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 42.7 mt -58.42 -46.67 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 118.798 0.727 . . . . 0.0 110.274 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.48 -12.52 61.43 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 66.6 m -103.54 -29.85 10.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 87.6 mmm -114.29 -18.71 11.52 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -168.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -70.87 111.48 6.32 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.42 1.009 . . . . 0.0 110.191 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.24 0.53 63.23 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.719 1.628 . . . . 0.0 114.953 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.12 122.74 16.85 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.403 1.601 . . . . 0.0 111.251 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -75.64 131.95 40.27 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 110.631 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.0 tt -139.55 106.81 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.011 1.324 . . . . 0.0 108.757 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 67.23 -124.32 22.41 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -169.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 25.5 mmt -99.62 13.57 33.05 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.428 1.491 . . . . 0.0 113.371 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -140.58 170.59 15.5 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.676 1.59 . . . . 0.0 112.717 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -121.22 134.69 55.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.004 1.322 . . . . 0.0 111.282 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.47 155.58 37.17 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.051 1.341 . . . . 0.0 111.547 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -130.3 141.9 50.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.935 1.294 . . . . 0.0 109.143 168.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.4 t -139.0 132.95 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.454 1.102 . . . . 0.0 109.169 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -143.85 154.95 43.91 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.514 1.126 . . . . 0.0 111.232 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 60.4 mt -66.95 160.12 27.02 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.527 0.731 . . . . 0.0 112.722 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -71.61 71.53 0.71 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.102 1.361 . . . . 0.0 110.388 167.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -165.16 146.99 7.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.94 1.696 . . . . 0.0 111.366 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 49.7 m 68.03 78.42 0.23 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.368 1.867 . . . . 0.0 113.164 172.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -65.71 -27.84 68.62 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -162.16 145.64 11.88 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.676 1.59 . . . . 0.0 111.346 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -130.92 3.12 4.4 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.103 1.761 . . . . 0.0 112.716 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 58.5 m -111.6 27.76 9.37 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.945 1.698 . . . . 0.0 112.27 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -56.79 -29.38 62.62 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.209 1.404 . . . . 0.0 113.768 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 37.2 m -106.65 16.97 23.88 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.607 1.563 . . . . 0.0 112.486 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 96.78 170.58 34.13 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.009 1.766 . . . . 0.0 112.324 -169.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.88 142.81 35.74 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.628 2.885 . . . . 0.0 110.952 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 65.6 m -100.77 3.25 41.99 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.112 0.965 . . . . 0.0 113.546 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 67.4 m -146.59 149.76 34.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.919 1.688 . . . . 0.0 111.477 -174.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.311 -1.271 . . . . 0.0 112.789 179.38 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . 0.516 ' N ' ' HG ' ' A' ' 381' ' ' SER . . . . . . . . 0 N--CA 1.48 1.603 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 30.6 m 70.13 -34.23 0.28 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 127.92 2.488 . . . . 0.0 114.91 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 72.4 m -142.1 143.68 33.16 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.12 2.168 . . . . 0.0 109.782 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 71.78 -129.73 16.48 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.633 0.635 . . . . 0.0 111.734 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 77.5 p -159.31 155.74 27.39 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.293 1.437 . . . . 0.0 111.57 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.516 ' HG ' ' N ' ' A' ' 376' ' ' GLY . 28.6 p -164.57 138.15 5.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.477 1.111 . . . . 0.0 112.041 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -107.11 171.82 17.23 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.413 1.482 . . . . 0.0 112.995 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 90.8 mt -142.29 134.77 27.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.671 1.589 . . . . 0.0 110.627 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 18.8 p -70.71 136.97 49.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.344 1.458 . . . . 0.0 110.467 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -141.36 143.03 33.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.993 1.317 . . . . 0.0 110.408 -169.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.36 25.07 0.41 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.067 1.347 . . . . 0.0 112.029 -171.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 32.9 p -90.67 14.18 14.06 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.829 1.652 . . . . 0.0 114.401 -169.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.87 143.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.866 1.266 . . . . 0.0 112.818 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -86.95 120.61 5.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.135 0.874 . . . . 0.0 113.031 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.83 -51.5 0.39 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.045 2.938 . . . . 0.0 116.46 169.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.4 115.29 5.51 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.912 1.285 . . . . 0.0 110.481 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 94.88 -5.45 69.14 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.992 1.282 . . . . 0.0 113.442 -175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 36.2 t -79.7 143.55 34.48 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.574 1.187 . . . . 0.0 111.341 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -118.93 15.25 13.38 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.852 1.261 . . . . 0.0 111.755 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -66.33 173.64 3.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.807 0.843 . . . . 0.0 111.655 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -153.43 160.34 42.57 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.6 -161.62 29.03 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 128.243 2.83 . . . . 0.0 113.365 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 169.01 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.68 2.92 . . . . 0.0 112.49 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -59.36 127.09 30.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.41 0.684 . . . . 0.0 111.145 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.36 -11.18 70.68 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.92 1.248 . . . . 0.0 114.01 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.86 -4.49 46.9 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.722 1.261 . . . . 0.0 114.118 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -108.29 118.21 36.18 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.118 1.367 . . . . 0.0 110.93 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.7 mt -120.19 132.0 55.21 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.175 1.79 . . . . 0.0 111.861 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -103.04 133.2 48.56 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.785 1.234 . . . . 0.0 108.557 167.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 8.3 mm -118.16 135.65 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.771 1.629 . . . . 0.0 108.26 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -133.93 160.45 37.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.574 1.15 . . . . 0.0 112.308 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 62.62 33.94 15.36 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.477 1.911 . . . . 0.0 113.282 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 45.2 mt -70.03 164.68 50.07 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.659 1.584 . . . . 0.0 111.455 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.03 141.47 94.36 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.702 2.268 . . . . 0.0 110.888 168.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -67.86 -8.29 35.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.959 1.304 . . . . 0.0 113.962 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.52 -9.2 16.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.424 1.889 . . . . 0.0 114.144 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.3 130.85 43.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.138 1.375 . . . . 0.0 111.643 -175.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -101.96 -179.63 27.69 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.367 0.984 . . . . 0.0 113.582 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.15 -33.69 74.98 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.149 0.98 . . . . 0.0 112.326 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -73.56 -40.81 63.65 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.989 1.716 . . . . 0.0 110.917 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -64.77 -41.38 95.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.708 0.803 . . . . 0.0 111.351 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.0 tp -67.0 -37.7 84.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.277 0.631 . . . . 0.0 111.858 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.63 -49.88 73.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.758 0.708 . . . . 0.0 110.943 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -63.39 -27.56 69.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.608 0.763 . . . . 0.0 112.851 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.5 ttm -72.45 -32.06 65.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.231 1.012 . . . . 0.0 113.051 173.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -107.38 -18.49 13.85 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -171.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 44.4 mtm -55.61 -33.49 18.09 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -57.77 -16.72 26.44 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.556 2.837 . . . . 0.0 115.992 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -99.23 -10.85 21.89 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.47 -154.36 25.88 Favored Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.411 1.005 . . . . 0.0 115.494 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -74.49 82.46 1.97 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.528 1.131 . . . . 0.0 112.962 -169.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.46 128.39 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.551 1.14 . . . . 0.0 109.951 172.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 73.5 t -94.13 -37.77 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.801 2.04 . . . . 0.0 110.85 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 63.3 m -151.29 146.01 25.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.859 1.263 . . . . 0.0 110.807 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.53 134.66 14.96 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.247 1.419 . . . . 0.0 110.402 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -155.6 136.26 13.42 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.692 0.797 . . . . 0.0 111.839 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.17 134.78 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.922 1.689 . . . . 0.0 107.734 169.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -82.17 136.54 35.12 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.033 0.533 . . . . 0.0 110.925 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 30.7 mm -119.68 137.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.285 1.434 . . . . 0.0 110.51 -169.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -73.24 131.27 41.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.783 1.233 . . . . 0.0 112.127 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -75.04 -13.57 60.51 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -104.07 -28.32 11.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.294 1.038 . . . . 0.0 112.642 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 77.8 p -117.3 -15.55 10.38 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.255 1.422 . . . . 0.0 114.057 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 25.1 m120 63.76 15.53 9.09 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.124 1.77 . . . . 0.0 113.495 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.74 154.6 21.5 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.421 1.488 . . . . 0.0 110.979 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 51.0 m -80.87 134.13 35.7 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.492 -0.755 . . . . 0.0 111.16 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.58 5.79 2.83 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -173.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.1 m 67.33 20.49 10.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.387 2.275 . . . . 0.0 113.061 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -145.02 156.18 43.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.854 0.862 . . . . 0.0 111.711 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.0 -174.86 28.26 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.906 1.717 . . . . 0.0 113.736 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -142.06 144.25 33.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.181 1.792 . . . . 0.0 110.196 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 98.8 t -141.97 142.72 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.499 1.519 . . . . 0.0 108.482 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 37.9 t -139.98 142.44 36.31 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.567 -0.708 . . . . 0.0 112.106 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.69 168.2 9.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.808 1.643 . . . . 0.0 113.422 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.17 -22.89 66.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.616 1.567 . . . . 0.0 113.282 170.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -160.07 157.69 25.47 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.232 1.413 . . . . 0.0 112.19 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.25 -15.65 39.16 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.629 2.219 . . . . 0.0 113.794 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.52 -43.72 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.53 1.514 . . . . 0.0 110.535 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.4 m -68.7 -31.26 70.22 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 112.072 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -75.84 -47.43 25.62 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.808 0.843 . . . . 0.0 112.474 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -62.47 -31.32 72.04 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.5 -0.75 . . . . 0.0 111.981 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.44 -30.92 71.95 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.312 0.645 . . . . 0.0 112.632 172.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.46 -42.59 43.24 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.447 0.699 . . . . 0.0 111.879 175.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.52 -46.08 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 118.738 0.699 . . . . 0.0 110.065 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -72.16 -12.46 61.19 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.6 m -104.02 -30.95 9.95 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.7 mmm -111.86 -18.04 12.78 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -70.06 112.1 6.2 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.429 1.013 . . . . 0.0 110.755 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.87 71.5 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.038 1.78 . . . . 0.0 114.94 -173.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -61.47 124.07 19.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.189 1.495 . . . . 0.0 111.331 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -78.39 131.0 36.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.215 0.531 . . . . 0.0 110.42 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.9 tt -136.7 104.84 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.027 1.331 . . . . 0.0 108.493 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.68 -121.52 20.03 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.1 mmt -99.87 9.95 42.12 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.418 1.487 . . . . 0.0 113.89 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -133.04 164.86 26.07 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.234 1.413 . . . . 0.0 112.557 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -120.83 131.89 54.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.743 1.217 . . . . 0.0 111.122 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.96 158.86 24.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.211 1.404 . . . . 0.0 112.224 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -136.85 141.99 42.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.069 1.348 . . . . 0.0 109.063 167.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.7 t -138.29 136.73 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.421 1.089 . . . . 0.0 108.95 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -149.13 151.28 34.11 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.774 0.83 . . . . 0.0 110.829 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.7 mt -60.24 156.65 15.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.931 0.872 . . . . 0.0 112.805 170.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -62.19 -23.28 66.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.359 1.064 . . . . 0.0 113.175 169.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -139.05 117.58 12.12 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.904 1.681 . . . . 0.0 110.719 -173.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 45.7 m -154.17 128.79 9.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.459 1.504 . . . . 0.0 110.011 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -144.24 146.04 32.42 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.481 1.512 . . . . 0.0 110.897 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -130.5 -7.2 4.17 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 23.6 t70 68.73 -42.91 0.49 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 129.101 2.96 . . . . 0.0 114.964 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 73.3 p -92.19 -6.73 50.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.576 1.55 . . . . 0.0 113.881 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -162.18 163.22 28.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.853 1.661 . . . . 0.0 112.811 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 24.6 p -85.17 157.88 20.53 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.307 1.443 . . . . 0.0 112.95 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -83.06 173.03 51.95 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.422 1.011 . . . . 0.0 113.574 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.86 151.61 40.48 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.07 3.18 . . . . 0.0 111.811 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 78.9 p -162.62 169.04 20.81 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.018 1.327 . . . . 0.0 112.09 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 10.5 m -151.94 150.62 30.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.8 1.64 . . . . 0.0 110.783 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.222 -1.321 . . . . 0.0 112.936 179.427 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 89.5 p -164.33 177.3 8.38 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.601 1.56 . . . . 0.0 111.429 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.1 m -74.09 -7.41 52.44 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -89.96 141.62 16.11 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.076 1.322 . . . . 0.0 112.596 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 74.3 p -92.06 -14.15 29.76 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 42.9 m 65.15 5.37 2.99 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.923 2.089 . . . . 0.0 114.949 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -80.57 127.65 8.04 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.687 1.137 . . . . 0.0 112.317 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 92.3 mt -146.87 145.25 29.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.586 1.954 . . . . 0.0 110.009 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 85.0 m -142.7 130.17 21.22 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.689 1.595 . . . . 0.0 109.542 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -161.39 131.13 4.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.788 1.635 . . . . 0.0 108.732 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -112.61 -3.47 14.32 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 23.6 m -66.64 -13.74 61.56 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.793 -1.192 . . . . 0.0 114.193 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 1.8 pp -66.02 -4.13 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.482 2.313 . . . . 0.0 114.897 -171.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -69.96 -22.32 77.07 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.864 169.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -166.19 -47.05 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -73.79 111.97 9.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.474 1.109 . . . . 0.0 111.999 -170.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.86 -3.71 84.82 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.613 1.577 . . . . 0.0 112.911 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.8 m -78.01 163.68 25.73 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.0 1.32 . . . . 0.0 111.991 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -125.26 33.12 5.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.746 1.218 . . . . 0.0 110.657 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -69.4 171.59 8.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.83 1.252 . . . . 0.0 110.74 168.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -158.83 165.41 34.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.474 0.709 . . . . 0.0 112.903 168.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -102.57 -165.23 26.29 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 126.074 1.797 . . . . 0.0 113.876 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.73 179.74 5.69 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.259 3.306 . . . . 0.0 112.702 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -54.63 124.3 15.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.538 1.135 . . . . 0.0 111.738 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.84 -6.32 83.64 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.775 1.179 . . . . 0.0 114.547 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.62 -3.15 55.44 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.765 1.283 . . . . 0.0 114.362 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -115.39 128.36 56.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.343 1.057 . . . . 0.0 111.005 -169.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 23.0 mt -126.01 143.1 51.23 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.041 2.136 . . . . 0.0 112.483 -168.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -110.65 135.59 51.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.693 1.597 . . . . 0.0 108.499 167.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.66 135.56 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.707 1.603 . . . . 0.0 107.905 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -131.84 160.59 35.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.872 1.269 . . . . 0.0 112.771 -176.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 69.76 27.74 4.55 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.732 2.413 . . . . 0.0 113.858 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.7 mt -66.59 158.52 78.69 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 124.916 1.286 . . . . 0.0 112.133 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.24 147.26 96.08 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.972 2.448 . . . . 0.0 111.299 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -70.97 -9.06 57.24 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.25 -8.29 17.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.505 1.922 . . . . 0.0 114.035 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.8 124.79 24.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.869 1.268 . . . . 0.0 110.741 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.23 -173.97 24.25 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.54 1.067 . . . . 0.0 113.914 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -70.07 -35.22 74.06 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -172.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -74.95 -28.64 60.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.477 0.711 . . . . 0.0 111.641 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -70.39 -43.14 70.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.236 0.614 . . . . 0.0 110.698 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.18 -35.81 80.46 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.069 0.548 . . . . 0.0 111.764 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.7 tp -62.07 -51.01 69.7 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.84 0.746 . . . . 0.0 110.913 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -68.07 -22.81 64.91 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.4 ttm -73.93 -28.76 61.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.316 1.046 . . . . 0.0 112.888 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -109.86 -17.85 13.54 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.6 mtm -54.28 -33.62 17.07 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 170.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -58.95 -15.94 29.81 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.569 2.846 . . . . 0.0 116.229 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -101.48 -9.3 21.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.59 -158.93 27.88 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.831 1.205 . . . . 0.0 114.884 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -75.0 94.42 2.85 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.084 0.954 . . . . 0.0 112.172 -170.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 96.2 t -74.27 131.48 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.972 1.309 . . . . 0.0 110.445 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 34.1 t -106.75 -20.9 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 128.082 2.553 . . . . 0.0 112.06 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.8 t -160.26 148.3 16.62 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.659 1.184 . . . . 0.0 110.657 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -159.91 124.46 3.86 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.143 1.377 . . . . 0.0 110.573 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -155.16 146.78 23.16 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.129 -0.982 . . . . 0.0 112.695 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 23.9 t -119.42 131.03 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.036 1.734 . . . . 0.0 107.763 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -81.87 137.07 35.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.111 0.564 . . . . 0.0 110.54 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 53.9 mt -130.39 141.07 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.59 1.556 . . . . 0.0 109.764 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -84.54 126.35 33.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.438 0.695 . . . . 0.0 111.27 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.78 -16.44 61.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -83.35 -19.98 35.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.227 1.011 . . . . 0.0 112.995 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.0 p -133.53 -19.54 2.12 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 57.4 t30 62.9 17.84 10.32 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.19 1.796 . . . . 0.0 112.989 -171.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 94.2 mt -94.12 145.55 24.61 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.106 1.362 . . . . 0.0 111.055 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 66.4 m -72.22 133.57 45.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.094 0.958 . . . . 0.0 112.024 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -74.07 9.86 1.43 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.567 1.547 . . . . 0.0 114.522 -174.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 57.0 m 68.47 19.11 8.88 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.441 2.296 . . . . 0.0 113.69 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -145.56 154.34 42.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.453 1.024 . . . . 0.0 112.534 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.2 -176.1 27.01 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.282 1.896 . . . . 0.0 113.509 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -143.49 143.65 31.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.354 1.862 . . . . 0.0 110.068 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 80.7 t -142.53 147.48 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.442 1.497 . . . . 0.0 108.815 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.1 m -139.92 152.18 46.18 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.668 0.787 . . . . 0.0 112.003 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -121.24 169.02 10.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.535 1.534 . . . . 0.0 113.126 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.71 -22.53 65.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.081 1.353 . . . . 0.0 113.356 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -160.7 158.07 24.29 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.304 1.441 . . . . 0.0 112.306 -171.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.24 -16.04 43.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.656 2.238 . . . . 0.0 113.969 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.27 -44.31 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.595 1.543 . . . . 0.0 110.569 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.7 m -68.58 -31.47 70.68 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.01 0.924 . . . . 0.0 111.91 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.22 -48.47 34.75 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.931 0.892 . . . . 0.0 112.071 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -62.59 -32.89 73.96 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.436 -0.79 . . . . 0.0 111.882 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.65 -29.42 70.42 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.88 -42.3 33.84 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.525 0.73 . . . . 0.0 111.439 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.7 mt -58.5 -46.32 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 118.859 0.754 . . . . 0.0 110.201 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -71.18 -13.02 61.79 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.4 m -104.17 -27.78 11.85 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.5 mmm -115.34 -19.23 10.81 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -169.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -70.93 109.96 5.37 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.177 0.899 . . . . 0.0 109.903 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 97.18 2.36 59.2 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.619 1.58 . . . . 0.0 114.978 -171.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -62.04 125.06 22.55 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.574 1.687 . . . . 0.0 111.699 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -80.73 129.98 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.387 0.675 . . . . 0.0 110.965 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt -149.51 133.93 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.866 1.266 . . . . 0.0 110.492 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.87 -99.46 0.42 Allowed Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.722 0.677 . . . . 0.0 111.574 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 89.9 mtp -133.88 18.86 3.82 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.469 1.907 . . . . 0.0 112.287 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -146.27 -176.6 5.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.703 1.601 . . . . 0.0 112.783 -171.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.42 138.05 52.88 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.01 1.324 . . . . 0.0 111.582 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 69.1 mt -72.29 159.43 34.06 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.177 1.391 . . . . 0.0 111.992 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -129.17 141.92 51.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.178 1.391 . . . . 0.0 109.24 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 25.2 t -139.46 135.56 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.587 1.155 . . . . 0.0 109.144 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -155.97 151.06 26.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.195 0.598 . . . . 0.0 111.938 -172.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.04 152.41 40.34 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -63.07 -16.67 60.7 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.799 1.239 . . . . 0.0 113.104 169.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 29.7 ttt85 -58.71 -39.09 79.79 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.09 -1.007 . . . . 0.0 111.619 171.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 15.0 m -73.12 -10.87 60.24 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -84.35 -8.38 59.02 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.048 1.339 . . . . 0.0 112.313 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -135.01 -12.19 2.21 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.533 1.533 . . . . 0.0 114.563 -170.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -157.41 163.02 38.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.741 2.017 . . . . 0.0 110.459 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.8 p -153.07 -0.39 0.25 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -66.38 142.48 57.6 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.792 -1.192 . . . . 0.0 112.713 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.5 t -166.8 169.14 13.59 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.251 1.421 . . . . 0.0 111.444 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -164.83 167.08 38.4 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.429 1.49 . . . . 0.0 113.529 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.51 154.1 44.8 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.959 3.106 . . . . 0.0 111.669 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 34.8 p -84.33 -4.42 58.86 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.647 1.179 . . . . 0.0 114.107 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 67.6 m -147.83 149.54 32.51 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.381 1.872 . . . . 0.0 111.207 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 CA-C-O 118.253 -1.304 . . . . 0.0 112.926 178.826 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 36.7 p -70.3 -15.33 62.88 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.9 p -81.03 -1.36 43.7 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.958 1.703 . . . . 0.0 113.883 170.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.55 -168.17 18.3 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.91 1.719 . . . . 0.0 113.416 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 18.4 m -168.98 164.35 11.46 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.714 2.405 . . . . 0.0 110.37 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 15.1 m -72.96 -8.63 56.55 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 65.87 10.99 53.14 Favored Glycine 0 N--CA 1.476 1.321 0 C-N-CA 125.229 1.395 . . . . 0.0 115.79 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 7.7 mp 63.23 15.1 8.33 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 127.024 2.13 . . . . 0.0 112.246 -169.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 42.1 m -76.18 -35.96 58.89 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.108 1.363 . . . . 0.0 111.951 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -83.65 75.21 10.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.946 0.899 . . . . 0.0 110.557 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -128.62 11.66 6.26 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.138 1.375 . . . . 0.0 112.407 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 66.2 p -148.97 137.1 20.83 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.021 1.728 . . . . 0.0 109.288 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.95 149.67 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.107 1.363 . . . . 0.0 111.63 -168.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -80.72 61.37 4.51 Favored Glycine 0 N--CA 1.471 1.001 0 C-N-CA 124.894 1.235 . . . . 0.0 112.222 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.98 -40.36 0.45 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 129.033 2.933 . . . . 0.0 114.487 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -69.53 124.08 22.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.511 1.525 . . . . 0.0 111.287 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.65 6.48 70.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.747 1.641 . . . . 0.0 113.256 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.3 t -80.02 163.47 24.19 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.391 1.076 . . . . 0.0 113.224 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -126.99 8.73 6.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.917 1.287 . . . . 0.0 112.243 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -68.3 166.8 15.74 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.342 -0.849 . . . . 0.0 111.966 168.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.01 165.85 34.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.319 1.048 . . . . 0.0 112.267 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.63 -161.41 25.01 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 126.007 1.765 . . . . 0.0 113.976 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.26 177.64 8.01 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.098 3.199 . . . . 0.0 112.749 -174.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.9 126.83 28.8 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.107 0.963 . . . . 0.0 111.408 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.02 -7.27 82.59 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.042 1.306 . . . . 0.0 114.463 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.59 -2.11 45.55 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -114.8 122.22 45.68 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.27 1.028 . . . . 0.0 110.775 -168.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.7 mt -121.92 138.22 54.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.39 1.876 . . . . 0.0 111.971 -168.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -108.85 135.01 50.76 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.099 1.359 . . . . 0.0 108.834 167.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.95 135.31 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.978 1.711 . . . . 0.0 107.833 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -133.56 159.34 40.74 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.783 1.233 . . . . 0.0 112.434 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 68.5 30.58 5.19 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.218 2.207 . . . . 0.0 113.234 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.29 156.12 86.04 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.355 1.062 . . . . 0.0 111.556 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.71 148.41 74.49 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.183 2.589 . . . . 0.0 111.639 169.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -66.62 -19.36 65.75 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.45 -10.14 39.02 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -176.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.29 136.85 57.08 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.568 1.147 . . . . 0.0 113.203 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -113.11 -178.77 19.5 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.548 1.547 . . . . 0.0 112.799 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -64.48 -32.06 73.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.016 0.926 . . . . 0.0 113.131 -174.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -72.57 -35.21 67.92 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.08 0.952 . . . . 0.0 111.65 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -67.45 -41.69 84.31 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.737 0.699 . . . . 0.0 110.934 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.96 -36.53 78.0 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.101 0.56 . . . . 0.0 112.126 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 64.8 tp -64.08 -51.25 64.94 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.711 0.687 . . . . 0.0 111.097 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -65.47 -29.02 69.63 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.328 0.651 . . . . 0.0 112.274 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 47.0 ttm -67.85 -29.95 69.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.35 1.06 . . . . 0.0 113.006 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -106.24 -14.06 15.23 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.9 mtt -50.3 -37.64 30.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -61.06 -18.77 59.89 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.212 2.608 . . . . 0.0 115.75 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -97.4 -10.34 25.68 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.39 -159.37 27.73 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 125.217 1.389 . . . . 0.0 114.64 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -74.15 85.8 1.87 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.461 1.105 . . . . 0.0 112.436 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.18 125.89 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.134 0.974 . . . . 0.0 109.281 169.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.83 -33.68 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.146 1.779 . . . . 0.0 110.864 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 19.4 m -159.44 145.48 16.22 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.498 1.519 . . . . 0.0 110.875 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.78 143.74 24.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.582 1.553 . . . . 0.0 110.826 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -159.06 142.66 14.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.089 0.955 . . . . 0.0 112.947 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.97 138.88 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.136 1.774 . . . . 0.0 107.166 169.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -83.46 127.56 33.8 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 47.3 mm -115.51 138.46 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.987 1.315 . . . . 0.0 111.191 -168.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -71.92 127.8 33.73 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.994 1.318 . . . . 0.0 111.507 174.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -72.45 -11.43 60.67 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -173.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -104.54 -34.23 8.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.48 1.112 . . . . 0.0 112.272 -176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 72.9 p -107.09 -17.59 14.13 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 66.57 16.91 10.54 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.502 1.921 . . . . 0.0 113.14 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 90.2 mt -93.98 162.7 13.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.502 1.521 . . . . 0.0 111.787 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 36.1 t -66.65 138.57 57.53 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.631 -0.668 . . . . 0.0 111.923 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -75.97 3.55 10.03 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.241 1.016 . . . . 0.0 112.949 169.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 28.3 m 75.78 20.56 1.78 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.388 2.675 . . . . 0.0 113.179 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.52 158.02 43.8 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.816 0.846 . . . . 0.0 112.168 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.63 -173.7 28.44 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.979 1.752 . . . . 0.0 113.757 -170.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -147.09 140.44 25.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.592 1.957 . . . . 0.0 110.041 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 71.7 t -146.29 137.49 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.346 1.458 . . . . 0.0 109.278 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 74.0 m -135.56 141.72 45.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.638 0.775 . . . . 0.0 112.681 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -110.37 170.78 7.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.315 1.846 . . . . 0.0 112.183 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.72 -2.21 45.93 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -157.6 157.3 29.83 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 126.023 1.729 . . . . 0.0 111.887 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.06 -12.61 15.99 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.281 1.987 . . . . 0.0 113.899 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.9 t -79.28 -44.29 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.891 1.678 . . . . 0.0 110.648 -174.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 40.6 m -63.55 -31.96 73.28 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.339 1.056 . . . . 0.0 111.875 171.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -71.43 -51.47 23.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.088 0.955 . . . . 0.0 111.741 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -66.85 -29.66 69.63 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.312 -0.868 . . . . 0.0 112.241 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.44 71.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.791 0.723 . . . . 0.0 112.733 170.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.91 -41.71 61.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.78 0.718 . . . . 0.0 111.466 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 38.1 mt -56.59 -49.29 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 118.964 0.802 . . . . 0.0 110.308 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -70.45 -12.27 61.46 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.5 m -104.06 -28.0 11.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.7 mmm -116.43 -18.09 10.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -70.6 112.2 6.67 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.416 1.007 . . . . 0.0 110.113 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.57 3.22 64.77 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.953 1.74 . . . . 0.0 114.815 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.71 125.43 23.93 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.332 1.566 . . . . 0.0 111.355 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -86.15 130.04 34.65 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.034 0.533 . . . . 0.0 111.066 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.8 tt -149.51 130.95 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.3 1.44 . . . . 0.0 110.081 -173.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.53 -98.91 0.43 Allowed Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -173.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 75.3 mtm -137.11 20.35 2.99 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.377 1.871 . . . . 0.0 112.272 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.35 174.55 11.02 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.698 1.599 . . . . 0.0 112.522 -173.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -124.32 132.76 53.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.356 1.062 . . . . 0.0 111.703 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 60.8 mt -69.58 154.5 41.9 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.051 1.34 . . . . 0.0 112.343 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -124.17 138.98 54.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.639 1.176 . . . . 0.0 108.156 166.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 33.1 t -135.23 135.23 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.362 1.065 . . . . 0.0 108.212 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -152.02 146.66 25.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.277 0.631 . . . . 0.0 111.593 -169.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.75 157.77 29.37 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.862 0.865 . . . . 0.0 112.821 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -76.13 56.72 1.04 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.282 1.433 . . . . 0.0 110.581 168.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -161.02 132.72 5.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.785 1.634 . . . . 0.0 111.227 -169.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 66.9 p -155.9 7.51 0.22 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.054 1.341 . . . . 0.0 113.619 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -161.3 155.87 23.19 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.393 1.877 . . . . 0.0 110.717 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -148.38 144.87 27.79 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.671 1.189 . . . . 0.0 111.73 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -149.26 23.85 0.92 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 112.63 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 18.2 m -159.09 129.85 6.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.233 1.813 . . . . 0.0 110.181 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.28 24.86 14.83 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.271 1.428 . . . . 0.0 113.002 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 18.3 m -68.27 -13.72 62.46 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.184 1.394 . . . . 0.0 114.646 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 91.97 172.35 42.1 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.452 1.501 . . . . 0.0 114.144 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.7 162.56 32.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.344 3.363 . . . . 0.0 112.001 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 49.3 p -81.71 -1.55 47.35 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.734 1.213 . . . . 0.0 114.26 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 10.5 t -163.54 160.09 22.71 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.242 1.817 . . . . 0.0 111.121 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.277 1.418 . . . . 0.0 112.945 -178.074 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.544 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 18.9 m -81.86 -8.08 59.66 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -173.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.0 t -161.59 154.87 21.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.691 1.596 . . . . 0.0 111.114 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -96.82 167.71 24.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.191 1.377 . . . . 0.0 113.888 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 49.0 m -136.23 15.49 3.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.96 1.304 . . . . 0.0 112.798 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 83.4 p -164.22 174.22 11.45 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.766 1.626 . . . . 0.0 111.987 -170.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 92.1 -23.0 28.95 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.28 1.419 . . . . 0.0 114.703 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 8.2 mp 66.15 -179.17 0.2 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.409 2.284 . . . . 0.0 112.613 173.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 36.8 p -61.86 -16.86 53.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.827 1.651 . . . . 0.0 114.531 -172.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -63.19 -17.67 62.66 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.728 1.211 . . . . 0.0 112.635 171.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -98.34 -0.96 42.76 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.55 1.14 . . . . 0.0 112.686 172.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 16.3 m -100.31 9.6 42.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.319 1.448 . . . . 0.0 112.957 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 39.0 pt -75.78 148.96 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.304 1.442 . . . . 0.0 113.355 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -85.82 163.39 36.58 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.685 1.136 . . . . 0.0 112.645 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -73.11 -37.56 66.64 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.95 119.32 12.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.501 1.12 . . . . 0.0 111.563 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.67 3.28 86.28 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.608 1.575 . . . . 0.0 113.652 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 17.1 t -84.8 174.63 9.72 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.225 1.013 . . . . 0.0 112.514 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -132.77 21.36 4.21 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.067 1.747 . . . . 0.0 110.852 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -61.83 161.28 10.55 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.001 0.92 . . . . 0.0 112.6 168.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.56 155.62 45.02 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.04 -170.48 32.35 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.155 1.836 . . . . 0.0 113.301 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -70.03 177.43 5.77 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.151 3.234 . . . . 0.0 112.558 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.13 125.76 24.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.866 0.866 . . . . 0.0 111.198 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.23 -7.46 75.75 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.99 1.281 . . . . 0.0 114.609 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -103.55 8.7 37.69 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -117.96 123.95 47.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.03 1.332 . . . . 0.0 110.709 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 30.7 mt -124.64 140.4 52.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.351 1.86 . . . . 0.0 112.531 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -111.19 133.72 53.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.445 1.498 . . . . 0.0 109.147 168.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.29 137.33 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 126.108 1.763 . . . . 0.0 107.935 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -134.04 161.63 34.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.459 1.504 . . . . 0.0 112.051 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 63.01 33.28 14.92 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.233 1.813 . . . . 0.0 113.307 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 52.9 mt -65.75 159.07 71.63 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 124.296 1.038 . . . . 0.0 111.01 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -55.46 144.42 73.35 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.89 2.394 . . . . 0.0 111.967 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -55.69 -11.9 1.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.811 2.444 . . . . 0.0 115.587 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -131.05 0.74 4.22 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.294 1.838 . . . . 0.0 114.264 -169.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.04 133.64 51.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.604 1.562 . . . . 0.0 111.363 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.32 -179.86 23.91 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.899 1.238 . . . . 0.0 113.563 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -65.41 -32.45 74.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.046 0.938 . . . . 0.0 112.541 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -74.68 -39.96 61.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.828 1.651 . . . . 0.0 110.876 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -62.13 -44.36 96.81 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.93 0.892 . . . . 0.0 111.015 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 26.4 tp -66.16 -43.09 87.97 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.156 0.582 . . . . 0.0 111.803 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.4 tp -57.21 -54.17 49.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 111.211 175.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -73.96 -20.88 60.22 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 39.7 ttp -76.97 -22.29 53.43 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.037 0.835 . . . . 0.0 113.03 170.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -102.97 -15.59 16.08 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.964 1.305 . . . . 0.0 113.872 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 36.1 mtt -48.21 -37.86 17.68 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -62.41 -17.62 58.67 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.108 2.538 . . . . 0.0 115.488 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -97.04 -10.43 26.15 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.94 0.896 . . . . 0.0 113.327 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.41 -163.91 28.72 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.405 1.478 . . . . 0.0 114.449 171.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.12 100.61 2.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.932 0.893 . . . . 0.0 111.896 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.6 t -76.19 129.14 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.911 1.284 . . . . 0.0 110.191 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 42.1 t -94.63 -33.6 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.742 2.017 . . . . 0.0 111.541 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 8.6 t -155.75 152.96 29.15 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.96 1.304 . . . . 0.0 110.748 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.91 130.8 8.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.387 1.475 . . . . 0.0 110.351 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -153.95 144.93 22.71 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.465 -0.772 . . . . 0.0 112.544 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.31 131.46 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.203 1.801 . . . . 0.0 107.229 170.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -79.01 138.91 38.24 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.39 0.614 . . . . 0.0 111.11 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 35.6 mm -121.53 145.54 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.451 1.5 . . . . 0.0 110.601 -168.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -76.25 128.41 34.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.897 1.279 . . . . 0.0 111.866 171.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.73 -14.95 62.64 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -110.46 -29.96 7.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.623 1.169 . . . . 0.0 112.979 -174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 65.7 p -108.71 -15.09 14.48 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.327 1.051 . . . . 0.0 113.692 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 25.2 m120 64.92 17.19 10.93 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.33 1.852 . . . . 0.0 113.443 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 88.4 mt -89.24 151.76 21.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.277 1.431 . . . . 0.0 111.753 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 61.3 m -74.99 134.98 41.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.724 0.81 . . . . 0.0 111.893 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -82.05 3.75 25.58 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.082 1.353 . . . . 0.0 114.454 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 34.5 m 69.15 20.16 7.7 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.966 2.107 . . . . 0.0 113.626 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -144.43 156.33 44.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.184 0.994 . . . . 0.0 111.444 172.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.54 -175.36 28.38 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.715 1.626 . . . . 0.0 114.103 -169.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -139.3 146.67 40.63 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.571 1.948 . . . . 0.0 110.049 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 64.2 t -144.94 144.09 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.165 1.386 . . . . 0.0 109.188 174.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 95.7 p -137.16 155.12 49.96 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.389 -0.819 . . . . 0.0 112.884 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -126.82 162.24 26.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.321 1.448 . . . . 0.0 113.462 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.5 -19.78 64.55 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.277 1.031 . . . . 0.0 113.252 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -147.68 153.71 43.43 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.721 1.608 . . . . 0.0 111.066 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.61 -17.53 11.16 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.896 2.397 . . . . 0.0 113.785 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 90.8 t -71.45 -39.6 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.314 0.961 . . . . 0.0 110.333 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 7.8 m -62.44 -34.37 76.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.041 0.936 . . . . 0.0 111.77 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -73.01 -48.2 38.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.583 1.153 . . . . 0.0 111.97 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -59.3 -38.75 81.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.673 0.789 . . . . 0.0 111.895 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.95 -29.16 70.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.587 0.755 . . . . 0.0 112.957 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.91 -43.38 45.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.626 0.648 . . . . 0.0 111.098 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 41.4 mt -58.24 -47.39 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.272 0.942 . . . . 0.0 110.246 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -67.14 -17.93 65.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.327 1.051 . . . . 0.0 113.589 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.7 m -104.41 -23.66 13.15 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.5 mmt -112.49 -22.52 10.78 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.686 1.194 . . . . 0.0 113.542 -171.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -70.9 112.52 7.14 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 120.014 1.279 . . . . 0.0 110.831 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 88.15 1.88 81.23 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.587 1.565 . . . . 0.0 114.694 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.88 125.31 23.24 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.937 1.369 . . . . 0.0 111.3 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -77.35 131.71 38.21 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.34 0.59 . . . . 0.0 110.37 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 18.8 tt -138.25 98.65 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.394 1.477 . . . . 0.0 108.093 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.0 -122.66 11.78 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -168.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 92.7 mtp -100.03 11.91 38.17 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.382 1.473 . . . . 0.0 113.574 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -134.64 168.2 19.42 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.58 1.552 . . . . 0.0 112.537 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -124.17 137.05 54.59 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.809 1.244 . . . . 0.0 111.536 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.53 163.91 26.83 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.183 1.393 . . . . 0.0 112.574 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -137.33 139.68 41.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.863 1.665 . . . . 0.0 108.693 167.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.42 140.34 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.39 1.076 . . . . 0.0 109.881 -175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -149.19 154.28 38.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.683 1.193 . . . . 0.0 110.643 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.06 159.23 14.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.957 0.884 . . . . 0.0 111.562 167.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.37 109.35 1.12 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.553 1.141 . . . . 0.0 110.18 168.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 65.02 167.46 0.18 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.836 2.054 . . . . 0.0 112.443 -171.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 73.9 p -160.79 161.63 32.09 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.989 -1.069 . . . . 0.0 112.671 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -157.55 135.98 11.21 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.771 1.629 . . . . 0.0 110.484 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -161.08 149.23 15.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.847 1.259 . . . . 0.0 111.861 -175.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -144.82 16.65 1.6 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.165 1.386 . . . . 0.0 112.666 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 32.5 t -169.49 137.25 1.79 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.278 1.431 . . . . 0.0 111.636 -175.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -78.61 36.17 0.25 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.99 1.316 . . . . 0.0 112.942 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.4 t -161.56 172.0 17.11 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.561 1.944 . . . . 0.0 111.164 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 86.86 -164.96 36.02 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 124.821 1.201 . . . . 0.0 113.159 -174.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.76 147.92 51.47 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.698 2.932 . . . . 0.0 111.725 -176.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 20.7 t -165.43 168.86 16.26 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.621 1.568 . . . . 0.0 111.132 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 50.4 m -86.72 -13.23 45.95 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.102 0.961 . . . . 0.0 113.54 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 125.444 1.497 . . . . 0.0 112.82 -176.932 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 11.6 m -162.98 148.09 11.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.347 1.859 . . . . 0.0 110.63 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 52.7 p -94.69 -4.37 47.67 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 176.62 -165.36 35.57 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.061 1.315 . . . . 0.0 113.871 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 4.3 m -163.02 156.0 19.21 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.669 1.988 . . . . 0.0 110.806 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 7.8 t -161.71 175.45 11.99 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.954 1.302 . . . . 0.0 111.678 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -100.95 -149.75 23.49 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.98 1.752 . . . . 0.0 112.731 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 5.5 tp -89.81 17.59 6.5 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.333 1.453 . . . . 0.0 113.626 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 72.5 p 52.62 -90.39 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.372 3.069 . . . . 0.0 112.916 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -141.85 14.93 2.11 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.217 1.807 . . . . 0.0 111.35 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -87.86 2.17 52.12 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.819 -1.176 . . . . 0.0 112.495 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 25.2 p -75.24 9.36 2.1 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.28 1.832 . . . . 0.0 114.203 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 1.9 pp -81.7 -6.18 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.796 1.639 . . . . 0.0 114.164 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -97.2 -155.98 30.42 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.687 1.613 . . . . 0.0 112.426 174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.02 -35.79 80.69 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.17 -0.606 . . . . 0.0 112.36 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -65.97 121.02 14.15 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.919 1.288 . . . . 0.0 111.288 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 88.25 -0.88 84.06 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.5 1.524 . . . . 0.0 113.537 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.1 t -79.53 166.0 22.4 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.177 0.989 . . . . 0.0 112.881 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -128.68 18.1 6.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.665 1.586 . . . . 0.0 111.156 174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -64.62 167.25 7.48 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.999 0.92 . . . . 0.0 111.672 167.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -153.43 154.98 35.48 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.664 0.786 . . . . 0.0 112.187 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.57 -154.72 23.72 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.393 1.473 . . . . 0.0 113.153 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -67.35 161.1 44.66 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.188 2.592 . . . . 0.0 111.494 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.49 124.58 21.31 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.982 0.513 . . . . 0.0 110.678 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.6 -16.51 44.19 Favored Glycine 0 N--CA 1.473 1.132 0 C-N-CA 124.985 1.278 . . . . 0.0 113.454 -171.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.71 21.93 8.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.35 1.46 . . . . 0.0 112.716 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.94 116.23 21.17 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.298 1.439 . . . . 0.0 110.449 -167.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.5 mt -123.67 138.97 54.43 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.855 1.662 . . . . 0.0 112.361 -169.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.96 134.21 52.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.311 1.444 . . . . 0.0 108.99 167.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.7 mp -118.51 135.74 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.089 1.755 . . . . 0.0 107.758 -172.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -134.32 158.99 42.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.035 1.334 . . . . 0.0 112.526 -174.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 70.75 27.47 3.61 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.892 2.477 . . . . 0.0 113.749 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.81 157.03 81.58 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.652 1.181 . . . . 0.0 112.038 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -59.36 150.82 72.5 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.001 2.467 . . . . 0.0 111.741 169.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -71.07 -10.3 59.53 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.509 1.123 . . . . 0.0 113.901 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.84 -6.97 15.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.949 2.1 . . . . 0.0 113.817 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.33 123.31 21.39 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.079 1.351 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -102.48 -176.81 27.35 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.405 1.002 . . . . 0.0 113.809 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -65.71 -34.7 78.8 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.793 0.837 . . . . 0.0 112.791 -175.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -77.58 -29.7 52.21 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.868 0.867 . . . . 0.0 111.807 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -68.4 -42.91 78.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.87 0.759 . . . . 0.0 110.657 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.5 tp -65.49 -40.27 92.88 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.184 0.593 . . . . 0.0 111.525 174.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 62.4 tp -61.19 -52.14 66.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.569 0.622 . . . . 0.0 111.313 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -64.37 -27.1 68.78 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.9 ttp -81.21 -20.15 41.71 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -110.3 -20.55 12.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 48.5 mtm -55.05 -31.57 9.86 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 169.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -57.28 -16.5 22.6 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.63 2.887 . . . . 0.0 116.106 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -98.26 -9.66 25.2 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.246 0.93 . . . . 0.0 113.437 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.79 -159.29 27.9 Favored Glycine 0 N--CA 1.469 0.892 0 C-N-CA 125.075 1.322 . . . . 0.0 115.047 170.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.0 90.71 1.51 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.3 1.04 . . . . 0.0 112.278 -171.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 86.1 t -71.58 130.47 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.762 1.225 . . . . 0.0 110.112 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 53.4 t -100.78 -27.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.286 2.235 . . . . 0.0 111.389 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 20.9 t -156.33 146.32 21.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.48 1.112 . . . . 0.0 110.657 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.63 132.36 9.53 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.573 1.549 . . . . 0.0 110.434 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -156.51 147.95 22.48 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.299 -0.876 . . . . 0.0 113.016 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.72 135.66 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.433 1.893 . . . . 0.0 107.646 173.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -85.22 137.06 33.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.41 0.684 . . . . 0.0 110.392 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 15.8 mt -131.85 137.49 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.301 1.44 . . . . 0.0 109.836 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -85.24 128.0 34.51 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.754 0.822 . . . . 0.0 111.897 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.41 -12.27 59.83 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.36 -20.75 31.46 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.097 0.959 . . . . 0.0 112.593 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 69.6 p -134.11 -18.97 2.01 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -171.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.6 t30 62.86 19.28 11.42 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.046 1.739 . . . . 0.0 112.657 -169.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.19 146.32 26.99 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.169 1.387 . . . . 0.0 111.159 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 66.0 m -72.24 136.97 46.5 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.551 1.141 . . . . 0.0 112.232 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -76.65 9.7 2.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.654 1.582 . . . . 0.0 114.289 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 55.5 m 69.72 19.16 7.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.53 2.332 . . . . 0.0 113.894 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -146.9 156.93 43.47 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.442 1.019 . . . . 0.0 112.528 173.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.81 -174.63 30.89 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.789 1.662 . . . . 0.0 113.702 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -138.99 147.48 42.21 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.333 1.853 . . . . 0.0 110.421 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.4 t -143.58 145.02 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.486 1.514 . . . . 0.0 108.865 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.5 t -143.47 147.99 35.38 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.416 -0.802 . . . . 0.0 112.647 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -117.85 167.17 11.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.154 1.782 . . . . 0.0 113.066 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.37 -13.58 62.14 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.143 1.377 . . . . 0.0 113.63 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -158.86 158.27 28.99 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 126.206 1.803 . . . . 0.0 111.664 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.98 -10.86 19.76 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.347 2.031 . . . . 0.0 113.844 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 29.0 t -77.1 -43.11 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 120.882 1.673 . . . . 0.0 110.555 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 27.2 m -64.86 -31.29 72.46 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.672 1.189 . . . . 0.0 111.773 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.75 -49.32 31.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.035 0.934 . . . . 0.0 111.76 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -61.76 -33.88 74.86 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.388 -0.82 . . . . 0.0 111.987 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.03 -29.63 70.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.318 0.647 . . . . 0.0 112.72 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.68 -41.53 45.09 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.704 0.684 . . . . 0.0 111.086 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 51.4 mt -57.99 -46.8 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 119.388 0.995 . . . . 0.0 110.208 174.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -70.87 -14.25 62.32 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 51.6 m -103.95 -26.6 12.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.9 mmm -114.69 -20.22 10.76 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -168.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -70.93 109.94 5.36 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.295 0.952 . . . . 0.0 109.765 173.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.46 2.4 61.8 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.443 1.497 . . . . 0.0 114.907 -171.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -63.94 126.42 27.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.489 1.645 . . . . 0.0 111.703 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -80.44 125.73 30.31 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.595 0.758 . . . . 0.0 110.203 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.5 tt -145.74 134.75 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.075 1.35 . . . . 0.0 109.953 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.93 -118.62 15.65 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 28.7 ptm -108.99 13.33 24.74 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.797 1.639 . . . . 0.0 113.843 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -143.66 -176.23 4.88 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.271 1.429 . . . . 0.0 113.243 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -124.37 142.12 51.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.539 1.535 . . . . 0.0 111.801 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.1 mt -76.7 161.64 28.35 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.297 1.439 . . . . 0.0 112.751 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -128.89 141.03 51.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.554 1.542 . . . . 0.0 108.709 167.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.4 t -138.47 136.82 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.481 1.112 . . . . 0.0 109.16 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -152.1 151.17 30.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.979 0.912 . . . . 0.0 111.056 -172.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.7 155.41 22.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.03 0.919 . . . . 0.0 112.899 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -56.89 131.56 49.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.759 1.224 . . . . 0.0 111.901 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -102.95 131.16 50.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.976 1.311 . . . . 0.0 111.334 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 51.9 p -93.34 173.85 7.5 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.692 1.997 . . . . 0.0 113.067 175.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 71.31 11.05 6.74 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.219 1.808 . . . . 0.0 115.311 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -151.22 147.26 26.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.813 1.245 . . . . 0.0 112.604 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -154.58 155.45 34.78 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.62 1.968 . . . . 0.0 110.68 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 22.5 m -76.76 -5.81 49.66 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -66.95 137.54 56.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.892 1.277 . . . . 0.0 112.348 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.3 t -152.61 -177.2 6.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.965 1.706 . . . . 0.0 110.63 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 93.36 171.86 39.79 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 125.639 1.59 . . . . 0.0 113.737 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.41 158.74 40.44 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.158 3.238 . . . . 0.0 112.254 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 26.0 t -164.34 153.92 13.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.572 1.549 . . . . 0.0 111.045 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 30.9 m -82.68 -6.75 59.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.135 1.35 . . . . 0.0 113.018 179.896 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 112.125 -0.39 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 95.8 p -163.85 176.12 9.78 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.423 1.489 . . . . 0.0 111.683 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 47.6 p -82.86 0.76 42.61 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.843 1.257 . . . . 0.0 114.24 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -77.93 155.48 42.73 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.802 1.192 . . . . 0.0 113.558 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 19.4 m -89.62 -3.5 58.24 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 50.0 m 65.11 -0.66 1.03 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.721 2.008 . . . . 0.0 115.913 171.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 75.79 11.74 84.36 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.934 1.254 . . . . 0.0 114.356 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 56.7 tp -74.04 110.84 8.65 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.61 1.205 . . . . 0.0 111.417 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.2 m -61.52 -24.56 66.7 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.389 1.875 . . . . 0.0 113.816 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -62.11 -12.14 17.9 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.084 1.354 . . . . 0.0 113.421 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -79.59 -3.07 45.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.661 1.185 . . . . 0.0 112.906 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 15.5 t -116.97 140.83 49.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.403 1.481 . . . . 0.0 111.157 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.89 151.58 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.065 1.746 . . . . 0.0 111.257 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -132.68 -114.78 1.59 Allowed Glycine 0 N--CA 1.47 0.918 0 C-N-CA 125.361 1.458 . . . . 0.0 112.426 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.48 -51.07 2.7 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 112.892 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.46 122.49 18.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.207 1.003 . . . . 0.0 111.005 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.68 -6.61 82.27 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.343 1.449 . . . . 0.0 113.293 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 66.2 m -98.42 131.4 44.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.242 1.417 . . . . 0.0 110.067 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -103.74 38.51 1.8 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.186 0.995 . . . . 0.0 112.254 -170.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -74.24 -177.44 3.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.667 0.787 . . . . 0.0 110.877 168.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.42 166.63 31.77 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 169.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.77 -165.48 29.28 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.158 1.837 . . . . 0.0 113.572 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.44 171.32 16.44 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.031 3.154 . . . . 0.0 112.47 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.98 126.62 28.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.663 0.785 . . . . 0.0 111.334 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.79 -11.71 71.49 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.8 1.19 . . . . 0.0 114.027 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -91.82 -1.44 57.35 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.659 1.229 . . . . 0.0 113.963 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -113.4 125.04 53.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.941 1.296 . . . . 0.0 111.458 -169.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.0 mt -124.71 140.23 53.12 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.756 2.022 . . . . 0.0 111.751 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -110.84 132.25 54.36 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.09 1.356 . . . . 0.0 108.594 167.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.67 134.96 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.982 1.713 . . . . 0.0 107.602 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.8 160.34 37.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.242 1.417 . . . . 0.0 112.292 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 69.66 28.88 4.36 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.555 2.342 . . . . 0.0 113.693 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 58.5 mt -68.58 161.2 72.37 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.653 1.181 . . . . 0.0 111.417 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.68 151.1 78.66 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.96 2.44 . . . . 0.0 111.259 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -72.06 -9.07 57.89 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.692 1.197 . . . . 0.0 113.959 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -112.76 -6.72 13.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.256 2.222 . . . . 0.0 113.838 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 130.15 42.29 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.167 1.387 . . . . 0.0 110.898 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.77 178.9 25.16 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.387 0.994 . . . . 0.0 113.842 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -64.6 -33.97 77.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.725 0.81 . . . . 0.0 112.58 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.4 -31.17 57.81 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.087 0.955 . . . . 0.0 111.812 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -66.99 -42.68 84.63 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.821 0.737 . . . . 0.0 110.652 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.55 -39.87 88.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.357 0.663 . . . . 0.0 111.745 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.17 -52.08 65.26 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.641 0.655 . . . . 0.0 111.31 174.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -63.72 -28.01 69.59 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 40.7 ttp -80.61 -19.93 44.35 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -111.19 -19.48 12.67 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.3 mtm -55.05 -31.73 10.33 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -57.52 -16.74 24.95 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.579 2.853 . . . . 0.0 116.25 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -97.51 -9.53 26.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.41 -162.32 28.21 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.17 1.367 . . . . 0.0 114.348 172.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -72.8 88.14 1.31 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.642 0.777 . . . . 0.0 112.182 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.5 t -65.27 127.41 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.363 1.065 . . . . 0.0 109.403 170.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 45.5 t -91.64 -38.86 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.671 1.988 . . . . 0.0 110.841 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.61 149.52 23.89 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.641 1.176 . . . . 0.0 111.181 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.39 140.29 20.07 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.345 1.458 . . . . 0.0 110.738 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -155.8 140.14 16.68 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.474 -0.766 . . . . 0.0 111.788 -169.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.47 130.8 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.548 1.539 . . . . 0.0 107.498 168.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -84.34 141.76 30.66 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.32 0.648 . . . . 0.0 111.172 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 42.5 mm -118.15 134.9 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.235 1.414 . . . . 0.0 110.269 -169.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -82.26 128.0 33.75 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.927 0.891 . . . . 0.0 111.781 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -67.66 -12.04 59.59 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -89.99 -21.31 22.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.417 1.087 . . . . 0.0 112.835 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 76.3 p -137.64 -17.76 1.27 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -169.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 64.73 15.06 9.54 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.287 1.835 . . . . 0.0 113.17 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.54 161.18 15.06 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.382 1.473 . . . . 0.0 111.082 175.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 64.5 m -76.65 136.09 39.15 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.66 -0.65 . . . . 0.0 111.561 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.3 4.9 2.53 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -174.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 56.9 m 67.11 19.76 10.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.863 2.065 . . . . 0.0 113.115 -172.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -146.81 155.25 42.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.864 0.865 . . . . 0.0 112.311 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.88 -175.6 27.99 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.152 1.834 . . . . 0.0 113.559 -170.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -136.25 145.5 45.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.716 2.006 . . . . 0.0 110.285 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 61.4 t -143.27 141.14 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.318 1.447 . . . . 0.0 108.529 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 37.3 p -137.53 146.7 44.45 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.027 0.931 . . . . 0.0 112.18 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -119.82 169.29 10.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.178 1.391 . . . . 0.0 113.223 -174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.03 -23.75 66.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.972 1.309 . . . . 0.0 113.26 169.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -160.0 157.93 25.96 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.24 1.416 . . . . 0.0 112.394 -171.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.13 -15.14 42.47 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.765 2.31 . . . . 0.0 114.026 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.18 -44.78 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 120.754 1.615 . . . . 0.0 110.679 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 57.4 m -68.06 -30.97 70.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.991 0.917 . . . . 0.0 111.886 174.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.64 42.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.659 0.784 . . . . 0.0 111.81 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -58.57 -39.24 79.77 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.487 -0.758 . . . . 0.0 111.947 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.84 -28.76 69.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -79.14 -44.27 22.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.705 0.684 . . . . 0.0 111.386 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 49.4 mt -57.07 -47.53 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.523 1.056 . . . . 0.0 110.151 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -74.66 -10.86 59.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.199 0.999 . . . . 0.0 113.227 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -104.28 -26.55 12.44 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.7 mmm -113.12 -19.86 11.69 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -168.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -70.9 111.19 6.12 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 119.385 0.993 . . . . 0.0 109.954 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.48 2.55 65.45 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.142 1.83 . . . . 0.0 115.172 -171.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.06 124.99 23.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.256 1.528 . . . . 0.0 111.543 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -73.5 131.12 41.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.852 0.296 . . . . 0.0 110.594 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.0 tt -137.24 109.88 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.311 1.044 . . . . 0.0 108.325 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 63.09 -118.43 13.95 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -168.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 62.7 mtt -99.96 -1.97 35.81 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.057 1.343 . . . . 0.0 113.623 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -95.39 168.2 10.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.658 1.183 . . . . 0.0 112.697 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -128.85 125.71 38.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.219 1.408 . . . . 0.0 108.515 166.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 79.7 mt -68.81 160.98 29.5 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.349 1.06 . . . . 0.0 112.079 -176.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -126.2 141.39 51.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.636 1.574 . . . . 0.0 108.638 168.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.07 136.45 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.121 0.968 . . . . 0.0 109.418 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -149.83 146.1 26.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.178 0.991 . . . . 0.0 111.279 -172.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.74 150.17 47.83 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.786 0.834 . . . . 0.0 113.236 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.27 -31.05 72.11 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.568 0.747 . . . . 0.0 111.322 168.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -77.63 82.75 4.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.695 1.598 . . . . 0.0 110.186 170.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 80.4 p -161.14 164.42 30.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.064 1.745 . . . . 0.0 111.025 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -69.99 151.69 45.29 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -169.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -110.97 11.97 22.17 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.807 2.043 . . . . 0.0 113.276 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -156.05 166.96 31.92 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.686 2.394 . . . . 0.0 109.458 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 7.4 m 68.01 20.23 9.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.031 1.732 . . . . 0.0 112.903 -173.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -73.96 -3.67 30.49 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -168.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 77.4 p -161.52 160.22 28.83 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.954 1.702 . . . . 0.0 111.432 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 163.86 -146.83 11.97 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.02 1.295 . . . . 0.0 112.527 -175.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.18 -14.95 20.61 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.118 2.546 . . . . 0.0 113.404 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 60.8 p -116.01 0.56 13.07 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.095 1.358 . . . . 0.0 114.29 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 19.9 t -166.44 144.66 5.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.249 1.42 . . . . 0.0 111.549 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.347 -1.252 . . . . 0.0 112.872 -179.802 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 19.2 m -83.29 -7.22 59.62 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.5 t -162.93 165.13 25.44 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.839 1.656 . . . . 0.0 111.122 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 82.05 -165.39 45.3 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.944 1.259 . . . . 0.0 113.565 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 79.1 p -163.44 162.63 24.87 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.57 1.548 . . . . 0.0 111.645 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 77.6 p -163.51 164.11 24.46 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.895 1.278 . . . . 0.0 112.306 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -91.09 -146.32 16.84 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.189 1.376 . . . . 0.0 112.925 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 61.5 tp -150.77 130.5 13.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.197 1.399 . . . . 0.0 110.461 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 73.6 p -146.75 174.4 11.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.842 2.057 . . . . 0.0 110.353 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -125.55 44.85 2.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.211 1.405 . . . . 0.0 109.629 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -128.18 13.68 6.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.377 1.471 . . . . 0.0 112.362 -170.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 10.6 m -73.59 26.59 0.07 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.851 2.061 . . . . 0.0 115.291 -169.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 34.0 pt -73.24 140.45 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.712 -1.242 . . . . 0.0 112.578 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -132.98 20.16 4.31 Favored Glycine 0 N--CA 1.474 1.228 0 C-N-CA 125.158 1.361 . . . . 0.0 114.764 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.09 99.2 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.254 1.027 . . . . 0.0 113.73 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -68.64 118.8 12.11 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.652 1.181 . . . . 0.0 110.399 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.76 -3.24 74.08 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.194 0.902 . . . . 0.0 113.211 -176.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.1 t -98.35 163.8 12.55 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.356 1.062 . . . . 0.0 111.62 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -134.4 18.06 3.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.947 1.299 . . . . 0.0 112.216 -170.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.52 169.59 3.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.461 1.104 . . . . 0.0 111.783 168.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.41 158.9 44.32 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.838 -1.164 . . . . 0.0 111.855 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.72 -162.08 26.92 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.903 1.716 . . . . 0.0 113.401 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.46 171.23 14.51 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.822 3.015 . . . . 0.0 112.628 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.31 121.09 9.94 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.084 0.954 . . . . 0.0 111.359 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.11 -4.0 73.84 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.949 1.261 . . . . 0.0 114.675 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.15 2.71 55.92 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.002 1.401 . . . . 0.0 114.173 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -118.35 125.66 50.5 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.721 1.208 . . . . 0.0 111.343 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.47 137.45 54.79 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.477 1.911 . . . . 0.0 112.026 -169.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.64 133.88 50.63 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.155 1.382 . . . . 0.0 108.352 167.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 9.3 mm -117.53 136.41 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.641 1.576 . . . . 0.0 108.517 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -135.37 161.5 35.26 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.114 0.965 . . . . 0.0 112.569 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 62.03 36.62 15.36 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.334 1.854 . . . . 0.0 113.299 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 46.0 mt -70.93 162.92 69.29 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.052 1.341 . . . . 0.0 111.392 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.87 149.06 90.32 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.04 2.493 . . . . 0.0 111.231 168.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -71.07 -10.45 59.78 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -104.1 -9.53 18.67 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.473 1.909 . . . . 0.0 114.27 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.28 126.94 31.14 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.608 1.163 . . . . 0.0 111.211 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -105.22 -174.79 24.31 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.961 1.267 . . . . 0.0 112.9 171.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -62.51 -34.6 77.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.743 0.817 . . . . 0.0 112.925 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -77.55 -30.52 52.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.856 0.862 . . . . 0.0 112.001 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -70.1 -40.43 74.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.606 0.639 . . . . 0.0 110.615 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 23.4 tp -66.42 -39.23 88.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.342 0.657 . . . . 0.0 111.601 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 64.1 tp -61.61 -49.67 75.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.81 0.732 . . . . 0.0 111.053 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -68.64 -23.02 64.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.7 ttm -73.56 -29.88 62.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.021 0.929 . . . . 0.0 113.002 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -109.23 -17.8 13.75 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -171.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.0 mtm -53.61 -33.09 12.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -59.53 -15.36 30.2 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.479 2.786 . . . . 0.0 116.475 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -102.48 -10.69 19.15 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -175.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 154.09 -169.45 32.58 Favored Glycine 0 N--CA 1.469 0.882 0 C-N-CA 125.089 1.328 . . . . 0.0 113.991 174.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -73.93 99.68 3.32 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.14 -0.624 . . . . 0.0 110.991 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.7 t -72.2 125.73 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.22 1.008 . . . . 0.0 109.336 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 37.3 t -86.64 -36.12 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.363 1.865 . . . . 0.0 111.017 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 3.7 m -161.22 151.59 17.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.213 1.805 . . . . 0.0 110.47 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.14 134.22 15.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.523 1.529 . . . . 0.0 110.225 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -153.36 135.5 14.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.392 0.677 . . . . 0.0 112.08 -174.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.7 t -106.73 135.02 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.205 1.802 . . . . 0.0 107.086 168.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.58 140.43 32.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.249 0.62 . . . . 0.0 111.171 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.5 mm -120.88 137.7 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.166 1.386 . . . . 0.0 110.917 -168.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.09 133.13 42.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.183 1.393 . . . . 0.0 112.47 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -77.99 -7.09 56.38 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -172.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -111.92 -18.85 12.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.517 1.127 . . . . 0.0 113.063 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.2 p -126.37 -15.3 5.69 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.34 1.456 . . . . 0.0 113.982 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 53.3 t30 64.17 16.0 9.72 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.082 1.753 . . . . 0.0 113.355 -175.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.09 153.98 20.83 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.413 1.485 . . . . 0.0 111.216 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 63.0 m -76.47 134.46 39.52 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.538 -0.726 . . . . 0.0 111.603 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.02 3.54 8.22 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 64.1 m 69.11 20.03 7.8 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.167 2.187 . . . . 0.0 113.614 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.27 156.86 44.83 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.898 0.879 . . . . 0.0 112.063 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.1 -172.01 26.74 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.664 1.602 . . . . 0.0 114.316 -169.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -144.32 144.89 31.68 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.491 1.916 . . . . 0.0 110.127 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 78.9 t -144.88 139.08 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.529 1.532 . . . . 0.0 109.049 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 77.8 p -134.43 153.39 51.94 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.913 0.885 . . . . 0.0 112.66 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -128.65 167.57 17.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.86 1.264 . . . . 0.0 114.179 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -67.57 -21.48 65.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.487 1.515 . . . . 0.0 114.607 172.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -152.4 156.48 33.56 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.526 1.531 . . . . 0.0 111.931 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -63.37 -29.77 72.38 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.652 2.901 . . . . 0.0 113.415 174.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.8 -39.57 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.001 0.921 . . . . 0.0 110.865 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 16.3 m -58.92 -35.61 73.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.089 0.955 . . . . 0.0 111.61 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -76.95 -48.41 18.18 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.237 1.415 . . . . 0.0 112.576 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -61.18 -32.21 71.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.321 1.048 . . . . 0.0 112.367 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.15 72.22 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.305 0.642 . . . . 0.0 112.64 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.81 33.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.532 0.733 . . . . 0.0 111.841 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 38.6 mt -58.01 -46.5 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.121 0.873 . . . . 0.0 110.235 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -72.39 -12.81 61.28 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.9 m -103.9 -30.4 10.36 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 83.9 mmm -112.84 -18.75 12.2 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -169.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -70.16 111.97 6.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.66 1.118 . . . . 0.0 110.496 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.24 1.76 69.11 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.744 1.64 . . . . 0.0 114.821 -173.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.13 124.72 21.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.255 1.528 . . . . 0.0 111.636 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -80.27 127.48 32.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.603 0.761 . . . . 0.0 110.19 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.2 tt -148.57 132.36 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.953 1.301 . . . . 0.0 109.793 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.8 -120.37 22.13 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -173.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.17 16.0 24.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.625 1.57 . . . . 0.0 113.008 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -139.01 -176.4 4.49 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.415 1.486 . . . . 0.0 113.341 -170.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -132.48 136.56 46.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.643 1.577 . . . . 0.0 110.942 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 53.3 mt -68.14 161.65 26.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.19 1.396 . . . . 0.0 112.485 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -137.55 142.61 41.37 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.668 1.587 . . . . 0.0 109.161 167.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 34.6 t -139.31 133.11 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.591 1.156 . . . . 0.0 109.019 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -142.25 151.92 42.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.195 0.998 . . . . 0.0 111.482 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 58.9 mt -66.36 152.8 44.28 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.938 0.875 . . . . 0.0 113.151 172.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -66.91 140.26 57.76 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.536 1.134 . . . . 0.0 111.534 169.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -137.11 130.12 30.74 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.886 1.674 . . . . 0.0 110.822 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 10.3 t -168.65 168.93 10.51 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.121 1.768 . . . . 0.0 111.003 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -138.36 -42.32 0.5 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.378 1.471 . . . . 0.0 112.767 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -168.21 154.13 7.12 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.561 1.944 . . . . 0.0 111.549 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -113.83 -0.05 14.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.815 1.646 . . . . 0.0 113.502 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 74.4 p -169.6 172.98 6.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.491 1.916 . . . . 0.0 111.195 -169.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -144.47 -12.78 0.6 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.725 1.61 . . . . 0.0 114.174 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 7.7 t -151.1 177.2 10.42 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.618 1.167 . . . . 0.0 112.959 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -88.96 -101.44 1.01 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.994 1.759 . . . . 0.0 111.486 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.9 99.46 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.375 2.717 . . . . 0.0 109.016 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 35.9 t -173.11 169.21 4.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.65 1.58 . . . . 0.0 110.835 -168.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 51.8 p -76.64 -9.53 58.73 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.028 -1.045 . . . . 0.0 112.229 167.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.339 0 C-N-CA 128.042 2.734 . . . . 0.0 111.933 176.612 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.617 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 29.2 p -68.96 -16.61 63.78 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.1 p -70.7 -10.59 59.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.052 1.341 . . . . 0.0 113.736 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -86.07 8.15 74.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.595 1.569 . . . . 0.0 114.134 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 8.4 t -157.64 -171.86 3.73 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.481 1.513 . . . . 0.0 111.567 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 45.5 m -80.37 54.09 1.94 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.022 1.729 . . . . 0.0 112.427 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.44 -14.61 79.35 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.801 1.191 . . . . 0.0 115.002 -174.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 62.8 tp -83.24 123.78 29.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.732 1.213 . . . . 0.0 110.202 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 76.2 p -73.42 -32.62 64.52 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.559 1.144 . . . . 0.0 113.277 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 67.28 18.06 10.26 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.693 1.997 . . . . 0.0 112.517 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -92.59 -7.31 47.45 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.01 -1.056 . . . . 0.0 113.766 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 78.5 p -94.34 11.9 28.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.165 1.386 . . . . 0.0 113.526 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 16.8 pt -86.0 169.03 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.785 1.634 . . . . 0.0 113.038 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.12 131.32 7.26 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.194 1.378 . . . . 0.0 111.547 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.18 -60.1 0.42 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.997 2.519 . . . . 0.0 110.746 -169.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.02 116.55 7.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.923 1.289 . . . . 0.0 110.181 169.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.0 -9.08 67.29 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.452 1.501 . . . . 0.0 113.173 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.6 m -76.52 158.67 31.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.168 0.987 . . . . 0.0 110.078 169.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -139.86 31.51 2.02 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.379 -0.826 . . . . 0.0 112.133 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -69.33 174.15 5.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.548 0.739 . . . . 0.0 111.007 167.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.78 160.59 43.43 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -101.92 -160.19 26.56 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.982 1.753 . . . . 0.0 113.453 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.23 172.41 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.899 3.066 . . . . 0.0 112.862 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -59.18 120.63 9.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.419 1.088 . . . . 0.0 110.917 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.01 -3.53 70.32 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.003 1.287 . . . . 0.0 114.708 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.18 0.86 51.74 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.975 1.388 . . . . 0.0 114.421 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -117.15 123.54 46.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.645 1.178 . . . . 0.0 111.271 -169.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 19.0 mt -123.6 141.51 51.94 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.532 1.933 . . . . 0.0 112.525 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -111.61 134.19 53.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.784 1.634 . . . . 0.0 108.463 167.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.87 135.64 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.733 1.613 . . . . 0.0 107.832 -172.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -131.55 162.42 30.34 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.128 1.371 . . . . 0.0 111.92 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 63.02 37.06 12.0 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.465 1.906 . . . . 0.0 113.273 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 54.6 mt -70.11 161.62 74.47 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.792 1.237 . . . . 0.0 112.083 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.99 154.14 58.88 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.418 2.746 . . . . 0.0 111.123 168.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -75.51 -19.91 59.06 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -96.76 -6.38 36.36 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.57 1.548 . . . . 0.0 114.207 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.01 128.12 35.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.862 1.265 . . . . 0.0 111.819 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -107.26 -177.56 22.67 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.963 1.268 . . . . 0.0 113.506 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.46 -34.2 77.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.11 0.964 . . . . 0.0 112.703 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -75.97 -27.24 57.41 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.402 1.081 . . . . 0.0 111.676 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -75.5 -42.29 53.17 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.881 0.872 . . . . 0.0 110.723 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 27.1 tp -64.76 -36.63 84.91 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.334 0.653 . . . . 0.0 111.686 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.4 -51.22 69.64 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.417 0.553 . . . . 0.0 110.702 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -69.01 -20.99 64.16 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.7 ttm -73.98 -26.95 60.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.108 0.963 . . . . 0.0 112.817 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -113.03 -18.29 12.23 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.9 mtm -53.24 -34.03 16.77 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 170.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -59.44 -16.88 37.75 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.559 2.839 . . . . 0.0 116.215 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -100.2 -9.01 22.92 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.408 1.004 . . . . 0.0 113.664 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.78 -163.37 28.57 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.981 1.277 . . . . 0.0 114.75 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -70.68 96.53 1.23 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.311 1.044 . . . . 0.0 112.285 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 80.3 t -74.85 128.43 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.089 1.355 . . . . 0.0 109.881 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 38.7 t -88.69 -36.78 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.57 1.948 . . . . 0.0 111.045 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.8 m -160.25 150.73 18.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.511 1.525 . . . . 0.0 110.814 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -152.4 130.39 11.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.232 1.813 . . . . 0.0 109.637 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -152.71 144.73 23.76 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.539 -0.726 . . . . 0.0 112.854 -171.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.0 t -119.18 135.93 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.554 1.942 . . . . 0.0 108.219 176.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -85.19 131.94 34.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.539 0.736 . . . . 0.0 109.853 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 44.1 mm -114.43 135.74 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.723 1.209 . . . . 0.0 111.316 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.28 131.88 43.3 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.437 1.495 . . . . 0.0 111.938 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -82.04 -2.0 50.28 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -171.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -108.52 -27.63 9.78 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.672 1.189 . . . . 0.0 112.297 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.2 p -119.28 -15.31 9.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.292 1.437 . . . . 0.0 114.236 -174.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 51.6 t30 63.79 15.25 8.9 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.063 1.745 . . . . 0.0 113.271 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.9 mt -86.96 160.58 18.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.496 1.518 . . . . 0.0 111.315 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 27.4 t -62.08 138.69 58.42 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.68 -0.638 . . . . 0.0 110.867 168.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -72.34 2.65 5.74 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 66.5 m 73.52 20.36 3.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.265 2.626 . . . . 0.0 113.003 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -146.38 155.68 42.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.678 0.791 . . . . 0.0 112.394 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.38 -173.95 29.57 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.968 1.747 . . . . 0.0 113.675 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -140.94 145.67 36.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.406 1.883 . . . . 0.0 110.141 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.1 t -145.36 139.18 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.155 1.382 . . . . 0.0 109.279 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.1 p -133.38 149.06 51.86 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.327 1.051 . . . . 0.0 112.328 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -121.55 163.34 19.03 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.099 1.359 . . . . 0.0 113.323 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.27 -18.2 63.12 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.293 1.037 . . . . 0.0 113.073 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -145.52 151.78 47.8 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.273 1.429 . . . . 0.0 112.182 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.91 -29.34 58.09 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.829 3.019 . . . . 0.0 113.868 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.45 -40.97 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.705 0.802 . . . . 0.0 110.916 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.1 m -62.06 -33.27 74.09 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.856 0.862 . . . . 0.0 111.918 173.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -74.72 -49.26 21.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.993 1.317 . . . . 0.0 112.129 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -60.99 -33.65 73.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.062 0.945 . . . . 0.0 112.126 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.11 -31.05 72.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.358 0.663 . . . . 0.0 112.642 172.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -76.36 -41.53 47.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.344 0.658 . . . . 0.0 111.68 175.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 40.2 mt -58.14 -47.29 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.03 0.832 . . . . 0.0 110.153 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.24 -14.27 62.18 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.9 m -102.18 -29.78 11.52 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 86.1 mmm -113.32 -18.04 12.15 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -169.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -70.26 111.78 6.12 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.491 1.041 . . . . 0.0 110.551 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.93 1.75 67.27 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.885 1.707 . . . . 0.0 114.77 -173.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.9 124.43 20.46 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.215 1.507 . . . . 0.0 111.615 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -80.39 127.71 32.71 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.613 0.765 . . . . 0.0 110.175 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.5 tt -148.31 131.99 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.888 1.275 . . . . 0.0 109.713 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.74 -118.78 14.95 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -173.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -109.71 16.36 22.16 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.871 1.668 . . . . 0.0 112.624 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -138.98 -176.46 4.5 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.615 1.566 . . . . 0.0 113.173 -171.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -132.5 137.24 47.12 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.528 1.531 . . . . 0.0 110.941 173.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 59.5 mt -68.96 161.01 29.77 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.978 1.311 . . . . 0.0 112.328 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.96 141.21 42.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.435 1.494 . . . . 0.0 108.967 168.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.35 138.2 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.532 1.133 . . . . 0.0 109.302 -175.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -151.02 152.76 33.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.241 1.016 . . . . 0.0 110.757 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.32 157.63 16.13 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.6 0.76 . . . . 0.0 112.778 170.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -53.69 134.1 41.81 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.942 1.297 . . . . 0.0 112.673 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -103.5 9.34 37.65 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.676 1.59 . . . . 0.0 114.617 -171.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 69.0 m -138.52 152.03 47.88 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.376 1.47 . . . . 0.0 111.205 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -138.29 156.26 47.82 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.936 1.294 . . . . 0.0 112.424 -174.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -71.87 167.77 19.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.874 1.27 . . . . 0.0 112.902 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -153.14 128.48 9.87 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.986 1.314 . . . . 0.0 110.4 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 53.5 p -69.87 -19.57 63.43 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -171.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -72.64 -4.72 32.7 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 44.8 m -113.69 12.29 18.35 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.922 1.689 . . . . 0.0 112.713 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -82.19 -171.1 45.9 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.326 1.441 . . . . 0.0 114.253 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.98 -10.93 30.43 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.772 2.981 . . . . 0.0 113.796 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 24.8 p -73.35 -8.5 56.14 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.949 1.3 . . . . 0.0 113.841 170.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 94.5 p -136.76 3.78 2.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.084 1.354 . . . . 0.0 114.263 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.197 0 CA-C-O 118.2 -1.333 . . . . 0.0 113.247 178.993 . . . . . . . . 0 0 . 1 stop_ save_